data_5jyu_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 5jyu _Structure_validation_residue.Date_analyzed 2017-03-24 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig full ' A' A ' 613' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 . . . . . 0 N--CA 1.484 1.269 0 CA-C-O 120.779 0.324 . . . . 0.0 110.704 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 614' ' ' GLY . . . . . . . . . . . . . . . -158.69 165.06 33.91 Favored Glycine 0 N--CA 1.449 -0.466 0 C-N-CA 121.046 -0.597 . . . . 0.0 111.659 179.704 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 615' ' ' ARG . . . . . . . . . . . . . 89.7 mtm180 -116.8 129.4 56.07 Favored 'General case' 0 C--O 1.235 0.328 0 CA-C-O 120.929 0.395 . . . . 0.0 111.278 -179.547 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 616' ' ' ILE . . . . . 0.409 ' O ' ' HA ' ' A' ' 640' ' ' VAL . 86.0 mt -126.92 134.15 66.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 115.808 -0.633 . . . . 0.0 109.882 178.929 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 617' ' ' VAL . . . . . . . . . . . . . 99.4 t -107.35 126.66 63.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 120.955 0.407 . . . . 0.0 110.253 -179.862 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 618' ' ' LEU . . . . . . . . . . . . . 1.1 tt -108.91 126.52 53.16 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.534 -179.076 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 619' ' ' VAL . . . . . 0.432 ' HA ' ' O ' ' A' ' 643' ' ' LEU . 79.8 t -116.39 118.14 57.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-O 121.197 0.522 . . . . 0.0 110.355 -179.861 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 620' ' ' SER . . . . . . . . . . . . . 84.6 p -166.64 164.2 16.83 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.006 -0.997 . . . . 0.0 110.506 -179.52 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 621' ' ' GLU . . . . . . . . . . . . . 61.1 mt-10 -104.29 -12.52 16.58 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.911 -0.586 . . . . 0.0 111.787 178.606 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 622' ' ' ASP . . . . . . . . . . . . . 36.3 t70 -96.33 110.33 22.68 Favored 'General case' 0 C--O 1.232 0.136 0 CA-C-O 121.123 0.487 . . . . 0.0 111.895 -178.442 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 623' ' ' GLU . . . . . 0.411 ' O ' HG22 ' A' ' 627' ' ' THR . 88.5 tt0 -63.62 -40.04 95.89 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.292 -0.867 . . . . 0.0 112.606 179.977 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 624' ' ' ALA . . . . . . . . . . . . . . . -60.74 -45.52 93.99 Favored 'General case' 0 N--CA 1.466 0.371 0 N-CA-C 112.908 0.707 . . . . 0.0 112.908 -177.596 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 625' ' ' THR . . . . . . . . . . . . . 92.2 m -68.37 -39.11 81.89 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.199 0.523 . . . . 0.0 109.837 179.547 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 626' ' ' SER . . . . . . . . . . . . . 66.7 m -61.16 -40.55 94.28 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.124 -0.944 . . . . 0.0 112.435 -178.873 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 627' ' ' THR . . . . . 0.411 HG22 ' O ' ' A' ' 623' ' ' GLU . 72.3 p -64.3 -39.29 93.63 Favored 'General case' 0 N--CA 1.465 0.288 0 N-CA-C 112.388 0.514 . . . . 0.0 112.388 -179.015 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 628' ' ' LEU . . . . . . . . . . . . . 62.2 tp -69.9 -45.89 66.62 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 112.229 0.455 . . . . 0.0 112.229 -179.636 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 629' ' ' ILE . . . . . . . . . . . . . 19.6 tt -71.51 -37.15 63.09 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.451 0 N-CA-C 112.885 0.698 . . . . 0.0 112.885 -178.391 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 630' ' ' CYS . . . . . 0.438 ' SG ' HG11 ' A' ' 640' ' ' VAL . 87.7 m -63.21 -38.8 92.59 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-O 120.711 0.291 . . . . 0.0 111.002 179.927 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 631' ' ' SER . . . . . . . . . . . . . 71.8 m -61.72 -40.25 94.39 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.73 -179.909 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 632' ' ' ILE . . . . . . . . . . . . . 96.8 mt -62.32 -49.57 83.41 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.314 0 CA-C-O 121.093 0.473 . . . . 0.0 110.725 179.895 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 633' ' ' LEU . . . . . . . . . . . . . 90.6 mt -66.99 -40.21 87.31 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-N 115.652 -0.704 . . . . 0.0 112.522 -179.507 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 634' ' ' THR . . . . . 0.534 ' HA ' ' O ' ' A' ' 638' ' ' TYR . 82.7 m -65.83 -40.68 92.02 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-O 120.699 0.285 . . . . 0.0 111.103 -179.389 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 635' ' ' THR . . . . . . . . . . . . . 92.2 m -58.85 -38.57 79.06 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.351 179.208 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 636' ' ' ALA . . . . . . . . . . . . . . . -64.7 -17.12 63.81 Favored 'General case' 0 CA--C 1.532 0.288 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.357 178.837 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 637' ' ' GLY . . . . . . . . . . . . . . . 108.91 6.9 29.84 Favored Glycine 0 C--N 1.334 0.467 0 C-N-CA 120.973 -0.632 . . . . 0.0 113.21 179.767 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 638' ' ' TYR . . . . . 0.534 ' O ' ' HA ' ' A' ' 634' ' ' THR . 97.1 m-85 -100.74 142.27 32.44 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.878 0.37 . . . . 0.0 111.479 -179.802 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 639' ' ' GLN . . . . . . . . . . . . . 78.9 mt-30 -89.32 135.81 33.38 Favored 'General case' 0 CA--C 1.519 -0.226 0 CA-C-N 116.243 -0.435 . . . . 0.0 109.96 179.308 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 640' ' ' VAL . . . . . 0.438 HG11 ' SG ' ' A' ' 630' ' ' CYS . 57.8 t -118.63 131.04 72.55 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-O 121.121 0.486 . . . . 0.0 112.272 -179.123 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 641' ' ' ILE . . . . . . . . . . . . . 46.0 mm -110.14 118.62 57.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 N-CA-C 108.348 -0.982 . . . . 0.0 108.348 178.248 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 642' ' ' TRP . . . . . . . . . . . . . 24.2 t90 -92.83 127.11 38.22 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 112.534 0.568 . . . . 0.0 112.534 -178.104 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 643' ' ' LEU . . . . . 0.432 ' O ' ' HA ' ' A' ' 619' ' ' VAL . 4.0 mp -123.6 137.55 54.72 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.471 -0.786 . . . . 0.0 110.109 178.886 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 644' ' ' VAL . . . . . . . . . . . . . 19.1 m -101.56 12.4 6.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 N-CA-C 112.03 0.382 . . . . 0.0 112.03 -179.798 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 645' ' ' ASP . . . . . 0.493 ' O ' ' HB2' ' A' ' 666' ' ' SER . 12.0 t0 -126.87 -72.99 0.62 Allowed 'General case' 0 N--CA 1.466 0.355 0 N-CA-C 111.98 0.363 . . . . 0.0 111.98 -178.82 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 646' ' ' GLY . . . . . . . . . . . . . . . 105.45 29.13 5.19 Favored Glycine 0 CA--C 1.519 0.328 0 C-N-CA 120.61 -0.805 . . . . 0.0 113.898 -179.939 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 647' ' ' GLU . . . . . . . . . . . . . 79.4 mm-40 -67.95 133.53 49.23 Favored 'General case' 0 N--CA 1.454 -0.255 0 CA-C-N 117.161 0.481 . . . . 0.0 110.236 179.243 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 648' ' ' VAL . . . . . . . . . . . . . 11.2 p -62.94 -32.76 57.17 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.587 0 CA-C-N 115.139 -0.937 . . . . 0.0 112.283 -178.594 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 649' ' ' GLU . . . . . . . . . . . . . 95.4 mt-10 -63.45 -44.96 93.01 Favored 'General case' 0 C--O 1.232 0.178 0 CA-C-O 120.982 0.42 . . . . 0.0 110.251 179.883 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 650' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -72.65 -40.97 65.96 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.918 178.775 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 651' ' ' LEU . . . . . . . . . . . . . 88.3 mt -63.95 -40.9 97.48 Favored 'General case' 0 N--CA 1.462 0.174 0 CA-C-N 116.428 -0.351 . . . . 0.0 110.786 179.339 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 652' ' ' LEU . . . . . . . . . . . . . 63.0 tp -65.04 -43.77 91.27 Favored 'General case' 0 CA--C 1.534 0.334 0 CA-C-N 116.488 -0.324 . . . . 0.0 110.985 178.719 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 653' ' ' ALA . . . . . . . . . . . . . . . -63.29 -39.99 96.11 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-O 121.129 0.49 . . . . 0.0 111.553 -179.93 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 654' ' ' LEU . . . . . . . . . . . . . 76.2 mt -100.63 30.12 4.13 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.591 -0.731 . . . . 0.0 110.023 179.916 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 655' ' ' THR . . . . . . . . . . . . . 5.1 t -44.03 108.16 0.68 Allowed Pre-proline 0 CA--C 1.537 0.461 0 O-C-N 124.197 0.936 . . . . 0.0 113.249 -178.263 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 656' ' ' PRO . . . . . . . . . . . . . 26.9 Cg_endo -91.97 -176.96 0.84 Allowed 'Trans proline' 0 N--CA 1.462 -0.375 0 C-N-CA 123.861 3.041 . . . . 0.0 112.567 178.94 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 657' ' ' ILE . . . . . . . . . . . . . 96.9 mt -71.52 -37.97 66.13 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 N-CA-C 108.268 -1.012 . . . . 0.0 108.268 177.952 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 658' ' ' ALA . . . . . 0.414 ' HA ' ' O ' ' A' ' 687' ' ' LYS . . . -151.11 153.53 35.21 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 114.214 -1.357 . . . . 0.0 111.566 -178.808 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 659' ' ' VAL . . . . . . . . . . . . . 22.5 m -121.05 143.7 32.46 Favored 'Isoleucine or valine' 0 C--O 1.235 0.325 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.578 178.72 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 660' ' ' LEU . . . . . . . . . . . . . 4.9 mp -115.08 111.42 21.03 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 108.713 -0.847 . . . . 0.0 108.713 178.541 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 661' ' ' LEU . . . . . . . . . . . . . 66.6 mt -103.82 116.6 32.59 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 110.051 -0.351 . . . . 0.0 110.051 -178.472 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 662' ' ' ALA . . . . . . . . . . . . . . . -107.68 135.37 49.23 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 112.412 0.523 . . . . 0.0 112.412 -178.903 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 663' ' ' GLU . . . . . . . . . . . . . 98.1 mt-10 -76.31 146.75 78.4 Favored Pre-proline 0 C--N 1.327 -0.399 0 CA-C-N 115.58 -0.737 . . . . 0.0 110.222 178.327 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 664' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -72.43 140.19 64.87 Favored 'Cis proline' 0 C--N 1.35 0.609 0 C-N-CA 123.403 -1.499 . . . . 0.0 112.802 -0.41 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 665' ' ' PHE . . . . . 0.49 ' HB3' ' CZ ' ' A' ' 667' ' ' TYR . 0.1 OUTLIER -76.71 112.36 13.2 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.451 -0.795 . . . . 0.0 112.321 179.868 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 666' ' ' SER . . . . . 0.493 ' HB2' ' O ' ' A' ' 645' ' ' ASP . 68.5 m -65.07 -40.97 95.42 Favored 'General case' 0 N--CA 1.468 0.469 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.464 179.306 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 667' ' ' TYR . . . . . 0.49 ' CZ ' ' HB3' ' A' ' 665' ' ' PHE . 19.2 p90 -60.51 -16.64 39.12 Favored 'General case' 0 CA--C 1.537 0.464 0 N-CA-C 112.896 0.702 . . . . 0.0 112.896 -179.933 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 668' ' ' GLY . . . . . . . . . . . . . . . 100.67 -112.67 4.48 Favored Glycine 0 N--CA 1.452 -0.245 0 C-N-CA 120.547 -0.835 . . . . 0.0 113.667 179.167 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 669' ' ' ASP . . . . . . . . . . . . . 49.8 t0 -81.87 110.19 16.93 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.044 0.449 . . . . 0.0 111.547 -178.386 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 670' ' ' VAL . . . . . 0.449 ' O ' HG23 ' A' ' 674' ' ' VAL . 13.4 p -65.11 -31.93 56.08 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.307 0 CA-C-N 115.546 -0.752 . . . . 0.0 112.642 -179.821 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 671' ' ' GLN . . . . . . . . . . . . . 52.2 tt0 -61.51 -43.36 99.0 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-O 120.812 0.339 . . . . 0.0 110.93 -179.307 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 672' ' ' GLU . . . . . . . . . . . . . 95.1 mt-10 -65.56 -40.6 92.98 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.723 179.165 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 673' ' ' LEU . . . . . . . . . . . . . 61.9 tp -64.04 -44.81 91.37 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.216 179.35 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 674' ' ' VAL . . . . . 0.449 HG23 ' O ' ' A' ' 670' ' ' VAL . 59.9 t -63.28 -43.83 98.86 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.21 0 CA-C-N 115.864 -0.607 . . . . 0.0 109.597 179.381 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 675' ' ' ASP . . . . . . . . . . . . . 37.4 t70 -60.36 -41.13 93.04 Favored 'General case' 0 CA--C 1.521 -0.141 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.521 178.81 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 676' ' ' GLN . . . . . . . . . . . . . 76.7 mt-30 -69.94 -41.76 74.15 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-N 116.668 -0.242 . . . . 0.0 110.898 179.986 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 677' ' ' LEU . . . . . . . . . . . . . 85.6 mt -66.8 -41.83 86.94 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.641 179.456 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 678' ' ' ARG . . . . . . . . . . . . . 70.4 ttp85 -67.36 -38.97 85.63 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.927 179.834 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 679' ' ' GLN . . . . . . . . . . . . . 10.6 tp-100 -64.36 -38.13 89.96 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.486 -0.779 . . . . 0.0 110.785 179.893 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 680' ' ' ARG . . . . . . . . . . . . . 89.3 mmt-85 -83.91 -42.88 15.85 Favored 'General case' 0 C--N 1.333 -0.131 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.203 -179.541 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 681' ' ' CYS . . . . . . . . . . . . . 76.0 m -127.86 133.65 49.36 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.33 179.687 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 682' ' ' THR . . . . . 0.414 ' HB ' ' HD2' ' A' ' 683' ' ' PRO . 65.0 p -67.18 158.35 81.84 Favored Pre-proline 0 C--N 1.321 -0.66 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.12 179.802 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 683' ' ' PRO . . . . . 0.414 ' HD2' ' HB ' ' A' ' 682' ' ' THR . 19.8 Cg_endo -58.38 -26.97 79.83 Favored 'Trans proline' 0 C--N 1.349 0.577 0 C-N-CA 122.139 1.893 . . . . 0.0 112.291 -179.819 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 684' ' ' GLU . . . . . . . . . . . . . 51.4 mp0 -71.43 -39.1 71.26 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 121.165 0.507 . . . . 0.0 110.087 178.478 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 685' ' ' GLN . . . . . . . . . . . . . 91.0 mt-30 -71.88 -39.91 69.29 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.322 -0.854 . . . . 0.0 112.183 179.612 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 686' ' ' LEU . . . . . . . . . . . . . 2.8 tt -135.79 119.08 16.68 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.547 -178.371 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 687' ' ' LYS . . . . . 0.414 ' O ' ' HA ' ' A' ' 658' ' ' ALA . 74.6 mmtt -88.12 144.82 26.26 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 121.191 0.519 . . . . 0.0 110.241 178.649 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 688' ' ' ILE . . . . . . . . . . . . . 79.9 mt -124.0 122.49 64.62 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.751 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.986 -179.293 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 689' ' ' PHE . . . . . . . . . . . . . 97.8 m-85 -121.99 147.06 46.53 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.482 -0.781 . . . . 0.0 110.291 179.134 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 690' ' ' ILE . . . . . . . . . . . . . 19.0 tt -123.58 137.69 55.92 Favored 'Isoleucine or valine' 0 C--O 1.235 0.331 0 CA-C-O 121.325 0.583 . . . . 0.0 111.186 -179.768 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 691' ' ' LEU . . . . . . . . . . . . . 69.0 mt -112.28 136.35 51.83 Favored 'General case' 0 C--O 1.235 0.313 0 CA-C-N 115.522 -0.763 . . . . 0.0 110.661 -179.429 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 692' ' ' GLY . . . . . 0.632 ' O ' ' HA ' ' A' ' 705' ' ' PRO . . . 168.37 -178.61 41.87 Favored Glycine 0 N--CA 1.446 -0.672 0 C-N-CA 120.876 -0.678 . . . . 0.0 111.706 179.709 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 693' ' ' SER . . . . . . . . . . . . . 80.0 p -67.64 -36.14 80.2 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 120.98 0.419 . . . . 0.0 110.836 179.35 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 694' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -128.98 135.36 48.88 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.913 -0.585 . . . . 0.0 109.919 179.274 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 695' ' ' GLY . . . . . . . . . . . . . . . -73.12 108.57 2.54 Favored Glycine 0 N--CA 1.45 -0.412 0 C-N-CA 120.646 -0.788 . . . . 0.0 112.626 179.963 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 696' ' ' ASN . . . . . . . . . . . . . 62.9 t30 -86.99 91.39 8.68 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 109.994 -0.373 . . . . 0.0 109.994 179.482 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 697' ' ' TYR . . . . . . . . . . . . . 53.0 t80 -71.49 97.13 1.6 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.913 -0.585 . . . . 0.0 111.726 -178.845 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 698' ' ' GLN . . . . . . . . . . . . . 95.9 mm-40 -122.97 35.86 4.78 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.532 -0.758 . . . . 0.0 109.564 178.618 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 699' ' ' GLY . . . . . . . . . . . . . . . 103.87 10.15 35.64 Favored Glycine 0 N--CA 1.453 -0.171 0 C-N-CA 120.781 -0.723 . . . . 0.0 112.006 -178.628 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 700' ' ' VAL . . . . . . . . . . . . . 31.5 m -81.84 150.58 4.45 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.365 0 CA-C-O 121.282 0.563 . . . . 0.0 110.53 179.804 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 701' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -70.08 -40.36 75.05 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 115.365 -0.834 . . . . 0.0 112.151 -179.319 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 702' ' ' ARG . . . . . . . . . . . . . 58.1 ttm-85 -158.08 149.69 21.5 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.826 0.346 . . . . 0.0 111.354 -179.07 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 703' ' ' TYR . . . . . . . . . . . . . 23.7 p90 -107.79 141.59 39.11 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.162 179.125 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 704' ' ' ILE . . . . . . . . . . . . . 44.9 mt -125.57 85.79 58.26 Favored Pre-proline 0 C--N 1.328 -0.364 0 CA-C-O 121.044 0.449 . . . . 0.0 110.293 -179.655 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 705' ' ' PRO . . . . . 0.632 ' HA ' ' O ' ' A' ' 692' ' ' GLY . 38.5 Cg_exo -63.15 144.34 92.0 Favored 'Trans proline' 0 C--N 1.35 0.61 0 C-N-CA 123.781 2.987 . . . . 0.0 114.272 -179.235 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 706' ' ' LEU . . . . . . . . . . . . . 80.6 mt -80.88 145.82 58.26 Favored Pre-proline 0 CA--C 1.533 0.291 0 CA-C-N 115.527 -0.761 . . . . 0.0 110.276 178.076 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 707' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -74.88 141.49 71.92 Favored 'Cis proline' 0 C--N 1.345 0.357 0 C-N-CA 123.121 -1.616 . . . . 0.0 112.051 -1.086 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 708' ' ' ILE . . . . . . . . . . . . . 72.1 mt -78.97 119.8 28.9 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.399 179.513 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 709' ' ' HIS . . . . . . . . . . . . . 71.1 m80 -84.65 123.1 74.75 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.34 179.644 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 710' ' ' PRO . . . . . . . . . . . . . 24.9 Cg_endo -61.59 -31.92 87.29 Favored 'Trans proline' 0 C--N 1.349 0.566 0 C-N-CA 122.869 2.379 . . . . 0.0 113.958 -178.886 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 711' ' ' GLU . . . . . . . . . . . . . 42.6 tt0 -66.08 -41.66 90.42 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 112.179 0.437 . . . . 0.0 112.179 -179.193 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 712' ' ' SER . . . . . . . . . . . . . 80.7 p -95.2 -20.43 19.24 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 112.44 0.533 . . . . 0.0 112.44 -178.266 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 713' ' ' PHE . . . . . . . . . . . . . 77.9 t80 -60.17 -49.89 75.86 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-O 120.759 0.314 . . . . 0.0 111.406 -179.694 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 714' ' ' LEU . . . . . . . . . . . . . 52.6 tp -64.25 -39.45 93.97 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.064 -0.517 . . . . 0.0 109.651 179.799 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 715' ' ' GLN . . . . . . . . . . . . . 64.4 tt0 -61.99 -43.77 98.14 Favored 'General case' 0 CA--C 1.532 0.262 0 CA-C-N 115.534 -0.757 . . . . 0.0 110.827 179.034 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 716' ' ' GLN . . . . . . . . . . . . . 96.5 mt-30 -63.78 -41.39 97.95 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 116.583 -0.28 . . . . 0.0 111.135 179.656 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 717' ' ' VAL . . . . . . . . . . . . . 68.7 t -63.08 -45.28 99.13 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 N-CA-C 109.947 -0.39 . . . . 0.0 109.947 179.097 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 718' ' ' THR . . . . . . . . . . . . . 89.4 m -62.88 -44.55 95.8 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.887 179.425 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 719' ' ' MET . . . . . 0.475 ' O ' HG23 ' A' ' 722' ' ' THR . 0.6 OUTLIER -63.18 -43.57 97.87 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 116.523 -0.308 . . . . 0.0 110.776 179.555 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 720' ' ' GLY . . . . . . . . . . . . . . . -64.48 -40.96 98.14 Favored Glycine 0 C--N 1.332 0.361 0 C-N-CA 120.509 -0.853 . . . . 0.0 111.631 178.15 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 721' ' ' LEU . . . . . . . . . . . . . 61.3 tp -65.87 -42.52 90.26 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 122.81 0.444 . . . . 0.0 112.189 179.656 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 722' ' ' THR . . . . . 0.475 HG23 ' O ' ' A' ' 719' ' ' MET . 4.9 t -71.28 -3.55 21.07 Favored 'General case' 0 CA--C 1.535 0.396 0 N-CA-C 113.032 0.752 . . . . 0.0 113.032 -178.607 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 723' ' ' SER . . . . . . . . . . . . . 83.0 p -69.35 -20.29 63.85 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.682 0.277 . . . . 0.0 110.973 179.495 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 724' ' ' LEU . . . . . . . . . . . . . 91.8 mt -64.22 -40.96 97.13 Favored 'General case' 0 CA--C 1.529 0.171 0 CA-C-N 116.077 -0.51 . . . . 0.0 111.989 -179.872 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 725' ' ' ALA . . . . . . . . . . . . . . . -156.75 148.39 22.57 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.661 -0.245 . . . . 0.0 111.182 -179.837 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 726' ' ' THR . . . . . . . . . . . . . 63.6 p -70.64 -28.73 65.04 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.341 -0.39 . . . . 0.0 111.591 179.943 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 727' ' ' SER . . . . . . . . . . . . . 7.4 m -86.86 67.43 9.81 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.904 -179.981 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 728' ' ' ALA . . . . . . . . . . . . . . . -62.32 -39.89 94.52 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.482 179.745 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 729' ' ' GLN . . . . . . . . . . . . . 96.6 mt-30 . . . . . 0 C--O 1.25 1.108 0 CA-C-O 118.225 -0.893 . . . . 0.0 110.662 179.954 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 613' ' ' GLU . . . . . . . . . . . . . 3.9 pt-20 . . . . . 0 N--CA 1.489 1.483 0 CA-C-O 120.975 0.417 . . . . 0.0 110.841 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 614' ' ' GLY . . . . . . . . . . . . . . . -84.0 64.97 4.19 Favored Glycine 0 N--CA 1.453 -0.169 0 C-N-CA 120.887 -0.673 . . . . 0.0 112.628 -179.882 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 615' ' ' ARG . . . . . . . . . . . . . 35.5 mtp-105 -115.01 130.32 56.91 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.04 0.448 . . . . 0.0 111.029 -179.96 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 616' ' ' ILE . . . . . 0.435 ' O ' ' HA ' ' A' ' 640' ' ' VAL . 84.7 mt -124.12 134.08 67.55 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-N 115.578 -0.737 . . . . 0.0 109.89 179.835 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 617' ' ' VAL . . . . . . . . . . . . . 93.4 t -106.6 127.15 62.26 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-O 121.108 0.48 . . . . 0.0 109.786 -179.923 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 618' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -107.01 127.13 53.18 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.821 -178.501 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 619' ' ' VAL . . . . . . . . . . . . . 58.8 t -116.65 118.66 59.51 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 N-CA-C 109.624 -0.51 . . . . 0.0 109.624 179.898 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 620' ' ' SER . . . . . . . . . . . . . 25.2 t -169.59 139.55 2.06 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.693 -0.685 . . . . 0.0 111.039 -179.536 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 621' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -77.02 -27.7 54.68 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.624 -0.716 . . . . 0.0 111.118 179.002 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 622' ' ' ASP . . . . . . . . . . . . . 44.1 t0 -84.02 110.63 18.6 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-O 121.173 0.511 . . . . 0.0 111.97 -178.433 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 623' ' ' GLU . . . . . . . . . . . . . 88.6 tt0 -63.43 -40.05 96.13 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.031 -0.986 . . . . 0.0 112.112 179.495 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 624' ' ' ALA . . . . . . . . . . . . . . . -61.14 -45.44 94.66 Favored 'General case' 0 N--CA 1.466 0.351 0 N-CA-C 112.902 0.704 . . . . 0.0 112.902 -177.831 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 625' ' ' THR . . . . . . . . . . . . . 95.6 m -69.77 -40.69 75.94 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-O 121.149 0.5 . . . . 0.0 110.348 -179.977 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 626' ' ' SER . . . . . . . . . . . . . 67.5 m -62.25 -41.03 98.07 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.492 -0.776 . . . . 0.0 111.653 -179.405 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 627' ' ' THR . . . . . . . . . . . . . 92.2 m -61.56 -46.1 91.32 Favored 'General case' 0 CA--C 1.534 0.351 0 N-CA-C 112.384 0.513 . . . . 0.0 112.384 -179.3 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 628' ' ' LEU . . . . . . . . . . . . . 62.9 tp -62.79 -47.31 84.05 Favored 'General case' 0 CA--C 1.533 0.322 0 N-CA-C 112.626 0.602 . . . . 0.0 112.626 -178.714 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 629' ' ' ILE . . . . . . . . . . . . . 16.3 tt -70.87 -35.77 61.37 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.434 0 N-CA-C 112.964 0.727 . . . . 0.0 112.964 -178.648 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 630' ' ' CYS . . . . . 0.494 ' SG ' HG11 ' A' ' 640' ' ' VAL . 87.2 m -62.4 -39.69 94.09 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-O 120.668 0.27 . . . . 0.0 111.148 -179.863 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 631' ' ' SER . . . . . . . . . . . . . 67.8 m -62.29 -41.17 98.28 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.74 179.908 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 632' ' ' ILE . . . . . . . . . . . . . 97.1 mt -62.72 -48.14 89.58 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.272 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.754 179.705 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 633' ' ' LEU . . . . . . . . . . . . . 79.4 mt -66.36 -40.39 89.76 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-N 115.835 -0.621 . . . . 0.0 112.582 -179.733 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 634' ' ' THR . . . . . 0.495 ' HA ' ' O ' ' A' ' 638' ' ' TYR . 73.4 m -65.58 -40.35 92.66 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.713 0.292 . . . . 0.0 110.668 -179.54 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 635' ' ' THR . . . . . . . . . . . . . 92.1 m -59.54 -38.92 82.3 Favored 'General case' 0 CA--C 1.531 0.232 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.222 179.075 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 636' ' ' ALA . . . . . . . . . . . . . . . -64.56 -17.65 64.14 Favored 'General case' 0 CA--C 1.532 0.288 0 CA-C-N 115.918 -0.583 . . . . 0.0 111.396 178.882 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 637' ' ' GLY . . . . . . . . . . . . . . . 109.2 6.06 29.92 Favored Glycine 0 C--N 1.334 0.435 0 C-N-CA 121.004 -0.617 . . . . 0.0 113.233 179.684 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 638' ' ' TYR . . . . . 0.495 ' O ' ' HA ' ' A' ' 634' ' ' THR . 93.9 m-85 -100.31 142.49 31.71 Favored 'General case' 0 C--N 1.329 -0.318 0 O-C-N 122.581 -0.364 . . . . 0.0 111.497 179.93 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 639' ' ' GLN . . . . . . . . . . . . . 78.3 mt-30 -88.9 134.14 34.05 Favored 'General case' 0 CA--C 1.518 -0.254 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.052 179.376 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 640' ' ' VAL . . . . . 0.494 HG11 ' SG ' ' A' ' 630' ' ' CYS . 58.5 t -118.8 130.87 73.03 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.5 0 CA-C-O 121.016 0.436 . . . . 0.0 111.985 -179.336 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 641' ' ' ILE . . . . . . . . . . . . . 37.8 mm -108.86 117.57 54.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 N-CA-C 108.444 -0.947 . . . . 0.0 108.444 178.603 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 642' ' ' TRP . . . . . . . . . . . . . 23.9 t90 -89.24 125.68 35.18 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.165 0.507 . . . . 0.0 112.025 -178.517 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 643' ' ' LEU . . . . . . . . . . . . . 3.1 mp -120.13 134.22 55.31 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.581 -0.736 . . . . 0.0 110.698 179.263 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 644' ' ' VAL . . . . . . . . . . . . . 8.4 m -106.72 23.4 3.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.942 -179.789 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 645' ' ' ASP . . . . . . . . . . . . . 18.2 t0 -145.51 -32.62 0.37 Allowed 'General case' 0 N--CA 1.469 0.521 0 N-CA-C 113.193 0.812 . . . . 0.0 113.193 -178.211 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 646' ' ' GLY . . . . . . . . . . . . . . . 74.44 27.33 65.83 Favored Glycine 0 CA--C 1.52 0.402 0 C-N-CA 120.757 -0.735 . . . . 0.0 113.761 -179.692 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 647' ' ' GLU . . . . . . . . . . . . . 8.3 mm-40 -63.85 122.32 16.17 Favored 'General case' 0 C--O 1.232 0.137 0 CA-C-O 121.087 0.47 . . . . 0.0 110.938 179.745 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 648' ' ' VAL . . . . . . . . . . . . . 27.8 m -64.62 -30.24 49.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 115.458 -0.792 . . . . 0.0 112.013 -179.287 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 649' ' ' GLU . . . . . . . . . . . . . 97.9 mt-10 -64.27 -43.74 93.88 Favored 'General case' 0 C--O 1.231 0.123 0 N-CA-C 109.773 -0.454 . . . . 0.0 109.773 179.182 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 650' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -71.68 -40.35 69.62 Favored 'General case' 0 N--CA 1.455 -0.178 0 CA-C-N 115.676 -0.693 . . . . 0.0 110.404 178.569 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 651' ' ' LEU . . . . . . . . . . . . . 83.7 mt -64.0 -41.07 97.6 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.185 179.155 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 652' ' ' LEU . . . . . . . . . . . . . 60.2 tp -64.01 -44.67 91.9 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.909 178.896 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 653' ' ' ALA . . . . . . . . . . . . . . . -63.35 -39.66 95.16 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-O 121.034 0.445 . . . . 0.0 111.704 179.611 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 654' ' ' LEU . . . . . . . . . . . . . 76.3 mt -100.28 29.35 4.39 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.828 -179.66 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 655' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -31.38 103.84 0.21 Allowed Pre-proline 0 N--CA 1.471 0.602 0 N-CA-C 114.311 1.226 . . . . 0.0 114.311 -178.268 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 656' ' ' PRO . . . . . . . . . . . . . 41.4 Cg_endo -90.22 177.37 2.42 Favored 'Trans proline' 0 C--N 1.346 0.411 0 C-N-CA 123.739 2.959 . . . . 0.0 112.068 177.959 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 657' ' ' ILE . . . . . . . . . . . . . 19.4 pt -83.6 -26.24 7.63 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-O 121.389 0.614 . . . . 0.0 109.871 177.868 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 658' ' ' ALA . . . . . 0.405 ' HA ' ' O ' ' A' ' 687' ' ' LYS . . . -158.16 154.11 26.85 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.209 -0.905 . . . . 0.0 111.0 -179.967 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 659' ' ' VAL . . . . . . . . . . . . . 30.4 m -124.38 148.08 28.73 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-O 121.27 0.557 . . . . 0.0 111.104 179.119 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 660' ' ' LEU . . . . . . . . . . . . . 11.9 mt -116.64 118.81 33.62 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.444 -0.798 . . . . 0.0 110.271 179.174 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 661' ' ' LEU . . . . . . . . . . . . . 63.3 mt -105.9 112.15 25.08 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 108.774 -0.824 . . . . 0.0 108.774 179.24 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 662' ' ' ALA . . . . . . . . . . . . . . . -109.75 135.68 50.29 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 113.159 0.8 . . . . 0.0 113.159 -178.119 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 663' ' ' GLU . . . . . 0.423 ' HG2' ' CE1' ' A' ' 665' ' ' PHE . 48.6 mt-10 -69.23 137.49 89.18 Favored Pre-proline 0 CA--C 1.535 0.384 0 CA-C-N 115.309 -0.859 . . . . 0.0 110.516 177.923 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 664' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -76.44 141.97 71.7 Favored 'Cis proline' 0 C--N 1.348 0.543 0 C-N-CA 123.533 -1.444 . . . . 0.0 112.506 -0.974 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 665' ' ' PHE . . . . . 0.423 ' CE1' ' HG2' ' A' ' 663' ' ' GLU . 49.9 m-85 -77.64 119.72 21.59 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.942 -0.572 . . . . 0.0 111.031 -179.742 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 666' ' ' SER . . . . . . . . . . . . . 79.3 p -67.41 -37.93 83.84 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.224 -0.443 . . . . 0.0 111.614 179.652 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 667' ' ' TYR . . . . . . . . . . . . . 56.3 t80 -67.29 -24.36 65.76 Favored 'General case' 0 CA--C 1.533 0.301 0 CA-C-O 120.704 0.288 . . . . 0.0 111.718 179.424 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 668' ' ' GLY . . . . . . . . . . . . . . . 100.66 -103.82 2.67 Favored Glycine 0 CA--C 1.52 0.372 0 C-N-CA 120.246 -0.978 . . . . 0.0 113.324 -179.844 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 669' ' ' ASP . . . . . 0.437 ' OD1' ' HG2' ' A' ' 671' ' ' GLN . 47.6 t0 -80.25 109.85 15.12 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-O 121.218 0.532 . . . . 0.0 111.65 -178.369 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 670' ' ' VAL . . . . . . . . . . . . . 67.7 t -63.25 -42.2 95.57 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.357 0 N-CA-C 113.805 1.039 . . . . 0.0 113.805 -179.181 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 671' ' ' GLN . . . . . 0.439 ' O ' HG22 ' A' ' 674' ' ' VAL . 19.2 pt20 -59.1 -34.6 72.2 Favored 'General case' 0 N--CA 1.466 0.331 0 N-CA-C 111.81 0.3 . . . . 0.0 111.81 -177.605 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 672' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 -70.53 -40.72 73.27 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.963 0.411 . . . . 0.0 110.57 178.134 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 673' ' ' LEU . . . . . . . . . . . . . 59.8 tp -65.19 -44.55 88.07 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.672 -0.694 . . . . 0.0 111.141 -179.887 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 674' ' ' VAL . . . . . 0.439 HG22 ' O ' ' A' ' 671' ' ' GLN . 34.4 m -66.99 -36.78 77.97 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.197 0 CA-C-N 116.4 -0.363 . . . . 0.0 110.056 179.964 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 675' ' ' ASP . . . . . . . . . . . . . 36.9 t70 -62.83 -41.19 99.24 Favored 'General case' 0 CA--C 1.518 -0.252 0 CA-C-N 116.266 -0.425 . . . . 0.0 109.929 177.626 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 676' ' ' GLN . . . . . . . . . . . . . 96.4 mt-30 -69.32 -41.5 76.62 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.978 -179.783 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 677' ' ' LEU . . . . . . . . . . . . . 84.8 mt -68.33 -41.59 80.57 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.055 179.408 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 678' ' ' ARG . . . . . . . . . . . . . 79.6 ttt-85 -66.51 -38.25 86.81 Favored 'General case' 0 N--CA 1.468 0.467 0 CA-C-O 121.321 0.581 . . . . 0.0 110.844 -179.851 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 679' ' ' GLN . . . . . . . . . . . . . 71.2 tp60 -62.33 -38.64 90.25 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.36 -0.836 . . . . 0.0 110.852 -179.961 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 680' ' ' ARG . . . . . . . . . . . . . 31.3 mmm180 -84.8 -42.47 15.11 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.369 179.979 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 681' ' ' CYS . . . . . . . . . . . . . 77.4 m -127.12 130.5 49.94 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 120.903 0.383 . . . . 0.0 110.6 179.919 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 682' ' ' THR . . . . . 0.45 ' HB ' ' HD2' ' A' ' 683' ' ' PRO . 59.6 p -71.06 160.03 83.73 Favored Pre-proline 0 C--N 1.323 -0.578 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.708 -179.846 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 683' ' ' PRO . . . . . 0.45 ' HD2' ' HB ' ' A' ' 682' ' ' THR . 18.1 Cg_endo -59.13 -23.65 70.08 Favored 'Trans proline' 0 C--N 1.352 0.725 0 C-N-CA 122.536 2.158 . . . . 0.0 112.944 -179.915 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 684' ' ' GLU . . . . . 0.406 ' HG2' ' OG1' ' A' ' 682' ' ' THR . 24.8 pt-20 -79.5 -14.56 58.8 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.981 0.419 . . . . 0.0 110.286 178.871 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 685' ' ' GLN . . . . . . . . . . . . . 91.1 mt-30 -101.73 -34.83 9.3 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.959 -0.564 . . . . 0.0 111.624 -179.741 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 686' ' ' LEU . . . . . . . . . . . . . 2.9 tt -139.75 129.32 24.36 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.457 -0.338 . . . . 0.0 111.33 -178.809 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 687' ' ' LYS . . . . . 0.405 ' O ' ' HA ' ' A' ' 658' ' ' ALA . 0.1 OUTLIER -99.13 144.07 28.68 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 121.348 0.594 . . . . 0.0 110.566 178.744 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 688' ' ' ILE . . . . . . . . . . . . . 75.6 mt -121.58 122.21 66.49 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.81 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.66 -179.135 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 689' ' ' PHE . . . . . . . . . . . . . 95.8 m-85 -120.1 147.06 45.32 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.497 -0.774 . . . . 0.0 110.567 179.411 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 690' ' ' ILE . . . . . . . . . . . . . 18.3 tt -123.52 137.19 57.59 Favored 'Isoleucine or valine' 0 C--O 1.236 0.37 0 CA-C-O 121.248 0.546 . . . . 0.0 111.418 -179.349 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 691' ' ' LEU . . . . . 0.424 ' CD2' ' HB ' ' A' ' 704' ' ' ILE . 51.3 mt -111.85 136.15 51.53 Favored 'General case' 0 C--O 1.235 0.312 0 CA-C-N 115.618 -0.719 . . . . 0.0 110.644 -179.638 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 692' ' ' GLY . . . . . 0.611 ' O ' ' HA ' ' A' ' 705' ' ' PRO . . . 165.99 -178.17 40.77 Favored Glycine 0 N--CA 1.446 -0.679 0 C-N-CA 121.01 -0.614 . . . . 0.0 112.019 179.697 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 693' ' ' SER . . . . . . . . . . . . . 79.8 p -67.27 -36.86 82.45 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.021 0.439 . . . . 0.0 110.808 179.393 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 694' ' ' LYS . . . . . . . . . . . . . 64.7 tttp -129.91 128.84 42.98 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.891 -0.595 . . . . 0.0 109.666 179.239 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 695' ' ' GLY . . . . . . . . . . . . . . . -74.56 119.32 6.08 Favored Glycine 0 N--CA 1.445 -0.764 0 C-N-CA 120.54 -0.838 . . . . 0.0 112.993 -179.526 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 696' ' ' ASN . . . . . . . . . . . . . 65.5 t30 -88.19 92.23 9.08 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 109.433 -0.58 . . . . 0.0 109.433 179.003 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 697' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -71.77 61.98 0.4 Allowed 'General case' 0 CA--C 1.532 0.277 0 N-CA-C 112.994 0.739 . . . . 0.0 112.994 -178.205 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 698' ' ' GLN . . . . . . . . . . . . . 97.2 mt-30 -124.34 91.56 3.48 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 109.511 -0.552 . . . . 0.0 109.511 177.943 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 699' ' ' GLY . . . . . . . . . . . . . . . 83.03 13.89 76.29 Favored Glycine 0 CA--C 1.521 0.419 0 C-N-CA 120.542 -0.837 . . . . 0.0 113.394 -179.963 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 700' ' ' VAL . . . . . . . . . . . . . 29.0 m -118.97 147.3 22.58 Favored 'Isoleucine or valine' 0 C--O 1.234 0.257 0 CA-C-N 117.234 0.517 . . . . 0.0 110.246 179.854 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 701' ' ' ASP . . . . . . . . . . . . . 36.0 t70 -75.38 -42.41 54.01 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.684 -0.689 . . . . 0.0 112.625 -179.166 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 702' ' ' ARG . . . . . . . . . . . . . 67.8 mtp85 -146.01 165.84 27.85 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-O 120.737 0.303 . . . . 0.0 110.827 -178.232 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 703' ' ' TYR . . . . . . . . . . . . . 52.2 p90 -125.38 144.82 50.33 Favored 'General case' 0 C--O 1.234 0.255 0 CA-C-N 116.312 -0.403 . . . . 0.0 110.612 179.427 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 704' ' ' ILE . . . . . 0.424 ' HB ' ' CD2' ' A' ' 691' ' ' LEU . 49.2 mt -126.15 96.84 35.99 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-N 116.144 -0.48 . . . . 0.0 109.884 179.77 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 705' ' ' PRO . . . . . 0.611 ' HA ' ' O ' ' A' ' 692' ' ' GLY . 71.9 Cg_endo -73.85 150.42 44.15 Favored 'Trans proline' 0 C--N 1.348 0.517 0 C-N-CA 123.005 2.47 . . . . 0.0 114.47 -178.433 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 706' ' ' LEU . . . . . . . . . . . . . 76.2 mt -87.69 145.38 36.89 Favored Pre-proline 0 CA--C 1.531 0.245 0 CA-C-N 115.217 -0.901 . . . . 0.0 110.358 178.386 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 707' ' ' PRO . . . . . . . . . . . . . 15.4 Cg_exo -71.34 139.0 56.15 Favored 'Cis proline' 0 C--N 1.346 0.399 0 C-N-CA 123.746 -1.356 . . . . 0.0 111.965 -1.744 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 708' ' ' ILE . . . . . . . . . . . . . 74.2 mt -78.64 118.69 26.34 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 N-CA-C 109.932 -0.395 . . . . 0.0 109.932 179.13 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 709' ' ' HIS . . . . . . . . . . . . . 67.8 m80 -87.44 121.54 71.13 Favored Pre-proline 0 C--N 1.328 -0.364 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.439 179.529 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 710' ' ' PRO . . . . . . . . . . . . . 81.8 Cg_exo -53.72 -38.49 84.86 Favored 'Trans proline' 0 C--N 1.35 0.652 0 C-N-CA 123.579 2.853 . . . . 0.0 114.44 -178.895 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 711' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -64.99 -42.61 94.36 Favored 'General case' 0 N--CA 1.463 0.221 0 N-CA-C 112.034 0.383 . . . . 0.0 112.034 -178.754 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 712' ' ' SER . . . . . . . . . . . . . 49.4 m -82.34 -29.57 30.92 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.513 -0.312 . . . . 0.0 111.248 -179.703 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 713' ' ' PHE . . . . . 0.439 ' O ' HG21 ' A' ' 717' ' ' VAL . 84.4 t80 -60.38 -50.3 74.14 Favored 'General case' 0 C--N 1.328 -0.34 0 O-C-N 123.175 0.297 . . . . 0.0 111.483 -179.394 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 714' ' ' LEU . . . . . . . . . . . . . 91.4 mt -65.88 -40.64 91.79 Favored 'General case' 0 C--O 1.234 0.272 0 CA-C-N 116.503 -0.317 . . . . 0.0 110.889 179.848 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 715' ' ' GLN . . . . . . . . . . . . . 98.8 mm-40 -65.36 -40.95 94.22 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.055 178.897 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 716' ' ' GLN . . . . . . . . . . . . . 61.5 tt0 -63.86 -42.31 97.56 Favored 'General case' 0 C--O 1.233 0.185 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.7 -179.899 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 717' ' ' VAL . . . . . 0.439 HG21 ' O ' ' A' ' 713' ' ' PHE . 66.1 t -63.69 -43.77 98.18 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.135 0 N-CA-C 109.843 -0.429 . . . . 0.0 109.843 178.582 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 718' ' ' THR . . . . . . . . . . . . . 89.9 m -61.86 -43.94 97.83 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-N 115.57 -0.741 . . . . 0.0 110.922 179.394 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 719' ' ' MET . . . . . . . . . . . . . 98.0 mtp -61.5 -43.62 98.54 Favored 'General case' 0 N--CA 1.462 0.167 0 CA-C-O 120.578 0.228 . . . . 0.0 110.542 179.547 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 720' ' ' GLY . . . . . . . . . . . . . . . -65.52 -41.61 96.14 Favored Glycine 0 C--N 1.333 0.369 0 C-N-CA 120.621 -0.8 . . . . 0.0 111.88 178.421 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 721' ' ' LEU . . . . . . . . . . . . . 62.1 tp -63.95 -43.86 94.55 Favored 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 122.789 0.436 . . . . 0.0 111.827 179.798 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 722' ' ' THR . . . . . . . . . . . . . 41.0 p -73.56 -10.31 59.57 Favored 'General case' 0 N--CA 1.465 0.277 0 N-CA-C 112.243 0.46 . . . . 0.0 112.243 -179.379 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 723' ' ' SER . . . . . . . . . . . . . 74.6 m -84.18 -4.29 58.71 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.844 0.354 . . . . 0.0 110.651 179.137 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 724' ' ' LEU . . . . . . . . . . . . . 67.3 tp -99.9 121.4 41.27 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.533 179.796 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 725' ' ' ALA . . . . . . . . . . . . . . . -146.82 152.65 39.1 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.637 179.918 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 726' ' ' THR . . . . . . . . . . . . . 72.5 p -128.04 159.2 35.77 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.816 -179.962 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 727' ' ' SER . . . . . . . . . . . . . 87.3 p -70.07 -23.74 63.12 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-N 116.361 -0.381 . . . . 0.0 111.591 179.851 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 728' ' ' ALA . . . . . . . . . . . . . . . -147.79 152.25 37.38 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.545 179.919 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 729' ' ' GLN . . . . . . . . . . . . . 96.7 mt-30 . . . . . 0 C--O 1.25 1.088 0 CA-C-O 118.291 -0.861 . . . . 0.0 110.752 -179.962 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 613' ' ' GLU . . . . . 0.491 ' HA ' ' O ' ' A' ' 637' ' ' GLY . 2.1 mp0 . . . . . 0 N--CA 1.487 1.39 0 CA-C-O 121.009 0.433 . . . . 0.0 110.656 . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 614' ' ' GLY . . . . . . . . . . . . . . . -82.42 176.78 53.65 Favored Glycine 0 C--N 1.33 0.202 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.604 179.968 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 615' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -115.27 131.39 56.95 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.942 0.401 . . . . 0.0 111.163 -179.813 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 616' ' ' ILE . . . . . 0.595 ' O ' ' HA ' ' A' ' 640' ' ' VAL . 85.2 mt -130.76 138.56 53.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 115.624 -0.716 . . . . 0.0 109.354 179.078 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 617' ' ' VAL . . . . . . . . . . . . . 33.0 m -110.61 146.72 15.4 Favored 'Isoleucine or valine' 0 C--O 1.235 0.334 0 C-N-CA 119.89 -0.724 . . . . 0.0 110.962 -179.931 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 618' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -116.48 126.87 53.99 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.857 -0.611 . . . . 0.0 110.716 179.895 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 619' ' ' VAL . . . . . . . . . . . . . 96.7 t -117.07 117.82 56.66 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 N-CA-C 109.537 -0.542 . . . . 0.0 109.537 179.512 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 620' ' ' SER . . . . . . . . . . . . . 83.3 p -170.06 163.8 9.29 Favored 'General case' 0 N--CA 1.453 -0.32 0 CA-C-N 115.521 -0.763 . . . . 0.0 111.145 -178.991 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 621' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -103.87 -5.52 22.26 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.315 -0.857 . . . . 0.0 111.17 178.584 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 622' ' ' ASP . . . . . . . . . . . . . 52.7 t0 -102.63 107.52 18.47 Favored 'General case' 0 C--O 1.233 0.234 0 CA-C-O 121.035 0.445 . . . . 0.0 111.076 -178.723 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 623' ' ' GLU . . . . . 0.41 ' O ' HG22 ' A' ' 627' ' ' THR . 98.0 mt-10 -64.58 -39.31 93.51 Favored 'General case' 0 CA--C 1.532 0.281 0 CA-C-N 115.591 -0.732 . . . . 0.0 112.415 179.834 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 624' ' ' ALA . . . . . . . . . . . . . . . -61.41 -43.99 97.92 Favored 'General case' 0 N--CA 1.466 0.339 0 N-CA-C 112.361 0.504 . . . . 0.0 112.361 -178.355 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 625' ' ' THR . . . . . . . . . . . . . 85.8 m -68.28 -39.48 82.13 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.385 0.612 . . . . 0.0 109.893 179.629 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 626' ' ' SER . . . . . 0.405 ' O ' HG22 ' A' ' 629' ' ' ILE . 67.0 m -61.66 -40.35 94.6 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 114.899 -1.046 . . . . 0.0 112.577 -178.832 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 627' ' ' THR . . . . . 0.41 HG22 ' O ' ' A' ' 623' ' ' GLU . 77.0 p -63.03 -39.31 94.36 Favored 'General case' 0 N--CA 1.466 0.336 0 N-CA-C 112.316 0.487 . . . . 0.0 112.316 -179.026 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 628' ' ' LEU . . . . . . . . . . . . . 62.4 tp -67.91 -46.32 71.89 Favored 'General case' 0 CA--C 1.533 0.293 0 N-CA-C 112.138 0.422 . . . . 0.0 112.138 -179.816 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 629' ' ' ILE . . . . . 0.405 HG22 ' O ' ' A' ' 626' ' ' SER . 20.6 tt -71.98 -36.76 58.57 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.417 0 N-CA-C 112.822 0.675 . . . . 0.0 112.822 -178.586 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 630' ' ' CYS . . . . . . . . . . . . . 81.1 m -62.64 -40.0 95.63 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-O 120.673 0.273 . . . . 0.0 110.95 -179.808 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 631' ' ' SER . . . . . . . . . . . . . 66.1 m -63.11 -41.21 99.31 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.738 179.768 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 632' ' ' ILE . . . . . . . . . . . . . 97.0 mt -62.54 -48.89 86.1 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.324 0 CA-C-O 120.962 0.411 . . . . 0.0 110.921 179.969 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 633' ' ' LEU . . . . . . . . . . . . . 82.2 mt -67.21 -40.73 86.5 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-N 115.853 -0.612 . . . . 0.0 112.461 -179.412 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 634' ' ' THR . . . . . 0.524 ' HA ' ' O ' ' A' ' 638' ' ' TYR . 86.0 m -66.35 -40.75 90.0 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.6 0.238 . . . . 0.0 111.054 -179.602 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 635' ' ' THR . . . . . . . . . . . . . 93.5 m -59.66 -38.95 82.86 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-O 120.885 0.374 . . . . 0.0 110.351 179.168 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 636' ' ' ALA . . . . . . . . . . . . . . . -64.21 -16.92 62.98 Favored 'General case' 0 CA--C 1.532 0.282 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.538 179.012 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 637' ' ' GLY . . . . . 0.491 ' O ' ' HA ' ' A' ' 613' ' ' GLU . . . 108.91 6.81 29.91 Favored Glycine 0 C--N 1.334 0.441 0 C-N-CA 120.996 -0.621 . . . . 0.0 113.115 179.781 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 638' ' ' TYR . . . . . 0.524 ' O ' ' HA ' ' A' ' 634' ' ' THR . 91.4 m-85 -100.16 142.53 31.51 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 120.843 0.354 . . . . 0.0 111.387 -179.95 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 639' ' ' GLN . . . . . . . . . . . . . 98.6 mm-40 -90.06 133.57 34.76 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.215 -0.448 . . . . 0.0 109.806 179.397 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 640' ' ' VAL . . . . . 0.595 ' HA ' ' O ' ' A' ' 616' ' ' ILE . 0.9 OUTLIER -122.21 138.97 50.62 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 N-CA-C 113.336 0.865 . . . . 0.0 113.336 -179.376 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 641' ' ' ILE . . . . . 0.409 HD13 HG22 ' A' ' 641' ' ' ILE . 48.6 mm -119.73 123.82 71.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 N-CA-C 108.533 -0.914 . . . . 0.0 108.533 178.041 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 642' ' ' TRP . . . . . . . . . . . . . 67.8 t90 -96.68 128.71 43.88 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 112.531 0.567 . . . . 0.0 112.531 -178.452 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 643' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -119.42 124.02 45.51 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 115.283 -0.871 . . . . 0.0 110.073 179.144 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 644' ' ' VAL . . . . . . . . . . . . . 7.8 p -93.09 3.62 8.11 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.475 0 CA-C-O 121.054 0.454 . . . . 0.0 111.531 -179.453 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 645' ' ' ASP . . . . . . . . . . . . . 15.4 t0 -125.74 -28.49 3.24 Favored 'General case' 0 N--CA 1.47 0.558 0 N-CA-C 113.089 0.774 . . . . 0.0 113.089 -177.471 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 646' ' ' GLY . . . . . . . . . . . . . . . 73.37 28.8 65.16 Favored Glycine 0 CA--C 1.52 0.377 0 C-N-CA 120.664 -0.779 . . . . 0.0 114.084 179.948 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 647' ' ' GLU . . . . . . . . . . . . . 33.7 mt-10 -65.6 123.13 18.86 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 121.384 0.611 . . . . 0.0 111.012 179.757 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 648' ' ' VAL . . . . . . . . . . . . . 77.3 t -61.36 -39.63 83.41 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-N 114.797 -1.092 . . . . 0.0 111.592 -179.396 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 649' ' ' GLU . . . . . . . . . . . . . 50.5 mp0 -60.53 -43.43 97.17 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.691 0.281 . . . . 0.0 110.439 -179.614 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 650' ' ' ARG . . . . . . . . . . . . . 95.6 mtt-85 -70.56 -41.6 72.23 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.731 178.686 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 651' ' ' LEU . . . . . . . . . . . . . 94.2 mt -65.89 -40.44 91.56 Favored 'General case' 0 N--CA 1.462 0.14 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.895 179.631 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 652' ' ' LEU . . . . . . . . . . . . . 63.3 tp -64.25 -43.21 95.58 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.102 179.028 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 653' ' ' ALA . . . . . . . . . . . . . . . -62.4 -39.67 94.0 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-O 121.164 0.507 . . . . 0.0 111.247 179.967 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 654' ' ' LEU . . . . . . . . . . . . . 76.6 mt -101.22 30.78 3.98 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.572 -0.74 . . . . 0.0 109.97 179.81 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 655' ' ' THR . . . . . . . . . . . . . 5.6 t -42.73 110.74 0.9 Allowed Pre-proline 0 N--CA 1.468 0.471 0 O-C-N 124.189 0.931 . . . . 0.0 113.276 -178.13 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 656' ' ' PRO . . . . . . . . . . . . . 23.5 Cg_endo -92.53 -175.61 0.6 Allowed 'Trans proline' 0 C--N 1.345 0.352 0 C-N-CA 124.069 3.179 . . . . 0.0 112.513 179.374 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 657' ' ' ILE . . . . . . . . . . . . . 27.2 pt -83.23 -24.11 8.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-O 121.239 0.542 . . . . 0.0 110.171 178.041 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 658' ' ' ALA . . . . . 0.408 ' HA ' ' O ' ' A' ' 687' ' ' LYS . . . -156.37 152.9 28.14 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.368 -0.833 . . . . 0.0 111.165 -179.756 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 659' ' ' VAL . . . . . . . . . . . . . 35.4 m -122.73 147.08 27.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-O 121.178 0.514 . . . . 0.0 111.266 179.49 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 660' ' ' LEU . . . . . . . . . . . . . 11.8 mt -116.69 115.39 25.56 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.436 -0.802 . . . . 0.0 109.814 178.646 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 661' ' ' LEU . . . . . . . . . . . . . 73.1 mt -106.11 114.57 28.79 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 109.557 -0.534 . . . . 0.0 109.557 -179.985 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 662' ' ' ALA . . . . . . . . . . . . . . . -106.07 131.22 53.6 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 112.57 0.581 . . . . 0.0 112.57 -178.873 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 663' ' ' GLU . . . . . . . . . . . . . 57.5 mt-10 -71.59 139.28 83.59 Favored Pre-proline 0 CA--C 1.535 0.396 0 CA-C-N 115.506 -0.77 . . . . 0.0 110.56 178.24 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 664' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -74.62 141.91 73.19 Favored 'Cis proline' 0 C--N 1.349 0.605 0 C-N-CA 123.367 -1.514 . . . . 0.0 112.448 -0.911 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 665' ' ' PHE . . . . . . . . . . . . . 40.8 m-85 -66.15 126.21 27.95 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.87 -179.892 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 666' ' ' SER . . . . . . . . . . . . . 66.7 m -64.01 -41.17 97.55 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.313 179.719 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 667' ' ' TYR . . . . . . . . . . . . . 53.1 t80 -68.63 -21.06 64.5 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-N 115.815 -0.63 . . . . 0.0 111.413 179.82 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 668' ' ' GLY . . . . . . . . . . . . . . . 102.52 -102.75 2.33 Favored Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 120.54 -0.838 . . . . 0.0 112.121 -178.712 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 669' ' ' ASP . . . . . . . . . . . . . 51.1 t0 -77.29 108.2 10.24 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.049 0.452 . . . . 0.0 110.399 -179.836 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 670' ' ' VAL . . . . . . . . . . . . . 11.2 p -62.7 -32.26 54.99 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.332 0 CA-C-N 115.472 -0.786 . . . . 0.0 112.918 -179.064 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 671' ' ' GLN . . . . . 0.474 ' O ' HG22 ' A' ' 674' ' ' VAL . 97.2 mt-30 -62.56 -40.88 98.26 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-O 120.898 0.38 . . . . 0.0 111.246 -179.179 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 672' ' ' GLU . . . . . . . . . . . . . 95.3 mt-10 -67.46 -40.58 85.38 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.917 0.389 . . . . 0.0 110.395 178.706 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 673' ' ' LEU . . . . . . . . . . . . . 63.3 tp -64.42 -45.34 87.99 Favored 'General case' 0 CA--C 1.53 0.193 0 CA-C-N 115.665 -0.698 . . . . 0.0 111.254 -179.924 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 674' ' ' VAL . . . . . 0.474 HG22 ' O ' ' A' ' 671' ' ' GLN . 27.2 m -67.77 -36.69 76.74 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.172 0 N-CA-C 110.211 -0.292 . . . . 0.0 110.211 179.813 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 675' ' ' ASP . . . . . . . . . . . . . 37.0 t70 -63.48 -40.62 97.58 Favored 'General case' 0 CA--C 1.521 -0.167 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.343 177.896 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 676' ' ' GLN . . . . . . . . . . . . . 76.9 mt-30 -69.51 -40.84 76.73 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.042 -179.533 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 677' ' ' LEU . . . . . . . . . . . . . 7.3 mp -69.21 -43.31 74.36 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.901 179.485 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 678' ' ' ARG . . . . . . . . . . . . . 61.9 ttp180 -64.62 -38.46 91.07 Favored 'General case' 0 N--CA 1.468 0.428 0 CA-C-O 121.248 0.546 . . . . 0.0 110.804 179.868 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 679' ' ' GLN . . . . . . . . . . . . . 71.3 tp60 -62.76 -38.87 92.26 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.512 -0.767 . . . . 0.0 111.036 -179.965 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 680' ' ' ARG . . . . . . . . . . . . . 31.4 mmm180 -84.54 -42.59 15.34 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 120.814 0.34 . . . . 0.0 111.431 -179.801 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 681' ' ' CYS . . . . . . . . . . . . . 74.3 m -126.47 130.69 51.13 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.343 -0.389 . . . . 0.0 110.307 179.727 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 682' ' ' THR . . . . . . . . . . . . . 68.2 p -68.88 158.95 84.73 Favored Pre-proline 0 C--N 1.325 -0.49 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.583 -179.709 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 683' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_exo -54.46 -32.25 72.44 Favored 'Trans proline' 0 C--N 1.349 0.588 0 C-N-CA 122.614 2.209 . . . . 0.0 112.389 179.636 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 684' ' ' GLU . . . . . . . . . . . . . 51.9 mp0 -70.65 -39.34 73.67 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.691 179.599 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 685' ' ' GLN . . . . . . . . . . . . . 71.8 tp60 -71.95 -41.64 67.55 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.829 -0.623 . . . . 0.0 111.852 179.888 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 686' ' ' LEU . . . . . . . . . . . . . 62.6 tp -129.72 119.89 24.21 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.759 -178.476 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 687' ' ' LYS . . . . . 0.408 ' O ' ' HA ' ' A' ' 658' ' ' ALA . 3.0 mptp? -85.13 145.01 27.84 Favored 'General case' 0 C--N 1.331 -0.229 0 N-CA-C 109.916 -0.401 . . . . 0.0 109.916 178.603 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 688' ' ' ILE . . . . . . . . . . . . . 80.0 mt -123.38 119.87 58.63 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.808 0 CA-C-O 121.328 0.585 . . . . 0.0 111.341 -178.977 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 689' ' ' PHE . . . . . 0.402 ' CD2' ' HB2' ' A' ' 702' ' ' ARG . 98.3 m-85 -117.61 144.86 44.76 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 114.958 -1.019 . . . . 0.0 109.934 178.983 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 690' ' ' ILE . . . . . . . . . . . . . 17.4 tt -124.97 137.76 56.5 Favored 'Isoleucine or valine' 0 C--O 1.237 0.398 0 CA-C-O 121.276 0.56 . . . . 0.0 111.751 -179.768 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 691' ' ' LEU . . . . . . . . . . . . . 58.7 mt -110.18 130.15 55.59 Favored 'General case' 0 C--O 1.234 0.269 0 CA-C-N 115.525 -0.761 . . . . 0.0 109.7 179.544 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 692' ' ' GLY . . . . . 0.599 ' O ' ' HA ' ' A' ' 705' ' ' PRO . . . 167.3 -166.73 39.45 Favored Glycine 0 N--CA 1.446 -0.673 0 C-N-CA 120.628 -0.796 . . . . 0.0 112.051 -179.714 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 693' ' ' SER . . . . . . . . . . . . . 89.6 p -87.52 -14.41 40.38 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 120.616 0.246 . . . . 0.0 111.623 179.93 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 694' ' ' LYS . . . . . . . . . . . . . 68.9 mttm -128.86 136.18 50.1 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.217 0.532 . . . . 0.0 111.384 -179.947 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 695' ' ' GLY . . . . . . . . . . . . . . . -117.27 22.97 10.04 Favored Glycine 0 N--CA 1.45 -0.428 0 CA-C-N 115.384 -0.826 . . . . 0.0 112.383 179.493 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 696' ' ' ASN . . . . . . . . . . . . . 21.5 p-10 -93.41 11.48 28.22 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 111.865 0.32 . . . . 0.0 111.865 -179.231 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 697' ' ' TYR . . . . . . . . . . . . . 81.6 m-85 -73.25 142.9 47.24 Favored 'General case' 0 N--CA 1.45 -0.439 0 CA-C-O 121.376 0.607 . . . . 0.0 110.84 179.914 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 698' ' ' GLN . . . . . . . . . . . . . 98.3 mm-40 -88.54 151.98 22.16 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-N 115.1 -0.955 . . . . 0.0 110.729 -179.653 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 699' ' ' GLY . . . . . . . . . . . . . . . 93.4 3.09 65.17 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.641 -0.79 . . . . 0.0 112.897 -179.725 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 700' ' ' VAL . . . . . . . . . . . . . 21.8 m -119.76 152.46 22.4 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.303 0 CA-C-O 120.859 0.362 . . . . 0.0 110.055 179.363 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 701' ' ' ASP . . . . . . . . . . . . . 66.5 m-20 -89.56 -36.59 15.25 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.114 -0.493 . . . . 0.0 112.25 -178.861 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 702' ' ' ARG . . . . . 0.402 ' HB2' ' CD2' ' A' ' 689' ' ' PHE . 2.3 mpt_? -141.2 163.84 31.88 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.812 0.339 . . . . 0.0 110.62 -178.689 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 703' ' ' TYR . . . . . . . . . . . . . 50.2 p90 -131.3 144.32 51.18 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.779 179.576 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 704' ' ' ILE . . . . . . . . . . . . . 52.3 mt -129.64 87.98 51.07 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.45 -179.774 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 705' ' ' PRO . . . . . 0.599 ' HA ' ' O ' ' A' ' 692' ' ' GLY . 31.2 Cg_exo -61.88 142.59 93.81 Favored 'Trans proline' 0 C--N 1.348 0.535 0 C-N-CA 123.511 2.807 . . . . 0.0 114.025 -179.236 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 706' ' ' LEU . . . . . . . . . . . . . 82.3 mt -80.52 145.22 58.52 Favored Pre-proline 0 CA--C 1.531 0.242 0 CA-C-N 115.544 -0.753 . . . . 0.0 110.336 178.28 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 707' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -74.48 142.88 76.09 Favored 'Cis proline' 0 C--N 1.345 0.382 0 C-N-CA 123.051 -1.645 . . . . 0.0 112.115 -1.31 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 708' ' ' ILE . . . . . . . . . . . . . 68.8 mt -75.46 121.28 26.84 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.305 179.469 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 709' ' ' HIS . . . . . . . . . . . . . 69.1 m80 -90.39 119.96 69.09 Favored Pre-proline 0 C--N 1.328 -0.355 0 CA-C-N 116.345 -0.388 . . . . 0.0 110.074 179.145 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 710' ' ' PRO . . . . . . . . . . . . . 82.8 Cg_exo -53.59 -38.27 83.83 Favored 'Trans proline' 0 N--CA 1.48 0.718 0 C-N-CA 123.471 2.781 . . . . 0.0 114.433 -178.961 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 711' ' ' GLU . . . . . . . . . . . . . 42.8 tt0 -64.28 -43.66 94.08 Favored 'General case' 0 CA--C 1.531 0.222 0 N-CA-C 112.13 0.418 . . . . 0.0 112.13 -178.746 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 712' ' ' SER . . . . . . . . . . . . . 48.9 m -87.29 -22.52 25.1 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 111.856 0.317 . . . . 0.0 111.856 -178.89 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 713' ' ' PHE . . . . . . . . . . . . . 82.4 t80 -60.0 -49.7 76.65 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.808 0.337 . . . . 0.0 110.899 -179.672 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 714' ' ' LEU . . . . . . . . . . . . . 89.8 mt -64.84 -38.51 91.22 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.348 179.29 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 715' ' ' GLN . . . . . . . . . . . . . 30.6 mm100 -63.48 -41.96 98.56 Favored 'General case' 0 CA--C 1.529 0.162 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.187 179.528 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 716' ' ' GLN . . . . . . . . . . . . . 87.3 mt-30 -64.43 -41.29 96.66 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-O 120.53 0.205 . . . . 0.0 111.072 179.53 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 717' ' ' VAL . . . . . . . . . . . . . 73.4 t -63.79 -44.34 98.2 Favored 'Isoleucine or valine' 0 C--O 1.233 0.2 0 CA-C-O 121.06 0.457 . . . . 0.0 109.822 178.919 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 718' ' ' THR . . . . . . . . . . . . . 91.3 m -62.29 -45.37 93.57 Favored 'General case' 0 CA--C 1.53 0.203 0 CA-C-N 115.479 -0.782 . . . . 0.0 110.826 179.427 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 719' ' ' MET . . . . . . . . . . . . . 95.3 mmm -62.27 -40.54 96.56 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-N 116.452 -0.34 . . . . 0.0 110.573 179.58 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 720' ' ' GLY . . . . . . . . . . . . . . . -62.36 -41.33 99.76 Favored Glycine 0 C--N 1.332 0.317 0 C-N-CA 120.644 -0.788 . . . . 0.0 111.793 178.596 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 721' ' ' LEU . . . . . . . . . . . . . 98.6 mt -65.96 -40.56 91.42 Favored 'General case' 0 N--CA 1.461 0.116 0 CA-C-O 120.737 0.303 . . . . 0.0 111.082 179.299 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 722' ' ' THR . . . . . . . . . . . . . 75.9 p -70.78 -24.81 62.66 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.451 179.804 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 723' ' ' SER . . . . . . . . . . . . . 75.0 m -64.37 -40.06 95.09 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-O 120.861 0.362 . . . . 0.0 110.196 178.732 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 724' ' ' LEU . . . . . . . . . . . . . 64.7 tp -63.81 -46.84 83.32 Favored 'General case' 0 CA--C 1.53 0.187 0 CA-C-N 115.714 -0.676 . . . . 0.0 111.356 179.525 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 725' ' ' ALA . . . . . . . . . . . . . . . -154.92 148.88 25.72 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.943 -179.817 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 726' ' ' THR . . . . . . . . . . . . . 73.5 p -80.72 160.54 24.92 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.255 179.919 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 727' ' ' SER . . . . . . . . . . . . . 97.4 p -153.19 162.93 40.75 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.279 -0.418 . . . . 0.0 110.451 179.97 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 728' ' ' ALA . . . . . . . . . . . . . . . -147.1 153.46 39.96 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.4 -0.364 . . . . 0.0 110.634 -179.863 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 729' ' ' GLN . . . . . . . . . . . . . 96.7 mt-30 . . . . . 0 C--O 1.249 1.076 0 CA-C-O 118.283 -0.865 . . . . 0.0 110.8 -179.971 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 613' ' ' GLU . . . . . . . . . . . . . 15.6 mt-10 . . . . . 0 N--CA 1.485 1.294 0 CA-C-O 120.814 0.34 . . . . 0.0 110.624 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 614' ' ' GLY . . . . . . . . . . . . . . . -161.87 165.48 35.79 Favored Glycine 0 N--CA 1.45 -0.386 0 N-CA-C 111.495 -0.642 . . . . 0.0 111.495 179.677 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 615' ' ' ARG . . . . . . . . . . . . . 83.7 mtp180 -116.58 130.08 56.54 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.011 0.434 . . . . 0.0 111.087 -179.743 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 616' ' ' ILE . . . . . . . . . . . . . 83.7 mt -124.75 134.26 67.3 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-N 115.54 -0.755 . . . . 0.0 109.746 179.393 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 617' ' ' VAL . . . . . . . . . . . . . 96.2 t -105.77 127.04 61.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-O 121.046 0.45 . . . . 0.0 110.044 -179.908 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 618' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -109.22 129.08 55.5 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.703 -0.68 . . . . 0.0 111.045 -178.58 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 619' ' ' VAL . . . . . . . . . . . . . 80.0 t -117.87 118.67 59.07 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.124 179.905 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 620' ' ' SER . . . . . . . . . . . . . 22.8 t -172.36 137.34 0.86 Allowed 'General case' 0 C--O 1.232 0.176 0 CA-C-N 115.621 -0.718 . . . . 0.0 110.826 -179.899 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 621' ' ' GLU . . . . . . . . . . . . . 25.7 pt-20 -85.3 -10.49 56.37 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.804 179.206 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 622' ' ' ASP . . . . . . . . . . . . . 36.0 t70 -90.63 109.67 20.83 Favored 'General case' 0 C--O 1.232 0.179 0 CA-C-O 120.894 0.378 . . . . 0.0 110.62 -179.528 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 623' ' ' GLU . . . . . . . . . . . . . 51.1 mp0 -63.0 -39.77 95.77 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.597 -0.729 . . . . 0.0 112.755 -178.776 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 624' ' ' ALA . . . . . . . . . . . . . . . -61.04 -45.95 92.71 Favored 'General case' 0 N--CA 1.466 0.357 0 N-CA-C 112.674 0.62 . . . . 0.0 112.674 -178.033 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 625' ' ' THR . . . . . . . . . . . . . 89.2 m -71.27 -41.36 70.14 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.011 0.434 . . . . 0.0 110.665 179.752 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 626' ' ' SER . . . . . 0.501 ' O ' HG21 ' A' ' 629' ' ' ILE . 66.9 m -63.16 -41.94 99.34 Favored 'General case' 0 CA--C 1.531 0.246 0 CA-C-N 115.707 -0.679 . . . . 0.0 112.674 -178.215 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 627' ' ' THR . . . . . . . . . . . . . 34.4 p -66.34 -40.89 90.13 Favored 'General case' 0 N--CA 1.466 0.373 0 N-CA-C 112.047 0.388 . . . . 0.0 112.047 -179.868 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 628' ' ' LEU . . . . . . . . . . . . . 61.8 tp -66.46 -44.39 82.89 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.647 179.612 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 629' ' ' ILE . . . . . 0.501 HG21 ' O ' ' A' ' 626' ' ' SER . 2.5 tp -69.25 -37.09 75.49 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.555 0 N-CA-C 112.705 0.631 . . . . 0.0 112.705 -178.574 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 630' ' ' CYS . . . . . . . . . . . . . 89.6 m -64.08 -39.46 94.12 Favored 'General case' 0 N--CA 1.465 0.297 0 N-CA-C 111.624 0.231 . . . . 0.0 111.624 -179.527 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 631' ' ' SER . . . . . . . . . . . . . 68.7 m -61.95 -41.61 98.18 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.162 -179.321 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 632' ' ' ILE . . . . . . . . . . . . . 97.1 mt -62.85 -48.15 89.43 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.306 0 CA-C-O 120.987 0.422 . . . . 0.0 110.912 179.836 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 633' ' ' LEU . . . . . . . . . . . . . 80.7 mt -66.47 -40.47 89.38 Favored 'General case' 0 C--O 1.234 0.255 0 CA-C-N 115.907 -0.588 . . . . 0.0 112.432 -179.565 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 634' ' ' THR . . . . . 0.478 ' HA ' ' O ' ' A' ' 638' ' ' TYR . 78.7 m -65.68 -40.16 92.07 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.652 0.263 . . . . 0.0 110.858 -179.373 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 635' ' ' THR . . . . . . . . . . . . . 92.9 m -59.05 -38.88 80.4 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.331 179.24 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 636' ' ' ALA . . . . . . . . . . . . . . . -64.69 -17.72 64.35 Favored 'General case' 0 CA--C 1.533 0.307 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.412 178.932 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 637' ' ' GLY . . . . . . . . . . . . . . . 109.01 6.61 29.85 Favored Glycine 0 C--N 1.333 0.381 0 C-N-CA 120.918 -0.658 . . . . 0.0 113.102 179.836 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 638' ' ' TYR . . . . . 0.478 ' O ' ' HA ' ' A' ' 634' ' ' THR . 93.1 m-85 -100.49 141.84 32.79 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.841 0.353 . . . . 0.0 111.46 -179.935 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 639' ' ' GLN . . . . . . . . . . . . . 78.7 mt-30 -89.18 134.55 33.98 Favored 'General case' 0 CA--C 1.517 -0.309 0 CA-C-N 116.229 -0.441 . . . . 0.0 109.894 179.172 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 640' ' ' VAL . . . . . . . . . . . . . 57.3 t -118.9 131.58 71.27 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 N-CA-C 112.6 0.593 . . . . 0.0 112.6 -178.726 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 641' ' ' ILE . . . . . . . . . . . . . 42.7 mm -107.72 114.4 46.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 N-CA-C 108.116 -1.068 . . . . 0.0 108.116 177.926 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 642' ' ' TRP . . . . . . . . . . . . . 22.6 t90 -93.92 124.42 37.91 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.203 0.525 . . . . 0.0 112.225 -178.193 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 643' ' ' LEU . . . . . . . . . . . . . 90.0 mt -121.34 141.44 50.94 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-N 115.558 -0.746 . . . . 0.0 110.73 179.239 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 644' ' ' VAL . . . . . . . . . . . . . 5.8 m -108.79 23.6 3.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 N-CA-C 112.07 0.396 . . . . 0.0 112.07 -179.818 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 645' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -136.84 -37.21 0.67 Allowed 'General case' 0 N--CA 1.47 0.565 0 N-CA-C 112.934 0.716 . . . . 0.0 112.934 -178.301 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 646' ' ' GLY . . . . . . . . . . . . . . . 76.56 21.27 75.35 Favored Glycine 0 CA--C 1.52 0.345 0 C-N-CA 120.76 -0.734 . . . . 0.0 113.359 -179.485 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 647' ' ' GLU . . . . . . . . . . . . . 86.5 tt0 -62.49 123.47 18.41 Favored 'General case' 0 N--CA 1.456 -0.173 0 CA-C-O 121.261 0.553 . . . . 0.0 110.411 -179.718 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 648' ' ' VAL . . . . . . . . . . . . . 9.3 p -63.2 -31.75 53.87 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-N 114.981 -1.009 . . . . 0.0 112.661 -178.459 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 649' ' ' GLU . . . . . . . . . . . . . 99.1 mt-10 -63.46 -41.81 98.61 Favored 'General case' 0 N--CA 1.461 0.116 0 C-N-CA 120.71 -0.396 . . . . 0.0 110.107 179.615 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 650' ' ' ARG . . . . . . . . . . . . . 2.2 mpt_? -73.13 -40.04 65.24 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.254 178.482 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 651' ' ' LEU . . . . . . . . . . . . . 84.9 mt -63.09 -41.75 99.46 Favored 'General case' 0 CA--C 1.521 -0.157 0 CA-C-N 116.361 -0.381 . . . . 0.0 109.982 178.848 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 652' ' ' LEU . . . . . . . . . . . . . 62.1 tp -65.32 -43.29 91.48 Favored 'General case' 0 CA--C 1.53 0.203 0 CA-C-N 115.882 -0.599 . . . . 0.0 111.111 178.597 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 653' ' ' ALA . . . . . . . . . . . . . . . -62.76 -39.56 94.56 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-O 121.007 0.432 . . . . 0.0 111.988 179.966 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 654' ' ' LEU . . . . . . . . . . . . . 76.1 mt -101.94 29.78 4.81 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.2 -179.275 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 655' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -33.58 104.8 0.24 Allowed Pre-proline 0 N--CA 1.47 0.537 0 O-C-N 124.537 1.148 . . . . 0.0 113.925 -179.459 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 656' ' ' PRO . . . . . . . . . . . . . 34.0 Cg_endo -91.5 -176.56 0.87 Allowed 'Trans proline' 0 C--N 1.345 0.347 0 C-N-CA 123.456 2.77 . . . . 0.0 111.789 178.31 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 657' ' ' ILE . . . . . . . . . . . . . 22.8 pt -81.57 -25.06 9.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 121.333 0.587 . . . . 0.0 109.758 178.205 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 658' ' ' ALA . . . . . 0.448 ' HA ' ' O ' ' A' ' 687' ' ' LYS . . . -159.43 153.81 23.93 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.15 -0.932 . . . . 0.0 111.25 -179.825 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 659' ' ' VAL . . . . . . . . . . . . . 18.2 m -121.44 145.29 28.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-O 121.09 0.472 . . . . 0.0 110.633 178.816 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 660' ' ' LEU . . . . . . . . . . . . . 14.8 mt -117.13 120.37 38.11 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.498 -0.774 . . . . 0.0 110.355 179.646 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 661' ' ' LEU . . . . . . . . . . . . . 72.5 mt -107.78 110.79 22.69 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 109.177 -0.675 . . . . 0.0 109.177 179.397 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 662' ' ' ALA . . . . . . . . . . . . . . . -107.76 128.26 54.42 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 112.533 0.568 . . . . 0.0 112.533 -178.467 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 663' ' ' GLU . . . . . . . . . . . . . 99.7 mt-10 -70.06 145.28 93.77 Favored Pre-proline 0 C--N 1.326 -0.427 0 CA-C-N 115.623 -0.717 . . . . 0.0 110.482 177.903 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 664' ' ' PRO . . . . . . . . . . . . . 64.1 Cg_endo -73.92 140.59 68.1 Favored 'Cis proline' 0 C--N 1.347 0.492 0 C-N-CA 123.364 -1.515 . . . . 0.0 112.543 -1.204 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 665' ' ' PHE . . . . . . . . . . . . . 41.0 m-85 -74.06 142.82 45.65 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.914 -0.585 . . . . 0.0 111.509 -179.756 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 666' ' ' SER . . . . . . . . . . . . . 65.7 p -93.56 -32.75 14.01 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.09 179.203 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 667' ' ' TYR . . . . . . . . . . . . . 65.7 t80 -68.88 -24.19 64.3 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 116.246 -0.433 . . . . 0.0 111.662 179.129 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 668' ' ' GLY . . . . . . . . . . . . . . . 99.91 -103.96 2.75 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.58 -0.819 . . . . 0.0 112.087 -179.197 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 669' ' ' ASP . . . . . . . . . . . . . 50.1 t0 -82.7 105.85 14.07 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.802 0.334 . . . . 0.0 110.179 179.889 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 670' ' ' VAL . . . . . 0.472 ' O ' HG21 ' A' ' 674' ' ' VAL . 12.4 m -71.08 -23.74 23.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 N-CA-C 113.589 0.959 . . . . 0.0 113.589 -178.884 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 671' ' ' GLN . . . . . . . . . . . . . 77.5 mt-30 -61.47 -42.21 98.43 Favored 'General case' 0 N--CA 1.462 0.15 0 CA-C-N 118.259 0.481 . . . . 0.0 110.563 -179.424 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 672' ' ' GLU . . . . . . . . . . . . . 95.1 mt-10 -65.84 -40.78 92.08 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.42 178.548 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 673' ' ' LEU . . . . . . . . . . . . . 61.8 tp -64.48 -43.81 92.98 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.076 179.384 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 674' ' ' VAL . . . . . 0.472 HG21 ' O ' ' A' ' 670' ' ' VAL . 54.7 t -62.59 -44.61 99.53 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 CA-C-N 115.762 -0.654 . . . . 0.0 109.65 179.34 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 675' ' ' ASP . . . . . . . . . . . . . 37.4 t70 -60.46 -41.01 93.28 Favored 'General case' 0 CA--C 1.522 -0.133 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.291 178.512 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 676' ' ' GLN . . . . . . . . . . . . . 96.6 mt-30 -68.12 -41.67 81.38 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.251 -0.432 . . . . 0.0 110.521 179.816 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 677' ' ' LEU . . . . . . . . . . . . . 84.0 mt -65.77 -42.39 90.89 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.139 179.568 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 678' ' ' ARG . . . . . 0.416 ' HA ' ' O ' ' A' ' 681' ' ' CYS . 37.1 mtp-105 -70.01 -36.29 75.0 Favored 'General case' 0 N--CA 1.468 0.466 0 CA-C-O 121.072 0.463 . . . . 0.0 111.092 179.72 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 679' ' ' GLN . . . . . . . . . . . . . 50.1 tt0 -64.27 -37.0 85.94 Favored 'General case' 0 N--CA 1.451 -0.388 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.211 179.592 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 680' ' ' ARG . . . . . . . . . . . . . 89.6 mmt-85 -83.92 -44.32 14.37 Favored 'General case' 0 C--N 1.333 -0.122 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.041 179.678 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 681' ' ' CYS . . . . . 0.416 ' O ' ' HA ' ' A' ' 678' ' ' ARG . 73.8 m -128.95 131.79 47.53 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.563 179.895 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 682' ' ' THR . . . . . . . . . . . . . 68.9 p -70.69 159.62 84.56 Favored Pre-proline 0 C--N 1.321 -0.651 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.577 -179.96 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 683' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_exo -53.87 -32.78 68.7 Favored 'Trans proline' 0 C--N 1.351 0.672 0 C-N-CA 122.718 2.279 . . . . 0.0 112.781 179.918 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 684' ' ' GLU . . . . . . . . . . . . . 98.3 mt-10 -69.34 -38.78 78.32 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.052 0.454 . . . . 0.0 110.49 179.721 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 685' ' ' GLN . . . . . . . . . . . . . 91.1 mt-30 -71.75 -40.19 69.5 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.454 -0.794 . . . . 0.0 111.837 179.996 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 686' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -142.88 128.31 18.95 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.996 0.427 . . . . 0.0 111.788 -178.72 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 687' ' ' LYS . . . . . 0.448 ' O ' ' HA ' ' A' ' 658' ' ' ALA . 46.7 mmtm -90.83 147.18 23.36 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.401 0.619 . . . . 0.0 111.341 179.195 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 688' ' ' ILE . . . . . . . . . . . . . 79.3 mt -121.81 121.07 63.35 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.742 0 CA-C-N 115.472 -0.786 . . . . 0.0 110.4 -179.868 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 689' ' ' PHE . . . . . . . . . . . . . 92.1 m-85 -121.82 145.4 48.1 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.534 -0.757 . . . . 0.0 110.276 179.386 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 690' ' ' ILE . . . . . . . . . . . . . 19.2 tt -127.28 138.74 53.92 Favored 'Isoleucine or valine' 0 C--O 1.236 0.363 0 CA-C-O 121.259 0.552 . . . . 0.0 111.802 -178.912 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 691' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -118.88 116.02 25.62 Favored 'General case' 0 C--O 1.234 0.288 0 CA-C-N 115.551 -0.749 . . . . 0.0 110.434 179.887 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 692' ' ' GLY . . . . . . . . . . . . . . . 161.94 129.09 0.99 Allowed Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.62 -0.8 . . . . 0.0 112.994 179.46 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 693' ' ' SER . . . . . . . . . . . . . 48.2 m 49.82 -114.68 0.74 Allowed 'General case' 0 CA--C 1.529 0.145 0 C-N-CA 123.101 0.56 . . . . 0.0 111.444 179.914 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 694' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -100.02 -12.17 19.96 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.26 -179.862 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 695' ' ' GLY . . . . . 0.433 ' HA3' ' HB2' ' A' ' 703' ' ' TYR . . . 69.76 28.7 71.75 Favored Glycine 0 CA--C 1.519 0.309 0 C-N-CA 120.979 -0.629 . . . . 0.0 113.263 -179.93 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 696' ' ' ASN . . . . . . . . . . . . . 65.4 t30 -81.24 74.34 8.24 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.205 0.526 . . . . 0.0 110.978 -179.681 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 697' ' ' TYR . . . . . . . . . . . . . 97.5 m-85 -131.36 148.31 52.66 Favored 'General case' 0 N--CA 1.453 -0.294 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.283 179.792 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 698' ' ' GLN . . . . . . . . . . . . . 19.3 pt20 -89.76 153.87 20.36 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.906 -179.439 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 699' ' ' GLY . . . . . . . . . . . . . . . 90.46 4.46 70.65 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.596 -0.811 . . . . 0.0 113.524 179.636 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 700' ' ' VAL . . . . . . . . . . . . . 28.9 m -116.03 145.05 22.3 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.335 0 CA-C-N 117.489 0.644 . . . . 0.0 110.537 179.4 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 701' ' ' ASP . . . . . . . . . . . . . 36.8 t70 -71.61 -40.81 69.58 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.347 -0.842 . . . . 0.0 112.111 -179.615 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 702' ' ' ARG . . . . . . . . . . . . . 36.4 ttm180 -155.13 148.8 25.36 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.782 0.325 . . . . 0.0 110.548 -179.192 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 703' ' ' TYR . . . . . 0.433 ' HB2' ' HA3' ' A' ' 695' ' ' GLY . 25.7 p90 -106.58 146.93 30.07 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.693 -179.486 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 704' ' ' ILE . . . . . . . . . . . . . 54.6 mt -121.41 95.56 48.27 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-N 115.783 -0.644 . . . . 0.0 109.836 179.504 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 705' ' ' PRO . . . . . . . . . . . . . 81.2 Cg_endo -74.95 154.89 43.06 Favored 'Trans proline' 0 C--N 1.347 0.469 0 C-N-CA 122.981 2.454 . . . . 0.0 113.901 -178.766 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 706' ' ' LEU . . . . . 0.533 ' HA ' ' C ' ' A' ' 707' ' ' PRO . 6.4 mp -103.14 147.84 34.75 Favored Pre-proline 0 CA--C 1.532 0.263 0 CA-C-N 115.403 -0.817 . . . . 0.0 109.781 178.68 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 707' ' ' PRO . . . . . 0.533 ' C ' ' HA ' ' A' ' 706' ' ' LEU . 32.6 Cg_exo -63.2 136.79 23.21 Favored 'Cis proline' 0 C--N 1.35 0.641 0 C-N-CA 123.848 -1.313 . . . . 0.0 112.424 -1.159 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 708' ' ' ILE . . . . . 0.448 HG13 ' HG ' ' A' ' 706' ' ' LEU . 72.0 mt -81.54 119.37 31.01 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.353 179.44 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 709' ' ' HIS . . . . . . . . . . . . . 68.8 m80 -87.37 122.88 70.53 Favored Pre-proline 0 C--N 1.325 -0.469 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.17 179.348 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 710' ' ' PRO . . . . . . . . . . . . . 20.5 Cg_endo -60.41 -31.43 92.63 Favored 'Trans proline' 0 C--N 1.349 0.578 0 C-N-CA 122.944 2.429 . . . . 0.0 113.511 -178.92 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 711' ' ' GLU . . . . . . . . . . . . . 88.7 tt0 -64.7 -43.68 92.69 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.83 -179.753 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 712' ' ' SER . . . . . . . . . . . . . 68.2 m -91.65 -20.45 21.6 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 112.06 0.393 . . . . 0.0 112.06 -178.669 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 713' ' ' PHE . . . . . . . . . . . . . 85.3 t80 -60.22 -49.36 77.92 Favored 'General case' 0 C--O 1.234 0.256 0 CA-C-O 120.814 0.34 . . . . 0.0 110.584 179.935 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 714' ' ' LEU . . . . . . . . . . . . . 96.2 mt -65.07 -37.7 88.38 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.189 179.254 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 715' ' ' GLN . . . . . . . . . . . . . 97.4 mt-30 -62.18 -41.85 98.72 Favored 'General case' 0 C--N 1.333 -0.125 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.973 179.083 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 716' ' ' GLN . . . . . . . . . . . . . 86.3 mt-30 -63.81 -42.59 97.66 Favored 'General case' 0 N--CA 1.463 0.187 0 CA-C-N 116.669 -0.241 . . . . 0.0 111.112 179.49 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 717' ' ' VAL . . . . . . . . . . . . . 77.5 t -64.64 -45.36 95.6 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 CA-C-O 120.929 0.395 . . . . 0.0 110.309 179.413 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 718' ' ' THR . . . . . . . . . . . . . 89.8 m -61.14 -48.18 82.82 Favored 'General case' 0 C--O 1.224 -0.271 0 CA-C-N 115.655 -0.702 . . . . 0.0 110.911 179.848 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 719' ' ' MET . . . . . . . . . . . . . 38.5 mmt -62.84 -39.26 93.8 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-O 120.796 0.331 . . . . 0.0 110.634 179.729 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 720' ' ' GLY . . . . . . . . . . . . . . . -61.65 -39.78 97.86 Favored Glycine 0 CA--C 1.522 0.528 0 CA-C-N 115.767 -0.651 . . . . 0.0 113.26 179.582 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 721' ' ' LEU . . . . . . . . . . . . . 1.7 pp -88.65 -33.91 17.44 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 117.33 0.565 . . . . 0.0 111.954 -179.358 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 722' ' ' THR . . . . . . . . . . . . . 95.2 m -63.86 -39.83 95.13 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.506 -0.315 . . . . 0.0 111.606 -179.675 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 723' ' ' SER . . . . . . . . . . . . . 80.5 p -61.84 -35.68 78.98 Favored 'General case' 0 CA--C 1.533 0.291 0 CA-C-N 116.696 -0.229 . . . . 0.0 111.207 179.627 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 724' ' ' LEU . . . . . . . . . . . . . 1.5 tm? -69.45 -45.71 68.43 Favored 'General case' 0 CA--C 1.532 0.266 0 CA-C-N 116.452 -0.34 . . . . 0.0 110.69 179.094 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 725' ' ' ALA . . . . . . . . . . . . . . . -155.89 148.11 23.52 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.1 -179.951 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 726' ' ' THR . . . . . . . . . . . . . 73.6 p -80.93 160.31 24.7 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.295 179.899 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 727' ' ' SER . . . . . . . . . . . . . 60.5 m -126.98 148.83 50.08 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.424 -0.353 . . . . 0.0 110.615 179.864 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 728' ' ' ALA . . . . . . . . . . . . . . . -147.28 153.97 40.4 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.734 -179.899 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 729' ' ' GLN . . . . . . . . . . . . . 96.7 mt-30 . . . . . 0 C--O 1.248 1.024 0 CA-C-O 118.375 -0.822 . . . . 0.0 110.758 -179.957 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 613' ' ' GLU . . . . . 0.493 ' HA ' ' O ' ' A' ' 637' ' ' GLY . 4.1 pt-20 . . . . . 0 N--CA 1.49 1.535 0 CA-C-O 121.103 0.477 . . . . 0.0 110.765 . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 614' ' ' GLY . . . . . . . . . . . . . . . -82.93 177.64 53.26 Favored Glycine 0 CA--C 1.519 0.325 0 C-N-CA 120.939 -0.648 . . . . 0.0 112.85 -179.939 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 615' ' ' ARG . . . . . . . . . . . . . 48.6 mtm105 -108.74 128.25 54.71 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.721 0.296 . . . . 0.0 110.902 -179.709 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 616' ' ' ILE . . . . . 0.443 ' O ' ' HA ' ' A' ' 640' ' ' VAL . 85.4 mt -124.68 133.43 69.44 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.328 179.099 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 617' ' ' VAL . . . . . . . . . . . . . 86.2 t -105.73 127.63 60.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 121.042 0.449 . . . . 0.0 110.095 179.808 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 618' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -109.27 127.27 54.14 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.75 -178.73 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 619' ' ' VAL . . . . . . . . . . . . . 67.9 t -116.66 118.88 60.24 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 N-CA-C 109.463 -0.569 . . . . 0.0 109.463 179.585 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 620' ' ' SER . . . . . . . . . . . . . 34.9 t -168.63 144.94 3.67 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.599 -0.728 . . . . 0.0 111.297 -179.068 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 621' ' ' GLU . . . . . . . . . . . . . 99.2 mt-10 -91.05 -11.79 37.67 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.797 -0.638 . . . . 0.0 111.378 178.867 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 622' ' ' ASP . . . . . . . . . . . . . 29.0 t70 -93.3 111.56 23.25 Favored 'General case' 0 C--O 1.231 0.131 0 CA-C-O 120.877 0.37 . . . . 0.0 111.243 -178.766 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 623' ' ' GLU . . . . . . . . . . . . . 51.3 mp0 -63.8 -38.92 92.89 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.729 -0.669 . . . . 0.0 112.52 -179.611 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 624' ' ' ALA . . . . . . . . . . . . . . . -60.76 -45.61 93.67 Favored 'General case' 0 N--CA 1.465 0.315 0 N-CA-C 112.947 0.721 . . . . 0.0 112.947 -177.822 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 625' ' ' THR . . . . . . . . . . . . . 25.0 p -75.24 -36.31 61.31 Favored 'General case' 0 C--N 1.33 -0.242 0 C-N-CA 120.503 -0.479 . . . . 0.0 111.167 179.414 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 626' ' ' SER . . . . . 0.422 ' O ' HG22 ' A' ' 629' ' ' ILE . 66.5 m -64.38 -42.78 95.97 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.99 -178.79 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 627' ' ' THR . . . . . . . . . . . . . 34.6 p -67.17 -41.46 85.92 Favored 'General case' 0 N--CA 1.465 0.29 0 N-CA-C 111.917 0.34 . . . . 0.0 111.917 -179.904 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 628' ' ' LEU . . . . . . . . . . . . . 61.7 tp -67.42 -44.06 79.69 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.519 179.64 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 629' ' ' ILE . . . . . 0.422 HG22 ' O ' ' A' ' 626' ' ' SER . 1.7 tp -69.67 -37.37 73.9 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.562 0 N-CA-C 112.586 0.587 . . . . 0.0 112.586 -178.389 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 630' ' ' CYS . . . . . . . . . . . . . 87.2 m -64.27 -39.18 93.4 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-O 120.747 0.308 . . . . 0.0 111.32 -179.83 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 631' ' ' SER . . . . . . . . . . . . . 68.3 m -62.02 -41.75 98.42 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.031 -0.532 . . . . 0.0 110.934 -179.42 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 632' ' ' ILE . . . . . . . . . . . . . 97.0 mt -63.29 -48.4 87.58 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.282 0 CA-C-O 120.844 0.354 . . . . 0.0 110.846 179.736 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 633' ' ' LEU . . . . . . . . . . . . . 83.5 mt -66.41 -40.36 89.56 Favored 'General case' 0 C--O 1.234 0.28 0 CA-C-N 116.075 -0.511 . . . . 0.0 112.314 -179.673 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 634' ' ' THR . . . . . 0.504 ' HA ' ' O ' ' A' ' 638' ' ' TYR . 84.7 m -65.81 -40.17 91.62 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.679 0.276 . . . . 0.0 110.919 -179.471 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 635' ' ' THR . . . . . . . . . . . . . 93.6 m -58.97 -38.75 79.83 Favored 'General case' 0 CA--C 1.53 0.205 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.498 179.43 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 636' ' ' ALA . . . . . . . . . . . . . . . -64.37 -17.23 63.54 Favored 'General case' 0 CA--C 1.533 0.318 0 CA-C-N 115.95 -0.568 . . . . 0.0 111.518 178.852 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 637' ' ' GLY . . . . . 0.493 ' O ' ' HA ' ' A' ' 613' ' ' GLU . . . 108.92 7.38 29.24 Favored Glycine 0 C--N 1.333 0.374 0 C-N-CA 120.94 -0.647 . . . . 0.0 113.1 179.836 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 638' ' ' TYR . . . . . 0.504 ' O ' ' HA ' ' A' ' 634' ' ' THR . 93.4 m-85 -100.01 141.31 32.99 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.837 0.351 . . . . 0.0 111.417 -179.886 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 639' ' ' GLN . . . . . . . . . . . . . 98.3 mt-30 -88.05 132.92 34.1 Favored 'General case' 0 CA--C 1.518 -0.283 0 N-CA-C 109.625 -0.509 . . . . 0.0 109.625 178.981 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 640' ' ' VAL . . . . . 0.443 ' HA ' ' O ' ' A' ' 616' ' ' ILE . 58.0 t -119.3 131.15 72.78 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 N-CA-C 112.653 0.612 . . . . 0.0 112.653 -178.823 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 641' ' ' ILE . . . . . . . . . . . . . 4.0 mp -110.23 116.41 52.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 N-CA-C 107.907 -1.146 . . . . 0.0 107.907 177.787 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 642' ' ' TRP . . . . . . . . . . . . . 19.7 t90 -96.03 124.53 40.08 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 121.222 0.535 . . . . 0.0 112.222 -177.879 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 643' ' ' LEU . . . . . . . . . . . . . 89.8 mt -121.77 142.14 50.51 Favored 'General case' 0 C--O 1.232 0.157 0 CA-C-N 115.413 -0.812 . . . . 0.0 110.647 179.332 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 644' ' ' VAL . . . . . . . . . . . . . 7.1 m -109.63 22.11 4.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.25 179.731 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 645' ' ' ASP . . . . . . . . . . . . . 11.5 t0 -128.45 -48.2 1.29 Allowed 'General case' 0 N--CA 1.468 0.472 0 N-CA-C 112.929 0.714 . . . . 0.0 112.929 -177.308 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 646' ' ' GLY . . . . . . . . . . . . . . . 80.69 23.95 59.21 Favored Glycine 0 CA--C 1.523 0.557 0 C-N-CA 120.665 -0.779 . . . . 0.0 113.928 -179.786 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 647' ' ' GLU . . . . . . . . . . . . . 77.5 mm-40 -68.24 131.43 45.35 Favored 'General case' 0 C--N 1.333 -0.125 0 CA-C-N 117.303 0.551 . . . . 0.0 110.928 179.697 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 648' ' ' VAL . . . . . . . . . . . . . 77.8 t -61.17 -41.52 89.81 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 CA-C-N 114.821 -1.081 . . . . 0.0 111.669 -179.398 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 649' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -61.59 -42.82 99.41 Favored 'General case' 0 C--N 1.331 -0.203 0 C-N-CA 120.772 -0.371 . . . . 0.0 110.496 -179.791 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 650' ' ' ARG . . . . . . . . . . . . . 80.8 mtp180 -70.5 -40.82 73.33 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.466 -0.334 . . . . 0.0 110.621 178.775 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 651' ' ' LEU . . . . . . . . . . . . . 84.3 mt -65.17 -41.09 94.97 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.558 178.863 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 652' ' ' LEU . . . . . . . . . . . . . 62.8 tp -65.2 -42.99 93.02 Favored 'General case' 0 CA--C 1.532 0.263 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.133 178.985 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 653' ' ' ALA . . . . . . . . . . . . . . . -62.7 -40.0 95.76 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-O 121.049 0.452 . . . . 0.0 111.58 -179.762 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 654' ' ' LEU . . . . . . . . . . . . . 76.1 mt -101.91 30.09 4.62 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.76 -0.654 . . . . 0.0 109.969 179.813 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 655' ' ' THR . . . . . 0.406 HG22 ' O ' ' A' ' 655' ' ' THR . 6.1 t -43.86 109.84 0.88 Allowed Pre-proline 0 CA--C 1.538 0.498 0 O-C-N 124.159 0.912 . . . . 0.0 113.416 -177.877 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 656' ' ' PRO . . . . . . . . . . . . . 27.4 Cg_endo -92.72 -175.36 0.55 Allowed 'Trans proline' 0 C--N 1.344 0.321 0 C-N-CA 124.008 3.138 . . . . 0.0 112.281 178.918 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 657' ' ' ILE . . . . . 0.402 ' O ' ' HA ' ' A' ' 686' ' ' LEU . 24.8 pt -82.19 -23.1 9.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-O 121.278 0.561 . . . . 0.0 109.824 178.223 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 658' ' ' ALA . . . . . . . . . . . . . . . -158.72 151.81 22.52 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.271 -0.877 . . . . 0.0 110.853 179.725 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 659' ' ' VAL . . . . . . . . . . . . . 29.1 m -121.39 145.0 28.64 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-O 121.316 0.579 . . . . 0.0 110.774 178.952 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 660' ' ' LEU . . . . . . . . . . . . . 4.6 mp -113.94 116.19 28.86 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.455 -0.793 . . . . 0.0 109.172 178.943 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 661' ' ' LEU . . . . . . . . . . . . . 50.6 mt -103.6 110.27 22.27 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 109.387 -0.597 . . . . 0.0 109.387 -179.102 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 662' ' ' ALA . . . . . . . . . . . . . . . -107.71 136.19 47.87 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 112.523 0.564 . . . . 0.0 112.523 -178.595 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 663' ' ' GLU . . . . . . . . . . . . . 95.1 mt-10 -70.88 145.77 92.27 Favored Pre-proline 0 C--N 1.327 -0.39 0 CA-C-N 115.596 -0.729 . . . . 0.0 110.359 178.116 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 664' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -76.42 142.68 73.94 Favored 'Cis proline' 0 C--N 1.349 0.599 0 C-N-CA 123.363 -1.515 . . . . 0.0 112.621 -1.083 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 665' ' ' PHE . . . . . . . . . . . . . 20.1 m-85 -68.87 134.82 50.15 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.997 179.602 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 666' ' ' SER . . . . . . . . . . . . . 56.8 p -96.85 -33.99 11.44 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.845 0.355 . . . . 0.0 111.536 179.579 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 667' ' ' TYR . . . . . . . . . . . . . 16.7 p90 -69.42 -17.94 63.7 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-N 116.042 -0.526 . . . . 0.0 112.049 179.446 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 668' ' ' GLY . . . . . . . . . . . . . . . 101.05 -107.9 3.35 Favored Glycine 0 CA--C 1.521 0.447 0 C-N-CA 120.664 -0.779 . . . . 0.0 113.918 179.445 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 669' ' ' ASP . . . . . . . . . . . . . 28.9 t70 -82.22 115.31 21.25 Favored 'General case' 0 N--CA 1.465 0.3 0 N-CA-C 112.258 0.466 . . . . 0.0 112.258 -177.901 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 670' ' ' VAL . . . . . . . . . . . . . 73.1 t -61.55 -42.3 93.51 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.36 0 CA-C-N 115.413 -0.812 . . . . 0.0 112.712 -179.807 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 671' ' ' GLN . . . . . . . . . . . . . 26.6 mp0 -60.87 -41.27 95.6 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 111.989 0.366 . . . . 0.0 111.989 -177.598 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 672' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 -65.0 -40.78 95.45 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.795 0.331 . . . . 0.0 110.862 178.959 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 673' ' ' LEU . . . . . . . . . . . . . 66.9 tp -64.47 -44.57 90.63 Favored 'General case' 0 C--N 1.333 -0.137 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.117 178.923 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 674' ' ' VAL . . . . . . . . . . . . . 53.2 t -62.86 -43.63 99.01 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 CA-C-N 115.46 -0.791 . . . . 0.0 110.158 179.875 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 675' ' ' ASP . . . . . . . . . . . . . 37.3 t70 -59.71 -40.65 88.67 Favored 'General case' 0 CA--C 1.521 -0.165 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.156 178.81 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 676' ' ' GLN . . . . . . . . . . . . . 56.6 mt-30 -70.67 -41.44 72.05 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.861 179.875 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 677' ' ' LEU . . . . . . . . . . . . . 86.1 mt -65.8 -42.06 91.14 Favored 'General case' 0 C--N 1.334 -0.089 0 CA-C-N 116.538 -0.301 . . . . 0.0 111.013 179.376 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 678' ' ' ARG . . . . . . . . . . . . . 7.7 mmm180 -68.98 -37.07 78.56 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-O 121.03 0.443 . . . . 0.0 111.534 179.657 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 679' ' ' GLN . . . . . . . . . . . . . 49.5 tt0 -65.36 -37.09 85.97 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.468 179.621 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 680' ' ' ARG . . . . . . . . . . . . . 89.4 mmt-85 -84.36 -44.2 13.98 Favored 'General case' 0 N--CA 1.461 0.116 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.783 -179.952 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 681' ' ' CYS . . . . . . . . . . . . . 71.9 m -126.65 138.03 53.37 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 121.258 0.551 . . . . 0.0 111.631 -179.071 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 682' ' ' THR . . . . . . . . . . . . . 54.0 p -71.18 162.28 73.45 Favored Pre-proline 0 C--N 1.323 -0.55 0 CA-C-N 115.647 -0.706 . . . . 0.0 109.941 178.934 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 683' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_exo -53.85 -33.99 73.7 Favored 'Trans proline' 0 C--N 1.35 0.615 0 C-N-CA 122.661 2.241 . . . . 0.0 112.849 -179.535 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 684' ' ' GLU . . . . . . . . . . . . . 51.8 mp0 -68.34 -38.55 81.6 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.996 0.427 . . . . 0.0 110.672 -179.988 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 685' ' ' GLN . . . . . . . . . . . . . 79.0 mt-30 -71.65 -39.57 70.26 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.511 -0.768 . . . . 0.0 112.49 -179.639 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 686' ' ' LEU . . . . . 0.402 ' HA ' ' O ' ' A' ' 657' ' ' ILE . 2.4 tt -139.0 120.01 14.48 Favored 'General case' 0 CA--C 1.531 0.23 0 N-CA-C 112.706 0.632 . . . . 0.0 112.706 -177.654 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 687' ' ' LYS . . . . . . . . . . . . . 47.4 mmtm -93.94 147.49 23.05 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.083 177.718 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 688' ' ' ILE . . . . . . . . . . . . . 79.6 mt -121.62 120.85 62.92 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 CA-C-O 121.393 0.616 . . . . 0.0 111.902 -178.67 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 689' ' ' PHE . . . . . . . . . . . . . 98.4 m-85 -121.1 146.86 46.29 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 114.864 -1.062 . . . . 0.0 109.79 178.838 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 690' ' ' ILE . . . . . . . . . . . . . 18.7 tt -125.7 136.74 59.9 Favored 'Isoleucine or valine' 0 C--O 1.235 0.307 0 CA-C-O 121.438 0.637 . . . . 0.0 111.934 -179.518 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 691' ' ' LEU . . . . . 0.402 ' CD2' ' HB ' ' A' ' 704' ' ' ILE . 76.2 mt -113.48 134.54 54.62 Favored 'General case' 0 C--O 1.235 0.306 0 CA-C-N 115.243 -0.889 . . . . 0.0 110.441 179.998 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 692' ' ' GLY . . . . . 0.641 ' O ' ' HA ' ' A' ' 705' ' ' PRO . . . 163.04 -173.85 39.28 Favored Glycine 0 N--CA 1.447 -0.575 0 C-N-CA 120.461 -0.876 . . . . 0.0 112.202 179.778 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 693' ' ' SER . . . . . . . . . . . . . 80.2 p -68.38 -37.66 80.62 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 120.94 0.4 . . . . 0.0 111.026 179.42 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 694' ' ' LYS . . . . . . . . . . . . . 64.5 mttp -126.37 134.15 51.13 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.193 179.317 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 695' ' ' GLY . . . . . 0.46 ' HA3' ' HB2' ' A' ' 703' ' ' TYR . . . -108.65 17.13 33.58 Favored Glycine 0 N--CA 1.449 -0.451 0 C-N-CA 120.921 -0.657 . . . . 0.0 112.825 179.585 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 696' ' ' ASN . . . . . . . . . . . . . 64.8 t30 -81.61 70.98 8.61 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 121.044 0.45 . . . . 0.0 111.088 -179.418 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 697' ' ' TYR . . . . . . . . . . . . . 97.1 m-85 -130.18 143.04 50.55 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.018 179.299 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 698' ' ' GLN . . . . . . . . . . . . . 22.0 mp0 -81.57 146.02 30.34 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.665 -179.933 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 699' ' ' GLY . . . . . . . . . . . . . . . 96.05 5.85 59.37 Favored Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.45 -0.881 . . . . 0.0 114.155 179.1 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 700' ' ' VAL . . . . . . . . . . . . . 22.9 m -118.16 152.25 20.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 117.773 0.786 . . . . 0.0 109.868 179.075 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 701' ' ' ASP . . . . . . . . . . . . . 65.1 m-20 -83.92 -39.96 19.15 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 116.024 -0.534 . . . . 0.0 112.107 -178.458 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 702' ' ' ARG . . . . . . . . . . . . . 63.1 mtp85 -146.58 160.68 41.85 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.736 0.303 . . . . 0.0 110.728 -179.356 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 703' ' ' TYR . . . . . 0.46 ' HB2' ' HA3' ' A' ' 695' ' ' GLY . 16.6 p90 -122.49 140.35 52.84 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.072 0.463 . . . . 0.0 111.193 179.673 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 704' ' ' ILE . . . . . 0.402 ' HB ' ' CD2' ' A' ' 691' ' ' LEU . 53.7 mt -127.4 86.26 59.01 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-N 115.946 -0.57 . . . . 0.0 109.54 179.487 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 705' ' ' PRO . . . . . 0.641 ' HA ' ' O ' ' A' ' 692' ' ' GLY . 73.4 Cg_endo -73.03 152.16 50.97 Favored 'Trans proline' 0 C--N 1.349 0.562 0 C-N-CA 123.158 2.572 . . . . 0.0 114.384 -178.425 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 706' ' ' LEU . . . . . . . . . . . . . 76.7 mt -79.9 145.71 62.28 Favored Pre-proline 0 CA--C 1.531 0.246 0 CA-C-N 115.169 -0.923 . . . . 0.0 110.645 178.681 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 707' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -74.36 139.78 63.59 Favored 'Cis proline' 0 C--N 1.345 0.371 0 C-N-CA 123.081 -1.633 . . . . 0.0 112.112 -1.27 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 708' ' ' ILE . . . . . . . . . . . . . 78.4 mt -83.41 119.5 32.87 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 CA-C-O 120.983 0.42 . . . . 0.0 110.445 179.646 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 709' ' ' HIS . . . . . . . . . . . . . 70.0 m80 -86.81 124.05 69.69 Favored Pre-proline 0 C--N 1.328 -0.366 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.5 179.517 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 710' ' ' PRO . . . . . . . . . . . . . 23.2 Cg_endo -60.99 -30.3 89.61 Favored 'Trans proline' 0 C--N 1.348 0.535 0 C-N-CA 122.993 2.462 . . . . 0.0 113.63 -179.308 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 711' ' ' GLU . . . . . . . . . . . . . 51.5 mp0 -66.11 -39.87 90.26 Favored 'General case' 0 C--N 1.331 -0.225 0 N-CA-C 112.208 0.448 . . . . 0.0 112.208 -179.381 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 712' ' ' SER . . . . . . . . . . . . . 79.9 p -98.5 -17.08 18.92 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 112.28 0.474 . . . . 0.0 112.28 -178.648 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 713' ' ' PHE . . . . . 0.439 ' O ' HG22 ' A' ' 717' ' ' VAL . 86.2 t80 -59.99 -49.68 76.74 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.669 0.271 . . . . 0.0 110.911 -179.82 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 714' ' ' LEU . . . . . . . . . . . . . 93.0 mt -64.74 -38.66 91.73 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.434 179.372 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 715' ' ' GLN . . . . . . . . . . . . . 22.6 tm0? -63.67 -43.34 96.99 Favored 'General case' 0 CA--C 1.534 0.344 0 CA-C-N 115.514 -0.766 . . . . 0.0 111.13 179.616 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 716' ' ' GLN . . . . . . . . . . . . . 84.7 mm-40 -66.15 -41.45 90.39 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-O 120.712 0.292 . . . . 0.0 111.156 179.773 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 717' ' ' VAL . . . . . 0.439 HG22 ' O ' ' A' ' 713' ' ' PHE . 65.3 t -63.31 -44.95 99.35 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.158 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.692 179.55 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 718' ' ' THR . . . . . . . . . . . . . 89.9 m -62.12 -44.91 95.6 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.141 179.929 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 719' ' ' MET . . . . . 0.567 ' O ' HG23 ' A' ' 722' ' ' THR . 24.8 mmt -63.71 -40.34 96.52 Favored 'General case' 0 C--O 1.224 -0.275 0 C-N-CA 121.188 -0.205 . . . . 0.0 110.824 179.403 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 720' ' ' GLY . . . . . . . . . . . . . . . -68.36 -42.37 82.61 Favored Glycine 0 C--N 1.332 0.327 0 C-N-CA 120.314 -0.946 . . . . 0.0 112.124 177.976 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 721' ' ' LEU . . . . . . . . . . . . . 59.7 tp -67.99 -42.88 80.12 Favored 'General case' 0 CA--C 1.531 0.212 0 C-N-CA 122.628 0.371 . . . . 0.0 111.793 179.512 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 722' ' ' THR . . . . . 0.567 HG23 ' O ' ' A' ' 719' ' ' MET . 4.1 p 59.27 20.77 8.91 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 123.437 0.695 . . . . 0.0 111.92 -179.607 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 723' ' ' SER . . . . . . . . . . . . . 49.8 m 61.08 32.66 19.72 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-N 115.855 -0.611 . . . . 0.0 111.421 -179.218 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 724' ' ' LEU . . . . . . . . . . . . . 85.0 mt 57.79 -102.18 0.14 Allowed 'General case' 0 N--CA 1.467 0.393 0 CA-C-N 115.706 -0.679 . . . . 0.0 111.978 179.298 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 725' ' ' ALA . . . . . . . . . . . . . . . -121.24 24.56 9.97 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.713 0.292 . . . . 0.0 111.341 -179.529 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 726' ' ' THR . . . . . . . . . . . . . 74.4 p -125.9 159.67 31.96 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.867 0.365 . . . . 0.0 111.089 -179.71 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 727' ' ' SER . . . . . . . . . . . . . 60.1 m -128.23 148.48 50.63 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.568 179.861 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 728' ' ' ALA . . . . . . . . . . . . . . . -62.44 -40.01 95.2 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.581 179.88 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 729' ' ' GLN . . . . . . . . . . . . . 96.6 mt-30 . . . . . 0 C--O 1.249 1.052 0 CA-C-O 118.073 -0.965 . . . . 0.0 110.682 179.911 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 613' ' ' GLU . . . . . . . . . . . . . 75.6 mm-40 . . . . . 0 N--CA 1.486 1.328 0 CA-C-O 120.878 0.371 . . . . 0.0 110.804 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 614' ' ' GLY . . . . . . . . . . . . . . . -169.96 166.97 40.14 Favored Glycine 0 N--CA 1.45 -0.411 0 C-N-CA 120.601 -0.809 . . . . 0.0 112.598 -179.965 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 615' ' ' ARG . . . . . . . . . . . . . 13.6 tpt180 -115.83 118.69 33.69 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 109.986 -0.375 . . . . 0.0 109.986 179.927 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 616' ' ' ILE . . . . . 0.431 ' O ' ' HA ' ' A' ' 640' ' ' VAL . 83.4 mt -124.04 134.42 66.61 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 116.473 -0.331 . . . . 0.0 110.883 -179.679 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 617' ' ' VAL . . . . . . . . . . . . . 91.9 t -108.6 128.65 64.1 Favored 'Isoleucine or valine' 0 C--O 1.234 0.276 0 CA-C-O 120.943 0.401 . . . . 0.0 110.036 179.479 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 618' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -108.78 129.03 55.38 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.944 -0.571 . . . . 0.0 111.001 -178.546 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 619' ' ' VAL . . . . . . . . . . . . . 61.7 t -116.72 117.51 55.69 Favored 'Isoleucine or valine' 0 C--O 1.235 0.324 0 CA-C-O 121.03 0.443 . . . . 0.0 109.827 179.748 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 620' ' ' SER . . . . . . . . . . . . . 23.3 t -172.44 148.27 2.01 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.395 -0.82 . . . . 0.0 110.686 -179.633 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 621' ' ' GLU . . . . . . . . . . . . . 4.4 mm-40 -96.21 -4.9 41.63 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.931 178.652 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 622' ' ' ASP . . . . . . . . . . . . . 61.0 t0 -92.42 107.3 19.11 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-O 120.747 0.308 . . . . 0.0 110.17 -179.67 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 623' ' ' GLU . . . . . . . . . . . . . 51.1 mp0 -63.57 -40.15 96.23 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.836 -0.62 . . . . 0.0 112.514 -179.003 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 624' ' ' ALA . . . . . . . . . . . . . . . -61.6 -45.18 95.17 Favored 'General case' 0 N--CA 1.463 0.214 0 N-CA-C 112.423 0.527 . . . . 0.0 112.423 -178.306 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 625' ' ' THR . . . . . . . . . . . . . 94.8 m -71.43 -41.17 69.85 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.721 0.296 . . . . 0.0 110.82 179.708 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 626' ' ' SER . . . . . . . . . . . . . 66.4 m -62.56 -41.49 98.94 Favored 'General case' 0 CA--C 1.53 0.179 0 CA-C-N 115.915 -0.584 . . . . 0.0 112.438 -178.489 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 627' ' ' THR . . . . . . . . . . . . . 35.3 p -68.66 -40.43 80.21 Favored 'General case' 0 N--CA 1.465 0.294 0 N-CA-C 112.511 0.56 . . . . 0.0 112.511 -179.935 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 628' ' ' LEU . . . . . . . . . . . . . 63.5 tp -64.17 -47.02 81.45 Favored 'General case' 0 CA--C 1.532 0.253 0 N-CA-C 112.052 0.39 . . . . 0.0 112.052 -179.602 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 629' ' ' ILE . . . . . . . . . . . . . 20.2 tt -70.79 -34.55 56.75 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.399 0 N-CA-C 112.483 0.549 . . . . 0.0 112.483 -179.221 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 630' ' ' CYS . . . . . . . . . . . . . 48.9 t -60.49 -44.68 95.69 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.484 -179.238 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 631' ' ' SER . . . . . . . . . . . . . 47.2 t -61.77 -42.62 99.23 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.141 -179.694 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 632' ' ' ILE . . . . . . . . . . . . . 97.4 mt -61.81 -48.17 89.87 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.289 0 CA-C-O 120.852 0.358 . . . . 0.0 110.65 179.974 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 633' ' ' LEU . . . . . . . . . . . . . 80.8 mt -66.35 -40.23 89.68 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.005 -0.543 . . . . 0.0 112.04 179.845 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 634' ' ' THR . . . . . 0.515 ' HA ' ' O ' ' A' ' 638' ' ' TYR . 89.9 m -65.84 -40.17 91.48 Favored 'General case' 0 CA--C 1.531 0.231 0 CA-C-O 120.685 0.279 . . . . 0.0 110.931 -179.612 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 635' ' ' THR . . . . . . . . . . . . . 92.2 m -59.01 -38.55 79.47 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.34 179.249 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 636' ' ' ALA . . . . . . . . . . . . . . . -67.31 -11.95 58.9 Favored 'General case' 0 CA--C 1.534 0.364 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.371 179.104 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 637' ' ' GLY . . . . . . . . . . . . . . . 103.5 7.69 42.09 Favored Glycine 0 C--N 1.334 0.421 0 C-N-CA 120.972 -0.632 . . . . 0.0 113.333 179.617 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 638' ' ' TYR . . . . . 0.515 ' O ' ' HA ' ' A' ' 634' ' ' THR . 96.0 m-85 -99.89 141.73 32.32 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.823 0.344 . . . . 0.0 111.319 -179.738 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 639' ' ' GLN . . . . . . . . . . . . . 98.4 mm-40 -90.69 134.32 34.49 Favored 'General case' 0 CA--C 1.517 -0.326 0 CA-C-N 116.309 -0.405 . . . . 0.0 109.911 179.537 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 640' ' ' VAL . . . . . 0.431 ' HA ' ' O ' ' A' ' 616' ' ' ILE . 60.6 t -118.91 130.36 73.84 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-O 121.008 0.432 . . . . 0.0 112.151 -179.318 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 641' ' ' ILE . . . . . . . . . . . . . 47.5 mm -109.28 117.93 55.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 N-CA-C 108.468 -0.938 . . . . 0.0 108.468 178.197 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 642' ' ' TRP . . . . . . . . . . . . . 24.6 t90 -90.63 124.31 34.95 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 112.405 0.52 . . . . 0.0 112.405 -178.237 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 643' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -119.54 132.94 55.85 Favored 'General case' 0 CA--C 1.53 0.204 0 CA-C-N 115.596 -0.729 . . . . 0.0 110.048 178.907 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 644' ' ' VAL . . . . . . . . . . . . . 19.0 m -103.0 18.0 4.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 N-CA-C 112.426 0.528 . . . . 0.0 112.426 -179.049 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 645' ' ' ASP . . . . . . . . . . . . . 16.4 t0 -144.17 -28.32 0.51 Allowed 'General case' 0 N--CA 1.47 0.562 0 N-CA-C 113.382 0.882 . . . . 0.0 113.382 -178.023 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 646' ' ' GLY . . . . . . . . . . . . . . . 73.88 28.75 64.22 Favored Glycine 0 CA--C 1.523 0.543 0 C-N-CA 120.734 -0.746 . . . . 0.0 114.461 179.76 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 647' ' ' GLU . . . . . . . . . . . . . 92.7 mt-10 -63.77 126.38 27.41 Favored 'General case' 0 C--N 1.334 -0.106 0 CA-C-N 117.683 0.742 . . . . 0.0 111.167 179.606 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 648' ' ' VAL . . . . . . . . . . . . . 75.0 t -61.59 -39.42 83.03 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-N 114.752 -1.113 . . . . 0.0 111.543 -179.653 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 649' ' ' GLU . . . . . . . . . . . . . 50.5 mp0 -60.7 -43.18 98.1 Favored 'General case' 0 C--N 1.331 -0.198 0 N-CA-C 110.038 -0.356 . . . . 0.0 110.038 -179.908 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 650' ' ' ARG . . . . . . . . . . . . . 16.2 mmp_? -70.21 -40.8 74.35 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.49 178.412 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 651' ' ' LEU . . . . . . . . . . . . . 89.2 mt -64.72 -41.03 96.27 Favored 'General case' 0 N--CA 1.462 0.171 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.413 179.2 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 652' ' ' LEU . . . . . . . . . . . . . 60.8 tp -65.23 -42.91 92.94 Favored 'General case' 0 CA--C 1.531 0.213 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.114 178.89 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 653' ' ' ALA . . . . . . . . . . . . . . . -62.56 -39.44 93.67 Favored 'General case' 0 N--CA 1.463 0.209 0 CA-C-O 120.989 0.423 . . . . 0.0 111.796 179.947 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 654' ' ' LEU . . . . . . . . . . . . . 75.8 mt -102.59 30.25 4.78 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.897 -179.447 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 655' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -31.1 104.02 0.21 Allowed Pre-proline 0 N--CA 1.471 0.624 0 O-C-N 124.595 1.185 . . . . 0.0 114.081 -179.129 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 656' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -90.75 177.11 2.24 Favored 'Trans proline' 0 C--N 1.345 0.356 0 C-N-CA 123.617 2.878 . . . . 0.0 112.37 178.557 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 657' ' ' ILE . . . . . . . . . . . . . 19.4 pt -83.81 -24.83 7.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-O 121.271 0.558 . . . . 0.0 109.649 177.85 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 658' ' ' ALA . . . . . 0.486 ' HA ' ' O ' ' A' ' 687' ' ' LYS . . . -157.18 153.23 27.33 Favored 'General case' 0 N--CA 1.449 -0.507 0 CA-C-N 115.21 -0.905 . . . . 0.0 111.006 -179.959 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 659' ' ' VAL . . . . . . . . . . . . . 31.5 m -122.96 147.16 27.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-O 121.138 0.494 . . . . 0.0 111.039 179.109 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 660' ' ' LEU . . . . . . . . . . . . . 12.1 mt -116.59 119.95 37.16 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.414 -0.812 . . . . 0.0 110.125 179.105 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 661' ' ' LEU . . . . . . . . . . . . . 75.5 mt -108.39 113.35 26.35 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 109.794 -0.447 . . . . 0.0 109.794 179.744 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 662' ' ' ALA . . . . . . . . . . . . . . . -108.47 113.8 27.13 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 111.962 0.356 . . . . 0.0 111.962 -179.474 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 663' ' ' GLU . . . . . 0.574 ' HA ' ' C ' ' A' ' 664' ' ' PRO . 23.5 pt-20 -67.62 148.74 98.55 Favored Pre-proline 0 CA--C 1.537 0.477 0 CA-C-N 115.78 -0.645 . . . . 0.0 111.054 178.931 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 664' ' ' PRO . . . . . 0.574 ' C ' ' HA ' ' A' ' 663' ' ' GLU . 40.3 Cg_exo -60.91 138.26 21.51 Favored 'Cis proline' 0 C--N 1.353 0.775 0 C-N-CA 124.082 -1.216 . . . . 0.0 112.491 -0.891 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 665' ' ' PHE . . . . . . . . . . . . . 59.3 m-85 -82.64 121.78 27.28 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.979 -179.175 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 666' ' ' SER . . . . . . . . . . . . . 79.0 p -66.27 -38.45 87.83 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.954 -0.567 . . . . 0.0 111.924 -179.867 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 667' ' ' TYR . . . . . . . . . . . . . 63.2 t80 -65.93 -23.99 66.73 Favored 'General case' 0 CA--C 1.534 0.342 0 CA-C-O 120.804 0.335 . . . . 0.0 111.551 179.328 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 668' ' ' GLY . . . . . . . . . . . . . . . 99.96 -104.03 2.76 Favored Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.518 -0.849 . . . . 0.0 112.291 -179.524 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 669' ' ' ASP . . . . . . . . . . . . . 49.5 t0 -83.15 106.27 14.81 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.916 0.389 . . . . 0.0 110.412 -179.887 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 670' ' ' VAL . . . . . 0.424 ' O ' HG21 ' A' ' 674' ' ' VAL . 11.5 m -70.23 -23.13 24.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 N-CA-C 113.25 0.833 . . . . 0.0 113.25 -179.122 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 671' ' ' GLN . . . . . . . . . . . . . 77.8 mt-30 -61.63 -42.33 98.74 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-O 121.073 0.463 . . . . 0.0 110.22 179.943 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 672' ' ' GLU . . . . . . . . . . . . . 95.1 mt-10 -66.51 -40.42 89.2 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.657 -0.701 . . . . 0.0 110.462 178.634 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 673' ' ' LEU . . . . . . . . . . . . . 62.7 tp -63.03 -44.56 95.6 Favored 'General case' 0 N--CA 1.462 0.129 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.148 179.443 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 674' ' ' VAL . . . . . 0.424 HG21 ' O ' ' A' ' 670' ' ' VAL . 55.6 t -63.0 -43.87 99.34 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.15 0 CA-C-N 115.805 -0.634 . . . . 0.0 109.557 179.111 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 675' ' ' ASP . . . . . . . . . . . . . 37.3 t70 -60.5 -40.91 93.07 Favored 'General case' 0 CA--C 1.521 -0.155 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.38 178.771 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 676' ' ' GLN . . . . . . . . . . . . . 95.4 mt-30 -69.88 -41.89 74.19 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.083 -179.937 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 677' ' ' LEU . . . . . . . . . . . . . 86.3 mt -67.09 -41.52 86.19 Favored 'General case' 0 C--O 1.226 -0.174 0 CA-C-N 116.443 -0.344 . . . . 0.0 110.801 178.999 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 678' ' ' ARG . . . . . . . . . . . . . 62.4 ttp180 -66.43 -38.6 87.79 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-O 121.304 0.574 . . . . 0.0 110.588 179.689 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 679' ' ' GLN . . . . . . . . . . . . . 53.7 tt0 -62.62 -39.13 92.82 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.25 -0.886 . . . . 0.0 110.781 179.915 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 680' ' ' ARG . . . . . . . . . . . . . 38.2 mmt180 -84.82 -42.41 15.14 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.385 -0.37 . . . . 0.0 111.462 -179.739 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 681' ' ' CYS . . . . . . . . . . . . . 76.6 m -126.5 131.63 51.58 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.374 -0.375 . . . . 0.0 110.254 179.744 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 682' ' ' THR . . . . . 0.453 ' HB ' ' HD2' ' A' ' 683' ' ' PRO . 65.4 p -68.81 159.04 84.16 Favored Pre-proline 0 C--N 1.322 -0.607 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.854 -179.614 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 683' ' ' PRO . . . . . 0.453 ' HD2' ' HB ' ' A' ' 682' ' ' THR . 19.3 Cg_endo -59.91 -18.88 52.14 Favored 'Trans proline' 0 C--N 1.351 0.687 0 C-N-CA 122.75 2.3 . . . . 0.0 112.963 -179.793 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 684' ' ' GLU . . . . . . . . . . . . . 51.5 mt-10 -87.74 -12.1 46.21 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.751 0.31 . . . . 0.0 110.584 178.959 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 685' ' ' GLN . . . . . . . . . . . . . 91.6 mt-30 -100.79 -34.22 9.92 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.341 -0.39 . . . . 0.0 111.571 -179.889 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 686' ' ' LEU . . . . . . . . . . . . . 3.1 tt -135.44 125.23 25.5 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.874 -179.298 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 687' ' ' LYS . . . . . 0.486 ' O ' ' HA ' ' A' ' 658' ' ' ALA . 74.2 mmtt -94.35 146.56 23.97 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.148 0.499 . . . . 0.0 110.194 179.47 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 688' ' ' ILE . . . . . . . . . . . . . 78.7 mt -122.77 121.35 63.17 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.767 0 CA-C-O 121.246 0.546 . . . . 0.0 110.981 -179.199 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 689' ' ' PHE . . . . . . . . . . . . . 98.3 m-85 -117.65 142.16 47.55 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.036 -0.983 . . . . 0.0 110.094 179.102 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 690' ' ' ILE . . . . . . . . . . . . . 18.0 tt -121.18 136.5 57.93 Favored 'Isoleucine or valine' 0 C--O 1.237 0.395 0 CA-C-O 121.122 0.487 . . . . 0.0 111.095 179.795 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 691' ' ' LEU . . . . . 0.415 ' CD2' ' HB ' ' A' ' 704' ' ' ILE . 72.2 mt -107.86 135.28 49.52 Favored 'General case' 0 C--O 1.233 0.237 0 CA-C-N 115.8 -0.637 . . . . 0.0 110.566 -179.897 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 692' ' ' GLY . . . . . 0.602 ' O ' ' HA ' ' A' ' 705' ' ' PRO . . . 161.95 -163.33 34.74 Favored Glycine 0 N--CA 1.449 -0.488 0 C-N-CA 120.449 -0.882 . . . . 0.0 112.97 179.859 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 693' ' ' SER . . . . . . . . . . . . . 60.4 m -97.18 111.1 23.49 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 109.155 -0.683 . . . . 0.0 109.155 179.328 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 694' ' ' LYS . . . . . . . . . . . . . 88.5 tttt 63.2 83.1 0.17 Allowed 'General case' 0 N--CA 1.465 0.289 0 O-C-N 123.871 0.732 . . . . 0.0 109.648 -178.713 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 695' ' ' GLY . . . . . . . . . . . . . . . -75.77 58.02 3.03 Favored Glycine 0 CA--C 1.519 0.314 0 CA-C-N 115.776 -0.647 . . . . 0.0 113.726 -178.603 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 696' ' ' ASN . . . . . . . . . . . . . 66.4 t30 -89.5 88.91 7.62 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 109.611 -0.515 . . . . 0.0 109.611 179.058 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 697' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -140.97 -171.45 3.26 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.814 -179.181 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 698' ' ' GLN . . . . . . . . . . . . . 27.1 pt20 -127.33 152.67 47.16 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.869 -0.605 . . . . 0.0 109.755 -179.882 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 699' ' ' GLY . . . . . . . . . . . . . . . 91.6 -6.67 80.17 Favored Glycine 0 N--CA 1.449 -0.464 0 C-N-CA 120.337 -0.935 . . . . 0.0 112.432 -179.436 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 700' ' ' VAL . . . . . . . . . . . . . 28.6 m -109.58 141.04 25.96 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.368 0 CA-C-O 121.241 0.543 . . . . 0.0 110.378 179.571 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 701' ' ' ASP . . . . . 0.425 ' O ' ' HD2' ' A' ' 702' ' ' ARG . 35.0 t70 -72.63 -41.21 65.76 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.411 -0.813 . . . . 0.0 111.67 -179.66 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 702' ' ' ARG . . . . . 0.425 ' HD2' ' O ' ' A' ' 701' ' ' ASP . 5.7 mpt_? -144.0 169.2 18.27 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.491 -179.136 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 703' ' ' TYR . . . . . . . . . . . . . 53.6 p90 -132.71 146.64 52.03 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.12 179.277 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 704' ' ' ILE . . . . . 0.415 ' HB ' ' CD2' ' A' ' 691' ' ' LEU . 53.5 mt -129.92 105.52 16.78 Favored Pre-proline 0 C--N 1.326 -0.428 0 CA-C-N 116.538 -0.301 . . . . 0.0 110.534 179.769 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 705' ' ' PRO . . . . . 0.602 ' HA ' ' O ' ' A' ' 692' ' ' GLY . 70.3 Cg_endo -72.32 151.9 54.74 Favored 'Trans proline' 0 C--N 1.346 0.403 0 C-N-CA 122.904 2.403 . . . . 0.0 113.711 -179.267 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 706' ' ' LEU . . . . . 0.422 ' HA ' ' C ' ' A' ' 707' ' ' PRO . 88.9 mt -104.66 148.43 36.04 Favored Pre-proline 0 N--CA 1.453 -0.28 0 CA-C-N 115.347 -0.842 . . . . 0.0 110.003 178.954 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 707' ' ' PRO . . . . . 0.422 ' C ' ' HA ' ' A' ' 706' ' ' LEU . 58.3 Cg_endo -70.89 139.69 59.48 Favored 'Cis proline' 0 C--N 1.346 0.412 0 C-N-CA 122.956 -1.685 . . . . 0.0 112.625 -0.465 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 708' ' ' ILE . . . . . . . . . . . . . 3.1 pt -63.51 132.58 29.39 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-N 115.672 -0.695 . . . . 0.0 112.222 179.237 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 709' ' ' HIS . . . . . . . . . . . . . 70.4 m80 -99.57 112.43 63.52 Favored Pre-proline 0 C--N 1.322 -0.6 0 N-CA-C 107.822 -1.177 . . . . 0.0 107.822 177.252 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 710' ' ' PRO . . . . . . . . . . . . . 84.7 Cg_exo -51.51 -36.92 61.3 Favored 'Trans proline' 0 N--CA 1.478 0.568 0 C-N-CA 123.313 2.675 . . . . 0.0 114.558 -177.418 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 711' ' ' GLU . . . . . . . . . . . . . 88.7 tt0 -63.78 -43.29 96.8 Favored 'General case' 0 CA--C 1.535 0.369 0 N-CA-C 112.118 0.414 . . . . 0.0 112.118 -178.928 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 712' ' ' SER . . . . . . . . . . . . . 57.3 m -95.32 -15.66 22.96 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 111.967 0.358 . . . . 0.0 111.967 -178.803 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 713' ' ' PHE . . . . . . . . . . . . . 86.4 t80 -60.58 -49.48 77.38 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.81 0.338 . . . . 0.0 110.414 179.704 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 714' ' ' LEU . . . . . . . . . . . . . 92.0 mt -64.77 -37.25 86.98 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.804 -0.634 . . . . 0.0 110.073 179.184 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 715' ' ' GLN . . . . . . . . . . . . . 65.4 tt0 -61.57 -43.51 98.73 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.656 179.228 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 716' ' ' GLN . . . . . . . . . . . . . 30.3 mm100 -64.17 -40.57 96.41 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-N 116.494 -0.321 . . . . 0.0 110.677 179.374 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 717' ' ' VAL . . . . . . . . . . . . . 71.3 t -63.4 -43.4 98.49 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.164 0 CA-C-O 121.057 0.456 . . . . 0.0 109.824 178.928 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 718' ' ' THR . . . . . . . . . . . . . 88.1 m -61.88 -41.21 97.59 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-N 115.605 -0.725 . . . . 0.0 111.125 179.314 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 719' ' ' MET . . . . . . . . . . . . . 98.1 mtp -61.51 -40.41 94.49 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.28 179.998 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 720' ' ' GLY . . . . . . . . . . . . . . . -84.21 -15.57 69.05 Favored Glycine 0 CA--C 1.521 0.435 0 C-N-CA 120.435 -0.888 . . . . 0.0 112.786 179.387 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 721' ' ' LEU . . . . . . . . . . . . . 60.5 tp -67.42 -40.3 85.54 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-O 120.795 0.331 . . . . 0.0 111.611 179.709 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 722' ' ' THR . . . . . . . . . . . . . 15.1 t -64.67 165.94 9.53 Favored 'General case' 0 CA--C 1.535 0.376 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.322 -179.687 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 723' ' ' SER . . . . . . . . . . . . . 49.0 m 63.1 40.47 9.0 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-O 121.332 0.587 . . . . 0.0 110.699 -178.655 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 724' ' ' LEU . . . . . . . . . . . . . 60.2 tp -103.81 126.14 50.74 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.37 -0.832 . . . . 0.0 109.727 -179.991 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 725' ' ' ALA . . . . . . . . . . . . . . . -62.16 -39.8 93.83 Favored 'General case' 0 N--CA 1.464 0.26 0 N-CA-C 112.887 0.699 . . . . 0.0 112.887 -178.888 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 726' ' ' THR . . . . . . . . . . . . . 4.8 t -91.64 134.4 34.73 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.274 0.559 . . . . 0.0 111.421 -179.329 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 727' ' ' SER . . . . . . . . . . . . . 78.5 p -102.76 4.37 37.89 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.06 179.677 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 728' ' ' ALA . . . . . . . . . . . . . . . -83.27 79.55 9.36 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.298 -179.462 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 729' ' ' GLN . . . . . . . . . . . . . 77.4 mt-30 . . . . . 0 C--O 1.25 1.126 0 CA-C-O 118.407 -0.806 . . . . 0.0 111.373 179.665 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 613' ' ' GLU . . . . . 0.532 ' HA ' ' O ' ' A' ' 637' ' ' GLY . 59.7 mt-10 . . . . . 0 N--CA 1.487 1.402 0 CA-C-O 121.068 0.461 . . . . 0.0 110.619 . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 614' ' ' GLY . . . . . . . . . . . . . . . -86.26 -177.3 49.79 Favored Glycine 0 CA--C 1.519 0.295 0 CA-C-N 115.668 -0.696 . . . . 0.0 112.908 -179.887 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 615' ' ' ARG . . . . . . . . . . . . . 48.1 mtm105 -111.6 131.78 55.02 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.749 0.309 . . . . 0.0 111.078 -179.764 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 616' ' ' ILE . . . . . 0.447 ' O ' ' HA ' ' A' ' 640' ' ' VAL . 85.5 mt -125.01 133.27 69.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.117 179.169 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 617' ' ' VAL . . . . . . . . . . . . . 98.0 t -107.2 127.76 62.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 120.891 0.377 . . . . 0.0 110.241 -179.992 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 618' ' ' LEU . . . . . . . . . . . . . 1.1 tt -109.51 127.96 54.83 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.916 -0.583 . . . . 0.0 110.795 -178.87 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 619' ' ' VAL . . . . . . . . . . . . . 61.5 t -116.93 118.66 59.54 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.426 0 N-CA-C 109.835 -0.432 . . . . 0.0 109.835 179.713 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 620' ' ' SER . . . . . . . . . . . . . 82.7 p -166.59 163.81 16.92 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.514 -0.767 . . . . 0.0 110.767 -179.58 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 621' ' ' GLU . . . . . . . . . . . . . 99.3 mt-10 -102.41 -5.16 24.42 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.608 -0.724 . . . . 0.0 111.187 178.572 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 622' ' ' ASP . . . . . . . . . . . . . 50.5 t0 -102.43 108.1 19.31 Favored 'General case' 0 CA--C 1.531 0.231 0 CA-C-O 121.132 0.492 . . . . 0.0 111.354 -178.308 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 623' ' ' GLU . . . . . . . . . . . . . 42.3 tt0 -64.2 -40.69 96.6 Favored 'General case' 0 CA--C 1.534 0.333 0 CA-C-N 115.296 -0.866 . . . . 0.0 112.002 179.642 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 624' ' ' ALA . . . . . . . . . . . . . . . -60.88 -43.5 98.36 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-N 116.342 -0.39 . . . . 0.0 112.05 -178.661 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 625' ' ' THR . . . . . . . . . . . . . 88.0 m -67.55 -39.92 84.98 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 109.657 -0.497 . . . . 0.0 109.657 179.495 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 626' ' ' SER . . . . . . . . . . . . . 73.1 m -61.53 -40.26 93.99 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.191 -0.913 . . . . 0.0 112.342 -179.078 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 627' ' ' THR . . . . . . . . . . . . . 74.3 p -65.97 -39.95 90.84 Favored 'General case' 0 N--CA 1.465 0.32 0 N-CA-C 112.499 0.555 . . . . 0.0 112.499 -179.506 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 628' ' ' LEU . . . . . . . . . . . . . 62.6 tp -68.28 -46.25 70.87 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 112.03 0.381 . . . . 0.0 112.03 -179.734 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 629' ' ' ILE . . . . . . . . . . . . . 21.4 tt -70.82 -35.93 62.29 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.358 0 N-CA-C 112.59 0.589 . . . . 0.0 112.59 -178.982 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 630' ' ' CYS . . . . . . . . . . . . . 43.0 t -61.25 -42.37 98.51 Favored 'General case' 0 CA--C 1.521 -0.162 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.067 -179.648 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 631' ' ' SER . . . . . . . . . . . . . 68.2 m -61.57 -41.53 97.53 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.249 -179.361 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 632' ' ' ILE . . . . . . . . . . . . . 97.1 mt -62.92 -48.99 85.4 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.319 0 CA-C-O 121.014 0.435 . . . . 0.0 111.048 179.84 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 633' ' ' LEU . . . . . . . . . . . . . 91.6 mt -67.72 -39.61 84.29 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.728 -0.669 . . . . 0.0 112.315 -179.412 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 634' ' ' THR . . . . . 0.535 ' HA ' ' O ' ' A' ' 638' ' ' TYR . 83.9 m -65.32 -40.03 93.2 Favored 'General case' 0 N--CA 1.464 0.225 0 CA-C-O 120.598 0.237 . . . . 0.0 111.013 -179.53 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 635' ' ' THR . . . . . . . . . . . . . 93.0 m -58.22 -37.99 75.92 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.479 179.347 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 636' ' ' ALA . . . . . . . . . . . . . . . -68.47 -9.84 51.46 Favored 'General case' 0 CA--C 1.534 0.362 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.625 179.153 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 637' ' ' GLY . . . . . 0.532 ' O ' ' HA ' ' A' ' 613' ' ' GLU . . . 101.69 7.35 48.28 Favored Glycine 0 C--N 1.333 0.393 0 C-N-CA 121.043 -0.599 . . . . 0.0 113.233 179.606 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 638' ' ' TYR . . . . . 0.535 ' O ' ' HA ' ' A' ' 634' ' ' THR . 90.9 m-85 -99.77 141.19 32.91 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.724 0.297 . . . . 0.0 111.403 -179.66 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 639' ' ' GLN . . . . . . . . . . . . . 98.3 mm-40 -90.85 135.31 33.81 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.139 179.624 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 640' ' ' VAL . . . . . 0.447 ' HA ' ' O ' ' A' ' 616' ' ' ILE . 60.2 t -117.91 129.79 73.76 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 CA-C-O 121.169 0.509 . . . . 0.0 112.285 -179.507 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 641' ' ' ILE . . . . . . . . . . . . . 4.2 mp -112.56 120.17 62.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 N-CA-C 108.382 -0.969 . . . . 0.0 108.382 178.376 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 642' ' ' TRP . . . . . . . . . . . . . 26.1 t90 -93.55 127.05 39.03 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-O 121.203 0.525 . . . . 0.0 112.316 -178.283 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 643' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -118.12 129.45 55.54 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-N 115.402 -0.817 . . . . 0.0 110.129 179.08 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 644' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -108.18 41.87 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.709 -0.223 . . . . 0.0 111.403 -179.414 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 645' ' ' ASP . . . . . . . . . . . . . 17.7 t0 -156.9 -31.86 0.08 Allowed 'General case' 0 N--CA 1.469 0.513 0 N-CA-C 112.796 0.665 . . . . 0.0 112.796 -178.805 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 646' ' ' GLY . . . . . . . . . . . . . . . 74.77 28.44 62.97 Favored Glycine 0 CA--C 1.52 0.371 0 C-N-CA 120.596 -0.811 . . . . 0.0 113.399 -179.675 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 647' ' ' GLU . . . . . . . . . . . . . 8.8 mm-40 -67.88 120.3 13.95 Favored 'General case' 0 N--CA 1.456 -0.126 0 CA-C-O 121.067 0.46 . . . . 0.0 110.869 179.79 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 648' ' ' VAL . . . . . . . . . . . . . 75.7 t -60.93 -40.96 87.12 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-N 115.229 -0.896 . . . . 0.0 111.404 -179.558 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 649' ' ' GLU . . . . . . . . . . . . . 79.1 mm-40 -61.63 -42.57 99.07 Favored 'General case' 0 C--N 1.332 -0.194 0 C-N-CA 120.805 -0.358 . . . . 0.0 110.277 -179.973 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 650' ' ' ARG . . . . . . . . . . . . . 6.3 mmp_? -70.37 -40.91 73.74 Favored 'General case' 0 C--O 1.233 0.189 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.612 178.629 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 651' ' ' LEU . . . . . . . . . . . . . 90.8 mt -65.01 -41.03 95.71 Favored 'General case' 0 N--CA 1.461 0.117 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.29 179.292 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 652' ' ' LEU . . . . . . . . . . . . . 62.4 tp -65.15 -43.03 93.13 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.029 178.746 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 653' ' ' ALA . . . . . . . . . . . . . . . -62.78 -39.99 95.91 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-O 121.078 0.466 . . . . 0.0 111.604 -179.919 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 654' ' ' LEU . . . . . . . . . . . . . 76.1 mt -100.53 29.77 4.27 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.036 179.782 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 655' ' ' THR . . . . . . . . . . . . . 5.7 t -43.11 109.39 0.76 Allowed Pre-proline 0 N--CA 1.468 0.428 0 O-C-N 124.248 0.967 . . . . 0.0 113.395 -178.013 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 656' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_endo -94.08 -174.6 0.39 Allowed 'Trans proline' 0 N--CA 1.462 -0.339 0 C-N-CA 124.289 3.326 . . . . 0.0 111.951 178.84 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 657' ' ' ILE . . . . . . . . . . . . . 25.3 pt -81.34 -24.74 10.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-O 121.263 0.554 . . . . 0.0 109.731 178.04 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 658' ' ' ALA . . . . . 0.41 ' HA ' ' O ' ' A' ' 687' ' ' LYS . . . -157.78 151.29 23.67 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.324 -0.853 . . . . 0.0 111.167 -179.944 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 659' ' ' VAL . . . . . . . . . . . . . 20.2 m -121.16 144.33 30.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-O 121.064 0.459 . . . . 0.0 110.409 178.82 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 660' ' ' LEU . . . . . . . . . . . . . 6.1 mp -115.04 117.75 31.47 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.728 -0.669 . . . . 0.0 109.849 179.522 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 661' ' ' LEU . . . . . . . . . . . . . 10.7 mt -103.2 108.48 19.7 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 109.111 -0.7 . . . . 0.0 109.111 -179.617 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 662' ' ' ALA . . . . . . . . . . . . . . . -104.61 131.07 52.45 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 112.41 0.522 . . . . 0.0 112.41 -178.484 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 663' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -71.47 146.58 91.78 Favored Pre-proline 0 C--N 1.327 -0.383 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.363 178.261 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 664' ' ' PRO . . . . . . . . . . . . . 66.9 Cg_endo -73.6 141.56 72.13 Favored 'Cis proline' 0 C--N 1.348 0.551 0 C-N-CA 123.245 -1.565 . . . . 0.0 112.614 -0.805 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 665' ' ' PHE . . . . . . . . . . . . . 22.6 m-85 -72.8 139.87 47.32 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.703 -0.681 . . . . 0.0 111.193 179.783 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 666' ' ' SER . . . . . . . . . . . . . 10.8 p -95.56 -29.26 14.45 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 116.33 -0.396 . . . . 0.0 111.718 179.84 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 667' ' ' TYR . . . . . . . . . . . . . 13.6 p90 -74.09 -18.75 60.77 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.296 -0.411 . . . . 0.0 112.089 179.852 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 668' ' ' GLY . . . . . . . . . . . . . . . 100.41 -104.58 2.81 Favored Glycine 0 CA--C 1.521 0.417 0 C-N-CA 120.649 -0.786 . . . . 0.0 113.635 179.675 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 669' ' ' ASP . . . . . . . . . . . . . 28.5 t70 -82.62 111.19 18.36 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-O 120.981 0.419 . . . . 0.0 111.424 -178.411 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 670' ' ' VAL . . . . . 0.428 ' O ' HG22 ' A' ' 674' ' ' VAL . 11.7 p -65.36 -32.62 59.01 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.394 0 N-CA-C 113.482 0.919 . . . . 0.0 113.482 -179.192 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 671' ' ' GLN . . . . . . . . . . . . . 22.1 mp0 -61.85 -41.9 98.38 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-O 120.703 0.287 . . . . 0.0 111.11 -179.124 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 672' ' ' GLU . . . . . . . . . . . . . 95.4 mt-10 -65.44 -40.44 93.28 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.994 179.248 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 673' ' ' LEU . . . . . . . . . . . . . 64.2 tp -63.42 -44.82 93.5 Favored 'General case' 0 CA--C 1.52 -0.175 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.107 179.104 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 674' ' ' VAL . . . . . 0.428 HG22 ' O ' ' A' ' 670' ' ' VAL . 59.7 t -62.71 -44.35 99.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 115.503 -0.771 . . . . 0.0 109.729 179.783 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 675' ' ' ASP . . . . . . . . . . . . . 38.0 t70 -60.48 -41.18 93.7 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 115.925 -0.579 . . . . 0.0 110.585 178.731 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 676' ' ' GLN . . . . . 0.404 ' O ' ' HG2' ' A' ' 680' ' ' ARG . 77.0 mt-30 -70.2 -41.42 73.71 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.499 -0.318 . . . . 0.0 111.005 -179.55 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 677' ' ' LEU . . . . . . . . . . . . . 87.8 mt -66.74 -41.84 87.21 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.927 179.506 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 678' ' ' ARG . . . . . 0.425 ' NH1' ' HD3' ' A' ' 683' ' ' PRO . 7.8 mmm180 -67.52 -36.83 81.79 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-O 121.178 0.513 . . . . 0.0 111.314 179.572 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 679' ' ' GLN . . . . . . . . . . . . . 64.5 tt0 -63.51 -39.01 93.31 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.461 -0.79 . . . . 0.0 110.848 179.794 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 680' ' ' ARG . . . . . 0.404 ' HG2' ' O ' ' A' ' 676' ' ' GLN . 37.1 mmt180 -87.28 -41.04 13.96 Favored 'General case' 0 C--N 1.331 -0.203 0 N-CA-C 112.294 0.479 . . . . 0.0 112.294 -179.078 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 681' ' ' CYS . . . . . . . . . . . . . 76.9 m -124.84 137.98 54.28 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.212 0.529 . . . . 0.0 111.625 -178.948 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 682' ' ' THR . . . . . 0.451 ' HB ' ' HD2' ' A' ' 683' ' ' PRO . 66.2 p -70.24 159.46 84.49 Favored Pre-proline 0 C--N 1.323 -0.564 0 CA-C-N 115.596 -0.729 . . . . 0.0 109.69 178.762 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 683' ' ' PRO . . . . . 0.451 ' HD2' ' HB ' ' A' ' 682' ' ' THR . 23.5 Cg_endo -60.81 -27.75 85.31 Favored 'Trans proline' 0 C--N 1.349 0.598 0 C-N-CA 121.779 1.653 . . . . 0.0 112.092 -179.786 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 684' ' ' GLU . . . . . . . . . . . . . 51.6 mp0 -71.98 -38.94 69.63 Favored 'General case' 0 C--N 1.333 -0.142 0 CA-C-O 121.044 0.45 . . . . 0.0 110.288 178.924 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 685' ' ' GLN . . . . . . . . . . . . . 65.0 tt0 -71.56 -42.24 68.07 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 115.392 -0.822 . . . . 0.0 112.267 -179.728 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 686' ' ' LEU . . . . . . . . . . . . . 65.3 tp -135.88 120.53 18.32 Favored 'General case' 0 C--N 1.332 -0.193 0 N-CA-C 112.513 0.56 . . . . 0.0 112.513 -178.044 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 687' ' ' LYS . . . . . 0.41 ' O ' ' HA ' ' A' ' 658' ' ' ALA . 73.6 mmtt -91.21 146.46 23.81 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 121.158 0.504 . . . . 0.0 110.031 177.553 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 688' ' ' ILE . . . . . . . . . . . . . 76.8 mt -123.81 121.1 61.49 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.771 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.811 -179.013 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 689' ' ' PHE . . . . . . . . . . . . . 98.6 m-85 -121.36 141.4 50.99 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.631 -0.713 . . . . 0.0 110.81 179.257 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 690' ' ' ILE . . . . . . . . . . . . . 97.5 mt -117.77 132.86 66.34 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.495 0 CA-C-O 121.184 0.516 . . . . 0.0 111.995 179.722 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 691' ' ' LEU . . . . . . . . . . . . . 3.7 mp -112.88 129.4 56.47 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-N 115.522 -0.763 . . . . 0.0 110.717 179.736 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 692' ' ' GLY . . . . . 0.608 ' O ' ' HA ' ' A' ' 705' ' ' PRO . . . 173.4 -173.57 45.77 Favored Glycine 0 N--CA 1.448 -0.555 0 C-N-CA 120.898 -0.667 . . . . 0.0 111.723 -179.907 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 693' ' ' SER . . . . . . . . . . . . . 80.8 p -64.59 -35.69 81.8 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.985 0.422 . . . . 0.0 110.73 179.568 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 694' ' ' LYS . . . . . . . . . . . . . 23.2 pttp -142.41 135.95 29.04 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.011 178.535 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 695' ' ' GLY . . . . . 0.486 ' HA3' ' CG ' ' A' ' 703' ' ' TYR . . . -75.73 131.59 12.15 Favored Glycine 0 N--CA 1.448 -0.511 0 C-N-CA 120.595 -0.812 . . . . 0.0 112.269 179.646 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 696' ' ' ASN . . . . . . . . . . . . . 29.3 m120 -63.96 -38.69 92.01 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-O 120.57 0.224 . . . . 0.0 111.39 179.947 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 697' ' ' TYR . . . . . . . . . . . . . 2.6 t80 58.84 35.75 24.38 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-N 115.651 -0.704 . . . . 0.0 111.637 -179.87 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 698' ' ' GLN . . . . . . . . . . . . . 97.3 mm-40 -107.32 82.66 1.7 Allowed 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.627 -0.26 . . . . 0.0 110.825 179.934 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 699' ' ' GLY . . . . . . . . . . . . . . . 80.12 15.24 79.19 Favored Glycine 0 CA--C 1.52 0.385 0 C-N-CA 120.338 -0.934 . . . . 0.0 113.463 179.366 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 700' ' ' VAL . . . . . . . . . . . . . 31.4 m -107.75 152.04 9.6 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-O 121.226 0.536 . . . . 0.0 110.9 -179.215 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 701' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -69.74 -42.01 74.51 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.143 -0.935 . . . . 0.0 112.599 -178.42 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 702' ' ' ARG . . . . . . . . . . . . . 37.9 ttm180 -162.7 158.15 22.68 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.776 0.322 . . . . 0.0 111.078 -178.562 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 703' ' ' TYR . . . . . 0.486 ' CG ' ' HA3' ' A' ' 695' ' ' GLY . 52.8 p90 -124.82 147.76 48.56 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.255 -0.43 . . . . 0.0 109.93 179.285 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 704' ' ' ILE . . . . . . . . . . . . . 58.7 mt -123.76 102.46 35.24 Favored Pre-proline 0 C--N 1.326 -0.423 0 CA-C-O 120.833 0.349 . . . . 0.0 111.223 -179.482 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 705' ' ' PRO . . . . . 0.608 ' HA ' ' O ' ' A' ' 692' ' ' GLY . 34.5 Cg_exo -60.96 143.19 99.29 Favored 'Trans proline' 0 C--N 1.348 0.514 0 C-N-CA 123.456 2.771 . . . . 0.0 113.883 179.909 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 706' ' ' LEU . . . . . . . . . . . . . 95.4 mt -98.66 151.97 37.67 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-N 115.403 -0.817 . . . . 0.0 109.973 178.408 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 707' ' ' PRO . . . . . . . . . . . . . 63.4 Cg_endo -72.99 139.5 61.72 Favored 'Cis proline' 0 C--N 1.345 0.379 0 C-N-CA 123.067 -1.639 . . . . 0.0 112.882 -0.19 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 708' ' ' ILE . . . . . . . . . . . . . 1.4 pt -66.68 134.28 30.22 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-N 115.652 -0.704 . . . . 0.0 111.913 178.715 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 709' ' ' HIS . . . . . . . . . . . . . 71.3 m80 -98.15 114.49 65.21 Favored Pre-proline 0 C--N 1.32 -0.679 0 N-CA-C 108.217 -1.031 . . . . 0.0 108.217 177.54 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 710' ' ' PRO . . . . . . . . . . . . . 85.2 Cg_exo -51.66 -37.13 63.45 Favored 'Trans proline' 0 N--CA 1.477 0.504 0 C-N-CA 123.174 2.582 . . . . 0.0 114.277 -177.957 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 711' ' ' GLU . . . . . . . . . . . . . 51.1 mp0 -64.72 -39.59 93.91 Favored 'General case' 0 CA--C 1.532 0.284 0 N-CA-C 112.458 0.54 . . . . 0.0 112.458 -178.964 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 712' ' ' SER . . . . . . . . . . . . . 80.9 p -98.6 -23.18 15.59 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 112.552 0.575 . . . . 0.0 112.552 -178.435 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 713' ' ' PHE . . . . . . . . . . . . . 82.5 t80 -59.91 -49.07 79.15 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 120.644 0.259 . . . . 0.0 111.229 -179.833 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 714' ' ' LEU . . . . . . . . . . . . . 58.8 tp -62.17 -41.03 97.92 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.189 -0.459 . . . . 0.0 109.917 179.906 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 715' ' ' GLN . . . . . . . . . . . . . 30.5 mm100 -62.95 -42.38 99.8 Favored 'General case' 0 CA--C 1.53 0.185 0 CA-C-N 115.742 -0.663 . . . . 0.0 111.124 179.02 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 716' ' ' GLN . . . . . . . . . . . . . 96.3 mt-30 -64.6 -42.4 95.59 Favored 'General case' 0 N--CA 1.462 0.169 0 CA-C-O 120.645 0.26 . . . . 0.0 111.243 179.589 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 717' ' ' VAL . . . . . . . . . . . . . 71.3 t -64.28 -44.53 97.35 Favored 'Isoleucine or valine' 0 C--O 1.233 0.213 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.456 179.288 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 718' ' ' THR . . . . . 0.467 ' O ' ' HG ' ' A' ' 721' ' ' LEU . 91.4 m -60.94 -47.0 88.42 Favored 'General case' 0 N--CA 1.457 -0.076 0 CA-C-N 115.824 -0.625 . . . . 0.0 110.907 179.904 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 719' ' ' MET . . . . . . . . . . . . . 38.6 mmt -62.55 -39.72 94.54 Favored 'General case' 0 C--O 1.234 0.264 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.404 179.356 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 720' ' ' GLY . . . . . . . . . . . . . . . -62.3 -40.22 98.73 Favored Glycine 0 N--CA 1.451 -0.316 0 CA-C-N 115.814 -0.63 . . . . 0.0 113.176 179.423 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 721' ' ' LEU . . . . . 0.467 ' HG ' ' O ' ' A' ' 718' ' ' THR . 2.6 pp -80.2 -33.43 38.18 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-N 117.087 0.444 . . . . 0.0 111.965 -179.533 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 722' ' ' THR . . . . . 0.547 ' HA ' ' O ' ' A' ' 725' ' ' ALA . 56.3 p -68.91 -18.1 64.06 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-O 120.684 0.278 . . . . 0.0 111.696 179.993 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 723' ' ' SER . . . . . . . . . . . . . 75.0 m -62.71 -38.99 92.65 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.39 178.816 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 724' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -87.92 -47.78 8.31 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.304 179.812 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 725' ' ' ALA . . . . . 0.547 ' O ' ' HA ' ' A' ' 722' ' ' THR . . . -150.05 156.61 41.99 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 120.845 0.355 . . . . 0.0 111.337 -179.437 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 726' ' ' THR . . . . . . . . . . . . . 75.1 p -118.64 154.27 32.95 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.467 -0.333 . . . . 0.0 110.975 -179.952 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 727' ' ' SER . . . . . . . . . . . . . 45.9 t -149.35 148.43 29.49 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.272 -179.847 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 728' ' ' ALA . . . . . . . . . . . . . . . -62.32 -39.73 93.99 Favored 'General case' 0 C--N 1.333 -0.142 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.455 179.888 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 729' ' ' GLN . . . . . . . . . . . . . 3.3 mm100 . . . . . 0 C--O 1.25 1.107 0 CA-C-O 118.373 -0.823 . . . . 0.0 111.44 179.979 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 613' ' ' GLU . . . . . . . . . . . . . 3.1 pt-20 . . . . . 0 N--CA 1.489 1.488 0 CA-C-O 121.003 0.43 . . . . 0.0 110.794 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 614' ' ' GLY . . . . . . . . . . . . . . . 100.01 148.73 23.02 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.941 -0.647 . . . . 0.0 112.577 179.981 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 615' ' ' ARG . . . . . . . . . . . . . 95.5 mtm-85 -117.72 133.32 56.06 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.566 0.222 . . . . 0.0 110.913 -179.895 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 616' ' ' ILE . . . . . 0.454 ' O ' ' HA ' ' A' ' 640' ' ' VAL . 84.9 mt -124.45 133.41 69.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 N-CA-C 109.613 -0.514 . . . . 0.0 109.613 178.627 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 617' ' ' VAL . . . . . . . . . . . . . 33.7 m -109.66 146.73 14.71 Favored 'Isoleucine or valine' 0 C--O 1.235 0.326 0 C-N-CA 120.023 -0.671 . . . . 0.0 110.32 -179.793 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 618' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -120.5 122.28 40.29 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.327 -179.765 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 619' ' ' VAL . . . . . 0.482 ' HA ' ' O ' ' A' ' 643' ' ' LEU . 59.4 t -116.46 116.19 51.47 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 N-CA-C 108.784 -0.821 . . . . 0.0 108.784 179.513 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 620' ' ' SER . . . . . . . . . . . . . 29.9 t -165.68 144.08 6.01 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.59 -0.732 . . . . 0.0 111.685 -179.001 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 621' ' ' GLU . . . . . . . . . . . . . 88.2 tt0 -76.69 -28.14 55.78 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.242 -0.89 . . . . 0.0 110.923 178.626 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 622' ' ' ASP . . . . . . . . . . . . . 57.2 t0 -86.13 108.07 18.14 Favored 'General case' 0 C--O 1.234 0.271 0 CA-C-O 121.075 0.464 . . . . 0.0 111.034 -178.436 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 623' ' ' GLU . . . . . 0.42 ' O ' HG23 ' A' ' 627' ' ' THR . 50.9 mp0 -63.98 -39.29 93.8 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.375 -0.83 . . . . 0.0 112.139 179.817 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 624' ' ' ALA . . . . . . . . . . . . . . . -60.8 -44.3 97.03 Favored 'General case' 0 N--CA 1.465 0.286 0 N-CA-C 112.447 0.536 . . . . 0.0 112.447 -178.232 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 625' ' ' THR . . . . . . . . . . . . . 87.0 m -68.34 -40.4 81.57 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.289 0.566 . . . . 0.0 109.986 179.779 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 626' ' ' SER . . . . . . . . . . . . . 68.0 m -62.83 -40.91 98.85 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.179 -0.919 . . . . 0.0 112.27 -179.074 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 627' ' ' THR . . . . . 0.42 HG23 ' O ' ' A' ' 623' ' ' GLU . 60.4 p -67.11 -39.85 86.76 Favored 'General case' 0 N--CA 1.466 0.332 0 N-CA-C 112.77 0.656 . . . . 0.0 112.77 -179.577 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 628' ' ' LEU . . . . . . . . . . . . . 63.7 tp -64.68 -46.97 80.15 Favored 'General case' 0 N--CA 1.464 0.238 0 N-CA-C 111.858 0.318 . . . . 0.0 111.858 -179.317 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 629' ' ' ILE . . . . . . . . . . . . . 18.5 tt -72.52 -32.73 42.8 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.433 0 N-CA-C 112.421 0.526 . . . . 0.0 112.421 -179.12 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 630' ' ' CYS . . . . . . . . . . . . . 51.6 t -60.16 -45.0 94.56 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.275 -179.343 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 631' ' ' SER . . . . . . . . . . . . . 47.1 t -61.56 -42.31 98.65 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.009 -179.694 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 632' ' ' ILE . . . . . . . . . . . . . 97.2 mt -61.84 -48.17 89.84 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.314 0 CA-C-O 120.796 0.331 . . . . 0.0 110.679 180.0 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 633' ' ' LEU . . . . . . . . . . . . . 74.4 mt -65.82 -40.42 91.82 Favored 'General case' 0 C--O 1.234 0.281 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.863 179.635 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 634' ' ' THR . . . . . 0.527 ' HA ' ' O ' ' A' ' 638' ' ' TYR . 90.3 m -65.89 -40.78 91.88 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-O 120.718 0.294 . . . . 0.0 110.983 -179.69 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 635' ' ' THR . . . . . . . . . . . . . 91.9 m -59.44 -38.9 81.9 Favored 'General case' 0 CA--C 1.53 0.185 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.369 179.212 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 636' ' ' ALA . . . . . . . . . . . . . . . -64.33 -16.74 62.78 Favored 'General case' 0 CA--C 1.533 0.288 0 CA-C-N 115.879 -0.6 . . . . 0.0 111.385 178.989 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 637' ' ' GLY . . . . . . . . . . . . . . . 108.97 7.26 29.29 Favored Glycine 0 C--N 1.334 0.459 0 C-N-CA 120.973 -0.632 . . . . 0.0 113.227 179.693 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 638' ' ' TYR . . . . . 0.527 ' O ' ' HA ' ' A' ' 634' ' ' THR . 97.9 m-85 -100.8 141.36 33.79 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.882 0.341 . . . . 0.0 111.418 -179.961 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 639' ' ' GLN . . . . . . . . . . . . . 98.9 mm-40 -86.4 133.7 33.76 Favored 'General case' 0 CA--C 1.516 -0.339 0 N-CA-C 109.869 -0.419 . . . . 0.0 109.869 178.98 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 640' ' ' VAL . . . . . 0.454 ' HA ' ' O ' ' A' ' 616' ' ' ILE . 63.2 t -119.42 130.71 73.65 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 N-CA-C 112.411 0.522 . . . . 0.0 112.411 -179.254 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 641' ' ' ILE . . . . . . . . . . . . . 4.0 mp -113.77 120.13 62.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 N-CA-C 108.521 -0.918 . . . . 0.0 108.521 178.224 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 642' ' ' TRP . . . . . . . . . . . . . 62.8 t90 -94.42 126.45 39.7 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.224 0.535 . . . . 0.0 112.031 -178.575 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 643' ' ' LEU . . . . . 0.482 ' O ' ' HA ' ' A' ' 619' ' ' VAL . 88.3 mt -127.59 143.01 51.21 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.203 -0.908 . . . . 0.0 110.8 179.91 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 644' ' ' VAL . . . . . . . . . . . . . 3.6 p -128.89 78.82 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-O 121.796 0.808 . . . . 0.0 109.853 177.953 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 645' ' ' ASP . . . . . . . . . . . . . 37.8 t70 -176.75 -33.26 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.453 0 CA-C-N 115.452 -0.795 . . . . 0.0 111.659 -179.176 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 646' ' ' GLY . . . . . . . . . . . . . . . 72.78 28.67 66.64 Favored Glycine 0 CA--C 1.52 0.356 0 C-N-CA 120.978 -0.629 . . . . 0.0 113.26 -179.441 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 647' ' ' GLU . . . . . . . . . . . . . 4.9 tp10 -72.41 119.3 16.43 Favored 'General case' 0 N--CA 1.455 -0.191 0 CA-C-O 121.139 0.495 . . . . 0.0 110.961 -179.684 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 648' ' ' VAL . . . . . . . . . . . . . 75.5 t -61.74 -40.04 85.43 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-N 115.201 -0.909 . . . . 0.0 111.653 -179.843 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 649' ' ' GLU . . . . . . . . . . . . . 50.0 mp0 -60.9 -43.26 98.78 Favored 'General case' 0 C--N 1.332 -0.173 0 C-N-CA 120.795 -0.362 . . . . 0.0 110.424 -179.806 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 650' ' ' ARG . . . . . . . . . . . . . 84.1 mtt85 -68.89 -40.99 78.9 Favored 'General case' 0 CA--C 1.53 0.2 0 CA-C-N 116.426 -0.352 . . . . 0.0 110.541 178.453 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 651' ' ' LEU . . . . . . . . . . . . . 83.5 mt -65.52 -40.83 93.44 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 116.321 -0.399 . . . . 0.0 110.431 178.771 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 652' ' ' LEU . . . . . . . . . . . . . 61.8 tp -64.73 -42.59 95.1 Favored 'General case' 0 CA--C 1.53 0.182 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.01 178.95 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 653' ' ' ALA . . . . . . . . . . . . . . . -62.21 -39.12 91.7 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.548 179.726 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 654' ' ' LEU . . . . . . . . . . . . . 75.5 mt -99.64 30.1 3.78 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.91 -179.663 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 655' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -30.78 104.38 0.21 Allowed Pre-proline 0 N--CA 1.473 0.724 0 O-C-N 124.548 1.155 . . . . 0.0 113.876 -179.248 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 656' ' ' PRO . . . . . . . . . . . . . 20.9 Cg_endo -96.57 179.63 0.48 Allowed 'Trans proline' 0 N--CA 1.461 -0.429 0 C-N-CA 124.029 3.153 . . . . 0.0 112.454 178.878 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 657' ' ' ILE . . . . . . . . . . . . . 26.8 pt -84.17 -25.87 7.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-O 121.374 0.607 . . . . 0.0 109.914 178.09 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 658' ' ' ALA . . . . . . . . . . . . . . . -155.76 152.91 29.08 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.182 -0.917 . . . . 0.0 111.004 -179.655 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 659' ' ' VAL . . . . . . . . . . . . . 30.7 m -120.38 142.48 35.99 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-O 121.152 0.501 . . . . 0.0 110.521 179.034 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 660' ' ' LEU . . . . . . . . . . . . . 5.7 mp -114.86 116.37 28.46 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.702 -0.681 . . . . 0.0 109.777 179.316 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 661' ' ' LEU . . . . . . . . . . . . . 69.6 mt -107.59 114.88 29.17 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 109.403 -0.591 . . . . 0.0 109.403 -179.578 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 662' ' ' ALA . . . . . . . . . . . . . . . -111.33 130.26 55.73 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 113.32 0.859 . . . . 0.0 113.32 -178.352 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 663' ' ' GLU . . . . . . . . . . . . . 12.1 mm-40 -71.64 146.68 91.42 Favored Pre-proline 0 CA--C 1.534 0.342 0 CA-C-N 115.32 -0.854 . . . . 0.0 110.236 177.728 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 664' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -74.23 141.83 72.94 Favored 'Cis proline' 0 C--N 1.348 0.525 0 C-N-CA 123.382 -1.508 . . . . 0.0 112.72 -0.793 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 665' ' ' PHE . . . . . . . . . . . . . 22.1 m-30 -75.75 138.66 41.38 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.714 -0.675 . . . . 0.0 111.153 179.416 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 666' ' ' SER . . . . . . . . . . . . . 78.9 p -93.05 -23.99 18.46 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.431 -0.35 . . . . 0.0 111.64 179.88 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 667' ' ' TYR . . . . . . . . . . . . . 13.6 p90 -78.91 -17.94 54.69 Favored 'General case' 0 N--CA 1.464 0.262 0 N-CA-C 112.067 0.395 . . . . 0.0 112.067 179.593 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 668' ' ' GLY . . . . . . . . . . . . . . . 100.08 -104.82 2.88 Favored Glycine 0 CA--C 1.521 0.45 0 C-N-CA 120.477 -0.868 . . . . 0.0 114.183 178.969 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 669' ' ' ASP . . . . . . . . . . . . . 27.2 t70 -83.43 108.13 16.39 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-O 120.952 0.406 . . . . 0.0 111.838 -177.835 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 670' ' ' VAL . . . . . . . . . . . . . 9.9 p -66.44 -29.08 45.4 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.413 0 N-CA-C 113.108 0.781 . . . . 0.0 113.108 -179.744 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 671' ' ' GLN . . . . . 0.513 ' O ' HG11 ' A' ' 674' ' ' VAL . 21.9 mp0 -61.66 -41.78 98.01 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-O 120.752 0.31 . . . . 0.0 111.185 -179.293 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 672' ' ' GLU . . . . . . . . . . . . . 95.4 mt-10 -66.91 -40.86 87.78 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.496 -0.32 . . . . 0.0 110.644 178.616 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 673' ' ' LEU . . . . . . . . . . . . . 64.2 tp -63.96 -46.14 86.0 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 115.831 -0.622 . . . . 0.0 111.105 -179.959 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 674' ' ' VAL . . . . . 0.513 HG11 ' O ' ' A' ' 671' ' ' GLN . 8.7 p -65.71 -37.76 80.7 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.246 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.067 -179.617 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 675' ' ' ASP . . . . . 0.423 ' O ' ' HB2' ' A' ' 679' ' ' GLN . 36.9 t70 -62.15 -40.02 94.57 Favored 'General case' 0 CA--C 1.518 -0.28 0 N-CA-C 109.761 -0.459 . . . . 0.0 109.761 177.571 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 676' ' ' GLN . . . . . . . . . . . . . 96.7 mt-30 -70.44 -40.77 73.58 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.84 179.737 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 677' ' ' LEU . . . . . . . . . . . . . 86.4 mt -66.57 -40.9 89.22 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.467 179.566 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 678' ' ' ARG . . . . . 0.559 ' HA ' ' O ' ' A' ' 681' ' ' CYS . 84.9 mtp180 -80.59 -15.62 56.17 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-O 120.816 0.341 . . . . 0.0 111.639 -179.232 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 679' ' ' GLN . . . . . 0.423 ' HB2' ' O ' ' A' ' 675' ' ' ASP . 52.1 tt0 -65.2 -39.4 92.78 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.96 179.901 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 680' ' ' ARG . . . . . 0.414 ' H ' ' HG2' ' A' ' 680' ' ' ARG . 0.0 OUTLIER -107.01 -32.97 7.63 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.916 -179.651 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 681' ' ' CYS . . . . . 0.559 ' O ' ' HA ' ' A' ' 678' ' ' ARG . 72.2 m -113.78 130.25 56.47 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.862 0.363 . . . . 0.0 111.038 -179.703 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 682' ' ' THR . . . . . . . . . . . . . 72.8 p -75.04 158.27 84.51 Favored Pre-proline 0 C--N 1.327 -0.4 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.121 179.487 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 683' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_endo -60.58 -27.12 84.28 Favored 'Trans proline' 0 C--N 1.347 0.492 0 C-N-CA 122.038 1.825 . . . . 0.0 112.108 179.36 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 684' ' ' GLU . . . . . . . . . . . . . 51.7 mp0 -72.11 -39.58 68.79 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 120.981 0.419 . . . . 0.0 110.277 178.714 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 685' ' ' GLN . . . . . . . . . . . . . 54.0 tt0 -72.15 -42.22 66.21 Favored 'General case' 0 C--O 1.232 0.144 0 CA-C-N 115.856 -0.611 . . . . 0.0 111.41 179.523 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 686' ' ' LEU . . . . . . . . . . . . . 63.4 tp -127.78 116.61 20.46 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.337 -179.031 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 687' ' ' LYS . . . . . . . . . . . . . 68.8 mttm -85.64 146.55 26.8 Favored 'General case' 0 CA--C 1.519 -0.229 0 CA-C-O 121.129 0.49 . . . . 0.0 110.452 179.06 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 688' ' ' ILE . . . . . . . . . . . . . 76.9 mt -124.52 120.16 58.25 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.644 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.371 -178.632 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 689' ' ' PHE . . . . . . . . . . . . . 98.8 m-85 -119.09 144.64 46.49 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.021 -0.991 . . . . 0.0 109.981 178.831 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 690' ' ' ILE . . . . . . . . . . . . . 18.5 tt -124.79 138.32 54.55 Favored 'Isoleucine or valine' 0 C--O 1.236 0.379 0 CA-C-O 121.186 0.517 . . . . 0.0 111.526 -179.623 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 691' ' ' LEU . . . . . . . . . . . . . 63.3 mt -109.46 130.51 55.5 Favored 'General case' 0 C--O 1.233 0.229 0 CA-C-N 115.591 -0.731 . . . . 0.0 110.267 179.756 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 692' ' ' GLY . . . . . 0.644 ' O ' ' HA ' ' A' ' 705' ' ' PRO . . . 169.97 178.85 41.24 Favored Glycine 0 N--CA 1.444 -0.795 0 C-N-CA 120.808 -0.71 . . . . 0.0 111.977 179.782 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 693' ' ' SER . . . . . . . . . . . . . 79.8 p -67.69 -36.6 80.96 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.743 0.306 . . . . 0.0 111.298 179.598 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 694' ' ' LYS . . . . . . . . . . . . . 17.0 mmmt -121.31 136.65 54.94 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.191 0.519 . . . . 0.0 110.647 179.78 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 695' ' ' GLY . . . . . 0.428 ' HA3' ' CB ' ' A' ' 703' ' ' TYR . . . -101.95 17.11 55.1 Favored Glycine 0 N--CA 1.449 -0.464 0 CA-C-N 115.418 -0.81 . . . . 0.0 112.987 179.702 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 696' ' ' ASN . . . . . . . . . . . . . 64.7 t30 -80.97 69.73 7.62 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 121.193 0.521 . . . . 0.0 111.271 -179.267 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 697' ' ' TYR . . . . . . . . . . . . . 95.5 m-85 -132.15 146.9 52.34 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.689 -0.687 . . . . 0.0 110.001 179.269 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 698' ' ' GLN . . . . . . . . . . . . . 25.2 pt20 -94.2 152.32 18.81 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.719 -179.739 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 699' ' ' GLY . . . . . . . . . . . . . . . 90.66 4.59 69.91 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.651 -0.785 . . . . 0.0 113.482 179.818 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 700' ' ' VAL . . . . . . . . . . . . . 25.6 m -117.98 152.05 20.0 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.312 0 CA-C-N 117.369 0.585 . . . . 0.0 110.118 179.49 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 701' ' ' ASP . . . . . . . . . . . . . 64.2 m-20 -86.72 -33.2 20.09 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.789 -0.641 . . . . 0.0 111.893 -178.972 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 702' ' ' ARG . . . . . . . . . . . . . 6.2 mmp_? -150.37 163.87 37.27 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.84 0.352 . . . . 0.0 111.055 -179.29 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 703' ' ' TYR . . . . . 0.428 ' CB ' ' HA3' ' A' ' 695' ' ' GLY . 52.5 p90 -128.5 143.06 50.91 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.936 -0.574 . . . . 0.0 110.323 179.372 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 704' ' ' ILE . . . . . . . . . . . . . 47.5 mt -127.36 107.68 21.27 Favored Pre-proline 0 C--N 1.325 -0.474 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.247 179.726 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 705' ' ' PRO . . . . . 0.644 ' HA ' ' O ' ' A' ' 692' ' ' GLY . 64.7 Cg_endo -71.5 151.82 59.45 Favored 'Trans proline' 0 C--N 1.346 0.4 0 C-N-CA 122.794 2.329 . . . . 0.0 113.749 -179.157 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 706' ' ' LEU . . . . . 0.423 ' HA ' ' C ' ' A' ' 707' ' ' PRO . 87.5 mt -105.4 147.67 35.0 Favored Pre-proline 0 N--CA 1.453 -0.32 0 CA-C-N 115.447 -0.797 . . . . 0.0 109.999 178.962 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 707' ' ' PRO . . . . . 0.423 ' C ' ' HA ' ' A' ' 706' ' ' LEU . 58.3 Cg_endo -70.76 139.5 57.92 Favored 'Cis proline' 0 C--N 1.347 0.499 0 C-N-CA 122.991 -1.67 . . . . 0.0 112.622 -0.26 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 708' ' ' ILE . . . . . . . . . . . . . 2.5 pt -63.48 131.64 29.09 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 115.543 -0.753 . . . . 0.0 112.233 179.196 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 709' ' ' HIS . . . . . . . . . . . . . 70.5 m80 -97.0 115.82 65.85 Favored Pre-proline 0 C--N 1.323 -0.586 0 N-CA-C 107.904 -1.147 . . . . 0.0 107.904 177.309 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 710' ' ' PRO . . . . . . . . . . . . . 20.2 Cg_endo -59.41 -30.62 93.13 Favored 'Trans proline' 0 C--N 1.345 0.362 0 C-N-CA 122.647 2.231 . . . . 0.0 114.306 -177.118 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 711' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -67.55 -40.02 84.97 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 112.02 0.378 . . . . 0.0 112.02 -179.378 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 712' ' ' SER . . . . . . . . . . . . . 50.5 m -95.1 -23.2 17.42 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 112.017 0.377 . . . . 0.0 112.017 -178.917 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 713' ' ' PHE . . . . . . . . . . . . . 66.9 t80 -59.97 -49.74 76.48 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-O 120.725 0.297 . . . . 0.0 111.198 -179.757 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 714' ' ' LEU . . . . . . . . . . . . . 90.6 mt -64.6 -38.03 89.59 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.173 179.346 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 715' ' ' GLN . . . . . . . . . . . . . 53.9 tt0 -61.78 -43.86 98.02 Favored 'General case' 0 CA--C 1.532 0.266 0 CA-C-N 115.638 -0.71 . . . . 0.0 110.759 179.093 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 716' ' ' GLN . . . . . . . . . . . . . 87.9 mt-30 -64.26 -41.87 96.75 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-N 116.506 -0.316 . . . . 0.0 111.257 179.456 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 717' ' ' VAL . . . . . . . . . . . . . 69.4 t -63.48 -45.76 96.99 Favored 'Isoleucine or valine' 0 C--O 1.231 0.113 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.196 179.34 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 718' ' ' THR . . . . . . . . . . . . . 89.0 m -62.7 -44.55 95.94 Favored 'General case' 0 CA--C 1.529 0.146 0 CA-C-N 115.857 -0.611 . . . . 0.0 110.793 179.486 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 719' ' ' MET . . . . . . . . . . . . . 10.9 tpt -60.43 -47.01 87.96 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.396 179.67 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 720' ' ' GLY . . . . . . . . . . . . . . . -63.19 -40.73 99.44 Favored Glycine 0 C--N 1.332 0.343 0 C-N-CA 120.747 -0.74 . . . . 0.0 111.906 178.604 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 721' ' ' LEU . . . . . . . . . . . . . 62.2 tp -62.37 -43.31 99.13 Favored 'General case' 0 CA--C 1.531 0.217 0 C-N-CA 122.758 0.423 . . . . 0.0 111.318 179.586 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 722' ' ' THR . . . . . . . . . . . . . 73.7 p -72.83 -11.2 60.51 Favored 'General case' 0 N--CA 1.464 0.24 0 N-CA-C 112.0 0.37 . . . . 0.0 112.0 179.975 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 723' ' ' SER . . . . . . . . . . . . . 69.7 m -88.25 -1.87 58.27 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.509 -0.314 . . . . 0.0 111.198 -179.946 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 724' ' ' LEU . . . . . . . . . . . . . 2.1 tt -62.47 -44.13 97.14 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-N 116.44 -0.345 . . . . 0.0 111.29 179.714 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 725' ' ' ALA . . . . . . . . . . . . . . . -149.04 151.3 34.25 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.757 -179.884 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 726' ' ' THR . . . . . . . . . . . . . 75.1 p -80.81 160.63 24.78 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.33 -0.395 . . . . 0.0 111.305 179.787 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 727' ' ' SER . . . . . . . . . . . . . 61.5 m -126.74 148.36 49.9 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.619 179.919 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 728' ' ' ALA . . . . . . . . . . . . . . . -70.22 142.54 52.38 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.134 179.902 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 729' ' ' GLN . . . . . . . . . . . . . 97.0 mt-30 . . . . . 0 C--O 1.247 0.969 0 CA-C-O 118.34 -0.838 . . . . 0.0 110.793 -179.848 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 613' ' ' GLU . . . . . . . . . . . . . 98.0 mt-10 . . . . . 0 N--CA 1.488 1.452 0 CA-C-O 120.887 0.375 . . . . 0.0 110.706 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 614' ' ' GLY . . . . . . . . . . . . . . . 80.31 15.09 79.24 Favored Glycine 0 N--CA 1.453 -0.171 0 C-N-CA 120.897 -0.668 . . . . 0.0 112.486 -179.61 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 615' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -110.23 148.06 32.59 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.928 0.394 . . . . 0.0 111.151 -179.509 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 616' ' ' ILE . . . . . 0.622 ' O ' ' HA ' ' A' ' 640' ' ' VAL . 82.0 mt -119.12 135.47 59.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 115.763 -0.653 . . . . 0.0 109.639 179.684 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 617' ' ' VAL . . . . . . . . . . . . . 33.4 m -109.67 147.21 14.24 Favored 'Isoleucine or valine' 0 C--O 1.234 0.283 0 C-N-CA 120.16 -0.616 . . . . 0.0 110.687 -179.714 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 618' ' ' LEU . . . . . . . . . . . . . 1.3 tt -121.47 126.52 49.46 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.413 -179.525 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 619' ' ' VAL . . . . . . . . . . . . . 67.5 t -115.02 117.0 54.28 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-O 121.088 0.471 . . . . 0.0 110.172 -179.972 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 620' ' ' SER . . . . . . . . . . . . . 36.7 t -172.49 146.68 1.78 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.081 -0.963 . . . . 0.0 110.459 -179.686 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 621' ' ' GLU . . . . . 0.422 ' HG3' ' OG ' ' A' ' 666' ' ' SER . 97.8 mt-10 -92.11 -2.65 56.49 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.02 178.704 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 622' ' ' ASP . . . . . . . . . . . . . 58.0 t0 -92.25 107.06 18.93 Favored 'General case' 0 CA--C 1.531 0.223 0 CA-C-O 121.06 0.457 . . . . 0.0 111.127 -178.961 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 623' ' ' GLU . . . . . . . . . . . . . 42.2 tt0 -64.39 -38.56 91.46 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-N 115.351 -0.84 . . . . 0.0 111.999 179.914 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 624' ' ' ALA . . . . . . . . . . . . . . . -60.46 -42.1 95.48 Favored 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 112.06 0.393 . . . . 0.0 112.06 -178.654 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 625' ' ' THR . . . . . . . . . . . . . 21.7 p -75.83 -37.04 59.44 Favored 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 120.604 -0.439 . . . . 0.0 111.754 179.462 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 626' ' ' SER . . . . . . . . . . . . . 89.7 p -65.69 -39.38 91.23 Favored 'General case' 0 CA--C 1.53 0.179 0 N-CA-C 111.818 0.303 . . . . 0.0 111.818 -178.71 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 627' ' ' THR . . . . . . . . . . . . . 38.6 p -69.77 -39.05 76.9 Favored 'General case' 0 N--CA 1.464 0.238 0 N-CA-C 112.224 0.453 . . . . 0.0 112.224 179.526 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 628' ' ' LEU . . . . . . . . . . . . . 61.7 tp -70.77 -44.26 67.06 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 121.057 0.456 . . . . 0.0 112.021 179.803 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 629' ' ' ILE . . . . . . . . . . . . . 14.1 tt -72.8 -30.07 31.77 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.533 0 N-CA-C 113.729 1.011 . . . . 0.0 113.729 -177.601 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 630' ' ' CYS . . . . . . . . . . . . . 19.0 p -64.89 -27.94 69.2 Favored 'General case' 0 N--CA 1.466 0.352 0 N-CA-C 112.185 0.439 . . . . 0.0 112.185 -177.996 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 631' ' ' SER . . . . . . . . . . . . . 96.8 p -66.7 -39.56 88.12 Favored 'General case' 0 C--N 1.33 -0.259 0 C-N-CA 120.938 -0.305 . . . . 0.0 111.283 179.955 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 632' ' ' ILE . . . . . . . . . . . . . 96.7 mt -64.57 -48.91 82.91 Favored 'Isoleucine or valine' 0 C--O 1.234 0.274 0 CA-C-O 120.977 0.418 . . . . 0.0 111.302 -179.587 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 633' ' ' LEU . . . . . . . . . . . . . 88.1 mt -65.1 -41.75 94.68 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-N 115.804 -0.634 . . . . 0.0 112.391 -179.038 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 634' ' ' THR . . . . . . . . . . . . . 54.9 m -68.18 -39.79 82.44 Favored 'General case' 0 CA--C 1.532 0.271 0 C-N-CA 121.209 -0.197 . . . . 0.0 111.457 -179.156 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 635' ' ' THR . . . . . . . . . . . . . 95.0 m -59.48 -38.89 82.01 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-O 120.899 0.38 . . . . 0.0 110.409 179.542 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 636' ' ' ALA . . . . . . . . . . . . . . . -63.06 -18.9 63.87 Favored 'General case' 0 CA--C 1.532 0.258 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.165 178.819 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 637' ' ' GLY . . . . . . . . . . . . . . . 107.09 2.98 36.17 Favored Glycine 0 C--N 1.332 0.342 0 C-N-CA 121.117 -0.563 . . . . 0.0 112.801 179.809 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 638' ' ' TYR . . . . . . . . . . . . . 88.9 m-85 -100.88 142.61 32.11 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.082 0.468 . . . . 0.0 111.625 -179.886 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 639' ' ' GLN . . . . . . . . . . . . . 74.2 mt-30 -90.38 139.37 30.74 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.04 -0.527 . . . . 0.0 109.923 179.308 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 640' ' ' VAL . . . . . 0.622 ' HA ' ' O ' ' A' ' 616' ' ' ILE . 7.1 p -125.06 138.83 52.98 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.585 -179.556 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 641' ' ' ILE . . . . . . . . . . . . . 48.1 mm -113.67 119.97 62.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 115.971 -0.559 . . . . 0.0 109.502 179.127 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 642' ' ' TRP . . . . . . . . . . . . . 21.6 t90 -90.68 122.13 33.18 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.047 0.451 . . . . 0.0 111.581 -179.019 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 643' ' ' LEU . . . . . . . . . . . . . 88.9 mt -121.11 138.94 53.96 Favored 'General case' 0 CA--C 1.53 0.185 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.402 179.175 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 644' ' ' VAL . . . . . . . . . . . . . 9.6 m -108.31 25.91 2.42 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 116.426 -0.352 . . . . 0.0 111.723 -179.883 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 645' ' ' ASP . . . . . . . . . . . . . 11.5 t0 -134.92 -47.6 0.73 Allowed 'General case' 0 N--CA 1.467 0.398 0 N-CA-C 112.891 0.7 . . . . 0.0 112.891 -177.928 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 646' ' ' GLY . . . . . . . . . . . . . . . 80.96 24.7 57.41 Favored Glycine 0 CA--C 1.52 0.353 0 C-N-CA 120.636 -0.792 . . . . 0.0 113.871 -179.555 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 647' ' ' GLU . . . . . . . . . . . . . 71.4 mm-40 -68.97 132.33 46.52 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-O 121.295 0.569 . . . . 0.0 111.173 179.698 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 648' ' ' VAL . . . . . . . . . . . . . 78.1 t -62.03 -40.29 86.82 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 CA-C-N 114.729 -1.123 . . . . 0.0 111.612 -179.47 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 649' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -61.39 -42.96 99.56 Favored 'General case' 0 C--N 1.331 -0.212 0 C-N-CA 120.77 -0.372 . . . . 0.0 110.56 -179.799 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 650' ' ' ARG . . . . . . . . . . . . . 80.5 mtp180 -70.02 -40.62 75.11 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-N 116.563 -0.29 . . . . 0.0 110.47 178.64 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 651' ' ' LEU . . . . . . . . . . . . . 84.9 mt -65.14 -41.14 95.05 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.449 178.745 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 652' ' ' LEU . . . . . . . . . . . . . 62.2 tp -65.52 -43.23 90.68 Favored 'General case' 0 CA--C 1.53 0.197 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.227 178.857 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 653' ' ' ALA . . . . . . . . . . . . . . . -62.31 -39.44 93.02 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-O 121.075 0.464 . . . . 0.0 111.629 179.871 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 654' ' ' LEU . . . . . . . . . . . . . 75.5 mt -101.07 30.98 3.82 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.846 -0.615 . . . . 0.0 110.325 -179.929 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 655' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -30.3 104.12 0.2 Allowed Pre-proline 0 N--CA 1.474 0.762 0 O-C-N 124.731 1.269 . . . . 0.0 114.008 -178.249 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 656' ' ' PRO . . . . . . . . . . . . . 32.7 Cg_endo -90.76 177.05 2.25 Favored 'Trans proline' 0 C--N 1.345 0.372 0 C-N-CA 124.106 3.204 . . . . 0.0 112.559 178.8 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 657' ' ' ILE . . . . . 0.477 ' O ' ' HA ' ' A' ' 686' ' ' LEU . 17.7 pt -86.91 -25.01 6.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 121.484 0.659 . . . . 0.0 109.806 177.599 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 658' ' ' ALA . . . . . . . . . . . . . . . -158.64 152.74 23.82 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.069 -0.969 . . . . 0.0 110.475 179.255 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 659' ' ' VAL . . . . . . . . . . . . . 34.6 m -120.21 142.27 36.7 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-O 121.43 0.633 . . . . 0.0 111.277 179.52 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 660' ' ' LEU . . . . . . . . . . . . . 21.3 mt -112.63 111.66 22.62 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.198 -0.91 . . . . 0.0 108.606 178.265 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 661' ' ' LEU . . . . . . . . . . . . . 47.3 mt -103.61 111.33 23.76 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 109.746 -0.464 . . . . 0.0 109.746 -178.797 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 662' ' ' ALA . . . . . . . . . . . . . . . -105.67 132.68 51.51 Favored 'General case' 0 C--N 1.327 -0.413 0 N-CA-C 112.315 0.487 . . . . 0.0 112.315 -178.637 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 663' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -72.27 145.25 88.01 Favored Pre-proline 0 C--N 1.326 -0.416 0 CA-C-N 115.76 -0.655 . . . . 0.0 110.363 178.564 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 664' ' ' PRO . . . . . . . . . . . . . 69.1 Cg_endo -73.27 139.68 62.81 Favored 'Cis proline' 0 C--N 1.348 0.508 0 C-N-CA 123.122 -1.616 . . . . 0.0 112.775 -0.849 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 665' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -75.74 141.78 42.54 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.892 -0.594 . . . . 0.0 111.383 179.554 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 666' ' ' SER . . . . . 0.422 ' OG ' ' HG3' ' A' ' 621' ' ' GLU . 1.1 m -97.12 -34.94 10.96 Favored 'General case' 0 CA--C 1.53 0.191 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.389 -179.367 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 667' ' ' TYR . . . . . . . . . . . . . 22.5 p90 -63.47 -20.15 65.34 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-N 115.94 -0.573 . . . . 0.0 112.5 179.838 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 668' ' ' GLY . . . . . . . . . . . . . . . 100.82 -111.17 4.08 Favored Glycine 0 N--CA 1.449 -0.436 0 C-N-CA 120.712 -0.756 . . . . 0.0 113.74 179.482 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 669' ' ' ASP . . . . . . . . . . . . . 36.2 t70 -79.97 118.01 21.33 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-O 121.119 0.485 . . . . 0.0 112.097 -178.213 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 670' ' ' VAL . . . . . . . . . . . . . 72.2 t -61.42 -42.21 92.92 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.351 0 CA-C-N 115.355 -0.839 . . . . 0.0 112.547 -179.699 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 671' ' ' GLN . . . . . . . . . . . . . 96.8 mt-30 -61.32 -41.85 97.7 Favored 'General case' 0 N--CA 1.464 0.246 0 N-CA-C 111.985 0.365 . . . . 0.0 111.985 -178.066 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 672' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 -64.72 -40.76 95.88 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.578 0.228 . . . . 0.0 110.994 179.342 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 673' ' ' LEU . . . . . . . . . . . . . 64.5 tp -64.57 -44.6 90.2 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.189 179.103 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 674' ' ' VAL . . . . . . . . . . . . . 56.5 t -63.0 -44.18 99.51 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-N 115.718 -0.674 . . . . 0.0 109.916 179.706 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 675' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -59.42 -40.41 86.63 Favored 'General case' 0 CA--C 1.521 -0.171 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.264 179.171 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 676' ' ' GLN . . . . . 0.581 ' O ' ' HG3' ' A' ' 680' ' ' ARG . 57.0 mt-30 -70.84 -41.49 71.4 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.451 -0.341 . . . . 0.0 110.919 179.777 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 677' ' ' LEU . . . . . . . . . . . . . 85.7 mt -67.68 -41.76 83.16 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.988 179.999 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 678' ' ' ARG . . . . . 0.482 ' HA ' ' O ' ' A' ' 681' ' ' CYS . 39.9 ptt180 -73.81 -27.23 61.01 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-O 120.882 0.372 . . . . 0.0 111.439 -178.989 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 679' ' ' GLN . . . . . . . . . . . . . 52.9 tt0 -65.92 -38.61 89.12 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.613 179.326 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 680' ' ' ARG . . . . . 0.581 ' HG3' ' O ' ' A' ' 676' ' ' GLN . 49.0 mtt-85 -92.74 -41.02 10.37 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.788 -0.642 . . . . 0.0 111.914 -179.032 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 681' ' ' CYS . . . . . 0.482 ' O ' ' HA ' ' A' ' 678' ' ' ARG . 78.5 m -122.66 134.07 54.5 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 120.949 0.404 . . . . 0.0 110.718 -179.932 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 682' ' ' THR . . . . . . . . . . . . . 61.7 p -70.39 159.15 85.79 Favored Pre-proline 0 C--N 1.324 -0.52 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.43 179.669 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 683' ' ' PRO . . . . . . . . . . . . . 76.2 Cg_exo -54.83 -33.13 80.25 Favored 'Trans proline' 0 C--N 1.349 0.56 0 C-N-CA 122.629 2.219 . . . . 0.0 112.505 179.585 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 684' ' ' GLU . . . . . . . . . . . . . 51.7 mp0 -70.57 -38.78 74.14 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.653 179.724 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 685' ' ' GLN . . . . . . . . . . . . . 65.0 tt0 -71.26 -41.05 70.58 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 115.61 -0.723 . . . . 0.0 111.729 179.921 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 686' ' ' LEU . . . . . 0.477 ' HA ' ' O ' ' A' ' 657' ' ' ILE . 3.4 tt -134.42 119.42 18.55 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.454 -178.754 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 687' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -93.61 145.39 24.58 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.104 0.478 . . . . 0.0 110.289 179.061 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 688' ' ' ILE . . . . . . . . . . . . . 77.4 mt -120.27 122.18 67.6 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.76 0 CA-C-O 121.277 0.56 . . . . 0.0 111.421 -178.602 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 689' ' ' PHE . . . . . . . . . . . . . 92.0 m-85 -123.42 147.12 47.44 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.05 -0.977 . . . . 0.0 110.193 178.94 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 690' ' ' ILE . . . . . . . . . . . . . 18.8 tt -126.94 138.95 53.27 Favored 'Isoleucine or valine' 0 C--O 1.235 0.338 0 CA-C-O 121.349 0.595 . . . . 0.0 111.993 -179.845 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 691' ' ' LEU . . . . . 0.428 ' HG ' ' HB ' ' A' ' 704' ' ' ILE . 3.2 mp -110.88 133.48 53.34 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-N 115.347 -0.842 . . . . 0.0 111.014 -179.758 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 692' ' ' GLY . . . . . 0.504 ' O ' ' HA ' ' A' ' 705' ' ' PRO . . . 162.61 -164.24 35.61 Favored Glycine 0 N--CA 1.448 -0.531 0 C-N-CA 120.68 -0.772 . . . . 0.0 112.442 179.701 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 693' ' ' SER . . . . . . . . . . . . . 55.3 m -95.2 112.84 24.49 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 109.055 -0.72 . . . . 0.0 109.055 179.3 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 694' ' ' LYS . . . . . . . . . . . . . 88.6 tttt 63.13 80.45 0.23 Allowed 'General case' 0 N--CA 1.465 0.307 0 O-C-N 123.886 0.741 . . . . 0.0 109.479 -178.608 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 695' ' ' GLY . . . . . . . . . . . . . . . -75.63 55.71 2.95 Favored Glycine 0 C--N 1.332 0.313 0 CA-C-N 115.763 -0.653 . . . . 0.0 113.745 -178.726 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 696' ' ' ASN . . . . . . . . . . . . . 65.6 t30 -87.91 73.49 9.16 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 121.05 0.452 . . . . 0.0 109.998 179.385 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 697' ' ' TYR . . . . . . . . . . . . . 97.9 m-85 -127.22 145.37 50.8 Favored 'General case' 0 N--CA 1.452 -0.369 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.632 -179.606 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 698' ' ' GLN . . . . . . . . . . . . . 97.5 mt-30 -83.78 147.87 27.35 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.59 -0.732 . . . . 0.0 110.605 179.849 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 699' ' ' GLY . . . . . . . . . . . . . . . 94.35 3.58 63.08 Favored Glycine 0 CA--C 1.519 0.319 0 C-N-CA 120.503 -0.856 . . . . 0.0 113.842 179.21 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 700' ' ' VAL . . . . . . . . . . . . . 28.2 m -117.79 145.14 24.08 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.282 0 CA-C-N 117.604 0.702 . . . . 0.0 110.075 179.197 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 701' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -72.15 -43.93 63.88 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.558 -0.746 . . . . 0.0 111.794 -179.584 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 702' ' ' ARG . . . . . . . . . . . . . 71.9 mtp180 -146.67 164.17 33.54 Favored 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 109.845 -0.428 . . . . 0.0 109.845 -179.069 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 703' ' ' TYR . . . . . . . . . . . . . 52.3 p90 -122.82 146.0 47.93 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 120.877 0.37 . . . . 0.0 110.848 179.736 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 704' ' ' ILE . . . . . 0.451 HG22 HD11 ' A' ' 704' ' ' ILE . 41.1 mm -120.38 103.29 44.58 Favored Pre-proline 0 C--O 1.236 0.387 0 CA-C-N 116.092 -0.503 . . . . 0.0 110.511 179.85 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 705' ' ' PRO . . . . . 0.504 ' HA ' ' O ' ' A' ' 692' ' ' GLY . 72.8 Cg_endo -73.92 152.79 46.98 Favored 'Trans proline' 0 C--N 1.345 0.36 0 C-N-CA 122.723 2.282 . . . . 0.0 113.733 -179.547 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 706' ' ' LEU . . . . . 0.4 ' HA ' ' C ' ' A' ' 707' ' ' PRO . 91.5 mt -105.82 150.28 38.99 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-N 115.539 -0.755 . . . . 0.0 109.812 178.792 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 707' ' ' PRO . . . . . 0.4 ' C ' ' HA ' ' A' ' 706' ' ' LEU . 59.6 Cg_endo -71.63 139.91 62.07 Favored 'Cis proline' 0 C--N 1.345 0.372 0 C-N-CA 123.058 -1.643 . . . . 0.0 112.804 -0.238 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 708' ' ' ILE . . . . . . . . . . . . . 1.1 pt -65.55 129.93 30.29 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-N 115.619 -0.719 . . . . 0.0 112.073 178.992 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 709' ' ' HIS . . . . . . . . . . . . . 70.0 m80 -98.88 115.08 65.95 Favored Pre-proline 0 C--N 1.322 -0.625 0 N-CA-C 108.564 -0.902 . . . . 0.0 108.564 177.482 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 710' ' ' PRO . . . . . . . . . . . . . 86.9 Cg_exo -52.27 -37.44 70.7 Favored 'Trans proline' 0 N--CA 1.477 0.537 0 C-N-CA 123.395 2.73 . . . . 0.0 114.341 -178.05 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 711' ' ' GLU . . . . . . . . . . . . . 51.0 mp0 -65.41 -40.2 93.11 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 112.248 0.462 . . . . 0.0 112.248 -178.709 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 712' ' ' SER . . . . . . . . . . . . . 50.7 m -91.38 -29.06 17.3 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 112.264 0.468 . . . . 0.0 112.264 -178.628 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 713' ' ' PHE . . . . . . . . . . . . . 91.1 t80 -58.87 -48.38 81.58 Favored 'General case' 0 N--CA 1.462 0.171 0 CA-C-O 120.498 0.19 . . . . 0.0 110.763 -179.127 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 714' ' ' LEU . . . . . . . . . . . . . 60.1 tp -62.3 -41.95 98.94 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.459 -0.337 . . . . 0.0 110.266 179.516 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 715' ' ' GLN . . . . . . . . . . . . . 30.5 mm100 -62.74 -41.94 99.43 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 116.099 -0.501 . . . . 0.0 111.177 179.252 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 716' ' ' GLN . . . . . . . . . . . . . 1.9 mp0 -66.04 -45.46 81.34 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-O 120.634 0.254 . . . . 0.0 111.159 179.318 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 717' ' ' VAL . . . . . 0.421 ' O ' ' HG ' ' A' ' 721' ' ' LEU . 65.2 t -62.68 -45.09 99.67 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.131 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.733 179.769 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 718' ' ' THR . . . . . . . . . . . . . 92.0 m -60.61 -45.3 94.56 Favored 'General case' 0 C--O 1.232 0.164 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.708 179.676 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 719' ' ' MET . . . . . . . . . . . . . 11.0 tpt -60.87 -44.45 97.02 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.218 179.271 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 720' ' ' GLY . . . . . . . . . . . . . . . -62.96 -40.8 99.74 Favored Glycine 0 C--N 1.333 0.375 0 C-N-CA 121.029 -0.605 . . . . 0.0 112.622 179.001 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 721' ' ' LEU . . . . . 0.421 ' HG ' ' O ' ' A' ' 717' ' ' VAL . 97.7 mt -64.91 -39.42 93.49 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-O 120.77 0.319 . . . . 0.0 111.587 179.857 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 722' ' ' THR . . . . . . . . . . . . . 73.6 p -72.35 -9.73 58.88 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.778 -179.875 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 723' ' ' SER . . . . . . . . . . . . . 65.1 m -88.63 -1.67 58.19 Favored 'General case' 0 CA--C 1.532 0.267 0 CA-C-N 116.442 -0.345 . . . . 0.0 111.136 179.768 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 724' ' ' LEU . . . . . . . . . . . . . 1.5 pp -129.48 169.14 15.33 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.499 -0.319 . . . . 0.0 110.56 179.857 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 725' ' ' ALA . . . . . . . . . . . . . . . -144.71 149.31 35.38 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.784 179.997 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 726' ' ' THR . . . . . . . . . . . . . 86.9 m -121.78 128.76 52.08 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.311 179.997 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 727' ' ' SER . . . . . . . . . . . . . 93.6 p -150.72 161.95 41.63 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.492 -0.322 . . . . 0.0 110.608 -179.966 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 728' ' ' ALA . . . . . . . . . . . . . . . -62.06 -39.8 93.62 Favored 'General case' 0 N--CA 1.462 0.145 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.765 179.854 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 729' ' ' GLN . . . . . . . . . . . . . 96.6 mt-30 . . . . . 0 C--O 1.25 1.1 0 CA-C-O 118.192 -0.909 . . . . 0.0 110.929 179.959 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 613' ' ' GLU . . . . . . . . . . . . . 7.4 mt-10 . . . . . 0 N--CA 1.488 1.435 0 CA-C-O 120.984 0.421 . . . . 0.0 110.76 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 614' ' ' GLY . . . . . . . . . . . . . . . -82.11 70.71 3.09 Favored Glycine 0 N--CA 1.452 -0.244 0 C-N-CA 121.022 -0.609 . . . . 0.0 112.591 -179.996 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 615' ' ' ARG . . . . . . . . . . . . . 87.2 mtm180 -115.82 141.34 48.22 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.725 0.298 . . . . 0.0 110.716 -179.838 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 616' ' ' ILE . . . . . 0.483 ' O ' ' HA ' ' A' ' 640' ' ' VAL . 85.0 mt -123.79 134.96 65.0 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 N-CA-C 109.521 -0.548 . . . . 0.0 109.521 179.153 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 617' ' ' VAL . . . . . . . . . . . . . 33.1 m -112.9 147.6 16.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 C-N-CA 120.531 -0.468 . . . . 0.0 111.129 -179.046 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 618' ' ' LEU . . . . . 0.598 ' CD1' HG22 ' A' ' 629' ' ' ILE . 4.6 tt -119.66 130.98 55.33 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.003 179.936 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 619' ' ' VAL . . . . . . . . . . . . . 71.3 t -113.98 103.48 15.45 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-N 116.008 -0.542 . . . . 0.0 109.721 179.2 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 620' ' ' SER . . . . . . . . . . . . . 30.3 t -172.44 151.0 2.38 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.181 -0.918 . . . . 0.0 110.273 -179.634 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 621' ' ' GLU . . . . . 0.425 ' HG3' ' OG ' ' A' ' 666' ' ' SER . 97.1 mt-10 -91.93 -2.31 56.85 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.367 179.13 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 622' ' ' ASP . . . . . . . . . . . . . 29.0 t70 -91.1 110.63 21.9 Favored 'General case' 0 C--O 1.233 0.185 0 CA-C-O 121.161 0.505 . . . . 0.0 111.335 -178.866 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 623' ' ' GLU . . . . . . . . . . . . . 98.0 mt-10 -64.87 -38.44 90.97 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.466 -0.788 . . . . 0.0 112.597 179.959 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 624' ' ' ALA . . . . . . . . . . . . . . . -60.99 -45.28 95.44 Favored 'General case' 0 N--CA 1.464 0.247 0 N-CA-C 113.719 1.007 . . . . 0.0 113.719 -177.324 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 625' ' ' THR . . . . . . . . . . . . . 30.8 p -72.26 -36.21 68.98 Favored 'General case' 0 CA--C 1.518 -0.258 0 C-N-CA 120.364 -0.534 . . . . 0.0 111.12 -179.713 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 626' ' ' SER . . . . . . . . . . . . . 69.0 m -65.52 -42.74 91.67 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.967 -0.561 . . . . 0.0 111.061 -179.646 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 627' ' ' THR . . . . . . . . . . . . . 90.3 m -64.29 -46.5 83.35 Favored 'General case' 0 C--O 1.236 0.377 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.791 -179.93 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 628' ' ' LEU . . . . . . . . . . . . . 60.7 tp -64.9 -44.01 90.98 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.738 -179.431 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 629' ' ' ILE . . . . . 0.598 HG22 ' CD1' ' A' ' 618' ' ' LEU . 1.3 tp -68.31 -33.62 61.52 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.382 0 CA-C-N 116.299 -0.409 . . . . 0.0 111.301 -179.088 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 630' ' ' CYS . . . . . . . . . . . . . 46.0 t -62.1 -44.04 97.51 Favored 'General case' 0 CA--C 1.521 -0.136 0 CA-C-N 115.959 -0.564 . . . . 0.0 111.409 -179.248 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 631' ' ' SER . . . . . . . . . . . . . 71.4 m -61.57 -41.98 98.19 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.526 -178.951 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 632' ' ' ILE . . . . . . . . . . . . . 96.9 mt -63.47 -49.32 83.13 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.257 0 CA-C-O 121.119 0.485 . . . . 0.0 110.995 179.958 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 633' ' ' LEU . . . . . . . . . . . . . 95.9 mt -68.75 -38.82 80.4 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.632 -0.713 . . . . 0.0 112.598 -179.264 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 634' ' ' THR . . . . . 0.467 ' HA ' ' O ' ' A' ' 638' ' ' TYR . 88.9 m -64.33 -39.96 94.94 Favored 'General case' 0 N--CA 1.462 0.161 0 CA-C-O 120.697 0.284 . . . . 0.0 110.739 -179.684 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 635' ' ' THR . . . . . . . . . . . . . 92.0 m -58.94 -38.93 80.12 Favored 'General case' 0 C--O 1.233 0.197 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.006 179.019 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 636' ' ' ALA . . . . . . . . . . . . . . . -65.45 -18.31 65.22 Favored 'General case' 0 CA--C 1.534 0.333 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.03 178.468 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 637' ' ' GLY . . . . . . . . . . . . . . . 109.14 3.66 31.34 Favored Glycine 0 C--N 1.333 0.379 0 C-N-CA 121.16 -0.543 . . . . 0.0 113.345 179.619 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 638' ' ' TYR . . . . . 0.467 ' O ' ' HA ' ' A' ' 634' ' ' THR . 94.7 m-85 -100.98 142.19 32.8 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.994 0.397 . . . . 0.0 111.929 -179.761 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 639' ' ' GLN . . . . . . . . . . . . . 78.5 mt-30 -89.88 140.32 29.73 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.661 179.636 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 640' ' ' VAL . . . . . 0.483 ' HA ' ' O ' ' A' ' 616' ' ' ILE . 58.6 t -116.11 128.98 73.24 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-O 120.958 0.409 . . . . 0.0 111.635 -179.997 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 641' ' ' ILE . . . . . 0.428 HD11 HG23 ' A' ' 641' ' ' ILE . 47.0 mm -110.18 119.55 59.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 N-CA-C 109.404 -0.591 . . . . 0.0 109.404 179.104 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 642' ' ' TRP . . . . . . . . . . . . . 25.2 t90 -89.21 125.13 34.94 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.102 0.477 . . . . 0.0 111.932 -178.69 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 643' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -117.84 129.87 55.92 Favored 'General case' 0 C--O 1.234 0.287 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.668 179.327 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 644' ' ' VAL . . . . . . . . . . . . . 6.0 m -102.13 27.85 0.86 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.895 -179.762 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 645' ' ' ASP . . . . . . . . . . . . . 37.7 t70 -155.92 -34.83 0.09 Allowed 'General case' 0 N--CA 1.47 0.528 0 N-CA-C 112.525 0.565 . . . . 0.0 112.525 -178.3 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 646' ' ' GLY . . . . . . . . . . . . . . . 75.9 28.17 61.25 Favored Glycine 0 CA--C 1.518 0.227 0 C-N-CA 120.729 -0.748 . . . . 0.0 113.366 -179.359 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 647' ' ' GLU . . . . . . . . . . . . . 86.7 tt0 -62.65 123.59 18.79 Favored 'General case' 0 N--CA 1.454 -0.233 0 CA-C-O 121.26 0.552 . . . . 0.0 110.355 179.847 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 648' ' ' VAL . . . . . . . . . . . . . 72.8 t -61.11 -40.67 86.57 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 114.952 -1.022 . . . . 0.0 112.197 -178.494 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 649' ' ' GLU . . . . . . . . . . . . . 48.9 mp0 -60.67 -43.44 97.67 Favored 'General case' 0 C--N 1.33 -0.271 0 C-N-CA 120.792 -0.363 . . . . 0.0 110.669 -179.82 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 650' ' ' ARG . . . . . . . . . . . . . 82.7 mtp180 -70.54 -41.02 73.05 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.685 178.564 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 651' ' ' LEU . . . . . . . . . . . . . 96.5 mt -65.48 -40.06 92.66 Favored 'General case' 0 N--CA 1.462 0.14 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.521 179.311 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 652' ' ' LEU . . . . . . . . . . . . . 62.4 tp -63.7 -43.25 97.16 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.694 178.871 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 653' ' ' ALA . . . . . . . . . . . . . . . -62.27 -39.08 91.72 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-O 121.229 0.538 . . . . 0.0 111.204 179.35 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 654' ' ' LEU . . . . . . . . . . . . . 75.9 mt -98.62 30.79 3.12 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.649 -0.705 . . . . 0.0 110.37 179.922 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 655' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -30.33 104.52 0.21 Allowed Pre-proline 0 N--CA 1.474 0.735 0 O-C-N 124.617 1.198 . . . . 0.0 113.764 -178.531 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 656' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_endo -90.44 173.75 3.13 Favored 'Trans proline' 0 C--N 1.344 0.308 0 C-N-CA 123.985 3.123 . . . . 0.0 112.922 179.388 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 657' ' ' ILE . . . . . . . . . . . . . 18.2 pt -85.05 -26.33 6.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-O 121.454 0.645 . . . . 0.0 109.66 177.369 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 658' ' ' ALA . . . . . 0.421 ' HA ' ' O ' ' A' ' 687' ' ' LYS . . . -156.6 153.24 28.3 Favored 'General case' 0 N--CA 1.449 -0.492 0 CA-C-N 115.058 -0.973 . . . . 0.0 110.627 179.915 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 659' ' ' VAL . . . . . . . . . . . . . 34.0 m -120.88 145.2 27.72 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-O 121.194 0.521 . . . . 0.0 110.961 179.242 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 660' ' ' LEU . . . . . . . . . . . . . 15.5 mt -113.42 115.69 28.47 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.45 -0.796 . . . . 0.0 109.884 178.812 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 661' ' ' LEU . . . . . . . . . . . . . 67.9 mt -104.61 107.65 18.7 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 108.818 -0.808 . . . . 0.0 108.818 179.521 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 662' ' ' ALA . . . . . . . . . . . . . . . -107.13 134.23 50.56 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 112.765 0.654 . . . . 0.0 112.765 -178.132 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 663' ' ' GLU . . . . . . . . . . . . . 9.6 mm-40 -67.86 136.61 92.29 Favored Pre-proline 0 C--N 1.325 -0.473 0 CA-C-N 115.751 -0.659 . . . . 0.0 110.768 177.63 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 664' ' ' PRO . . . . . . . . . . . . . 92.8 Cg_endo -78.07 141.79 67.37 Favored 'Cis proline' 0 C--N 1.35 0.625 0 C-N-CA 123.538 -1.442 . . . . 0.0 112.402 -1.2 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 665' ' ' PHE . . . . . . . . . . . . . 23.4 m-85 -72.5 123.83 23.94 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.961 179.991 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 666' ' ' SER . . . . . 0.425 ' OG ' ' HG3' ' A' ' 621' ' ' GLU . 69.9 m -65.78 -41.18 92.3 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.302 179.612 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 667' ' ' TYR . . . . . . . . . . . . . 51.2 t80 -69.09 -23.61 64.03 Favored 'General case' 0 CA--C 1.533 0.314 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.692 179.935 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 668' ' ' GLY . . . . . . . . . . . . . . . 100.32 -103.69 2.68 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.504 -0.855 . . . . 0.0 112.435 -179.36 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 669' ' ' ASP . . . . . . . . . . . . . 37.5 t70 -80.7 110.21 15.98 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.91 0.386 . . . . 0.0 110.69 -179.654 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 670' ' ' VAL . . . . . 0.457 ' O ' HG23 ' A' ' 674' ' ' VAL . 12.1 m -69.46 -26.64 31.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 N-CA-C 113.726 1.009 . . . . 0.0 113.726 -179.039 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 671' ' ' GLN . . . . . . . . . . . . . 64.9 tt0 -60.41 -44.92 95.26 Favored 'General case' 0 CA--C 1.53 0.175 0 CA-C-N 118.043 0.383 . . . . 0.0 110.665 -179.293 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 672' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 -66.39 -40.13 89.48 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.648 178.854 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 673' ' ' LEU . . . . . . . . . . . . . 62.5 tp -63.1 -44.66 95.07 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.092 179.596 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 674' ' ' VAL . . . . . 0.457 HG23 ' O ' ' A' ' 670' ' ' VAL . 53.3 t -62.78 -44.16 99.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 115.753 -0.658 . . . . 0.0 109.61 179.056 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 675' ' ' ASP . . . . . . . . . . . . . 35.9 t70 -60.03 -40.82 90.66 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.573 179.164 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 676' ' ' GLN . . . . . . . . . . . . . 96.8 mt-30 -70.76 -40.44 72.66 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.943 0.401 . . . . 0.0 110.98 -179.779 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 677' ' ' LEU . . . . . . . . . . . . . 5.1 mp -70.09 -43.75 70.47 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.053 -0.522 . . . . 0.0 111.894 179.805 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 678' ' ' ARG . . . . . 0.558 ' HA ' ' O ' ' A' ' 681' ' ' CYS . 39.8 ptt180 -69.85 -26.33 64.15 Favored 'General case' 0 N--CA 1.468 0.468 0 CA-C-O 121.114 0.483 . . . . 0.0 110.713 -179.216 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 679' ' ' GLN . . . . . . . . . . . . . 63.3 tt0 -66.51 -39.12 88.5 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.539 -0.755 . . . . 0.0 110.416 178.876 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 680' ' ' ARG . . . . . . . . . . . . . 32.7 mmt180 -90.15 -34.2 15.94 Favored 'General case' 0 N--CA 1.462 0.147 0 CA-C-N 115.945 -0.57 . . . . 0.0 111.676 -179.128 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 681' ' ' CYS . . . . . 0.602 ' SG ' ' HB2' ' A' ' 686' ' ' LEU . 27.5 t -134.18 128.76 34.66 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 109.544 -0.539 . . . . 0.0 109.544 -179.593 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 682' ' ' THR . . . . . 0.431 ' HB ' ' HD2' ' A' ' 683' ' ' PRO . 70.2 p -71.88 158.16 88.24 Favored Pre-proline 0 C--N 1.324 -0.527 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.351 -178.621 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 683' ' ' PRO . . . . . 0.431 ' HD2' ' HB ' ' A' ' 682' ' ' THR . 20.1 Cg_endo -60.42 -23.75 75.81 Favored 'Trans proline' 0 C--N 1.351 0.669 0 C-N-CA 122.519 2.146 . . . . 0.0 112.628 179.777 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 684' ' ' GLU . . . . . . . . . . . . . 24.8 pt-20 -78.5 -18.04 55.36 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.017 0.436 . . . . 0.0 110.12 178.943 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 685' ' ' GLN . . . . . . . . . . . . . 95.0 mt-30 -99.65 -34.33 10.25 Favored 'General case' 0 CA--C 1.53 0.197 0 CA-C-N 115.88 -0.6 . . . . 0.0 111.012 179.81 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 686' ' ' LEU . . . . . 0.602 ' HB2' ' SG ' ' A' ' 681' ' ' CYS . 4.8 tt -134.09 124.59 26.41 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.94 -179.414 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 687' ' ' LYS . . . . . 0.421 ' O ' ' HA ' ' A' ' 658' ' ' ALA . 22.1 mtmm -94.46 147.01 23.68 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.2 0.524 . . . . 0.0 110.676 179.378 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 688' ' ' ILE . . . . . . . . . . . . . 78.0 mt -120.76 120.3 62.06 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.775 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.851 -179.325 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 689' ' ' PHE . . . . . . . . . . . . . 99.2 m-85 -119.42 145.94 45.81 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.289 -0.869 . . . . 0.0 110.091 179.327 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 690' ' ' ILE . . . . . . . . . . . . . 19.5 tt -124.83 135.29 64.47 Favored 'Isoleucine or valine' 0 C--O 1.235 0.33 0 CA-C-O 121.267 0.556 . . . . 0.0 111.437 -179.662 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 691' ' ' LEU . . . . . . . . . . . . . 76.4 mt -107.11 126.89 52.95 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-N 115.53 -0.759 . . . . 0.0 110.219 179.93 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 692' ' ' GLY . . . . . 0.685 ' O ' ' HA ' ' A' ' 705' ' ' PRO . . . 162.72 -168.66 37.68 Favored Glycine 0 N--CA 1.447 -0.581 0 C-N-CA 120.651 -0.785 . . . . 0.0 112.125 -179.957 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 693' ' ' SER . . . . . . . . . . . . . 62.4 m -98.73 126.52 44.38 Favored 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 109.117 -0.697 . . . . 0.0 109.117 179.42 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 694' ' ' LYS . . . . . . . . . . . . . 99.3 mttt 59.67 59.35 2.56 Favored 'General case' 0 N--CA 1.465 0.291 0 O-C-N 123.772 0.67 . . . . 0.0 110.234 -179.075 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 695' ' ' GLY . . . . . . . . . . . . . . . -70.27 52.05 0.81 Allowed Glycine 0 CA--C 1.524 0.606 0 CA-C-N 115.559 -0.746 . . . . 0.0 114.219 -178.913 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 696' ' ' ASN . . . . . . . . . . . . . 66.0 t30 -89.4 78.3 7.2 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.938 0.399 . . . . 0.0 110.32 179.438 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 697' ' ' TYR . . . . . . . . . . . . . 97.6 m-85 -128.08 150.24 50.04 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.401 -179.668 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 698' ' ' GLN . . . . . . . . . . . . . 98.0 mt-30 -82.74 148.19 28.0 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.723 -0.671 . . . . 0.0 110.665 -179.626 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 699' ' ' GLY . . . . . . . . . . . . . . . 94.08 3.61 63.57 Favored Glycine 0 N--CA 1.449 -0.462 0 C-N-CA 120.579 -0.82 . . . . 0.0 113.707 179.449 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 700' ' ' VAL . . . . . . . . . . . . . 26.6 m -117.82 142.42 32.26 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.344 0 CA-C-N 117.594 0.697 . . . . 0.0 110.506 179.256 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 701' ' ' ASP . . . . . . . . . . . . . 36.9 t70 -72.8 -41.58 64.78 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.499 -0.773 . . . . 0.0 111.795 -179.787 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 702' ' ' ARG . . . . . . . . . . . . . 4.5 mmp_? -146.11 158.42 43.87 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.942 -178.92 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 703' ' ' TYR . . . . . . . . . . . . . 25.5 p90 -119.3 137.99 53.32 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.377 179.438 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 704' ' ' ILE . . . . . 0.418 HD11 HG23 ' A' ' 704' ' ' ILE . 31.2 mm -119.45 106.35 42.6 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 120.752 0.31 . . . . 0.0 110.63 -179.914 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 705' ' ' PRO . . . . . 0.685 ' HA ' ' O ' ' A' ' 692' ' ' GLY . 72.9 Cg_endo -72.93 149.08 46.63 Favored 'Trans proline' 0 C--N 1.346 0.441 0 C-N-CA 122.851 2.368 . . . . 0.0 113.791 -179.455 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 706' ' ' LEU . . . . . 0.503 ' HA ' ' C ' ' A' ' 707' ' ' PRO . 91.0 mt -105.83 148.72 36.99 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-N 115.409 -0.814 . . . . 0.0 109.789 178.415 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 707' ' ' PRO . . . . . 0.503 ' C ' ' HA ' ' A' ' 706' ' ' LEU . 38.9 Cg_exo -64.29 137.91 30.3 Favored 'Cis proline' 0 C--N 1.35 0.615 0 C-N-CA 123.725 -1.365 . . . . 0.0 112.809 -1.137 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 708' ' ' ILE . . . . . . . . . . . . . 1.1 pt -66.36 139.24 21.5 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-O 121.227 0.537 . . . . 0.0 111.752 178.562 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 709' ' ' HIS . . . . . . . . . . . . . 70.5 m80 -105.65 111.53 64.72 Favored Pre-proline 0 C--N 1.319 -0.746 0 N-CA-C 108.637 -0.875 . . . . 0.0 108.637 177.676 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 710' ' ' PRO . . . . . . . . . . . . . 88.5 Cg_exo -52.95 -37.95 78.86 Favored 'Trans proline' 0 N--CA 1.478 0.582 0 C-N-CA 123.472 2.782 . . . . 0.0 114.31 -178.394 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 711' ' ' GLU . . . . . . . . . . . . . 42.5 tt0 -64.93 -42.36 94.75 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 112.277 0.473 . . . . 0.0 112.277 -178.611 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 712' ' ' SER . . . . . . . . . . . . . 46.3 m -89.64 -27.35 20.22 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 112.463 0.542 . . . . 0.0 112.463 -178.242 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 713' ' ' PHE . . . . . . . . . . . . . 88.6 t80 -59.32 -48.71 80.61 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-O 120.706 0.288 . . . . 0.0 110.988 -179.456 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 714' ' ' LEU . . . . . . . . . . . . . 59.1 tp -62.63 -41.89 99.28 Favored 'General case' 0 C--O 1.235 0.294 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.343 179.868 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 715' ' ' GLN . . . . . . . . . . . . . 59.3 mt-30 -63.69 -41.59 98.13 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.416 179.175 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 716' ' ' GLN . . . . . . . . . . . . . 82.9 mt-30 -64.29 -41.87 96.67 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-N 116.791 -0.186 . . . . 0.0 111.15 179.683 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 717' ' ' VAL . . . . . . . . . . . . . 68.2 t -63.84 -45.04 98.19 Favored 'Isoleucine or valine' 0 C--O 1.232 0.165 0 CA-C-O 121.057 0.455 . . . . 0.0 109.931 178.622 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 718' ' ' THR . . . . . . . . . . . . . 89.3 m -62.46 -44.27 96.82 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 115.517 -0.765 . . . . 0.0 110.858 179.521 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 719' ' ' MET . . . . . . . . . . . . . 63.5 tpp -59.98 -47.59 85.19 Favored 'General case' 0 N--CA 1.463 0.185 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.564 179.746 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 720' ' ' GLY . . . . . . . . . . . . . . . -62.64 -40.87 99.7 Favored Glycine 0 C--N 1.335 0.512 0 C-N-CA 120.638 -0.792 . . . . 0.0 111.752 178.738 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 721' ' ' LEU . . . . . . . . . . . . . 65.6 tp -62.7 -45.6 92.02 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.663 0.268 . . . . 0.0 111.315 179.156 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 722' ' ' THR . . . . . . . . . . . . . 73.1 p -70.95 -27.87 64.06 Favored 'General case' 0 N--CA 1.463 0.185 0 N-CA-C 112.539 0.57 . . . . 0.0 112.539 -179.834 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 723' ' ' SER . . . . . . . . . . . . . 73.0 p -71.57 -20.53 62.0 Favored 'General case' 0 CA--C 1.531 0.221 0 C-N-CA 121.194 -0.202 . . . . 0.0 111.467 179.967 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 724' ' ' LEU . . . . . . . . . . . . . 65.5 tp -63.0 -46.63 86.75 Favored 'General case' 0 CA--C 1.53 0.204 0 CA-C-N 116.471 -0.331 . . . . 0.0 111.348 179.984 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 725' ' ' ALA . . . . . . . . . . . . . . . -155.99 149.45 24.77 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.963 -179.879 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 726' ' ' THR . . . . . . . . . . . . . 72.7 p -81.01 159.96 24.69 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.398 -0.364 . . . . 0.0 111.243 179.951 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 727' ' ' SER . . . . . . . . . . . . . 98.3 p -153.08 162.54 41.19 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.566 -179.953 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 728' ' ' ALA . . . . . . . . . . . . . . . -148.24 154.06 39.55 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.652 179.987 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 729' ' ' GLN . . . . . . . . . . . . . 96.7 mt-30 . . . . . 0 C--O 1.248 1.0 0 CA-C-O 118.25 -0.881 . . . . 0.0 110.826 179.9 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 613' ' ' GLU . . . . . . . . . . . . . 3.3 mt-10 . . . . . 0 N--CA 1.488 1.469 0 CA-C-O 121.106 0.479 . . . . 0.0 110.626 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 614' ' ' GLY . . . . . . . . . . . . . . . 100.5 150.1 24.2 Favored Glycine 0 N--CA 1.451 -0.355 0 CA-C-N 115.664 -0.698 . . . . 0.0 112.163 -179.464 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 615' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -117.49 137.72 52.35 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.944 0.402 . . . . 0.0 111.271 -179.695 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 616' ' ' ILE . . . . . 0.455 ' O ' ' HA ' ' A' ' 640' ' ' VAL . 87.9 mt -122.71 133.23 69.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 115.73 -0.668 . . . . 0.0 109.669 178.943 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 617' ' ' VAL . . . . . . . . . . . . . 99.6 t -106.45 127.68 61.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-O 121.148 0.499 . . . . 0.0 110.235 -179.907 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 618' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -106.41 126.19 51.93 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.604 -178.771 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 619' ' ' VAL . . . . . 0.416 ' HA ' ' O ' ' A' ' 643' ' ' LEU . 59.6 t -115.78 118.46 58.86 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 N-CA-C 109.92 -0.4 . . . . 0.0 109.92 179.93 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 620' ' ' SER . . . . . . . . . . . . . 32.5 t -172.19 139.39 1.06 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.664 -0.698 . . . . 0.0 111.116 -179.472 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 621' ' ' GLU . . . . . 0.431 ' HB3' ' HB3' ' A' ' 666' ' ' SER . 25.9 pt-20 -84.05 -11.47 56.67 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.935 -0.575 . . . . 0.0 111.415 178.586 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 622' ' ' ASP . . . . . . . . . . . . . 62.5 t0 -91.4 107.48 19.24 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-O 120.854 0.359 . . . . 0.0 110.544 -179.051 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 623' ' ' GLU . . . . . . . . . . . . . 25.5 pm0 -67.2 -31.04 71.15 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.91 -0.587 . . . . 0.0 112.262 -179.884 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 624' ' ' ALA . . . . . . . . . . . . . . . -63.93 -45.35 89.62 Favored 'General case' 0 N--CA 1.464 0.23 0 N-CA-C 112.433 0.531 . . . . 0.0 112.433 -178.695 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 625' ' ' THR . . . . . . . . . . . . . 20.5 p -76.01 -36.13 59.27 Favored 'General case' 0 CA--C 1.517 -0.312 0 C-N-CA 120.95 -0.3 . . . . 0.0 111.34 179.943 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 626' ' ' SER . . . . . . . . . . . . . 68.5 m -63.44 -41.67 98.67 Favored 'General case' 0 N--CA 1.453 -0.286 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.324 -179.247 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 627' ' ' THR . . . . . . . . . . . . . 92.4 m -62.71 -47.05 85.27 Favored 'General case' 0 CA--C 1.532 0.286 0 CA-C-O 120.947 0.403 . . . . 0.0 111.506 179.846 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 628' ' ' LEU . . . . . . . . . . . . . 62.2 tp -66.77 -43.87 82.89 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.153 -0.476 . . . . 0.0 112.043 -179.736 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 629' ' ' ILE . . . . . . . . . . . . . 1.5 tp -70.21 -35.48 63.38 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.473 0 N-CA-C 113.236 0.828 . . . . 0.0 113.236 -177.965 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 630' ' ' CYS . . . . . . . . . . . . . 18.4 p -67.95 -29.48 68.54 Favored 'General case' 0 CA--C 1.521 -0.164 0 C-N-CA 121.071 -0.251 . . . . 0.0 111.202 -178.921 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 631' ' ' SER . . . . . . . . . . . . . 68.1 m -64.89 -41.81 95.3 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.887 179.558 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 632' ' ' ILE . . . . . . . . . . . . . 96.6 mt -63.54 -48.84 85.08 Favored 'Isoleucine or valine' 0 C--O 1.234 0.243 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.882 -179.972 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 633' ' ' LEU . . . . . . . . . . . . . 85.7 mt -65.36 -40.93 94.19 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-N 115.77 -0.65 . . . . 0.0 112.308 -179.492 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 634' ' ' THR . . . . . 0.512 ' HA ' ' O ' ' A' ' 638' ' ' TYR . 91.7 m -67.04 -40.5 87.2 Favored 'General case' 0 CA--C 1.531 0.222 0 CA-C-O 120.53 0.205 . . . . 0.0 111.207 -179.456 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 635' ' ' THR . . . . . . . . . . . . . 93.8 m -59.2 -38.59 80.27 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-O 120.845 0.355 . . . . 0.0 110.458 179.628 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 636' ' ' ALA . . . . . . . . . . . . . . . -63.87 -17.21 62.94 Favored 'General case' 0 CA--C 1.533 0.292 0 CA-C-N 115.922 -0.581 . . . . 0.0 111.453 178.981 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 637' ' ' GLY . . . . . . . . . . . . . . . 109.03 7.34 29.07 Favored Glycine 0 C--N 1.333 0.392 0 C-N-CA 120.888 -0.672 . . . . 0.0 113.077 179.866 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 638' ' ' TYR . . . . . 0.512 ' O ' ' HA ' ' A' ' 634' ' ' THR . 96.6 m-85 -100.26 140.56 34.33 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.828 0.347 . . . . 0.0 111.461 -179.936 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 639' ' ' GLN . . . . . . . . . . . . . 79.0 mt-30 -87.13 134.36 33.52 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 109.57 -0.53 . . . . 0.0 109.57 178.851 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 640' ' ' VAL . . . . . 0.455 ' HA ' ' O ' ' A' ' 616' ' ' ILE . 62.9 t -119.04 131.33 72.12 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 N-CA-C 112.756 0.651 . . . . 0.0 112.756 -178.62 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 641' ' ' ILE . . . . . . . . . . . . . 46.4 mm -109.87 118.58 57.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 N-CA-C 108.24 -1.022 . . . . 0.0 108.24 177.966 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 642' ' ' TRP . . . . . . . . . . . . . 22.1 t90 -90.79 125.77 35.81 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 112.558 0.577 . . . . 0.0 112.558 -177.981 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 643' ' ' LEU . . . . . 0.416 ' O ' ' HA ' ' A' ' 619' ' ' VAL . 0.8 OUTLIER -122.03 133.96 54.8 Favored 'General case' 0 C--O 1.232 0.182 0 CA-C-N 115.477 -0.783 . . . . 0.0 109.713 178.73 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 644' ' ' VAL . . . . . . . . . . . . . 18.8 m -105.13 13.87 7.54 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 N-CA-C 112.915 0.709 . . . . 0.0 112.915 -179.109 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 645' ' ' ASP . . . . . . . . . . . . . 40.1 p30 -137.31 -18.17 1.31 Allowed 'General case' 0 N--CA 1.472 0.639 0 N-CA-C 114.292 1.219 . . . . 0.0 114.292 -178.191 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 646' ' ' GLY . . . . . . . . . . . . . . . 67.39 28.64 73.67 Favored Glycine 0 CA--C 1.522 0.508 0 C-N-CA 120.875 -0.679 . . . . 0.0 114.084 179.58 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 647' ' ' GLU . . . . . . . . . . . . . 48.1 mt-10 -67.67 125.16 25.35 Favored 'General case' 0 C--N 1.333 -0.123 0 CA-C-N 117.694 0.747 . . . . 0.0 111.389 -179.396 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 648' ' ' VAL . . . . . . . . . . . . . 78.5 t -61.53 -39.17 82.06 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-N 114.541 -1.209 . . . . 0.0 111.536 -179.718 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 649' ' ' GLU . . . . . . . . . . . . . 50.2 mp0 -60.26 -42.83 96.19 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 120.84 0.353 . . . . 0.0 110.204 -179.69 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 650' ' ' ARG . . . . . . . . . . . . . 11.3 mpt_? -72.07 -41.67 67.1 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.532 178.405 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 651' ' ' LEU . . . . . . . . . . . . . 87.2 mt -63.52 -41.41 98.5 Favored 'General case' 0 N--CA 1.463 0.182 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.508 179.413 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 652' ' ' LEU . . . . . . . . . . . . . 61.0 tp -65.17 -43.8 90.57 Favored 'General case' 0 CA--C 1.531 0.223 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.21 179.008 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 653' ' ' ALA . . . . . . . . . . . . . . . -62.72 -39.36 93.82 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-O 120.98 0.419 . . . . 0.0 111.828 179.825 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 654' ' ' LEU . . . . . . . . . . . . . 74.6 mt -101.36 30.32 4.28 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.986 -179.459 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 655' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -31.08 104.25 0.21 Allowed Pre-proline 0 N--CA 1.472 0.664 0 O-C-N 124.488 1.117 . . . . 0.0 113.86 -179.175 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 656' ' ' PRO . . . . . . . . . . . . . 35.5 Cg_endo -91.07 178.16 1.89 Allowed 'Trans proline' 0 C--N 1.345 0.365 0 C-N-CA 123.635 2.89 . . . . 0.0 112.711 178.782 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 657' ' ' ILE . . . . . . . . . . . . . 24.3 pt -84.82 -25.26 7.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-O 121.447 0.641 . . . . 0.0 109.65 177.77 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 658' ' ' ALA . . . . . . . . . . . . . . . -157.72 153.16 26.17 Favored 'General case' 0 N--CA 1.449 -0.51 0 CA-C-N 115.035 -0.984 . . . . 0.0 110.718 179.894 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 659' ' ' VAL . . . . . . . . . . . . . 31.3 m -122.68 146.33 28.11 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-O 121.228 0.537 . . . . 0.0 110.889 179.054 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 660' ' ' LEU . . . . . . . . . . . . . 3.2 mp -115.86 118.39 32.86 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.453 -0.794 . . . . 0.0 109.785 179.141 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 661' ' ' LEU . . . . . . . . . . . . . 32.3 mt -108.37 112.96 25.66 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 109.549 -0.537 . . . . 0.0 109.549 -179.622 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 662' ' ' ALA . . . . . . . . . . . . . . . -105.8 131.17 53.46 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 112.399 0.518 . . . . 0.0 112.399 -178.907 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 663' ' ' GLU . . . . . 0.507 ' HA ' ' C ' ' A' ' 664' ' ' PRO . 76.7 mm-40 -81.88 147.06 57.33 Favored Pre-proline 0 CA--C 1.535 0.373 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.549 178.811 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 664' ' ' PRO . . . . . 0.507 ' C ' ' HA ' ' A' ' 663' ' ' GLU . 35.9 Cg_exo -63.77 135.18 19.47 Favored 'Cis proline' 0 C--N 1.353 0.801 0 C-N-CA 123.95 -1.271 . . . . 0.0 112.354 -1.376 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 665' ' ' PHE . . . . . 0.672 ' CE2' ' HB3' ' A' ' 667' ' ' TYR . 4.4 t80 -81.63 119.77 24.23 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.332 -179.44 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 666' ' ' SER . . . . . 0.431 ' HB3' ' HB3' ' A' ' 621' ' ' GLU . 80.8 p -66.64 -38.35 86.71 Favored 'General case' 0 CA--C 1.53 0.186 0 N-CA-C 112.592 0.59 . . . . 0.0 112.592 -179.616 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 667' ' ' TYR . . . . . 0.672 ' HB3' ' CE2' ' A' ' 665' ' ' PHE . 67.8 t80 -66.58 -22.98 66.14 Favored 'General case' 0 CA--C 1.533 0.303 0 CA-C-O 120.927 0.394 . . . . 0.0 111.315 179.737 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 668' ' ' GLY . . . . . . . . . . . . . . . 101.67 -104.22 2.65 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.62 -0.8 . . . . 0.0 113.573 179.789 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 669' ' ' ASP . . . . . 0.411 ' OD2' ' HG3' ' A' ' 672' ' ' GLU . 23.9 t70 -81.82 110.77 17.44 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.076 0.465 . . . . 0.0 112.03 -177.96 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 670' ' ' VAL . . . . . . . . . . . . . 72.9 t -62.22 -39.59 84.59 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.419 0 CA-C-N 115.307 -0.861 . . . . 0.0 112.655 179.925 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 671' ' ' GLN . . . . . . . . . . . . . 20.8 mp0 -59.66 -41.81 91.44 Favored 'General case' 0 N--CA 1.465 0.286 0 N-CA-C 111.75 0.278 . . . . 0.0 111.75 -177.513 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 672' ' ' GLU . . . . . 0.411 ' HG3' ' OD2' ' A' ' 669' ' ' ASP . 95.5 mt-10 -64.3 -40.29 95.64 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-N 116.622 -0.263 . . . . 0.0 111.064 179.413 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 673' ' ' LEU . . . . . . . . . . . . . 62.4 tp -64.83 -42.88 94.59 Favored 'General case' 0 C--N 1.331 -0.204 0 N-CA-C 109.715 -0.476 . . . . 0.0 109.715 178.995 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 674' ' ' VAL . . . . . 0.462 HG12 ' O ' ' A' ' 699' ' ' GLY . 53.7 t -62.24 -44.26 98.91 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.269 0 CA-C-N 115.463 -0.79 . . . . 0.0 109.736 179.439 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 675' ' ' ASP . . . . . . . . . . . . . 34.9 t70 -59.21 -40.0 84.43 Favored 'General case' 0 CA--C 1.519 -0.222 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.229 178.876 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 676' ' ' GLN . . . . . . . . . . . . . 55.9 mt-30 -71.21 -41.58 70.07 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.941 179.719 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 677' ' ' LEU . . . . . . . . . . . . . 86.7 mt -68.18 -41.75 81.01 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.893 179.946 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 678' ' ' ARG . . . . . 0.545 ' HA ' ' O ' ' A' ' 681' ' ' CYS . 40.0 ptt180 -72.95 -25.13 60.92 Favored 'General case' 0 N--CA 1.467 0.382 0 CA-C-O 120.998 0.428 . . . . 0.0 110.844 -179.435 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 679' ' ' GLN . . . . . . . . . . . . . 11.0 tp-100 -66.45 -38.67 87.88 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.62 -0.718 . . . . 0.0 110.121 178.809 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 680' ' ' ARG . . . . . . . . . . . . . 32.2 mmt180 -89.62 -43.54 10.69 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-N 115.882 -0.599 . . . . 0.0 111.338 -179.671 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 681' ' ' CYS . . . . . 0.545 ' O ' ' HA ' ' A' ' 678' ' ' ARG . 76.9 m -121.97 131.7 54.15 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.319 179.876 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 682' ' ' THR . . . . . 0.445 ' HB ' ' HD2' ' A' ' 683' ' ' PRO . 65.2 p -70.36 159.21 85.56 Favored Pre-proline 0 C--N 1.321 -0.634 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.597 -179.856 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 683' ' ' PRO . . . . . 0.445 ' HD2' ' HB ' ' A' ' 682' ' ' THR . 17.9 Cg_endo -59.39 -22.68 66.91 Favored 'Trans proline' 0 C--N 1.35 0.657 0 C-N-CA 122.569 2.18 . . . . 0.0 112.887 -179.724 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 684' ' ' GLU . . . . . . . . . . . . . 24.8 pt-20 -81.31 -15.04 56.62 Favored 'General case' 0 CA--C 1.531 0.24 0 CA-C-O 120.893 0.378 . . . . 0.0 110.663 178.981 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 685' ' ' GLN . . . . . . . . . . . . . 90.9 mt-30 -99.19 -34.1 10.49 Favored 'General case' 0 C--N 1.333 -0.136 0 CA-C-N 116.057 -0.52 . . . . 0.0 111.869 -179.593 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 686' ' ' LEU . . . . . . . . . . . . . 3.1 tt -135.53 125.3 25.49 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.566 -0.288 . . . . 0.0 111.273 -178.932 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 687' ' ' LYS . . . . . . . . . . . . . 75.6 mmtt -95.36 146.63 24.24 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 121.252 0.548 . . . . 0.0 110.377 179.087 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 688' ' ' ILE . . . . . . . . . . . . . 75.3 mt -122.62 121.01 62.47 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.781 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.194 -179.032 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 689' ' ' PHE . . . . . . . . . . . . . 97.7 m-85 -118.36 145.23 45.29 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.253 -0.885 . . . . 0.0 110.228 179.127 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 690' ' ' ILE . . . . . . . . . . . . . 18.8 tt -127.22 139.56 51.55 Favored 'Isoleucine or valine' 0 C--O 1.235 0.337 0 CA-C-O 121.196 0.522 . . . . 0.0 111.544 179.633 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 691' ' ' LEU . . . . . . . . . . . . . 81.9 mt -111.47 128.92 56.15 Favored 'General case' 0 C--O 1.235 0.327 0 CA-C-N 115.618 -0.719 . . . . 0.0 110.093 179.509 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 692' ' ' GLY . . . . . 0.549 ' O ' ' HA ' ' A' ' 705' ' ' PRO . . . -179.43 177.53 48.32 Favored Glycine 0 N--CA 1.446 -0.685 0 N-CA-C 111.48 -0.648 . . . . 0.0 111.48 -179.864 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 693' ' ' SER . . . . . . . . . . . . . 79.4 p -67.04 -39.72 87.0 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.786 0.293 . . . . 0.0 111.784 -179.794 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 694' ' ' LYS . . . . . . . . . . . . . 38.0 mtpt -133.48 133.87 42.8 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.201 0.524 . . . . 0.0 110.977 179.619 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 695' ' ' GLY . . . . . . . . . . . . . . . -124.1 108.83 1.19 Allowed Glycine 0 N--CA 1.446 -0.66 0 CA-C-N 115.473 -0.785 . . . . 0.0 112.076 178.983 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 696' ' ' ASN . . . . . . . . . . . . . 99.6 m-20 -109.41 -67.41 0.99 Allowed 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 120.826 0.346 . . . . 0.0 110.356 179.466 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 697' ' ' TYR . . . . . . . . . . . . . 53.9 p90 -157.09 155.86 31.81 Favored 'General case' 0 C--N 1.33 -0.247 0 N-CA-C 109.758 -0.46 . . . . 0.0 109.758 178.96 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 698' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER 174.58 25.42 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.284 0 O-C-N 124.062 0.851 . . . . 0.0 109.818 -179.978 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 699' ' ' GLY . . . . . 0.462 ' O ' HG12 ' A' ' 674' ' ' VAL . . . 80.36 14.86 79.58 Favored Glycine 0 C--N 1.335 0.495 0 C-N-CA 120.337 -0.935 . . . . 0.0 111.865 -178.62 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 700' ' ' VAL . . . . . . . . . . . . . 23.7 m -101.92 147.58 8.53 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.502 0 CA-C-O 121.446 0.641 . . . . 0.0 111.43 -178.372 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 701' ' ' ASP . . . . . . . . . . . . . 36.7 t70 -72.46 -40.95 66.59 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 114.905 -1.043 . . . . 0.0 111.87 -179.697 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 702' ' ' ARG . . . . . . . . . . . . . 95.1 mtt-85 -143.5 157.91 44.07 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-O 121.06 0.457 . . . . 0.0 111.376 -178.573 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 703' ' ' TYR . . . . . . . . . . . . . 24.8 p90 -125.54 143.96 50.77 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.244 179.41 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 704' ' ' ILE . . . . . . . . . . . . . 56.5 mt -126.98 87.62 56.27 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-O 120.922 0.391 . . . . 0.0 110.484 179.915 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 705' ' ' PRO . . . . . 0.549 ' HA ' ' O ' ' A' ' 692' ' ' GLY . 31.4 Cg_exo -61.73 142.56 94.41 Favored 'Trans proline' 0 C--N 1.348 0.534 0 C-N-CA 123.492 2.795 . . . . 0.0 113.859 -179.462 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 706' ' ' LEU . . . . . . . . . . . . . 90.9 mt -79.22 151.36 75.4 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-N 115.443 -0.799 . . . . 0.0 110.276 178.384 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 707' ' ' PRO . . . . . . . . . . . . . 63.4 Cg_endo -72.65 139.83 63.12 Favored 'Cis proline' 0 C--N 1.347 0.475 0 C-N-CA 123.226 -1.573 . . . . 0.0 112.766 -0.297 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 708' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -69.81 116.51 10.96 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-N 115.773 -0.648 . . . . 0.0 111.639 179.108 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 709' ' ' HIS . . . . . . . . . . . . . 98.4 m-70 -91.96 118.16 68.08 Favored Pre-proline 0 C--N 1.324 -0.541 0 N-CA-C 108.379 -0.971 . . . . 0.0 108.379 177.679 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 710' ' ' PRO . . . . . . . . . . . . . 86.4 Cg_exo -52.34 -37.46 71.53 Favored 'Trans proline' 0 C--N 1.348 0.541 0 C-N-CA 123.166 2.578 . . . . 0.0 114.279 -178.173 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 711' ' ' GLU . . . . . . . . . . . . . 88.8 tt0 -64.1 -44.08 93.4 Favored 'General case' 0 CA--C 1.531 0.236 0 N-CA-C 111.954 0.353 . . . . 0.0 111.954 -179.077 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 712' ' ' SER . . . . . . . . . . . . . 50.7 m -86.66 -26.25 24.43 Favored 'General case' 0 C--N 1.331 -0.225 0 N-CA-C 111.99 0.367 . . . . 0.0 111.99 -178.824 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 713' ' ' PHE . . . . . . . . . . . . . 69.9 t80 -59.64 -49.94 75.81 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-O 120.658 0.266 . . . . 0.0 111.095 -179.769 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 714' ' ' LEU . . . . . . . . . . . . . 56.9 tp -65.05 -40.06 94.21 Favored 'General case' 0 C--O 1.235 0.308 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.323 179.741 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 715' ' ' GLN . . . . . . . . . . . . . 30.4 mm100 -62.02 -42.03 98.72 Favored 'General case' 0 N--CA 1.462 0.148 0 CA-C-N 115.904 -0.589 . . . . 0.0 111.568 179.525 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 716' ' ' GLN . . . . . . . . . . . . . 98.0 mm-40 -64.0 -41.92 97.33 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-O 120.691 0.281 . . . . 0.0 110.969 179.603 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 717' ' ' VAL . . . . . . . . . . . . . 74.7 t -64.0 -45.07 97.77 Favored 'Isoleucine or valine' 0 C--O 1.232 0.171 0 CA-C-O 121.007 0.432 . . . . 0.0 110.019 179.115 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 718' ' ' THR . . . . . . . . . . . . . 89.5 m -61.97 -45.44 93.65 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-N 115.685 -0.689 . . . . 0.0 111.005 179.573 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 719' ' ' MET . . . . . . . . . . . . . 38.5 mmt -62.84 -40.98 99.09 Favored 'General case' 0 N--CA 1.462 0.174 0 CA-C-N 116.502 -0.317 . . . . 0.0 110.641 179.385 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 720' ' ' GLY . . . . . . . . . . . . . . . -64.2 -42.13 98.07 Favored Glycine 0 CA--C 1.519 0.326 0 C-N-CA 120.828 -0.701 . . . . 0.0 112.509 178.758 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 721' ' ' LEU . . . . . . . . . . . . . 97.8 mt -67.7 -38.57 83.84 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-O 120.927 0.394 . . . . 0.0 111.933 179.95 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 722' ' ' THR . . . . . . . . . . . . . 60.3 p -89.39 2.17 54.81 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 112.905 0.706 . . . . 0.0 112.905 -178.659 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 723' ' ' SER . . . . . . . . . . . . . 91.1 p -65.12 -35.62 81.68 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.819 0.342 . . . . 0.0 110.953 179.502 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 724' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -70.24 -45.14 67.07 Favored 'General case' 0 CA--C 1.53 0.18 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.197 -179.973 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 725' ' ' ALA . . . . . . . . . . . . . . . -153.38 147.78 25.97 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.416 -0.356 . . . . 0.0 111.043 -179.865 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 726' ' ' THR . . . . . . . . . . . . . 15.3 t -151.04 159.33 44.6 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.341 179.974 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 727' ' ' SER . . . . . . . . . . . . . 40.7 t -148.85 144.82 27.17 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.562 0.22 . . . . 0.0 110.483 -179.809 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 728' ' ' ALA . . . . . . . . . . . . . . . -148.5 152.61 37.18 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.604 -179.895 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 729' ' ' GLN . . . . . . . . . . . . . 96.7 mt-30 . . . . . 0 C--O 1.25 1.098 0 CA-C-O 118.139 -0.934 . . . . 0.0 110.801 179.941 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 613' ' ' GLU . . . . . . . . . . . . . 39.9 mt-10 . . . . . 0 N--CA 1.487 1.387 0 CA-C-O 120.932 0.396 . . . . 0.0 110.73 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 614' ' ' GLY . . . . . . . . . . . . . . . -176.71 -178.19 46.27 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.819 -0.705 . . . . 0.0 112.509 -179.832 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 615' ' ' ARG . . . . . . . . . . . . . 78.4 mtp85 -114.99 131.81 56.8 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.779 0.323 . . . . 0.0 110.905 -179.737 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 616' ' ' ILE . . . . . 0.464 ' O ' ' HA ' ' A' ' 640' ' ' VAL . 83.8 mt -126.63 134.28 66.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.098 179.725 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 617' ' ' VAL . . . . . 0.423 ' O ' HG13 ' A' ' 617' ' ' VAL . 0.5 OUTLIER -102.31 142.45 16.56 Favored 'Isoleucine or valine' 0 C--O 1.236 0.363 0 N-CA-C 109.656 -0.498 . . . . 0.0 109.656 -179.971 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 618' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -122.84 124.77 44.03 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.74 -178.91 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 619' ' ' VAL . . . . . . . . . . . . . 60.7 t -117.95 119.37 61.29 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 N-CA-C 109.321 -0.622 . . . . 0.0 109.321 179.825 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 620' ' ' SER . . . . . . . . . . . . . 32.4 t -166.31 140.09 4.17 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.942 -0.572 . . . . 0.0 111.505 -179.155 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 621' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -76.96 -28.23 55.1 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.446 -0.797 . . . . 0.0 111.034 178.884 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 622' ' ' ASP . . . . . . . . . . . . . 37.2 t70 -86.51 111.2 20.35 Favored 'General case' 0 CA--C 1.53 0.188 0 CA-C-O 121.102 0.477 . . . . 0.0 111.678 -178.646 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 623' ' ' GLU . . . . . . . . . . . . . 97.8 mt-10 -63.33 -39.15 93.75 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.342 -0.844 . . . . 0.0 112.647 -179.824 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 624' ' ' ALA . . . . . . . . . . . . . . . -60.53 -43.61 96.97 Favored 'General case' 0 N--CA 1.467 0.413 0 N-CA-C 112.662 0.615 . . . . 0.0 112.662 -178.068 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 625' ' ' THR . . . . . 0.441 ' O ' HG22 ' A' ' 629' ' ' ILE . 91.3 m -69.8 -40.24 76.08 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.113 0.483 . . . . 0.0 110.068 179.278 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 626' ' ' SER . . . . . . . . . . . . . 67.7 m -62.19 -41.53 98.44 Favored 'General case' 0 CA--C 1.531 0.236 0 CA-C-N 115.406 -0.815 . . . . 0.0 112.376 -178.774 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 627' ' ' THR . . . . . . . . . . . . . 48.8 p -68.14 -39.65 82.63 Favored 'General case' 0 N--CA 1.466 0.328 0 N-CA-C 112.427 0.529 . . . . 0.0 112.427 -179.587 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 628' ' ' LEU . . . . . . . . . . . . . 62.8 tp -65.09 -47.28 77.8 Favored 'General case' 0 N--CA 1.463 0.208 0 N-CA-C 111.983 0.364 . . . . 0.0 111.983 -179.384 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 629' ' ' ILE . . . . . 0.441 HG22 ' O ' ' A' ' 625' ' ' THR . 18.4 tt -71.93 -34.91 52.55 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.404 0 N-CA-C 112.402 0.519 . . . . 0.0 112.402 -179.119 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 630' ' ' CYS . . . . . . . . . . . . . 46.7 t -60.87 -43.01 98.98 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.143 -179.658 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 631' ' ' SER . . . . . . . . . . . . . 67.8 m -61.66 -41.29 97.32 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.047 -179.664 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 632' ' ' ILE . . . . . . . . . . . . . 97.2 mt -62.47 -48.17 89.52 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.249 0 CA-C-O 121.013 0.435 . . . . 0.0 110.725 179.638 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 633' ' ' LEU . . . . . . . . . . . . . 79.2 mt -66.48 -40.54 89.38 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.777 -0.647 . . . . 0.0 112.649 -179.699 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 634' ' ' THR . . . . . 0.49 ' HA ' ' O ' ' A' ' 638' ' ' TYR . 61.1 m -66.24 -40.36 90.17 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.628 0.251 . . . . 0.0 110.815 -179.276 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 635' ' ' THR . . . . . . . . . . . . . 92.4 m -59.29 -39.21 82.24 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.319 179.23 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 636' ' ' ALA . . . . . . . . . . . . . . . -65.06 -17.37 64.39 Favored 'General case' 0 CA--C 1.533 0.304 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.385 178.934 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 637' ' ' GLY . . . . . . . . . . . . . . . 108.9 7.05 29.71 Favored Glycine 0 C--N 1.333 0.411 0 C-N-CA 120.906 -0.664 . . . . 0.0 113.161 179.729 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 638' ' ' TYR . . . . . 0.49 ' O ' ' HA ' ' A' ' 634' ' ' THR . 96.3 m-85 -100.07 141.0 33.48 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.797 0.332 . . . . 0.0 111.265 -179.804 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 639' ' ' GLN . . . . . . . . . . . . . 98.3 mt-30 -88.88 133.59 34.23 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.086 179.378 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 640' ' ' VAL . . . . . 0.464 ' HA ' ' O ' ' A' ' 616' ' ' ILE . 60.6 t -119.99 131.52 72.16 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 N-CA-C 112.43 0.53 . . . . 0.0 112.43 -179.106 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 641' ' ' ILE . . . . . 0.403 ' O ' HG21 ' A' ' 617' ' ' VAL . 1.2 mp -112.59 118.98 59.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 N-CA-C 108.45 -0.944 . . . . 0.0 108.45 178.073 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 642' ' ' TRP . . . . . . . . . . . . . 28.4 t90 -93.35 128.49 39.4 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 121.345 0.593 . . . . 0.0 112.392 -178.116 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 643' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -121.86 135.56 54.9 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-N 115.225 -0.898 . . . . 0.0 110.389 179.388 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 644' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -109.31 32.63 0.89 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 N-CA-C 111.778 0.288 . . . . 0.0 111.778 -179.826 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 645' ' ' ASP . . . . . . . . . . . . . 15.5 t0 -150.35 -25.87 0.24 Allowed 'General case' 0 N--CA 1.471 0.594 0 N-CA-C 113.626 0.973 . . . . 0.0 113.626 -178.421 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 646' ' ' GLY . . . . . . . . . . . . . . . 72.38 28.36 68.0 Favored Glycine 0 CA--C 1.522 0.482 0 C-N-CA 120.58 -0.819 . . . . 0.0 113.325 -179.273 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 647' ' ' GLU . . . . . . . . . . . . . 7.9 mm-40 -69.0 118.39 11.85 Favored 'General case' 0 C--O 1.232 0.144 0 CA-C-O 120.969 0.414 . . . . 0.0 110.788 179.732 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 648' ' ' VAL . . . . . . . . . . . . . 28.0 m -64.09 -30.34 49.78 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-N 115.508 -0.769 . . . . 0.0 112.163 -179.255 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 649' ' ' GLU . . . . . . . . . . . . . 98.1 mt-10 -64.14 -44.3 92.57 Favored 'General case' 0 C--N 1.333 -0.127 0 CA-C-O 121.014 0.435 . . . . 0.0 110.153 179.542 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 650' ' ' ARG . . . . . . . . . . . . . 78.7 mtp85 -72.01 -41.02 68.05 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.635 178.838 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 651' ' ' LEU . . . . . . . . . . . . . 95.4 mt -65.62 -40.48 92.62 Favored 'General case' 0 CA--C 1.523 -0.087 0 CA-C-N 115.952 -0.567 . . . . 0.0 111.049 179.952 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 652' ' ' LEU . . . . . . . . . . . . . 62.2 tp -64.46 -43.85 92.96 Favored 'General case' 0 CA--C 1.533 0.29 0 CA-C-N 116.396 -0.366 . . . . 0.0 111.311 179.209 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 653' ' ' ALA . . . . . . . . . . . . . . . -62.68 -39.83 95.21 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-O 121.11 0.481 . . . . 0.0 111.464 -179.868 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 654' ' ' LEU . . . . . . . . . . . . . 76.1 mt -102.03 30.84 4.22 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.67 -0.695 . . . . 0.0 109.965 179.809 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 655' ' ' THR . . . . . . . . . . . . . 5.5 t -42.12 110.99 0.87 Allowed Pre-proline 0 CA--C 1.537 0.458 0 CA-C-N 115.079 -0.964 . . . . 0.0 113.531 -178.132 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 656' ' ' PRO . . . . . 0.515 ' O ' HD23 ' A' ' 686' ' ' LEU . 33.8 Cg_endo -91.01 -175.9 0.85 Allowed 'Trans proline' 0 C--N 1.346 0.435 0 C-N-CA 123.95 3.1 . . . . 0.0 112.343 178.956 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 657' ' ' ILE . . . . . . . . . . . . . 23.8 pt -82.82 -25.03 8.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 121.494 0.664 . . . . 0.0 109.991 177.912 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 658' ' ' ALA . . . . . . . . . . . . . . . -156.32 154.08 30.05 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 114.986 -1.006 . . . . 0.0 110.843 -179.706 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 659' ' ' VAL . . . . . . . . . . . . . 33.3 m -120.04 143.3 32.17 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-O 121.292 0.567 . . . . 0.0 110.982 179.378 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 660' ' ' LEU . . . . . . . . . . . . . 13.0 mt -115.16 114.91 25.9 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.418 -0.81 . . . . 0.0 109.666 178.727 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 661' ' ' LEU . . . . . . . . . . . . . 64.7 mt -106.49 112.57 25.62 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 109.125 -0.694 . . . . 0.0 109.125 -179.977 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 662' ' ' ALA . . . . . . . . . . . . . . . -107.49 133.02 52.58 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 113.11 0.781 . . . . 0.0 113.11 -178.164 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 663' ' ' GLU . . . . . . . . . . . . . 97.8 mt-10 -80.23 146.45 62.51 Favored Pre-proline 0 C--N 1.326 -0.439 0 CA-C-N 115.276 -0.875 . . . . 0.0 110.087 178.365 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 664' ' ' PRO . . . . . . . . . . . . . 67.1 Cg_endo -72.93 139.57 62.04 Favored 'Cis proline' 0 C--N 1.349 0.553 0 C-N-CA 123.217 -1.576 . . . . 0.0 112.771 -0.893 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 665' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -87.63 144.08 26.86 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.747 -0.66 . . . . 0.0 111.409 179.306 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 666' ' ' SER . . . . . . . . . . . . . 77.9 p -98.48 -20.25 17.2 Favored 'General case' 0 CA--C 1.531 0.232 0 N-CA-C 112.035 0.383 . . . . 0.0 112.035 -179.99 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 667' ' ' TYR . . . . . . . . . . . . . 14.7 p90 -70.44 -17.18 62.99 Favored 'General case' 0 N--CA 1.466 0.373 0 N-CA-C 112.179 0.437 . . . . 0.0 112.179 179.548 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 668' ' ' GLY . . . . . . . . . . . . . . . 100.16 -109.16 3.65 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.518 -0.848 . . . . 0.0 113.734 179.119 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 669' ' ' ASP . . . . . . . . . . . . . 27.1 t70 -84.43 110.72 18.85 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.83 0.348 . . . . 0.0 111.278 -178.363 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 670' ' ' VAL . . . . . . . . . . . . . 14.5 p -64.21 -32.65 58.31 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.416 0 N-CA-C 112.983 0.734 . . . . 0.0 112.983 -179.3 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 671' ' ' GLN . . . . . . . . . . . . . 21.1 mp0 -61.93 -42.17 98.79 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-O 120.854 0.359 . . . . 0.0 110.758 -179.419 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 672' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 -65.8 -39.77 91.25 Favored 'General case' 0 N--CA 1.461 0.086 0 CA-C-N 116.048 -0.523 . . . . 0.0 111.043 179.159 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 673' ' ' LEU . . . . . . . . . . . . . 63.9 tp -62.49 -43.98 97.49 Favored 'General case' 0 C--N 1.333 -0.15 0 N-CA-C 109.639 -0.504 . . . . 0.0 109.639 179.149 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 674' ' ' VAL . . . . . 0.41 HG12 ' O ' ' A' ' 699' ' ' GLY . 52.9 t -62.88 -44.57 99.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 115.419 -0.809 . . . . 0.0 109.606 178.825 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 675' ' ' ASP . . . . . . . . . . . . . 35.4 t70 -59.71 -40.61 88.53 Favored 'General case' 0 CA--C 1.522 -0.103 0 CA-C-N 115.745 -0.662 . . . . 0.0 110.773 179.314 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 676' ' ' GLN . . . . . . . . . . . . . 78.5 mt-30 -70.5 -41.29 72.85 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.903 0.382 . . . . 0.0 110.906 -179.866 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 677' ' ' LEU . . . . . . . . . . . . . 63.9 tp -68.16 -44.23 76.46 Favored 'General case' 0 N--CA 1.447 -0.578 0 CA-C-N 115.956 -0.566 . . . . 0.0 111.506 179.894 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 678' ' ' ARG . . . . . 0.581 ' HA ' ' O ' ' A' ' 681' ' ' CYS . 39.8 ptt180 -71.2 -24.8 62.29 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-O 120.983 0.421 . . . . 0.0 110.948 -179.208 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 679' ' ' GLN . . . . . . . . . . . . . 53.2 tt0 -65.92 -38.86 89.79 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.213 178.912 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 680' ' ' ARG . . . . . . . . . . . . . 31.7 mmt180 -89.37 -42.98 11.23 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.261 -179.781 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 681' ' ' CYS . . . . . 0.581 ' O ' ' HA ' ' A' ' 678' ' ' ARG . 77.3 m -122.87 133.26 54.43 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.275 179.787 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 682' ' ' THR . . . . . 0.415 ' HB ' ' HD2' ' A' ' 683' ' ' PRO . 61.3 p -68.33 158.53 84.37 Favored Pre-proline 0 C--N 1.323 -0.576 0 CA-C-N 116.407 -0.361 . . . . 0.0 110.391 -179.689 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 683' ' ' PRO . . . . . 0.415 ' HD2' ' HB ' ' A' ' 682' ' ' THR . 19.0 Cg_endo -58.89 -26.78 82.21 Favored 'Trans proline' 0 C--N 1.349 0.59 0 C-N-CA 122.226 1.951 . . . . 0.0 112.308 -179.952 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 684' ' ' GLU . . . . . . . . . . . . . 51.6 mp0 -71.61 -39.31 70.57 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 121.178 0.513 . . . . 0.0 109.94 178.36 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 685' ' ' GLN . . . . . . . . . . . . . 90.9 mt-30 -72.19 -40.36 67.95 Favored 'General case' 0 C--O 1.231 0.123 0 CA-C-N 115.414 -0.812 . . . . 0.0 112.032 179.471 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 686' ' ' LEU . . . . . 0.515 HD23 ' O ' ' A' ' 656' ' ' PRO . 0.7 OUTLIER -126.22 114.19 17.99 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.209 -0.45 . . . . 0.0 112.006 -178.264 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 687' ' ' LYS . . . . . . . . . . . . . 75.7 mmtt -84.81 144.85 28.19 Favored 'General case' 0 C--N 1.331 -0.222 0 N-CA-C 109.488 -0.56 . . . . 0.0 109.488 178.125 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 688' ' ' ILE . . . . . . . . . . . . . 76.5 mt -123.35 121.74 63.54 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.757 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.501 -178.025 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 689' ' ' PHE . . . . . . . . . . . . . 98.9 m-85 -121.63 145.06 48.37 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.095 -0.957 . . . . 0.0 110.204 178.794 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 690' ' ' ILE . . . . . . . . . . . . . 19.1 tt -124.86 139.03 52.22 Favored 'Isoleucine or valine' 0 C--O 1.235 0.303 0 CA-C-O 121.055 0.455 . . . . 0.0 111.222 179.729 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 691' ' ' LEU . . . . . 0.457 ' CD2' ' HB ' ' A' ' 704' ' ' ILE . 48.2 mt -112.0 138.38 48.71 Favored 'General case' 0 C--O 1.235 0.301 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.806 -179.329 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 692' ' ' GLY . . . . . 0.592 ' O ' ' HA ' ' A' ' 705' ' ' PRO . . . 165.71 -176.95 41.1 Favored Glycine 0 N--CA 1.449 -0.471 0 CA-C-N 115.868 -0.605 . . . . 0.0 111.802 179.654 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 693' ' ' SER . . . . . . . . . . . . . 79.9 p -67.32 -37.43 83.31 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.196 0.522 . . . . 0.0 110.658 179.119 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 694' ' ' LYS . . . . . . . . . . . . . 64.2 tttm -133.06 127.88 35.02 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.686 -0.688 . . . . 0.0 109.198 178.756 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 695' ' ' GLY . . . . . . . . . . . . . . . -70.64 129.14 18.87 Favored Glycine 0 N--CA 1.447 -0.597 0 C-N-CA 120.419 -0.896 . . . . 0.0 112.866 -179.777 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 696' ' ' ASN . . . . . . . . . . . . . 67.1 t30 -91.8 91.61 8.01 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 109.637 -0.505 . . . . 0.0 109.637 179.122 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 697' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -71.03 53.84 0.17 Allowed 'General case' 0 CA--C 1.535 0.372 0 N-CA-C 113.034 0.753 . . . . 0.0 113.034 -178.652 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 698' ' ' GLN . . . . . . . . . . . . . 99.2 mm-40 -117.08 77.15 1.09 Allowed 'General case' 0 N--CA 1.453 -0.318 0 N-CA-C 109.887 -0.412 . . . . 0.0 109.887 178.795 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 699' ' ' GLY . . . . . 0.41 ' O ' HG12 ' A' ' 674' ' ' VAL . . . 93.97 10.65 58.48 Favored Glycine 0 CA--C 1.52 0.403 0 C-N-CA 120.482 -0.866 . . . . 0.0 113.692 -179.971 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 700' ' ' VAL . . . . . . . . . . . . . 23.3 m -110.45 146.2 15.95 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.255 0 CA-C-N 117.595 0.698 . . . . 0.0 110.16 179.813 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 701' ' ' ASP . . . . . . . . . . . . . 32.0 t0 -72.85 -43.04 63.08 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.546 -0.752 . . . . 0.0 112.035 -179.047 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 702' ' ' ARG . . . . . . . . . . . . . 95.5 mtt-85 -146.91 162.32 38.94 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-O 120.813 0.339 . . . . 0.0 110.909 -178.663 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 703' ' ' TYR . . . . . . . . . . . . . 51.0 p90 -124.35 144.42 50.03 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.404 179.425 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 704' ' ' ILE . . . . . 0.457 ' HB ' ' CD2' ' A' ' 691' ' ' LEU . 39.8 mt -125.98 94.27 42.08 Favored Pre-proline 0 C--N 1.328 -0.36 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.046 -179.726 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 705' ' ' PRO . . . . . 0.592 ' HA ' ' O ' ' A' ' 692' ' ' GLY . 84.6 Cg_endo -74.92 151.24 39.71 Favored 'Trans proline' 0 C--N 1.346 0.42 0 C-N-CA 122.929 2.42 . . . . 0.0 114.069 -178.762 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 706' ' ' LEU . . . . . . . . . . . . . 79.4 mt -83.19 144.06 46.35 Favored Pre-proline 0 CA--C 1.532 0.269 0 CA-C-N 115.494 -0.775 . . . . 0.0 110.429 178.599 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 707' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -74.68 141.43 71.74 Favored 'Cis proline' 0 C--N 1.345 0.393 0 C-N-CA 123.052 -1.645 . . . . 0.0 112.191 -1.233 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 708' ' ' ILE . . . . . . . . . . . . . 74.1 mt -78.67 119.51 27.92 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-N 116.354 -0.384 . . . . 0.0 110.327 179.433 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 709' ' ' HIS . . . . . . . . . . . . . 70.1 m80 -85.77 122.11 73.08 Favored Pre-proline 0 C--N 1.327 -0.38 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.391 179.538 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 710' ' ' PRO . . . . . . . . . . . . . 27.4 Cg_endo -61.46 -30.73 87.29 Favored 'Trans proline' 0 C--N 1.349 0.596 0 C-N-CA 122.954 2.436 . . . . 0.0 113.913 -178.765 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 711' ' ' GLU . . . . . . . . . . . . . 88.7 tt0 -64.7 -43.5 93.29 Favored 'General case' 0 CA--C 1.531 0.231 0 N-CA-C 112.138 0.422 . . . . 0.0 112.138 -179.124 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 712' ' ' SER . . . . . . . . . . . . . 67.2 m -94.48 -18.44 21.48 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 111.979 0.363 . . . . 0.0 111.979 -178.763 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 713' ' ' PHE . . . . . . . . . . . . . 75.4 t80 -60.51 -49.23 78.37 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.843 0.354 . . . . 0.0 110.692 179.768 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 714' ' ' LEU . . . . . . . . . . . . . 92.7 mt -63.81 -38.22 90.28 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.23 179.24 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 715' ' ' GLN . . . . . . . . . . . . . 97.3 mt-30 -62.05 -39.77 93.47 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.498 179.0 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 716' ' ' GLN . . . . . . . . . . . . . 86.5 mt-30 -63.4 -41.24 98.75 Favored 'General case' 0 C--O 1.233 0.22 0 N-CA-C 109.957 -0.386 . . . . 0.0 109.957 178.404 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 717' ' ' VAL . . . . . . . . . . . . . 74.7 t -65.01 -45.39 94.69 Favored 'Isoleucine or valine' 0 C--O 1.232 0.169 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.145 178.535 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 718' ' ' THR . . . . . . . . . . . . . 40.4 p -64.31 -36.4 83.99 Favored 'General case' 0 C--O 1.234 0.243 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.339 179.517 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 719' ' ' MET . . . . . 0.488 ' O ' HG21 ' A' ' 722' ' ' THR . 18.6 tpt -62.89 -46.89 85.69 Favored 'General case' 0 C--O 1.232 0.182 0 N-CA-C 109.872 -0.418 . . . . 0.0 109.872 178.575 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 720' ' ' GLY . . . . . . . . . . . . . . . -65.36 -40.72 96.62 Favored Glycine 0 C--N 1.331 0.301 0 C-N-CA 120.971 -0.633 . . . . 0.0 112.222 178.553 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 721' ' ' LEU . . . . . . . . . . . . . 60.5 tp -62.65 -43.98 97.43 Favored 'General case' 0 CA--C 1.53 0.193 0 N-CA-C 111.803 0.298 . . . . 0.0 111.803 -179.771 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 722' ' ' THR . . . . . 0.488 HG21 ' O ' ' A' ' 719' ' ' MET . 6.1 t -71.4 -16.23 62.39 Favored 'General case' 0 CA--C 1.532 0.257 0 CA-C-O 120.664 0.268 . . . . 0.0 111.427 -179.899 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 723' ' ' SER . . . . . . . . . . . . . 56.1 m -91.19 -10.15 42.74 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.739 0.304 . . . . 0.0 110.965 179.378 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 724' ' ' LEU . . . . . . . . . . . . . 2.9 tt -65.77 -42.63 90.58 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.012 -179.995 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 725' ' ' ALA . . . . . . . . . . . . . . . -150.73 149.98 30.47 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.635 179.951 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 726' ' ' THR . . . . . . . . . . . . . 66.5 p -128.25 157.61 40.43 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.385 -0.371 . . . . 0.0 110.825 179.99 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 727' ' ' SER . . . . . . . . . . . . . 59.9 m -128.01 149.02 50.55 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.544 -0.298 . . . . 0.0 110.802 -179.962 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 728' ' ' ALA . . . . . . . . . . . . . . . -147.4 153.52 39.73 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.594 179.969 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 729' ' ' GLN . . . . . . . . . . . . . 77.8 mt-30 . . . . . 0 C--O 1.25 1.097 0 CA-C-O 118.1 -0.952 . . . . 0.0 110.733 -179.998 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 613' ' ' GLU . . . . . . . . . . . . . 75.5 mm-40 . . . . . 0 N--CA 1.488 1.47 0 CA-C-O 121.052 0.453 . . . . 0.0 110.684 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 614' ' ' GLY . . . . . . . . . . . . . . . -82.24 72.67 2.76 Favored Glycine 0 N--CA 1.453 -0.23 0 C-N-CA 121.025 -0.607 . . . . 0.0 112.446 179.903 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 615' ' ' ARG . . . . . . . . . . . . . 92.1 mtm-85 -109.84 129.72 55.6 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.688 0.28 . . . . 0.0 110.726 -179.745 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 616' ' ' ILE . . . . . 0.415 ' O ' ' HA ' ' A' ' 640' ' ' VAL . 84.4 mt -124.14 132.75 70.87 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-N 116.243 -0.435 . . . . 0.0 109.904 178.74 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 617' ' ' VAL . . . . . . . . . . . . . 97.0 t -108.03 128.47 63.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 121.04 0.448 . . . . 0.0 110.46 -179.691 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 618' ' ' LEU . . . . . . . . . . . . . 1.5 tt -109.35 129.88 55.51 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.773 -0.648 . . . . 0.0 110.953 -179.005 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 619' ' ' VAL . . . . . . . . . . . . . 64.1 t -117.63 119.18 60.88 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 N-CA-C 109.397 -0.594 . . . . 0.0 109.397 179.328 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 620' ' ' SER . . . . . . . . . . . . . 30.6 t -169.41 147.59 3.67 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.827 -0.624 . . . . 0.0 111.452 -179.239 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 621' ' ' GLU . . . . . . . . . . . . . 98.0 mt-10 -87.09 -11.27 50.68 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.573 -0.74 . . . . 0.0 110.883 178.542 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 622' ' ' ASP . . . . . . . . . . . . . 44.7 t0 -99.21 107.84 20.27 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-O 120.982 0.42 . . . . 0.0 111.529 -179.01 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 623' ' ' GLU . . . . . . . . . . . . . 24.8 pt-20 -68.21 -30.23 69.26 Favored 'General case' 0 CA--C 1.534 0.353 0 CA-C-N 115.774 -0.648 . . . . 0.0 112.071 179.474 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 624' ' ' ALA . . . . . . . . . . . . . . . -62.91 -46.67 86.71 Favored 'General case' 0 N--CA 1.465 0.311 0 N-CA-C 112.67 0.619 . . . . 0.0 112.67 -178.983 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 625' ' ' THR . . . . . . . . . . . . . 94.3 m -70.31 -40.21 74.34 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-O 121.165 0.507 . . . . 0.0 110.473 179.916 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 626' ' ' SER . . . . . 0.477 ' O ' HG23 ' A' ' 629' ' ' ILE . 70.8 m -61.82 -40.84 96.66 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.278 -0.874 . . . . 0.0 111.88 -178.985 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 627' ' ' THR . . . . . . . . . . . . . 92.9 m -61.59 -46.15 91.06 Favored 'General case' 0 CA--C 1.533 0.316 0 N-CA-C 112.01 0.374 . . . . 0.0 112.01 -179.774 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 628' ' ' LEU . . . . . . . . . . . . . 63.6 tp -62.55 -46.68 87.25 Favored 'General case' 0 CA--C 1.533 0.318 0 N-CA-C 112.682 0.623 . . . . 0.0 112.682 -178.953 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 629' ' ' ILE . . . . . 0.477 HG23 ' O ' ' A' ' 626' ' ' SER . 21.1 tt -68.98 -33.3 58.27 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.504 0 N-CA-C 113.027 0.751 . . . . 0.0 113.027 -178.58 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 630' ' ' CYS . . . . . . . . . . . . . 82.3 m -62.41 -39.93 94.87 Favored 'General case' 0 N--CA 1.466 0.348 0 N-CA-C 112.261 0.467 . . . . 0.0 112.261 -178.937 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 631' ' ' SER . . . . . . . . . . . . . 93.4 p -63.12 -39.51 94.89 Favored 'General case' 0 C--N 1.33 -0.26 0 C-N-CA 121.071 -0.252 . . . . 0.0 111.245 -179.492 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 632' ' ' ILE . . . . . . . . . . . . . 96.9 mt -65.06 -48.51 83.62 Favored 'Isoleucine or valine' 0 C--O 1.235 0.29 0 CA-C-O 121.015 0.436 . . . . 0.0 111.059 179.617 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 633' ' ' LEU . . . . . . . . . . . . . 83.1 mt -66.85 -40.11 87.81 Favored 'General case' 0 C--O 1.233 0.221 0 N-CA-C 112.726 0.639 . . . . 0.0 112.726 -179.374 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 634' ' ' THR . . . . . 0.488 ' HA ' ' O ' ' A' ' 638' ' ' TYR . 69.0 m -65.56 -40.12 92.44 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.663 0.268 . . . . 0.0 110.746 -179.604 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 635' ' ' THR . . . . . . . . . . . . . 93.7 m -59.23 -39.17 81.89 Favored 'General case' 0 N--CA 1.464 0.225 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.223 179.157 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 636' ' ' ALA . . . . . . . . . . . . . . . -64.7 -17.89 64.51 Favored 'General case' 0 CA--C 1.534 0.336 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.289 178.905 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 637' ' ' GLY . . . . . . . . . . . . . . . 108.94 6.23 30.29 Favored Glycine 0 C--N 1.333 0.372 0 C-N-CA 120.993 -0.622 . . . . 0.0 113.168 179.722 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 638' ' ' TYR . . . . . 0.488 ' O ' ' HA ' ' A' ' 634' ' ' THR . 96.5 m-85 -100.48 142.8 31.45 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.832 0.349 . . . . 0.0 111.469 -179.817 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 639' ' ' GLN . . . . . . . . . . . . . 78.5 mt-30 -91.61 134.83 34.34 Favored 'General case' 0 CA--C 1.517 -0.292 0 CA-C-N 116.227 -0.442 . . . . 0.0 109.965 179.237 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 640' ' ' VAL . . . . . 0.415 ' HA ' ' O ' ' A' ' 616' ' ' ILE . 58.3 t -117.92 130.4 72.85 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-O 121.065 0.46 . . . . 0.0 112.175 -179.333 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 641' ' ' ILE . . . . . . . . . . . . . 47.7 mm -111.99 119.43 60.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 N-CA-C 108.564 -0.902 . . . . 0.0 108.564 178.413 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 642' ' ' TRP . . . . . . . . . . . . . 61.9 t90 -97.6 127.4 43.53 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 112.509 0.559 . . . . 0.0 112.509 -178.49 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 643' ' ' LEU . . . . . . . . . . . . . 91.1 mt -120.74 137.12 54.66 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.406 -0.815 . . . . 0.0 109.999 178.6 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 644' ' ' VAL . . . . . . . . . . . . . 5.3 p -103.36 17.73 4.64 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.563 0 CA-C-O 121.228 0.537 . . . . 0.0 111.315 -179.52 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 645' ' ' ASP . . . . . . . . . . . . . 17.3 t0 -135.03 -39.84 0.76 Allowed 'General case' 0 N--CA 1.471 0.581 0 N-CA-C 112.707 0.632 . . . . 0.0 112.707 -178.087 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 646' ' ' GLY . . . . . . . . . . . . . . . 75.64 28.74 60.7 Favored Glycine 0 CA--C 1.523 0.553 0 N-CA-C 114.948 0.739 . . . . 0.0 114.948 179.441 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 647' ' ' GLU . . . . . . . . . . . . . 98.2 mt-10 -65.6 132.31 48.53 Favored 'General case' 0 N--CA 1.457 -0.081 0 CA-C-N 118.088 0.944 . . . . 0.0 110.875 179.495 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 648' ' ' VAL . . . . . . . . . . . . . 79.6 t -61.49 -39.99 84.84 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 CA-C-N 114.801 -1.09 . . . . 0.0 111.537 -179.408 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 649' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -61.03 -42.62 98.81 Favored 'General case' 0 C--N 1.331 -0.219 0 C-N-CA 120.701 -0.4 . . . . 0.0 110.307 179.906 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 650' ' ' ARG . . . . . . . . . . . . . 95.8 mtt-85 -70.24 -40.94 74.16 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-N 116.449 -0.341 . . . . 0.0 110.419 178.304 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 651' ' ' LEU . . . . . . . . . . . . . 81.8 mt -64.49 -41.4 96.47 Favored 'General case' 0 N--CA 1.463 0.176 0 CA-C-N 116.31 -0.404 . . . . 0.0 110.547 179.133 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 652' ' ' LEU . . . . . . . . . . . . . 61.8 tp -65.04 -44.31 89.5 Favored 'General case' 0 CA--C 1.531 0.238 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.11 178.853 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 653' ' ' ALA . . . . . . . . . . . . . . . -63.05 -40.21 97.02 Favored 'General case' 0 N--CA 1.466 0.354 0 CA-C-O 121.126 0.489 . . . . 0.0 111.58 -179.964 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 654' ' ' LEU . . . . . . . . . . . . . 75.1 mt -101.31 30.34 4.25 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.048 179.91 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 655' ' ' THR . . . . . . . . . . . . . 5.3 t -42.96 109.17 0.72 Allowed Pre-proline 0 CA--C 1.537 0.451 0 O-C-N 124.186 0.929 . . . . 0.0 113.444 -178.137 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 656' ' ' PRO . . . . . . . . . . . . . 26.3 Cg_endo -92.6 -176.07 0.64 Allowed 'Trans proline' 0 N--CA 1.461 -0.413 0 C-N-CA 123.963 3.109 . . . . 0.0 112.119 178.86 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 657' ' ' ILE . . . . . . . . . . . . . 24.9 pt -83.31 -24.6 8.04 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-O 121.324 0.583 . . . . 0.0 109.826 177.988 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 658' ' ' ALA . . . . . 0.448 ' HA ' ' O ' ' A' ' 687' ' ' LYS . . . -159.19 153.27 23.53 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.23 -0.895 . . . . 0.0 111.07 179.948 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 659' ' ' VAL . . . . . . . . . . . . . 27.8 m -123.27 147.67 27.48 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-O 121.281 0.562 . . . . 0.0 111.07 179.211 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 660' ' ' LEU . . . . . . . . . . . . . 17.8 mt -116.41 120.84 40.09 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.349 -0.841 . . . . 0.0 109.937 178.997 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 661' ' ' LEU . . . . . . . . . . . . . 73.1 mt -108.16 112.5 25.04 Favored 'General case' 0 C--N 1.327 -0.404 0 C-N-CA 120.644 -0.422 . . . . 0.0 109.956 179.969 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 662' ' ' ALA . . . . . . . . . . . . . . . -107.09 113.78 27.44 Favored 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 120.985 -0.286 . . . . 0.0 111.378 -179.747 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 663' ' ' GLU . . . . . 0.569 ' HA ' ' C ' ' A' ' 664' ' ' PRO . 24.6 pt-20 -65.64 145.87 99.01 Favored Pre-proline 0 C--N 1.326 -0.451 0 CA-C-N 115.871 -0.604 . . . . 0.0 111.183 179.394 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 664' ' ' PRO . . . . . 0.569 ' C ' ' HA ' ' A' ' 663' ' ' GLU . 36.1 Cg_exo -61.47 137.95 22.17 Favored 'Cis proline' 0 C--N 1.355 0.892 0 C-N-CA 124.05 -1.229 . . . . 0.0 112.732 -1.017 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 665' ' ' PHE . . . . . . . . . . . . . 33.7 m-85 -78.34 126.0 30.16 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.046 -0.525 . . . . 0.0 111.09 -179.15 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 666' ' ' SER . . . . . . . . . . . . . 67.8 m -63.95 -43.23 96.44 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.758 179.903 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 667' ' ' TYR . . . . . . . . . . . . . 62.1 t80 -69.63 -23.53 63.51 Favored 'General case' 0 CA--C 1.532 0.274 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.74 179.865 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 668' ' ' GLY . . . . . . . . . . . . . . . 100.38 -103.45 2.63 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.352 -0.928 . . . . 0.0 112.482 -179.166 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 669' ' ' ASP . . . . . . . . . . . . . 28.1 t70 -80.3 108.07 13.61 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-O 120.893 0.378 . . . . 0.0 110.281 -179.576 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 670' ' ' VAL . . . . . 0.452 ' O ' HG21 ' A' ' 674' ' ' VAL . 17.5 m -68.84 -27.31 35.28 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.225 0 N-CA-C 113.638 0.977 . . . . 0.0 113.638 -178.664 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 671' ' ' GLN . . . . . . . . . . . . . 24.1 mp0 -61.73 -42.26 98.72 Favored 'General case' 0 C--O 1.232 0.146 0 CA-C-N 117.995 0.361 . . . . 0.0 111.014 -179.392 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 672' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 -65.77 -39.83 91.4 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.393 178.448 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 673' ' ' LEU . . . . . 0.403 ' O ' HD12 ' A' ' 677' ' ' LEU . 63.6 tp -63.62 -44.82 92.82 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 115.586 -0.734 . . . . 0.0 110.079 179.264 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 674' ' ' VAL . . . . . 0.452 HG21 ' O ' ' A' ' 670' ' ' VAL . 56.0 t -63.1 -44.52 99.53 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.18 0 CA-C-N 115.606 -0.725 . . . . 0.0 109.917 179.376 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 675' ' ' ASP . . . . . 0.413 ' O ' ' HB2' ' A' ' 679' ' ' GLN . 36.4 t70 -59.53 -40.14 86.21 Favored 'General case' 0 CA--C 1.52 -0.176 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.699 179.346 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 676' ' ' GLN . . . . . . . . . . . . . 55.9 mt-30 -70.26 -40.0 74.63 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.884 0.373 . . . . 0.0 111.09 -179.753 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 677' ' ' LEU . . . . . 0.403 HD12 ' O ' ' A' ' 673' ' ' LEU . 7.0 mp -70.0 -44.21 69.83 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.696 179.918 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 678' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -74.41 -19.74 60.31 Favored 'General case' 0 N--CA 1.469 0.478 0 N-CA-C 111.884 0.327 . . . . 0.0 111.884 -179.058 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 679' ' ' GLN . . . . . 0.413 ' HB2' ' O ' ' A' ' 675' ' ' ASP . 53.6 tt0 -64.61 -39.52 93.85 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.583 -179.659 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 680' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -110.51 -20.26 12.63 Favored 'General case' 0 C--N 1.332 -0.174 0 N-CA-C 112.636 0.606 . . . . 0.0 112.636 -179.14 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 681' ' ' CYS . . . . . . . . . . . . . 76.7 m -119.52 132.42 55.76 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 120.877 0.37 . . . . 0.0 111.194 -179.985 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 682' ' ' THR . . . . . 0.441 ' HB ' ' HD2' ' A' ' 683' ' ' PRO . 57.3 p -74.9 159.95 81.82 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.168 179.421 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 683' ' ' PRO . . . . . 0.441 ' HD2' ' HB ' ' A' ' 682' ' ' THR . 17.9 Cg_endo -60.02 -28.55 87.32 Favored 'Trans proline' 0 C--N 1.35 0.652 0 C-N-CA 122.063 1.842 . . . . 0.0 112.312 179.527 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 684' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -71.64 -39.33 70.44 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-O 121.047 0.451 . . . . 0.0 109.981 178.742 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 685' ' ' GLN . . . . . . . . . . . . . 65.4 tt0 -71.63 -42.46 67.58 Favored 'General case' 0 C--O 1.232 0.155 0 CA-C-N 115.386 -0.824 . . . . 0.0 111.756 179.745 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 686' ' ' LEU . . . . . . . . . . . . . 2.6 tt -137.74 121.93 18.04 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.114 -178.805 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 687' ' ' LYS . . . . . 0.448 ' O ' ' HA ' ' A' ' 658' ' ' ALA . 61.0 mttp -102.39 146.92 27.37 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.227 179.273 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 688' ' ' ILE . . . . . . . . . . . . . 76.9 mt -121.35 120.96 63.47 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.797 0 CA-C-O 121.317 0.579 . . . . 0.0 111.071 -178.416 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 689' ' ' PHE . . . . . . . . . . . . . 95.4 m-85 -121.16 146.82 46.37 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.081 -0.963 . . . . 0.0 109.653 178.8 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 690' ' ' ILE . . . . . . . . . . . . . 19.8 tt -123.52 139.02 51.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-O 121.354 0.597 . . . . 0.0 112.096 -178.635 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 691' ' ' LEU . . . . . 0.409 ' CD2' ' HB ' ' A' ' 704' ' ' ILE . 73.2 mt -107.24 129.41 54.88 Favored 'General case' 0 C--O 1.235 0.33 0 CA-C-N 115.345 -0.843 . . . . 0.0 109.963 179.585 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 692' ' ' GLY . . . . . 0.616 ' O ' ' HA ' ' A' ' 705' ' ' PRO . . . 171.68 178.61 42.15 Favored Glycine 0 N--CA 1.444 -0.788 0 C-N-CA 120.341 -0.933 . . . . 0.0 113.156 179.832 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 693' ' ' SER . . . . . . . . . . . . . 80.2 p -69.49 -36.38 76.46 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 120.838 0.352 . . . . 0.0 111.216 179.628 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 694' ' ' LYS . . . . . . . . . . . . . 35.6 mmtp -119.54 137.36 53.88 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.114 0.483 . . . . 0.0 110.331 179.694 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 695' ' ' GLY . . . . . 0.475 ' HA3' ' CG ' ' A' ' 703' ' ' TYR . . . -102.35 16.46 55.21 Favored Glycine 0 N--CA 1.449 -0.483 0 CA-C-N 115.545 -0.752 . . . . 0.0 113.1 179.821 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 696' ' ' ASN . . . . . . . . . . . . . 64.4 t30 -81.33 68.39 7.63 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.092 0.472 . . . . 0.0 111.241 -179.315 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 697' ' ' TYR . . . . . . . . . . . . . 97.0 m-85 -131.03 142.03 50.27 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.889 -0.596 . . . . 0.0 109.942 179.107 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 698' ' ' GLN . . . . . . . . . . . . . 21.4 mp0 -90.98 149.43 21.86 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.923 -179.439 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 699' ' ' GLY . . . . . . . . . . . . . . . 92.88 4.12 65.41 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.704 -0.76 . . . . 0.0 113.995 179.167 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 700' ' ' VAL . . . . . . . . . . . . . 29.2 m -119.36 147.07 23.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 117.642 0.721 . . . . 0.0 110.662 179.42 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 701' ' ' ASP . . . . . . . . . . . . . 36.5 t70 -72.9 -43.63 62.22 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.442 -0.799 . . . . 0.0 111.996 -179.569 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 702' ' ' ARG . . . . . . . . . . . . . 69.0 mtp85 -146.73 163.63 35.34 Favored 'General case' 0 C--O 1.235 0.292 0 CA-C-O 120.795 0.331 . . . . 0.0 110.776 -179.056 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 703' ' ' TYR . . . . . 0.475 ' CG ' ' HA3' ' A' ' 695' ' ' GLY . 50.3 p90 -121.4 142.03 50.4 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.092 179.247 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 704' ' ' ILE . . . . . 0.409 ' HB ' ' CD2' ' A' ' 691' ' ' LEU . 58.9 mt -127.09 119.26 22.16 Favored Pre-proline 0 C--N 1.327 -0.402 0 CA-C-N 116.537 -0.301 . . . . 0.0 110.501 179.83 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 705' ' ' PRO . . . . . 0.616 ' HA ' ' O ' ' A' ' 692' ' ' GLY . 72.8 Cg_endo -72.56 156.42 53.92 Favored 'Trans proline' 0 C--N 1.345 0.357 0 C-N-CA 122.926 2.417 . . . . 0.0 113.775 -179.4 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 706' ' ' LEU . . . . . 0.536 ' HA ' ' C ' ' A' ' 707' ' ' PRO . 87.8 mt -124.4 142.75 41.12 Favored Pre-proline 0 C--N 1.33 -0.253 0 CA-C-N 115.421 -0.809 . . . . 0.0 109.692 179.104 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 707' ' ' PRO . . . . . 0.536 ' C ' ' HA ' ' A' ' 706' ' ' LEU . 31.2 Cg_exo -62.85 137.92 25.87 Favored 'Cis proline' 0 C--N 1.349 0.584 0 C-N-CA 123.752 -1.353 . . . . 0.0 112.791 -1.303 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 708' ' ' ILE . . . . . . . . . . . . . 2.9 pt -63.93 147.6 12.18 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-O 121.577 0.703 . . . . 0.0 112.26 179.056 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 709' ' ' HIS . . . . . . . . . . . . . 97.6 m-70 -103.65 112.17 65.48 Favored Pre-proline 0 C--N 1.32 -0.685 0 N-CA-C 107.722 -1.214 . . . . 0.0 107.722 177.491 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 710' ' ' PRO . . . . . . . . . . . . . 21.4 Cg_endo -59.51 -30.31 92.17 Favored 'Trans proline' 0 N--CA 1.475 0.432 0 C-N-CA 122.782 2.321 . . . . 0.0 114.609 -176.956 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 711' ' ' GLU . . . . . . . . . . . . . 88.7 tt0 -65.28 -43.21 91.94 Favored 'General case' 0 CA--C 1.533 0.293 0 N-CA-C 112.141 0.423 . . . . 0.0 112.141 -179.164 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 712' ' ' SER . . . . . . . . . . . . . 67.4 m -99.05 -15.08 19.17 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 112.341 0.497 . . . . 0.0 112.341 -178.711 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 713' ' ' PHE . . . . . . . . . . . . . 90.0 t80 -59.32 -48.77 80.36 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.866 0.365 . . . . 0.0 110.469 -179.721 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 714' ' ' LEU . . . . . . . . . . . . . 90.6 mt -64.0 -37.86 88.98 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.223 178.986 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 715' ' ' GLN . . . . . . . . . . . . . 97.3 mt-30 -63.25 -43.07 99.05 Favored 'General case' 0 CA--C 1.531 0.214 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.893 179.536 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 716' ' ' GLN . . . . . . . . . . . . . 2.9 mp0 -65.95 -41.83 90.75 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 116.576 -0.284 . . . . 0.0 111.154 179.296 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 717' ' ' VAL . . . . . . . . . . . . . 66.3 t -62.36 -45.47 98.69 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.175 0 CA-C-O 120.68 0.276 . . . . 0.0 110.436 179.373 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 718' ' ' THR . . . . . . . . . . . . . 89.5 m -62.37 -45.64 92.27 Favored 'General case' 0 CA--C 1.531 0.228 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.202 179.65 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 719' ' ' MET . . . . . . . . . . . . . 1.4 mpp? -66.85 -40.56 87.93 Favored 'General case' 0 N--CA 1.464 0.262 0 C-N-CA 121.157 -0.217 . . . . 0.0 110.754 179.368 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 720' ' ' GLY . . . . . . . . . . . . . . . -63.86 -42.98 98.24 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.267 -0.968 . . . . 0.0 111.36 177.968 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 721' ' ' LEU . . . . . . . . . . . . . 63.3 tp -66.88 -48.15 69.65 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 122.501 0.32 . . . . 0.0 111.196 178.647 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 722' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER 37.29 37.95 0.11 Allowed 'General case' 0 N--CA 1.478 0.969 0 N-CA-C 114.175 1.176 . . . . 0.0 114.175 -179.894 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 723' ' ' SER . . . . . 0.552 ' HA ' ' O ' ' A' ' 726' ' ' THR . 58.2 m 57.37 27.26 13.56 Favored 'General case' 0 N--CA 1.47 0.541 0 N-CA-C 112.999 0.741 . . . . 0.0 112.999 179.428 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 724' ' ' LEU . . . . . . . . . . . . . 1.7 mm? -73.87 -39.16 64.14 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-O 120.78 0.324 . . . . 0.0 111.119 179.104 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 725' ' ' ALA . . . . . . . . . . . . . . . -103.72 -49.95 3.54 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.367 -0.378 . . . . 0.0 111.47 -179.868 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 726' ' ' THR . . . . . 0.552 ' O ' ' HA ' ' A' ' 723' ' ' SER . 72.2 p -129.13 158.48 38.86 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.997 -179.894 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 727' ' ' SER . . . . . . . . . . . . . 96.2 p -149.16 162.6 39.67 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.397 -179.974 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 728' ' ' ALA . . . . . . . . . . . . . . . -146.35 153.27 40.32 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.715 -179.94 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 729' ' ' GLN . . . . . . . . . . . . . 96.8 mt-30 . . . . . 0 C--O 1.25 1.108 0 CA-C-O 118.13 -0.938 . . . . 0.0 110.839 -179.987 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 613' ' ' GLU . . . . . . . . . . . . . 57.9 mt-10 . . . . . 0 N--CA 1.488 1.454 0 CA-C-O 121.107 0.48 . . . . 0.0 110.747 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 614' ' ' GLY . . . . . . . . . . . . . . . -86.69 69.91 3.02 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.911 -0.661 . . . . 0.0 112.545 -179.898 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 615' ' ' ARG . . . . . . . . . . . . . 33.7 mtp-105 -111.39 126.55 55.05 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.077 0.465 . . . . 0.0 111.102 -179.827 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 616' ' ' ILE . . . . . 0.44 ' O ' ' HA ' ' A' ' 640' ' ' VAL . 83.8 mt -124.89 133.85 68.4 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-N 115.568 -0.742 . . . . 0.0 110.113 179.577 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 617' ' ' VAL . . . . . . . . . . . . . 96.8 t -105.43 126.67 60.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 N-CA-C 109.5 -0.555 . . . . 0.0 109.5 179.615 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 618' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -108.54 126.74 53.26 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.856 -0.611 . . . . 0.0 111.1 -178.329 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 619' ' ' VAL . . . . . . . . . . . . . 61.0 t -112.9 117.07 54.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 N-CA-C 109.04 -0.726 . . . . 0.0 109.04 179.578 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 620' ' ' SER . . . . . . . . . . . . . 47.9 t -163.05 135.68 5.47 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.552 -179.14 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 621' ' ' GLU . . . . . . . . . . . . . 88.2 tt0 -77.69 -28.39 51.04 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.517 -0.765 . . . . 0.0 110.843 178.697 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 622' ' ' ASP . . . . . . . . . . . . . 56.1 t0 -85.18 110.64 19.15 Favored 'General case' 0 C--O 1.235 0.342 0 CA-C-O 121.01 0.433 . . . . 0.0 111.205 -178.593 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 623' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -63.59 -39.47 94.47 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 115.444 -0.798 . . . . 0.0 112.344 179.954 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 624' ' ' ALA . . . . . . . . . . . . . . . -61.56 -44.16 97.54 Favored 'General case' 0 N--CA 1.465 0.301 0 N-CA-C 112.088 0.403 . . . . 0.0 112.088 -178.869 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 625' ' ' THR . . . . . . . . . . . . . 86.5 m -69.3 -40.66 77.57 Favored 'General case' 0 N--CA 1.454 -0.265 0 CA-C-O 121.137 0.494 . . . . 0.0 110.126 179.852 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 626' ' ' SER . . . . . . . . . . . . . 69.3 m -61.92 -41.65 98.19 Favored 'General case' 0 N--CA 1.453 -0.278 0 CA-C-N 115.412 -0.813 . . . . 0.0 111.497 -179.307 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 627' ' ' THR . . . . . . . . . . . . . 92.0 m -61.81 -46.32 90.04 Favored 'General case' 0 CA--C 1.533 0.305 0 N-CA-C 112.241 0.46 . . . . 0.0 112.241 -179.292 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 628' ' ' LEU . . . . . . . . . . . . . 62.7 tp -63.77 -47.15 82.14 Favored 'General case' 0 CA--C 1.533 0.316 0 N-CA-C 112.693 0.627 . . . . 0.0 112.693 -178.826 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 629' ' ' ILE . . . . . . . . . . . . . 17.3 tt -70.49 -36.78 67.66 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.409 0 N-CA-C 112.914 0.709 . . . . 0.0 112.914 -178.579 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 630' ' ' CYS . . . . . 0.433 ' SG ' HG11 ' A' ' 640' ' ' VAL . 85.3 m -62.9 -39.57 94.92 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-O 120.572 0.225 . . . . 0.0 110.935 -179.877 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 631' ' ' SER . . . . . . . . . . . . . 68.4 m -62.23 -41.32 98.29 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.796 179.982 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 632' ' ' ILE . . . . . 0.558 ' O ' HG21 ' A' ' 635' ' ' THR . 96.9 mt -63.12 -47.36 92.88 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.296 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.739 179.677 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 633' ' ' LEU . . . . . . . . . . . . . 80.7 mt -67.64 -40.29 84.61 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 112.425 0.528 . . . . 0.0 112.425 179.997 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 634' ' ' THR . . . . . 0.549 ' HA ' ' O ' ' A' ' 638' ' ' TYR . 90.9 m -66.06 -42.67 89.13 Favored 'General case' 0 CA--C 1.531 0.232 0 N-CA-C 111.533 0.197 . . . . 0.0 111.533 -179.051 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 635' ' ' THR . . . . . 0.558 HG21 ' O ' ' A' ' 632' ' ' ILE . 2.1 t -62.9 -17.64 61.94 Favored 'General case' 0 CA--C 1.534 0.345 0 CA-C-O 120.699 0.285 . . . . 0.0 111.32 179.651 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 636' ' ' ALA . . . . . . . . . . . . . . . -85.75 -1.84 57.61 Favored 'General case' 0 CA--C 1.53 0.211 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.825 178.852 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 637' ' ' GLY . . . . . . . . . . . . . . . 95.33 6.03 60.18 Favored Glycine 0 C--N 1.334 0.433 0 C-N-CA 120.998 -0.62 . . . . 0.0 113.152 179.873 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 638' ' ' TYR . . . . . 0.549 ' O ' ' HA ' ' A' ' 634' ' ' THR . 90.8 m-85 -100.24 142.86 31.14 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.888 0.375 . . . . 0.0 111.408 -179.839 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 639' ' ' GLN . . . . . . . . . . . . . 97.9 mt-30 -92.94 133.36 36.19 Favored 'General case' 0 CA--C 1.517 -0.31 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.082 179.241 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 640' ' ' VAL . . . . . 0.44 ' HA ' ' O ' ' A' ' 616' ' ' ILE . 57.9 t -118.08 130.56 72.77 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-O 121.122 0.487 . . . . 0.0 112.029 -179.232 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 641' ' ' ILE . . . . . . . . . . . . . 38.3 mm -107.7 116.91 52.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 N-CA-C 108.483 -0.932 . . . . 0.0 108.483 178.599 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 642' ' ' TRP . . . . . . . . . . . . . 27.4 t90 -87.17 127.13 35.15 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 112.309 0.485 . . . . 0.0 112.309 -178.623 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 643' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -122.16 128.72 51.57 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.642 -0.708 . . . . 0.0 110.2 178.97 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 644' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -107.6 39.96 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.671 -0.24 . . . . 0.0 111.526 -179.725 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 645' ' ' ASP . . . . . . . . . . . . . 36.0 t70 -154.59 -35.9 0.1 Allowed 'General case' 0 N--CA 1.469 0.486 0 N-CA-C 112.426 0.528 . . . . 0.0 112.426 -178.879 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 646' ' ' GLY . . . . . . . . . . . . . . . 77.66 20.55 73.85 Favored Glycine 0 N--CA 1.453 -0.219 0 C-N-CA 120.67 -0.776 . . . . 0.0 112.913 -179.59 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 647' ' ' GLU . . . . . . . . . . . . . 37.2 tt0 -61.45 121.15 11.96 Favored 'General case' 0 N--CA 1.456 -0.149 0 CA-C-O 120.941 0.401 . . . . 0.0 110.305 -179.764 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 648' ' ' VAL . . . . . . . . . . . . . 13.4 p -63.14 -34.14 65.03 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-N 115.493 -0.776 . . . . 0.0 112.132 -178.954 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 649' ' ' GLU . . . . . . . . . . . . . 49.0 mp0 -63.9 -42.99 97.29 Favored 'General case' 0 C--O 1.231 0.104 0 CA-C-O 121.005 0.431 . . . . 0.0 109.921 178.914 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 650' ' ' ARG . . . . . . . . . . . . . 24.9 tpp180 -67.95 -43.36 79.25 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.0 178.321 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 651' ' ' LEU . . . . . . . . . . . . . 89.6 mt -63.43 -41.42 98.68 Favored 'General case' 0 N--CA 1.462 0.144 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.361 179.206 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 652' ' ' LEU . . . . . . . . . . . . . 61.1 tp -65.41 -43.19 91.34 Favored 'General case' 0 CA--C 1.531 0.243 0 CA-C-N 116.022 -0.535 . . . . 0.0 111.083 178.611 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 653' ' ' ALA . . . . . . . . . . . . . . . -62.8 -39.72 95.15 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-O 120.931 0.396 . . . . 0.0 111.935 179.96 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 654' ' ' LEU . . . . . . . . . . . . . 78.4 mt -101.16 29.21 4.81 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.843 -179.627 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 655' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -32.16 104.76 0.23 Allowed Pre-proline 0 N--CA 1.471 0.606 0 N-CA-C 114.483 1.29 . . . . 0.0 114.483 -178.881 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 656' ' ' PRO . . . . . . . . . . . . . 25.4 Cg_endo -92.65 -177.63 0.8 Allowed 'Trans proline' 0 C--N 1.346 0.403 0 C-N-CA 123.673 2.915 . . . . 0.0 111.636 177.509 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 657' ' ' ILE . . . . . . . . . . . . . 23.0 pt -81.54 -26.11 10.02 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-O 121.394 0.616 . . . . 0.0 109.757 177.83 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 658' ' ' ALA . . . . . 0.468 ' HA ' ' O ' ' A' ' 687' ' ' LYS . . . -158.93 154.44 25.93 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.109 -0.95 . . . . 0.0 111.152 -179.759 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 659' ' ' VAL . . . . . . . . . . . . . 28.6 m -124.04 147.63 28.43 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-O 121.048 0.451 . . . . 0.0 110.995 179.174 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 660' ' ' LEU . . . . . . . . . . . . . 17.5 mt -115.63 117.77 31.24 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.66 -0.7 . . . . 0.0 109.555 178.656 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 661' ' ' LEU . . . . . . . . . . . . . 17.5 mt -104.96 113.05 26.41 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 109.336 -0.616 . . . . 0.0 109.336 -179.536 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 662' ' ' ALA . . . . . . . . . . . . . . . -102.27 128.81 48.64 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 112.591 0.589 . . . . 0.0 112.591 -179.064 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 663' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -71.48 143.5 87.78 Favored Pre-proline 0 CA--C 1.533 0.296 0 CA-C-N 115.359 -0.837 . . . . 0.0 110.749 178.315 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 664' ' ' PRO . . . . . . . . . . . . . 65.8 Cg_endo -72.95 142.53 74.99 Favored 'Cis proline' 0 C--N 1.348 0.516 0 C-N-CA 123.081 -1.633 . . . . 0.0 112.315 -0.931 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 665' ' ' PHE . . . . . . . . . . . . . 60.0 m-85 -69.91 118.13 12.37 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.524 179.98 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 666' ' ' SER . . . . . . . . . . . . . 78.7 p -65.26 -35.38 80.86 Favored 'General case' 0 CA--C 1.53 0.208 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.226 179.59 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 667' ' ' TYR . . . . . 0.429 ' CD2' ' HB2' ' A' ' 673' ' ' LEU . 75.0 t80 -65.33 -22.49 66.83 Favored 'General case' 0 CA--C 1.534 0.35 0 CA-C-N 115.982 -0.554 . . . . 0.0 111.491 178.83 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 668' ' ' GLY . . . . . . . . . . . . . . . 101.45 -103.24 2.51 Favored Glycine 0 N--CA 1.45 -0.412 0 C-N-CA 120.501 -0.857 . . . . 0.0 112.117 -178.83 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 669' ' ' ASP . . . . . . . . . . . . . 37.7 t70 -80.47 106.25 12.33 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 121.075 0.464 . . . . 0.0 110.427 -179.82 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 670' ' ' VAL . . . . . . . . . . . . . 13.5 p -63.04 -32.7 57.15 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.403 0 N-CA-C 113.122 0.786 . . . . 0.0 113.122 -179.002 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 671' ' ' GLN . . . . . . . . . . . . . 30.9 mm100 -62.79 -40.84 98.58 Favored 'General case' 0 N--CA 1.463 0.183 0 CA-C-O 120.664 0.268 . . . . 0.0 111.267 -178.844 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 672' ' ' GLU . . . . . . . . . . . . . 88.8 tt0 -63.58 -43.23 97.59 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.567 179.296 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 673' ' ' LEU . . . . . 0.429 ' HB2' ' CD2' ' A' ' 667' ' ' TYR . 62.4 tp -63.44 -44.63 93.99 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.462 179.873 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 674' ' ' VAL . . . . . . . . . . . . . 60.4 t -63.11 -44.89 99.72 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.177 0 CA-C-N 115.866 -0.606 . . . . 0.0 109.813 179.398 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 675' ' ' ASP . . . . . . . . . . . . . 35.4 t70 -60.14 -40.18 88.9 Favored 'General case' 0 CA--C 1.52 -0.195 0 CA-C-N 115.804 -0.635 . . . . 0.0 110.581 178.994 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 676' ' ' GLN . . . . . . . . . . . . . 96.8 mt-30 -70.07 -41.13 74.54 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.426 -0.352 . . . . 0.0 111.053 -179.742 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 677' ' ' LEU . . . . . . . . . . . . . 84.2 mt -68.16 -41.61 81.29 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.798 179.93 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 678' ' ' ARG . . . . . 0.424 ' HA ' ' O ' ' A' ' 681' ' ' CYS . 39.9 ptt180 -73.61 -26.59 60.87 Favored 'General case' 0 N--CA 1.469 0.494 0 CA-C-O 121.003 0.43 . . . . 0.0 110.98 -179.121 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 679' ' ' GLN . . . . . . . . . . . . . 53.3 tt0 -65.96 -39.25 90.27 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.328 179.157 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 680' ' ' ARG . . . . . . . . . . . . . 29.4 mmm180 -87.42 -42.67 12.65 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.944 -0.571 . . . . 0.0 111.685 -179.537 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 681' ' ' CYS . . . . . 0.424 ' O ' ' HA ' ' A' ' 678' ' ' ARG . 76.0 m -125.24 134.98 52.12 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 121.154 0.502 . . . . 0.0 111.429 -179.391 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 682' ' ' THR . . . . . . . . . . . . . 63.0 p -71.81 161.88 76.31 Favored Pre-proline 0 C--N 1.324 -0.514 0 CA-C-N 115.659 -0.7 . . . . 0.0 110.362 179.199 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 683' ' ' PRO . . . . . . . . . . . . . 79.3 Cg_exo -53.25 -34.29 69.12 Favored 'Trans proline' 0 C--N 1.351 0.71 0 C-N-CA 122.8 2.334 . . . . 0.0 112.943 -179.959 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 684' ' ' GLU . . . . . . . . . . . . . 51.2 mp0 -69.64 -38.91 77.34 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.99 0.424 . . . . 0.0 110.432 179.563 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 685' ' ' GLN . . . . . . . . . . . . . 91.2 mt-30 -71.7 -39.96 69.84 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.724 -0.671 . . . . 0.0 111.904 179.398 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 686' ' ' LEU . . . . . . . . . . . . . 3.3 tt -142.2 120.64 12.41 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.347 -178.7 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 687' ' ' LYS . . . . . 0.468 ' O ' ' HA ' ' A' ' 658' ' ' ALA . 68.7 mttm -94.32 146.35 24.1 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.319 0.581 . . . . 0.0 110.615 178.609 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 688' ' ' ILE . . . . . . . . . . . . . 80.4 mt -122.6 123.08 67.63 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.784 0 CA-C-N 115.563 -0.744 . . . . 0.0 111.16 -178.521 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 689' ' ' PHE . . . . . 0.462 ' CD2' ' HB2' ' A' ' 702' ' ' ARG . 61.3 m-85 -123.51 145.55 48.77 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.232 -0.895 . . . . 0.0 110.007 179.067 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 690' ' ' ILE . . . . . . . . . . . . . 96.6 mt -121.65 135.24 62.44 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.466 0 CA-C-O 121.313 0.578 . . . . 0.0 112.441 -179.15 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 691' ' ' LEU . . . . . 0.45 ' CD2' ' HB ' ' A' ' 704' ' ' ILE . 35.2 mt -106.68 128.16 53.96 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-N 115.052 -0.976 . . . . 0.0 109.491 179.629 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 692' ' ' GLY . . . . . 0.735 ' O ' ' HA ' ' A' ' 705' ' ' PRO . . . 165.48 -174.41 41.26 Favored Glycine 0 N--CA 1.447 -0.601 0 C-N-CA 120.335 -0.936 . . . . 0.0 112.204 179.899 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 693' ' ' SER . . . . . . . . . . . . . 80.1 p -67.56 -37.6 82.91 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 120.807 0.336 . . . . 0.0 111.446 179.837 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 694' ' ' LYS . . . . . . . . . . . . . 35.5 mmtp -124.69 133.99 53.01 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.217 0.532 . . . . 0.0 110.85 179.657 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 695' ' ' GLY . . . . . 0.518 ' HA3' ' CB ' ' A' ' 703' ' ' TYR . . . -111.68 19.32 23.83 Favored Glycine 0 N--CA 1.449 -0.482 0 CA-C-N 115.345 -0.843 . . . . 0.0 112.5 179.575 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 696' ' ' ASN . . . . . . . . . . . . . 65.1 t30 -81.93 73.33 8.97 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.023 0.44 . . . . 0.0 111.395 -179.081 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 697' ' ' TYR . . . . . . . . . . . . . 98.9 m-85 -130.51 145.03 51.78 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.928 -0.578 . . . . 0.0 109.707 179.116 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 698' ' ' GLN . . . . . . . . . . . . . 98.2 mt-30 -84.3 145.62 28.18 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.959 -179.91 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 699' ' ' GLY . . . . . . . . . . . . . . . 94.58 5.73 61.41 Favored Glycine 0 CA--C 1.519 0.294 0 C-N-CA 120.552 -0.832 . . . . 0.0 113.776 179.481 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 700' ' ' VAL . . . . . . . . . . . . . 21.4 m -119.46 152.61 21.98 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.271 0 CA-C-N 117.394 0.597 . . . . 0.0 109.947 179.268 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 701' ' ' ASP . . . . . . . . . . . . . 67.8 m-20 -88.93 -39.74 13.55 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 116.006 -0.543 . . . . 0.0 112.259 -178.926 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 702' ' ' ARG . . . . . 0.462 ' HB2' ' CD2' ' A' ' 689' ' ' PHE . 91.3 mmt-85 -144.69 161.74 38.45 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-O 120.805 0.336 . . . . 0.0 110.594 -178.611 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 703' ' ' TYR . . . . . 0.518 ' CB ' ' HA3' ' A' ' 695' ' ' GLY . 53.1 p90 -133.03 147.96 52.23 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.021 -0.536 . . . . 0.0 109.617 178.596 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 704' ' ' ILE . . . . . 0.45 ' HB ' ' CD2' ' A' ' 691' ' ' LEU . 58.8 mt -126.05 101.13 29.31 Favored Pre-proline 0 C--N 1.324 -0.528 0 CA-C-O 120.81 0.338 . . . . 0.0 110.846 -179.651 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 705' ' ' PRO . . . . . 0.735 ' HA ' ' O ' ' A' ' 692' ' ' GLY . 73.5 Cg_endo -73.52 152.58 48.89 Favored 'Trans proline' 0 C--N 1.347 0.454 0 C-N-CA 122.927 2.418 . . . . 0.0 113.34 -179.727 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 706' ' ' LEU . . . . . 0.551 ' HA ' ' C ' ' A' ' 707' ' ' PRO . 0.7 OUTLIER -105.21 151.86 39.67 Favored Pre-proline 0 CA--C 1.534 0.355 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.835 179.017 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 707' ' ' PRO . . . . . 0.551 ' C ' ' HA ' ' A' ' 706' ' ' LEU . 37.9 Cg_endo -65.68 136.84 29.78 Favored 'Cis proline' 0 C--N 1.35 0.63 0 C-N-CA 123.026 -1.656 . . . . 0.0 112.316 0.122 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 708' ' ' ILE . . . . . . . . . . . . . 69.1 mt -80.7 120.33 32.07 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-N 115.606 -0.724 . . . . 0.0 110.785 -179.398 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 709' ' ' HIS . . . . . . . . . . . . . 70.1 m80 -84.85 124.04 73.2 Favored Pre-proline 0 C--N 1.327 -0.386 0 CA-C-N 116.037 -0.528 . . . . 0.0 110.148 179.174 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 710' ' ' PRO . . . . . . . . . . . . . 24.0 Cg_endo -60.74 -31.56 92.05 Favored 'Trans proline' 0 C--N 1.348 0.545 0 C-N-CA 123.043 2.495 . . . . 0.0 114.014 -178.771 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 711' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -66.43 -40.1 89.31 Favored 'General case' 0 C--N 1.331 -0.233 0 N-CA-C 112.143 0.423 . . . . 0.0 112.143 -179.343 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 712' ' ' SER . . . . . . . . . . . . . 51.0 m -95.76 -15.96 22.24 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.513 -0.312 . . . . 0.0 111.733 -178.854 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 713' ' ' PHE . . . . . 0.426 ' O ' HG21 ' A' ' 717' ' ' VAL . 85.1 t80 -60.38 -49.74 76.4 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 120.874 0.369 . . . . 0.0 110.732 -179.994 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 714' ' ' LEU . . . . . . . . . . . . . 91.2 mt -64.39 -37.83 88.9 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.372 179.555 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 715' ' ' GLN . . . . . . . . . . . . . 99.3 mm-40 -63.68 -42.16 98.05 Favored 'General case' 0 CA--C 1.53 0.187 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.672 179.317 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 716' ' ' GLN . . . . . . . . . . . . . 30.6 mm100 -65.8 -40.39 91.85 Favored 'General case' 0 C--O 1.234 0.259 0 CA-C-N 116.431 -0.35 . . . . 0.0 110.652 179.19 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 717' ' ' VAL . . . . . 0.426 HG21 ' O ' ' A' ' 713' ' ' PHE . 65.7 t -62.9 -44.14 99.41 Favored 'Isoleucine or valine' 0 C--O 1.232 0.152 0 N-CA-C 109.831 -0.433 . . . . 0.0 109.831 178.934 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 718' ' ' THR . . . . . . . . . . . . . 90.7 m -61.73 -45.19 94.99 Favored 'General case' 0 CA--C 1.531 0.216 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.677 179.255 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 719' ' ' MET . . . . . . . . . . . . . 39.0 mmt -63.84 -41.09 97.9 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-N 116.727 -0.215 . . . . 0.0 110.482 178.839 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 720' ' ' GLY . . . . . . . . . . . . . . . -64.5 -42.76 97.36 Favored Glycine 0 N--CA 1.452 -0.26 0 C-N-CA 120.342 -0.932 . . . . 0.0 111.248 177.941 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 721' ' ' LEU . . . . . . . . . . . . . 64.4 tp -64.75 -48.88 72.94 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 122.935 0.494 . . . . 0.0 111.163 179.002 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 722' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 33.69 -96.76 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.783 0 N-CA-C 115.132 1.531 . . . . 0.0 115.132 -179.784 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 723' ' ' SER . . . . . . . . . . . . . 57.4 m -93.39 -2.72 54.38 Favored 'General case' 0 N--CA 1.467 0.42 0 N-CA-C 114.12 1.156 . . . . 0.0 114.12 -176.942 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 724' ' ' LEU . . . . . . . . . . . . . 64.9 tp -62.35 -45.74 91.83 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-O 120.891 0.376 . . . . 0.0 111.194 179.771 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 725' ' ' ALA . . . . . . . . . . . . . . . -152.46 153.19 33.04 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.678 -179.888 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 726' ' ' THR . . . . . . . . . . . . . 67.0 p -127.52 159.27 35.08 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.823 179.921 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 727' ' ' SER . . . . . . . . . . . . . 90.1 p -72.55 159.39 33.99 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.081 179.838 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 728' ' ' ALA . . . . . . . . . . . . . . . -147.88 153.82 39.61 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.645 -179.908 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 729' ' ' GLN . . . . . . . . . . . . . 96.7 mt-30 . . . . . 0 C--O 1.248 1.025 0 CA-C-O 118.29 -0.862 . . . . 0.0 110.781 -179.999 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 613' ' ' GLU . . . . . . . . . . . . . 93.6 mt-10 . . . . . 0 N--CA 1.488 1.427 0 CA-C-O 121.051 0.453 . . . . 0.0 110.465 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 614' ' ' GLY . . . . . . . . . . . . . . . -175.71 169.22 41.89 Favored Glycine 0 N--CA 1.449 -0.446 0 CA-C-N 115.808 -0.633 . . . . 0.0 111.991 179.768 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 615' ' ' ARG . . . . . . . . . . . . . 83.9 mtp180 -117.29 132.63 56.57 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.011 0.434 . . . . 0.0 111.066 -179.971 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 616' ' ' ILE . . . . . . . . . . . . . 87.0 mt -125.18 134.31 67.19 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 115.537 -0.756 . . . . 0.0 109.995 179.361 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 617' ' ' VAL . . . . . . . . . . . . . 95.3 t -105.91 126.26 61.35 Favored 'Isoleucine or valine' 0 C--O 1.235 0.305 0 CA-C-O 121.043 0.449 . . . . 0.0 109.832 179.878 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 618' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -109.2 126.01 52.82 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.773 -0.648 . . . . 0.0 110.624 -178.536 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 619' ' ' VAL . . . . . . . . . . . . . 62.4 t -117.95 119.59 61.97 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 N-CA-C 109.492 -0.559 . . . . 0.0 109.492 179.704 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 620' ' ' SER . . . . . . . . . . . . . 26.9 t -166.27 139.72 4.11 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.399 -179.351 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 621' ' ' GLU . . . . . . . . . . . . . 88.2 tt0 -77.11 -28.24 54.35 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.579 -0.737 . . . . 0.0 111.125 178.977 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 622' ' ' ASP . . . . . . . . . . . . . 56.8 t0 -83.43 110.14 17.92 Favored 'General case' 0 C--O 1.234 0.287 0 CA-C-O 120.946 0.403 . . . . 0.0 111.135 -178.473 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 623' ' ' GLU . . . . . . . . . . . . . 51.3 mp0 -63.62 -39.71 95.05 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-N 115.606 -0.725 . . . . 0.0 112.206 -179.776 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 624' ' ' ALA . . . . . . . . . . . . . . . -61.27 -43.95 98.03 Favored 'General case' 0 N--CA 1.463 0.179 0 N-CA-C 112.03 0.382 . . . . 0.0 112.03 -178.668 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 625' ' ' THR . . . . . 0.469 ' O ' HG21 ' A' ' 629' ' ' ILE . 85.4 m -70.26 -41.14 73.87 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.86 0.362 . . . . 0.0 110.291 179.542 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 626' ' ' SER . . . . . . . . . . . . . 66.7 m -62.46 -41.92 99.1 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.628 -0.714 . . . . 0.0 112.342 -178.564 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 627' ' ' THR . . . . . . . . . . . . . 40.1 p -68.56 -40.49 80.6 Favored 'General case' 0 N--CA 1.464 0.248 0 N-CA-C 112.614 0.598 . . . . 0.0 112.614 -179.729 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 628' ' ' LEU . . . . . . . . . . . . . 63.0 tp -64.41 -47.07 80.56 Favored 'General case' 0 N--CA 1.464 0.227 0 N-CA-C 111.952 0.353 . . . . 0.0 111.952 -179.509 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 629' ' ' ILE . . . . . 0.469 HG21 ' O ' ' A' ' 625' ' ' THR . 20.2 tt -70.6 -34.0 55.45 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.425 0 N-CA-C 112.36 0.504 . . . . 0.0 112.36 -179.273 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 630' ' ' CYS . . . . . . . . . . . . . 51.1 t -60.63 -44.93 95.79 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.427 -179.434 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 631' ' ' SER . . . . . . . . . . . . . 47.2 t -61.64 -42.36 98.79 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.079 -179.663 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 632' ' ' ILE . . . . . . . . . . . . . 97.2 mt -61.58 -48.1 90.31 Favored 'Isoleucine or valine' 0 C--O 1.235 0.312 0 CA-C-N 116.472 -0.331 . . . . 0.0 110.857 179.98 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 633' ' ' LEU . . . . . . . . . . . . . 80.6 mt -66.07 -39.81 90.37 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.92 179.654 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 634' ' ' THR . . . . . 0.51 ' HA ' ' O ' ' A' ' 638' ' ' TYR . 89.5 m -65.25 -40.44 94.01 Favored 'General case' 0 CA--C 1.529 0.151 0 CA-C-O 120.708 0.289 . . . . 0.0 110.671 -179.946 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 635' ' ' THR . . . . . . . . . . . . . 91.9 m -59.44 -38.4 80.63 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.226 179.149 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 636' ' ' ALA . . . . . . . . . . . . . . . -63.34 -17.62 62.77 Favored 'General case' 0 CA--C 1.534 0.327 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.465 178.963 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 637' ' ' GLY . . . . . . . . . . . . . . . 109.33 4.85 30.56 Favored Glycine 0 C--N 1.333 0.403 0 C-N-CA 121.06 -0.591 . . . . 0.0 113.332 179.695 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 638' ' ' TYR . . . . . 0.51 ' O ' ' HA ' ' A' ' 634' ' ' THR . 93.5 m-85 -100.9 142.61 32.13 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.739 0.304 . . . . 0.0 111.582 179.879 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 639' ' ' GLN . . . . . . . . . . . . . 75.1 mt-30 -86.25 135.27 33.62 Favored 'General case' 0 CA--C 1.519 -0.233 0 N-CA-C 109.829 -0.434 . . . . 0.0 109.829 179.206 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 640' ' ' VAL . . . . . . . . . . . . . 60.6 t -118.04 129.96 73.63 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 N-CA-C 112.333 0.494 . . . . 0.0 112.333 -179.159 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 641' ' ' ILE . . . . . . . . . . . . . 42.4 mm -109.83 117.3 54.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 N-CA-C 108.174 -1.047 . . . . 0.0 108.174 178.308 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 642' ' ' TRP . . . . . . . . . . . . . 26.9 t90 -92.25 128.08 37.97 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.318 0.58 . . . . 0.0 112.439 -178.321 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 643' ' ' LEU . . . . . . . . . . . . . 2.8 mp -122.04 134.46 54.79 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.304 -0.862 . . . . 0.0 110.492 179.014 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 644' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -111.61 36.26 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.592 -0.276 . . . . 0.0 111.226 179.952 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 645' ' ' ASP . . . . . . . . . . . . . 20.3 t0 -151.32 -34.66 0.14 Allowed 'General case' 0 N--CA 1.469 0.515 0 N-CA-C 112.508 0.558 . . . . 0.0 112.508 -178.502 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 646' ' ' GLY . . . . . . . . . . . . . . . 74.64 28.49 63.14 Favored Glycine 0 CA--C 1.521 0.443 0 C-N-CA 120.775 -0.726 . . . . 0.0 113.934 179.821 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 647' ' ' GLU . . . . . . . . . . . . . 58.9 mm-40 -65.16 120.56 12.93 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 117.329 0.564 . . . . 0.0 110.837 179.655 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 648' ' ' VAL . . . . . . . . . . . . . 79.3 t -61.33 -41.26 89.09 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-N 115.168 -0.924 . . . . 0.0 111.824 -179.097 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 649' ' ' GLU . . . . . . . . . . . . . 79.5 mm-40 -61.15 -42.41 98.49 Favored 'General case' 0 C--N 1.332 -0.183 0 C-N-CA 120.76 -0.376 . . . . 0.0 110.148 179.968 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 650' ' ' ARG . . . . . . . . . . . . . 89.9 mmt-85 -70.91 -40.71 72.0 Favored 'General case' 0 CA--C 1.53 0.175 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.47 178.513 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 651' ' ' LEU . . . . . . . . . . . . . 84.3 mt -64.3 -41.12 97.01 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.459 179.01 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 652' ' ' LEU . . . . . . . . . . . . . 61.6 tp -64.19 -43.3 95.52 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.838 178.765 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 653' ' ' ALA . . . . . . . . . . . . . . . -63.29 -39.87 95.79 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.396 -179.862 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 654' ' ' LEU . . . . . . . . . . . . . 75.3 mt -100.76 30.36 4.04 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.679 -0.691 . . . . 0.0 110.02 179.925 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 655' ' ' THR . . . . . 0.419 HG21 ' O ' ' A' ' 655' ' ' THR . 6.7 t -46.4 109.89 1.1 Allowed Pre-proline 0 CA--C 1.536 0.436 0 CA-C-O 121.982 0.896 . . . . 0.0 113.314 -177.949 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 656' ' ' PRO . . . . . . . . . . . . . 27.8 Cg_endo -92.3 -174.8 0.55 Allowed 'Trans proline' 0 C--N 1.344 0.339 0 C-N-CA 124.028 3.152 . . . . 0.0 111.765 178.636 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 657' ' ' ILE . . . . . . . . . . . . . 21.5 pt -80.45 -25.45 11.36 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-O 121.237 0.541 . . . . 0.0 109.82 178.158 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 658' ' ' ALA . . . . . 0.415 ' HA ' ' O ' ' A' ' 687' ' ' LYS . . . -157.43 151.67 24.81 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.321 -0.854 . . . . 0.0 111.245 -179.816 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 659' ' ' VAL . . . . . . . . . . . . . 16.3 m -121.44 145.72 27.58 Favored 'Isoleucine or valine' 0 C--O 1.235 0.33 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.737 178.833 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 660' ' ' LEU . . . . . . . . . . . . . 6.0 mp -116.72 119.83 36.69 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.227 179.577 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 661' ' ' LEU . . . . . . . . . . . . . 69.0 mt -109.18 114.25 27.79 Favored 'General case' 0 C--N 1.328 -0.355 0 C-N-CA 120.624 -0.43 . . . . 0.0 109.946 -179.932 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 662' ' ' ALA . . . . . . . . . . . . . . . -109.71 116.93 32.61 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 111.972 0.36 . . . . 0.0 111.972 -179.335 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 663' ' ' GLU . . . . . 0.502 ' HA ' ' C ' ' A' ' 664' ' ' PRO . 24.4 pt-20 -68.67 148.7 98.06 Favored Pre-proline 0 CA--C 1.538 0.488 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.747 178.782 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 664' ' ' PRO . . . . . 0.502 ' C ' ' HA ' ' A' ' 663' ' ' GLU . 43.4 Cg_endo -66.99 139.71 47.29 Favored 'Cis proline' 0 C--N 1.35 0.632 0 C-N-CA 123.351 -1.52 . . . . 0.0 112.451 -0.286 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 665' ' ' PHE . . . . . . . . . . . . . 56.1 m-85 -80.72 124.72 29.27 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.774 -179.234 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 666' ' ' SER . . . . . . . . . . . . . 78.6 p -64.48 -35.25 80.35 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.214 179.619 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 667' ' ' TYR . . . . . . . . . . . . . 53.4 t80 -67.58 -22.05 65.4 Favored 'General case' 0 CA--C 1.535 0.37 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.207 179.206 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 668' ' ' GLY . . . . . . . . . . . . . . . 101.91 -103.79 2.55 Favored Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.672 -0.775 . . . . 0.0 112.469 -179.187 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 669' ' ' ASP . . . . . . . . . . . . . 37.5 t70 -80.46 109.53 15.05 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.033 0.444 . . . . 0.0 110.738 -179.489 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 670' ' ' VAL . . . . . 0.408 ' O ' HG21 ' A' ' 674' ' ' VAL . 11.1 p -63.94 -30.96 51.37 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.449 0 N-CA-C 113.208 0.818 . . . . 0.0 113.208 -179.201 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 671' ' ' GLN . . . . . . . . . . . . . 57.3 mt-30 -62.06 -42.83 99.6 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-O 120.755 0.312 . . . . 0.0 111.471 -178.815 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 672' ' ' GLU . . . . . . . . . . . . . 95.2 mt-10 -65.14 -40.35 94.3 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.906 179.265 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 673' ' ' LEU . . . . . . . . . . . . . 61.8 tp -63.49 -45.35 91.13 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.127 179.518 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 674' ' ' VAL . . . . . 0.408 HG21 ' O ' ' A' ' 670' ' ' VAL . 62.5 t -64.16 -44.98 97.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 115.59 -0.732 . . . . 0.0 110.103 179.521 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 675' ' ' ASP . . . . . . . . . . . . . 37.2 t70 -60.06 -41.34 92.15 Favored 'General case' 0 CA--C 1.52 -0.189 0 CA-C-N 116.086 -0.507 . . . . 0.0 110.912 179.344 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 676' ' ' GLN . . . . . 0.459 ' O ' ' HG3' ' A' ' 680' ' ' ARG . 55.9 mt-30 -68.52 -41.47 79.91 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.485 -0.325 . . . . 0.0 111.119 -179.485 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 677' ' ' LEU . . . . . . . . . . . . . 87.7 mt -69.87 -42.26 73.71 Favored 'General case' 0 C--O 1.22 -0.479 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.078 179.952 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 678' ' ' ARG . . . . . . . . . . . . . 80.2 ttt180 -64.67 -38.67 91.79 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-O 121.296 0.569 . . . . 0.0 110.667 -179.701 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 679' ' ' GLN . . . . . . . . . . . . . 53.1 tt0 -63.06 -38.57 91.71 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.57 -0.741 . . . . 0.0 110.256 179.307 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 680' ' ' ARG . . . . . 0.459 ' HG3' ' O ' ' A' ' 676' ' ' GLN . 91.5 mtt-85 -85.12 -35.04 22.02 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 115.983 -0.553 . . . . 0.0 112.306 -179.326 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 681' ' ' CYS . . . . . 0.552 ' SG ' HD22 ' A' ' 686' ' ' LEU . 18.0 p -133.11 136.79 46.03 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 121.321 0.582 . . . . 0.0 111.202 -179.185 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 682' ' ' THR . . . . . . . . . . . . . 52.6 p -73.09 159.09 86.01 Favored Pre-proline 0 C--N 1.32 -0.684 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.367 179.34 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 683' ' ' PRO . . . . . . . . . . . . . 76.9 Cg_exo -55.3 -32.29 80.5 Favored 'Trans proline' 0 C--N 1.349 0.556 0 C-N-CA 122.708 2.272 . . . . 0.0 112.408 179.32 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 684' ' ' GLU . . . . . 0.405 ' O ' HD11 ' A' ' 724' ' ' LEU . 97.5 mt-10 -70.34 -38.15 74.78 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.95 179.739 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 685' ' ' GLN . . . . . . . . . . . . . 64.7 tt0 -70.66 -41.88 71.53 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.787 -179.48 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 686' ' ' LEU . . . . . 0.552 HD22 ' SG ' ' A' ' 681' ' ' CYS . 60.2 tp -135.04 120.82 19.58 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.526 -179.204 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 687' ' ' LYS . . . . . 0.415 ' O ' ' HA ' ' A' ' 658' ' ' ALA . 0.9 OUTLIER -85.11 143.59 28.75 Favored 'General case' 0 CA--C 1.52 -0.206 0 N-CA-C 109.576 -0.528 . . . . 0.0 109.576 178.534 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 688' ' ' ILE . . . . . . . . . . . . . 76.1 mt -123.36 121.08 61.91 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.77 0 CA-C-O 121.318 0.58 . . . . 0.0 111.327 -178.638 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 689' ' ' PHE . . . . . . . . . . . . . 98.6 m-85 -116.68 141.12 48.61 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 114.965 -1.016 . . . . 0.0 109.523 178.541 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 690' ' ' ILE . . . . . . . . . . . . . 19.9 tt -122.32 136.27 59.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-O 121.25 0.548 . . . . 0.0 111.369 -179.625 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 691' ' ' LEU . . . . . 0.428 ' HG ' ' HB ' ' A' ' 704' ' ' ILE . 1.3 mp -105.22 127.86 53.14 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.609 -0.723 . . . . 0.0 111.053 -179.712 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 692' ' ' GLY . . . . . 0.593 ' O ' ' HA ' ' A' ' 705' ' ' PRO . . . 168.55 179.66 40.97 Favored Glycine 0 N--CA 1.443 -0.857 0 CA-C-N 115.492 -0.776 . . . . 0.0 113.122 179.64 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 693' ' ' SER . . . . . . . . . . . . . 90.0 p -73.24 -21.63 60.59 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.058 0.456 . . . . 0.0 110.955 179.423 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 694' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -126.4 126.88 44.58 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.319 -179.923 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 695' ' ' GLY . . . . . 0.532 ' HA3' ' CB ' ' A' ' 703' ' ' TYR . . . -109.35 10.48 33.37 Favored Glycine 0 N--CA 1.448 -0.533 0 C-N-CA 120.692 -0.766 . . . . 0.0 113.152 -179.958 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 696' ' ' ASN . . . . . . . . . . . . . 65.7 t30 -84.12 73.1 10.44 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.144 0.497 . . . . 0.0 111.444 -179.236 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 697' ' ' TYR . . . . . . . . . . . . . 97.5 m-85 -129.91 148.28 51.76 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.827 -0.624 . . . . 0.0 109.737 179.152 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 698' ' ' GLN . . . . . . . . . . . . . 99.7 mm-40 -85.96 146.94 26.46 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.127 -179.365 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 699' ' ' GLY . . . . . . . . . . . . . . . 92.96 3.65 65.62 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.799 -0.715 . . . . 0.0 113.864 179.356 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 700' ' ' VAL . . . . . . . . . . . . . 26.1 m -119.46 147.77 22.86 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 117.467 0.634 . . . . 0.0 109.985 179.25 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 701' ' ' ASP . . . . . 0.538 ' O ' ' HD2' ' A' ' 702' ' ' ARG . 28.1 t0 -81.91 -41.31 21.06 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.764 -0.653 . . . . 0.0 111.739 -179.746 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 702' ' ' ARG . . . . . 0.538 ' HD2' ' O ' ' A' ' 701' ' ' ASP . 1.2 mpt_? -141.98 169.35 17.75 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.63 -178.592 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 703' ' ' TYR . . . . . 0.532 ' CB ' ' HA3' ' A' ' 695' ' ' GLY . 53.1 p90 -129.02 147.16 50.86 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.038 179.384 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 704' ' ' ILE . . . . . 0.428 ' HB ' ' HG ' ' A' ' 691' ' ' LEU . 44.5 mm -122.19 100.66 42.16 Favored Pre-proline 0 C--N 1.326 -0.448 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.868 -179.929 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 705' ' ' PRO . . . . . 0.593 ' HA ' ' O ' ' A' ' 692' ' ' GLY . 88.3 Cg_endo -76.55 149.24 30.38 Favored 'Trans proline' 0 CA--C 1.531 0.373 0 C-N-CA 122.63 2.22 . . . . 0.0 113.375 179.899 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 706' ' ' LEU . . . . . 0.594 ' HA ' ' C ' ' A' ' 707' ' ' PRO . 7.2 mp -112.13 151.52 43.7 Favored Pre-proline 0 C--N 1.33 -0.249 0 CA-C-N 115.887 -0.597 . . . . 0.0 109.539 178.509 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 707' ' ' PRO . . . . . 0.594 ' C ' ' HA ' ' A' ' 706' ' ' LEU . 43.3 Cg_exo -60.42 135.88 14.77 Favored 'Cis proline' 0 C--N 1.352 0.722 0 C-N-CA 123.849 -1.313 . . . . 0.0 113.071 -0.11 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 708' ' ' ILE . . . . . . . . . . . . . 2.8 pt -69.97 128.29 33.1 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-N 115.64 -0.709 . . . . 0.0 112.243 179.368 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 709' ' ' HIS . . . . . . . . . . . . . 67.3 m80 -99.86 115.56 65.46 Favored Pre-proline 0 C--N 1.322 -0.625 0 N-CA-C 108.208 -1.034 . . . . 0.0 108.208 177.374 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 710' ' ' PRO . . . . . . . . . . . . . 21.5 Cg_endo -59.55 -29.94 91.17 Favored 'Trans proline' 0 C--N 1.345 0.377 0 C-N-CA 122.842 2.361 . . . . 0.0 114.349 -177.297 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 711' ' ' GLU . . . . . . . . . . . . . 24.5 pt-20 -70.3 -32.21 69.88 Favored 'General case' 0 CA--C 1.532 0.268 0 N-CA-C 112.149 0.426 . . . . 0.0 112.149 -179.443 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 712' ' ' SER . . . . . . . . . . . . . 36.8 m -99.9 -24.02 14.78 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.759 -0.201 . . . . 0.0 111.395 -179.382 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 713' ' ' PHE . . . . . 0.421 ' O ' HG23 ' A' ' 717' ' ' VAL . 72.6 t80 -59.88 -49.17 78.74 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.262 -179.473 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 714' ' ' LEU . . . . . . . . . . . . . 8.1 mp -64.12 -39.86 94.95 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-O 120.842 0.353 . . . . 0.0 110.577 179.626 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 715' ' ' GLN . . . . . . . . . . . . . 24.1 tm0? -62.08 -44.09 97.43 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.694 -0.685 . . . . 0.0 110.928 179.449 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 716' ' ' GLN . . . . . . . . . . . . . 91.2 mm-40 -66.09 -41.89 90.05 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 116.566 -0.288 . . . . 0.0 111.496 179.426 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 717' ' ' VAL . . . . . 0.707 ' O ' ' HG ' ' A' ' 721' ' ' LEU . 68.4 t -63.99 -45.26 97.27 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.1 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.505 179.474 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 718' ' ' THR . . . . . . . . . . . . . 89.2 m -60.94 -42.7 98.69 Favored 'General case' 0 C--O 1.232 0.178 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.663 179.598 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 719' ' ' MET . . . . . . . . . . . . . 11.0 tpt -60.93 -41.55 96.43 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.342 179.299 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 720' ' ' GLY . . . . . . . . . . . . . . . -72.76 -17.51 78.29 Favored Glycine 0 CA--C 1.522 0.501 0 C-N-CA 120.938 -0.648 . . . . 0.0 113.345 179.493 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 721' ' ' LEU . . . . . 0.707 ' HG ' ' O ' ' A' ' 717' ' ' VAL . 92.9 mt -84.84 -11.08 56.43 Favored 'General case' 0 N--CA 1.467 0.423 0 CA-C-N 117.038 0.419 . . . . 0.0 111.539 179.964 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 722' ' ' THR . . . . . . . . . . . . . 68.7 p -68.63 162.34 26.17 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.052 -179.687 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 723' ' ' SER . . . . . . . . . . . . . 50.5 m 63.7 28.43 14.94 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-N 115.674 -0.694 . . . . 0.0 111.038 -178.901 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 724' ' ' LEU . . . . . 0.405 HD11 ' O ' ' A' ' 684' ' ' GLU . 39.9 tp -135.96 -70.93 0.47 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.288 179.542 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 725' ' ' ALA . . . . . . . . . . . . . . . -153.44 156.71 38.71 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.498 -179.965 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 726' ' ' THR . . . . . . . . . . . . . 72.1 p -81.01 159.09 24.93 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.729 0.3 . . . . 0.0 111.087 179.664 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 727' ' ' SER . . . . . . . . . . . . . 40.3 t -150.85 146.3 26.25 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.49 -0.323 . . . . 0.0 110.254 -179.963 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 728' ' ' ALA . . . . . . . . . . . . . . . -149.14 152.6 36.37 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.461 -0.336 . . . . 0.0 110.761 -179.908 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 729' ' ' GLN . . . . . . . . . . . . . 96.2 mt-30 . . . . . 0 C--O 1.25 1.083 0 CA-C-O 118.205 -0.902 . . . . 0.0 110.724 179.887 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 613' ' ' GLU . . . . . . . . . . . . . 58.1 mt-10 . . . . . 0 N--CA 1.487 1.391 0 CA-C-O 121.045 0.45 . . . . 0.0 110.799 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 614' ' ' GLY . . . . . . . . . . . . . . . -83.64 65.19 4.16 Favored Glycine 0 N--CA 1.453 -0.182 0 C-N-CA 120.961 -0.638 . . . . 0.0 112.605 -179.865 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 615' ' ' ARG . . . . . . . . . . . . . 88.1 mtm180 -111.98 130.16 55.95 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.91 0.386 . . . . 0.0 110.722 -179.99 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 616' ' ' ILE . . . . . . . . . . . . . 84.3 mt -123.48 133.64 68.61 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.034 179.562 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 617' ' ' VAL . . . . . . . . . . . . . 90.9 t -107.24 127.72 62.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-O 120.954 0.407 . . . . 0.0 110.039 179.999 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 618' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -109.65 130.72 55.49 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.919 -0.582 . . . . 0.0 111.117 -178.714 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 619' ' ' VAL . . . . . . . . . . . . . 67.4 t -118.88 118.24 57.06 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-N 115.986 -0.552 . . . . 0.0 109.718 179.447 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 620' ' ' SER . . . . . . . . . . . . . 82.7 p -168.09 165.33 13.44 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.524 -0.762 . . . . 0.0 111.118 -179.418 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 621' ' ' GLU . . . . . 0.417 ' OE2' ' HA ' ' A' ' 666' ' ' SER . 99.4 mt-10 -104.65 -9.92 17.88 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.472 -0.786 . . . . 0.0 111.278 178.205 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 622' ' ' ASP . . . . . . . . . . . . . 57.2 t0 -96.81 108.17 20.79 Favored 'General case' 0 CA--C 1.53 0.186 0 CA-C-O 121.097 0.475 . . . . 0.0 111.577 -177.923 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 623' ' ' GLU . . . . . . . . . . . . . 51.1 mp0 -65.56 -38.27 89.08 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-N 115.51 -0.768 . . . . 0.0 111.944 179.199 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 624' ' ' ALA . . . . . . . . . . . . . . . -60.33 -45.17 94.38 Favored 'General case' 0 N--CA 1.465 0.318 0 N-CA-C 112.825 0.676 . . . . 0.0 112.825 -178.029 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 625' ' ' THR . . . . . . . . . . . . . 21.9 p -72.04 -32.61 67.27 Favored 'General case' 0 CA--C 1.516 -0.344 0 C-N-CA 120.491 -0.484 . . . . 0.0 110.616 179.464 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 626' ' ' SER . . . . . 0.406 ' O ' HG21 ' A' ' 629' ' ' ILE . 68.0 m -64.83 -41.54 95.67 Favored 'General case' 0 N--CA 1.451 -0.41 0 CA-C-N 115.473 -0.785 . . . . 0.0 111.731 -179.425 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 627' ' ' THR . . . . . . . . . . . . . 72.7 p -65.41 -40.69 93.69 Favored 'General case' 0 N--CA 1.465 0.309 0 N-CA-C 112.033 0.383 . . . . 0.0 112.033 -179.654 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 628' ' ' LEU . . . . . . . . . . . . . 61.7 tp -69.55 -43.44 72.94 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.929 0.395 . . . . 0.0 111.507 179.588 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 629' ' ' ILE . . . . . 0.406 HG21 ' O ' ' A' ' 626' ' ' SER . 1.2 tp -70.03 -37.53 72.61 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.521 0 CA-C-N 115.968 -0.56 . . . . 0.0 112.375 -178.417 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 630' ' ' CYS . . . . . . . . . . . . . 88.3 m -64.55 -39.3 93.5 Favored 'General case' 0 N--CA 1.464 0.239 0 N-CA-C 111.706 0.261 . . . . 0.0 111.706 -179.618 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 631' ' ' SER . . . . . . . . . . . . . 67.4 m -61.7 -42.9 99.56 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.447 -0.342 . . . . 0.0 111.036 -179.169 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 632' ' ' ILE . . . . . . . . . . . . . 97.0 mt -63.8 -47.85 89.04 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.253 0 CA-C-O 121.057 0.456 . . . . 0.0 110.759 179.573 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 633' ' ' LEU . . . . . . . . . . . . . 83.9 mt -66.34 -40.43 89.84 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-N 115.697 -0.683 . . . . 0.0 112.372 -179.499 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 634' ' ' THR . . . . . 0.508 ' HA ' ' O ' ' A' ' 638' ' ' TYR . 91.0 m -65.93 -39.83 90.86 Favored 'General case' 0 CA--C 1.53 0.182 0 CA-C-O 120.682 0.277 . . . . 0.0 110.999 -179.741 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 635' ' ' THR . . . . . . . . . . . . . 93.6 m -58.57 -38.19 77.36 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.518 179.356 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 636' ' ' ALA . . . . . . . . . . . . . . . -68.66 -9.69 51.68 Favored 'General case' 0 CA--C 1.535 0.387 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.466 179.228 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 637' ' ' GLY . . . . . . . . . . . . . . . 101.91 8.48 45.09 Favored Glycine 0 C--N 1.334 0.437 0 C-N-CA 121.049 -0.596 . . . . 0.0 113.494 179.321 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 638' ' ' TYR . . . . . 0.508 ' O ' ' HA ' ' A' ' 634' ' ' THR . 98.8 m-85 -100.56 142.7 31.67 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.956 0.378 . . . . 0.0 111.592 -179.796 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 639' ' ' GLN . . . . . . . . . . . . . 78.5 mt-30 -92.58 134.91 34.54 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 109.525 -0.546 . . . . 0.0 109.525 178.936 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 640' ' ' VAL . . . . . . . . . . . . . 58.5 t -118.24 130.51 73.0 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 N-CA-C 112.391 0.515 . . . . 0.0 112.391 -178.963 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 641' ' ' ILE . . . . . . . . . . . . . 47.9 mm -111.6 118.99 58.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 N-CA-C 108.249 -1.019 . . . . 0.0 108.249 178.066 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 642' ' ' TRP . . . . . . . . . . . . . 75.5 t90 -99.68 128.04 45.79 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 112.689 0.626 . . . . 0.0 112.689 -178.046 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 643' ' ' LEU . . . . . . . . . . . . . 89.0 mt -119.47 136.76 54.18 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.332 -0.849 . . . . 0.0 110.264 178.97 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 644' ' ' VAL . . . . . . . . . . . . . 7.5 p -103.91 23.31 2.17 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.572 0 CA-C-O 121.4 0.619 . . . . 0.0 111.348 -179.409 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 645' ' ' ASP . . . . . . . . . . . . . 16.8 t0 -143.17 -33.75 0.44 Allowed 'General case' 0 N--CA 1.471 0.596 0 N-CA-C 113.012 0.745 . . . . 0.0 113.012 -178.239 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 646' ' ' GLY . . . . . . . . . . . . . . . 74.6 29.26 61.83 Favored Glycine 0 CA--C 1.523 0.532 0 C-N-CA 120.846 -0.692 . . . . 0.0 114.805 179.41 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 647' ' ' GLU . . . . . . . . . . . . . 93.8 mt-10 -63.45 126.5 27.68 Favored 'General case' 0 N--CA 1.461 0.081 0 CA-C-N 117.753 0.776 . . . . 0.0 111.102 179.68 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 648' ' ' VAL . . . . . . . . . . . . . 79.5 t -61.86 -39.74 84.59 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-N 114.826 -1.079 . . . . 0.0 111.504 -179.637 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 649' ' ' GLU . . . . . . . . . . . . . 50.4 mp0 -60.64 -42.52 97.09 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.872 0.368 . . . . 0.0 110.017 179.996 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 650' ' ' ARG . . . . . . . . . . . . . 16.2 mmp_? -70.39 -40.69 73.8 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.394 178.486 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 651' ' ' LEU . . . . . . . . . . . . . 81.0 mt -64.17 -41.63 97.05 Favored 'General case' 0 N--CA 1.462 0.173 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.395 178.977 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 652' ' ' LEU . . . . . . . . . . . . . 61.4 tp -65.29 -43.12 92.17 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.911 178.855 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 653' ' ' ALA . . . . . . . . . . . . . . . -62.86 -39.57 94.81 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.917 -179.969 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 654' ' ' LEU . . . . . . . . . . . . . 75.1 mt -101.24 29.8 4.53 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.094 -179.468 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 655' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -35.03 105.05 0.27 Allowed Pre-proline 0 N--CA 1.471 0.613 0 O-C-N 124.495 1.122 . . . . 0.0 113.71 -179.371 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 656' ' ' PRO . . . . . . . . . . . . . 29.7 Cg_endo -92.95 -176.29 0.6 Allowed 'Trans proline' 0 C--N 1.344 0.339 0 C-N-CA 123.732 2.955 . . . . 0.0 112.173 178.758 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 657' ' ' ILE . . . . . . . . . . . . . 19.7 pt -83.16 -26.51 7.88 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-O 121.303 0.573 . . . . 0.0 109.928 178.042 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 658' ' ' ALA . . . . . 0.415 ' HA ' ' O ' ' A' ' 687' ' ' LYS . . . -158.33 152.97 24.7 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.171 -0.922 . . . . 0.0 111.033 -179.738 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 659' ' ' VAL . . . . . . . . . . . . . 20.5 m -122.34 146.55 27.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-O 121.191 0.52 . . . . 0.0 110.964 178.966 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 660' ' ' LEU . . . . . . . . . . . . . 14.4 mt -115.06 119.45 36.5 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.42 -0.809 . . . . 0.0 110.17 179.403 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 661' ' ' LEU . . . . . . . . . . . . . 70.8 mt -106.36 111.34 23.88 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 109.018 -0.734 . . . . 0.0 109.018 179.408 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 662' ' ' ALA . . . . . . . . . . . . . . . -107.03 130.93 54.58 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 112.943 0.72 . . . . 0.0 112.943 -178.394 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 663' ' ' GLU . . . . . . . . . . . . . 8.9 mm-40 -68.37 139.08 91.87 Favored Pre-proline 0 CA--C 1.533 0.32 0 CA-C-N 115.635 -0.711 . . . . 0.0 110.889 177.768 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 664' ' ' PRO . . . . . . . . . . . . . 81.0 Cg_endo -77.57 142.0 69.58 Favored 'Cis proline' 0 C--N 1.349 0.569 0 C-N-CA 123.403 -1.499 . . . . 0.0 112.334 -1.366 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 665' ' ' PHE . . . . . . . . . . . . . 29.0 m-85 -74.58 127.35 32.89 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.399 -179.908 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 666' ' ' SER . . . . . 0.417 ' HA ' ' OE2' ' A' ' 621' ' ' GLU . 78.1 p -69.47 -38.19 77.62 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.568 179.266 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 667' ' ' TYR . . . . . . . . . . . . . 55.4 t80 -68.8 -23.64 64.31 Favored 'General case' 0 CA--C 1.534 0.331 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.506 179.626 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 668' ' ' GLY . . . . . . . . . . . . . . . 100.29 -104.33 2.78 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.602 -0.809 . . . . 0.0 112.331 -179.404 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 669' ' ' ASP . . . . . . . . . . . . . 37.6 t70 -82.19 109.26 16.32 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.874 0.369 . . . . 0.0 110.61 -179.868 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 670' ' ' VAL . . . . . 0.449 ' O ' HG21 ' A' ' 674' ' ' VAL . 7.5 m -70.81 -23.28 23.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 N-CA-C 113.675 0.991 . . . . 0.0 113.675 -179.048 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 671' ' ' GLN . . . . . . . . . . . . . 55.3 mt-30 -61.33 -42.86 99.38 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 118.149 0.431 . . . . 0.0 110.439 -179.366 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 672' ' ' GLU . . . . . . . . . . . . . 95.8 mt-10 -66.57 -39.85 88.67 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.347 178.386 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 673' ' ' LEU . . . . . . . . . . . . . 62.8 tp -63.51 -44.83 93.18 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.646 -0.706 . . . . 0.0 110.107 179.237 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 674' ' ' VAL . . . . . 0.449 HG21 ' O ' ' A' ' 670' ' ' VAL . 53.1 t -63.05 -43.68 99.14 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.21 0 CA-C-N 115.587 -0.733 . . . . 0.0 109.796 179.306 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 675' ' ' ASP . . . . . . . . . . . . . 37.3 t70 -59.91 -40.94 90.53 Favored 'General case' 0 CA--C 1.52 -0.178 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.335 178.955 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 676' ' ' GLN . . . . . 0.406 ' O ' ' HG2' ' A' ' 680' ' ' ARG . 55.6 mt-30 -70.32 -41.67 72.95 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.892 179.832 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 677' ' ' LEU . . . . . . . . . . . . . 85.3 mt -66.94 -42.0 86.01 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.888 179.394 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 678' ' ' ARG . . . . . . . . . . . . . 62.5 ttp180 -66.32 -38.66 88.2 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-O 121.333 0.587 . . . . 0.0 110.659 179.792 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 679' ' ' GLN . . . . . . . . . . . . . 53.6 tt0 -62.43 -38.93 91.62 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.215 -0.902 . . . . 0.0 110.674 -179.927 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 680' ' ' ARG . . . . . 0.406 ' HG2' ' O ' ' A' ' 676' ' ' GLN . 37.9 mmt180 -84.64 -43.29 14.53 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.384 -0.371 . . . . 0.0 111.24 -179.882 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 681' ' ' CYS . . . . . . . . . . . . . 73.8 m -127.89 130.31 48.33 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 120.89 0.376 . . . . 0.0 110.242 179.644 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 682' ' ' THR . . . . . 0.427 ' OG1' ' HG2' ' A' ' 684' ' ' GLU . 63.0 p -71.84 160.01 83.85 Favored Pre-proline 0 C--N 1.322 -0.607 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.854 -179.552 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 683' ' ' PRO . . . . . . . . . . . . . 76.5 Cg_exo -55.0 -30.07 67.88 Favored 'Trans proline' 0 C--N 1.35 0.642 0 C-N-CA 122.858 2.372 . . . . 0.0 112.811 179.877 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 684' ' ' GLU . . . . . 0.427 ' HG2' ' OG1' ' A' ' 682' ' ' THR . 10.8 pt-20 -75.83 -14.25 60.29 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.809 0.338 . . . . 0.0 110.998 179.817 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 685' ' ' GLN . . . . . . . . . . . . . 90.8 mt-30 -101.15 -40.04 7.38 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.505 -179.799 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 686' ' ' LEU . . . . . . . . . . . . . 59.9 tp -131.83 122.64 26.08 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.631 -179.145 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 687' ' ' LYS . . . . . 0.415 ' O ' ' HA ' ' A' ' 658' ' ' ALA . 46.9 mmtm -91.89 146.56 23.65 Favored 'General case' 0 CA--C 1.521 -0.147 0 CA-C-O 121.332 0.587 . . . . 0.0 110.917 178.736 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 688' ' ' ILE . . . . . . . . . . . . . 78.6 mt -123.18 122.58 65.76 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.761 0 CA-C-N 115.494 -0.776 . . . . 0.0 110.543 -179.385 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 689' ' ' PHE . . . . . . . . . . . . . 71.1 m-85 -122.51 147.23 46.61 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.34 -0.845 . . . . 0.0 110.197 179.561 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 690' ' ' ILE . . . . . . . . . . . . . 16.7 tt -122.3 135.96 60.7 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.326 0 CA-C-O 121.377 0.608 . . . . 0.0 112.26 -178.895 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 691' ' ' LEU . . . . . . . . . . . . . 79.8 mt -110.23 129.44 55.73 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-N 115.352 -0.84 . . . . 0.0 110.281 179.479 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 692' ' ' GLY . . . . . 0.697 ' O ' ' HA ' ' A' ' 705' ' ' PRO . . . 162.66 -178.09 38.54 Favored Glycine 0 N--CA 1.446 -0.68 0 C-N-CA 120.532 -0.842 . . . . 0.0 112.239 179.618 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 693' ' ' SER . . . . . . . . . . . . . 79.8 p -66.26 -36.54 83.25 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.973 0.416 . . . . 0.0 110.986 179.345 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 694' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -126.25 123.01 37.17 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.045 179.666 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 695' ' ' GLY . . . . . . . . . . . . . . . -112.52 18.12 22.99 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.8 -179.793 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 696' ' ' ASN . . . . . . . . . . . . . 65.2 t30 -82.05 72.94 9.11 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.189 0.519 . . . . 0.0 111.026 -179.46 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 697' ' ' TYR . . . . . . . . . . . . . 96.8 m-85 -130.71 149.81 52.18 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.632 -0.713 . . . . 0.0 109.66 179.527 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 698' ' ' GLN . . . . . . . . . . . . . 29.4 pt20 -79.93 150.05 30.65 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.959 -179.552 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 699' ' ' GLY . . . . . . . . . . . . . . . 93.34 2.42 65.83 Favored Glycine 0 N--CA 1.45 -0.425 0 C-N-CA 120.532 -0.842 . . . . 0.0 114.037 179.215 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 700' ' ' VAL . . . . . . . . . . . . . 24.3 m -117.58 141.94 34.06 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.255 0 CA-C-N 117.945 0.872 . . . . 0.0 110.503 179.359 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 701' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -74.28 -44.38 52.98 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.404 -0.816 . . . . 0.0 112.262 -179.34 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 702' ' ' ARG . . . . . . . . . . . . . 91.0 mmt-85 -141.67 157.29 45.25 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.737 0.303 . . . . 0.0 110.569 -178.636 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 703' ' ' TYR . . . . . . . . . . . . . 26.6 p90 -119.35 136.57 54.2 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.371 179.151 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 704' ' ' ILE . . . . . . . . . . . . . 60.3 mt -122.82 98.81 42.33 Favored Pre-proline 0 C--O 1.236 0.39 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.697 179.914 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 705' ' ' PRO . . . . . 0.697 ' HA ' ' O ' ' A' ' 692' ' ' GLY . 73.4 Cg_endo -73.66 154.67 49.54 Favored 'Trans proline' 0 C--N 1.345 0.393 0 C-N-CA 122.899 2.4 . . . . 0.0 113.24 -179.739 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 706' ' ' LEU . . . . . 0.627 ' HA ' ' C ' ' A' ' 707' ' ' PRO . 2.4 pp -119.99 154.97 55.77 Favored Pre-proline 0 C--N 1.328 -0.367 0 CA-C-N 115.793 -0.639 . . . . 0.0 110.566 178.981 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 707' ' ' PRO . . . . . 0.627 ' C ' ' HA ' ' A' ' 706' ' ' LEU . 53.0 Cg_exo -58.71 133.98 9.01 Favored 'Cis proline' 0 C--N 1.353 0.773 0 C-N-CA 123.698 -1.376 . . . . 0.0 112.865 -0.195 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 708' ' ' ILE . . . . . . . . . . . . . 12.8 pt -70.64 149.83 10.01 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-O 121.732 0.777 . . . . 0.0 112.654 -179.988 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 709' ' ' HIS . . . . . . . . . . . . . 68.4 m80 -108.13 112.19 61.54 Favored Pre-proline 0 C--N 1.317 -0.807 0 N-CA-C 107.154 -1.424 . . . . 0.0 107.154 176.864 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 710' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_endo -58.67 -30.81 93.33 Favored 'Trans proline' 0 C--N 1.345 0.386 0 C-N-CA 122.513 2.142 . . . . 0.0 113.931 -177.029 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 711' ' ' GLU . . . . . . . . . . . . . 42.6 tt0 -64.77 -42.42 95.11 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.796 0.331 . . . . 0.0 111.792 -179.927 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 712' ' ' SER . . . . . . . . . . . . . 56.8 m -96.62 -14.21 22.33 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 112.252 0.464 . . . . 0.0 112.252 -178.786 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 713' ' ' PHE . . . . . . . . . . . . . 92.3 t80 -60.66 -49.11 78.82 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-O 121.092 0.472 . . . . 0.0 110.226 179.796 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 714' ' ' LEU . . . . . 0.576 ' O ' HG13 ' A' ' 717' ' ' VAL . 91.0 mt -65.97 -36.92 84.65 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.64 -0.709 . . . . 0.0 110.143 178.885 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 715' ' ' GLN . . . . . . . . . . . . . 65.6 tt0 -62.14 -42.36 99.17 Favored 'General case' 0 CA--C 1.532 0.26 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.678 179.358 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 716' ' ' GLN . . . . . . . . . . . . . 87.7 mt-30 -64.35 -41.03 96.96 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 116.447 -0.342 . . . . 0.0 111.903 -179.874 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 717' ' ' VAL . . . . . 0.576 HG13 ' O ' ' A' ' 714' ' ' LEU . 5.5 p -69.81 -32.98 54.0 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.263 0 C-N-CA 120.414 -0.514 . . . . 0.0 110.183 179.592 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 718' ' ' THR . . . . . . . . . . . . . 93.8 m -62.15 -43.76 98.12 Favored 'General case' 0 C--O 1.232 0.168 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.436 178.285 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 719' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -61.66 -43.93 97.93 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-N 116.337 -0.392 . . . . 0.0 109.978 179.034 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 720' ' ' GLY . . . . . . . . . . . . . . . -64.26 -39.98 97.53 Favored Glycine 0 C--N 1.33 0.235 0 N-CA-C 111.389 -0.684 . . . . 0.0 111.389 177.915 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 721' ' ' LEU . . . . . . . . . . . . . 65.7 tp -62.25 -44.38 96.68 Favored 'General case' 0 CA--C 1.528 0.119 0 CA-C-N 115.456 -0.372 . . . . 0.0 111.3 179.486 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 722' ' ' THR . . . . . . . . . . . . . 67.8 p -65.86 -30.78 71.45 Favored 'General case' 0 N--CA 1.463 0.195 0 CA-C-O 120.823 0.344 . . . . 0.0 110.745 179.765 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 723' ' ' SER . . . . . . . . . . . . . 67.0 m -68.33 -40.69 81.54 Favored 'General case' 0 C--N 1.332 -0.195 0 N-CA-C 109.349 -0.611 . . . . 0.0 109.349 177.468 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 724' ' ' LEU . . . . . . . . . . . . . 67.6 tp -65.21 -46.48 80.51 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-N 115.089 -0.959 . . . . 0.0 111.567 179.139 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 725' ' ' ALA . . . . . . . . . . . . . . . -150.49 153.85 36.59 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.106 -179.483 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 726' ' ' THR . . . . . . . . . . . . . 71.2 p -72.24 -18.02 61.85 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.213 -0.449 . . . . 0.0 112.181 -179.67 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 727' ' ' SER . . . . . . . . . . . . . 90.6 p -71.71 157.19 38.38 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.767 0.318 . . . . 0.0 111.143 -179.99 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 728' ' ' ALA . . . . . . . . . . . . . . . -153.04 159.49 42.86 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.321 -0.399 . . . . 0.0 110.755 -179.792 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 729' ' ' GLN . . . . . . . . . . . . . 78.4 mt-30 . . . . . 0 C--O 1.25 1.112 0 CA-C-O 118.209 -0.9 . . . . 0.0 110.994 179.756 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 613' ' ' GLU . . . . . . . . . . . . . 57.4 mt-10 . . . . . 0 N--CA 1.487 1.421 0 CA-C-O 120.905 0.383 . . . . 0.0 110.736 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 614' ' ' GLY . . . . . . . . . . . . . . . -174.28 176.48 46.65 Favored Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.458 -179.996 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 615' ' ' ARG . . . . . . . . . . . . . 47.2 mtm105 -116.63 136.42 52.99 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.641 0.258 . . . . 0.0 110.964 -179.838 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 616' ' ' ILE . . . . . . . . . . . . . 84.6 mt -123.04 132.58 71.14 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-N 116.116 -0.493 . . . . 0.0 109.853 178.953 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 617' ' ' VAL . . . . . . . . . . . . . 96.0 t -106.82 126.43 62.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-O 120.919 0.39 . . . . 0.0 110.078 -179.916 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 618' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -109.12 128.3 54.89 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.6 -178.727 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 619' ' ' VAL . . . . . . . . . . . . . 65.6 t -117.8 120.01 63.32 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-O 121.002 0.43 . . . . 0.0 110.04 179.952 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 620' ' ' SER . . . . . . . . . . . . . 90.4 p -165.37 161.72 19.12 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.391 -0.822 . . . . 0.0 110.97 -179.645 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 621' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -99.49 -12.19 20.4 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.821 -0.627 . . . . 0.0 111.423 178.456 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 622' ' ' ASP . . . . . . . . . . . . . 57.8 t0 -100.6 108.35 20.24 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-O 120.795 0.331 . . . . 0.0 111.234 -178.512 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 623' ' ' GLU . . . . . . . . . . . . . 25.4 pm0 -65.94 -30.83 71.47 Favored 'General case' 0 CA--C 1.534 0.331 0 CA-C-N 115.754 -0.657 . . . . 0.0 112.394 179.948 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 624' ' ' ALA . . . . . . . . . . . . . . . -62.53 -43.86 97.78 Favored 'General case' 0 N--CA 1.464 0.275 0 CA-C-O 120.857 0.361 . . . . 0.0 111.825 -179.2 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 625' ' ' THR . . . . . . . . . . . . . 85.5 m -68.31 -39.96 81.84 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.109 0.481 . . . . 0.0 109.976 179.669 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 626' ' ' SER . . . . . . . . . . . . . 73.1 m -61.39 -40.39 94.19 Favored 'General case' 0 N--CA 1.455 -0.21 0 CA-C-N 115.35 -0.841 . . . . 0.0 112.35 -178.878 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 627' ' ' THR . . . . . . . . . . . . . 74.9 p -65.07 -35.77 82.22 Favored 'General case' 0 N--CA 1.466 0.337 0 N-CA-C 112.381 0.511 . . . . 0.0 112.381 -179.422 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 628' ' ' LEU . . . . . . . . . . . . . 1.8 mm? -74.02 -48.13 32.23 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 112.008 0.373 . . . . 0.0 112.008 -179.673 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 629' ' ' ILE . . . . . . . . . . . . . 21.2 tt -69.27 -36.73 73.9 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.399 0 N-CA-C 112.456 0.539 . . . . 0.0 112.456 -178.932 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 630' ' ' CYS . . . . . . . . . . . . . 45.1 t -61.42 -42.74 99.21 Favored 'General case' 0 CA--C 1.52 -0.206 0 CA-C-O 120.606 0.241 . . . . 0.0 110.925 -179.792 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 631' ' ' SER . . . . . . . . . . . . . 69.2 m -61.64 -41.64 97.79 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.833 -179.576 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 632' ' ' ILE . . . . . . . . . . . . . 97.2 mt -63.14 -48.69 86.54 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.323 0 CA-C-O 120.981 0.419 . . . . 0.0 111.021 179.693 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 633' ' ' LEU . . . . . . . . . . . . . 87.9 mt -67.67 -39.23 84.54 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-N 115.915 -0.584 . . . . 0.0 112.381 -179.636 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 634' ' ' THR . . . . . 0.476 ' HA ' ' O ' ' A' ' 638' ' ' TYR . 86.4 m -64.93 -39.95 94.3 Favored 'General case' 0 N--CA 1.463 0.187 0 CA-C-O 120.697 0.284 . . . . 0.0 110.686 -179.746 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 635' ' ' THR . . . . . . . . . . . . . 93.2 m -58.79 -38.75 79.25 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.191 179.273 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 636' ' ' ALA . . . . . . . . . . . . . . . -64.34 -17.91 64.14 Favored 'General case' 0 CA--C 1.534 0.329 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.308 178.794 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 637' ' ' GLY . . . . . . . . . . . . . . . 108.94 4.69 31.38 Favored Glycine 0 C--N 1.334 0.437 0 C-N-CA 121.072 -0.585 . . . . 0.0 113.321 179.631 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 638' ' ' TYR . . . . . 0.476 ' O ' ' HA ' ' A' ' 634' ' ' THR . 92.6 m-85 -100.48 141.72 32.95 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.846 0.355 . . . . 0.0 111.636 -179.822 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 639' ' ' GLN . . . . . . . . . . . . . 98.6 mm-40 -88.2 136.52 32.94 Favored 'General case' 0 CA--C 1.518 -0.266 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.224 179.64 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 640' ' ' VAL . . . . . . . . . . . . . 60.1 t -118.12 129.99 73.65 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 CA-C-O 121.098 0.475 . . . . 0.0 112.025 -179.62 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 641' ' ' ILE . . . . . . . . . . . . . 47.5 mm -111.21 119.52 59.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 N-CA-C 108.578 -0.897 . . . . 0.0 108.578 178.503 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 642' ' ' TRP . . . . . . . . . . . . . 25.1 t90 -92.66 127.51 38.19 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.178 0.514 . . . . 0.0 112.329 -178.353 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 643' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -119.55 130.31 55.1 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 115.495 -0.775 . . . . 0.0 110.142 178.827 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 644' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -107.73 37.79 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.718 -0.219 . . . . 0.0 111.403 -179.477 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 645' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -150.58 -37.14 0.14 Allowed 'General case' 0 N--CA 1.469 0.497 0 N-CA-C 112.544 0.572 . . . . 0.0 112.544 -178.768 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 646' ' ' GLY . . . . . . . . . . . . . . . 74.57 28.25 63.76 Favored Glycine 0 CA--C 1.519 0.308 0 C-N-CA 120.749 -0.738 . . . . 0.0 113.86 -179.856 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 647' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -70.49 128.64 36.84 Favored 'General case' 0 N--CA 1.456 -0.164 0 CA-C-N 117.263 0.532 . . . . 0.0 110.544 179.59 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 648' ' ' VAL . . . . . . . . . . . . . 76.6 t -61.42 -40.33 85.9 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 CA-C-N 115.101 -0.954 . . . . 0.0 111.237 -179.628 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 649' ' ' GLU . . . . . . . . . . . . . 50.3 mp0 -61.29 -43.48 98.8 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.743 0.306 . . . . 0.0 110.38 -179.856 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 650' ' ' ARG . . . . . . . . . . . . . 95.8 mtt-85 -69.55 -41.61 75.7 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.655 178.707 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 651' ' ' LEU . . . . . . . . . . . . . 88.4 mt -65.34 -41.18 94.15 Favored 'General case' 0 N--CA 1.462 0.15 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.648 179.379 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 652' ' ' LEU . . . . . . . . . . . . . 62.4 tp -65.95 -42.98 89.3 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.226 178.895 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 653' ' ' ALA . . . . . . . . . . . . . . . -62.89 -40.11 96.54 Favored 'General case' 0 N--CA 1.467 0.418 0 CA-C-O 121.082 0.468 . . . . 0.0 111.591 -179.645 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 654' ' ' LEU . . . . . . . . . . . . . 75.7 mt -101.6 29.63 4.76 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.103 179.849 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 655' ' ' THR . . . . . 0.408 HG21 ' O ' ' A' ' 655' ' ' THR . 6.2 t -43.36 109.72 0.83 Allowed Pre-proline 0 N--CA 1.467 0.399 0 O-C-N 124.24 0.963 . . . . 0.0 113.353 -177.899 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 656' ' ' PRO . . . . . . . . . . . . . 22.5 Cg_endo -93.07 -174.37 0.44 Allowed 'Trans proline' 0 C--N 1.345 0.373 0 C-N-CA 124.217 3.278 . . . . 0.0 111.852 178.744 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 657' ' ' ILE . . . . . . . . . . . . . 18.5 pt -81.13 -24.32 10.56 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-O 121.447 0.641 . . . . 0.0 109.791 177.903 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 658' ' ' ALA . . . . . . . . . . . . . . . -158.62 151.18 21.92 Favored 'General case' 0 N--CA 1.452 -0.332 0 CA-C-N 115.142 -0.935 . . . . 0.0 111.198 179.77 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 659' ' ' VAL . . . . . . . . . . . . . 19.3 m -120.86 145.19 27.7 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-O 121.325 0.583 . . . . 0.0 110.406 178.825 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 660' ' ' LEU . . . . . . . . . . . . . 2.0 tt -119.08 116.79 27.12 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.457 -0.792 . . . . 0.0 109.651 179.535 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 661' ' ' LEU . . . . . . . . . . . . . 41.3 mt -104.04 111.27 23.77 Favored 'General case' 0 C--N 1.323 -0.587 0 N-CA-C 109.307 -0.627 . . . . 0.0 109.307 -179.334 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 662' ' ' ALA . . . . . . . . . . . . . . . -104.83 130.1 53.01 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 112.402 0.519 . . . . 0.0 112.402 -178.381 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 663' ' ' GLU . . . . . . . . . . . . . 98.5 mt-10 -75.19 144.74 79.24 Favored Pre-proline 0 C--N 1.325 -0.471 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.288 178.294 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 664' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -72.26 139.43 60.18 Favored 'Cis proline' 0 C--N 1.349 0.563 0 C-N-CA 123.318 -1.534 . . . . 0.0 112.825 -0.573 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 665' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -85.87 153.11 22.46 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.495 -0.775 . . . . 0.0 111.809 179.955 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 666' ' ' SER . . . . . . . . . . . . . 5.5 p -104.88 -25.12 12.74 Favored 'General case' 0 CA--C 1.53 0.207 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.894 179.938 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 667' ' ' TYR . . . . . . . . . . . . . 18.0 p90 -68.59 -20.64 64.52 Favored 'General case' 0 N--CA 1.467 0.407 0 N-CA-C 112.102 0.408 . . . . 0.0 112.102 179.756 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 668' ' ' GLY . . . . . . . . . . . . . . . 100.13 -106.37 3.14 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.611 -0.804 . . . . 0.0 113.253 179.786 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 669' ' ' ASP . . . . . . . . . . . . . 25.5 t70 -84.67 112.15 20.21 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.728 0.299 . . . . 0.0 111.007 -178.863 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 670' ' ' VAL . . . . . 0.478 ' O ' HG22 ' A' ' 674' ' ' VAL . 14.3 p -64.37 -34.66 70.74 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.333 0 N-CA-C 113.122 0.786 . . . . 0.0 113.122 -179.031 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 671' ' ' GLN . . . . . . . . . . . . . 27.7 mp0 -62.4 -42.21 99.26 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.843 0.354 . . . . 0.0 110.904 -178.936 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 672' ' ' GLU . . . . . . . . . . . . . 95.8 mt-10 -66.4 -39.6 89.13 Favored 'General case' 0 N--CA 1.462 0.169 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.95 179.061 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 673' ' ' LEU . . . . . . . . . . . . . 62.6 tp -62.48 -43.36 99.01 Favored 'General case' 0 C--N 1.331 -0.229 0 N-CA-C 109.495 -0.557 . . . . 0.0 109.495 178.864 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 674' ' ' VAL . . . . . 0.478 HG22 ' O ' ' A' ' 670' ' ' VAL . 55.1 t -61.75 -44.83 99.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 115.256 -0.883 . . . . 0.0 109.913 178.945 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 675' ' ' ASP . . . . . . . . . . . . . 37.2 t70 -60.57 -40.11 90.48 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.396 179.058 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 676' ' ' GLN . . . . . . . . . . . . . 56.9 mt-30 -70.26 -41.29 73.66 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.006 -179.733 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 677' ' ' LEU . . . . . . . . . . . . . 85.7 mt -66.68 -42.43 86.53 Favored 'General case' 0 C--N 1.334 -0.1 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.373 179.346 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 678' ' ' ARG . . . . . 0.596 ' HA ' ' O ' ' A' ' 681' ' ' CYS . 83.6 mtp180 -72.14 -26.37 62.07 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-O 120.989 0.423 . . . . 0.0 111.371 -179.95 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 679' ' ' GLN . . . . . . . . . . . . . 52.7 tt0 -62.69 -39.01 92.64 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.589 -0.732 . . . . 0.0 110.459 179.491 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 680' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -95.41 -42.45 8.48 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.709 -179.701 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 681' ' ' CYS . . . . . 0.596 ' O ' ' HA ' ' A' ' 678' ' ' ARG . 76.7 m -121.14 131.31 54.17 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 120.774 0.321 . . . . 0.0 110.615 179.873 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 682' ' ' THR . . . . . . . . . . . . . 68.5 p -71.49 159.46 85.45 Favored Pre-proline 0 C--N 1.324 -0.506 0 CA-C-N 116.374 -0.376 . . . . 0.0 110.674 -179.978 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 683' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_exo -54.6 -31.79 71.87 Favored 'Trans proline' 0 C--N 1.35 0.643 0 C-N-CA 122.81 2.34 . . . . 0.0 112.715 179.611 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 684' ' ' GLU . . . . . . . . . . . . . 80.1 mm-40 -70.01 -39.1 76.05 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 121.084 0.469 . . . . 0.0 110.512 179.583 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 685' ' ' GLN . . . . . . . . . . . . . 91.0 mt-30 -72.85 -40.99 65.25 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.442 -0.799 . . . . 0.0 112.103 179.707 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 686' ' ' LEU . . . . . . . . . . . . . 60.6 tp -134.95 119.97 18.64 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.957 -178.373 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 687' ' ' LYS . . . . . . . . . . . . . 45.1 mmtm -89.14 146.4 24.82 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 121.356 0.598 . . . . 0.0 110.594 178.367 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 688' ' ' ILE . . . . . . . . . . . . . 75.5 mt -123.7 121.61 62.82 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.739 0 CA-C-N 115.635 -0.711 . . . . 0.0 110.663 -179.222 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 689' ' ' PHE . . . . . . . . . . . . . 91.1 m-85 -119.93 144.5 47.41 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.463 -0.789 . . . . 0.0 110.335 179.391 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 690' ' ' ILE . . . . . . . . . . . . . 19.6 tt -123.93 137.35 57.28 Favored 'Isoleucine or valine' 0 C--O 1.235 0.331 0 CA-C-O 121.361 0.601 . . . . 0.0 111.599 179.906 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 691' ' ' LEU . . . . . 0.493 HD21 ' O ' ' A' ' 704' ' ' ILE . 0.5 OUTLIER -110.84 129.3 55.9 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-N 115.434 -0.803 . . . . 0.0 111.057 -179.825 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 692' ' ' GLY . . . . . 0.602 ' O ' ' HA ' ' A' ' 705' ' ' PRO . . . 177.68 -178.61 48.41 Favored Glycine 0 N--CA 1.446 -0.634 0 CA-C-N 115.613 -0.721 . . . . 0.0 111.678 179.764 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 693' ' ' SER . . . . . . . . . . . . . 80.1 p -66.47 -37.22 84.62 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.947 0.403 . . . . 0.0 110.935 179.379 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 694' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -138.87 128.1 24.12 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.88 -0.6 . . . . 0.0 109.879 179.207 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 695' ' ' GLY . . . . . . . . . . . . . . . -82.64 122.36 5.72 Favored Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.44 -0.886 . . . . 0.0 112.135 179.771 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 696' ' ' ASN . . . . . . . . . . . . . 99.5 m-20 -63.32 -38.15 90.05 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-O 120.782 0.325 . . . . 0.0 111.14 179.7 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 697' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER 64.94 38.23 6.51 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 115.47 -0.786 . . . . 0.0 112.156 179.641 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 698' ' ' GLN . . . . . . . . . . . . . 97.6 mt-30 -115.01 94.66 4.84 Favored 'General case' 0 N--CA 1.451 -0.403 0 N-CA-C 109.709 -0.478 . . . . 0.0 109.709 178.972 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 699' ' ' GLY . . . . . 0.465 ' O ' HG11 ' A' ' 674' ' ' VAL . . . 90.8 8.09 65.66 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.684 -0.77 . . . . 0.0 113.295 -179.783 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 700' ' ' VAL . . . . . . . . . . . . . 33.1 m -118.38 148.94 20.91 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.333 0 O-C-N 122.246 -0.561 . . . . 0.0 110.038 179.792 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 701' ' ' ASP . . . . . . . . . . . . . 37.6 t70 -71.7 -43.96 65.05 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.593 -0.73 . . . . 0.0 112.307 -178.81 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 702' ' ' ARG . . . . . . . . . . . . . 94.4 mtt-85 -144.92 162.55 36.6 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.572 -0.285 . . . . 0.0 110.612 -178.606 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 703' ' ' TYR . . . . . . . . . . . . . 45.8 p90 -123.59 147.36 47.39 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 109.826 -0.435 . . . . 0.0 109.826 179.072 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 704' ' ' ILE . . . . . 0.493 ' O ' HD21 ' A' ' 691' ' ' LEU . 46.2 mt -121.98 99.28 44.13 Favored Pre-proline 0 C--N 1.327 -0.39 0 CA-C-N 116.594 -0.276 . . . . 0.0 110.927 -179.664 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 705' ' ' PRO . . . . . 0.602 ' HA ' ' O ' ' A' ' 692' ' ' GLY . 85.2 Cg_endo -79.99 141.74 15.1 Favored 'Trans proline' 0 CA--C 1.531 0.359 0 C-N-CA 122.633 2.222 . . . . 0.0 113.574 -179.941 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 706' ' ' LEU . . . . . . . . . . . . . 92.3 mt -81.76 151.27 67.59 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.412 178.03 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 707' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -75.46 142.78 75.28 Favored 'Cis proline' 0 C--N 1.346 0.416 0 C-N-CA 123.112 -1.62 . . . . 0.0 112.851 -0.776 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 708' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -69.86 106.87 1.57 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.817 178.671 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 709' ' ' HIS . . . . . . . . . . . . . 71.5 m80 -82.47 121.45 78.25 Favored Pre-proline 0 C--N 1.33 -0.277 0 N-CA-C 108.78 -0.822 . . . . 0.0 108.78 177.796 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 710' ' ' PRO . . . . . . . . . . . . . 22.6 Cg_endo -60.34 -30.4 90.94 Favored 'Trans proline' 0 C--N 1.346 0.419 0 C-N-CA 122.689 2.259 . . . . 0.0 114.081 -177.875 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 711' ' ' GLU . . . . . . . . . . . . . 51.4 mp0 -66.23 -40.48 90.3 Favored 'General case' 0 C--N 1.331 -0.23 0 N-CA-C 112.119 0.415 . . . . 0.0 112.119 -179.327 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 712' ' ' SER . . . . . . . . . . . . . 63.0 m -99.0 -17.74 18.14 Favored 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 112.194 0.442 . . . . 0.0 112.194 -178.64 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 713' ' ' PHE . . . . . . . . . . . . . 85.0 t80 -60.2 -48.65 80.84 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-O 120.744 0.307 . . . . 0.0 110.552 179.909 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 714' ' ' LEU . . . . . 0.578 ' O ' HG12 ' A' ' 717' ' ' VAL . 85.9 mt -62.9 -39.27 93.99 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.188 179.492 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 715' ' ' GLN . . . . . . . . . . . . . 97.0 mt-30 -63.57 -40.16 96.25 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.684 179.229 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 716' ' ' GLN . . . . . . . . . . . . . 96.7 mt-30 -63.72 -41.14 98.12 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-N 116.69 -0.232 . . . . 0.0 111.109 179.594 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 717' ' ' VAL . . . . . 0.578 HG12 ' O ' ' A' ' 714' ' ' LEU . 4.8 p -73.68 -36.07 45.83 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.34 0 C-N-CA 120.574 -0.45 . . . . 0.0 110.847 179.506 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 718' ' ' THR . . . . . 0.46 HG21 ' O ' ' A' ' 714' ' ' LEU . 35.2 p -64.57 -36.49 84.39 Favored 'General case' 0 C--N 1.341 0.238 0 N-CA-C 111.593 0.22 . . . . 0.0 111.593 179.242 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 719' ' ' MET . . . . . . . . . . . . . 98.3 mtp -63.8 -42.31 97.73 Favored 'General case' 0 C--O 1.235 0.303 0 CA-C-O 121.199 0.523 . . . . 0.0 109.753 178.579 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 720' ' ' GLY . . . . . . . . . . . . . . . -66.9 -39.6 93.4 Favored Glycine 0 N--CA 1.451 -0.32 0 CA-C-N 115.589 -0.732 . . . . 0.0 112.402 178.305 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 721' ' ' LEU . . . . . 0.491 ' HG ' ' O ' ' A' ' 717' ' ' VAL . 97.5 mt -63.42 -39.39 94.36 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-O 120.827 0.346 . . . . 0.0 111.455 -179.726 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 722' ' ' THR . . . . . . . . . . . . . 73.4 p -71.23 -11.33 60.87 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.921 0.391 . . . . 0.0 111.401 179.582 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 723' ' ' SER . . . . . . . . . . . . . 59.5 m -91.27 -1.99 57.53 Favored 'General case' 0 CA--C 1.532 0.255 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.01 179.588 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 724' ' ' LEU . . . . . . . . . . . . . 74.8 mt -73.03 141.09 47.66 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-N 116.51 -0.313 . . . . 0.0 111.159 179.672 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 725' ' ' ALA . . . . . . . . . . . . . . . -62.67 -39.77 94.98 Favored 'General case' 0 N--CA 1.461 0.111 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.123 179.192 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 726' ' ' THR . . . . . . . . . . . . . 87.8 m -121.55 128.92 52.51 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.21 179.571 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 727' ' ' SER . . . . . . . . . . . . . 63.6 m -123.31 149.37 44.93 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.67 0.271 . . . . 0.0 110.715 -179.728 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 728' ' ' ALA . . . . . . . . . . . . . . . -130.17 145.8 51.75 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.794 179.95 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 729' ' ' GLN . . . . . . . . . . . . . 10.2 tm0? . . . . . 0 C--O 1.248 1.01 0 CA-C-O 118.137 -0.935 . . . . 0.0 110.524 179.986 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 613' ' ' GLU . . . . . . . . . . . . . 77.8 mm-40 . . . . . 0 N--CA 1.485 1.294 0 CA-C-O 120.539 0.209 . . . . 0.0 110.817 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 614' ' ' GLY . . . . . . . . . . . . . . . 178.92 178.56 48.27 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.837 -0.697 . . . . 0.0 112.058 179.958 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 615' ' ' ARG . . . . . . . . . . . . . 27.5 ptt85 -117.54 148.23 42.07 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.219 0.533 . . . . 0.0 111.503 -179.946 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 616' ' ' ILE . . . . . . . . . . . . . 84.1 mt -124.01 135.87 62.17 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-N 115.268 -0.878 . . . . 0.0 110.644 -179.077 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 617' ' ' VAL . . . . . . . . . . . . . 79.9 t -105.28 127.14 60.21 Favored 'Isoleucine or valine' 0 C--O 1.234 0.285 0 N-CA-C 109.692 -0.484 . . . . 0.0 109.692 179.507 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 618' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -110.65 125.21 53.2 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.719 -0.673 . . . . 0.0 111.004 -178.421 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 619' ' ' VAL . . . . . 0.472 ' HA ' ' O ' ' A' ' 643' ' ' LEU . 59.3 t -118.39 117.99 56.5 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 N-CA-C 109.074 -0.713 . . . . 0.0 109.074 179.135 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 620' ' ' SER . . . . . . . . . . . . . 31.5 t -163.69 140.9 7.18 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.929 -179.039 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 621' ' ' GLU . . . . . . . . . . . . . 88.1 tt0 -77.47 -28.22 52.23 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.315 -0.857 . . . . 0.0 111.33 178.628 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 622' ' ' ASP . . . . . . . . . . . . . 62.9 t0 -85.71 108.82 18.22 Favored 'General case' 0 C--O 1.232 0.137 0 CA-C-O 121.167 0.508 . . . . 0.0 111.349 -178.279 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 623' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -64.7 -37.71 88.52 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.272 -0.876 . . . . 0.0 112.03 179.606 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 624' ' ' ALA . . . . . . . . . . . . . . . -60.82 -45.34 94.81 Favored 'General case' 0 N--CA 1.466 0.351 0 N-CA-C 112.739 0.644 . . . . 0.0 112.739 -178.2 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 625' ' ' THR . . . . . . . . . . . . . 18.5 p -73.4 -35.88 65.92 Favored 'General case' 0 CA--C 1.517 -0.324 0 C-N-CA 120.702 -0.399 . . . . 0.0 110.883 179.546 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 626' ' ' SER . . . . . 0.496 ' O ' HG22 ' A' ' 629' ' ' ILE . 68.1 m -63.77 -42.73 97.73 Favored 'General case' 0 N--CA 1.451 -0.42 0 CA-C-N 115.73 -0.668 . . . . 0.0 111.151 -179.676 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 627' ' ' THR . . . . . . . . . . . . . 91.3 m -62.31 -47.23 85.21 Favored 'General case' 0 CA--C 1.532 0.263 0 CA-C-O 120.848 0.356 . . . . 0.0 111.602 -179.93 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 628' ' ' LEU . . . . . . . . . . . . . 62.1 tp -65.04 -44.67 88.33 Favored 'General case' 0 CA--C 1.531 0.225 0 CA-C-N 116.128 -0.487 . . . . 0.0 112.1 -179.528 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 629' ' ' ILE . . . . . 0.496 HG22 ' O ' ' A' ' 626' ' ' SER . 1.4 tp -67.13 -32.48 57.93 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.548 0 N-CA-C 112.606 0.595 . . . . 0.0 112.606 -178.291 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 630' ' ' CYS . . . . . . . . . . . . . 76.8 m -63.95 -38.74 92.21 Favored 'General case' 0 N--CA 1.466 0.335 0 N-CA-C 112.54 0.57 . . . . 0.0 112.54 -179.361 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 631' ' ' SER . . . . . . . . . . . . . 95.4 p -62.25 -39.14 91.88 Favored 'General case' 0 C--N 1.33 -0.256 0 C-N-CA 121.149 -0.22 . . . . 0.0 111.565 -178.667 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 632' ' ' ILE . . . . . 0.533 ' O ' HG21 ' A' ' 635' ' ' THR . 96.5 mt -65.09 -48.01 85.53 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.279 0 CA-C-O 121.068 0.461 . . . . 0.0 110.961 179.635 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 633' ' ' LEU . . . . . . . . . . . . . 89.2 mt -67.67 -40.44 84.45 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.879 -0.601 . . . . 0.0 112.107 -179.631 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 634' ' ' THR . . . . . 0.511 ' HA ' ' O ' ' A' ' 638' ' ' TYR . 91.6 m -67.21 -41.65 85.41 Favored 'General case' 0 CA--C 1.53 0.195 0 CA-C-O 120.532 0.206 . . . . 0.0 111.338 -179.108 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 635' ' ' THR . . . . . 0.533 HG21 ' O ' ' A' ' 632' ' ' ILE . 0.9 OUTLIER -61.21 -18.96 60.91 Favored 'General case' 0 CA--C 1.535 0.389 0 CA-C-O 120.871 0.367 . . . . 0.0 111.248 179.789 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 636' ' ' ALA . . . . . . . . . . . . . . . -82.9 -3.33 56.84 Favored 'General case' 0 CA--C 1.53 0.211 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.837 178.841 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 637' ' ' GLY . . . . . . . . . . . . . . . 95.34 5.02 60.72 Favored Glycine 0 C--N 1.331 0.299 0 C-N-CA 121.118 -0.563 . . . . 0.0 113.05 179.778 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 638' ' ' TYR . . . . . 0.511 ' O ' ' HA ' ' A' ' 634' ' ' THR . 91.8 m-85 -100.7 139.3 36.58 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.85 0.357 . . . . 0.0 111.283 -179.971 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 639' ' ' GLN . . . . . . . . . . . . . 24.4 mp0 -85.97 138.0 32.31 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 109.929 -0.397 . . . . 0.0 109.929 179.197 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 640' ' ' VAL . . . . . . . . . . . . . 58.3 t -117.28 129.87 73.09 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-O 121.054 0.454 . . . . 0.0 111.926 -179.482 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 641' ' ' ILE . . . . . . . . . . . . . 31.1 mm -107.65 115.2 48.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 N-CA-C 108.349 -0.982 . . . . 0.0 108.349 178.611 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 642' ' ' TRP . . . . . . . . . . . . . 74.8 t90 -93.95 124.66 38.1 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.251 0.548 . . . . 0.0 112.418 -178.495 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 643' ' ' LEU . . . . . 0.472 ' O ' ' HA ' ' A' ' 619' ' ' VAL . 93.1 mt -127.87 145.48 50.93 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.151 -0.931 . . . . 0.0 110.703 179.412 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 644' ' ' VAL . . . . . . . . . . . . . 3.4 p -130.9 81.86 0.66 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.44 0 CA-C-O 121.609 0.719 . . . . 0.0 110.314 178.009 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 645' ' ' ASP . . . . . . . . . . . . . 19.1 t0 -179.41 -31.68 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.609 0 CA-C-N 115.559 -0.746 . . . . 0.0 111.651 -179.654 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 646' ' ' GLY . . . . . 0.419 ' HA3' ' HB3' ' A' ' 667' ' ' TYR . . . 73.06 28.72 65.97 Favored Glycine 0 CA--C 1.519 0.314 0 C-N-CA 121.077 -0.582 . . . . 0.0 113.428 -179.472 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 647' ' ' GLU . . . . . . . . . . . . . 7.3 mm-40 -69.31 115.55 8.72 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-O 121.084 0.469 . . . . 0.0 111.239 179.882 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 648' ' ' VAL . . . . . . . . . . . . . 79.0 t -61.33 -40.38 85.95 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-N 115.273 -0.876 . . . . 0.0 111.283 -179.71 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 649' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -61.16 -42.28 98.27 Favored 'General case' 0 C--N 1.332 -0.158 0 C-N-CA 120.769 -0.372 . . . . 0.0 110.213 -179.894 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 650' ' ' ARG . . . . . . . . . . . . . 90.4 mmt-85 -70.75 -41.2 72.08 Favored 'General case' 0 C--O 1.232 0.159 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.43 178.576 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 651' ' ' LEU . . . . . . . . . . . . . 84.1 mt -64.81 -41.59 95.67 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.745 179.403 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 652' ' ' LEU . . . . . . . . . . . . . 62.6 tp -65.27 -43.76 90.21 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.213 179.017 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 653' ' ' ALA . . . . . . . . . . . . . . . -63.2 -39.91 95.99 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-O 121.081 0.467 . . . . 0.0 111.412 -179.791 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 654' ' ' LEU . . . . . . . . . . . . . 75.7 mt -100.65 30.67 3.84 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.547 -0.751 . . . . 0.0 110.094 179.914 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 655' ' ' THR . . . . . 0.405 HG21 ' O ' ' A' ' 655' ' ' THR . 5.8 t -44.79 109.92 0.97 Allowed Pre-proline 0 CA--C 1.539 0.557 0 N-CA-C 113.418 0.896 . . . . 0.0 113.418 -178.283 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 656' ' ' PRO . . . . . 0.533 ' O ' HD23 ' A' ' 686' ' ' LEU . 27.4 Cg_endo -92.59 -174.68 0.51 Allowed 'Trans proline' 0 C--N 1.347 0.487 0 C-N-CA 124.369 3.379 . . . . 0.0 111.897 178.963 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 657' ' ' ILE . . . . . . . . . . . . . 23.1 pt -81.16 -25.1 10.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 121.423 0.63 . . . . 0.0 109.715 177.573 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 658' ' ' ALA . . . . . . . . . . . . . . . -157.7 152.66 25.51 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.157 -0.929 . . . . 0.0 110.993 -179.716 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 659' ' ' VAL . . . . . . . . . . . . . 24.9 m -120.93 145.33 27.58 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-O 121.116 0.484 . . . . 0.0 110.92 179.146 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 660' ' ' LEU . . . . . . . . . . . . . 2.9 mp -115.18 119.31 35.95 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.6 -0.727 . . . . 0.0 110.006 179.288 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 661' ' ' LEU . . . . . . . . . . . . . 69.2 mt -109.47 112.86 25.22 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 109.371 -0.603 . . . . 0.0 109.371 179.942 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 662' ' ' ALA . . . . . . . . . . . . . . . -110.41 131.93 54.62 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 113.431 0.9 . . . . 0.0 113.431 -178.23 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 663' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -73.12 147.0 87.8 Favored Pre-proline 0 C--N 1.326 -0.428 0 CA-C-N 115.484 -0.78 . . . . 0.0 110.208 178.11 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 664' ' ' PRO . . . . . . . . . . . . . 70.1 Cg_endo -73.89 142.86 76.02 Favored 'Cis proline' 0 C--N 1.348 0.523 0 C-N-CA 123.237 -1.568 . . . . 0.0 112.677 -0.879 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 665' ' ' PHE . . . . . . . . . . . . . 22.1 m-85 -77.6 136.96 38.32 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.72 -0.673 . . . . 0.0 111.002 179.351 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 666' ' ' SER . . . . . . . . . . . . . 78.2 p -91.29 -23.09 20.25 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.468 -0.333 . . . . 0.0 111.551 179.619 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 667' ' ' TYR . . . . . 0.419 ' HB3' ' HA3' ' A' ' 646' ' ' GLY . 12.7 p90 -80.91 -16.13 54.42 Favored 'General case' 0 CA--C 1.531 0.218 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.956 179.651 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 668' ' ' GLY . . . . . . . . . . . . . . . 100.18 -106.83 3.22 Favored Glycine 0 CA--C 1.521 0.414 0 C-N-CA 120.601 -0.809 . . . . 0.0 113.878 179.247 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 669' ' ' ASP . . . . . . . . . . . . . 35.2 t70 -82.88 111.21 18.57 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-O 120.941 0.401 . . . . 0.0 111.977 -178.049 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 670' ' ' VAL . . . . . . . . . . . . . 9.0 p -65.9 -30.03 48.73 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.449 0 N-CA-C 113.302 0.853 . . . . 0.0 113.302 -179.742 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 671' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -61.79 -41.71 98.08 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-N 117.888 0.313 . . . . 0.0 111.108 -179.078 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 672' ' ' GLU . . . . . . . . . . . . . 95.4 mt-10 -65.27 -40.2 93.62 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.839 179.112 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 673' ' ' LEU . . . . . . . . . . . . . 65.2 tp -64.19 -44.82 90.8 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.131 179.234 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 674' ' ' VAL . . . . . . . . . . . . . 59.1 t -62.99 -43.92 99.35 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.188 0 CA-C-N 115.777 -0.647 . . . . 0.0 109.859 179.642 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 675' ' ' ASP . . . . . . . . . . . . . 37.3 t70 -59.5 -41.02 88.93 Favored 'General case' 0 CA--C 1.518 -0.285 0 CA-C-N 115.87 -0.604 . . . . 0.0 110.476 178.93 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 676' ' ' GLN . . . . . . . . . . . . . 56.9 mt-30 -71.11 -41.17 70.93 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.015 179.958 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 677' ' ' LEU . . . . . . . . . . . . . 86.2 mt -67.2 -41.83 85.16 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 116.141 -0.482 . . . . 0.0 111.88 179.973 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 678' ' ' ARG . . . . . 0.544 ' HA ' ' O ' ' A' ' 681' ' ' CYS . 14.0 ptm180 -74.23 -24.66 59.35 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-O 121.106 0.479 . . . . 0.0 110.686 -179.296 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 679' ' ' GLN . . . . . . . . . . . . . 64.6 tt0 -65.71 -39.0 90.76 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.624 -0.716 . . . . 0.0 110.152 178.792 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 680' ' ' ARG . . . . . . . . . . . . . 33.1 mmt180 -89.37 -44.15 10.4 Favored 'General case' 0 C--N 1.333 -0.136 0 CA-C-N 115.8 -0.636 . . . . 0.0 111.377 -179.554 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 681' ' ' CYS . . . . . 0.544 ' O ' ' HA ' ' A' ' 678' ' ' ARG . 77.5 m -122.73 131.43 53.78 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.576 179.996 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 682' ' ' THR . . . . . 0.452 ' HB ' ' HD2' ' A' ' 683' ' ' PRO . 63.6 p -71.29 159.54 85.24 Favored Pre-proline 0 C--N 1.322 -0.619 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.575 -179.664 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 683' ' ' PRO . . . . . 0.452 ' HD2' ' HB ' ' A' ' 682' ' ' THR . 17.8 Cg_endo -59.41 -23.95 72.58 Favored 'Trans proline' 0 C--N 1.352 0.732 0 C-N-CA 122.483 2.122 . . . . 0.0 112.823 -179.829 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 684' ' ' GLU . . . . . . . . . . . . . 24.8 pt-20 -79.4 -15.8 57.26 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.977 0.418 . . . . 0.0 110.397 179.074 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 685' ' ' GLN . . . . . . . . . . . . . 90.8 mt-30 -98.8 -36.34 9.84 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.013 -0.539 . . . . 0.0 111.355 179.954 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 686' ' ' LEU . . . . . 0.533 HD23 ' O ' ' A' ' 656' ' ' PRO . 0.5 OUTLIER -128.03 115.27 18.23 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.696 -178.946 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 687' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -84.97 142.49 29.6 Favored 'General case' 0 CA--C 1.52 -0.187 0 N-CA-C 109.553 -0.536 . . . . 0.0 109.553 178.057 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 688' ' ' ILE . . . . . . . . . . . . . 78.7 mt -122.03 119.74 59.41 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.768 0 CA-C-O 121.336 0.589 . . . . 0.0 111.396 -178.96 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 689' ' ' PHE . . . . . . . . . . . . . 98.5 m-85 -117.09 141.89 47.69 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 114.906 -1.043 . . . . 0.0 109.59 178.779 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 690' ' ' ILE . . . . . . . . . . . . . 18.2 tt -123.1 135.91 61.57 Favored 'Isoleucine or valine' 0 C--O 1.237 0.398 0 CA-C-O 121.171 0.51 . . . . 0.0 111.415 -179.647 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 691' ' ' LEU . . . . . . . . . . . . . 39.6 mt -109.35 125.91 52.85 Favored 'General case' 0 C--O 1.234 0.266 0 CA-C-N 115.741 -0.663 . . . . 0.0 109.679 179.831 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 692' ' ' GLY . . . . . 0.55 ' O ' ' HA ' ' A' ' 705' ' ' PRO . . . 175.32 -179.48 46.52 Favored Glycine 0 N--CA 1.446 -0.668 0 C-N-CA 120.676 -0.774 . . . . 0.0 112.199 -179.91 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 693' ' ' SER . . . . . . . . . . . . . 80.3 p -67.09 -36.37 81.82 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 120.715 0.293 . . . . 0.0 111.632 179.776 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 694' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -123.73 137.51 54.69 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.242 0.544 . . . . 0.0 110.97 179.948 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 695' ' ' GLY . . . . . . . . . . . . . . . -102.9 14.72 55.94 Favored Glycine 0 N--CA 1.449 -0.436 0 CA-C-N 115.327 -0.851 . . . . 0.0 112.882 179.543 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 696' ' ' ASN . . . . . . . . . . . . . 64.7 t30 -81.23 69.74 7.91 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 121.148 0.499 . . . . 0.0 111.284 -179.217 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 697' ' ' TYR . . . . . . . . . . . . . 97.0 m-85 -131.93 146.38 52.07 Favored 'General case' 0 N--CA 1.453 -0.316 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.027 179.174 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 698' ' ' GLN . . . . . . . . . . . . . 78.4 mt-30 -93.16 147.91 22.48 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.525 -179.831 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 699' ' ' GLY . . . . . . . . . . . . . . . 94.83 4.11 61.92 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.559 -0.829 . . . . 0.0 113.576 179.687 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 700' ' ' VAL . . . . . . . . . . . . . 29.5 m -119.16 148.92 21.79 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.272 0 CA-C-N 117.412 0.606 . . . . 0.0 110.142 179.149 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 701' ' ' ASP . . . . . 0.412 ' O ' ' HD2' ' A' ' 702' ' ' ARG . 34.4 t0 -80.75 -42.29 22.06 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.752 -0.658 . . . . 0.0 111.92 -179.177 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 702' ' ' ARG . . . . . 0.412 ' HD2' ' O ' ' A' ' 701' ' ' ASP . 2.0 mpt_? -141.02 164.37 30.47 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.763 0.316 . . . . 0.0 110.657 -178.486 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 703' ' ' TYR . . . . . . . . . . . . . 52.5 p90 -131.36 144.58 51.34 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.496 179.3 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 704' ' ' ILE . . . . . 0.458 HD13 HG23 ' A' ' 704' ' ' ILE . 31.2 mm -123.41 101.46 37.49 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-N 116.056 -0.52 . . . . 0.0 109.69 179.397 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 705' ' ' PRO . . . . . 0.55 ' HA ' ' O ' ' A' ' 692' ' ' GLY . 69.0 Cg_endo -72.41 145.67 43.29 Favored 'Trans proline' 0 C--N 1.345 0.355 0 C-N-CA 122.304 2.003 . . . . 0.0 113.788 -179.093 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 706' ' ' LEU . . . . . 0.506 ' HA ' ' C ' ' A' ' 707' ' ' PRO . 81.5 mt -98.0 148.02 33.9 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-N 115.361 -0.836 . . . . 0.0 109.899 178.317 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 707' ' ' PRO . . . . . 0.506 ' C ' ' HA ' ' A' ' 706' ' ' LEU . 38.5 Cg_exo -64.34 138.22 31.72 Favored 'Cis proline' 0 C--N 1.348 0.551 0 C-N-CA 123.922 -1.283 . . . . 0.0 112.71 -1.219 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 708' ' ' ILE . . . . . . . . . . . . . 1.7 pt -68.04 137.42 24.6 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-O 121.383 0.611 . . . . 0.0 111.985 178.812 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 709' ' ' HIS . . . . . . . . . . . . . 69.8 m80 -107.15 111.2 63.54 Favored Pre-proline 0 C--N 1.321 -0.647 0 N-CA-C 108.377 -0.972 . . . . 0.0 108.377 177.297 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 710' ' ' PRO . . . . . . . . . . . . . 84.3 Cg_exo -53.03 -37.84 79.46 Favored 'Trans proline' 0 N--CA 1.479 0.636 0 C-N-CA 123.31 2.673 . . . . 0.0 114.381 -178.104 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 711' ' ' GLU . . . . . . . . . . . . . 88.7 tt0 -63.65 -42.88 98.06 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 112.208 0.447 . . . . 0.0 112.208 -178.903 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 712' ' ' SER . . . . . . . . . . . . . 51.1 m -90.64 -25.43 20.12 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 112.287 0.477 . . . . 0.0 112.287 -178.458 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 713' ' ' PHE . . . . . . . . . . . . . 68.1 t80 -59.25 -49.61 77.18 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-O 120.729 0.3 . . . . 0.0 111.228 -179.492 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 714' ' ' LEU . . . . . . . . . . . . . 58.3 tp -64.44 -41.28 96.66 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.259 179.731 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 715' ' ' GLN . . . . . . . . . . . . . 98.6 mm-40 -63.11 -42.55 99.58 Favored 'General case' 0 CA--C 1.531 0.245 0 CA-C-N 115.922 -0.581 . . . . 0.0 111.66 179.699 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 716' ' ' GLN . . . . . . . . . . . . . 79.6 mt-30 -64.13 -41.72 97.12 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-O 120.493 0.187 . . . . 0.0 111.349 179.947 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 717' ' ' VAL . . . . . . . . . . . . . 69.3 t -64.11 -44.16 97.59 Favored 'Isoleucine or valine' 0 C--O 1.234 0.248 0 CA-C-O 121.007 0.432 . . . . 0.0 109.945 178.758 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 718' ' ' THR . . . . . . . . . . . . . 90.3 m -61.88 -44.73 96.22 Favored 'General case' 0 CA--C 1.529 0.166 0 CA-C-N 115.673 -0.694 . . . . 0.0 111.041 179.708 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 719' ' ' MET . . . . . . . . . . . . . 38.7 mmt -61.31 -43.37 98.99 Favored 'General case' 0 N--CA 1.464 0.225 0 CA-C-O 120.545 0.212 . . . . 0.0 110.768 179.833 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 720' ' ' GLY . . . . . . . . . . . . . . . -64.03 -40.82 98.55 Favored Glycine 0 C--N 1.333 0.368 0 C-N-CA 120.747 -0.739 . . . . 0.0 111.624 178.235 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 721' ' ' LEU . . . . . . . . . . . . . 60.5 tp -64.64 -43.94 92.07 Favored 'General case' 0 CA--C 1.534 0.329 0 CA-C-N 115.349 -0.426 . . . . 0.0 111.353 179.327 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 722' ' ' THR . . . . . . . . . . . . . 70.4 p -70.74 -19.37 62.74 Favored 'General case' 0 N--CA 1.463 0.223 0 N-CA-C 112.127 0.418 . . . . 0.0 112.127 -179.958 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 723' ' ' SER . . . . . . . . . . . . . 73.3 m -63.65 -39.77 95.18 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-O 120.684 0.278 . . . . 0.0 110.582 179.111 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 724' ' ' LEU . . . . . . . . . . . . . 64.0 tp -63.56 -46.95 83.57 Favored 'General case' 0 C--O 1.232 0.153 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.232 179.526 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 725' ' ' ALA . . . . . . . . . . . . . . . -155.15 146.39 22.82 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.735 179.998 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 726' ' ' THR . . . . . . . . . . . . . 9.8 t -150.63 152.16 33.6 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.4 -0.364 . . . . 0.0 110.855 -179.806 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 727' ' ' SER . . . . . . . . . . . . . 90.2 p -87.99 -11.98 45.82 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.305 179.85 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 728' ' ' ALA . . . . . . . . . . . . . . . -149.15 150.57 32.89 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.445 -0.343 . . . . 0.0 110.89 -179.97 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 729' ' ' GLN . . . . . . . . . . . . . 9.1 tm0? . . . . . 0 C--O 1.249 1.052 0 CA-C-O 118.355 -0.831 . . . . 0.0 110.468 -179.874 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 613' ' ' GLU . . . . . 0.428 ' HA ' ' OXT' ' A' ' 729' ' ' GLN . 3.0 pt-20 . . . . . 0 N--CA 1.488 1.436 0 CA-C-O 121.084 0.469 . . . . 0.0 110.914 . . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 614' ' ' GLY . . . . . . . . . . . . . . . 108.42 131.52 6.46 Favored Glycine 0 N--CA 1.453 -0.229 0 CA-C-N 115.706 -0.679 . . . . 0.0 112.348 -179.94 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 615' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -117.23 125.23 50.81 Favored 'General case' 0 C--O 1.234 0.271 0 CA-C-O 120.802 0.334 . . . . 0.0 111.448 -179.394 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 616' ' ' ILE . . . . . 0.454 ' O ' ' HA ' ' A' ' 640' ' ' VAL . 85.9 mt -126.11 133.83 67.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 115.832 -0.622 . . . . 0.0 109.789 178.994 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 617' ' ' VAL . . . . . . . . . . . . . 91.5 t -106.78 127.94 61.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 121.055 0.455 . . . . 0.0 110.309 179.999 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 618' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -109.61 127.01 54.22 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.749 -0.66 . . . . 0.0 110.617 -178.93 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 619' ' ' VAL . . . . . . . . . . . . . 68.4 t -117.75 119.5 61.81 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-O 120.897 0.379 . . . . 0.0 110.186 179.979 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 620' ' ' SER . . . . . . . . . . . . . 32.1 t -171.36 137.9 1.14 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.638 -0.71 . . . . 0.0 110.923 -179.715 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 621' ' ' GLU . . . . . . . . . . . . . 26.3 pt-20 -82.99 -12.8 56.97 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.002 -0.545 . . . . 0.0 111.689 178.998 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 622' ' ' ASP . . . . . . . . . . . . . 35.8 t70 -91.22 110.06 21.33 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-O 120.884 0.373 . . . . 0.0 110.676 -179.333 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 623' ' ' GLU . . . . . . . . . . . . . 51.2 mp0 -63.16 -39.78 95.65 Favored 'General case' 0 CA--C 1.531 0.243 0 N-CA-C 112.763 0.653 . . . . 0.0 112.763 -178.854 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 624' ' ' ALA . . . . . . . . . . . . . . . -61.32 -45.73 93.22 Favored 'General case' 0 N--CA 1.464 0.246 0 N-CA-C 112.739 0.644 . . . . 0.0 112.739 -177.994 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 625' ' ' THR . . . . . 0.428 ' O ' HG22 ' A' ' 629' ' ' ILE . 89.7 m -70.84 -41.26 71.7 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.928 0.394 . . . . 0.0 110.623 179.629 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 626' ' ' SER . . . . . . . . . . . . . 66.7 m -62.47 -42.78 99.72 Favored 'General case' 0 CA--C 1.53 0.203 0 CA-C-N 115.713 -0.676 . . . . 0.0 112.468 -178.29 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 627' ' ' THR . . . . . . . . . . . . . 35.7 p -66.96 -39.65 87.31 Favored 'General case' 0 N--CA 1.466 0.345 0 N-CA-C 112.545 0.572 . . . . 0.0 112.545 -179.463 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 628' ' ' LEU . . . . . . . . . . . . . 62.9 tp -64.94 -47.07 78.99 Favored 'General case' 0 CA--C 1.533 0.322 0 N-CA-C 112.215 0.45 . . . . 0.0 112.215 -179.614 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 629' ' ' ILE . . . . . 0.428 HG22 ' O ' ' A' ' 625' ' ' THR . 16.0 tt -71.83 -36.55 58.83 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.395 0 N-CA-C 112.991 0.738 . . . . 0.0 112.991 -178.814 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 630' ' ' CYS . . . . . 0.454 ' SG ' HG12 ' A' ' 640' ' ' VAL . 85.8 m -62.63 -39.59 94.32 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-O 120.6 0.238 . . . . 0.0 111.242 -179.692 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 631' ' ' SER . . . . . . . . . . . . . 67.0 m -62.12 -41.23 98.02 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.684 179.7 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 632' ' ' ILE . . . . . . . . . . . . . 97.1 mt -63.02 -47.79 91.05 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.269 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.685 179.548 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 633' ' ' LEU . . . . . . . . . . . . . 79.8 mt -66.29 -40.34 89.97 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-N 115.902 -0.59 . . . . 0.0 112.335 -179.701 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 634' ' ' THR . . . . . 0.486 ' HA ' ' O ' ' A' ' 638' ' ' TYR . 77.1 m -65.94 -40.5 91.42 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 120.749 0.309 . . . . 0.0 110.629 -179.667 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 635' ' ' THR . . . . . . . . . . . . . 92.8 m -59.12 -38.82 80.5 Favored 'General case' 0 CA--C 1.529 0.161 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.248 178.983 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 636' ' ' ALA . . . . . . . . . . . . . . . -64.3 -17.48 63.69 Favored 'General case' 0 CA--C 1.533 0.294 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.363 178.759 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 637' ' ' GLY . . . . . . . . . . . . . . . 108.98 6.6 29.92 Favored Glycine 0 C--N 1.335 0.488 0 C-N-CA 121.063 -0.589 . . . . 0.0 113.331 179.61 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 638' ' ' TYR . . . . . 0.486 ' O ' ' HA ' ' A' ' 634' ' ' THR . 91.8 m-85 -100.35 141.72 32.81 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.913 0.356 . . . . 0.0 111.516 -179.862 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 639' ' ' GLN . . . . . . . . . . . . . 97.5 mt-30 -87.56 133.86 33.72 Favored 'General case' 0 CA--C 1.517 -0.307 0 N-CA-C 109.84 -0.43 . . . . 0.0 109.84 178.959 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 640' ' ' VAL . . . . . 0.454 ' HA ' ' O ' ' A' ' 616' ' ' ILE . 58.4 t -119.71 131.52 71.99 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 N-CA-C 112.69 0.626 . . . . 0.0 112.69 -179.022 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 641' ' ' ILE . . . . . . . . . . . . . 4.1 mp -109.57 116.35 51.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 N-CA-C 107.815 -1.18 . . . . 0.0 107.815 177.891 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 642' ' ' TRP . . . . . . . . . . . . . 20.9 t90 -96.64 125.77 41.34 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 112.549 0.574 . . . . 0.0 112.549 -177.695 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 643' ' ' LEU . . . . . . . . . . . . . 89.3 mt -122.61 143.48 49.73 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-N 115.417 -0.811 . . . . 0.0 110.594 179.304 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 644' ' ' VAL . . . . . . . . . . . . . 6.3 m -110.14 23.36 4.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 N-CA-C 112.565 0.58 . . . . 0.0 112.565 -179.799 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 645' ' ' ASP . . . . . . . . . . . . . 20.4 t0 -137.15 -34.71 0.71 Allowed 'General case' 0 N--CA 1.469 0.503 0 N-CA-C 113.221 0.823 . . . . 0.0 113.221 -178.24 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 646' ' ' GLY . . . . . . . . . . . . . . . 80.37 22.69 62.17 Favored Glycine 0 CA--C 1.522 0.476 0 C-N-CA 120.624 -0.798 . . . . 0.0 113.953 -179.683 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 647' ' ' GLU . . . . . . . . . . . . . 57.6 mm-40 -62.58 120.11 10.52 Favored 'General case' 0 C--O 1.231 0.124 0 CA-C-O 121.298 0.571 . . . . 0.0 111.104 179.98 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 648' ' ' VAL . . . . . . . . . . . . . 10.9 p -64.0 -31.02 51.62 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-N 114.941 -1.027 . . . . 0.0 111.974 -179.416 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 649' ' ' GLU . . . . . . . . . . . . . 78.8 mm-40 -63.54 -43.75 96.2 Favored 'General case' 0 C--O 1.232 0.144 0 N-CA-C 109.997 -0.371 . . . . 0.0 109.997 179.775 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 650' ' ' ARG . . . . . . . . . . . . . 74.6 mtm180 -71.63 -39.43 70.43 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.332 178.389 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 651' ' ' LEU . . . . . . . . . . . . . 85.8 mt -63.49 -41.7 98.56 Favored 'General case' 0 N--CA 1.462 0.172 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.187 179.027 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 652' ' ' LEU . . . . . . . . . . . . . 61.2 tp -64.61 -43.81 92.6 Favored 'General case' 0 CA--C 1.53 0.185 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.913 178.576 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 653' ' ' ALA . . . . . . . . . . . . . . . -62.97 -39.39 94.55 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.705 179.732 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 654' ' ' LEU . . . . . . . . . . . . . 75.2 mt -100.05 29.63 4.16 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.084 -179.413 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 655' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -31.59 104.33 0.22 Allowed Pre-proline 0 N--CA 1.473 0.718 0 O-C-N 124.527 1.142 . . . . 0.0 113.637 -179.516 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 656' ' ' PRO . . . . . . . . . . . . . 28.6 Cg_endo -93.56 177.91 1.19 Allowed 'Trans proline' 0 N--CA 1.461 -0.408 0 C-N-CA 123.634 2.889 . . . . 0.0 112.739 179.211 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 657' ' ' ILE . . . . . . . . . . . . . 89.6 mt -72.98 -38.49 56.12 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 N-CA-C 108.5 -0.926 . . . . 0.0 108.5 177.831 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 658' ' ' ALA . . . . . . . . . . . . . . . -151.66 155.06 37.6 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 114.216 -1.356 . . . . 0.0 111.609 -178.844 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 659' ' ' VAL . . . . . . . . . . . . . 17.5 m -122.06 146.38 27.29 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.897 178.924 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 660' ' ' LEU . . . . . . . . . . . . . 5.9 mt -117.85 116.99 28.08 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.525 -0.761 . . . . 0.0 110.277 179.263 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 661' ' ' LEU . . . . . . . . . . . . . 76.3 mt -106.22 113.6 27.23 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 179.44 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 662' ' ' ALA . . . . . . . . . . . . . . . -106.3 130.85 54.07 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 112.536 0.569 . . . . 0.0 112.536 -178.679 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 663' ' ' GLU . . . . . 0.45 ' HA ' ' C ' ' A' ' 664' ' ' PRO . 96.9 mt-10 -73.22 145.93 86.31 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-N 115.4 -0.818 . . . . 0.0 110.881 178.816 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 664' ' ' PRO . . . . . 0.45 ' C ' ' HA ' ' A' ' 663' ' ' GLU . 23.9 Cg_exo -67.38 136.8 34.27 Favored 'Cis proline' 0 C--N 1.349 0.57 0 C-N-CA 123.769 -1.346 . . . . 0.0 112.348 -1.697 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 665' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -72.79 116.15 12.93 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.921 179.66 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 666' ' ' SER . . . . . . . . . . . . . 80.2 p -64.83 -38.37 90.76 Favored 'General case' 0 CA--C 1.531 0.224 0 CA-C-N 116.131 -0.486 . . . . 0.0 112.257 -179.448 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 667' ' ' TYR . . . . . . . . . . . . . 69.1 t80 -65.67 -24.03 66.92 Favored 'General case' 0 CA--C 1.534 0.346 0 CA-C-O 120.766 0.317 . . . . 0.0 111.671 179.629 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 668' ' ' GLY . . . . . . . . . . . . . . . 100.27 -103.57 2.66 Favored Glycine 0 N--CA 1.45 -0.411 0 C-N-CA 120.395 -0.907 . . . . 0.0 112.283 -179.175 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 669' ' ' ASP . . . . . 0.433 ' OD2' ' HG3' ' A' ' 672' ' ' GLU . 27.6 t70 -82.52 103.99 12.47 Favored 'General case' 0 C--N 1.327 -0.402 0 O-C-N 122.671 -0.311 . . . . 0.0 110.246 -179.467 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 670' ' ' VAL . . . . . . . . . . . . . 16.9 m -66.46 -24.45 33.24 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.326 0 N-CA-C 113.116 0.784 . . . . 0.0 113.116 -179.126 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 671' ' ' GLN . . . . . 0.52 ' O ' HG22 ' A' ' 674' ' ' VAL . 23.7 mp0 -62.35 -39.71 93.99 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.882 0.372 . . . . 0.0 110.723 179.837 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 672' ' ' GLU . . . . . 0.433 ' HG3' ' OD2' ' A' ' 669' ' ' ASP . 95.6 mt-10 -64.89 -38.79 92.14 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.323 178.342 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 673' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -68.23 -46.67 69.89 Favored 'General case' 0 CA--C 1.519 -0.231 0 CA-C-N 115.925 -0.58 . . . . 0.0 111.322 179.981 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 674' ' ' VAL . . . . . 0.52 HG22 ' O ' ' A' ' 671' ' ' GLN . 34.3 m -65.37 -36.92 78.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 N-CA-C 109.977 -0.379 . . . . 0.0 109.977 -179.631 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 675' ' ' ASP . . . . . 0.424 ' O ' ' HB2' ' A' ' 679' ' ' GLN . 36.9 t70 -62.58 -40.86 98.22 Favored 'General case' 0 C--O 1.225 -0.232 0 N-CA-C 109.827 -0.435 . . . . 0.0 109.827 177.388 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 676' ' ' GLN . . . . . . . . . . . . . 55.3 mt-30 -70.64 -40.77 72.88 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.74 179.551 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 677' ' ' LEU . . . . . . . . . . . . . 85.2 mt -64.85 -41.17 95.92 Favored 'General case' 0 C--N 1.333 -0.113 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.28 179.559 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 678' ' ' ARG . . . . . 0.626 ' HA ' ' O ' ' A' ' 681' ' ' CYS . 84.9 mtp180 -81.9 -15.18 54.78 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-N 116.465 -0.334 . . . . 0.0 111.655 -179.312 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 679' ' ' GLN . . . . . 0.424 ' HB2' ' O ' ' A' ' 675' ' ' ASP . 53.1 tt0 -65.74 -39.9 91.57 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.154 179.835 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 680' ' ' ARG . . . . . 0.436 ' H ' ' HG2' ' A' ' 680' ' ' ARG . 0.0 OUTLIER -107.49 -29.12 9.4 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.405 -0.361 . . . . 0.0 111.909 -179.744 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 681' ' ' CYS . . . . . 0.626 ' O ' ' HA ' ' A' ' 678' ' ' ARG . 76.0 m -118.95 131.02 56.01 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.71 0.29 . . . . 0.0 110.563 179.684 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 682' ' ' THR . . . . . . . . . . . . . 63.4 p -72.69 158.08 87.87 Favored Pre-proline 0 C--N 1.325 -0.483 0 N-CA-C 110.09 -0.337 . . . . 0.0 110.09 179.859 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 683' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -60.02 -26.46 82.48 Favored 'Trans proline' 0 C--N 1.348 0.543 0 C-N-CA 122.169 1.913 . . . . 0.0 112.032 179.516 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 684' ' ' GLU . . . . . . . . . . . . . 51.6 mp0 -71.3 -38.74 71.75 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 121.063 0.459 . . . . 0.0 110.352 178.571 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 685' ' ' GLN . . . . . . . . . . . . . 90.1 mt-30 -72.42 -40.73 66.89 Favored 'General case' 0 N--CA 1.462 0.127 0 CA-C-N 115.611 -0.722 . . . . 0.0 111.942 179.516 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 686' ' ' LEU . . . . . . . . . . . . . 51.5 tp -131.31 119.25 21.48 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.501 -178.81 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 687' ' ' LYS . . . . . . . . . . . . . 75.2 mmtt -88.4 145.4 25.81 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.381 0.61 . . . . 0.0 110.647 179.191 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 688' ' ' ILE . . . . . . . . . . . . . 78.1 mt -123.78 120.91 61.05 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.679 0 CA-C-N 115.572 -0.74 . . . . 0.0 110.855 -179.072 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 689' ' ' PHE . . . . . 0.454 ' CD2' ' HB2' ' A' ' 702' ' ' ARG . 97.9 m-85 -118.76 144.78 46.06 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.09 -0.959 . . . . 0.0 110.096 179.418 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 690' ' ' ILE . . . . . . . . . . . . . 18.7 tt -127.01 139.96 50.42 Favored 'Isoleucine or valine' 0 C--O 1.236 0.363 0 CA-C-O 121.113 0.482 . . . . 0.0 111.196 179.518 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 691' ' ' LEU . . . . . 0.501 ' CD2' ' HB ' ' A' ' 704' ' ' ILE . 58.5 mt -110.37 133.23 53.46 Favored 'General case' 0 C--O 1.234 0.272 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.142 179.94 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 692' ' ' GLY . . . . . 0.587 ' O ' ' HA ' ' A' ' 705' ' ' PRO . . . 168.31 -176.56 42.71 Favored Glycine 0 N--CA 1.446 -0.666 0 CA-C-N 115.814 -0.63 . . . . 0.0 111.836 179.933 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 693' ' ' SER . . . . . . . . . . . . . 80.1 p -67.97 -36.62 80.35 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.811 0.339 . . . . 0.0 111.19 179.497 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 694' ' ' LYS . . . . . . . . . . . . . 64.7 mttp -124.39 136.77 54.33 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.045 0.45 . . . . 0.0 110.604 179.44 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 695' ' ' GLY . . . . . 0.504 ' HA3' ' CB ' ' A' ' 703' ' ' TYR . . . -103.56 14.01 53.98 Favored Glycine 0 N--CA 1.449 -0.438 0 CA-C-N 115.512 -0.767 . . . . 0.0 112.956 179.587 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 696' ' ' ASN . . . . . . . . . . . . . 64.9 t30 -82.03 72.29 9.08 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.958 0.408 . . . . 0.0 111.531 -179.091 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 697' ' ' TYR . . . . . . . . . . . . . 97.4 m-85 -131.37 144.92 51.58 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.175 178.959 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 698' ' ' GLN . . . . . . . . . . . . . 22.2 mp0 -82.4 147.21 28.91 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.747 179.81 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 699' ' ' GLY . . . . . . . . . . . . . . . 94.21 2.55 64.0 Favored Glycine 0 C--O 1.228 -0.224 0 C-N-CA 120.722 -0.752 . . . . 0.0 114.02 179.267 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 700' ' ' VAL . . . . . . . . . . . . . 24.9 m -119.61 150.51 22.1 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.298 0 CA-C-N 117.706 0.753 . . . . 0.0 110.165 179.283 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 701' ' ' ASP . . . . . . . . . . . . . 28.8 t0 -88.01 -39.79 14.39 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.958 -179.387 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 702' ' ' ARG . . . . . 0.454 ' HB2' ' CD2' ' A' ' 689' ' ' PHE . 90.7 mmt-85 -140.95 161.48 37.73 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.705 -178.394 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 703' ' ' TYR . . . . . 0.504 ' CB ' ' HA3' ' A' ' 695' ' ' GLY . 52.6 p90 -130.45 146.58 52.03 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.562 179.378 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 704' ' ' ILE . . . . . 0.501 ' HB ' ' CD2' ' A' ' 691' ' ' LEU . 52.9 mt -129.1 97.19 26.78 Favored Pre-proline 0 C--O 1.234 0.258 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.317 -179.982 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 705' ' ' PRO . . . . . 0.587 ' HA ' ' O ' ' A' ' 692' ' ' GLY . 74.5 Cg_endo -74.59 154.31 44.5 Favored 'Trans proline' 0 C--N 1.347 0.456 0 C-N-CA 122.92 2.413 . . . . 0.0 113.626 -179.126 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 706' ' ' LEU . . . . . 0.515 HD13 ' N ' ' A' ' 706' ' ' LEU . 7.2 mp -97.1 148.6 34.63 Favored Pre-proline 0 CA--C 1.531 0.25 0 CA-C-N 115.738 -0.664 . . . . 0.0 110.041 178.892 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 707' ' ' PRO . . . . . 0.474 ' C ' ' HA ' ' A' ' 706' ' ' LEU . 55.3 Cg_endo -69.48 138.41 48.19 Favored 'Cis proline' 0 C--N 1.347 0.495 0 C-N-CA 123.001 -1.666 . . . . 0.0 112.435 -0.293 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 708' ' ' ILE . . . . . . . . . . . . . 71.9 mt -81.16 118.94 29.81 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-N 115.859 -0.609 . . . . 0.0 110.55 -179.94 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 709' ' ' HIS . . . . . . . . . . . . . 68.6 m80 -89.45 122.55 68.29 Favored Pre-proline 0 C--N 1.327 -0.41 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.31 179.35 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 710' ' ' PRO . . . . . . . . . . . . . 88.2 Cg_exo -52.72 -38.65 77.38 Favored 'Trans proline' 0 N--CA 1.481 0.742 0 C-N-CA 123.474 2.782 . . . . 0.0 114.7 -178.622 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 711' ' ' GLU . . . . . . . . . . . . . 88.8 tt0 -64.03 -45.55 88.38 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-O 120.946 0.403 . . . . 0.0 111.59 -178.839 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 712' ' ' SER . . . . . . . . . . . . . 50.5 m -80.59 -26.67 37.73 Favored 'General case' 0 CA--C 1.516 -0.355 0 CA-C-N 116.09 -0.505 . . . . 0.0 111.181 -179.711 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 713' ' ' PHE . . . . . 0.539 ' O ' HG23 ' A' ' 717' ' ' VAL . 86.7 t80 -60.2 -50.0 75.4 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.668 -0.242 . . . . 0.0 111.069 -179.533 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 714' ' ' LEU . . . . . . . . . . . . . 1.5 mm? -66.31 -42.88 87.65 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-O 120.853 0.358 . . . . 0.0 110.746 179.876 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 715' ' ' GLN . . . . . . . . . . . . . 72.1 tp60 -63.19 -42.26 99.3 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.924 179.525 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 716' ' ' GLN . . . . . . . . . . . . . 70.0 tp60 -65.84 -41.51 91.64 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.852 179.694 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 717' ' ' VAL . . . . . 0.539 HG23 ' O ' ' A' ' 713' ' ' PHE . 55.7 t -63.41 -42.72 97.29 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.107 0 N-CA-C 109.875 -0.417 . . . . 0.0 109.875 178.524 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 718' ' ' THR . . . . . . . . . . . . . 91.9 m -61.09 -43.85 98.25 Favored 'General case' 0 C--O 1.235 0.298 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.364 179.13 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 719' ' ' MET . . . . . 0.57 ' O ' HG23 ' A' ' 722' ' ' THR . 18.3 tpt -61.17 -45.88 92.79 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.001 178.987 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 720' ' ' GLY . . . . . . . . . . . . . . . -65.27 -37.81 94.38 Favored Glycine 0 CA--C 1.52 0.364 0 CA-C-N 116.012 -0.54 . . . . 0.0 112.294 178.286 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 721' ' ' LEU . . . . . 0.432 ' O ' HD21 ' A' ' 724' ' ' LEU . 63.9 tp -60.99 -43.42 98.86 Favored 'General case' 0 N--CA 1.463 0.223 0 C-N-CA 123.255 0.622 . . . . 0.0 112.568 -179.359 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 722' ' ' THR . . . . . 0.57 HG23 ' O ' ' A' ' 719' ' ' MET . 5.4 t -64.99 161.68 18.16 Favored 'General case' 0 CA--C 1.534 0.345 0 CA-C-O 120.756 0.312 . . . . 0.0 111.595 -179.326 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 723' ' ' SER . . . . . . . . . . . . . 50.1 m 62.49 46.79 5.44 Favored 'General case' 0 N--CA 1.467 0.423 0 CA-C-N 115.946 -0.57 . . . . 0.0 111.227 -179.215 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 724' ' ' LEU . . . . . 0.465 HD11 ' O ' ' A' ' 726' ' ' THR . 1.3 pt? -119.87 -179.57 3.95 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.362 179.828 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 725' ' ' ALA . . . . . . . . . . . . . . . -78.41 -71.75 0.41 Allowed 'General case' 0 N--CA 1.462 0.154 0 N-CA-C 111.814 0.301 . . . . 0.0 111.814 -179.229 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 726' ' ' THR . . . . . 0.465 ' O ' HD11 ' A' ' 724' ' ' LEU . 77.8 p -130.75 149.98 52.14 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.585 0.231 . . . . 0.0 111.206 180.0 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 727' ' ' SER . . . . . . . . . . . . . 95.6 p -157.12 161.06 39.38 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.42 -0.355 . . . . 0.0 110.513 179.799 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 728' ' ' ALA . . . . . . . . . . . . . . . -149.61 147.14 27.77 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.374 -0.376 . . . . 0.0 110.527 179.519 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 729' ' ' GLN . . . . . 0.428 ' OXT' ' HA ' ' A' ' 613' ' ' GLU . 6.4 tm0? . . . . . 0 C--O 1.25 1.08 0 CA-C-O 118.063 -0.97 . . . . 0.0 110.377 179.885 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 613' ' ' GLU . . . . . . . . . . . . . 75.6 mm-40 . . . . . 0 N--CA 1.487 1.379 0 CA-C-O 120.895 0.379 . . . . 0.0 110.698 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 614' ' ' GLY . . . . . . . . . . . . . . . -178.85 173.34 45.61 Favored Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.662 -0.78 . . . . 0.0 112.534 179.863 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 615' ' ' ARG . . . . . . . . . . . . . 35.7 mtp-105 -117.32 126.55 52.9 Favored 'General case' 0 C--O 1.234 0.271 0 CA-C-O 120.72 0.295 . . . . 0.0 111.088 -179.873 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 616' ' ' ILE . . . . . 0.435 ' O ' ' HA ' ' A' ' 640' ' ' VAL . 84.7 mt -126.35 133.96 67.53 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.29 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.398 179.483 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 617' ' ' VAL . . . . . . . . . . . . . 77.2 t -104.53 127.67 58.73 Favored 'Isoleucine or valine' 0 C--O 1.234 0.289 0 CA-C-O 120.995 0.426 . . . . 0.0 109.887 179.658 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 618' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -111.92 127.44 55.85 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.809 -0.632 . . . . 0.0 111.02 -178.456 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 619' ' ' VAL . . . . . . . . . . . . . 80.4 t -115.73 117.75 56.58 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 N-CA-C 109.262 -0.644 . . . . 0.0 109.262 179.405 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 620' ' ' SER . . . . . . . . . . . . . 47.2 t -162.23 139.8 8.48 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.944 -0.571 . . . . 0.0 111.554 -178.838 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 621' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -82.15 -26.89 33.05 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.747 -0.661 . . . . 0.0 111.182 178.705 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 622' ' ' ASP . . . . . . . . . . . . . 36.9 t70 -86.08 112.74 21.55 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.921 0.391 . . . . 0.0 111.64 -178.32 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 623' ' ' GLU . . . . . 0.416 ' O ' HG22 ' A' ' 627' ' ' THR . 50.9 mp0 -62.9 -40.02 96.3 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.438 -0.801 . . . . 0.0 112.447 -179.593 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 624' ' ' ALA . . . . . . . . . . . . . . . -60.8 -45.53 94.04 Favored 'General case' 0 N--CA 1.466 0.337 0 N-CA-C 112.592 0.59 . . . . 0.0 112.592 -178.283 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 625' ' ' THR . . . . . 0.45 ' O ' HG22 ' A' ' 629' ' ' ILE . 90.6 m -68.8 -39.86 79.87 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.965 0.412 . . . . 0.0 110.021 179.538 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 626' ' ' SER . . . . . . . . . . . . . 69.1 m -61.44 -41.13 96.73 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.494 -0.775 . . . . 0.0 111.866 -178.937 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 627' ' ' THR . . . . . 0.416 HG22 ' O ' ' A' ' 623' ' ' GLU . 65.9 p -67.37 -35.23 78.92 Favored 'General case' 0 N--CA 1.466 0.336 0 N-CA-C 112.382 0.512 . . . . 0.0 112.382 -179.812 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 628' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -71.72 -49.42 39.55 Favored 'General case' 0 N--CA 1.463 0.22 0 N-CA-C 111.925 0.343 . . . . 0.0 111.925 -179.47 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 629' ' ' ILE . . . . . 0.45 HG22 ' O ' ' A' ' 625' ' ' THR . 18.7 tt -68.34 -37.52 78.05 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.384 0 N-CA-C 112.19 0.441 . . . . 0.0 112.19 -179.124 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 630' ' ' CYS . . . . . . . . . . . . . 48.2 t -61.61 -43.66 98.44 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.857 179.776 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 631' ' ' SER . . . . . . . . . . . . . 70.2 m -61.91 -41.51 98.0 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.962 -179.611 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 632' ' ' ILE . . . . . . . . . . . . . 97.4 mt -62.45 -48.54 87.8 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.283 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.863 179.819 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 633' ' ' LEU . . . . . . . . . . . . . 84.3 mt -67.2 -40.0 86.4 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-N 115.867 -0.606 . . . . 0.0 112.395 -179.708 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 634' ' ' THR . . . . . 0.518 ' HA ' ' O ' ' A' ' 638' ' ' TYR . 77.7 m -65.74 -40.08 91.76 Favored 'General case' 0 CA--C 1.529 0.168 0 CA-C-O 120.701 0.286 . . . . 0.0 110.852 -179.458 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 635' ' ' THR . . . . . . . . . . . . . 93.2 m -59.09 -38.95 80.71 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.261 179.28 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 636' ' ' ALA . . . . . . . . . . . . . . . -64.67 -16.84 63.44 Favored 'General case' 0 CA--C 1.533 0.305 0 CA-C-N 115.931 -0.577 . . . . 0.0 111.329 178.905 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 637' ' ' GLY . . . . . . . . . . . . . . . 108.67 7.34 29.82 Favored Glycine 0 C--N 1.333 0.413 0 C-N-CA 120.929 -0.653 . . . . 0.0 113.182 179.681 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 638' ' ' TYR . . . . . 0.518 ' O ' ' HA ' ' A' ' 634' ' ' THR . 96.5 m-85 -100.23 141.46 33.05 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.803 0.302 . . . . 0.0 111.415 -179.847 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 639' ' ' GLN . . . . . . . . . . . . . 78.5 mt-30 -87.91 133.26 33.96 Favored 'General case' 0 CA--C 1.517 -0.325 0 N-CA-C 109.796 -0.446 . . . . 0.0 109.796 179.199 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 640' ' ' VAL . . . . . 0.435 ' HA ' ' O ' ' A' ' 616' ' ' ILE . 60.1 t -118.11 130.47 72.93 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 N-CA-C 112.547 0.573 . . . . 0.0 112.547 -179.161 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 641' ' ' ILE . . . . . . . . . . . . . 4.0 mp -109.36 115.37 49.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 N-CA-C 108.013 -1.106 . . . . 0.0 108.013 178.09 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 642' ' ' TRP . . . . . . . . . . . . . 22.0 t90 -94.47 126.03 39.49 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 121.237 0.541 . . . . 0.0 112.26 -177.986 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 643' ' ' LEU . . . . . . . . . . . . . 89.6 mt -121.15 142.89 49.45 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-N 115.407 -0.815 . . . . 0.0 110.779 179.531 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 644' ' ' VAL . . . . . . . . . . . . . 5.7 m -102.93 27.26 1.01 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.81 179.711 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 645' ' ' ASP . . . . . 0.411 ' O ' ' HB2' ' A' ' 666' ' ' SER . 33.6 t70 -142.48 -73.86 0.3 Allowed 'General case' 0 N--CA 1.465 0.296 0 CA-C-O 120.736 0.303 . . . . 0.0 111.76 -179.458 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 646' ' ' GLY . . . . . . . . . . . . . . . 104.93 27.14 6.06 Favored Glycine 0 CA--C 1.518 0.278 0 C-N-CA 120.819 -0.705 . . . . 0.0 113.612 -179.894 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 647' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -71.07 143.35 50.72 Favored 'General case' 0 N--CA 1.453 -0.302 0 CA-C-O 121.529 0.681 . . . . 0.0 110.93 179.436 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 648' ' ' VAL . . . . . . . . . . . . . 78.5 t -61.22 -40.13 84.9 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 CA-C-N 114.553 -1.203 . . . . 0.0 112.666 -178.231 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 649' ' ' GLU . . . . . . . . . . . . . 98.3 mt-10 -60.31 -45.03 94.83 Favored 'General case' 0 C--O 1.232 0.157 0 C-N-CA 120.58 -0.448 . . . . 0.0 111.339 -178.531 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 650' ' ' ARG . . . . . . . . . . . . . 54.8 mmm-85 -71.02 -40.6 71.68 Favored 'General case' 0 C--N 1.33 -0.25 0 C-N-CA 121.02 -0.272 . . . . 0.0 110.987 178.682 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 651' ' ' LEU . . . . . . . . . . . . . 86.4 mt -64.52 -41.65 96.26 Favored 'General case' 0 N--CA 1.461 0.105 0 CA-C-N 116.438 -0.346 . . . . 0.0 110.615 179.393 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 652' ' ' LEU . . . . . . . . . . . . . 60.8 tp -65.81 -43.37 88.84 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.226 178.751 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 653' ' ' ALA . . . . . . . . . . . . . . . -63.02 -39.72 95.6 Favored 'General case' 0 N--CA 1.466 0.332 0 N-CA-C 112.075 0.398 . . . . 0.0 112.075 -179.802 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 654' ' ' LEU . . . . . . . . . . . . . 75.3 mt -101.74 29.15 5.1 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.091 -179.354 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 655' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -33.92 104.96 0.25 Allowed Pre-proline 0 N--CA 1.472 0.651 0 O-C-N 124.571 1.169 . . . . 0.0 114.095 -179.094 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 656' ' ' PRO . . . . . . . . . . . . . 22.8 Cg_endo -93.72 -179.35 0.81 Allowed 'Trans proline' 0 C--N 1.345 0.385 0 C-N-CA 123.814 3.009 . . . . 0.0 112.473 178.271 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 657' ' ' ILE . . . . . 0.442 ' O ' ' HA ' ' A' ' 686' ' ' LEU . 94.9 mt -72.04 -38.17 62.79 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 N-CA-C 108.557 -0.905 . . . . 0.0 108.557 177.765 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 658' ' ' ALA . . . . . . . . . . . . . . . -152.61 155.73 37.92 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 114.282 -1.326 . . . . 0.0 111.552 -178.598 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 659' ' ' VAL . . . . . . . . . . . . . 18.3 m -122.05 145.45 28.73 Favored 'Isoleucine or valine' 0 C--O 1.235 0.316 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.942 178.971 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 660' ' ' LEU . . . . . . . . . . . . . 5.4 mt -116.44 115.02 25.06 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.507 -0.77 . . . . 0.0 109.215 178.435 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 661' ' ' LEU . . . . . . . . . . . . . 62.0 mt -104.24 115.6 30.7 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 109.813 -0.44 . . . . 0.0 109.813 -179.088 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 662' ' ' ALA . . . . . . . . . . . . . . . -108.42 132.23 53.98 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 112.763 0.653 . . . . 0.0 112.763 -178.973 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 663' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -76.65 146.14 76.23 Favored Pre-proline 0 C--N 1.326 -0.421 0 CA-C-N 115.376 -0.829 . . . . 0.0 109.978 178.081 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 664' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -72.43 139.97 63.59 Favored 'Cis proline' 0 C--N 1.348 0.551 0 C-N-CA 123.446 -1.481 . . . . 0.0 112.897 -0.751 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 665' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -83.87 144.52 29.18 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.366 -0.833 . . . . 0.0 112.27 -179.816 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 666' ' ' SER . . . . . 0.411 ' HB2' ' O ' ' A' ' 645' ' ' ASP . 47.9 m -98.04 -33.74 11.06 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.251 179.301 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 667' ' ' TYR . . . . . . . . . . . . . 18.9 p90 -61.67 -16.11 45.84 Favored 'General case' 0 CA--C 1.536 0.409 0 N-CA-C 112.7 0.63 . . . . 0.0 112.7 179.863 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 668' ' ' GLY . . . . . . . . . . . . . . . 101.47 -120.38 6.84 Favored Glycine 0 N--CA 1.449 -0.489 0 C-N-CA 120.614 -0.803 . . . . 0.0 113.523 179.228 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 669' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -76.26 118.52 19.06 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.995 0.426 . . . . 0.0 111.849 -178.07 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 670' ' ' VAL . . . . . 0.435 ' O ' HG22 ' A' ' 674' ' ' VAL . 77.8 t -61.78 -43.15 96.85 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.289 0 CA-C-N 115.446 -0.797 . . . . 0.0 112.345 -179.469 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 671' ' ' GLN . . . . . . . . . . . . . 20.8 mp0 -60.76 -42.53 97.65 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.562 0.22 . . . . 0.0 111.447 -178.029 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 672' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -65.11 -40.32 94.35 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.515 -0.311 . . . . 0.0 110.957 179.408 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 673' ' ' LEU . . . . . . . . . . . . . 63.1 tp -63.4 -43.52 97.3 Favored 'General case' 0 C--N 1.331 -0.23 0 N-CA-C 109.561 -0.533 . . . . 0.0 109.561 178.754 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 674' ' ' VAL . . . . . 0.435 HG22 ' O ' ' A' ' 670' ' ' VAL . 55.0 t -61.83 -44.86 99.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 115.18 -0.918 . . . . 0.0 110.107 179.438 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 675' ' ' ASP . . . . . . . . . . . . . 99.5 m-20 -60.91 -39.61 89.99 Favored 'General case' 0 CA--C 1.519 -0.226 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.47 179.015 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 676' ' ' GLN . . . . . 0.405 ' O ' ' HG2' ' A' ' 680' ' ' ARG . 57.2 mt-30 -70.77 -41.85 71.19 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.396 -0.366 . . . . 0.0 110.709 179.788 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 677' ' ' LEU . . . . . . . . . . . . . 84.8 mt -65.21 -42.67 93.25 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.113 179.457 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 678' ' ' ARG . . . . . 0.486 ' HA ' ' O ' ' A' ' 681' ' ' CYS . 82.9 mtp180 -69.66 -35.71 75.4 Favored 'General case' 0 N--CA 1.468 0.444 0 CA-C-O 120.958 0.409 . . . . 0.0 111.194 179.677 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 679' ' ' GLN . . . . . . . . . . . . . 55.1 tt0 -63.93 -37.67 88.26 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.739 -0.664 . . . . 0.0 110.247 179.444 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 680' ' ' ARG . . . . . 0.405 ' HG2' ' O ' ' A' ' 676' ' ' GLN . 88.2 mmt-85 -84.47 -45.18 12.92 Favored 'General case' 0 N--CA 1.461 0.109 0 CA-C-N 116.321 -0.399 . . . . 0.0 110.97 179.749 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 681' ' ' CYS . . . . . 0.486 ' O ' ' HA ' ' A' ' 678' ' ' ARG . 76.8 m -127.99 132.19 49.19 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.408 179.944 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 682' ' ' THR . . . . . . . . . . . . . 69.3 p -67.55 157.5 85.72 Favored Pre-proline 0 C--N 1.322 -0.618 0 CA-C-N 116.49 -0.323 . . . . 0.0 110.233 179.891 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 683' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -59.41 -26.52 82.23 Favored 'Trans proline' 0 C--N 1.348 0.507 0 C-N-CA 122.167 1.912 . . . . 0.0 111.918 179.751 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 684' ' ' GLU . . . . . . . . . . . . . 51.9 mp0 -71.75 -38.59 70.39 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.278 0.561 . . . . 0.0 109.977 178.348 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 685' ' ' GLN . . . . . . . . . . . . . 64.9 tt0 -71.61 -41.55 68.76 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-N 115.35 -0.841 . . . . 0.0 111.418 -179.943 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 686' ' ' LEU . . . . . 0.442 ' HA ' ' O ' ' A' ' 657' ' ' ILE . 0.1 OUTLIER -138.92 127.4 23.06 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.727 -178.867 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 687' ' ' LYS . . . . . . . . . . . . . 21.2 mtmm -91.92 146.59 23.62 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.344 0.592 . . . . 0.0 110.661 179.242 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 688' ' ' ILE . . . . . . . . . . . . . 77.3 mt -122.75 123.56 68.55 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 CA-C-N 115.733 -0.667 . . . . 0.0 111.021 -179.277 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 689' ' ' PHE . . . . . . . . . . . . . 93.3 m-85 -122.75 147.29 46.67 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.409 -0.814 . . . . 0.0 110.408 179.166 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 690' ' ' ILE . . . . . . . . . . . . . 19.7 tt -126.66 140.88 47.66 Favored 'Isoleucine or valine' 0 C--O 1.235 0.326 0 CA-C-O 121.332 0.587 . . . . 0.0 111.965 -179.481 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 691' ' ' LEU . . . . . 0.443 ' CD2' ' HB ' ' A' ' 704' ' ' ILE . 77.6 mt -112.42 140.32 47.26 Favored 'General case' 0 C--O 1.234 0.263 0 CA-C-N 115.376 -0.829 . . . . 0.0 109.886 179.498 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 692' ' ' GLY . . . . . 0.421 ' O ' ' HA ' ' A' ' 705' ' ' PRO . . . 179.14 -167.64 37.92 Favored Glycine 0 N--CA 1.446 -0.658 0 C-N-CA 120.84 -0.695 . . . . 0.0 111.818 -179.675 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 693' ' ' SER . . . . . . . . . . . . . 79.9 p -63.24 -37.26 86.55 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.987 0.422 . . . . 0.0 111.019 179.836 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 694' ' ' LYS . . . . . . . . . . . . . 2.6 mmmt -143.35 -47.44 0.3 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.716 179.383 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 695' ' ' GLY . . . . . . . . . . . . . . . 114.78 129.26 4.66 Favored Glycine 0 N--CA 1.451 -0.302 0 N-CA-C 111.461 -0.656 . . . . 0.0 111.461 -179.442 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 696' ' ' ASN . . . . . . . . . . . . . 48.6 p-10 -81.11 -15.88 54.67 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 116.899 0.349 . . . . 0.0 111.822 -179.215 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 697' ' ' TYR . . . . . . . . . . . . . 2.6 t80 48.46 48.49 19.27 Favored 'General case' 0 N--CA 1.467 0.411 0 N-CA-C 112.774 0.657 . . . . 0.0 112.774 179.688 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 698' ' ' GLN . . . . . . . . . . . . . 98.5 mm-40 -111.41 96.96 6.42 Favored 'General case' 0 N--CA 1.454 -0.266 0 O-C-N 122.168 -0.333 . . . . 0.0 110.809 179.634 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 699' ' ' GLY . . . . . 0.426 ' O ' HG13 ' A' ' 674' ' ' VAL . . . 81.42 14.34 78.67 Favored Glycine 0 CA--C 1.521 0.447 0 C-N-CA 120.49 -0.862 . . . . 0.0 113.837 179.339 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 700' ' ' VAL . . . . . . . . . . . . . 33.1 m -116.08 151.66 17.84 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 117.378 0.589 . . . . 0.0 110.502 -179.757 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 701' ' ' ASP . . . . . . . . . . . . . 37.4 t70 -70.37 -42.86 71.21 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.483 -0.781 . . . . 0.0 111.891 -179.052 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 702' ' ' ARG . . . . . . . . . . . . . 77.5 mtp85 -145.66 158.47 43.84 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.904 0.383 . . . . 0.0 111.167 -178.795 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 703' ' ' TYR . . . . . . . . . . . . . 50.4 p90 -120.48 136.2 54.83 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 108.918 -0.771 . . . . 0.0 108.918 178.539 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 704' ' ' ILE . . . . . 0.443 ' HB ' ' CD2' ' A' ' 691' ' ' LEU . 42.5 mt -125.36 98.91 34.35 Favored Pre-proline 0 C--N 1.328 -0.366 0 C-N-CA 120.512 -0.475 . . . . 0.0 111.851 -179.115 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 705' ' ' PRO . . . . . 0.421 ' HA ' ' O ' ' A' ' 692' ' ' GLY . 32.5 Cg_exo -61.59 142.96 96.43 Favored 'Trans proline' 0 C--N 1.345 0.382 0 C-N-CA 123.304 2.669 . . . . 0.0 113.226 179.239 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 706' ' ' LEU . . . . . . . . . . . . . 87.7 mt -98.35 149.91 36.21 Favored Pre-proline 0 C--N 1.328 -0.359 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.028 178.796 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 707' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -72.35 139.84 62.71 Favored 'Cis proline' 0 C--N 1.345 0.388 0 C-N-CA 123.112 -1.62 . . . . 0.0 112.866 -0.138 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 708' ' ' ILE . . . . . . . . . . . . . 4.1 pt -63.67 145.13 13.96 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-N 115.538 -0.755 . . . . 0.0 112.071 178.843 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 709' ' ' HIS . . . . . . . . . . . . . 69.9 m80 -103.17 112.34 65.67 Favored Pre-proline 0 C--N 1.321 -0.668 0 N-CA-C 107.771 -1.196 . . . . 0.0 107.771 177.496 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 710' ' ' PRO . . . . . . . . . . . . . 20.1 Cg_endo -59.3 -30.18 92.2 Favored 'Trans proline' 0 N--CA 1.474 0.332 0 C-N-CA 122.658 2.238 . . . . 0.0 114.305 -177.31 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 711' ' ' GLU . . . . . . . . . . . . . 51.5 mp0 -66.67 -40.67 88.71 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 112.159 0.429 . . . . 0.0 112.159 -179.249 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 712' ' ' SER . . . . . . . . . . . . . 80.8 p -99.22 -17.91 17.89 Favored 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 112.401 0.519 . . . . 0.0 112.401 -178.701 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 713' ' ' PHE . . . . . . . . . . . . . 91.4 t80 -60.33 -49.08 79.0 Favored 'General case' 0 C--O 1.232 0.167 0 CA-C-O 120.789 0.328 . . . . 0.0 110.66 179.96 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 714' ' ' LEU . . . . . . . . . . . . . 87.9 mt -64.62 -38.45 91.06 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.524 179.311 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 715' ' ' GLN . . . . . . . . . . . . . 97.8 mt-30 -62.93 -42.61 99.86 Favored 'General case' 0 N--CA 1.461 0.096 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.144 179.541 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 716' ' ' GLN . . . . . . . . . . . . . 57.1 mt-30 -65.23 -41.0 94.82 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-N 116.584 -0.28 . . . . 0.0 111.027 179.956 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 717' ' ' VAL . . . . . . . . . . . . . 67.0 t -62.98 -44.78 99.86 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.171 0 N-CA-C 109.83 -0.433 . . . . 0.0 109.83 178.887 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 718' ' ' THR . . . . . . . . . . . . . 90.3 m -62.14 -45.24 94.3 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 115.586 -0.734 . . . . 0.0 110.853 179.472 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 719' ' ' MET . . . . . . . . . . . . . 38.6 mmt -62.05 -43.39 98.94 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 116.722 -0.217 . . . . 0.0 110.719 179.64 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 720' ' ' GLY . . . . . . . . . . . . . . . -63.68 -41.01 99.15 Favored Glycine 0 C--N 1.333 0.378 0 C-N-CA 120.693 -0.765 . . . . 0.0 111.482 178.232 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 721' ' ' LEU . . . . . . . . . . . . . 62.7 tp -63.4 -44.81 93.59 Favored 'General case' 0 CA--C 1.532 0.255 0 CA-C-N 115.329 -0.436 . . . . 0.0 111.137 179.118 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 722' ' ' THR . . . . . . . . . . . . . 71.5 p -69.66 -24.0 63.55 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-N 116.556 -0.293 . . . . 0.0 111.598 179.91 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 723' ' ' SER . . . . . . . . . . . . . 74.3 m -63.83 -39.61 94.64 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.82 0.343 . . . . 0.0 110.258 178.692 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 724' ' ' LEU . . . . . . . . . . . . . 65.1 tp -62.99 -47.08 84.66 Favored 'General case' 0 C--O 1.233 0.237 0 CA-C-N 115.827 -0.624 . . . . 0.0 111.338 179.539 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 725' ' ' ALA . . . . . . . . . . . . . . . -155.25 147.44 23.72 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.926 179.967 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 726' ' ' THR . . . . . . . . . . . . . 70.0 p -70.51 -28.04 64.66 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.594 -179.911 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 727' ' ' SER . . . . . . . . . . . . . 50.2 m 58.26 38.06 26.09 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-N 115.934 -0.575 . . . . 0.0 111.483 -179.938 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 728' ' ' ALA . . . . . . . . . . . . . . . -147.82 153.15 38.8 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.757 -179.989 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 729' ' ' GLN . . . . . . . . . . . . . 98.5 mm-40 . . . . . 0 C--O 1.247 0.961 0 CA-C-O 118.337 -0.84 . . . . 0.0 110.858 179.971 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 613' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 . . . . . 0 N--CA 1.484 1.269 0 CA-C-O 120.779 0.324 . . . . 0.0 110.704 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 614' ' ' GLY . . . . . . . . . . . . . . . -158.69 165.06 33.91 Favored Glycine 0 N--CA 1.449 -0.466 0 C-N-CA 121.046 -0.597 . . . . 0.0 111.659 179.704 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 615' ' ' ARG . . . . . . . . . . . . . 89.7 mtm180 -116.8 129.4 56.07 Favored 'General case' 0 C--O 1.235 0.328 0 CA-C-O 120.929 0.395 . . . . 0.0 111.278 -179.547 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 616' ' ' ILE . . . . . 0.418 ' O ' ' HA ' ' A' ' 640' ' ' VAL . 86.0 mt -126.92 134.15 66.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 115.808 -0.633 . . . . 0.0 109.882 178.929 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 617' ' ' VAL . . . . . . . . . . . . . 99.4 t -107.35 126.66 63.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 120.955 0.407 . . . . 0.0 110.253 -179.862 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 618' ' ' LEU . . . . . . . . . . . . . 1.1 tt -108.91 126.52 53.16 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.534 -179.076 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 619' ' ' VAL . . . . . 0.428 ' HA ' ' O ' ' A' ' 643' ' ' LEU . 79.8 t -116.39 118.14 57.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-O 121.197 0.522 . . . . 0.0 110.355 -179.861 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 620' ' ' SER . . . . . 0.559 ' HB3' ' HB3' ' A' ' 662' ' ' ALA . 84.6 p -166.64 164.2 16.83 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.006 -0.997 . . . . 0.0 110.506 -179.52 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 621' ' ' GLU . . . . . . . . . . . . . 61.1 mt-10 -104.29 -12.52 16.58 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.911 -0.586 . . . . 0.0 111.787 178.606 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 622' ' ' ASP . . . . . . . . . . . . . 36.3 t70 -96.33 110.33 22.68 Favored 'General case' 0 C--O 1.232 0.136 0 CA-C-O 121.123 0.487 . . . . 0.0 111.895 -178.442 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 623' ' ' GLU . . . . . 0.407 ' O ' HG23 ' A' ' 627' ' ' THR . 88.5 tt0 -63.62 -40.04 95.89 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.292 -0.867 . . . . 0.0 112.606 179.977 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 624' ' ' ALA . . . . . . . . . . . . . . . -60.74 -45.52 93.99 Favored 'General case' 0 N--CA 1.466 0.371 0 N-CA-C 112.908 0.707 . . . . 0.0 112.908 -177.596 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 625' ' ' THR . . . . . . . . . . . . . 92.2 m -68.37 -39.11 81.89 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.199 0.523 . . . . 0.0 109.837 179.547 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 626' ' ' SER . . . . . . . . . . . . . 66.7 m -61.16 -40.55 94.28 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.124 -0.944 . . . . 0.0 112.435 -178.873 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 627' ' ' THR . . . . . 0.407 HG23 ' O ' ' A' ' 623' ' ' GLU . 72.3 p -64.3 -39.29 93.63 Favored 'General case' 0 N--CA 1.465 0.288 0 N-CA-C 112.388 0.514 . . . . 0.0 112.388 -179.015 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 628' ' ' LEU . . . . . . . . . . . . . 62.2 tp -69.9 -45.89 66.62 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 112.229 0.455 . . . . 0.0 112.229 -179.636 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 629' ' ' ILE . . . . . . . . . . . . . 19.6 tt -71.51 -37.15 63.09 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.451 0 N-CA-C 112.885 0.698 . . . . 0.0 112.885 -178.391 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 630' ' ' CYS . . . . . . . . . . . . . 87.7 m -63.21 -38.8 92.59 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-O 120.711 0.291 . . . . 0.0 111.002 179.927 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 631' ' ' SER . . . . . . . . . . . . . 71.8 m -61.72 -40.25 94.39 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.73 -179.909 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 632' ' ' ILE . . . . . . . . . . . . . 96.8 mt -62.32 -49.57 83.41 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.314 0 CA-C-O 121.093 0.473 . . . . 0.0 110.725 179.895 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 633' ' ' LEU . . . . . . . . . . . . . 90.6 mt -66.99 -40.21 87.31 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-N 115.652 -0.704 . . . . 0.0 112.522 -179.507 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 634' ' ' THR . . . . . 0.545 ' HA ' ' O ' ' A' ' 638' ' ' TYR . 82.7 m -65.83 -40.68 92.02 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-O 120.699 0.285 . . . . 0.0 111.103 -179.389 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 635' ' ' THR . . . . . . . . . . . . . 92.2 m -58.85 -38.57 79.06 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.351 179.208 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 636' ' ' ALA . . . . . . . . . . . . . . . -64.7 -17.12 63.81 Favored 'General case' 0 CA--C 1.532 0.288 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.357 178.837 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 637' ' ' GLY . . . . . . . . . . . . . . . 108.91 6.9 29.84 Favored Glycine 0 C--N 1.334 0.467 0 C-N-CA 120.973 -0.632 . . . . 0.0 113.21 179.767 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 638' ' ' TYR . . . . . 0.545 ' O ' ' HA ' ' A' ' 634' ' ' THR . 97.1 m-85 -100.74 142.27 32.44 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.878 0.37 . . . . 0.0 111.479 -179.802 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 639' ' ' GLN . . . . . . . . . . . . . 78.9 mt-30 -89.32 135.81 33.38 Favored 'General case' 0 CA--C 1.519 -0.226 0 CA-C-N 116.243 -0.435 . . . . 0.0 109.96 179.308 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 640' ' ' VAL . . . . . 0.418 ' HA ' ' O ' ' A' ' 616' ' ' ILE . 57.8 t -118.63 131.04 72.55 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-O 121.121 0.486 . . . . 0.0 112.272 -179.123 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 641' ' ' ILE . . . . . . . . . . . . . 46.0 mm -110.14 118.62 57.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 N-CA-C 108.348 -0.982 . . . . 0.0 108.348 178.248 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 642' ' ' TRP . . . . . . . . . . . . . 24.2 t90 -92.83 127.11 38.22 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 112.534 0.568 . . . . 0.0 112.534 -178.104 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 643' ' ' LEU . . . . . 0.428 ' O ' ' HA ' ' A' ' 619' ' ' VAL . 4.0 mp -123.6 137.55 54.72 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.471 -0.786 . . . . 0.0 110.109 178.886 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 644' ' ' VAL . . . . . . . . . . . . . 19.1 m -101.56 12.4 6.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 N-CA-C 112.03 0.382 . . . . 0.0 112.03 -179.798 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 645' ' ' ASP . . . . . 0.51 ' O ' ' HB2' ' A' ' 666' ' ' SER . 12.0 t0 -126.87 -72.99 0.62 Allowed 'General case' 0 N--CA 1.466 0.355 0 N-CA-C 111.98 0.363 . . . . 0.0 111.98 -178.82 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 646' ' ' GLY . . . . . . . . . . . . . . . 105.45 29.13 5.19 Favored Glycine 0 CA--C 1.519 0.328 0 C-N-CA 120.61 -0.805 . . . . 0.0 113.898 -179.939 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 647' ' ' GLU . . . . . . . . . . . . . 79.4 mm-40 -67.95 133.53 49.23 Favored 'General case' 0 N--CA 1.454 -0.255 0 CA-C-N 117.161 0.481 . . . . 0.0 110.236 179.243 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 648' ' ' VAL . . . . . . . . . . . . . 11.2 p -62.94 -32.76 57.17 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.587 0 CA-C-N 115.139 -0.937 . . . . 0.0 112.283 -178.594 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 649' ' ' GLU . . . . . . . . . . . . . 95.4 mt-10 -63.45 -44.96 93.01 Favored 'General case' 0 C--O 1.232 0.178 0 CA-C-O 120.982 0.42 . . . . 0.0 110.251 179.883 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 650' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -72.65 -40.97 65.96 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.918 178.775 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 651' ' ' LEU . . . . . . . . . . . . . 88.3 mt -63.95 -40.9 97.48 Favored 'General case' 0 N--CA 1.462 0.174 0 CA-C-N 116.428 -0.351 . . . . 0.0 110.786 179.339 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 652' ' ' LEU . . . . . . . . . . . . . 63.0 tp -65.04 -43.77 91.27 Favored 'General case' 0 CA--C 1.534 0.334 0 CA-C-N 116.488 -0.324 . . . . 0.0 110.985 178.719 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 653' ' ' ALA . . . . . . . . . . . . . . . -63.29 -39.99 96.11 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-O 121.129 0.49 . . . . 0.0 111.553 -179.93 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 654' ' ' LEU . . . . . . . . . . . . . 76.2 mt -100.63 30.12 4.13 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.591 -0.731 . . . . 0.0 110.023 179.916 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 655' ' ' THR . . . . . . . . . . . . . 5.1 t -44.03 108.16 0.68 Allowed Pre-proline 0 CA--C 1.537 0.461 0 O-C-N 124.197 0.936 . . . . 0.0 113.249 -178.263 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 656' ' ' PRO . . . . . . . . . . . . . 26.9 Cg_endo -91.97 -176.96 0.84 Allowed 'Trans proline' 0 N--CA 1.462 -0.375 0 C-N-CA 123.861 3.041 . . . . 0.0 112.567 178.94 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 657' ' ' ILE . . . . . 0.41 ' O ' ' HA ' ' A' ' 686' ' ' LEU . 96.9 mt -71.52 -37.97 66.13 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 N-CA-C 108.268 -1.012 . . . . 0.0 108.268 177.952 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 658' ' ' ALA . . . . . 0.487 ' HB2' ' HB2' ' A' ' 687' ' ' LYS . . . -151.11 153.53 35.21 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 114.214 -1.357 . . . . 0.0 111.566 -178.808 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 659' ' ' VAL . . . . . . . . . . . . . 22.5 m -121.05 143.7 32.46 Favored 'Isoleucine or valine' 0 C--O 1.235 0.325 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.578 178.72 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 660' ' ' LEU . . . . . . . . . . . . . 4.9 mp -115.08 111.42 21.03 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 108.713 -0.847 . . . . 0.0 108.713 178.541 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 661' ' ' LEU . . . . . . . . . . . . . 66.6 mt -103.82 116.6 32.59 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 110.051 -0.351 . . . . 0.0 110.051 -178.472 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 662' ' ' ALA . . . . . 0.559 ' HB3' ' HB3' ' A' ' 620' ' ' SER . . . -107.68 135.37 49.23 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 112.412 0.523 . . . . 0.0 112.412 -178.903 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 663' ' ' GLU . . . . . . . . . . . . . 98.1 mt-10 -76.31 146.75 78.4 Favored Pre-proline 0 C--N 1.327 -0.399 0 CA-C-N 115.58 -0.737 . . . . 0.0 110.222 178.327 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 664' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -72.43 140.19 64.87 Favored 'Cis proline' 0 C--N 1.35 0.609 0 C-N-CA 123.403 -1.499 . . . . 0.0 112.802 -0.41 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 665' ' ' PHE . . . . . 0.509 ' HB3' ' CZ ' ' A' ' 667' ' ' TYR . 0.1 OUTLIER -76.71 112.36 13.2 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.451 -0.795 . . . . 0.0 112.321 179.868 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 666' ' ' SER . . . . . 0.51 ' HB2' ' O ' ' A' ' 645' ' ' ASP . 68.5 m -65.07 -40.97 95.42 Favored 'General case' 0 N--CA 1.468 0.469 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.464 179.306 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 667' ' ' TYR . . . . . 0.509 ' CZ ' ' HB3' ' A' ' 665' ' ' PHE . 19.2 p90 -60.51 -16.64 39.12 Favored 'General case' 0 CA--C 1.537 0.464 0 N-CA-C 112.896 0.702 . . . . 0.0 112.896 -179.933 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 668' ' ' GLY . . . . . . . . . . . . . . . 100.67 -112.67 4.48 Favored Glycine 0 N--CA 1.452 -0.245 0 C-N-CA 120.547 -0.835 . . . . 0.0 113.667 179.167 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 669' ' ' ASP . . . . . . . . . . . . . 49.8 t0 -81.87 110.19 16.93 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.044 0.449 . . . . 0.0 111.547 -178.386 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 670' ' ' VAL . . . . . 0.402 ' O ' HG23 ' A' ' 674' ' ' VAL . 13.4 p -65.11 -31.93 56.08 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.307 0 CA-C-N 115.546 -0.752 . . . . 0.0 112.642 -179.821 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 671' ' ' GLN . . . . . . . . . . . . . 52.2 tt0 -61.51 -43.36 99.0 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-O 120.812 0.339 . . . . 0.0 110.93 -179.307 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 672' ' ' GLU . . . . . . . . . . . . . 95.1 mt-10 -65.56 -40.6 92.98 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.723 179.165 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 673' ' ' LEU . . . . . . . . . . . . . 61.9 tp -64.04 -44.81 91.37 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.216 179.35 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 674' ' ' VAL . . . . . 0.402 HG23 ' O ' ' A' ' 670' ' ' VAL . 59.9 t -63.28 -43.83 98.86 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.21 0 CA-C-N 115.864 -0.607 . . . . 0.0 109.597 179.381 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 675' ' ' ASP . . . . . . . . . . . . . 37.4 t70 -60.36 -41.13 93.04 Favored 'General case' 0 CA--C 1.521 -0.141 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.521 178.81 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 676' ' ' GLN . . . . . 0.414 ' O ' ' HG2' ' A' ' 680' ' ' ARG . 76.7 mt-30 -69.94 -41.76 74.15 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-N 116.668 -0.242 . . . . 0.0 110.898 179.986 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 677' ' ' LEU . . . . . . . . . . . . . 85.6 mt -66.8 -41.83 86.94 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.641 179.456 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 678' ' ' ARG . . . . . . . . . . . . . 70.4 ttp85 -67.36 -38.97 85.63 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.927 179.834 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 679' ' ' GLN . . . . . . . . . . . . . 10.6 tp-100 -64.36 -38.13 89.96 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.486 -0.779 . . . . 0.0 110.785 179.893 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 680' ' ' ARG . . . . . 0.414 ' HG2' ' O ' ' A' ' 676' ' ' GLN . 89.3 mmt-85 -83.91 -42.88 15.85 Favored 'General case' 0 C--N 1.333 -0.131 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.203 -179.541 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 681' ' ' CYS . . . . . . . . . . . . . 76.0 m -127.86 133.65 49.36 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.33 179.687 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 682' ' ' THR . . . . . 0.428 ' HB ' ' HD2' ' A' ' 683' ' ' PRO . 65.0 p -67.18 158.35 81.84 Favored Pre-proline 0 C--N 1.321 -0.66 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.12 179.802 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 683' ' ' PRO . . . . . 0.428 ' HD2' ' HB ' ' A' ' 682' ' ' THR . 19.8 Cg_endo -58.38 -26.97 79.83 Favored 'Trans proline' 0 C--N 1.349 0.577 0 C-N-CA 122.139 1.893 . . . . 0.0 112.291 -179.819 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 684' ' ' GLU . . . . . . . . . . . . . 51.4 mp0 -71.43 -39.1 71.26 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 121.165 0.507 . . . . 0.0 110.087 178.478 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 685' ' ' GLN . . . . . . . . . . . . . 91.0 mt-30 -71.88 -39.91 69.29 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.322 -0.854 . . . . 0.0 112.183 179.612 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 686' ' ' LEU . . . . . 0.41 ' HA ' ' O ' ' A' ' 657' ' ' ILE . 2.8 tt -135.79 119.08 16.68 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.547 -178.371 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 687' ' ' LYS . . . . . 0.487 ' HB2' ' HB2' ' A' ' 658' ' ' ALA . 74.6 mmtt -88.12 144.82 26.26 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 121.191 0.519 . . . . 0.0 110.241 178.649 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 688' ' ' ILE . . . . . . . . . . . . . 79.9 mt -124.0 122.49 64.62 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.751 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.986 -179.293 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 689' ' ' PHE . . . . . . . . . . . . . 97.8 m-85 -121.99 147.06 46.53 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.482 -0.781 . . . . 0.0 110.291 179.134 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 690' ' ' ILE . . . . . . . . . . . . . 19.0 tt -123.58 137.69 55.92 Favored 'Isoleucine or valine' 0 C--O 1.235 0.331 0 CA-C-O 121.325 0.583 . . . . 0.0 111.186 -179.768 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 691' ' ' LEU . . . . . 0.439 HD23 ' HB ' ' A' ' 704' ' ' ILE . 69.0 mt -112.28 136.35 51.83 Favored 'General case' 0 C--O 1.235 0.313 0 CA-C-N 115.522 -0.763 . . . . 0.0 110.661 -179.429 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 692' ' ' GLY . . . . . 0.655 ' O ' ' HA ' ' A' ' 705' ' ' PRO . . . 168.37 -178.61 41.87 Favored Glycine 0 N--CA 1.446 -0.672 0 C-N-CA 120.876 -0.678 . . . . 0.0 111.706 179.709 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 693' ' ' SER . . . . . . . . . . . . . 80.0 p -67.64 -36.14 80.2 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 120.98 0.419 . . . . 0.0 110.836 179.35 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 694' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -128.98 135.36 48.88 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.913 -0.585 . . . . 0.0 109.919 179.274 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 695' ' ' GLY . . . . . . . . . . . . . . . -73.12 108.57 2.54 Favored Glycine 0 N--CA 1.45 -0.412 0 C-N-CA 120.646 -0.788 . . . . 0.0 112.626 179.963 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 696' ' ' ASN . . . . . . . . . . . . . 62.9 t30 -86.99 91.39 8.68 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 109.994 -0.373 . . . . 0.0 109.994 179.482 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 697' ' ' TYR . . . . . . . . . . . . . 53.0 t80 -71.49 97.13 1.6 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.913 -0.585 . . . . 0.0 111.726 -178.845 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 698' ' ' GLN . . . . . . . . . . . . . 95.9 mm-40 -122.97 35.86 4.78 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.532 -0.758 . . . . 0.0 109.564 178.618 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 699' ' ' GLY . . . . . . . . . . . . . . . 103.87 10.15 35.64 Favored Glycine 0 N--CA 1.453 -0.171 0 C-N-CA 120.781 -0.723 . . . . 0.0 112.006 -178.628 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 700' ' ' VAL . . . . . . . . . . . . . 31.5 m -81.84 150.58 4.45 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.365 0 CA-C-O 121.282 0.563 . . . . 0.0 110.53 179.804 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 701' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -70.08 -40.36 75.05 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 115.365 -0.834 . . . . 0.0 112.151 -179.319 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 702' ' ' ARG . . . . . . . . . . . . . 58.1 ttm-85 -158.08 149.69 21.5 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.826 0.346 . . . . 0.0 111.354 -179.07 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 703' ' ' TYR . . . . . . . . . . . . . 23.7 p90 -107.79 141.59 39.11 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.162 179.125 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 704' ' ' ILE . . . . . 0.498 HG22 HG12 ' A' ' 708' ' ' ILE . 44.9 mt -125.57 85.79 58.26 Favored Pre-proline 0 C--N 1.328 -0.364 0 CA-C-O 121.044 0.449 . . . . 0.0 110.293 -179.655 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 705' ' ' PRO . . . . . 0.655 ' HA ' ' O ' ' A' ' 692' ' ' GLY . 38.5 Cg_exo -63.15 144.34 92.0 Favored 'Trans proline' 0 C--N 1.35 0.61 0 C-N-CA 123.781 2.987 . . . . 0.0 114.272 -179.235 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 706' ' ' LEU . . . . . 0.825 HD23 HG13 ' A' ' 708' ' ' ILE . 80.6 mt -80.88 145.82 58.26 Favored Pre-proline 0 CA--C 1.533 0.291 0 CA-C-N 115.527 -0.761 . . . . 0.0 110.276 178.076 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 707' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -74.88 141.49 71.92 Favored 'Cis proline' 0 C--N 1.345 0.357 0 C-N-CA 123.121 -1.616 . . . . 0.0 112.051 -1.086 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 708' ' ' ILE . . . . . 0.825 HG13 HD23 ' A' ' 706' ' ' LEU . 72.1 mt -78.97 119.8 28.9 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.399 179.513 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 709' ' ' HIS . . . . . . . . . . . . . 71.1 m80 -84.65 123.1 74.75 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.34 179.644 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 710' ' ' PRO . . . . . . . . . . . . . 24.9 Cg_endo -61.59 -31.92 87.29 Favored 'Trans proline' 0 C--N 1.349 0.566 0 C-N-CA 122.869 2.379 . . . . 0.0 113.958 -178.886 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 711' ' ' GLU . . . . . . . . . . . . . 42.6 tt0 -66.08 -41.66 90.42 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 112.179 0.437 . . . . 0.0 112.179 -179.193 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 712' ' ' SER . . . . . . . . . . . . . 80.7 p -95.2 -20.43 19.24 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 112.44 0.533 . . . . 0.0 112.44 -178.266 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 713' ' ' PHE . . . . . . . . . . . . . 77.9 t80 -60.17 -49.89 75.86 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-O 120.759 0.314 . . . . 0.0 111.406 -179.694 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 714' ' ' LEU . . . . . . . . . . . . . 52.6 tp -64.25 -39.45 93.97 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.064 -0.517 . . . . 0.0 109.651 179.799 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 715' ' ' GLN . . . . . . . . . . . . . 64.4 tt0 -61.99 -43.77 98.14 Favored 'General case' 0 CA--C 1.532 0.262 0 CA-C-N 115.534 -0.757 . . . . 0.0 110.827 179.034 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 716' ' ' GLN . . . . . . . . . . . . . 96.5 mt-30 -63.78 -41.39 97.95 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 116.583 -0.28 . . . . 0.0 111.135 179.656 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 717' ' ' VAL . . . . . . . . . . . . . 68.7 t -63.08 -45.28 99.13 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 N-CA-C 109.947 -0.39 . . . . 0.0 109.947 179.097 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 718' ' ' THR . . . . . . . . . . . . . 89.4 m -62.88 -44.55 95.8 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.887 179.425 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 719' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -63.18 -43.57 97.87 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 116.523 -0.308 . . . . 0.0 110.776 179.555 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 720' ' ' GLY . . . . . . . . . . . . . . . -64.48 -40.96 98.14 Favored Glycine 0 C--N 1.332 0.361 0 C-N-CA 120.509 -0.853 . . . . 0.0 111.631 178.15 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 721' ' ' LEU . . . . . . . . . . . . . 61.3 tp -65.87 -42.52 90.26 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 122.81 0.444 . . . . 0.0 112.189 179.656 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 722' ' ' THR . . . . . . . . . . . . . 4.9 t -71.28 -3.55 21.07 Favored 'General case' 0 CA--C 1.535 0.396 0 N-CA-C 113.032 0.752 . . . . 0.0 113.032 -178.607 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 723' ' ' SER . . . . . . . . . . . . . 83.0 p -69.35 -20.29 63.85 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.682 0.277 . . . . 0.0 110.973 179.495 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 724' ' ' LEU . . . . . . . . . . . . . 91.8 mt -64.22 -40.96 97.13 Favored 'General case' 0 CA--C 1.529 0.171 0 CA-C-N 116.077 -0.51 . . . . 0.0 111.989 -179.872 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 725' ' ' ALA . . . . . . . . . . . . . . . -156.75 148.39 22.57 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.661 -0.245 . . . . 0.0 111.182 -179.837 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 726' ' ' THR . . . . . . . . . . . . . 63.6 p -70.64 -28.73 65.04 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.341 -0.39 . . . . 0.0 111.591 179.943 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 727' ' ' SER . . . . . . . . . . . . . 7.4 m -86.86 67.43 9.81 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.904 -179.981 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 728' ' ' ALA . . . . . . . . . . . . . . . -62.32 -39.89 94.52 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.482 179.745 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 729' ' ' GLN . . . . . . . . . . . . . 96.6 mt-30 . . . . . 0 C--O 1.25 1.108 0 CA-C-O 118.225 -0.893 . . . . 0.0 110.662 179.954 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 613' ' ' GLU . . . . . . . . . . . . . 3.9 pt-20 . . . . . 0 N--CA 1.489 1.483 0 CA-C-O 120.975 0.417 . . . . 0.0 110.841 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 614' ' ' GLY . . . . . . . . . . . . . . . -84.0 64.97 4.19 Favored Glycine 0 N--CA 1.453 -0.169 0 C-N-CA 120.887 -0.673 . . . . 0.0 112.628 -179.882 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 615' ' ' ARG . . . . . 0.405 HH22 ' HB3' ' A' ' 654' ' ' LEU . 35.5 mtp-105 -115.01 130.32 56.91 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.04 0.448 . . . . 0.0 111.029 -179.96 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 616' ' ' ILE . . . . . 0.446 ' O ' ' HA ' ' A' ' 640' ' ' VAL . 84.7 mt -124.12 134.08 67.55 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-N 115.578 -0.737 . . . . 0.0 109.89 179.835 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 617' ' ' VAL . . . . . 0.413 HG23 ' HB3' ' A' ' 656' ' ' PRO . 93.4 t -106.6 127.15 62.26 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-O 121.108 0.48 . . . . 0.0 109.786 -179.923 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 618' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -107.01 127.13 53.18 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.821 -178.501 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 619' ' ' VAL . . . . . . . . . . . . . 58.8 t -116.65 118.66 59.51 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 N-CA-C 109.624 -0.51 . . . . 0.0 109.624 179.898 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 620' ' ' SER . . . . . 0.532 ' HB2' ' HB3' ' A' ' 662' ' ' ALA . 25.2 t -169.59 139.55 2.06 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.693 -0.685 . . . . 0.0 111.039 -179.536 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 621' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -77.02 -27.7 54.68 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.624 -0.716 . . . . 0.0 111.118 179.002 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 622' ' ' ASP . . . . . . . . . . . . . 44.1 t0 -84.02 110.63 18.6 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-O 121.173 0.511 . . . . 0.0 111.97 -178.433 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 623' ' ' GLU . . . . . . . . . . . . . 88.6 tt0 -63.43 -40.05 96.13 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.031 -0.986 . . . . 0.0 112.112 179.495 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 624' ' ' ALA . . . . . . . . . . . . . . . -61.14 -45.44 94.66 Favored 'General case' 0 N--CA 1.466 0.351 0 N-CA-C 112.902 0.704 . . . . 0.0 112.902 -177.831 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 625' ' ' THR . . . . . . . . . . . . . 95.6 m -69.77 -40.69 75.94 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-O 121.149 0.5 . . . . 0.0 110.348 -179.977 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 626' ' ' SER . . . . . . . . . . . . . 67.5 m -62.25 -41.03 98.07 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.492 -0.776 . . . . 0.0 111.653 -179.405 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 627' ' ' THR . . . . . . . . . . . . . 92.2 m -61.56 -46.1 91.32 Favored 'General case' 0 CA--C 1.534 0.351 0 N-CA-C 112.384 0.513 . . . . 0.0 112.384 -179.3 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 628' ' ' LEU . . . . . . . . . . . . . 62.9 tp -62.79 -47.31 84.05 Favored 'General case' 0 CA--C 1.533 0.322 0 N-CA-C 112.626 0.602 . . . . 0.0 112.626 -178.714 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 629' ' ' ILE . . . . . . . . . . . . . 16.3 tt -70.87 -35.77 61.37 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.434 0 N-CA-C 112.964 0.727 . . . . 0.0 112.964 -178.648 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 630' ' ' CYS . . . . . . . . . . . . . 87.2 m -62.4 -39.69 94.09 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-O 120.668 0.27 . . . . 0.0 111.148 -179.863 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 631' ' ' SER . . . . . . . . . . . . . 67.8 m -62.29 -41.17 98.28 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.74 179.908 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 632' ' ' ILE . . . . . . . . . . . . . 97.1 mt -62.72 -48.14 89.58 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.272 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.754 179.705 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 633' ' ' LEU . . . . . . . . . . . . . 79.4 mt -66.36 -40.39 89.76 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-N 115.835 -0.621 . . . . 0.0 112.582 -179.733 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 634' ' ' THR . . . . . 0.504 ' HA ' ' O ' ' A' ' 638' ' ' TYR . 73.4 m -65.58 -40.35 92.66 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.713 0.292 . . . . 0.0 110.668 -179.54 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 635' ' ' THR . . . . . . . . . . . . . 92.1 m -59.54 -38.92 82.3 Favored 'General case' 0 CA--C 1.531 0.232 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.222 179.075 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 636' ' ' ALA . . . . . . . . . . . . . . . -64.56 -17.65 64.14 Favored 'General case' 0 CA--C 1.532 0.288 0 CA-C-N 115.918 -0.583 . . . . 0.0 111.396 178.882 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 637' ' ' GLY . . . . . . . . . . . . . . . 109.2 6.06 29.92 Favored Glycine 0 C--N 1.334 0.435 0 C-N-CA 121.004 -0.617 . . . . 0.0 113.233 179.684 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 638' ' ' TYR . . . . . 0.504 ' O ' ' HA ' ' A' ' 634' ' ' THR . 93.9 m-85 -100.31 142.49 31.71 Favored 'General case' 0 C--N 1.329 -0.318 0 O-C-N 122.581 -0.364 . . . . 0.0 111.497 179.93 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 639' ' ' GLN . . . . . . . . . . . . . 78.3 mt-30 -88.9 134.14 34.05 Favored 'General case' 0 CA--C 1.518 -0.254 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.052 179.376 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 640' ' ' VAL . . . . . 0.446 ' HA ' ' O ' ' A' ' 616' ' ' ILE . 58.5 t -118.8 130.87 73.03 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.5 0 CA-C-O 121.016 0.436 . . . . 0.0 111.985 -179.336 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 641' ' ' ILE . . . . . . . . . . . . . 37.8 mm -108.86 117.57 54.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 N-CA-C 108.444 -0.947 . . . . 0.0 108.444 178.603 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 642' ' ' TRP . . . . . . . . . . . . . 23.9 t90 -89.24 125.68 35.18 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.165 0.507 . . . . 0.0 112.025 -178.517 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 643' ' ' LEU . . . . . . . . . . . . . 3.1 mp -120.13 134.22 55.31 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.581 -0.736 . . . . 0.0 110.698 179.263 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 644' ' ' VAL . . . . . . . . . . . . . 8.4 m -106.72 23.4 3.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.942 -179.789 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 645' ' ' ASP . . . . . . . . . . . . . 18.2 t0 -145.51 -32.62 0.37 Allowed 'General case' 0 N--CA 1.469 0.521 0 N-CA-C 113.193 0.812 . . . . 0.0 113.193 -178.211 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 646' ' ' GLY . . . . . . . . . . . . . . . 74.44 27.33 65.83 Favored Glycine 0 CA--C 1.52 0.402 0 C-N-CA 120.757 -0.735 . . . . 0.0 113.761 -179.692 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 647' ' ' GLU . . . . . . . . . . . . . 8.3 mm-40 -63.85 122.32 16.17 Favored 'General case' 0 C--O 1.232 0.137 0 CA-C-O 121.087 0.47 . . . . 0.0 110.938 179.745 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 648' ' ' VAL . . . . . . . . . . . . . 27.8 m -64.62 -30.24 49.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 115.458 -0.792 . . . . 0.0 112.013 -179.287 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 649' ' ' GLU . . . . . . . . . . . . . 97.9 mt-10 -64.27 -43.74 93.88 Favored 'General case' 0 C--O 1.231 0.123 0 N-CA-C 109.773 -0.454 . . . . 0.0 109.773 179.182 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 650' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -71.68 -40.35 69.62 Favored 'General case' 0 N--CA 1.455 -0.178 0 CA-C-N 115.676 -0.693 . . . . 0.0 110.404 178.569 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 651' ' ' LEU . . . . . . . . . . . . . 83.7 mt -64.0 -41.07 97.6 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.185 179.155 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 652' ' ' LEU . . . . . . . . . . . . . 60.2 tp -64.01 -44.67 91.9 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.909 178.896 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 653' ' ' ALA . . . . . . . . . . . . . . . -63.35 -39.66 95.16 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-O 121.034 0.445 . . . . 0.0 111.704 179.611 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 654' ' ' LEU . . . . . 0.405 ' HB3' HH22 ' A' ' 615' ' ' ARG . 76.3 mt -100.28 29.35 4.39 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.828 -179.66 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 655' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -31.38 103.84 0.21 Allowed Pre-proline 0 N--CA 1.471 0.602 0 N-CA-C 114.311 1.226 . . . . 0.0 114.311 -178.268 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 656' ' ' PRO . . . . . 0.413 ' HB3' HG23 ' A' ' 617' ' ' VAL . 41.4 Cg_endo -90.22 177.37 2.42 Favored 'Trans proline' 0 C--N 1.346 0.411 0 C-N-CA 123.739 2.959 . . . . 0.0 112.068 177.959 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 657' ' ' ILE . . . . . . . . . . . . . 19.4 pt -83.6 -26.24 7.63 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-O 121.389 0.614 . . . . 0.0 109.871 177.868 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 658' ' ' ALA . . . . . 0.401 ' HA ' ' O ' ' A' ' 687' ' ' LYS . . . -158.16 154.11 26.85 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.209 -0.905 . . . . 0.0 111.0 -179.967 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 659' ' ' VAL . . . . . . . . . . . . . 30.4 m -124.38 148.08 28.73 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-O 121.27 0.557 . . . . 0.0 111.104 179.119 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 660' ' ' LEU . . . . . . . . . . . . . 11.9 mt -116.64 118.81 33.62 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.444 -0.798 . . . . 0.0 110.271 179.174 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 661' ' ' LEU . . . . . . . . . . . . . 63.3 mt -105.9 112.15 25.08 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 108.774 -0.824 . . . . 0.0 108.774 179.24 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 662' ' ' ALA . . . . . 0.631 ' HB2' HD12 ' A' ' 691' ' ' LEU . . . -109.75 135.68 50.29 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 113.159 0.8 . . . . 0.0 113.159 -178.119 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 663' ' ' GLU . . . . . 0.444 ' HG2' ' CE1' ' A' ' 665' ' ' PHE . 48.6 mt-10 -69.23 137.49 89.18 Favored Pre-proline 0 CA--C 1.535 0.384 0 CA-C-N 115.309 -0.859 . . . . 0.0 110.516 177.923 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 664' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -76.44 141.97 71.7 Favored 'Cis proline' 0 C--N 1.348 0.543 0 C-N-CA 123.533 -1.444 . . . . 0.0 112.506 -0.974 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 665' ' ' PHE . . . . . 0.504 ' HZ ' HD11 ' A' ' 690' ' ' ILE . 49.9 m-85 -77.64 119.72 21.59 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.942 -0.572 . . . . 0.0 111.031 -179.742 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 666' ' ' SER . . . . . . . . . . . . . 79.3 p -67.41 -37.93 83.84 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.224 -0.443 . . . . 0.0 111.614 179.652 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 667' ' ' TYR . . . . . . . . . . . . . 56.3 t80 -67.29 -24.36 65.76 Favored 'General case' 0 CA--C 1.533 0.301 0 CA-C-O 120.704 0.288 . . . . 0.0 111.718 179.424 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 668' ' ' GLY . . . . . . . . . . . . . . . 100.66 -103.82 2.67 Favored Glycine 0 CA--C 1.52 0.372 0 C-N-CA 120.246 -0.978 . . . . 0.0 113.324 -179.844 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 669' ' ' ASP . . . . . 0.447 ' OD1' ' HG2' ' A' ' 671' ' ' GLN . 47.6 t0 -80.25 109.85 15.12 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-O 121.218 0.532 . . . . 0.0 111.65 -178.369 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 670' ' ' VAL . . . . . . . . . . . . . 67.7 t -63.25 -42.2 95.57 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.357 0 N-CA-C 113.805 1.039 . . . . 0.0 113.805 -179.181 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 671' ' ' GLN . . . . . 0.47 ' HA ' HG22 ' A' ' 674' ' ' VAL . 19.2 pt20 -59.1 -34.6 72.2 Favored 'General case' 0 N--CA 1.466 0.331 0 N-CA-C 111.81 0.3 . . . . 0.0 111.81 -177.605 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 672' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 -70.53 -40.72 73.27 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.963 0.411 . . . . 0.0 110.57 178.134 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 673' ' ' LEU . . . . . . . . . . . . . 59.8 tp -65.19 -44.55 88.07 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.672 -0.694 . . . . 0.0 111.141 -179.887 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 674' ' ' VAL . . . . . 0.47 HG22 ' HA ' ' A' ' 671' ' ' GLN . 34.4 m -66.99 -36.78 77.97 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.197 0 CA-C-N 116.4 -0.363 . . . . 0.0 110.056 179.964 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 675' ' ' ASP . . . . . . . . . . . . . 36.9 t70 -62.83 -41.19 99.24 Favored 'General case' 0 CA--C 1.518 -0.252 0 CA-C-N 116.266 -0.425 . . . . 0.0 109.929 177.626 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 676' ' ' GLN . . . . . . . . . . . . . 96.4 mt-30 -69.32 -41.5 76.62 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.978 -179.783 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 677' ' ' LEU . . . . . . . . . . . . . 84.8 mt -68.33 -41.59 80.57 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.055 179.408 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 678' ' ' ARG . . . . . . . . . . . . . 79.6 ttt-85 -66.51 -38.25 86.81 Favored 'General case' 0 N--CA 1.468 0.467 0 CA-C-O 121.321 0.581 . . . . 0.0 110.844 -179.851 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 679' ' ' GLN . . . . . . . . . . . . . 71.2 tp60 -62.33 -38.64 90.25 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.36 -0.836 . . . . 0.0 110.852 -179.961 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 680' ' ' ARG . . . . . . . . . . . . . 31.3 mmm180 -84.8 -42.47 15.11 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.369 179.979 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 681' ' ' CYS . . . . . . . . . . . . . 77.4 m -127.12 130.5 49.94 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 120.903 0.383 . . . . 0.0 110.6 179.919 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 682' ' ' THR . . . . . 0.472 ' HB ' ' HD2' ' A' ' 683' ' ' PRO . 59.6 p -71.06 160.03 83.73 Favored Pre-proline 0 C--N 1.323 -0.578 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.708 -179.846 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 683' ' ' PRO . . . . . 0.472 ' HD2' ' HB ' ' A' ' 682' ' ' THR . 18.1 Cg_endo -59.13 -23.65 70.08 Favored 'Trans proline' 0 C--N 1.352 0.725 0 C-N-CA 122.536 2.158 . . . . 0.0 112.944 -179.915 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 684' ' ' GLU . . . . . 0.423 ' HG2' ' OG1' ' A' ' 682' ' ' THR . 24.8 pt-20 -79.5 -14.56 58.8 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.981 0.419 . . . . 0.0 110.286 178.871 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 685' ' ' GLN . . . . . . . . . . . . . 91.1 mt-30 -101.73 -34.83 9.3 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.959 -0.564 . . . . 0.0 111.624 -179.741 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 686' ' ' LEU . . . . . . . . . . . . . 2.9 tt -139.75 129.32 24.36 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.457 -0.338 . . . . 0.0 111.33 -178.809 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 687' ' ' LYS . . . . . 0.401 ' O ' ' HA ' ' A' ' 658' ' ' ALA . 0.1 OUTLIER -99.13 144.07 28.68 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 121.348 0.594 . . . . 0.0 110.566 178.744 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 688' ' ' ILE . . . . . 0.549 HG22 HG12 ' A' ' 700' ' ' VAL . 75.6 mt -121.58 122.21 66.49 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.81 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.66 -179.135 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 689' ' ' PHE . . . . . . . . . . . . . 95.8 m-85 -120.1 147.06 45.32 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.497 -0.774 . . . . 0.0 110.567 179.411 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 690' ' ' ILE . . . . . 0.504 HD11 ' HZ ' ' A' ' 665' ' ' PHE . 18.3 tt -123.52 137.19 57.59 Favored 'Isoleucine or valine' 0 C--O 1.236 0.37 0 CA-C-O 121.248 0.546 . . . . 0.0 111.418 -179.349 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 691' ' ' LEU . . . . . 0.631 HD12 ' HB2' ' A' ' 662' ' ' ALA . 51.3 mt -111.85 136.15 51.53 Favored 'General case' 0 C--O 1.235 0.312 0 CA-C-N 115.618 -0.719 . . . . 0.0 110.644 -179.638 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 692' ' ' GLY . . . . . 0.666 ' O ' ' HA ' ' A' ' 705' ' ' PRO . . . 165.99 -178.17 40.77 Favored Glycine 0 N--CA 1.446 -0.679 0 C-N-CA 121.01 -0.614 . . . . 0.0 112.019 179.697 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 693' ' ' SER . . . . . . . . . . . . . 79.8 p -67.27 -36.86 82.45 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.021 0.439 . . . . 0.0 110.808 179.393 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 694' ' ' LYS . . . . . . . . . . . . . 64.7 tttp -129.91 128.84 42.98 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.891 -0.595 . . . . 0.0 109.666 179.239 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 695' ' ' GLY . . . . . . . . . . . . . . . -74.56 119.32 6.08 Favored Glycine 0 N--CA 1.445 -0.764 0 C-N-CA 120.54 -0.838 . . . . 0.0 112.993 -179.526 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 696' ' ' ASN . . . . . . . . . . . . . 65.5 t30 -88.19 92.23 9.08 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 109.433 -0.58 . . . . 0.0 109.433 179.003 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 697' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -71.77 61.98 0.4 Allowed 'General case' 0 CA--C 1.532 0.277 0 N-CA-C 112.994 0.739 . . . . 0.0 112.994 -178.205 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 698' ' ' GLN . . . . . . . . . . . . . 97.2 mt-30 -124.34 91.56 3.48 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 109.511 -0.552 . . . . 0.0 109.511 177.943 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 699' ' ' GLY . . . . . 0.428 ' HA3' HG21 ' A' ' 674' ' ' VAL . . . 83.03 13.89 76.29 Favored Glycine 0 CA--C 1.521 0.419 0 C-N-CA 120.542 -0.837 . . . . 0.0 113.394 -179.963 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 700' ' ' VAL . . . . . 0.549 HG12 HG22 ' A' ' 688' ' ' ILE . 29.0 m -118.97 147.3 22.58 Favored 'Isoleucine or valine' 0 C--O 1.234 0.257 0 CA-C-N 117.234 0.517 . . . . 0.0 110.246 179.854 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 701' ' ' ASP . . . . . . . . . . . . . 36.0 t70 -75.38 -42.41 54.01 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.684 -0.689 . . . . 0.0 112.625 -179.166 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 702' ' ' ARG . . . . . . . . . . . . . 67.8 mtp85 -146.01 165.84 27.85 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-O 120.737 0.303 . . . . 0.0 110.827 -178.232 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 703' ' ' TYR . . . . . . . . . . . . . 52.2 p90 -125.38 144.82 50.33 Favored 'General case' 0 C--O 1.234 0.255 0 CA-C-N 116.312 -0.403 . . . . 0.0 110.612 179.427 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 704' ' ' ILE . . . . . 0.546 ' HB ' HD23 ' A' ' 691' ' ' LEU . 49.2 mt -126.15 96.84 35.99 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-N 116.144 -0.48 . . . . 0.0 109.884 179.77 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 705' ' ' PRO . . . . . 0.666 ' HA ' ' O ' ' A' ' 692' ' ' GLY . 71.9 Cg_endo -73.85 150.42 44.15 Favored 'Trans proline' 0 C--N 1.348 0.517 0 C-N-CA 123.005 2.47 . . . . 0.0 114.47 -178.433 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 706' ' ' LEU . . . . . 0.864 HD23 HG13 ' A' ' 708' ' ' ILE . 76.2 mt -87.69 145.38 36.89 Favored Pre-proline 0 CA--C 1.531 0.245 0 CA-C-N 115.217 -0.901 . . . . 0.0 110.358 178.386 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 707' ' ' PRO . . . . . . . . . . . . . 15.4 Cg_exo -71.34 139.0 56.15 Favored 'Cis proline' 0 C--N 1.346 0.399 0 C-N-CA 123.746 -1.356 . . . . 0.0 111.965 -1.744 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 708' ' ' ILE . . . . . 0.864 HG13 HD23 ' A' ' 706' ' ' LEU . 74.2 mt -78.64 118.69 26.34 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 N-CA-C 109.932 -0.395 . . . . 0.0 109.932 179.13 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 709' ' ' HIS . . . . . . . . . . . . . 67.8 m80 -87.44 121.54 71.13 Favored Pre-proline 0 C--N 1.328 -0.364 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.439 179.529 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 710' ' ' PRO . . . . . . . . . . . . . 81.8 Cg_exo -53.72 -38.49 84.86 Favored 'Trans proline' 0 C--N 1.35 0.652 0 C-N-CA 123.579 2.853 . . . . 0.0 114.44 -178.895 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 711' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -64.99 -42.61 94.36 Favored 'General case' 0 N--CA 1.463 0.221 0 N-CA-C 112.034 0.383 . . . . 0.0 112.034 -178.754 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 712' ' ' SER . . . . . . . . . . . . . 49.4 m -82.34 -29.57 30.92 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.513 -0.312 . . . . 0.0 111.248 -179.703 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 713' ' ' PHE . . . . . . . . . . . . . 84.4 t80 -60.38 -50.3 74.14 Favored 'General case' 0 C--N 1.328 -0.34 0 O-C-N 123.175 0.297 . . . . 0.0 111.483 -179.394 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 714' ' ' LEU . . . . . . . . . . . . . 91.4 mt -65.88 -40.64 91.79 Favored 'General case' 0 C--O 1.234 0.272 0 CA-C-N 116.503 -0.317 . . . . 0.0 110.889 179.848 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 715' ' ' GLN . . . . . . . . . . . . . 98.8 mm-40 -65.36 -40.95 94.22 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.055 178.897 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 716' ' ' GLN . . . . . . . . . . . . . 61.5 tt0 -63.86 -42.31 97.56 Favored 'General case' 0 C--O 1.233 0.185 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.7 -179.899 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 717' ' ' VAL . . . . . . . . . . . . . 66.1 t -63.69 -43.77 98.18 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.135 0 N-CA-C 109.843 -0.429 . . . . 0.0 109.843 178.582 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 718' ' ' THR . . . . . . . . . . . . . 89.9 m -61.86 -43.94 97.83 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-N 115.57 -0.741 . . . . 0.0 110.922 179.394 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 719' ' ' MET . . . . . . . . . . . . . 98.0 mtp -61.5 -43.62 98.54 Favored 'General case' 0 N--CA 1.462 0.167 0 CA-C-O 120.578 0.228 . . . . 0.0 110.542 179.547 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 720' ' ' GLY . . . . . . . . . . . . . . . -65.52 -41.61 96.14 Favored Glycine 0 C--N 1.333 0.369 0 C-N-CA 120.621 -0.8 . . . . 0.0 111.88 178.421 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 721' ' ' LEU . . . . . . . . . . . . . 62.1 tp -63.95 -43.86 94.55 Favored 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 122.789 0.436 . . . . 0.0 111.827 179.798 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 722' ' ' THR . . . . . . . . . . . . . 41.0 p -73.56 -10.31 59.57 Favored 'General case' 0 N--CA 1.465 0.277 0 N-CA-C 112.243 0.46 . . . . 0.0 112.243 -179.379 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 723' ' ' SER . . . . . . . . . . . . . 74.6 m -84.18 -4.29 58.71 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.844 0.354 . . . . 0.0 110.651 179.137 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 724' ' ' LEU . . . . . . . . . . . . . 67.3 tp -99.9 121.4 41.27 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.533 179.796 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 725' ' ' ALA . . . . . . . . . . . . . . . -146.82 152.65 39.1 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.637 179.918 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 726' ' ' THR . . . . . . . . . . . . . 72.5 p -128.04 159.2 35.77 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.816 -179.962 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 727' ' ' SER . . . . . . . . . . . . . 87.3 p -70.07 -23.74 63.12 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-N 116.361 -0.381 . . . . 0.0 111.591 179.851 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 728' ' ' ALA . . . . . . . . . . . . . . . -147.79 152.25 37.38 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.545 179.919 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 729' ' ' GLN . . . . . . . . . . . . . 96.7 mt-30 . . . . . 0 C--O 1.25 1.088 0 CA-C-O 118.291 -0.861 . . . . 0.0 110.752 -179.962 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 613' ' ' GLU . . . . . 0.499 ' HA ' ' O ' ' A' ' 637' ' ' GLY . 2.1 mp0 . . . . . 0 N--CA 1.487 1.39 0 CA-C-O 121.009 0.433 . . . . 0.0 110.656 . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 614' ' ' GLY . . . . . . . . . . . . . . . -82.42 176.78 53.65 Favored Glycine 0 C--N 1.33 0.202 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.604 179.968 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 615' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -115.27 131.39 56.95 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.942 0.401 . . . . 0.0 111.163 -179.813 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 616' ' ' ILE . . . . . 0.592 ' O ' ' HA ' ' A' ' 640' ' ' VAL . 85.2 mt -130.76 138.56 53.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 115.624 -0.716 . . . . 0.0 109.354 179.078 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 617' ' ' VAL . . . . . 0.541 HG22 HG12 ' A' ' 659' ' ' VAL . 33.0 m -110.61 146.72 15.4 Favored 'Isoleucine or valine' 0 C--O 1.235 0.334 0 C-N-CA 119.89 -0.724 . . . . 0.0 110.962 -179.931 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 618' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -116.48 126.87 53.99 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.857 -0.611 . . . . 0.0 110.716 179.895 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 619' ' ' VAL . . . . . . . . . . . . . 96.7 t -117.07 117.82 56.66 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 N-CA-C 109.537 -0.542 . . . . 0.0 109.537 179.512 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 620' ' ' SER . . . . . 0.544 ' HB3' ' HB3' ' A' ' 662' ' ' ALA . 83.3 p -170.06 163.8 9.29 Favored 'General case' 0 N--CA 1.453 -0.32 0 CA-C-N 115.521 -0.763 . . . . 0.0 111.145 -178.991 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 621' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -103.87 -5.52 22.26 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.315 -0.857 . . . . 0.0 111.17 178.584 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 622' ' ' ASP . . . . . . . . . . . . . 52.7 t0 -102.63 107.52 18.47 Favored 'General case' 0 C--O 1.233 0.234 0 CA-C-O 121.035 0.445 . . . . 0.0 111.076 -178.723 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 623' ' ' GLU . . . . . 0.413 ' O ' HG23 ' A' ' 627' ' ' THR . 98.0 mt-10 -64.58 -39.31 93.51 Favored 'General case' 0 CA--C 1.532 0.281 0 CA-C-N 115.591 -0.732 . . . . 0.0 112.415 179.834 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 624' ' ' ALA . . . . . . . . . . . . . . . -61.41 -43.99 97.92 Favored 'General case' 0 N--CA 1.466 0.339 0 N-CA-C 112.361 0.504 . . . . 0.0 112.361 -178.355 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 625' ' ' THR . . . . . . . . . . . . . 85.8 m -68.28 -39.48 82.13 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.385 0.612 . . . . 0.0 109.893 179.629 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 626' ' ' SER . . . . . . . . . . . . . 67.0 m -61.66 -40.35 94.6 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 114.899 -1.046 . . . . 0.0 112.577 -178.832 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 627' ' ' THR . . . . . 0.413 HG23 ' O ' ' A' ' 623' ' ' GLU . 77.0 p -63.03 -39.31 94.36 Favored 'General case' 0 N--CA 1.466 0.336 0 N-CA-C 112.316 0.487 . . . . 0.0 112.316 -179.026 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 628' ' ' LEU . . . . . . . . . . . . . 62.4 tp -67.91 -46.32 71.89 Favored 'General case' 0 CA--C 1.533 0.293 0 N-CA-C 112.138 0.422 . . . . 0.0 112.138 -179.816 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 629' ' ' ILE . . . . . . . . . . . . . 20.6 tt -71.98 -36.76 58.57 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.417 0 N-CA-C 112.822 0.675 . . . . 0.0 112.822 -178.586 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 630' ' ' CYS . . . . . . . . . . . . . 81.1 m -62.64 -40.0 95.63 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-O 120.673 0.273 . . . . 0.0 110.95 -179.808 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 631' ' ' SER . . . . . . . . . . . . . 66.1 m -63.11 -41.21 99.31 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.738 179.768 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 632' ' ' ILE . . . . . . . . . . . . . 97.0 mt -62.54 -48.89 86.1 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.324 0 CA-C-O 120.962 0.411 . . . . 0.0 110.921 179.969 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 633' ' ' LEU . . . . . . . . . . . . . 82.2 mt -67.21 -40.73 86.5 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-N 115.853 -0.612 . . . . 0.0 112.461 -179.412 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 634' ' ' THR . . . . . 0.531 ' HA ' ' O ' ' A' ' 638' ' ' TYR . 86.0 m -66.35 -40.75 90.0 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.6 0.238 . . . . 0.0 111.054 -179.602 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 635' ' ' THR . . . . . . . . . . . . . 93.5 m -59.66 -38.95 82.86 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-O 120.885 0.374 . . . . 0.0 110.351 179.168 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 636' ' ' ALA . . . . . . . . . . . . . . . -64.21 -16.92 62.98 Favored 'General case' 0 CA--C 1.532 0.282 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.538 179.012 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 637' ' ' GLY . . . . . 0.499 ' O ' ' HA ' ' A' ' 613' ' ' GLU . . . 108.91 6.81 29.91 Favored Glycine 0 C--N 1.334 0.441 0 C-N-CA 120.996 -0.621 . . . . 0.0 113.115 179.781 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 638' ' ' TYR . . . . . 0.531 ' O ' ' HA ' ' A' ' 634' ' ' THR . 91.4 m-85 -100.16 142.53 31.51 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 120.843 0.354 . . . . 0.0 111.387 -179.95 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 639' ' ' GLN . . . . . . . . . . . . . 98.6 mm-40 -90.06 133.57 34.76 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.215 -0.448 . . . . 0.0 109.806 179.397 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 640' ' ' VAL . . . . . 0.592 ' HA ' ' O ' ' A' ' 616' ' ' ILE . 0.9 OUTLIER -122.21 138.97 50.62 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 N-CA-C 113.336 0.865 . . . . 0.0 113.336 -179.376 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 641' ' ' ILE . . . . . . . . . . . . . 48.6 mm -119.73 123.82 71.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 N-CA-C 108.533 -0.914 . . . . 0.0 108.533 178.041 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 642' ' ' TRP . . . . . 0.406 ' CH2' ' HB ' ' A' ' 644' ' ' VAL . 67.8 t90 -96.68 128.71 43.88 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 112.531 0.567 . . . . 0.0 112.531 -178.452 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 643' ' ' LEU . . . . . 0.408 HD13 ' HA ' ' A' ' 643' ' ' LEU . 0.7 OUTLIER -119.42 124.02 45.51 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 115.283 -0.871 . . . . 0.0 110.073 179.144 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 644' ' ' VAL . . . . . 0.406 ' HB ' ' CH2' ' A' ' 642' ' ' TRP . 7.8 p -93.09 3.62 8.11 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.475 0 CA-C-O 121.054 0.454 . . . . 0.0 111.531 -179.453 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 645' ' ' ASP . . . . . . . . . . . . . 15.4 t0 -125.74 -28.49 3.24 Favored 'General case' 0 N--CA 1.47 0.558 0 N-CA-C 113.089 0.774 . . . . 0.0 113.089 -177.471 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 646' ' ' GLY . . . . . . . . . . . . . . . 73.37 28.8 65.16 Favored Glycine 0 CA--C 1.52 0.377 0 C-N-CA 120.664 -0.779 . . . . 0.0 114.084 179.948 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 647' ' ' GLU . . . . . . . . . . . . . 33.7 mt-10 -65.6 123.13 18.86 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 121.384 0.611 . . . . 0.0 111.012 179.757 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 648' ' ' VAL . . . . . . . . . . . . . 77.3 t -61.36 -39.63 83.41 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-N 114.797 -1.092 . . . . 0.0 111.592 -179.396 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 649' ' ' GLU . . . . . . . . . . . . . 50.5 mp0 -60.53 -43.43 97.17 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.691 0.281 . . . . 0.0 110.439 -179.614 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 650' ' ' ARG . . . . . . . . . . . . . 95.6 mtt-85 -70.56 -41.6 72.23 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.731 178.686 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 651' ' ' LEU . . . . . 0.478 HD22 HG21 ' A' ' 617' ' ' VAL . 94.2 mt -65.89 -40.44 91.56 Favored 'General case' 0 N--CA 1.462 0.14 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.895 179.631 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 652' ' ' LEU . . . . . . . . . . . . . 63.3 tp -64.25 -43.21 95.58 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.102 179.028 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 653' ' ' ALA . . . . . . . . . . . . . . . -62.4 -39.67 94.0 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-O 121.164 0.507 . . . . 0.0 111.247 179.967 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 654' ' ' LEU . . . . . . . . . . . . . 76.6 mt -101.22 30.78 3.98 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.572 -0.74 . . . . 0.0 109.97 179.81 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 655' ' ' THR . . . . . . . . . . . . . 5.6 t -42.73 110.74 0.9 Allowed Pre-proline 0 N--CA 1.468 0.471 0 O-C-N 124.189 0.931 . . . . 0.0 113.276 -178.13 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 656' ' ' PRO . . . . . 0.437 ' HG3' HG22 ' A' ' 617' ' ' VAL . 23.5 Cg_endo -92.53 -175.61 0.6 Allowed 'Trans proline' 0 C--N 1.345 0.352 0 C-N-CA 124.069 3.179 . . . . 0.0 112.513 179.374 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 657' ' ' ILE . . . . . . . . . . . . . 27.2 pt -83.23 -24.11 8.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-O 121.239 0.542 . . . . 0.0 110.171 178.041 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 658' ' ' ALA . . . . . 0.408 ' HA ' ' O ' ' A' ' 687' ' ' LYS . . . -156.37 152.9 28.14 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.368 -0.833 . . . . 0.0 111.165 -179.756 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 659' ' ' VAL . . . . . 0.724 HG13 HD11 ' A' ' 686' ' ' LEU . 35.4 m -122.73 147.08 27.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-O 121.178 0.514 . . . . 0.0 111.266 179.49 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 660' ' ' LEU . . . . . . . . . . . . . 11.8 mt -116.69 115.39 25.56 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.436 -0.802 . . . . 0.0 109.814 178.646 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 661' ' ' LEU . . . . . . . . . . . . . 73.1 mt -106.11 114.57 28.79 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 109.557 -0.534 . . . . 0.0 109.557 -179.985 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 662' ' ' ALA . . . . . 0.544 ' HB3' ' HB3' ' A' ' 620' ' ' SER . . . -106.07 131.22 53.6 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 112.57 0.581 . . . . 0.0 112.57 -178.873 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 663' ' ' GLU . . . . . . . . . . . . . 57.5 mt-10 -71.59 139.28 83.59 Favored Pre-proline 0 CA--C 1.535 0.396 0 CA-C-N 115.506 -0.77 . . . . 0.0 110.56 178.24 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 664' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -74.62 141.91 73.19 Favored 'Cis proline' 0 C--N 1.349 0.605 0 C-N-CA 123.367 -1.514 . . . . 0.0 112.448 -0.911 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 665' ' ' PHE . . . . . 0.467 ' HZ ' HD11 ' A' ' 690' ' ' ILE . 40.8 m-85 -66.15 126.21 27.95 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.87 -179.892 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 666' ' ' SER . . . . . . . . . . . . . 66.7 m -64.01 -41.17 97.55 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.313 179.719 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 667' ' ' TYR . . . . . . . . . . . . . 53.1 t80 -68.63 -21.06 64.5 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-N 115.815 -0.63 . . . . 0.0 111.413 179.82 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 668' ' ' GLY . . . . . . . . . . . . . . . 102.52 -102.75 2.33 Favored Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 120.54 -0.838 . . . . 0.0 112.121 -178.712 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 669' ' ' ASP . . . . . . . . . . . . . 51.1 t0 -77.29 108.2 10.24 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.049 0.452 . . . . 0.0 110.399 -179.836 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 670' ' ' VAL . . . . . . . . . . . . . 11.2 p -62.7 -32.26 54.99 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.332 0 CA-C-N 115.472 -0.786 . . . . 0.0 112.918 -179.064 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 671' ' ' GLN . . . . . . . . . . . . . 97.2 mt-30 -62.56 -40.88 98.26 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-O 120.898 0.38 . . . . 0.0 111.246 -179.179 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 672' ' ' GLU . . . . . . . . . . . . . 95.3 mt-10 -67.46 -40.58 85.38 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.917 0.389 . . . . 0.0 110.395 178.706 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 673' ' ' LEU . . . . . . . . . . . . . 63.3 tp -64.42 -45.34 87.99 Favored 'General case' 0 CA--C 1.53 0.193 0 CA-C-N 115.665 -0.698 . . . . 0.0 111.254 -179.924 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 674' ' ' VAL . . . . . . . . . . . . . 27.2 m -67.77 -36.69 76.74 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.172 0 N-CA-C 110.211 -0.292 . . . . 0.0 110.211 179.813 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 675' ' ' ASP . . . . . . . . . . . . . 37.0 t70 -63.48 -40.62 97.58 Favored 'General case' 0 CA--C 1.521 -0.167 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.343 177.896 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 676' ' ' GLN . . . . . . . . . . . . . 76.9 mt-30 -69.51 -40.84 76.73 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.042 -179.533 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 677' ' ' LEU . . . . . . . . . . . . . 7.3 mp -69.21 -43.31 74.36 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.901 179.485 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 678' ' ' ARG . . . . . . . . . . . . . 61.9 ttp180 -64.62 -38.46 91.07 Favored 'General case' 0 N--CA 1.468 0.428 0 CA-C-O 121.248 0.546 . . . . 0.0 110.804 179.868 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 679' ' ' GLN . . . . . . . . . . . . . 71.3 tp60 -62.76 -38.87 92.26 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.512 -0.767 . . . . 0.0 111.036 -179.965 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 680' ' ' ARG . . . . . . . . . . . . . 31.4 mmm180 -84.54 -42.59 15.34 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 120.814 0.34 . . . . 0.0 111.431 -179.801 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 681' ' ' CYS . . . . . . . . . . . . . 74.3 m -126.47 130.69 51.13 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.343 -0.389 . . . . 0.0 110.307 179.727 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 682' ' ' THR . . . . . . . . . . . . . 68.2 p -68.88 158.95 84.73 Favored Pre-proline 0 C--N 1.325 -0.49 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.583 -179.709 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 683' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_exo -54.46 -32.25 72.44 Favored 'Trans proline' 0 C--N 1.349 0.588 0 C-N-CA 122.614 2.209 . . . . 0.0 112.389 179.636 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 684' ' ' GLU . . . . . . . . . . . . . 51.9 mp0 -70.65 -39.34 73.67 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.691 179.599 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 685' ' ' GLN . . . . . . . . . . . . . 71.8 tp60 -71.95 -41.64 67.55 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.829 -0.623 . . . . 0.0 111.852 179.888 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 686' ' ' LEU . . . . . 0.724 HD11 HG13 ' A' ' 659' ' ' VAL . 62.6 tp -129.72 119.89 24.21 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.759 -178.476 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 687' ' ' LYS . . . . . 0.408 ' O ' ' HA ' ' A' ' 658' ' ' ALA . 3.0 mptp? -85.13 145.01 27.84 Favored 'General case' 0 C--N 1.331 -0.229 0 N-CA-C 109.916 -0.401 . . . . 0.0 109.916 178.603 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 688' ' ' ILE . . . . . 0.428 HG22 HG12 ' A' ' 700' ' ' VAL . 80.0 mt -123.38 119.87 58.63 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.808 0 CA-C-O 121.328 0.585 . . . . 0.0 111.341 -178.977 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 689' ' ' PHE . . . . . 0.415 ' CD2' ' HB2' ' A' ' 702' ' ' ARG . 98.3 m-85 -117.61 144.86 44.76 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 114.958 -1.019 . . . . 0.0 109.934 178.983 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 690' ' ' ILE . . . . . 0.467 HD11 ' HZ ' ' A' ' 665' ' ' PHE . 17.4 tt -124.97 137.76 56.5 Favored 'Isoleucine or valine' 0 C--O 1.237 0.398 0 CA-C-O 121.276 0.56 . . . . 0.0 111.751 -179.768 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 691' ' ' LEU . . . . . 0.5 HD23 ' HB ' ' A' ' 704' ' ' ILE . 58.7 mt -110.18 130.15 55.59 Favored 'General case' 0 C--O 1.234 0.269 0 CA-C-N 115.525 -0.761 . . . . 0.0 109.7 179.544 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 692' ' ' GLY . . . . . 0.631 ' O ' ' HA ' ' A' ' 705' ' ' PRO . . . 167.3 -166.73 39.45 Favored Glycine 0 N--CA 1.446 -0.673 0 C-N-CA 120.628 -0.796 . . . . 0.0 112.051 -179.714 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 693' ' ' SER . . . . . . . . . . . . . 89.6 p -87.52 -14.41 40.38 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 120.616 0.246 . . . . 0.0 111.623 179.93 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 694' ' ' LYS . . . . . . . . . . . . . 68.9 mttm -128.86 136.18 50.1 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.217 0.532 . . . . 0.0 111.384 -179.947 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 695' ' ' GLY . . . . . 0.414 ' HA3' ' CB ' ' A' ' 703' ' ' TYR . . . -117.27 22.97 10.04 Favored Glycine 0 N--CA 1.45 -0.428 0 CA-C-N 115.384 -0.826 . . . . 0.0 112.383 179.493 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 696' ' ' ASN . . . . . . . . . . . . . 21.5 p-10 -93.41 11.48 28.22 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 111.865 0.32 . . . . 0.0 111.865 -179.231 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 697' ' ' TYR . . . . . . . . . . . . . 81.6 m-85 -73.25 142.9 47.24 Favored 'General case' 0 N--CA 1.45 -0.439 0 CA-C-O 121.376 0.607 . . . . 0.0 110.84 179.914 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 698' ' ' GLN . . . . . . . . . . . . . 98.3 mm-40 -88.54 151.98 22.16 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-N 115.1 -0.955 . . . . 0.0 110.729 -179.653 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 699' ' ' GLY . . . . . . . . . . . . . . . 93.4 3.09 65.17 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.641 -0.79 . . . . 0.0 112.897 -179.725 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 700' ' ' VAL . . . . . 0.428 HG12 HG22 ' A' ' 688' ' ' ILE . 21.8 m -119.76 152.46 22.4 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.303 0 CA-C-O 120.859 0.362 . . . . 0.0 110.055 179.363 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 701' ' ' ASP . . . . . . . . . . . . . 66.5 m-20 -89.56 -36.59 15.25 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.114 -0.493 . . . . 0.0 112.25 -178.861 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 702' ' ' ARG . . . . . 0.415 ' HB2' ' CD2' ' A' ' 689' ' ' PHE . 2.3 mpt_? -141.2 163.84 31.88 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.812 0.339 . . . . 0.0 110.62 -178.689 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 703' ' ' TYR . . . . . 0.414 ' CB ' ' HA3' ' A' ' 695' ' ' GLY . 50.2 p90 -131.3 144.32 51.18 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.779 179.576 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 704' ' ' ILE . . . . . 0.5 ' HB ' HD23 ' A' ' 691' ' ' LEU . 52.3 mt -129.64 87.98 51.07 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.45 -179.774 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 705' ' ' PRO . . . . . 0.631 ' HA ' ' O ' ' A' ' 692' ' ' GLY . 31.2 Cg_exo -61.88 142.59 93.81 Favored 'Trans proline' 0 C--N 1.348 0.535 0 C-N-CA 123.511 2.807 . . . . 0.0 114.025 -179.236 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 706' ' ' LEU . . . . . 0.76 HD23 HG13 ' A' ' 708' ' ' ILE . 82.3 mt -80.52 145.22 58.52 Favored Pre-proline 0 CA--C 1.531 0.242 0 CA-C-N 115.544 -0.753 . . . . 0.0 110.336 178.28 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 707' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -74.48 142.88 76.09 Favored 'Cis proline' 0 C--N 1.345 0.382 0 C-N-CA 123.051 -1.645 . . . . 0.0 112.115 -1.31 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 708' ' ' ILE . . . . . 0.76 HG13 HD23 ' A' ' 706' ' ' LEU . 68.8 mt -75.46 121.28 26.84 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.305 179.469 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 709' ' ' HIS . . . . . . . . . . . . . 69.1 m80 -90.39 119.96 69.09 Favored Pre-proline 0 C--N 1.328 -0.355 0 CA-C-N 116.345 -0.388 . . . . 0.0 110.074 179.145 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 710' ' ' PRO . . . . . . . . . . . . . 82.8 Cg_exo -53.59 -38.27 83.83 Favored 'Trans proline' 0 N--CA 1.48 0.718 0 C-N-CA 123.471 2.781 . . . . 0.0 114.433 -178.961 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 711' ' ' GLU . . . . . . . . . . . . . 42.8 tt0 -64.28 -43.66 94.08 Favored 'General case' 0 CA--C 1.531 0.222 0 N-CA-C 112.13 0.418 . . . . 0.0 112.13 -178.746 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 712' ' ' SER . . . . . . . . . . . . . 48.9 m -87.29 -22.52 25.1 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 111.856 0.317 . . . . 0.0 111.856 -178.89 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 713' ' ' PHE . . . . . . . . . . . . . 82.4 t80 -60.0 -49.7 76.65 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.808 0.337 . . . . 0.0 110.899 -179.672 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 714' ' ' LEU . . . . . . . . . . . . . 89.8 mt -64.84 -38.51 91.22 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.348 179.29 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 715' ' ' GLN . . . . . . . . . . . . . 30.6 mm100 -63.48 -41.96 98.56 Favored 'General case' 0 CA--C 1.529 0.162 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.187 179.528 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 716' ' ' GLN . . . . . . . . . . . . . 87.3 mt-30 -64.43 -41.29 96.66 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-O 120.53 0.205 . . . . 0.0 111.072 179.53 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 717' ' ' VAL . . . . . . . . . . . . . 73.4 t -63.79 -44.34 98.2 Favored 'Isoleucine or valine' 0 C--O 1.233 0.2 0 CA-C-O 121.06 0.457 . . . . 0.0 109.822 178.919 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 718' ' ' THR . . . . . . . . . . . . . 91.3 m -62.29 -45.37 93.57 Favored 'General case' 0 CA--C 1.53 0.203 0 CA-C-N 115.479 -0.782 . . . . 0.0 110.826 179.427 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 719' ' ' MET . . . . . . . . . . . . . 95.3 mmm -62.27 -40.54 96.56 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-N 116.452 -0.34 . . . . 0.0 110.573 179.58 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 720' ' ' GLY . . . . . . . . . . . . . . . -62.36 -41.33 99.76 Favored Glycine 0 C--N 1.332 0.317 0 C-N-CA 120.644 -0.788 . . . . 0.0 111.793 178.596 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 721' ' ' LEU . . . . . . . . . . . . . 98.6 mt -65.96 -40.56 91.42 Favored 'General case' 0 N--CA 1.461 0.116 0 CA-C-O 120.737 0.303 . . . . 0.0 111.082 179.299 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 722' ' ' THR . . . . . . . . . . . . . 75.9 p -70.78 -24.81 62.66 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.451 179.804 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 723' ' ' SER . . . . . . . . . . . . . 75.0 m -64.37 -40.06 95.09 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-O 120.861 0.362 . . . . 0.0 110.196 178.732 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 724' ' ' LEU . . . . . . . . . . . . . 64.7 tp -63.81 -46.84 83.32 Favored 'General case' 0 CA--C 1.53 0.187 0 CA-C-N 115.714 -0.676 . . . . 0.0 111.356 179.525 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 725' ' ' ALA . . . . . . . . . . . . . . . -154.92 148.88 25.72 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.943 -179.817 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 726' ' ' THR . . . . . . . . . . . . . 73.5 p -80.72 160.54 24.92 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.255 179.919 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 727' ' ' SER . . . . . . . . . . . . . 97.4 p -153.19 162.93 40.75 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.279 -0.418 . . . . 0.0 110.451 179.97 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 728' ' ' ALA . . . . . . . . . . . . . . . -147.1 153.46 39.96 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.4 -0.364 . . . . 0.0 110.634 -179.863 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 729' ' ' GLN . . . . . . . . . . . . . 96.7 mt-30 . . . . . 0 C--O 1.249 1.076 0 CA-C-O 118.283 -0.865 . . . . 0.0 110.8 -179.971 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 613' ' ' GLU . . . . . . . . . . . . . 15.6 mt-10 . . . . . 0 N--CA 1.485 1.294 0 CA-C-O 120.814 0.34 . . . . 0.0 110.624 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 614' ' ' GLY . . . . . . . . . . . . . . . -161.87 165.48 35.79 Favored Glycine 0 N--CA 1.45 -0.386 0 N-CA-C 111.495 -0.642 . . . . 0.0 111.495 179.677 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 615' ' ' ARG . . . . . . . . . . . . . 83.7 mtp180 -116.58 130.08 56.54 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.011 0.434 . . . . 0.0 111.087 -179.743 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 616' ' ' ILE . . . . . 0.406 ' O ' ' HA ' ' A' ' 640' ' ' VAL . 83.7 mt -124.75 134.26 67.3 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-N 115.54 -0.755 . . . . 0.0 109.746 179.393 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 617' ' ' VAL . . . . . . . . . . . . . 96.2 t -105.77 127.04 61.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-O 121.046 0.45 . . . . 0.0 110.044 -179.908 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 618' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -109.22 129.08 55.5 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.703 -0.68 . . . . 0.0 111.045 -178.58 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 619' ' ' VAL . . . . . . . . . . . . . 80.0 t -117.87 118.67 59.07 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.124 179.905 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 620' ' ' SER . . . . . 0.483 ' HB2' ' HB3' ' A' ' 662' ' ' ALA . 22.8 t -172.36 137.34 0.86 Allowed 'General case' 0 C--O 1.232 0.176 0 CA-C-N 115.621 -0.718 . . . . 0.0 110.826 -179.899 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 621' ' ' GLU . . . . . . . . . . . . . 25.7 pt-20 -85.3 -10.49 56.37 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.804 179.206 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 622' ' ' ASP . . . . . . . . . . . . . 36.0 t70 -90.63 109.67 20.83 Favored 'General case' 0 C--O 1.232 0.179 0 CA-C-O 120.894 0.378 . . . . 0.0 110.62 -179.528 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 623' ' ' GLU . . . . . . . . . . . . . 51.1 mp0 -63.0 -39.77 95.77 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.597 -0.729 . . . . 0.0 112.755 -178.776 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 624' ' ' ALA . . . . . . . . . . . . . . . -61.04 -45.95 92.71 Favored 'General case' 0 N--CA 1.466 0.357 0 N-CA-C 112.674 0.62 . . . . 0.0 112.674 -178.033 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 625' ' ' THR . . . . . . . . . . . . . 89.2 m -71.27 -41.36 70.14 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.011 0.434 . . . . 0.0 110.665 179.752 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 626' ' ' SER . . . . . . . . . . . . . 66.9 m -63.16 -41.94 99.34 Favored 'General case' 0 CA--C 1.531 0.246 0 CA-C-N 115.707 -0.679 . . . . 0.0 112.674 -178.215 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 627' ' ' THR . . . . . . . . . . . . . 34.4 p -66.34 -40.89 90.13 Favored 'General case' 0 N--CA 1.466 0.373 0 N-CA-C 112.047 0.388 . . . . 0.0 112.047 -179.868 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 628' ' ' LEU . . . . . . . . . . . . . 61.8 tp -66.46 -44.39 82.89 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.647 179.612 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 629' ' ' ILE . . . . . . . . . . . . . 2.5 tp -69.25 -37.09 75.49 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.555 0 N-CA-C 112.705 0.631 . . . . 0.0 112.705 -178.574 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 630' ' ' CYS . . . . . . . . . . . . . 89.6 m -64.08 -39.46 94.12 Favored 'General case' 0 N--CA 1.465 0.297 0 N-CA-C 111.624 0.231 . . . . 0.0 111.624 -179.527 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 631' ' ' SER . . . . . . . . . . . . . 68.7 m -61.95 -41.61 98.18 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.162 -179.321 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 632' ' ' ILE . . . . . . . . . . . . . 97.1 mt -62.85 -48.15 89.43 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.306 0 CA-C-O 120.987 0.422 . . . . 0.0 110.912 179.836 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 633' ' ' LEU . . . . . . . . . . . . . 80.7 mt -66.47 -40.47 89.38 Favored 'General case' 0 C--O 1.234 0.255 0 CA-C-N 115.907 -0.588 . . . . 0.0 112.432 -179.565 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 634' ' ' THR . . . . . 0.488 ' HA ' ' O ' ' A' ' 638' ' ' TYR . 78.7 m -65.68 -40.16 92.07 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.652 0.263 . . . . 0.0 110.858 -179.373 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 635' ' ' THR . . . . . . . . . . . . . 92.9 m -59.05 -38.88 80.4 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.331 179.24 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 636' ' ' ALA . . . . . . . . . . . . . . . -64.69 -17.72 64.35 Favored 'General case' 0 CA--C 1.533 0.307 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.412 178.932 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 637' ' ' GLY . . . . . . . . . . . . . . . 109.01 6.61 29.85 Favored Glycine 0 C--N 1.333 0.381 0 C-N-CA 120.918 -0.658 . . . . 0.0 113.102 179.836 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 638' ' ' TYR . . . . . 0.488 ' O ' ' HA ' ' A' ' 634' ' ' THR . 93.1 m-85 -100.49 141.84 32.79 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.841 0.353 . . . . 0.0 111.46 -179.935 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 639' ' ' GLN . . . . . . . . . . . . . 78.7 mt-30 -89.18 134.55 33.98 Favored 'General case' 0 CA--C 1.517 -0.309 0 CA-C-N 116.229 -0.441 . . . . 0.0 109.894 179.172 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 640' ' ' VAL . . . . . 0.406 ' HA ' ' O ' ' A' ' 616' ' ' ILE . 57.3 t -118.9 131.58 71.27 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 N-CA-C 112.6 0.593 . . . . 0.0 112.6 -178.726 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 641' ' ' ILE . . . . . . . . . . . . . 42.7 mm -107.72 114.4 46.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 N-CA-C 108.116 -1.068 . . . . 0.0 108.116 177.926 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 642' ' ' TRP . . . . . . . . . . . . . 22.6 t90 -93.92 124.42 37.91 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.203 0.525 . . . . 0.0 112.225 -178.193 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 643' ' ' LEU . . . . . . . . . . . . . 90.0 mt -121.34 141.44 50.94 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-N 115.558 -0.746 . . . . 0.0 110.73 179.239 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 644' ' ' VAL . . . . . . . . . . . . . 5.8 m -108.79 23.6 3.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 N-CA-C 112.07 0.396 . . . . 0.0 112.07 -179.818 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 645' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -136.84 -37.21 0.67 Allowed 'General case' 0 N--CA 1.47 0.565 0 N-CA-C 112.934 0.716 . . . . 0.0 112.934 -178.301 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 646' ' ' GLY . . . . . . . . . . . . . . . 76.56 21.27 75.35 Favored Glycine 0 CA--C 1.52 0.345 0 C-N-CA 120.76 -0.734 . . . . 0.0 113.359 -179.485 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 647' ' ' GLU . . . . . . . . . . . . . 86.5 tt0 -62.49 123.47 18.41 Favored 'General case' 0 N--CA 1.456 -0.173 0 CA-C-O 121.261 0.553 . . . . 0.0 110.411 -179.718 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 648' ' ' VAL . . . . . . . . . . . . . 9.3 p -63.2 -31.75 53.87 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-N 114.981 -1.009 . . . . 0.0 112.661 -178.459 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 649' ' ' GLU . . . . . . . . . . . . . 99.1 mt-10 -63.46 -41.81 98.61 Favored 'General case' 0 N--CA 1.461 0.116 0 C-N-CA 120.71 -0.396 . . . . 0.0 110.107 179.615 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 650' ' ' ARG . . . . . . . . . . . . . 2.2 mpt_? -73.13 -40.04 65.24 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.254 178.482 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 651' ' ' LEU . . . . . . . . . . . . . 84.9 mt -63.09 -41.75 99.46 Favored 'General case' 0 CA--C 1.521 -0.157 0 CA-C-N 116.361 -0.381 . . . . 0.0 109.982 178.848 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 652' ' ' LEU . . . . . . . . . . . . . 62.1 tp -65.32 -43.29 91.48 Favored 'General case' 0 CA--C 1.53 0.203 0 CA-C-N 115.882 -0.599 . . . . 0.0 111.111 178.597 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 653' ' ' ALA . . . . . . . . . . . . . . . -62.76 -39.56 94.56 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-O 121.007 0.432 . . . . 0.0 111.988 179.966 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 654' ' ' LEU . . . . . . . . . . . . . 76.1 mt -101.94 29.78 4.81 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.2 -179.275 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 655' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -33.58 104.8 0.24 Allowed Pre-proline 0 N--CA 1.47 0.537 0 O-C-N 124.537 1.148 . . . . 0.0 113.925 -179.459 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 656' ' ' PRO . . . . . . . . . . . . . 34.0 Cg_endo -91.5 -176.56 0.87 Allowed 'Trans proline' 0 C--N 1.345 0.347 0 C-N-CA 123.456 2.77 . . . . 0.0 111.789 178.31 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 657' ' ' ILE . . . . . . . . . . . . . 22.8 pt -81.57 -25.06 9.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 121.333 0.587 . . . . 0.0 109.758 178.205 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 658' ' ' ALA . . . . . 0.439 ' HA ' ' O ' ' A' ' 687' ' ' LYS . . . -159.43 153.81 23.93 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.15 -0.932 . . . . 0.0 111.25 -179.825 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 659' ' ' VAL . . . . . 0.513 HG13 HD11 ' A' ' 686' ' ' LEU . 18.2 m -121.44 145.29 28.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-O 121.09 0.472 . . . . 0.0 110.633 178.816 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 660' ' ' LEU . . . . . 0.509 HD22 HD11 ' A' ' 691' ' ' LEU . 14.8 mt -117.13 120.37 38.11 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.498 -0.774 . . . . 0.0 110.355 179.646 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 661' ' ' LEU . . . . . . . . . . . . . 72.5 mt -107.78 110.79 22.69 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 109.177 -0.675 . . . . 0.0 109.177 179.397 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 662' ' ' ALA . . . . . 0.533 ' HB2' HD13 ' A' ' 691' ' ' LEU . . . -107.76 128.26 54.42 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 112.533 0.568 . . . . 0.0 112.533 -178.467 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 663' ' ' GLU . . . . . . . . . . . . . 99.7 mt-10 -70.06 145.28 93.77 Favored Pre-proline 0 C--N 1.326 -0.427 0 CA-C-N 115.623 -0.717 . . . . 0.0 110.482 177.903 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 664' ' ' PRO . . . . . . . . . . . . . 64.1 Cg_endo -73.92 140.59 68.1 Favored 'Cis proline' 0 C--N 1.347 0.492 0 C-N-CA 123.364 -1.515 . . . . 0.0 112.543 -1.204 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 665' ' ' PHE . . . . . 0.762 ' HZ ' HD11 ' A' ' 690' ' ' ILE . 41.0 m-85 -74.06 142.82 45.65 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.914 -0.585 . . . . 0.0 111.509 -179.756 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 666' ' ' SER . . . . . . . . . . . . . 65.7 p -93.56 -32.75 14.01 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.09 179.203 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 667' ' ' TYR . . . . . . . . . . . . . 65.7 t80 -68.88 -24.19 64.3 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 116.246 -0.433 . . . . 0.0 111.662 179.129 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 668' ' ' GLY . . . . . . . . . . . . . . . 99.91 -103.96 2.75 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.58 -0.819 . . . . 0.0 112.087 -179.197 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 669' ' ' ASP . . . . . . . . . . . . . 50.1 t0 -82.7 105.85 14.07 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.802 0.334 . . . . 0.0 110.179 179.889 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 670' ' ' VAL . . . . . 0.452 ' O ' HG23 ' A' ' 674' ' ' VAL . 12.4 m -71.08 -23.74 23.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 N-CA-C 113.589 0.959 . . . . 0.0 113.589 -178.884 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 671' ' ' GLN . . . . . . . . . . . . . 77.5 mt-30 -61.47 -42.21 98.43 Favored 'General case' 0 N--CA 1.462 0.15 0 CA-C-N 118.259 0.481 . . . . 0.0 110.563 -179.424 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 672' ' ' GLU . . . . . . . . . . . . . 95.1 mt-10 -65.84 -40.78 92.08 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.42 178.548 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 673' ' ' LEU . . . . . . . . . . . . . 61.8 tp -64.48 -43.81 92.98 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.076 179.384 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 674' ' ' VAL . . . . . 0.547 HG11 ' HA3' ' A' ' 699' ' ' GLY . 54.7 t -62.59 -44.61 99.53 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 CA-C-N 115.762 -0.654 . . . . 0.0 109.65 179.34 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 675' ' ' ASP . . . . . . . . . . . . . 37.4 t70 -60.46 -41.01 93.28 Favored 'General case' 0 CA--C 1.522 -0.133 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.291 178.512 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 676' ' ' GLN . . . . . 0.41 ' O ' ' HG2' ' A' ' 680' ' ' ARG . 96.6 mt-30 -68.12 -41.67 81.38 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.251 -0.432 . . . . 0.0 110.521 179.816 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 677' ' ' LEU . . . . . . . . . . . . . 84.0 mt -65.77 -42.39 90.89 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.139 179.568 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 678' ' ' ARG . . . . . 0.417 ' HA ' ' O ' ' A' ' 681' ' ' CYS . 37.1 mtp-105 -70.01 -36.29 75.0 Favored 'General case' 0 N--CA 1.468 0.466 0 CA-C-O 121.072 0.463 . . . . 0.0 111.092 179.72 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 679' ' ' GLN . . . . . . . . . . . . . 50.1 tt0 -64.27 -37.0 85.94 Favored 'General case' 0 N--CA 1.451 -0.388 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.211 179.592 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 680' ' ' ARG . . . . . 0.41 ' HG2' ' O ' ' A' ' 676' ' ' GLN . 89.6 mmt-85 -83.92 -44.32 14.37 Favored 'General case' 0 C--N 1.333 -0.122 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.041 179.678 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 681' ' ' CYS . . . . . 0.417 ' O ' ' HA ' ' A' ' 678' ' ' ARG . 73.8 m -128.95 131.79 47.53 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.563 179.895 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 682' ' ' THR . . . . . . . . . . . . . 68.9 p -70.69 159.62 84.56 Favored Pre-proline 0 C--N 1.321 -0.651 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.577 -179.96 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 683' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_exo -53.87 -32.78 68.7 Favored 'Trans proline' 0 C--N 1.351 0.672 0 C-N-CA 122.718 2.279 . . . . 0.0 112.781 179.918 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 684' ' ' GLU . . . . . . . . . . . . . 98.3 mt-10 -69.34 -38.78 78.32 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.052 0.454 . . . . 0.0 110.49 179.721 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 685' ' ' GLN . . . . . . . . . . . . . 91.1 mt-30 -71.75 -40.19 69.5 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.454 -0.794 . . . . 0.0 111.837 179.996 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 686' ' ' LEU . . . . . 0.513 HD11 HG13 ' A' ' 659' ' ' VAL . 0.1 OUTLIER -142.88 128.31 18.95 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.996 0.427 . . . . 0.0 111.788 -178.72 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 687' ' ' LYS . . . . . 0.439 ' O ' ' HA ' ' A' ' 658' ' ' ALA . 46.7 mmtm -90.83 147.18 23.36 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.401 0.619 . . . . 0.0 111.341 179.195 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 688' ' ' ILE . . . . . 0.526 HG22 HG12 ' A' ' 700' ' ' VAL . 79.3 mt -121.81 121.07 63.35 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.742 0 CA-C-N 115.472 -0.786 . . . . 0.0 110.4 -179.868 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 689' ' ' PHE . . . . . . . . . . . . . 92.1 m-85 -121.82 145.4 48.1 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.534 -0.757 . . . . 0.0 110.276 179.386 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 690' ' ' ILE . . . . . 0.762 HD11 ' HZ ' ' A' ' 665' ' ' PHE . 19.2 tt -127.28 138.74 53.92 Favored 'Isoleucine or valine' 0 C--O 1.236 0.363 0 CA-C-O 121.259 0.552 . . . . 0.0 111.802 -178.912 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 691' ' ' LEU . . . . . 0.533 HD13 ' HB2' ' A' ' 662' ' ' ALA . 0.8 OUTLIER -118.88 116.02 25.62 Favored 'General case' 0 C--O 1.234 0.288 0 CA-C-N 115.551 -0.749 . . . . 0.0 110.434 179.887 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 692' ' ' GLY . . . . . . . . . . . . . . . 161.94 129.09 0.99 Allowed Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.62 -0.8 . . . . 0.0 112.994 179.46 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 693' ' ' SER . . . . . . . . . . . . . 48.2 m 49.82 -114.68 0.74 Allowed 'General case' 0 CA--C 1.529 0.145 0 C-N-CA 123.101 0.56 . . . . 0.0 111.444 179.914 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 694' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -100.02 -12.17 19.96 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.26 -179.862 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 695' ' ' GLY . . . . . 0.466 ' HA3' ' HB2' ' A' ' 703' ' ' TYR . . . 69.76 28.7 71.75 Favored Glycine 0 CA--C 1.519 0.309 0 C-N-CA 120.979 -0.629 . . . . 0.0 113.263 -179.93 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 696' ' ' ASN . . . . . . . . . . . . . 65.4 t30 -81.24 74.34 8.24 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.205 0.526 . . . . 0.0 110.978 -179.681 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 697' ' ' TYR . . . . . 0.426 ' CD1' HD13 ' A' ' 690' ' ' ILE . 97.5 m-85 -131.36 148.31 52.66 Favored 'General case' 0 N--CA 1.453 -0.294 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.283 179.792 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 698' ' ' GLN . . . . . . . . . . . . . 19.3 pt20 -89.76 153.87 20.36 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.906 -179.439 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 699' ' ' GLY . . . . . 0.547 ' HA3' HG11 ' A' ' 674' ' ' VAL . . . 90.46 4.46 70.65 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.596 -0.811 . . . . 0.0 113.524 179.636 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 700' ' ' VAL . . . . . 0.526 HG12 HG22 ' A' ' 688' ' ' ILE . 28.9 m -116.03 145.05 22.3 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.335 0 CA-C-N 117.489 0.644 . . . . 0.0 110.537 179.4 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 701' ' ' ASP . . . . . . . . . . . . . 36.8 t70 -71.61 -40.81 69.58 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.347 -0.842 . . . . 0.0 112.111 -179.615 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 702' ' ' ARG . . . . . . . . . . . . . 36.4 ttm180 -155.13 148.8 25.36 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.782 0.325 . . . . 0.0 110.548 -179.192 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 703' ' ' TYR . . . . . 0.466 ' HB2' ' HA3' ' A' ' 695' ' ' GLY . 25.7 p90 -106.58 146.93 30.07 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.693 -179.486 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 704' ' ' ILE . . . . . 0.412 HD13 ' CE1' ' A' ' 713' ' ' PHE . 54.6 mt -121.41 95.56 48.27 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-N 115.783 -0.644 . . . . 0.0 109.836 179.504 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 705' ' ' PRO . . . . . . . . . . . . . 81.2 Cg_endo -74.95 154.89 43.06 Favored 'Trans proline' 0 C--N 1.347 0.469 0 C-N-CA 122.981 2.454 . . . . 0.0 113.901 -178.766 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 706' ' ' LEU . . . . . 0.521 ' HA ' ' C ' ' A' ' 707' ' ' PRO . 6.4 mp -103.14 147.84 34.75 Favored Pre-proline 0 CA--C 1.532 0.263 0 CA-C-N 115.403 -0.817 . . . . 0.0 109.781 178.68 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 707' ' ' PRO . . . . . 0.521 ' C ' ' HA ' ' A' ' 706' ' ' LEU . 32.6 Cg_exo -63.2 136.79 23.21 Favored 'Cis proline' 0 C--N 1.35 0.641 0 C-N-CA 123.848 -1.313 . . . . 0.0 112.424 -1.159 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 708' ' ' ILE . . . . . 0.48 HG13 ' HG ' ' A' ' 706' ' ' LEU . 72.0 mt -81.54 119.37 31.01 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.353 179.44 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 709' ' ' HIS . . . . . . . . . . . . . 68.8 m80 -87.37 122.88 70.53 Favored Pre-proline 0 C--N 1.325 -0.469 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.17 179.348 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 710' ' ' PRO . . . . . . . . . . . . . 20.5 Cg_endo -60.41 -31.43 92.63 Favored 'Trans proline' 0 C--N 1.349 0.578 0 C-N-CA 122.944 2.429 . . . . 0.0 113.511 -178.92 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 711' ' ' GLU . . . . . . . . . . . . . 88.7 tt0 -64.7 -43.68 92.69 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.83 -179.753 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 712' ' ' SER . . . . . . . . . . . . . 68.2 m -91.65 -20.45 21.6 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 112.06 0.393 . . . . 0.0 112.06 -178.669 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 713' ' ' PHE . . . . . 0.412 ' CE1' HD13 ' A' ' 704' ' ' ILE . 85.3 t80 -60.22 -49.36 77.92 Favored 'General case' 0 C--O 1.234 0.256 0 CA-C-O 120.814 0.34 . . . . 0.0 110.584 179.935 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 714' ' ' LEU . . . . . . . . . . . . . 96.2 mt -65.07 -37.7 88.38 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.189 179.254 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 715' ' ' GLN . . . . . . . . . . . . . 97.4 mt-30 -62.18 -41.85 98.72 Favored 'General case' 0 C--N 1.333 -0.125 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.973 179.083 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 716' ' ' GLN . . . . . . . . . . . . . 86.3 mt-30 -63.81 -42.59 97.66 Favored 'General case' 0 N--CA 1.463 0.187 0 CA-C-N 116.669 -0.241 . . . . 0.0 111.112 179.49 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 717' ' ' VAL . . . . . . . . . . . . . 77.5 t -64.64 -45.36 95.6 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 CA-C-O 120.929 0.395 . . . . 0.0 110.309 179.413 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 718' ' ' THR . . . . . . . . . . . . . 89.8 m -61.14 -48.18 82.82 Favored 'General case' 0 C--O 1.224 -0.271 0 CA-C-N 115.655 -0.702 . . . . 0.0 110.911 179.848 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 719' ' ' MET . . . . . . . . . . . . . 38.5 mmt -62.84 -39.26 93.8 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-O 120.796 0.331 . . . . 0.0 110.634 179.729 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 720' ' ' GLY . . . . . . . . . . . . . . . -61.65 -39.78 97.86 Favored Glycine 0 CA--C 1.522 0.528 0 CA-C-N 115.767 -0.651 . . . . 0.0 113.26 179.582 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 721' ' ' LEU . . . . . . . . . . . . . 1.7 pp -88.65 -33.91 17.44 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 117.33 0.565 . . . . 0.0 111.954 -179.358 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 722' ' ' THR . . . . . . . . . . . . . 95.2 m -63.86 -39.83 95.13 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.506 -0.315 . . . . 0.0 111.606 -179.675 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 723' ' ' SER . . . . . . . . . . . . . 80.5 p -61.84 -35.68 78.98 Favored 'General case' 0 CA--C 1.533 0.291 0 CA-C-N 116.696 -0.229 . . . . 0.0 111.207 179.627 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 724' ' ' LEU . . . . . . . . . . . . . 1.5 tm? -69.45 -45.71 68.43 Favored 'General case' 0 CA--C 1.532 0.266 0 CA-C-N 116.452 -0.34 . . . . 0.0 110.69 179.094 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 725' ' ' ALA . . . . . . . . . . . . . . . -155.89 148.11 23.52 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.1 -179.951 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 726' ' ' THR . . . . . . . . . . . . . 73.6 p -80.93 160.31 24.7 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.295 179.899 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 727' ' ' SER . . . . . . . . . . . . . 60.5 m -126.98 148.83 50.08 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.424 -0.353 . . . . 0.0 110.615 179.864 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 728' ' ' ALA . . . . . . . . . . . . . . . -147.28 153.97 40.4 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.734 -179.899 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 729' ' ' GLN . . . . . . . . . . . . . 96.7 mt-30 . . . . . 0 C--O 1.248 1.024 0 CA-C-O 118.375 -0.822 . . . . 0.0 110.758 -179.957 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 613' ' ' GLU . . . . . 0.498 ' HA ' ' O ' ' A' ' 637' ' ' GLY . 4.1 pt-20 . . . . . 0 N--CA 1.49 1.535 0 CA-C-O 121.103 0.477 . . . . 0.0 110.765 . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 614' ' ' GLY . . . . . . . . . . . . . . . -82.93 177.64 53.26 Favored Glycine 0 CA--C 1.519 0.325 0 C-N-CA 120.939 -0.648 . . . . 0.0 112.85 -179.939 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 615' ' ' ARG . . . . . . . . . . . . . 48.6 mtm105 -108.74 128.25 54.71 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.721 0.296 . . . . 0.0 110.902 -179.709 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 616' ' ' ILE . . . . . 0.453 ' O ' ' HA ' ' A' ' 640' ' ' VAL . 85.4 mt -124.68 133.43 69.44 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.328 179.099 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 617' ' ' VAL . . . . . . . . . . . . . 86.2 t -105.73 127.63 60.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 121.042 0.449 . . . . 0.0 110.095 179.808 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 618' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -109.27 127.27 54.14 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.75 -178.73 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 619' ' ' VAL . . . . . . . . . . . . . 67.9 t -116.66 118.88 60.24 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 N-CA-C 109.463 -0.569 . . . . 0.0 109.463 179.585 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 620' ' ' SER . . . . . 0.795 ' HB2' ' HB3' ' A' ' 662' ' ' ALA . 34.9 t -168.63 144.94 3.67 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.599 -0.728 . . . . 0.0 111.297 -179.068 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 621' ' ' GLU . . . . . . . . . . . . . 99.2 mt-10 -91.05 -11.79 37.67 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.797 -0.638 . . . . 0.0 111.378 178.867 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 622' ' ' ASP . . . . . . . . . . . . . 29.0 t70 -93.3 111.56 23.25 Favored 'General case' 0 C--O 1.231 0.131 0 CA-C-O 120.877 0.37 . . . . 0.0 111.243 -178.766 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 623' ' ' GLU . . . . . . . . . . . . . 51.3 mp0 -63.8 -38.92 92.89 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.729 -0.669 . . . . 0.0 112.52 -179.611 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 624' ' ' ALA . . . . . . . . . . . . . . . -60.76 -45.61 93.67 Favored 'General case' 0 N--CA 1.465 0.315 0 N-CA-C 112.947 0.721 . . . . 0.0 112.947 -177.822 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 625' ' ' THR . . . . . . . . . . . . . 25.0 p -75.24 -36.31 61.31 Favored 'General case' 0 C--N 1.33 -0.242 0 C-N-CA 120.503 -0.479 . . . . 0.0 111.167 179.414 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 626' ' ' SER . . . . . . . . . . . . . 66.5 m -64.38 -42.78 95.97 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.99 -178.79 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 627' ' ' THR . . . . . . . . . . . . . 34.6 p -67.17 -41.46 85.92 Favored 'General case' 0 N--CA 1.465 0.29 0 N-CA-C 111.917 0.34 . . . . 0.0 111.917 -179.904 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 628' ' ' LEU . . . . . . . . . . . . . 61.7 tp -67.42 -44.06 79.69 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.519 179.64 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 629' ' ' ILE . . . . . . . . . . . . . 1.7 tp -69.67 -37.37 73.9 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.562 0 N-CA-C 112.586 0.587 . . . . 0.0 112.586 -178.389 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 630' ' ' CYS . . . . . . . . . . . . . 87.2 m -64.27 -39.18 93.4 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-O 120.747 0.308 . . . . 0.0 111.32 -179.83 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 631' ' ' SER . . . . . . . . . . . . . 68.3 m -62.02 -41.75 98.42 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.031 -0.532 . . . . 0.0 110.934 -179.42 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 632' ' ' ILE . . . . . . . . . . . . . 97.0 mt -63.29 -48.4 87.58 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.282 0 CA-C-O 120.844 0.354 . . . . 0.0 110.846 179.736 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 633' ' ' LEU . . . . . . . . . . . . . 83.5 mt -66.41 -40.36 89.56 Favored 'General case' 0 C--O 1.234 0.28 0 CA-C-N 116.075 -0.511 . . . . 0.0 112.314 -179.673 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 634' ' ' THR . . . . . 0.515 ' HA ' ' O ' ' A' ' 638' ' ' TYR . 84.7 m -65.81 -40.17 91.62 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.679 0.276 . . . . 0.0 110.919 -179.471 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 635' ' ' THR . . . . . . . . . . . . . 93.6 m -58.97 -38.75 79.83 Favored 'General case' 0 CA--C 1.53 0.205 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.498 179.43 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 636' ' ' ALA . . . . . . . . . . . . . . . -64.37 -17.23 63.54 Favored 'General case' 0 CA--C 1.533 0.318 0 CA-C-N 115.95 -0.568 . . . . 0.0 111.518 178.852 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 637' ' ' GLY . . . . . 0.498 ' O ' ' HA ' ' A' ' 613' ' ' GLU . . . 108.92 7.38 29.24 Favored Glycine 0 C--N 1.333 0.374 0 C-N-CA 120.94 -0.647 . . . . 0.0 113.1 179.836 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 638' ' ' TYR . . . . . 0.515 ' O ' ' HA ' ' A' ' 634' ' ' THR . 93.4 m-85 -100.01 141.31 32.99 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.837 0.351 . . . . 0.0 111.417 -179.886 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 639' ' ' GLN . . . . . . . . . . . . . 98.3 mt-30 -88.05 132.92 34.1 Favored 'General case' 0 CA--C 1.518 -0.283 0 N-CA-C 109.625 -0.509 . . . . 0.0 109.625 178.981 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 640' ' ' VAL . . . . . 0.453 ' HA ' ' O ' ' A' ' 616' ' ' ILE . 58.0 t -119.3 131.15 72.78 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 N-CA-C 112.653 0.612 . . . . 0.0 112.653 -178.823 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 641' ' ' ILE . . . . . . . . . . . . . 4.0 mp -110.23 116.41 52.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 N-CA-C 107.907 -1.146 . . . . 0.0 107.907 177.787 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 642' ' ' TRP . . . . . . . . . . . . . 19.7 t90 -96.03 124.53 40.08 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 121.222 0.535 . . . . 0.0 112.222 -177.879 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 643' ' ' LEU . . . . . . . . . . . . . 89.8 mt -121.77 142.14 50.51 Favored 'General case' 0 C--O 1.232 0.157 0 CA-C-N 115.413 -0.812 . . . . 0.0 110.647 179.332 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 644' ' ' VAL . . . . . . . . . . . . . 7.1 m -109.63 22.11 4.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.25 179.731 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 645' ' ' ASP . . . . . . . . . . . . . 11.5 t0 -128.45 -48.2 1.29 Allowed 'General case' 0 N--CA 1.468 0.472 0 N-CA-C 112.929 0.714 . . . . 0.0 112.929 -177.308 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 646' ' ' GLY . . . . . . . . . . . . . . . 80.69 23.95 59.21 Favored Glycine 0 CA--C 1.523 0.557 0 C-N-CA 120.665 -0.779 . . . . 0.0 113.928 -179.786 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 647' ' ' GLU . . . . . . . . . . . . . 77.5 mm-40 -68.24 131.43 45.35 Favored 'General case' 0 C--N 1.333 -0.125 0 CA-C-N 117.303 0.551 . . . . 0.0 110.928 179.697 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 648' ' ' VAL . . . . . . . . . . . . . 77.8 t -61.17 -41.52 89.81 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 CA-C-N 114.821 -1.081 . . . . 0.0 111.669 -179.398 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 649' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -61.59 -42.82 99.41 Favored 'General case' 0 C--N 1.331 -0.203 0 C-N-CA 120.772 -0.371 . . . . 0.0 110.496 -179.791 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 650' ' ' ARG . . . . . . . . . . . . . 80.8 mtp180 -70.5 -40.82 73.33 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.466 -0.334 . . . . 0.0 110.621 178.775 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 651' ' ' LEU . . . . . . . . . . . . . 84.3 mt -65.17 -41.09 94.97 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.558 178.863 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 652' ' ' LEU . . . . . . . . . . . . . 62.8 tp -65.2 -42.99 93.02 Favored 'General case' 0 CA--C 1.532 0.263 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.133 178.985 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 653' ' ' ALA . . . . . . . . . . . . . . . -62.7 -40.0 95.76 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-O 121.049 0.452 . . . . 0.0 111.58 -179.762 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 654' ' ' LEU . . . . . . . . . . . . . 76.1 mt -101.91 30.09 4.62 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.76 -0.654 . . . . 0.0 109.969 179.813 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 655' ' ' THR . . . . . . . . . . . . . 6.1 t -43.86 109.84 0.88 Allowed Pre-proline 0 CA--C 1.538 0.498 0 O-C-N 124.159 0.912 . . . . 0.0 113.416 -177.877 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 656' ' ' PRO . . . . . . . . . . . . . 27.4 Cg_endo -92.72 -175.36 0.55 Allowed 'Trans proline' 0 C--N 1.344 0.321 0 C-N-CA 124.008 3.138 . . . . 0.0 112.281 178.918 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 657' ' ' ILE . . . . . 0.433 ' O ' ' HA ' ' A' ' 686' ' ' LEU . 24.8 pt -82.19 -23.1 9.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-O 121.278 0.561 . . . . 0.0 109.824 178.223 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 658' ' ' ALA . . . . . 0.421 ' HB2' ' HB2' ' A' ' 687' ' ' LYS . . . -158.72 151.81 22.52 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.271 -0.877 . . . . 0.0 110.853 179.725 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 659' ' ' VAL . . . . . . . . . . . . . 29.1 m -121.39 145.0 28.64 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-O 121.316 0.579 . . . . 0.0 110.774 178.952 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 660' ' ' LEU . . . . . 0.508 HD23 HD11 ' A' ' 691' ' ' LEU . 4.6 mp -113.94 116.19 28.86 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.455 -0.793 . . . . 0.0 109.172 178.943 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 661' ' ' LEU . . . . . . . . . . . . . 50.6 mt -103.6 110.27 22.27 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 109.387 -0.597 . . . . 0.0 109.387 -179.102 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 662' ' ' ALA . . . . . 0.795 ' HB3' ' HB2' ' A' ' 620' ' ' SER . . . -107.71 136.19 47.87 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 112.523 0.564 . . . . 0.0 112.523 -178.595 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 663' ' ' GLU . . . . . . . . . . . . . 95.1 mt-10 -70.88 145.77 92.27 Favored Pre-proline 0 C--N 1.327 -0.39 0 CA-C-N 115.596 -0.729 . . . . 0.0 110.359 178.116 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 664' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -76.42 142.68 73.94 Favored 'Cis proline' 0 C--N 1.349 0.599 0 C-N-CA 123.363 -1.515 . . . . 0.0 112.621 -1.083 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 665' ' ' PHE . . . . . 0.471 ' CZ ' HD11 ' A' ' 690' ' ' ILE . 20.1 m-85 -68.87 134.82 50.15 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.997 179.602 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 666' ' ' SER . . . . . . . . . . . . . 56.8 p -96.85 -33.99 11.44 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.845 0.355 . . . . 0.0 111.536 179.579 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 667' ' ' TYR . . . . . . . . . . . . . 16.7 p90 -69.42 -17.94 63.7 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-N 116.042 -0.526 . . . . 0.0 112.049 179.446 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 668' ' ' GLY . . . . . . . . . . . . . . . 101.05 -107.9 3.35 Favored Glycine 0 CA--C 1.521 0.447 0 C-N-CA 120.664 -0.779 . . . . 0.0 113.918 179.445 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 669' ' ' ASP . . . . . . . . . . . . . 28.9 t70 -82.22 115.31 21.25 Favored 'General case' 0 N--CA 1.465 0.3 0 N-CA-C 112.258 0.466 . . . . 0.0 112.258 -177.901 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 670' ' ' VAL . . . . . . . . . . . . . 73.1 t -61.55 -42.3 93.51 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.36 0 CA-C-N 115.413 -0.812 . . . . 0.0 112.712 -179.807 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 671' ' ' GLN . . . . . . . . . . . . . 26.6 mp0 -60.87 -41.27 95.6 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 111.989 0.366 . . . . 0.0 111.989 -177.598 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 672' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 -65.0 -40.78 95.45 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.795 0.331 . . . . 0.0 110.862 178.959 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 673' ' ' LEU . . . . . . . . . . . . . 66.9 tp -64.47 -44.57 90.63 Favored 'General case' 0 C--N 1.333 -0.137 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.117 178.923 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 674' ' ' VAL . . . . . 0.57 HG11 ' HA3' ' A' ' 699' ' ' GLY . 53.2 t -62.86 -43.63 99.01 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 CA-C-N 115.46 -0.791 . . . . 0.0 110.158 179.875 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 675' ' ' ASP . . . . . . . . . . . . . 37.3 t70 -59.71 -40.65 88.67 Favored 'General case' 0 CA--C 1.521 -0.165 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.156 178.81 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 676' ' ' GLN . . . . . 0.408 ' O ' ' HG2' ' A' ' 680' ' ' ARG . 56.6 mt-30 -70.67 -41.44 72.05 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.861 179.875 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 677' ' ' LEU . . . . . . . . . . . . . 86.1 mt -65.8 -42.06 91.14 Favored 'General case' 0 C--N 1.334 -0.089 0 CA-C-N 116.538 -0.301 . . . . 0.0 111.013 179.376 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 678' ' ' ARG . . . . . . . . . . . . . 7.7 mmm180 -68.98 -37.07 78.56 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-O 121.03 0.443 . . . . 0.0 111.534 179.657 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 679' ' ' GLN . . . . . . . . . . . . . 49.5 tt0 -65.36 -37.09 85.97 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.468 179.621 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 680' ' ' ARG . . . . . 0.408 ' HG2' ' O ' ' A' ' 676' ' ' GLN . 89.4 mmt-85 -84.36 -44.2 13.98 Favored 'General case' 0 N--CA 1.461 0.116 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.783 -179.952 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 681' ' ' CYS . . . . . . . . . . . . . 71.9 m -126.65 138.03 53.37 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 121.258 0.551 . . . . 0.0 111.631 -179.071 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 682' ' ' THR . . . . . . . . . . . . . 54.0 p -71.18 162.28 73.45 Favored Pre-proline 0 C--N 1.323 -0.55 0 CA-C-N 115.647 -0.706 . . . . 0.0 109.941 178.934 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 683' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_exo -53.85 -33.99 73.7 Favored 'Trans proline' 0 C--N 1.35 0.615 0 C-N-CA 122.661 2.241 . . . . 0.0 112.849 -179.535 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 684' ' ' GLU . . . . . . . . . . . . . 51.8 mp0 -68.34 -38.55 81.6 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.996 0.427 . . . . 0.0 110.672 -179.988 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 685' ' ' GLN . . . . . . . . . . . . . 79.0 mt-30 -71.65 -39.57 70.26 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.511 -0.768 . . . . 0.0 112.49 -179.639 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 686' ' ' LEU . . . . . 0.433 ' HA ' ' O ' ' A' ' 657' ' ' ILE . 2.4 tt -139.0 120.01 14.48 Favored 'General case' 0 CA--C 1.531 0.23 0 N-CA-C 112.706 0.632 . . . . 0.0 112.706 -177.654 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 687' ' ' LYS . . . . . 0.421 ' HB2' ' HB2' ' A' ' 658' ' ' ALA . 47.4 mmtm -93.94 147.49 23.05 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.083 177.718 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 688' ' ' ILE . . . . . . . . . . . . . 79.6 mt -121.62 120.85 62.92 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 CA-C-O 121.393 0.616 . . . . 0.0 111.902 -178.67 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 689' ' ' PHE . . . . . . . . . . . . . 98.4 m-85 -121.1 146.86 46.29 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 114.864 -1.062 . . . . 0.0 109.79 178.838 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 690' ' ' ILE . . . . . 0.471 HD11 ' CZ ' ' A' ' 665' ' ' PHE . 18.7 tt -125.7 136.74 59.9 Favored 'Isoleucine or valine' 0 C--O 1.235 0.307 0 CA-C-O 121.438 0.637 . . . . 0.0 111.934 -179.518 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 691' ' ' LEU . . . . . 0.524 HD23 ' HB ' ' A' ' 704' ' ' ILE . 76.2 mt -113.48 134.54 54.62 Favored 'General case' 0 C--O 1.235 0.306 0 CA-C-N 115.243 -0.889 . . . . 0.0 110.441 179.998 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 692' ' ' GLY . . . . . 0.666 ' O ' ' HA ' ' A' ' 705' ' ' PRO . . . 163.04 -173.85 39.28 Favored Glycine 0 N--CA 1.447 -0.575 0 C-N-CA 120.461 -0.876 . . . . 0.0 112.202 179.778 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 693' ' ' SER . . . . . . . . . . . . . 80.2 p -68.38 -37.66 80.62 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 120.94 0.4 . . . . 0.0 111.026 179.42 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 694' ' ' LYS . . . . . . . . . . . . . 64.5 mttp -126.37 134.15 51.13 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.193 179.317 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 695' ' ' GLY . . . . . 0.497 ' HA3' ' HB2' ' A' ' 703' ' ' TYR . . . -108.65 17.13 33.58 Favored Glycine 0 N--CA 1.449 -0.451 0 C-N-CA 120.921 -0.657 . . . . 0.0 112.825 179.585 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 696' ' ' ASN . . . . . . . . . . . . . 64.8 t30 -81.61 70.98 8.61 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 121.044 0.45 . . . . 0.0 111.088 -179.418 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 697' ' ' TYR . . . . . . . . . . . . . 97.1 m-85 -130.18 143.04 50.55 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.018 179.299 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 698' ' ' GLN . . . . . . . . . . . . . 22.0 mp0 -81.57 146.02 30.34 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.665 -179.933 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 699' ' ' GLY . . . . . 0.57 ' HA3' HG11 ' A' ' 674' ' ' VAL . . . 96.05 5.85 59.37 Favored Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.45 -0.881 . . . . 0.0 114.155 179.1 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 700' ' ' VAL . . . . . . . . . . . . . 22.9 m -118.16 152.25 20.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 117.773 0.786 . . . . 0.0 109.868 179.075 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 701' ' ' ASP . . . . . . . . . . . . . 65.1 m-20 -83.92 -39.96 19.15 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 116.024 -0.534 . . . . 0.0 112.107 -178.458 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 702' ' ' ARG . . . . . . . . . . . . . 63.1 mtp85 -146.58 160.68 41.85 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.736 0.303 . . . . 0.0 110.728 -179.356 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 703' ' ' TYR . . . . . 0.497 ' HB2' ' HA3' ' A' ' 695' ' ' GLY . 16.6 p90 -122.49 140.35 52.84 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.072 0.463 . . . . 0.0 111.193 179.673 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 704' ' ' ILE . . . . . 0.543 HG22 HG12 ' A' ' 708' ' ' ILE . 53.7 mt -127.4 86.26 59.01 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-N 115.946 -0.57 . . . . 0.0 109.54 179.487 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 705' ' ' PRO . . . . . 0.666 ' HA ' ' O ' ' A' ' 692' ' ' GLY . 73.4 Cg_endo -73.03 152.16 50.97 Favored 'Trans proline' 0 C--N 1.349 0.562 0 C-N-CA 123.158 2.572 . . . . 0.0 114.384 -178.425 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 706' ' ' LEU . . . . . 0.761 HD23 HG13 ' A' ' 708' ' ' ILE . 76.7 mt -79.9 145.71 62.28 Favored Pre-proline 0 CA--C 1.531 0.246 0 CA-C-N 115.169 -0.923 . . . . 0.0 110.645 178.681 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 707' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -74.36 139.78 63.59 Favored 'Cis proline' 0 C--N 1.345 0.371 0 C-N-CA 123.081 -1.633 . . . . 0.0 112.112 -1.27 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 708' ' ' ILE . . . . . 0.761 HG13 HD23 ' A' ' 706' ' ' LEU . 78.4 mt -83.41 119.5 32.87 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 CA-C-O 120.983 0.42 . . . . 0.0 110.445 179.646 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 709' ' ' HIS . . . . . . . . . . . . . 70.0 m80 -86.81 124.05 69.69 Favored Pre-proline 0 C--N 1.328 -0.366 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.5 179.517 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 710' ' ' PRO . . . . . . . . . . . . . 23.2 Cg_endo -60.99 -30.3 89.61 Favored 'Trans proline' 0 C--N 1.348 0.535 0 C-N-CA 122.993 2.462 . . . . 0.0 113.63 -179.308 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 711' ' ' GLU . . . . . . . . . . . . . 51.5 mp0 -66.11 -39.87 90.26 Favored 'General case' 0 C--N 1.331 -0.225 0 N-CA-C 112.208 0.448 . . . . 0.0 112.208 -179.381 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 712' ' ' SER . . . . . . . . . . . . . 79.9 p -98.5 -17.08 18.92 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 112.28 0.474 . . . . 0.0 112.28 -178.648 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 713' ' ' PHE . . . . . . . . . . . . . 86.2 t80 -59.99 -49.68 76.74 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.669 0.271 . . . . 0.0 110.911 -179.82 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 714' ' ' LEU . . . . . . . . . . . . . 93.0 mt -64.74 -38.66 91.73 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.434 179.372 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 715' ' ' GLN . . . . . . . . . . . . . 22.6 tm0? -63.67 -43.34 96.99 Favored 'General case' 0 CA--C 1.534 0.344 0 CA-C-N 115.514 -0.766 . . . . 0.0 111.13 179.616 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 716' ' ' GLN . . . . . . . . . . . . . 84.7 mm-40 -66.15 -41.45 90.39 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-O 120.712 0.292 . . . . 0.0 111.156 179.773 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 717' ' ' VAL . . . . . . . . . . . . . 65.3 t -63.31 -44.95 99.35 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.158 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.692 179.55 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 718' ' ' THR . . . . . . . . . . . . . 89.9 m -62.12 -44.91 95.6 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.141 179.929 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 719' ' ' MET . . . . . 0.405 ' O ' HG22 ' A' ' 722' ' ' THR . 24.8 mmt -63.71 -40.34 96.52 Favored 'General case' 0 C--O 1.224 -0.275 0 C-N-CA 121.188 -0.205 . . . . 0.0 110.824 179.403 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 720' ' ' GLY . . . . . . . . . . . . . . . -68.36 -42.37 82.61 Favored Glycine 0 C--N 1.332 0.327 0 C-N-CA 120.314 -0.946 . . . . 0.0 112.124 177.976 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 721' ' ' LEU . . . . . . . . . . . . . 59.7 tp -67.99 -42.88 80.12 Favored 'General case' 0 CA--C 1.531 0.212 0 C-N-CA 122.628 0.371 . . . . 0.0 111.793 179.512 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 722' ' ' THR . . . . . 0.405 HG22 ' O ' ' A' ' 719' ' ' MET . 4.1 p 59.27 20.77 8.91 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 123.437 0.695 . . . . 0.0 111.92 -179.607 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 723' ' ' SER . . . . . . . . . . . . . 49.8 m 61.08 32.66 19.72 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-N 115.855 -0.611 . . . . 0.0 111.421 -179.218 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 724' ' ' LEU . . . . . . . . . . . . . 85.0 mt 57.79 -102.18 0.14 Allowed 'General case' 0 N--CA 1.467 0.393 0 CA-C-N 115.706 -0.679 . . . . 0.0 111.978 179.298 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 725' ' ' ALA . . . . . . . . . . . . . . . -121.24 24.56 9.97 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.713 0.292 . . . . 0.0 111.341 -179.529 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 726' ' ' THR . . . . . . . . . . . . . 74.4 p -125.9 159.67 31.96 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.867 0.365 . . . . 0.0 111.089 -179.71 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 727' ' ' SER . . . . . . . . . . . . . 60.1 m -128.23 148.48 50.63 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.568 179.861 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 728' ' ' ALA . . . . . . . . . . . . . . . -62.44 -40.01 95.2 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.581 179.88 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 729' ' ' GLN . . . . . . . . . . . . . 96.6 mt-30 . . . . . 0 C--O 1.249 1.052 0 CA-C-O 118.073 -0.965 . . . . 0.0 110.682 179.911 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 613' ' ' GLU . . . . . . . . . . . . . 75.6 mm-40 . . . . . 0 N--CA 1.486 1.328 0 CA-C-O 120.878 0.371 . . . . 0.0 110.804 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 614' ' ' GLY . . . . . . . . . . . . . . . -169.96 166.97 40.14 Favored Glycine 0 N--CA 1.45 -0.411 0 C-N-CA 120.601 -0.809 . . . . 0.0 112.598 -179.965 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 615' ' ' ARG . . . . . . . . . . . . . 13.6 tpt180 -115.83 118.69 33.69 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 109.986 -0.375 . . . . 0.0 109.986 179.927 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 616' ' ' ILE . . . . . 0.442 ' O ' ' HA ' ' A' ' 640' ' ' VAL . 83.4 mt -124.04 134.42 66.61 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 116.473 -0.331 . . . . 0.0 110.883 -179.679 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 617' ' ' VAL . . . . . 0.441 HG23 ' HB3' ' A' ' 656' ' ' PRO . 91.9 t -108.6 128.65 64.1 Favored 'Isoleucine or valine' 0 C--O 1.234 0.276 0 CA-C-O 120.943 0.401 . . . . 0.0 110.036 179.479 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 618' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -108.78 129.03 55.38 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.944 -0.571 . . . . 0.0 111.001 -178.546 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 619' ' ' VAL . . . . . . . . . . . . . 61.7 t -116.72 117.51 55.69 Favored 'Isoleucine or valine' 0 C--O 1.235 0.324 0 CA-C-O 121.03 0.443 . . . . 0.0 109.827 179.748 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 620' ' ' SER . . . . . 0.55 ' HB2' ' HB3' ' A' ' 662' ' ' ALA . 23.3 t -172.44 148.27 2.01 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.395 -0.82 . . . . 0.0 110.686 -179.633 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 621' ' ' GLU . . . . . . . . . . . . . 4.4 mm-40 -96.21 -4.9 41.63 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.931 178.652 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 622' ' ' ASP . . . . . . . . . . . . . 61.0 t0 -92.42 107.3 19.11 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-O 120.747 0.308 . . . . 0.0 110.17 -179.67 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 623' ' ' GLU . . . . . . . . . . . . . 51.1 mp0 -63.57 -40.15 96.23 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.836 -0.62 . . . . 0.0 112.514 -179.003 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 624' ' ' ALA . . . . . . . . . . . . . . . -61.6 -45.18 95.17 Favored 'General case' 0 N--CA 1.463 0.214 0 N-CA-C 112.423 0.527 . . . . 0.0 112.423 -178.306 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 625' ' ' THR . . . . . 0.45 ' O ' HG22 ' A' ' 629' ' ' ILE . 94.8 m -71.43 -41.17 69.85 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.721 0.296 . . . . 0.0 110.82 179.708 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 626' ' ' SER . . . . . . . . . . . . . 66.4 m -62.56 -41.49 98.94 Favored 'General case' 0 CA--C 1.53 0.179 0 CA-C-N 115.915 -0.584 . . . . 0.0 112.438 -178.489 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 627' ' ' THR . . . . . . . . . . . . . 35.3 p -68.66 -40.43 80.21 Favored 'General case' 0 N--CA 1.465 0.294 0 N-CA-C 112.511 0.56 . . . . 0.0 112.511 -179.935 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 628' ' ' LEU . . . . . . . . . . . . . 63.5 tp -64.17 -47.02 81.45 Favored 'General case' 0 CA--C 1.532 0.253 0 N-CA-C 112.052 0.39 . . . . 0.0 112.052 -179.602 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 629' ' ' ILE . . . . . 0.45 HG22 ' O ' ' A' ' 625' ' ' THR . 20.2 tt -70.79 -34.55 56.75 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.399 0 N-CA-C 112.483 0.549 . . . . 0.0 112.483 -179.221 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 630' ' ' CYS . . . . . . . . . . . . . 48.9 t -60.49 -44.68 95.69 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.484 -179.238 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 631' ' ' SER . . . . . . . . . . . . . 47.2 t -61.77 -42.62 99.23 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.141 -179.694 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 632' ' ' ILE . . . . . . . . . . . . . 97.4 mt -61.81 -48.17 89.87 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.289 0 CA-C-O 120.852 0.358 . . . . 0.0 110.65 179.974 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 633' ' ' LEU . . . . . . . . . . . . . 80.8 mt -66.35 -40.23 89.68 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.005 -0.543 . . . . 0.0 112.04 179.845 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 634' ' ' THR . . . . . 0.525 ' HA ' ' O ' ' A' ' 638' ' ' TYR . 89.9 m -65.84 -40.17 91.48 Favored 'General case' 0 CA--C 1.531 0.231 0 CA-C-O 120.685 0.279 . . . . 0.0 110.931 -179.612 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 635' ' ' THR . . . . . . . . . . . . . 92.2 m -59.01 -38.55 79.47 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.34 179.249 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 636' ' ' ALA . . . . . . . . . . . . . . . -67.31 -11.95 58.9 Favored 'General case' 0 CA--C 1.534 0.364 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.371 179.104 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 637' ' ' GLY . . . . . . . . . . . . . . . 103.5 7.69 42.09 Favored Glycine 0 C--N 1.334 0.421 0 C-N-CA 120.972 -0.632 . . . . 0.0 113.333 179.617 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 638' ' ' TYR . . . . . 0.525 ' O ' ' HA ' ' A' ' 634' ' ' THR . 96.0 m-85 -99.89 141.73 32.32 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.823 0.344 . . . . 0.0 111.319 -179.738 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 639' ' ' GLN . . . . . . . . . . . . . 98.4 mm-40 -90.69 134.32 34.49 Favored 'General case' 0 CA--C 1.517 -0.326 0 CA-C-N 116.309 -0.405 . . . . 0.0 109.911 179.537 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 640' ' ' VAL . . . . . 0.442 ' HA ' ' O ' ' A' ' 616' ' ' ILE . 60.6 t -118.91 130.36 73.84 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-O 121.008 0.432 . . . . 0.0 112.151 -179.318 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 641' ' ' ILE . . . . . . . . . . . . . 47.5 mm -109.28 117.93 55.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 N-CA-C 108.468 -0.938 . . . . 0.0 108.468 178.197 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 642' ' ' TRP . . . . . . . . . . . . . 24.6 t90 -90.63 124.31 34.95 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 112.405 0.52 . . . . 0.0 112.405 -178.237 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 643' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -119.54 132.94 55.85 Favored 'General case' 0 CA--C 1.53 0.204 0 CA-C-N 115.596 -0.729 . . . . 0.0 110.048 178.907 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 644' ' ' VAL . . . . . . . . . . . . . 19.0 m -103.0 18.0 4.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 N-CA-C 112.426 0.528 . . . . 0.0 112.426 -179.049 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 645' ' ' ASP . . . . . . . . . . . . . 16.4 t0 -144.17 -28.32 0.51 Allowed 'General case' 0 N--CA 1.47 0.562 0 N-CA-C 113.382 0.882 . . . . 0.0 113.382 -178.023 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 646' ' ' GLY . . . . . . . . . . . . . . . 73.88 28.75 64.22 Favored Glycine 0 CA--C 1.523 0.543 0 C-N-CA 120.734 -0.746 . . . . 0.0 114.461 179.76 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 647' ' ' GLU . . . . . . . . . . . . . 92.7 mt-10 -63.77 126.38 27.41 Favored 'General case' 0 C--N 1.334 -0.106 0 CA-C-N 117.683 0.742 . . . . 0.0 111.167 179.606 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 648' ' ' VAL . . . . . . . . . . . . . 75.0 t -61.59 -39.42 83.03 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-N 114.752 -1.113 . . . . 0.0 111.543 -179.653 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 649' ' ' GLU . . . . . . . . . . . . . 50.5 mp0 -60.7 -43.18 98.1 Favored 'General case' 0 C--N 1.331 -0.198 0 N-CA-C 110.038 -0.356 . . . . 0.0 110.038 -179.908 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 650' ' ' ARG . . . . . . . . . . . . . 16.2 mmp_? -70.21 -40.8 74.35 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.49 178.412 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 651' ' ' LEU . . . . . . . . . . . . . 89.2 mt -64.72 -41.03 96.27 Favored 'General case' 0 N--CA 1.462 0.171 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.413 179.2 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 652' ' ' LEU . . . . . . . . . . . . . 60.8 tp -65.23 -42.91 92.94 Favored 'General case' 0 CA--C 1.531 0.213 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.114 178.89 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 653' ' ' ALA . . . . . . . . . . . . . . . -62.56 -39.44 93.67 Favored 'General case' 0 N--CA 1.463 0.209 0 CA-C-O 120.989 0.423 . . . . 0.0 111.796 179.947 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 654' ' ' LEU . . . . . . . . . . . . . 75.8 mt -102.59 30.25 4.78 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.897 -179.447 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 655' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -31.1 104.02 0.21 Allowed Pre-proline 0 N--CA 1.471 0.624 0 O-C-N 124.595 1.185 . . . . 0.0 114.081 -179.129 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 656' ' ' PRO . . . . . 0.441 ' HB3' HG23 ' A' ' 617' ' ' VAL . 37.5 Cg_endo -90.75 177.11 2.24 Favored 'Trans proline' 0 C--N 1.345 0.356 0 C-N-CA 123.617 2.878 . . . . 0.0 112.37 178.557 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 657' ' ' ILE . . . . . . . . . . . . . 19.4 pt -83.81 -24.83 7.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-O 121.271 0.558 . . . . 0.0 109.649 177.85 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 658' ' ' ALA . . . . . 0.482 ' HA ' ' O ' ' A' ' 687' ' ' LYS . . . -157.18 153.23 27.33 Favored 'General case' 0 N--CA 1.449 -0.507 0 CA-C-N 115.21 -0.905 . . . . 0.0 111.006 -179.959 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 659' ' ' VAL . . . . . . . . . . . . . 31.5 m -122.96 147.16 27.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-O 121.138 0.494 . . . . 0.0 111.039 179.109 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 660' ' ' LEU . . . . . . . . . . . . . 12.1 mt -116.59 119.95 37.16 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.414 -0.812 . . . . 0.0 110.125 179.105 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 661' ' ' LEU . . . . . . . . . . . . . 75.5 mt -108.39 113.35 26.35 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 109.794 -0.447 . . . . 0.0 109.794 179.744 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 662' ' ' ALA . . . . . 0.55 ' HB3' ' HB2' ' A' ' 620' ' ' SER . . . -108.47 113.8 27.13 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 111.962 0.356 . . . . 0.0 111.962 -179.474 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 663' ' ' GLU . . . . . 0.59 ' HA ' ' C ' ' A' ' 664' ' ' PRO . 23.5 pt-20 -67.62 148.74 98.55 Favored Pre-proline 0 CA--C 1.537 0.477 0 CA-C-N 115.78 -0.645 . . . . 0.0 111.054 178.931 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 664' ' ' PRO . . . . . 0.59 ' C ' ' HA ' ' A' ' 663' ' ' GLU . 40.3 Cg_exo -60.91 138.26 21.51 Favored 'Cis proline' 0 C--N 1.353 0.775 0 C-N-CA 124.082 -1.216 . . . . 0.0 112.491 -0.891 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 665' ' ' PHE . . . . . 0.476 ' HZ ' HD11 ' A' ' 690' ' ' ILE . 59.3 m-85 -82.64 121.78 27.28 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.979 -179.175 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 666' ' ' SER . . . . . . . . . . . . . 79.0 p -66.27 -38.45 87.83 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.954 -0.567 . . . . 0.0 111.924 -179.867 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 667' ' ' TYR . . . . . . . . . . . . . 63.2 t80 -65.93 -23.99 66.73 Favored 'General case' 0 CA--C 1.534 0.342 0 CA-C-O 120.804 0.335 . . . . 0.0 111.551 179.328 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 668' ' ' GLY . . . . . . . . . . . . . . . 99.96 -104.03 2.76 Favored Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.518 -0.849 . . . . 0.0 112.291 -179.524 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 669' ' ' ASP . . . . . . . . . . . . . 49.5 t0 -83.15 106.27 14.81 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.916 0.389 . . . . 0.0 110.412 -179.887 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 670' ' ' VAL . . . . . 0.407 ' O ' HG23 ' A' ' 674' ' ' VAL . 11.5 m -70.23 -23.13 24.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 N-CA-C 113.25 0.833 . . . . 0.0 113.25 -179.122 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 671' ' ' GLN . . . . . . . . . . . . . 77.8 mt-30 -61.63 -42.33 98.74 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-O 121.073 0.463 . . . . 0.0 110.22 179.943 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 672' ' ' GLU . . . . . . . . . . . . . 95.1 mt-10 -66.51 -40.42 89.2 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.657 -0.701 . . . . 0.0 110.462 178.634 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 673' ' ' LEU . . . . . . . . . . . . . 62.7 tp -63.03 -44.56 95.6 Favored 'General case' 0 N--CA 1.462 0.129 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.148 179.443 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 674' ' ' VAL . . . . . 0.618 HG11 ' HA3' ' A' ' 699' ' ' GLY . 55.6 t -63.0 -43.87 99.34 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.15 0 CA-C-N 115.805 -0.634 . . . . 0.0 109.557 179.111 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 675' ' ' ASP . . . . . . . . . . . . . 37.3 t70 -60.5 -40.91 93.07 Favored 'General case' 0 CA--C 1.521 -0.155 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.38 178.771 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 676' ' ' GLN . . . . . 0.408 ' O ' ' HG2' ' A' ' 680' ' ' ARG . 95.4 mt-30 -69.88 -41.89 74.19 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.083 -179.937 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 677' ' ' LEU . . . . . . . . . . . . . 86.3 mt -67.09 -41.52 86.19 Favored 'General case' 0 C--O 1.226 -0.174 0 CA-C-N 116.443 -0.344 . . . . 0.0 110.801 178.999 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 678' ' ' ARG . . . . . . . . . . . . . 62.4 ttp180 -66.43 -38.6 87.79 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-O 121.304 0.574 . . . . 0.0 110.588 179.689 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 679' ' ' GLN . . . . . . . . . . . . . 53.7 tt0 -62.62 -39.13 92.82 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.25 -0.886 . . . . 0.0 110.781 179.915 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 680' ' ' ARG . . . . . 0.408 ' HG2' ' O ' ' A' ' 676' ' ' GLN . 38.2 mmt180 -84.82 -42.41 15.14 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.385 -0.37 . . . . 0.0 111.462 -179.739 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 681' ' ' CYS . . . . . . . . . . . . . 76.6 m -126.5 131.63 51.58 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.374 -0.375 . . . . 0.0 110.254 179.744 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 682' ' ' THR . . . . . 0.47 ' HB ' ' HD2' ' A' ' 683' ' ' PRO . 65.4 p -68.81 159.04 84.16 Favored Pre-proline 0 C--N 1.322 -0.607 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.854 -179.614 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 683' ' ' PRO . . . . . 0.47 ' HD2' ' HB ' ' A' ' 682' ' ' THR . 19.3 Cg_endo -59.91 -18.88 52.14 Favored 'Trans proline' 0 C--N 1.351 0.687 0 C-N-CA 122.75 2.3 . . . . 0.0 112.963 -179.793 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 684' ' ' GLU . . . . . . . . . . . . . 51.5 mt-10 -87.74 -12.1 46.21 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.751 0.31 . . . . 0.0 110.584 178.959 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 685' ' ' GLN . . . . . . . . . . . . . 91.6 mt-30 -100.79 -34.22 9.92 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.341 -0.39 . . . . 0.0 111.571 -179.889 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 686' ' ' LEU . . . . . . . . . . . . . 3.1 tt -135.44 125.23 25.5 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.874 -179.298 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 687' ' ' LYS . . . . . 0.482 ' O ' ' HA ' ' A' ' 658' ' ' ALA . 74.2 mmtt -94.35 146.56 23.97 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.148 0.499 . . . . 0.0 110.194 179.47 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 688' ' ' ILE . . . . . 0.529 HG22 HG12 ' A' ' 700' ' ' VAL . 78.7 mt -122.77 121.35 63.17 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.767 0 CA-C-O 121.246 0.546 . . . . 0.0 110.981 -179.199 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 689' ' ' PHE . . . . . . . . . . . . . 98.3 m-85 -117.65 142.16 47.55 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.036 -0.983 . . . . 0.0 110.094 179.102 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 690' ' ' ILE . . . . . 0.476 HD11 ' HZ ' ' A' ' 665' ' ' PHE . 18.0 tt -121.18 136.5 57.93 Favored 'Isoleucine or valine' 0 C--O 1.237 0.395 0 CA-C-O 121.122 0.487 . . . . 0.0 111.095 179.795 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 691' ' ' LEU . . . . . 0.617 HD23 ' HB ' ' A' ' 704' ' ' ILE . 72.2 mt -107.86 135.28 49.52 Favored 'General case' 0 C--O 1.233 0.237 0 CA-C-N 115.8 -0.637 . . . . 0.0 110.566 -179.897 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 692' ' ' GLY . . . . . 0.637 ' O ' ' HA ' ' A' ' 705' ' ' PRO . . . 161.95 -163.33 34.74 Favored Glycine 0 N--CA 1.449 -0.488 0 C-N-CA 120.449 -0.882 . . . . 0.0 112.97 179.859 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 693' ' ' SER . . . . . . . . . . . . . 60.4 m -97.18 111.1 23.49 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 109.155 -0.683 . . . . 0.0 109.155 179.328 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 694' ' ' LYS . . . . . . . . . . . . . 88.5 tttt 63.2 83.1 0.17 Allowed 'General case' 0 N--CA 1.465 0.289 0 O-C-N 123.871 0.732 . . . . 0.0 109.648 -178.713 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 695' ' ' GLY . . . . . 0.409 ' HA3' ' HB2' ' A' ' 703' ' ' TYR . . . -75.77 58.02 3.03 Favored Glycine 0 CA--C 1.519 0.314 0 CA-C-N 115.776 -0.647 . . . . 0.0 113.726 -178.603 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 696' ' ' ASN . . . . . . . . . . . . . 66.4 t30 -89.5 88.91 7.62 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 109.611 -0.515 . . . . 0.0 109.611 179.058 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 697' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -140.97 -171.45 3.26 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.814 -179.181 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 698' ' ' GLN . . . . . . . . . . . . . 27.1 pt20 -127.33 152.67 47.16 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.869 -0.605 . . . . 0.0 109.755 -179.882 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 699' ' ' GLY . . . . . 0.618 ' HA3' HG11 ' A' ' 674' ' ' VAL . . . 91.6 -6.67 80.17 Favored Glycine 0 N--CA 1.449 -0.464 0 C-N-CA 120.337 -0.935 . . . . 0.0 112.432 -179.436 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 700' ' ' VAL . . . . . 0.529 HG12 HG22 ' A' ' 688' ' ' ILE . 28.6 m -109.58 141.04 25.96 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.368 0 CA-C-O 121.241 0.543 . . . . 0.0 110.378 179.571 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 701' ' ' ASP . . . . . 0.424 ' O ' ' HD2' ' A' ' 702' ' ' ARG . 35.0 t70 -72.63 -41.21 65.76 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.411 -0.813 . . . . 0.0 111.67 -179.66 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 702' ' ' ARG . . . . . 0.424 ' HD2' ' O ' ' A' ' 701' ' ' ASP . 5.7 mpt_? -144.0 169.2 18.27 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.491 -179.136 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 703' ' ' TYR . . . . . 0.409 ' HB2' ' HA3' ' A' ' 695' ' ' GLY . 53.6 p90 -132.71 146.64 52.03 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.12 179.277 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 704' ' ' ILE . . . . . 0.617 ' HB ' HD23 ' A' ' 691' ' ' LEU . 53.5 mt -129.92 105.52 16.78 Favored Pre-proline 0 C--N 1.326 -0.428 0 CA-C-N 116.538 -0.301 . . . . 0.0 110.534 179.769 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 705' ' ' PRO . . . . . 0.637 ' HA ' ' O ' ' A' ' 692' ' ' GLY . 70.3 Cg_endo -72.32 151.9 54.74 Favored 'Trans proline' 0 C--N 1.346 0.403 0 C-N-CA 122.904 2.403 . . . . 0.0 113.711 -179.267 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 706' ' ' LEU . . . . . 0.572 HD23 HG23 ' A' ' 708' ' ' ILE . 88.9 mt -104.66 148.43 36.04 Favored Pre-proline 0 N--CA 1.453 -0.28 0 CA-C-N 115.347 -0.842 . . . . 0.0 110.003 178.954 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 707' ' ' PRO . . . . . 0.433 ' C ' ' HA ' ' A' ' 706' ' ' LEU . 58.3 Cg_endo -70.89 139.69 59.48 Favored 'Cis proline' 0 C--N 1.346 0.412 0 C-N-CA 122.956 -1.685 . . . . 0.0 112.625 -0.465 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 708' ' ' ILE . . . . . 0.572 HG23 HD23 ' A' ' 706' ' ' LEU . 3.1 pt -63.51 132.58 29.39 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-N 115.672 -0.695 . . . . 0.0 112.222 179.237 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 709' ' ' HIS . . . . . . . . . . . . . 70.4 m80 -99.57 112.43 63.52 Favored Pre-proline 0 C--N 1.322 -0.6 0 N-CA-C 107.822 -1.177 . . . . 0.0 107.822 177.252 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 710' ' ' PRO . . . . . . . . . . . . . 84.7 Cg_exo -51.51 -36.92 61.3 Favored 'Trans proline' 0 N--CA 1.478 0.568 0 C-N-CA 123.313 2.675 . . . . 0.0 114.558 -177.418 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 711' ' ' GLU . . . . . . . . . . . . . 88.7 tt0 -63.78 -43.29 96.8 Favored 'General case' 0 CA--C 1.535 0.369 0 N-CA-C 112.118 0.414 . . . . 0.0 112.118 -178.928 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 712' ' ' SER . . . . . . . . . . . . . 57.3 m -95.32 -15.66 22.96 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 111.967 0.358 . . . . 0.0 111.967 -178.803 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 713' ' ' PHE . . . . . . . . . . . . . 86.4 t80 -60.58 -49.48 77.38 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.81 0.338 . . . . 0.0 110.414 179.704 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 714' ' ' LEU . . . . . . . . . . . . . 92.0 mt -64.77 -37.25 86.98 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.804 -0.634 . . . . 0.0 110.073 179.184 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 715' ' ' GLN . . . . . . . . . . . . . 65.4 tt0 -61.57 -43.51 98.73 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.656 179.228 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 716' ' ' GLN . . . . . . . . . . . . . 30.3 mm100 -64.17 -40.57 96.41 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-N 116.494 -0.321 . . . . 0.0 110.677 179.374 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 717' ' ' VAL . . . . . . . . . . . . . 71.3 t -63.4 -43.4 98.49 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.164 0 CA-C-O 121.057 0.456 . . . . 0.0 109.824 178.928 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 718' ' ' THR . . . . . . . . . . . . . 88.1 m -61.88 -41.21 97.59 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-N 115.605 -0.725 . . . . 0.0 111.125 179.314 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 719' ' ' MET . . . . . 0.418 ' O ' HG22 ' A' ' 722' ' ' THR . 98.1 mtp -61.51 -40.41 94.49 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.28 179.998 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 720' ' ' GLY . . . . . . . . . . . . . . . -84.21 -15.57 69.05 Favored Glycine 0 CA--C 1.521 0.435 0 C-N-CA 120.435 -0.888 . . . . 0.0 112.786 179.387 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 721' ' ' LEU . . . . . . . . . . . . . 60.5 tp -67.42 -40.3 85.54 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-O 120.795 0.331 . . . . 0.0 111.611 179.709 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 722' ' ' THR . . . . . 0.418 HG22 ' O ' ' A' ' 719' ' ' MET . 15.1 t -64.67 165.94 9.53 Favored 'General case' 0 CA--C 1.535 0.376 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.322 -179.687 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 723' ' ' SER . . . . . . . . . . . . . 49.0 m 63.1 40.47 9.0 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-O 121.332 0.587 . . . . 0.0 110.699 -178.655 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 724' ' ' LEU . . . . . . . . . . . . . 60.2 tp -103.81 126.14 50.74 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.37 -0.832 . . . . 0.0 109.727 -179.991 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 725' ' ' ALA . . . . . . . . . . . . . . . -62.16 -39.8 93.83 Favored 'General case' 0 N--CA 1.464 0.26 0 N-CA-C 112.887 0.699 . . . . 0.0 112.887 -178.888 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 726' ' ' THR . . . . . . . . . . . . . 4.8 t -91.64 134.4 34.73 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.274 0.559 . . . . 0.0 111.421 -179.329 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 727' ' ' SER . . . . . . . . . . . . . 78.5 p -102.76 4.37 37.89 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.06 179.677 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 728' ' ' ALA . . . . . . . . . . . . . . . -83.27 79.55 9.36 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.298 -179.462 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 729' ' ' GLN . . . . . . . . . . . . . 77.4 mt-30 . . . . . 0 C--O 1.25 1.126 0 CA-C-O 118.407 -0.806 . . . . 0.0 111.373 179.665 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 613' ' ' GLU . . . . . 0.537 ' HA ' ' O ' ' A' ' 637' ' ' GLY . 59.7 mt-10 . . . . . 0 N--CA 1.487 1.402 0 CA-C-O 121.068 0.461 . . . . 0.0 110.619 . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 614' ' ' GLY . . . . . . . . . . . . . . . -86.26 -177.3 49.79 Favored Glycine 0 CA--C 1.519 0.295 0 CA-C-N 115.668 -0.696 . . . . 0.0 112.908 -179.887 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 615' ' ' ARG . . . . . . . . . . . . . 48.1 mtm105 -111.6 131.78 55.02 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.749 0.309 . . . . 0.0 111.078 -179.764 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 616' ' ' ILE . . . . . 0.464 ' O ' ' HA ' ' A' ' 640' ' ' VAL . 85.5 mt -125.01 133.27 69.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.117 179.169 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 617' ' ' VAL . . . . . . . . . . . . . 98.0 t -107.2 127.76 62.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 120.891 0.377 . . . . 0.0 110.241 -179.992 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 618' ' ' LEU . . . . . 0.456 HD11 HD13 ' A' ' 629' ' ' ILE . 1.1 tt -109.51 127.96 54.83 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.916 -0.583 . . . . 0.0 110.795 -178.87 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 619' ' ' VAL . . . . . . . . . . . . . 61.5 t -116.93 118.66 59.54 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.426 0 N-CA-C 109.835 -0.432 . . . . 0.0 109.835 179.713 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 620' ' ' SER . . . . . 0.744 ' HB3' ' HB3' ' A' ' 662' ' ' ALA . 82.7 p -166.59 163.81 16.92 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.514 -0.767 . . . . 0.0 110.767 -179.58 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 621' ' ' GLU . . . . . . . . . . . . . 99.3 mt-10 -102.41 -5.16 24.42 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.608 -0.724 . . . . 0.0 111.187 178.572 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 622' ' ' ASP . . . . . . . . . . . . . 50.5 t0 -102.43 108.1 19.31 Favored 'General case' 0 CA--C 1.531 0.231 0 CA-C-O 121.132 0.492 . . . . 0.0 111.354 -178.308 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 623' ' ' GLU . . . . . . . . . . . . . 42.3 tt0 -64.2 -40.69 96.6 Favored 'General case' 0 CA--C 1.534 0.333 0 CA-C-N 115.296 -0.866 . . . . 0.0 112.002 179.642 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 624' ' ' ALA . . . . . . . . . . . . . . . -60.88 -43.5 98.36 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-N 116.342 -0.39 . . . . 0.0 112.05 -178.661 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 625' ' ' THR . . . . . . . . . . . . . 88.0 m -67.55 -39.92 84.98 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 109.657 -0.497 . . . . 0.0 109.657 179.495 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 626' ' ' SER . . . . . . . . . . . . . 73.1 m -61.53 -40.26 93.99 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.191 -0.913 . . . . 0.0 112.342 -179.078 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 627' ' ' THR . . . . . . . . . . . . . 74.3 p -65.97 -39.95 90.84 Favored 'General case' 0 N--CA 1.465 0.32 0 N-CA-C 112.499 0.555 . . . . 0.0 112.499 -179.506 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 628' ' ' LEU . . . . . . . . . . . . . 62.6 tp -68.28 -46.25 70.87 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 112.03 0.381 . . . . 0.0 112.03 -179.734 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 629' ' ' ILE . . . . . 0.456 HD13 HD11 ' A' ' 618' ' ' LEU . 21.4 tt -70.82 -35.93 62.29 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.358 0 N-CA-C 112.59 0.589 . . . . 0.0 112.59 -178.982 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 630' ' ' CYS . . . . . . . . . . . . . 43.0 t -61.25 -42.37 98.51 Favored 'General case' 0 CA--C 1.521 -0.162 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.067 -179.648 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 631' ' ' SER . . . . . . . . . . . . . 68.2 m -61.57 -41.53 97.53 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.249 -179.361 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 632' ' ' ILE . . . . . . . . . . . . . 97.1 mt -62.92 -48.99 85.4 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.319 0 CA-C-O 121.014 0.435 . . . . 0.0 111.048 179.84 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 633' ' ' LEU . . . . . . . . . . . . . 91.6 mt -67.72 -39.61 84.29 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.728 -0.669 . . . . 0.0 112.315 -179.412 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 634' ' ' THR . . . . . 0.546 ' HA ' ' O ' ' A' ' 638' ' ' TYR . 83.9 m -65.32 -40.03 93.2 Favored 'General case' 0 N--CA 1.464 0.225 0 CA-C-O 120.598 0.237 . . . . 0.0 111.013 -179.53 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 635' ' ' THR . . . . . . . . . . . . . 93.0 m -58.22 -37.99 75.92 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.479 179.347 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 636' ' ' ALA . . . . . . . . . . . . . . . -68.47 -9.84 51.46 Favored 'General case' 0 CA--C 1.534 0.362 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.625 179.153 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 637' ' ' GLY . . . . . 0.537 ' O ' ' HA ' ' A' ' 613' ' ' GLU . . . 101.69 7.35 48.28 Favored Glycine 0 C--N 1.333 0.393 0 C-N-CA 121.043 -0.599 . . . . 0.0 113.233 179.606 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 638' ' ' TYR . . . . . 0.546 ' O ' ' HA ' ' A' ' 634' ' ' THR . 90.9 m-85 -99.77 141.19 32.91 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.724 0.297 . . . . 0.0 111.403 -179.66 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 639' ' ' GLN . . . . . . . . . . . . . 98.3 mm-40 -90.85 135.31 33.81 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.139 179.624 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 640' ' ' VAL . . . . . 0.464 ' HA ' ' O ' ' A' ' 616' ' ' ILE . 60.2 t -117.91 129.79 73.76 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 CA-C-O 121.169 0.509 . . . . 0.0 112.285 -179.507 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 641' ' ' ILE . . . . . . . . . . . . . 4.2 mp -112.56 120.17 62.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 N-CA-C 108.382 -0.969 . . . . 0.0 108.382 178.376 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 642' ' ' TRP . . . . . . . . . . . . . 26.1 t90 -93.55 127.05 39.03 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-O 121.203 0.525 . . . . 0.0 112.316 -178.283 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 643' ' ' LEU . . . . . 0.404 HD13 ' HA ' ' A' ' 643' ' ' LEU . 0.9 OUTLIER -118.12 129.45 55.54 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-N 115.402 -0.817 . . . . 0.0 110.129 179.08 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 644' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -108.18 41.87 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.709 -0.223 . . . . 0.0 111.403 -179.414 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 645' ' ' ASP . . . . . . . . . . . . . 17.7 t0 -156.9 -31.86 0.08 Allowed 'General case' 0 N--CA 1.469 0.513 0 N-CA-C 112.796 0.665 . . . . 0.0 112.796 -178.805 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 646' ' ' GLY . . . . . . . . . . . . . . . 74.77 28.44 62.97 Favored Glycine 0 CA--C 1.52 0.371 0 C-N-CA 120.596 -0.811 . . . . 0.0 113.399 -179.675 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 647' ' ' GLU . . . . . . . . . . . . . 8.8 mm-40 -67.88 120.3 13.95 Favored 'General case' 0 N--CA 1.456 -0.126 0 CA-C-O 121.067 0.46 . . . . 0.0 110.869 179.79 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 648' ' ' VAL . . . . . . . . . . . . . 75.7 t -60.93 -40.96 87.12 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-N 115.229 -0.896 . . . . 0.0 111.404 -179.558 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 649' ' ' GLU . . . . . . . . . . . . . 79.1 mm-40 -61.63 -42.57 99.07 Favored 'General case' 0 C--N 1.332 -0.194 0 C-N-CA 120.805 -0.358 . . . . 0.0 110.277 -179.973 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 650' ' ' ARG . . . . . . . . . . . . . 6.3 mmp_? -70.37 -40.91 73.74 Favored 'General case' 0 C--O 1.233 0.189 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.612 178.629 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 651' ' ' LEU . . . . . . . . . . . . . 90.8 mt -65.01 -41.03 95.71 Favored 'General case' 0 N--CA 1.461 0.117 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.29 179.292 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 652' ' ' LEU . . . . . . . . . . . . . 62.4 tp -65.15 -43.03 93.13 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.029 178.746 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 653' ' ' ALA . . . . . . . . . . . . . . . -62.78 -39.99 95.91 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-O 121.078 0.466 . . . . 0.0 111.604 -179.919 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 654' ' ' LEU . . . . . . . . . . . . . 76.1 mt -100.53 29.77 4.27 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.036 179.782 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 655' ' ' THR . . . . . . . . . . . . . 5.7 t -43.11 109.39 0.76 Allowed Pre-proline 0 N--CA 1.468 0.428 0 O-C-N 124.248 0.967 . . . . 0.0 113.395 -178.013 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 656' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_endo -94.08 -174.6 0.39 Allowed 'Trans proline' 0 N--CA 1.462 -0.339 0 C-N-CA 124.289 3.326 . . . . 0.0 111.951 178.84 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 657' ' ' ILE . . . . . . . . . . . . . 25.3 pt -81.34 -24.74 10.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-O 121.263 0.554 . . . . 0.0 109.731 178.04 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 658' ' ' ALA . . . . . 0.451 ' HB2' ' HB2' ' A' ' 687' ' ' LYS . . . -157.78 151.29 23.67 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.324 -0.853 . . . . 0.0 111.167 -179.944 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 659' ' ' VAL . . . . . 0.571 HG13 HD11 ' A' ' 686' ' ' LEU . 20.2 m -121.16 144.33 30.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-O 121.064 0.459 . . . . 0.0 110.409 178.82 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 660' ' ' LEU . . . . . . . . . . . . . 6.1 mp -115.04 117.75 31.47 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.728 -0.669 . . . . 0.0 109.849 179.522 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 661' ' ' LEU . . . . . . . . . . . . . 10.7 mt -103.2 108.48 19.7 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 109.111 -0.7 . . . . 0.0 109.111 -179.617 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 662' ' ' ALA . . . . . 0.744 ' HB3' ' HB3' ' A' ' 620' ' ' SER . . . -104.61 131.07 52.45 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 112.41 0.522 . . . . 0.0 112.41 -178.484 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 663' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -71.47 146.58 91.78 Favored Pre-proline 0 C--N 1.327 -0.383 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.363 178.261 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 664' ' ' PRO . . . . . . . . . . . . . 66.9 Cg_endo -73.6 141.56 72.13 Favored 'Cis proline' 0 C--N 1.348 0.551 0 C-N-CA 123.245 -1.565 . . . . 0.0 112.614 -0.805 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 665' ' ' PHE . . . . . . . . . . . . . 22.6 m-85 -72.8 139.87 47.32 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.703 -0.681 . . . . 0.0 111.193 179.783 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 666' ' ' SER . . . . . . . . . . . . . 10.8 p -95.56 -29.26 14.45 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 116.33 -0.396 . . . . 0.0 111.718 179.84 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 667' ' ' TYR . . . . . . . . . . . . . 13.6 p90 -74.09 -18.75 60.77 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.296 -0.411 . . . . 0.0 112.089 179.852 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 668' ' ' GLY . . . . . . . . . . . . . . . 100.41 -104.58 2.81 Favored Glycine 0 CA--C 1.521 0.417 0 C-N-CA 120.649 -0.786 . . . . 0.0 113.635 179.675 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 669' ' ' ASP . . . . . . . . . . . . . 28.5 t70 -82.62 111.19 18.36 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-O 120.981 0.419 . . . . 0.0 111.424 -178.411 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 670' ' ' VAL . . . . . . . . . . . . . 11.7 p -65.36 -32.62 59.01 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.394 0 N-CA-C 113.482 0.919 . . . . 0.0 113.482 -179.192 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 671' ' ' GLN . . . . . . . . . . . . . 22.1 mp0 -61.85 -41.9 98.38 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-O 120.703 0.287 . . . . 0.0 111.11 -179.124 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 672' ' ' GLU . . . . . . . . . . . . . 95.4 mt-10 -65.44 -40.44 93.28 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.994 179.248 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 673' ' ' LEU . . . . . . . . . . . . . 64.2 tp -63.42 -44.82 93.5 Favored 'General case' 0 CA--C 1.52 -0.175 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.107 179.104 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 674' ' ' VAL . . . . . . . . . . . . . 59.7 t -62.71 -44.35 99.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 115.503 -0.771 . . . . 0.0 109.729 179.783 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 675' ' ' ASP . . . . . . . . . . . . . 38.0 t70 -60.48 -41.18 93.7 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 115.925 -0.579 . . . . 0.0 110.585 178.731 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 676' ' ' GLN . . . . . 0.415 ' O ' ' HG2' ' A' ' 680' ' ' ARG . 77.0 mt-30 -70.2 -41.42 73.71 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.499 -0.318 . . . . 0.0 111.005 -179.55 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 677' ' ' LEU . . . . . . . . . . . . . 87.8 mt -66.74 -41.84 87.21 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.927 179.506 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 678' ' ' ARG . . . . . 0.445 ' NH1' ' HD3' ' A' ' 683' ' ' PRO . 7.8 mmm180 -67.52 -36.83 81.79 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-O 121.178 0.513 . . . . 0.0 111.314 179.572 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 679' ' ' GLN . . . . . . . . . . . . . 64.5 tt0 -63.51 -39.01 93.31 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.461 -0.79 . . . . 0.0 110.848 179.794 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 680' ' ' ARG . . . . . 0.415 ' HG2' ' O ' ' A' ' 676' ' ' GLN . 37.1 mmt180 -87.28 -41.04 13.96 Favored 'General case' 0 C--N 1.331 -0.203 0 N-CA-C 112.294 0.479 . . . . 0.0 112.294 -179.078 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 681' ' ' CYS . . . . . . . . . . . . . 76.9 m -124.84 137.98 54.28 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.212 0.529 . . . . 0.0 111.625 -178.948 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 682' ' ' THR . . . . . 0.468 ' HB ' ' HD2' ' A' ' 683' ' ' PRO . 66.2 p -70.24 159.46 84.49 Favored Pre-proline 0 C--N 1.323 -0.564 0 CA-C-N 115.596 -0.729 . . . . 0.0 109.69 178.762 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 683' ' ' PRO . . . . . 0.468 ' HD2' ' HB ' ' A' ' 682' ' ' THR . 23.5 Cg_endo -60.81 -27.75 85.31 Favored 'Trans proline' 0 C--N 1.349 0.598 0 C-N-CA 121.779 1.653 . . . . 0.0 112.092 -179.786 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 684' ' ' GLU . . . . . . . . . . . . . 51.6 mp0 -71.98 -38.94 69.63 Favored 'General case' 0 C--N 1.333 -0.142 0 CA-C-O 121.044 0.45 . . . . 0.0 110.288 178.924 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 685' ' ' GLN . . . . . . . . . . . . . 65.0 tt0 -71.56 -42.24 68.07 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 115.392 -0.822 . . . . 0.0 112.267 -179.728 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 686' ' ' LEU . . . . . 0.571 HD11 HG13 ' A' ' 659' ' ' VAL . 65.3 tp -135.88 120.53 18.32 Favored 'General case' 0 C--N 1.332 -0.193 0 N-CA-C 112.513 0.56 . . . . 0.0 112.513 -178.044 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 687' ' ' LYS . . . . . 0.451 ' HB2' ' HB2' ' A' ' 658' ' ' ALA . 73.6 mmtt -91.21 146.46 23.81 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 121.158 0.504 . . . . 0.0 110.031 177.553 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 688' ' ' ILE . . . . . . . . . . . . . 76.8 mt -123.81 121.1 61.49 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.771 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.811 -179.013 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 689' ' ' PHE . . . . . . . . . . . . . 98.6 m-85 -121.36 141.4 50.99 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.631 -0.713 . . . . 0.0 110.81 179.257 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 690' ' ' ILE . . . . . 0.47 ' CD1' HG11 ' A' ' 700' ' ' VAL . 97.5 mt -117.77 132.86 66.34 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.495 0 CA-C-O 121.184 0.516 . . . . 0.0 111.995 179.722 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 691' ' ' LEU . . . . . 0.409 ' HG ' ' HB ' ' A' ' 704' ' ' ILE . 3.7 mp -112.88 129.4 56.47 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-N 115.522 -0.763 . . . . 0.0 110.717 179.736 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 692' ' ' GLY . . . . . 0.645 ' O ' ' HA ' ' A' ' 705' ' ' PRO . . . 173.4 -173.57 45.77 Favored Glycine 0 N--CA 1.448 -0.555 0 C-N-CA 120.898 -0.667 . . . . 0.0 111.723 -179.907 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 693' ' ' SER . . . . . . . . . . . . . 80.8 p -64.59 -35.69 81.8 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.985 0.422 . . . . 0.0 110.73 179.568 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 694' ' ' LYS . . . . . . . . . . . . . 23.2 pttp -142.41 135.95 29.04 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.011 178.535 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 695' ' ' GLY . . . . . 0.497 ' HA3' ' CG ' ' A' ' 703' ' ' TYR . . . -75.73 131.59 12.15 Favored Glycine 0 N--CA 1.448 -0.511 0 C-N-CA 120.595 -0.812 . . . . 0.0 112.269 179.646 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 696' ' ' ASN . . . . . . . . . . . . . 29.3 m120 -63.96 -38.69 92.01 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-O 120.57 0.224 . . . . 0.0 111.39 179.947 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 697' ' ' TYR . . . . . . . . . . . . . 2.6 t80 58.84 35.75 24.38 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-N 115.651 -0.704 . . . . 0.0 111.637 -179.87 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 698' ' ' GLN . . . . . . . . . . . . . 97.3 mm-40 -107.32 82.66 1.7 Allowed 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.627 -0.26 . . . . 0.0 110.825 179.934 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 699' ' ' GLY . . . . . . . . . . . . . . . 80.12 15.24 79.19 Favored Glycine 0 CA--C 1.52 0.385 0 C-N-CA 120.338 -0.934 . . . . 0.0 113.463 179.366 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 700' ' ' VAL . . . . . 0.47 HG11 ' CD1' ' A' ' 690' ' ' ILE . 31.4 m -107.75 152.04 9.6 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-O 121.226 0.536 . . . . 0.0 110.9 -179.215 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 701' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -69.74 -42.01 74.51 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.143 -0.935 . . . . 0.0 112.599 -178.42 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 702' ' ' ARG . . . . . . . . . . . . . 37.9 ttm180 -162.7 158.15 22.68 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.776 0.322 . . . . 0.0 111.078 -178.562 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 703' ' ' TYR . . . . . 0.497 ' CG ' ' HA3' ' A' ' 695' ' ' GLY . 52.8 p90 -124.82 147.76 48.56 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.255 -0.43 . . . . 0.0 109.93 179.285 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 704' ' ' ILE . . . . . 0.409 ' HB ' ' HG ' ' A' ' 691' ' ' LEU . 58.7 mt -123.76 102.46 35.24 Favored Pre-proline 0 C--N 1.326 -0.423 0 CA-C-O 120.833 0.349 . . . . 0.0 111.223 -179.482 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 705' ' ' PRO . . . . . 0.645 ' HA ' ' O ' ' A' ' 692' ' ' GLY . 34.5 Cg_exo -60.96 143.19 99.29 Favored 'Trans proline' 0 C--N 1.348 0.514 0 C-N-CA 123.456 2.771 . . . . 0.0 113.883 179.909 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 706' ' ' LEU . . . . . 0.419 HD23 HG23 ' A' ' 708' ' ' ILE . 95.4 mt -98.66 151.97 37.67 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-N 115.403 -0.817 . . . . 0.0 109.973 178.408 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 707' ' ' PRO . . . . . . . . . . . . . 63.4 Cg_endo -72.99 139.5 61.72 Favored 'Cis proline' 0 C--N 1.345 0.379 0 C-N-CA 123.067 -1.639 . . . . 0.0 112.882 -0.19 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 708' ' ' ILE . . . . . 0.419 HG23 HD23 ' A' ' 706' ' ' LEU . 1.4 pt -66.68 134.28 30.22 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-N 115.652 -0.704 . . . . 0.0 111.913 178.715 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 709' ' ' HIS . . . . . . . . . . . . . 71.3 m80 -98.15 114.49 65.21 Favored Pre-proline 0 C--N 1.32 -0.679 0 N-CA-C 108.217 -1.031 . . . . 0.0 108.217 177.54 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 710' ' ' PRO . . . . . . . . . . . . . 85.2 Cg_exo -51.66 -37.13 63.45 Favored 'Trans proline' 0 N--CA 1.477 0.504 0 C-N-CA 123.174 2.582 . . . . 0.0 114.277 -177.957 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 711' ' ' GLU . . . . . . . . . . . . . 51.1 mp0 -64.72 -39.59 93.91 Favored 'General case' 0 CA--C 1.532 0.284 0 N-CA-C 112.458 0.54 . . . . 0.0 112.458 -178.964 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 712' ' ' SER . . . . . . . . . . . . . 80.9 p -98.6 -23.18 15.59 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 112.552 0.575 . . . . 0.0 112.552 -178.435 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 713' ' ' PHE . . . . . . . . . . . . . 82.5 t80 -59.91 -49.07 79.15 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 120.644 0.259 . . . . 0.0 111.229 -179.833 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 714' ' ' LEU . . . . . . . . . . . . . 58.8 tp -62.17 -41.03 97.92 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.189 -0.459 . . . . 0.0 109.917 179.906 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 715' ' ' GLN . . . . . . . . . . . . . 30.5 mm100 -62.95 -42.38 99.8 Favored 'General case' 0 CA--C 1.53 0.185 0 CA-C-N 115.742 -0.663 . . . . 0.0 111.124 179.02 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 716' ' ' GLN . . . . . . . . . . . . . 96.3 mt-30 -64.6 -42.4 95.59 Favored 'General case' 0 N--CA 1.462 0.169 0 CA-C-O 120.645 0.26 . . . . 0.0 111.243 179.589 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 717' ' ' VAL . . . . . . . . . . . . . 71.3 t -64.28 -44.53 97.35 Favored 'Isoleucine or valine' 0 C--O 1.233 0.213 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.456 179.288 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 718' ' ' THR . . . . . 0.475 ' O ' ' HG ' ' A' ' 721' ' ' LEU . 91.4 m -60.94 -47.0 88.42 Favored 'General case' 0 N--CA 1.457 -0.076 0 CA-C-N 115.824 -0.625 . . . . 0.0 110.907 179.904 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 719' ' ' MET . . . . . . . . . . . . . 38.6 mmt -62.55 -39.72 94.54 Favored 'General case' 0 C--O 1.234 0.264 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.404 179.356 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 720' ' ' GLY . . . . . . . . . . . . . . . -62.3 -40.22 98.73 Favored Glycine 0 N--CA 1.451 -0.316 0 CA-C-N 115.814 -0.63 . . . . 0.0 113.176 179.423 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 721' ' ' LEU . . . . . 0.475 ' HG ' ' O ' ' A' ' 718' ' ' THR . 2.6 pp -80.2 -33.43 38.18 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-N 117.087 0.444 . . . . 0.0 111.965 -179.533 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 722' ' ' THR . . . . . 0.555 ' HA ' ' O ' ' A' ' 725' ' ' ALA . 56.3 p -68.91 -18.1 64.06 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-O 120.684 0.278 . . . . 0.0 111.696 179.993 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 723' ' ' SER . . . . . . . . . . . . . 75.0 m -62.71 -38.99 92.65 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.39 178.816 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 724' ' ' LEU . . . . . 0.51 HD22 ' HA ' ' A' ' 724' ' ' LEU . 0.2 OUTLIER -87.92 -47.78 8.31 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.304 179.812 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 725' ' ' ALA . . . . . 0.555 ' O ' ' HA ' ' A' ' 722' ' ' THR . . . -150.05 156.61 41.99 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 120.845 0.355 . . . . 0.0 111.337 -179.437 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 726' ' ' THR . . . . . . . . . . . . . 75.1 p -118.64 154.27 32.95 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.467 -0.333 . . . . 0.0 110.975 -179.952 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 727' ' ' SER . . . . . . . . . . . . . 45.9 t -149.35 148.43 29.49 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.272 -179.847 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 728' ' ' ALA . . . . . . . . . . . . . . . -62.32 -39.73 93.99 Favored 'General case' 0 C--N 1.333 -0.142 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.455 179.888 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 729' ' ' GLN . . . . . . . . . . . . . 3.3 mm100 . . . . . 0 C--O 1.25 1.107 0 CA-C-O 118.373 -0.823 . . . . 0.0 111.44 179.979 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 613' ' ' GLU . . . . . . . . . . . . . 3.1 pt-20 . . . . . 0 N--CA 1.489 1.488 0 CA-C-O 121.003 0.43 . . . . 0.0 110.794 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 614' ' ' GLY . . . . . . . . . . . . . . . 100.01 148.73 23.02 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.941 -0.647 . . . . 0.0 112.577 179.981 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 615' ' ' ARG . . . . . . . . . . . . . 95.5 mtm-85 -117.72 133.32 56.06 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.566 0.222 . . . . 0.0 110.913 -179.895 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 616' ' ' ILE . . . . . 0.464 ' O ' ' HA ' ' A' ' 640' ' ' VAL . 84.9 mt -124.45 133.41 69.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 N-CA-C 109.613 -0.514 . . . . 0.0 109.613 178.627 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 617' ' ' VAL . . . . . 0.468 ' CG2' HG12 ' A' ' 659' ' ' VAL . 33.7 m -109.66 146.73 14.71 Favored 'Isoleucine or valine' 0 C--O 1.235 0.326 0 C-N-CA 120.023 -0.671 . . . . 0.0 110.32 -179.793 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 618' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -120.5 122.28 40.29 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.327 -179.765 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 619' ' ' VAL . . . . . 0.477 ' HA ' ' O ' ' A' ' 643' ' ' LEU . 59.4 t -116.46 116.19 51.47 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 N-CA-C 108.784 -0.821 . . . . 0.0 108.784 179.513 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 620' ' ' SER . . . . . 0.583 ' HB2' ' HB3' ' A' ' 662' ' ' ALA . 29.9 t -165.68 144.08 6.01 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.59 -0.732 . . . . 0.0 111.685 -179.001 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 621' ' ' GLU . . . . . . . . . . . . . 88.2 tt0 -76.69 -28.14 55.78 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.242 -0.89 . . . . 0.0 110.923 178.626 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 622' ' ' ASP . . . . . . . . . . . . . 57.2 t0 -86.13 108.07 18.14 Favored 'General case' 0 C--O 1.234 0.271 0 CA-C-O 121.075 0.464 . . . . 0.0 111.034 -178.436 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 623' ' ' GLU . . . . . . . . . . . . . 50.9 mp0 -63.98 -39.29 93.8 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.375 -0.83 . . . . 0.0 112.139 179.817 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 624' ' ' ALA . . . . . . . . . . . . . . . -60.8 -44.3 97.03 Favored 'General case' 0 N--CA 1.465 0.286 0 N-CA-C 112.447 0.536 . . . . 0.0 112.447 -178.232 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 625' ' ' THR . . . . . . . . . . . . . 87.0 m -68.34 -40.4 81.57 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.289 0.566 . . . . 0.0 109.986 179.779 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 626' ' ' SER . . . . . . . . . . . . . 68.0 m -62.83 -40.91 98.85 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.179 -0.919 . . . . 0.0 112.27 -179.074 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 627' ' ' THR . . . . . . . . . . . . . 60.4 p -67.11 -39.85 86.76 Favored 'General case' 0 N--CA 1.466 0.332 0 N-CA-C 112.77 0.656 . . . . 0.0 112.77 -179.577 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 628' ' ' LEU . . . . . . . . . . . . . 63.7 tp -64.68 -46.97 80.15 Favored 'General case' 0 N--CA 1.464 0.238 0 N-CA-C 111.858 0.318 . . . . 0.0 111.858 -179.317 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 629' ' ' ILE . . . . . 0.451 HD13 HD11 ' A' ' 691' ' ' LEU . 18.5 tt -72.52 -32.73 42.8 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.433 0 N-CA-C 112.421 0.526 . . . . 0.0 112.421 -179.12 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 630' ' ' CYS . . . . . . . . . . . . . 51.6 t -60.16 -45.0 94.56 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.275 -179.343 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 631' ' ' SER . . . . . . . . . . . . . 47.1 t -61.56 -42.31 98.65 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.009 -179.694 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 632' ' ' ILE . . . . . . . . . . . . . 97.2 mt -61.84 -48.17 89.84 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.314 0 CA-C-O 120.796 0.331 . . . . 0.0 110.679 180.0 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 633' ' ' LEU . . . . . . . . . . . . . 74.4 mt -65.82 -40.42 91.82 Favored 'General case' 0 C--O 1.234 0.281 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.863 179.635 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 634' ' ' THR . . . . . 0.537 ' HA ' ' O ' ' A' ' 638' ' ' TYR . 90.3 m -65.89 -40.78 91.88 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-O 120.718 0.294 . . . . 0.0 110.983 -179.69 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 635' ' ' THR . . . . . . . . . . . . . 91.9 m -59.44 -38.9 81.9 Favored 'General case' 0 CA--C 1.53 0.185 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.369 179.212 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 636' ' ' ALA . . . . . . . . . . . . . . . -64.33 -16.74 62.78 Favored 'General case' 0 CA--C 1.533 0.288 0 CA-C-N 115.879 -0.6 . . . . 0.0 111.385 178.989 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 637' ' ' GLY . . . . . . . . . . . . . . . 108.97 7.26 29.29 Favored Glycine 0 C--N 1.334 0.459 0 C-N-CA 120.973 -0.632 . . . . 0.0 113.227 179.693 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 638' ' ' TYR . . . . . 0.537 ' O ' ' HA ' ' A' ' 634' ' ' THR . 97.9 m-85 -100.8 141.36 33.79 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.882 0.341 . . . . 0.0 111.418 -179.961 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 639' ' ' GLN . . . . . . . . . . . . . 98.9 mm-40 -86.4 133.7 33.76 Favored 'General case' 0 CA--C 1.516 -0.339 0 N-CA-C 109.869 -0.419 . . . . 0.0 109.869 178.98 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 640' ' ' VAL . . . . . 0.464 ' HA ' ' O ' ' A' ' 616' ' ' ILE . 63.2 t -119.42 130.71 73.65 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 N-CA-C 112.411 0.522 . . . . 0.0 112.411 -179.254 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 641' ' ' ILE . . . . . . . . . . . . . 4.0 mp -113.77 120.13 62.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 N-CA-C 108.521 -0.918 . . . . 0.0 108.521 178.224 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 642' ' ' TRP . . . . . . . . . . . . . 62.8 t90 -94.42 126.45 39.7 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.224 0.535 . . . . 0.0 112.031 -178.575 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 643' ' ' LEU . . . . . 0.477 ' O ' ' HA ' ' A' ' 619' ' ' VAL . 88.3 mt -127.59 143.01 51.21 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.203 -0.908 . . . . 0.0 110.8 179.91 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 644' ' ' VAL . . . . . . . . . . . . . 3.6 p -128.89 78.82 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-O 121.796 0.808 . . . . 0.0 109.853 177.953 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 645' ' ' ASP . . . . . . . . . . . . . 37.8 t70 -176.75 -33.26 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.453 0 CA-C-N 115.452 -0.795 . . . . 0.0 111.659 -179.176 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 646' ' ' GLY . . . . . . . . . . . . . . . 72.78 28.67 66.64 Favored Glycine 0 CA--C 1.52 0.356 0 C-N-CA 120.978 -0.629 . . . . 0.0 113.26 -179.441 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 647' ' ' GLU . . . . . . . . . . . . . 4.9 tp10 -72.41 119.3 16.43 Favored 'General case' 0 N--CA 1.455 -0.191 0 CA-C-O 121.139 0.495 . . . . 0.0 110.961 -179.684 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 648' ' ' VAL . . . . . . . . . . . . . 75.5 t -61.74 -40.04 85.43 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-N 115.201 -0.909 . . . . 0.0 111.653 -179.843 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 649' ' ' GLU . . . . . . . . . . . . . 50.0 mp0 -60.9 -43.26 98.78 Favored 'General case' 0 C--N 1.332 -0.173 0 C-N-CA 120.795 -0.362 . . . . 0.0 110.424 -179.806 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 650' ' ' ARG . . . . . . . . . . . . . 84.1 mtt85 -68.89 -40.99 78.9 Favored 'General case' 0 CA--C 1.53 0.2 0 CA-C-N 116.426 -0.352 . . . . 0.0 110.541 178.453 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 651' ' ' LEU . . . . . . . . . . . . . 83.5 mt -65.52 -40.83 93.44 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 116.321 -0.399 . . . . 0.0 110.431 178.771 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 652' ' ' LEU . . . . . . . . . . . . . 61.8 tp -64.73 -42.59 95.1 Favored 'General case' 0 CA--C 1.53 0.182 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.01 178.95 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 653' ' ' ALA . . . . . . . . . . . . . . . -62.21 -39.12 91.7 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.548 179.726 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 654' ' ' LEU . . . . . . . . . . . . . 75.5 mt -99.64 30.1 3.78 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.91 -179.663 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 655' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -30.78 104.38 0.21 Allowed Pre-proline 0 N--CA 1.473 0.724 0 O-C-N 124.548 1.155 . . . . 0.0 113.876 -179.248 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 656' ' ' PRO . . . . . . . . . . . . . 20.9 Cg_endo -96.57 179.63 0.48 Allowed 'Trans proline' 0 N--CA 1.461 -0.429 0 C-N-CA 124.029 3.153 . . . . 0.0 112.454 178.878 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 657' ' ' ILE . . . . . . . . . . . . . 26.8 pt -84.17 -25.87 7.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-O 121.374 0.607 . . . . 0.0 109.914 178.09 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 658' ' ' ALA . . . . . 0.485 ' HB2' ' HB2' ' A' ' 687' ' ' LYS . . . -155.76 152.91 29.08 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.182 -0.917 . . . . 0.0 111.004 -179.655 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 659' ' ' VAL . . . . . 0.745 HG13 HD11 ' A' ' 686' ' ' LEU . 30.7 m -120.38 142.48 35.99 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-O 121.152 0.501 . . . . 0.0 110.521 179.034 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 660' ' ' LEU . . . . . . . . . . . . . 5.7 mp -114.86 116.37 28.46 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.702 -0.681 . . . . 0.0 109.777 179.316 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 661' ' ' LEU . . . . . . . . . . . . . 69.6 mt -107.59 114.88 29.17 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 109.403 -0.591 . . . . 0.0 109.403 -179.578 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 662' ' ' ALA . . . . . 0.646 ' HB2' HD12 ' A' ' 691' ' ' LEU . . . -111.33 130.26 55.73 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 113.32 0.859 . . . . 0.0 113.32 -178.352 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 663' ' ' GLU . . . . . . . . . . . . . 12.1 mm-40 -71.64 146.68 91.42 Favored Pre-proline 0 CA--C 1.534 0.342 0 CA-C-N 115.32 -0.854 . . . . 0.0 110.236 177.728 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 664' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -74.23 141.83 72.94 Favored 'Cis proline' 0 C--N 1.348 0.525 0 C-N-CA 123.382 -1.508 . . . . 0.0 112.72 -0.793 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 665' ' ' PHE . . . . . . . . . . . . . 22.1 m-30 -75.75 138.66 41.38 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.714 -0.675 . . . . 0.0 111.153 179.416 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 666' ' ' SER . . . . . . . . . . . . . 78.9 p -93.05 -23.99 18.46 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.431 -0.35 . . . . 0.0 111.64 179.88 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 667' ' ' TYR . . . . . . . . . . . . . 13.6 p90 -78.91 -17.94 54.69 Favored 'General case' 0 N--CA 1.464 0.262 0 N-CA-C 112.067 0.395 . . . . 0.0 112.067 179.593 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 668' ' ' GLY . . . . . . . . . . . . . . . 100.08 -104.82 2.88 Favored Glycine 0 CA--C 1.521 0.45 0 C-N-CA 120.477 -0.868 . . . . 0.0 114.183 178.969 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 669' ' ' ASP . . . . . . . . . . . . . 27.2 t70 -83.43 108.13 16.39 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-O 120.952 0.406 . . . . 0.0 111.838 -177.835 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 670' ' ' VAL . . . . . . . . . . . . . 9.9 p -66.44 -29.08 45.4 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.413 0 N-CA-C 113.108 0.781 . . . . 0.0 113.108 -179.744 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 671' ' ' GLN . . . . . . . . . . . . . 21.9 mp0 -61.66 -41.78 98.01 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-O 120.752 0.31 . . . . 0.0 111.185 -179.293 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 672' ' ' GLU . . . . . . . . . . . . . 95.4 mt-10 -66.91 -40.86 87.78 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.496 -0.32 . . . . 0.0 110.644 178.616 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 673' ' ' LEU . . . . . . . . . . . . . 64.2 tp -63.96 -46.14 86.0 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 115.831 -0.622 . . . . 0.0 111.105 -179.959 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 674' ' ' VAL . . . . . 0.56 HG21 ' HA3' ' A' ' 699' ' ' GLY . 8.7 p -65.71 -37.76 80.7 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.246 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.067 -179.617 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 675' ' ' ASP . . . . . 0.431 ' O ' ' HB2' ' A' ' 679' ' ' GLN . 36.9 t70 -62.15 -40.02 94.57 Favored 'General case' 0 CA--C 1.518 -0.28 0 N-CA-C 109.761 -0.459 . . . . 0.0 109.761 177.571 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 676' ' ' GLN . . . . . . . . . . . . . 96.7 mt-30 -70.44 -40.77 73.58 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.84 179.737 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 677' ' ' LEU . . . . . . . . . . . . . 86.4 mt -66.57 -40.9 89.22 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.467 179.566 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 678' ' ' ARG . . . . . 0.567 ' HA ' ' O ' ' A' ' 681' ' ' CYS . 84.9 mtp180 -80.59 -15.62 56.17 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-O 120.816 0.341 . . . . 0.0 111.639 -179.232 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 679' ' ' GLN . . . . . 0.431 ' HB2' ' O ' ' A' ' 675' ' ' ASP . 52.1 tt0 -65.2 -39.4 92.78 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.96 179.901 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 680' ' ' ARG . . . . . 0.443 ' H ' ' HG2' ' A' ' 680' ' ' ARG . 0.0 OUTLIER -107.01 -32.97 7.63 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.916 -179.651 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 681' ' ' CYS . . . . . 0.567 ' O ' ' HA ' ' A' ' 678' ' ' ARG . 72.2 m -113.78 130.25 56.47 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.862 0.363 . . . . 0.0 111.038 -179.703 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 682' ' ' THR . . . . . 0.406 ' HB ' ' HD2' ' A' ' 683' ' ' PRO . 72.8 p -75.04 158.27 84.51 Favored Pre-proline 0 C--N 1.327 -0.4 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.121 179.487 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 683' ' ' PRO . . . . . 0.406 ' HD2' ' HB ' ' A' ' 682' ' ' THR . 19.4 Cg_endo -60.58 -27.12 84.28 Favored 'Trans proline' 0 C--N 1.347 0.492 0 C-N-CA 122.038 1.825 . . . . 0.0 112.108 179.36 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 684' ' ' GLU . . . . . . . . . . . . . 51.7 mp0 -72.11 -39.58 68.79 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 120.981 0.419 . . . . 0.0 110.277 178.714 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 685' ' ' GLN . . . . . . . . . . . . . 54.0 tt0 -72.15 -42.22 66.21 Favored 'General case' 0 C--O 1.232 0.144 0 CA-C-N 115.856 -0.611 . . . . 0.0 111.41 179.523 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 686' ' ' LEU . . . . . 0.745 HD11 HG13 ' A' ' 659' ' ' VAL . 63.4 tp -127.78 116.61 20.46 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.337 -179.031 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 687' ' ' LYS . . . . . 0.485 ' HB2' ' HB2' ' A' ' 658' ' ' ALA . 68.8 mttm -85.64 146.55 26.8 Favored 'General case' 0 CA--C 1.519 -0.229 0 CA-C-O 121.129 0.49 . . . . 0.0 110.452 179.06 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 688' ' ' ILE . . . . . 0.508 HG22 HG12 ' A' ' 700' ' ' VAL . 76.9 mt -124.52 120.16 58.25 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.644 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.371 -178.632 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 689' ' ' PHE . . . . . . . . . . . . . 98.8 m-85 -119.09 144.64 46.49 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.021 -0.991 . . . . 0.0 109.981 178.831 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 690' ' ' ILE . . . . . . . . . . . . . 18.5 tt -124.79 138.32 54.55 Favored 'Isoleucine or valine' 0 C--O 1.236 0.379 0 CA-C-O 121.186 0.517 . . . . 0.0 111.526 -179.623 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 691' ' ' LEU . . . . . 0.646 HD12 ' HB2' ' A' ' 662' ' ' ALA . 63.3 mt -109.46 130.51 55.5 Favored 'General case' 0 C--O 1.233 0.229 0 CA-C-N 115.591 -0.731 . . . . 0.0 110.267 179.756 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 692' ' ' GLY . . . . . 0.672 ' O ' ' HA ' ' A' ' 705' ' ' PRO . . . 169.97 178.85 41.24 Favored Glycine 0 N--CA 1.444 -0.795 0 C-N-CA 120.808 -0.71 . . . . 0.0 111.977 179.782 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 693' ' ' SER . . . . . . . . . . . . . 79.8 p -67.69 -36.6 80.96 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.743 0.306 . . . . 0.0 111.298 179.598 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 694' ' ' LYS . . . . . . . . . . . . . 17.0 mmmt -121.31 136.65 54.94 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.191 0.519 . . . . 0.0 110.647 179.78 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 695' ' ' GLY . . . . . 0.445 ' HA3' ' CB ' ' A' ' 703' ' ' TYR . . . -101.95 17.11 55.1 Favored Glycine 0 N--CA 1.449 -0.464 0 CA-C-N 115.418 -0.81 . . . . 0.0 112.987 179.702 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 696' ' ' ASN . . . . . . . . . . . . . 64.7 t30 -80.97 69.73 7.62 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 121.193 0.521 . . . . 0.0 111.271 -179.267 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 697' ' ' TYR . . . . . . . . . . . . . 95.5 m-85 -132.15 146.9 52.34 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.689 -0.687 . . . . 0.0 110.001 179.269 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 698' ' ' GLN . . . . . . . . . . . . . 25.2 pt20 -94.2 152.32 18.81 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.719 -179.739 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 699' ' ' GLY . . . . . 0.56 ' HA3' HG21 ' A' ' 674' ' ' VAL . . . 90.66 4.59 69.91 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.651 -0.785 . . . . 0.0 113.482 179.818 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 700' ' ' VAL . . . . . 0.508 HG12 HG22 ' A' ' 688' ' ' ILE . 25.6 m -117.98 152.05 20.0 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.312 0 CA-C-N 117.369 0.585 . . . . 0.0 110.118 179.49 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 701' ' ' ASP . . . . . . . . . . . . . 64.2 m-20 -86.72 -33.2 20.09 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.789 -0.641 . . . . 0.0 111.893 -178.972 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 702' ' ' ARG . . . . . . . . . . . . . 6.2 mmp_? -150.37 163.87 37.27 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.84 0.352 . . . . 0.0 111.055 -179.29 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 703' ' ' TYR . . . . . 0.445 ' CB ' ' HA3' ' A' ' 695' ' ' GLY . 52.5 p90 -128.5 143.06 50.91 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.936 -0.574 . . . . 0.0 110.323 179.372 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 704' ' ' ILE . . . . . 0.554 ' HB ' HD23 ' A' ' 691' ' ' LEU . 47.5 mt -127.36 107.68 21.27 Favored Pre-proline 0 C--N 1.325 -0.474 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.247 179.726 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 705' ' ' PRO . . . . . 0.672 ' HA ' ' O ' ' A' ' 692' ' ' GLY . 64.7 Cg_endo -71.5 151.82 59.45 Favored 'Trans proline' 0 C--N 1.346 0.4 0 C-N-CA 122.794 2.329 . . . . 0.0 113.749 -179.157 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 706' ' ' LEU . . . . . 0.55 HD23 HG23 ' A' ' 708' ' ' ILE . 87.5 mt -105.4 147.67 35.0 Favored Pre-proline 0 N--CA 1.453 -0.32 0 CA-C-N 115.447 -0.797 . . . . 0.0 109.999 178.962 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 707' ' ' PRO . . . . . 0.434 ' C ' ' HA ' ' A' ' 706' ' ' LEU . 58.3 Cg_endo -70.76 139.5 57.92 Favored 'Cis proline' 0 C--N 1.347 0.499 0 C-N-CA 122.991 -1.67 . . . . 0.0 112.622 -0.26 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 708' ' ' ILE . . . . . 0.55 HG23 HD23 ' A' ' 706' ' ' LEU . 2.5 pt -63.48 131.64 29.09 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 115.543 -0.753 . . . . 0.0 112.233 179.196 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 709' ' ' HIS . . . . . . . . . . . . . 70.5 m80 -97.0 115.82 65.85 Favored Pre-proline 0 C--N 1.323 -0.586 0 N-CA-C 107.904 -1.147 . . . . 0.0 107.904 177.309 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 710' ' ' PRO . . . . . . . . . . . . . 20.2 Cg_endo -59.41 -30.62 93.13 Favored 'Trans proline' 0 C--N 1.345 0.362 0 C-N-CA 122.647 2.231 . . . . 0.0 114.306 -177.118 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 711' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -67.55 -40.02 84.97 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 112.02 0.378 . . . . 0.0 112.02 -179.378 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 712' ' ' SER . . . . . . . . . . . . . 50.5 m -95.1 -23.2 17.42 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 112.017 0.377 . . . . 0.0 112.017 -178.917 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 713' ' ' PHE . . . . . . . . . . . . . 66.9 t80 -59.97 -49.74 76.48 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-O 120.725 0.297 . . . . 0.0 111.198 -179.757 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 714' ' ' LEU . . . . . . . . . . . . . 90.6 mt -64.6 -38.03 89.59 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.173 179.346 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 715' ' ' GLN . . . . . . . . . . . . . 53.9 tt0 -61.78 -43.86 98.02 Favored 'General case' 0 CA--C 1.532 0.266 0 CA-C-N 115.638 -0.71 . . . . 0.0 110.759 179.093 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 716' ' ' GLN . . . . . . . . . . . . . 87.9 mt-30 -64.26 -41.87 96.75 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-N 116.506 -0.316 . . . . 0.0 111.257 179.456 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 717' ' ' VAL . . . . . . . . . . . . . 69.4 t -63.48 -45.76 96.99 Favored 'Isoleucine or valine' 0 C--O 1.231 0.113 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.196 179.34 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 718' ' ' THR . . . . . . . . . . . . . 89.0 m -62.7 -44.55 95.94 Favored 'General case' 0 CA--C 1.529 0.146 0 CA-C-N 115.857 -0.611 . . . . 0.0 110.793 179.486 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 719' ' ' MET . . . . . . . . . . . . . 10.9 tpt -60.43 -47.01 87.96 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.396 179.67 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 720' ' ' GLY . . . . . . . . . . . . . . . -63.19 -40.73 99.44 Favored Glycine 0 C--N 1.332 0.343 0 C-N-CA 120.747 -0.74 . . . . 0.0 111.906 178.604 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 721' ' ' LEU . . . . . . . . . . . . . 62.2 tp -62.37 -43.31 99.13 Favored 'General case' 0 CA--C 1.531 0.217 0 C-N-CA 122.758 0.423 . . . . 0.0 111.318 179.586 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 722' ' ' THR . . . . . . . . . . . . . 73.7 p -72.83 -11.2 60.51 Favored 'General case' 0 N--CA 1.464 0.24 0 N-CA-C 112.0 0.37 . . . . 0.0 112.0 179.975 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 723' ' ' SER . . . . . . . . . . . . . 69.7 m -88.25 -1.87 58.27 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.509 -0.314 . . . . 0.0 111.198 -179.946 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 724' ' ' LEU . . . . . . . . . . . . . 2.1 tt -62.47 -44.13 97.14 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-N 116.44 -0.345 . . . . 0.0 111.29 179.714 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 725' ' ' ALA . . . . . . . . . . . . . . . -149.04 151.3 34.25 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.757 -179.884 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 726' ' ' THR . . . . . . . . . . . . . 75.1 p -80.81 160.63 24.78 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.33 -0.395 . . . . 0.0 111.305 179.787 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 727' ' ' SER . . . . . . . . . . . . . 61.5 m -126.74 148.36 49.9 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.619 179.919 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 728' ' ' ALA . . . . . . . . . . . . . . . -70.22 142.54 52.38 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.134 179.902 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 729' ' ' GLN . . . . . . . . . . . . . 97.0 mt-30 . . . . . 0 C--O 1.247 0.969 0 CA-C-O 118.34 -0.838 . . . . 0.0 110.793 -179.848 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 613' ' ' GLU . . . . . . . . . . . . . 98.0 mt-10 . . . . . 0 N--CA 1.488 1.452 0 CA-C-O 120.887 0.375 . . . . 0.0 110.706 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 614' ' ' GLY . . . . . . . . . . . . . . . 80.31 15.09 79.24 Favored Glycine 0 N--CA 1.453 -0.171 0 C-N-CA 120.897 -0.668 . . . . 0.0 112.486 -179.61 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 615' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -110.23 148.06 32.59 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.928 0.394 . . . . 0.0 111.151 -179.509 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 616' ' ' ILE . . . . . 0.633 ' O ' ' HA ' ' A' ' 640' ' ' VAL . 82.0 mt -119.12 135.47 59.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 115.763 -0.653 . . . . 0.0 109.639 179.684 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 617' ' ' VAL . . . . . 0.476 ' CG2' HG12 ' A' ' 659' ' ' VAL . 33.4 m -109.67 147.21 14.24 Favored 'Isoleucine or valine' 0 C--O 1.234 0.283 0 C-N-CA 120.16 -0.616 . . . . 0.0 110.687 -179.714 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 618' ' ' LEU . . . . . . . . . . . . . 1.3 tt -121.47 126.52 49.46 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.413 -179.525 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 619' ' ' VAL . . . . . . . . . . . . . 67.5 t -115.02 117.0 54.28 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-O 121.088 0.471 . . . . 0.0 110.172 -179.972 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 620' ' ' SER . . . . . 0.732 ' HB2' ' HB3' ' A' ' 662' ' ' ALA . 36.7 t -172.49 146.68 1.78 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.081 -0.963 . . . . 0.0 110.459 -179.686 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 621' ' ' GLU . . . . . 0.434 ' HG3' ' OG ' ' A' ' 666' ' ' SER . 97.8 mt-10 -92.11 -2.65 56.49 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.02 178.704 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 622' ' ' ASP . . . . . . . . . . . . . 58.0 t0 -92.25 107.06 18.93 Favored 'General case' 0 CA--C 1.531 0.223 0 CA-C-O 121.06 0.457 . . . . 0.0 111.127 -178.961 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 623' ' ' GLU . . . . . . . . . . . . . 42.2 tt0 -64.39 -38.56 91.46 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-N 115.351 -0.84 . . . . 0.0 111.999 179.914 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 624' ' ' ALA . . . . . . . . . . . . . . . -60.46 -42.1 95.48 Favored 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 112.06 0.393 . . . . 0.0 112.06 -178.654 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 625' ' ' THR . . . . . . . . . . . . . 21.7 p -75.83 -37.04 59.44 Favored 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 120.604 -0.439 . . . . 0.0 111.754 179.462 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 626' ' ' SER . . . . . . . . . . . . . 89.7 p -65.69 -39.38 91.23 Favored 'General case' 0 CA--C 1.53 0.179 0 N-CA-C 111.818 0.303 . . . . 0.0 111.818 -178.71 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 627' ' ' THR . . . . . . . . . . . . . 38.6 p -69.77 -39.05 76.9 Favored 'General case' 0 N--CA 1.464 0.238 0 N-CA-C 112.224 0.453 . . . . 0.0 112.224 179.526 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 628' ' ' LEU . . . . . . . . . . . . . 61.7 tp -70.77 -44.26 67.06 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 121.057 0.456 . . . . 0.0 112.021 179.803 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 629' ' ' ILE . . . . . . . . . . . . . 14.1 tt -72.8 -30.07 31.77 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.533 0 N-CA-C 113.729 1.011 . . . . 0.0 113.729 -177.601 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 630' ' ' CYS . . . . . . . . . . . . . 19.0 p -64.89 -27.94 69.2 Favored 'General case' 0 N--CA 1.466 0.352 0 N-CA-C 112.185 0.439 . . . . 0.0 112.185 -177.996 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 631' ' ' SER . . . . . . . . . . . . . 96.8 p -66.7 -39.56 88.12 Favored 'General case' 0 C--N 1.33 -0.259 0 C-N-CA 120.938 -0.305 . . . . 0.0 111.283 179.955 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 632' ' ' ILE . . . . . . . . . . . . . 96.7 mt -64.57 -48.91 82.91 Favored 'Isoleucine or valine' 0 C--O 1.234 0.274 0 CA-C-O 120.977 0.418 . . . . 0.0 111.302 -179.587 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 633' ' ' LEU . . . . . . . . . . . . . 88.1 mt -65.1 -41.75 94.68 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-N 115.804 -0.634 . . . . 0.0 112.391 -179.038 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 634' ' ' THR . . . . . . . . . . . . . 54.9 m -68.18 -39.79 82.44 Favored 'General case' 0 CA--C 1.532 0.271 0 C-N-CA 121.209 -0.197 . . . . 0.0 111.457 -179.156 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 635' ' ' THR . . . . . . . . . . . . . 95.0 m -59.48 -38.89 82.01 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-O 120.899 0.38 . . . . 0.0 110.409 179.542 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 636' ' ' ALA . . . . . . . . . . . . . . . -63.06 -18.9 63.87 Favored 'General case' 0 CA--C 1.532 0.258 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.165 178.819 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 637' ' ' GLY . . . . . . . . . . . . . . . 107.09 2.98 36.17 Favored Glycine 0 C--N 1.332 0.342 0 C-N-CA 121.117 -0.563 . . . . 0.0 112.801 179.809 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 638' ' ' TYR . . . . . . . . . . . . . 88.9 m-85 -100.88 142.61 32.11 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.082 0.468 . . . . 0.0 111.625 -179.886 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 639' ' ' GLN . . . . . . . . . . . . . 74.2 mt-30 -90.38 139.37 30.74 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.04 -0.527 . . . . 0.0 109.923 179.308 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 640' ' ' VAL . . . . . 0.633 ' HA ' ' O ' ' A' ' 616' ' ' ILE . 7.1 p -125.06 138.83 52.98 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.585 -179.556 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 641' ' ' ILE . . . . . 0.431 ' HB ' HG12 ' A' ' 617' ' ' VAL . 48.1 mm -113.67 119.97 62.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 115.971 -0.559 . . . . 0.0 109.502 179.127 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 642' ' ' TRP . . . . . . . . . . . . . 21.6 t90 -90.68 122.13 33.18 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.047 0.451 . . . . 0.0 111.581 -179.019 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 643' ' ' LEU . . . . . . . . . . . . . 88.9 mt -121.11 138.94 53.96 Favored 'General case' 0 CA--C 1.53 0.185 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.402 179.175 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 644' ' ' VAL . . . . . . . . . . . . . 9.6 m -108.31 25.91 2.42 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 116.426 -0.352 . . . . 0.0 111.723 -179.883 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 645' ' ' ASP . . . . . . . . . . . . . 11.5 t0 -134.92 -47.6 0.73 Allowed 'General case' 0 N--CA 1.467 0.398 0 N-CA-C 112.891 0.7 . . . . 0.0 112.891 -177.928 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 646' ' ' GLY . . . . . . . . . . . . . . . 80.96 24.7 57.41 Favored Glycine 0 CA--C 1.52 0.353 0 C-N-CA 120.636 -0.792 . . . . 0.0 113.871 -179.555 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 647' ' ' GLU . . . . . . . . . . . . . 71.4 mm-40 -68.97 132.33 46.52 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-O 121.295 0.569 . . . . 0.0 111.173 179.698 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 648' ' ' VAL . . . . . . . . . . . . . 78.1 t -62.03 -40.29 86.82 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 CA-C-N 114.729 -1.123 . . . . 0.0 111.612 -179.47 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 649' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -61.39 -42.96 99.56 Favored 'General case' 0 C--N 1.331 -0.212 0 C-N-CA 120.77 -0.372 . . . . 0.0 110.56 -179.799 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 650' ' ' ARG . . . . . . . . . . . . . 80.5 mtp180 -70.02 -40.62 75.11 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-N 116.563 -0.29 . . . . 0.0 110.47 178.64 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 651' ' ' LEU . . . . . . . . . . . . . 84.9 mt -65.14 -41.14 95.05 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.449 178.745 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 652' ' ' LEU . . . . . . . . . . . . . 62.2 tp -65.52 -43.23 90.68 Favored 'General case' 0 CA--C 1.53 0.197 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.227 178.857 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 653' ' ' ALA . . . . . . . . . . . . . . . -62.31 -39.44 93.02 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-O 121.075 0.464 . . . . 0.0 111.629 179.871 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 654' ' ' LEU . . . . . . . . . . . . . 75.5 mt -101.07 30.98 3.82 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.846 -0.615 . . . . 0.0 110.325 -179.929 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 655' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -30.3 104.12 0.2 Allowed Pre-proline 0 N--CA 1.474 0.762 0 O-C-N 124.731 1.269 . . . . 0.0 114.008 -178.249 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 656' ' ' PRO . . . . . . . . . . . . . 32.7 Cg_endo -90.76 177.05 2.25 Favored 'Trans proline' 0 C--N 1.345 0.372 0 C-N-CA 124.106 3.204 . . . . 0.0 112.559 178.8 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 657' ' ' ILE . . . . . 0.497 ' O ' ' HA ' ' A' ' 686' ' ' LEU . 17.7 pt -86.91 -25.01 6.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 121.484 0.659 . . . . 0.0 109.806 177.599 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 658' ' ' ALA . . . . . . . . . . . . . . . -158.64 152.74 23.82 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.069 -0.969 . . . . 0.0 110.475 179.255 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 659' ' ' VAL . . . . . 0.492 HG13 HD21 ' A' ' 686' ' ' LEU . 34.6 m -120.21 142.27 36.7 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-O 121.43 0.633 . . . . 0.0 111.277 179.52 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 660' ' ' LEU . . . . . 0.441 HD23 ' HB2' ' A' ' 689' ' ' PHE . 21.3 mt -112.63 111.66 22.62 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.198 -0.91 . . . . 0.0 108.606 178.265 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 661' ' ' LEU . . . . . . . . . . . . . 47.3 mt -103.61 111.33 23.76 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 109.746 -0.464 . . . . 0.0 109.746 -178.797 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 662' ' ' ALA . . . . . 0.732 ' HB3' ' HB2' ' A' ' 620' ' ' SER . . . -105.67 132.68 51.51 Favored 'General case' 0 C--N 1.327 -0.413 0 N-CA-C 112.315 0.487 . . . . 0.0 112.315 -178.637 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 663' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -72.27 145.25 88.01 Favored Pre-proline 0 C--N 1.326 -0.416 0 CA-C-N 115.76 -0.655 . . . . 0.0 110.363 178.564 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 664' ' ' PRO . . . . . . . . . . . . . 69.1 Cg_endo -73.27 139.68 62.81 Favored 'Cis proline' 0 C--N 1.348 0.508 0 C-N-CA 123.122 -1.616 . . . . 0.0 112.775 -0.849 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 665' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -75.74 141.78 42.54 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.892 -0.594 . . . . 0.0 111.383 179.554 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 666' ' ' SER . . . . . 0.434 ' OG ' ' HG3' ' A' ' 621' ' ' GLU . 1.1 m -97.12 -34.94 10.96 Favored 'General case' 0 CA--C 1.53 0.191 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.389 -179.367 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 667' ' ' TYR . . . . . . . . . . . . . 22.5 p90 -63.47 -20.15 65.34 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-N 115.94 -0.573 . . . . 0.0 112.5 179.838 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 668' ' ' GLY . . . . . . . . . . . . . . . 100.82 -111.17 4.08 Favored Glycine 0 N--CA 1.449 -0.436 0 C-N-CA 120.712 -0.756 . . . . 0.0 113.74 179.482 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 669' ' ' ASP . . . . . . . . . . . . . 36.2 t70 -79.97 118.01 21.33 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-O 121.119 0.485 . . . . 0.0 112.097 -178.213 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 670' ' ' VAL . . . . . . . . . . . . . 72.2 t -61.42 -42.21 92.92 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.351 0 CA-C-N 115.355 -0.839 . . . . 0.0 112.547 -179.699 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 671' ' ' GLN . . . . . . . . . . . . . 96.8 mt-30 -61.32 -41.85 97.7 Favored 'General case' 0 N--CA 1.464 0.246 0 N-CA-C 111.985 0.365 . . . . 0.0 111.985 -178.066 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 672' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 -64.72 -40.76 95.88 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.578 0.228 . . . . 0.0 110.994 179.342 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 673' ' ' LEU . . . . . . . . . . . . . 64.5 tp -64.57 -44.6 90.2 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.189 179.103 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 674' ' ' VAL . . . . . 0.587 HG11 ' HA3' ' A' ' 699' ' ' GLY . 56.5 t -63.0 -44.18 99.51 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-N 115.718 -0.674 . . . . 0.0 109.916 179.706 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 675' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -59.42 -40.41 86.63 Favored 'General case' 0 CA--C 1.521 -0.171 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.264 179.171 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 676' ' ' GLN . . . . . 0.59 ' O ' ' HG3' ' A' ' 680' ' ' ARG . 57.0 mt-30 -70.84 -41.49 71.4 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.451 -0.341 . . . . 0.0 110.919 179.777 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 677' ' ' LEU . . . . . . . . . . . . . 85.7 mt -67.68 -41.76 83.16 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.988 179.999 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 678' ' ' ARG . . . . . 0.485 ' HA ' ' O ' ' A' ' 681' ' ' CYS . 39.9 ptt180 -73.81 -27.23 61.01 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-O 120.882 0.372 . . . . 0.0 111.439 -178.989 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 679' ' ' GLN . . . . . . . . . . . . . 52.9 tt0 -65.92 -38.61 89.12 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.613 179.326 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 680' ' ' ARG . . . . . 0.59 ' HG3' ' O ' ' A' ' 676' ' ' GLN . 49.0 mtt-85 -92.74 -41.02 10.37 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.788 -0.642 . . . . 0.0 111.914 -179.032 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 681' ' ' CYS . . . . . 0.485 ' O ' ' HA ' ' A' ' 678' ' ' ARG . 78.5 m -122.66 134.07 54.5 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 120.949 0.404 . . . . 0.0 110.718 -179.932 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 682' ' ' THR . . . . . . . . . . . . . 61.7 p -70.39 159.15 85.79 Favored Pre-proline 0 C--N 1.324 -0.52 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.43 179.669 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 683' ' ' PRO . . . . . . . . . . . . . 76.2 Cg_exo -54.83 -33.13 80.25 Favored 'Trans proline' 0 C--N 1.349 0.56 0 C-N-CA 122.629 2.219 . . . . 0.0 112.505 179.585 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 684' ' ' GLU . . . . . . . . . . . . . 51.7 mp0 -70.57 -38.78 74.14 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.653 179.724 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 685' ' ' GLN . . . . . . . . . . . . . 65.0 tt0 -71.26 -41.05 70.58 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 115.61 -0.723 . . . . 0.0 111.729 179.921 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 686' ' ' LEU . . . . . 0.497 ' HA ' ' O ' ' A' ' 657' ' ' ILE . 3.4 tt -134.42 119.42 18.55 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.454 -178.754 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 687' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -93.61 145.39 24.58 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.104 0.478 . . . . 0.0 110.289 179.061 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 688' ' ' ILE . . . . . 0.517 HG22 HG12 ' A' ' 700' ' ' VAL . 77.4 mt -120.27 122.18 67.6 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.76 0 CA-C-O 121.277 0.56 . . . . 0.0 111.421 -178.602 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 689' ' ' PHE . . . . . 0.441 ' HB2' HD23 ' A' ' 660' ' ' LEU . 92.0 m-85 -123.42 147.12 47.44 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.05 -0.977 . . . . 0.0 110.193 178.94 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 690' ' ' ILE . . . . . . . . . . . . . 18.8 tt -126.94 138.95 53.27 Favored 'Isoleucine or valine' 0 C--O 1.235 0.338 0 CA-C-O 121.349 0.595 . . . . 0.0 111.993 -179.845 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 691' ' ' LEU . . . . . 0.427 ' HG ' ' HB ' ' A' ' 704' ' ' ILE . 3.2 mp -110.88 133.48 53.34 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-N 115.347 -0.842 . . . . 0.0 111.014 -179.758 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 692' ' ' GLY . . . . . 0.552 ' O ' ' HA ' ' A' ' 705' ' ' PRO . . . 162.61 -164.24 35.61 Favored Glycine 0 N--CA 1.448 -0.531 0 C-N-CA 120.68 -0.772 . . . . 0.0 112.442 179.701 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 693' ' ' SER . . . . . . . . . . . . . 55.3 m -95.2 112.84 24.49 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 109.055 -0.72 . . . . 0.0 109.055 179.3 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 694' ' ' LYS . . . . . . . . . . . . . 88.6 tttt 63.13 80.45 0.23 Allowed 'General case' 0 N--CA 1.465 0.307 0 O-C-N 123.886 0.741 . . . . 0.0 109.479 -178.608 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 695' ' ' GLY . . . . . 0.418 ' HA3' ' HB2' ' A' ' 703' ' ' TYR . . . -75.63 55.71 2.95 Favored Glycine 0 C--N 1.332 0.313 0 CA-C-N 115.763 -0.653 . . . . 0.0 113.745 -178.726 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 696' ' ' ASN . . . . . . . . . . . . . 65.6 t30 -87.91 73.49 9.16 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 121.05 0.452 . . . . 0.0 109.998 179.385 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 697' ' ' TYR . . . . . . . . . . . . . 97.9 m-85 -127.22 145.37 50.8 Favored 'General case' 0 N--CA 1.452 -0.369 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.632 -179.606 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 698' ' ' GLN . . . . . . . . . . . . . 97.5 mt-30 -83.78 147.87 27.35 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.59 -0.732 . . . . 0.0 110.605 179.849 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 699' ' ' GLY . . . . . 0.587 ' HA3' HG11 ' A' ' 674' ' ' VAL . . . 94.35 3.58 63.08 Favored Glycine 0 CA--C 1.519 0.319 0 C-N-CA 120.503 -0.856 . . . . 0.0 113.842 179.21 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 700' ' ' VAL . . . . . 0.517 HG12 HG22 ' A' ' 688' ' ' ILE . 28.2 m -117.79 145.14 24.08 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.282 0 CA-C-N 117.604 0.702 . . . . 0.0 110.075 179.197 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 701' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -72.15 -43.93 63.88 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.558 -0.746 . . . . 0.0 111.794 -179.584 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 702' ' ' ARG . . . . . . . . . . . . . 71.9 mtp180 -146.67 164.17 33.54 Favored 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 109.845 -0.428 . . . . 0.0 109.845 -179.069 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 703' ' ' TYR . . . . . 0.418 ' HB2' ' HA3' ' A' ' 695' ' ' GLY . 52.3 p90 -122.82 146.0 47.93 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 120.877 0.37 . . . . 0.0 110.848 179.736 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 704' ' ' ILE . . . . . 0.427 ' HB ' ' HG ' ' A' ' 691' ' ' LEU . 41.1 mm -120.38 103.29 44.58 Favored Pre-proline 0 C--O 1.236 0.387 0 CA-C-N 116.092 -0.503 . . . . 0.0 110.511 179.85 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 705' ' ' PRO . . . . . 0.552 ' HA ' ' O ' ' A' ' 692' ' ' GLY . 72.8 Cg_endo -73.92 152.79 46.98 Favored 'Trans proline' 0 C--N 1.345 0.36 0 C-N-CA 122.723 2.282 . . . . 0.0 113.733 -179.547 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 706' ' ' LEU . . . . . 0.412 HD23 HG23 ' A' ' 708' ' ' ILE . 91.5 mt -105.82 150.28 38.99 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-N 115.539 -0.755 . . . . 0.0 109.812 178.792 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 707' ' ' PRO . . . . . 0.404 ' C ' ' HA ' ' A' ' 706' ' ' LEU . 59.6 Cg_endo -71.63 139.91 62.07 Favored 'Cis proline' 0 C--N 1.345 0.372 0 C-N-CA 123.058 -1.643 . . . . 0.0 112.804 -0.238 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 708' ' ' ILE . . . . . 0.412 HG23 HD23 ' A' ' 706' ' ' LEU . 1.1 pt -65.55 129.93 30.29 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-N 115.619 -0.719 . . . . 0.0 112.073 178.992 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 709' ' ' HIS . . . . . . . . . . . . . 70.0 m80 -98.88 115.08 65.95 Favored Pre-proline 0 C--N 1.322 -0.625 0 N-CA-C 108.564 -0.902 . . . . 0.0 108.564 177.482 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 710' ' ' PRO . . . . . . . . . . . . . 86.9 Cg_exo -52.27 -37.44 70.7 Favored 'Trans proline' 0 N--CA 1.477 0.537 0 C-N-CA 123.395 2.73 . . . . 0.0 114.341 -178.05 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 711' ' ' GLU . . . . . . . . . . . . . 51.0 mp0 -65.41 -40.2 93.11 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 112.248 0.462 . . . . 0.0 112.248 -178.709 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 712' ' ' SER . . . . . . . . . . . . . 50.7 m -91.38 -29.06 17.3 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 112.264 0.468 . . . . 0.0 112.264 -178.628 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 713' ' ' PHE . . . . . . . . . . . . . 91.1 t80 -58.87 -48.38 81.58 Favored 'General case' 0 N--CA 1.462 0.171 0 CA-C-O 120.498 0.19 . . . . 0.0 110.763 -179.127 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 714' ' ' LEU . . . . . . . . . . . . . 60.1 tp -62.3 -41.95 98.94 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.459 -0.337 . . . . 0.0 110.266 179.516 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 715' ' ' GLN . . . . . . . . . . . . . 30.5 mm100 -62.74 -41.94 99.43 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 116.099 -0.501 . . . . 0.0 111.177 179.252 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 716' ' ' GLN . . . . . . . . . . . . . 1.9 mp0 -66.04 -45.46 81.34 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-O 120.634 0.254 . . . . 0.0 111.159 179.318 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 717' ' ' VAL . . . . . 0.43 ' O ' ' HG ' ' A' ' 721' ' ' LEU . 65.2 t -62.68 -45.09 99.67 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.131 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.733 179.769 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 718' ' ' THR . . . . . . . . . . . . . 92.0 m -60.61 -45.3 94.56 Favored 'General case' 0 C--O 1.232 0.164 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.708 179.676 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 719' ' ' MET . . . . . . . . . . . . . 11.0 tpt -60.87 -44.45 97.02 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.218 179.271 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 720' ' ' GLY . . . . . . . . . . . . . . . -62.96 -40.8 99.74 Favored Glycine 0 C--N 1.333 0.375 0 C-N-CA 121.029 -0.605 . . . . 0.0 112.622 179.001 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 721' ' ' LEU . . . . . 0.43 ' HG ' ' O ' ' A' ' 717' ' ' VAL . 97.7 mt -64.91 -39.42 93.49 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-O 120.77 0.319 . . . . 0.0 111.587 179.857 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 722' ' ' THR . . . . . . . . . . . . . 73.6 p -72.35 -9.73 58.88 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.778 -179.875 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 723' ' ' SER . . . . . . . . . . . . . 65.1 m -88.63 -1.67 58.19 Favored 'General case' 0 CA--C 1.532 0.267 0 CA-C-N 116.442 -0.345 . . . . 0.0 111.136 179.768 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 724' ' ' LEU . . . . . . . . . . . . . 1.5 pp -129.48 169.14 15.33 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.499 -0.319 . . . . 0.0 110.56 179.857 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 725' ' ' ALA . . . . . . . . . . . . . . . -144.71 149.31 35.38 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.784 179.997 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 726' ' ' THR . . . . . . . . . . . . . 86.9 m -121.78 128.76 52.08 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.311 179.997 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 727' ' ' SER . . . . . . . . . . . . . 93.6 p -150.72 161.95 41.63 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.492 -0.322 . . . . 0.0 110.608 -179.966 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 728' ' ' ALA . . . . . . . . . . . . . . . -62.06 -39.8 93.62 Favored 'General case' 0 N--CA 1.462 0.145 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.765 179.854 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 729' ' ' GLN . . . . . . . . . . . . . 96.6 mt-30 . . . . . 0 C--O 1.25 1.1 0 CA-C-O 118.192 -0.909 . . . . 0.0 110.929 179.959 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 613' ' ' GLU . . . . . . . . . . . . . 7.4 mt-10 . . . . . 0 N--CA 1.488 1.435 0 CA-C-O 120.984 0.421 . . . . 0.0 110.76 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 614' ' ' GLY . . . . . . . . . . . . . . . -82.11 70.71 3.09 Favored Glycine 0 N--CA 1.452 -0.244 0 C-N-CA 121.022 -0.609 . . . . 0.0 112.591 -179.996 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 615' ' ' ARG . . . . . . . . . . . . . 87.2 mtm180 -115.82 141.34 48.22 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.725 0.298 . . . . 0.0 110.716 -179.838 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 616' ' ' ILE . . . . . 0.496 ' O ' ' HA ' ' A' ' 640' ' ' VAL . 85.0 mt -123.79 134.96 65.0 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 N-CA-C 109.521 -0.548 . . . . 0.0 109.521 179.153 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 617' ' ' VAL . . . . . 0.675 HG12 ' HB ' ' A' ' 641' ' ' ILE . 33.1 m -112.9 147.6 16.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 C-N-CA 120.531 -0.468 . . . . 0.0 111.129 -179.046 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 618' ' ' LEU . . . . . 0.559 ' CD1' HG21 ' A' ' 629' ' ' ILE . 4.6 tt -119.66 130.98 55.33 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.003 179.936 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 619' ' ' VAL . . . . . . . . . . . . . 71.3 t -113.98 103.48 15.45 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-N 116.008 -0.542 . . . . 0.0 109.721 179.2 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 620' ' ' SER . . . . . 0.484 ' HB2' ' HB3' ' A' ' 662' ' ' ALA . 30.3 t -172.44 151.0 2.38 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.181 -0.918 . . . . 0.0 110.273 -179.634 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 621' ' ' GLU . . . . . 0.442 ' HG3' ' OG ' ' A' ' 666' ' ' SER . 97.1 mt-10 -91.93 -2.31 56.85 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.367 179.13 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 622' ' ' ASP . . . . . . . . . . . . . 29.0 t70 -91.1 110.63 21.9 Favored 'General case' 0 C--O 1.233 0.185 0 CA-C-O 121.161 0.505 . . . . 0.0 111.335 -178.866 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 623' ' ' GLU . . . . . 0.405 ' HG2' ' CH2' ' A' ' 642' ' ' TRP . 98.0 mt-10 -64.87 -38.44 90.97 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.466 -0.788 . . . . 0.0 112.597 179.959 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 624' ' ' ALA . . . . . . . . . . . . . . . -60.99 -45.28 95.44 Favored 'General case' 0 N--CA 1.464 0.247 0 N-CA-C 113.719 1.007 . . . . 0.0 113.719 -177.324 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 625' ' ' THR . . . . . . . . . . . . . 30.8 p -72.26 -36.21 68.98 Favored 'General case' 0 CA--C 1.518 -0.258 0 C-N-CA 120.364 -0.534 . . . . 0.0 111.12 -179.713 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 626' ' ' SER . . . . . . . . . . . . . 69.0 m -65.52 -42.74 91.67 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.967 -0.561 . . . . 0.0 111.061 -179.646 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 627' ' ' THR . . . . . . . . . . . . . 90.3 m -64.29 -46.5 83.35 Favored 'General case' 0 C--O 1.236 0.377 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.791 -179.93 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 628' ' ' LEU . . . . . . . . . . . . . 60.7 tp -64.9 -44.01 90.98 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.738 -179.431 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 629' ' ' ILE . . . . . 0.559 HG21 ' CD1' ' A' ' 618' ' ' LEU . 1.3 tp -68.31 -33.62 61.52 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.382 0 CA-C-N 116.299 -0.409 . . . . 0.0 111.301 -179.088 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 630' ' ' CYS . . . . . . . . . . . . . 46.0 t -62.1 -44.04 97.51 Favored 'General case' 0 CA--C 1.521 -0.136 0 CA-C-N 115.959 -0.564 . . . . 0.0 111.409 -179.248 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 631' ' ' SER . . . . . . . . . . . . . 71.4 m -61.57 -41.98 98.19 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.526 -178.951 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 632' ' ' ILE . . . . . . . . . . . . . 96.9 mt -63.47 -49.32 83.13 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.257 0 CA-C-O 121.119 0.485 . . . . 0.0 110.995 179.958 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 633' ' ' LEU . . . . . . . . . . . . . 95.9 mt -68.75 -38.82 80.4 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.632 -0.713 . . . . 0.0 112.598 -179.264 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 634' ' ' THR . . . . . 0.479 ' HA ' ' O ' ' A' ' 638' ' ' TYR . 88.9 m -64.33 -39.96 94.94 Favored 'General case' 0 N--CA 1.462 0.161 0 CA-C-O 120.697 0.284 . . . . 0.0 110.739 -179.684 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 635' ' ' THR . . . . . . . . . . . . . 92.0 m -58.94 -38.93 80.12 Favored 'General case' 0 C--O 1.233 0.197 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.006 179.019 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 636' ' ' ALA . . . . . . . . . . . . . . . -65.45 -18.31 65.22 Favored 'General case' 0 CA--C 1.534 0.333 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.03 178.468 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 637' ' ' GLY . . . . . . . . . . . . . . . 109.14 3.66 31.34 Favored Glycine 0 C--N 1.333 0.379 0 C-N-CA 121.16 -0.543 . . . . 0.0 113.345 179.619 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 638' ' ' TYR . . . . . 0.479 ' O ' ' HA ' ' A' ' 634' ' ' THR . 94.7 m-85 -100.98 142.19 32.8 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.994 0.397 . . . . 0.0 111.929 -179.761 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 639' ' ' GLN . . . . . . . . . . . . . 78.5 mt-30 -89.88 140.32 29.73 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.661 179.636 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 640' ' ' VAL . . . . . 0.496 ' HA ' ' O ' ' A' ' 616' ' ' ILE . 58.6 t -116.11 128.98 73.24 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-O 120.958 0.409 . . . . 0.0 111.635 -179.997 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 641' ' ' ILE . . . . . 0.675 ' HB ' HG12 ' A' ' 617' ' ' VAL . 47.0 mm -110.18 119.55 59.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 N-CA-C 109.404 -0.591 . . . . 0.0 109.404 179.104 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 642' ' ' TRP . . . . . 0.405 ' CH2' ' HG2' ' A' ' 623' ' ' GLU . 25.2 t90 -89.21 125.13 34.94 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.102 0.477 . . . . 0.0 111.932 -178.69 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 643' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -117.84 129.87 55.92 Favored 'General case' 0 C--O 1.234 0.287 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.668 179.327 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 644' ' ' VAL . . . . . . . . . . . . . 6.0 m -102.13 27.85 0.86 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.895 -179.762 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 645' ' ' ASP . . . . . . . . . . . . . 37.7 t70 -155.92 -34.83 0.09 Allowed 'General case' 0 N--CA 1.47 0.528 0 N-CA-C 112.525 0.565 . . . . 0.0 112.525 -178.3 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 646' ' ' GLY . . . . . . . . . . . . . . . 75.9 28.17 61.25 Favored Glycine 0 CA--C 1.518 0.227 0 C-N-CA 120.729 -0.748 . . . . 0.0 113.366 -179.359 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 647' ' ' GLU . . . . . . . . . . . . . 86.7 tt0 -62.65 123.59 18.79 Favored 'General case' 0 N--CA 1.454 -0.233 0 CA-C-O 121.26 0.552 . . . . 0.0 110.355 179.847 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 648' ' ' VAL . . . . . . . . . . . . . 72.8 t -61.11 -40.67 86.57 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 114.952 -1.022 . . . . 0.0 112.197 -178.494 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 649' ' ' GLU . . . . . . . . . . . . . 48.9 mp0 -60.67 -43.44 97.67 Favored 'General case' 0 C--N 1.33 -0.271 0 C-N-CA 120.792 -0.363 . . . . 0.0 110.669 -179.82 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 650' ' ' ARG . . . . . . . . . . . . . 82.7 mtp180 -70.54 -41.02 73.05 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.685 178.564 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 651' ' ' LEU . . . . . 0.506 HD22 HG21 ' A' ' 617' ' ' VAL . 96.5 mt -65.48 -40.06 92.66 Favored 'General case' 0 N--CA 1.462 0.14 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.521 179.311 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 652' ' ' LEU . . . . . . . . . . . . . 62.4 tp -63.7 -43.25 97.16 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.694 178.871 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 653' ' ' ALA . . . . . . . . . . . . . . . -62.27 -39.08 91.72 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-O 121.229 0.538 . . . . 0.0 111.204 179.35 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 654' ' ' LEU . . . . . . . . . . . . . 75.9 mt -98.62 30.79 3.12 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.649 -0.705 . . . . 0.0 110.37 179.922 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 655' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -30.33 104.52 0.21 Allowed Pre-proline 0 N--CA 1.474 0.735 0 O-C-N 124.617 1.198 . . . . 0.0 113.764 -178.531 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 656' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_endo -90.44 173.75 3.13 Favored 'Trans proline' 0 C--N 1.344 0.308 0 C-N-CA 123.985 3.123 . . . . 0.0 112.922 179.388 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 657' ' ' ILE . . . . . . . . . . . . . 18.2 pt -85.05 -26.33 6.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-O 121.454 0.645 . . . . 0.0 109.66 177.369 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 658' ' ' ALA . . . . . 0.42 ' HA ' ' O ' ' A' ' 687' ' ' LYS . . . -156.6 153.24 28.3 Favored 'General case' 0 N--CA 1.449 -0.492 0 CA-C-N 115.058 -0.973 . . . . 0.0 110.627 179.915 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 659' ' ' VAL . . . . . 0.489 HG12 ' CG2' ' A' ' 617' ' ' VAL . 34.0 m -120.88 145.2 27.72 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-O 121.194 0.521 . . . . 0.0 110.961 179.242 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 660' ' ' LEU . . . . . . . . . . . . . 15.5 mt -113.42 115.69 28.47 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.45 -0.796 . . . . 0.0 109.884 178.812 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 661' ' ' LEU . . . . . . . . . . . . . 67.9 mt -104.61 107.65 18.7 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 108.818 -0.808 . . . . 0.0 108.818 179.521 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 662' ' ' ALA . . . . . 0.498 ' HB2' HD12 ' A' ' 691' ' ' LEU . . . -107.13 134.23 50.56 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 112.765 0.654 . . . . 0.0 112.765 -178.132 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 663' ' ' GLU . . . . . . . . . . . . . 9.6 mm-40 -67.86 136.61 92.29 Favored Pre-proline 0 C--N 1.325 -0.473 0 CA-C-N 115.751 -0.659 . . . . 0.0 110.768 177.63 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 664' ' ' PRO . . . . . . . . . . . . . 92.8 Cg_endo -78.07 141.79 67.37 Favored 'Cis proline' 0 C--N 1.35 0.625 0 C-N-CA 123.538 -1.442 . . . . 0.0 112.402 -1.2 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 665' ' ' PHE . . . . . 0.695 ' HZ ' HD11 ' A' ' 690' ' ' ILE . 23.4 m-85 -72.5 123.83 23.94 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.961 179.991 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 666' ' ' SER . . . . . 0.442 ' OG ' ' HG3' ' A' ' 621' ' ' GLU . 69.9 m -65.78 -41.18 92.3 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.302 179.612 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 667' ' ' TYR . . . . . . . . . . . . . 51.2 t80 -69.09 -23.61 64.03 Favored 'General case' 0 CA--C 1.533 0.314 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.692 179.935 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 668' ' ' GLY . . . . . . . . . . . . . . . 100.32 -103.69 2.68 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.504 -0.855 . . . . 0.0 112.435 -179.36 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 669' ' ' ASP . . . . . . . . . . . . . 37.5 t70 -80.7 110.21 15.98 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.91 0.386 . . . . 0.0 110.69 -179.654 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 670' ' ' VAL . . . . . 0.429 ' O ' HG23 ' A' ' 674' ' ' VAL . 12.1 m -69.46 -26.64 31.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 N-CA-C 113.726 1.009 . . . . 0.0 113.726 -179.039 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 671' ' ' GLN . . . . . . . . . . . . . 64.9 tt0 -60.41 -44.92 95.26 Favored 'General case' 0 CA--C 1.53 0.175 0 CA-C-N 118.043 0.383 . . . . 0.0 110.665 -179.293 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 672' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 -66.39 -40.13 89.48 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.648 178.854 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 673' ' ' LEU . . . . . . . . . . . . . 62.5 tp -63.1 -44.66 95.07 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.092 179.596 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 674' ' ' VAL . . . . . 0.597 HG11 ' HA3' ' A' ' 699' ' ' GLY . 53.3 t -62.78 -44.16 99.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 115.753 -0.658 . . . . 0.0 109.61 179.056 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 675' ' ' ASP . . . . . . . . . . . . . 35.9 t70 -60.03 -40.82 90.66 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.573 179.164 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 676' ' ' GLN . . . . . . . . . . . . . 96.8 mt-30 -70.76 -40.44 72.66 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.943 0.401 . . . . 0.0 110.98 -179.779 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 677' ' ' LEU . . . . . . . . . . . . . 5.1 mp -70.09 -43.75 70.47 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.053 -0.522 . . . . 0.0 111.894 179.805 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 678' ' ' ARG . . . . . 0.556 ' HA ' ' O ' ' A' ' 681' ' ' CYS . 39.8 ptt180 -69.85 -26.33 64.15 Favored 'General case' 0 N--CA 1.468 0.468 0 CA-C-O 121.114 0.483 . . . . 0.0 110.713 -179.216 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 679' ' ' GLN . . . . . . . . . . . . . 63.3 tt0 -66.51 -39.12 88.5 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.539 -0.755 . . . . 0.0 110.416 178.876 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 680' ' ' ARG . . . . . . . . . . . . . 32.7 mmt180 -90.15 -34.2 15.94 Favored 'General case' 0 N--CA 1.462 0.147 0 CA-C-N 115.945 -0.57 . . . . 0.0 111.676 -179.128 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 681' ' ' CYS . . . . . 0.615 ' SG ' ' HB2' ' A' ' 686' ' ' LEU . 27.5 t -134.18 128.76 34.66 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 109.544 -0.539 . . . . 0.0 109.544 -179.593 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 682' ' ' THR . . . . . 0.448 ' HB ' ' HD2' ' A' ' 683' ' ' PRO . 70.2 p -71.88 158.16 88.24 Favored Pre-proline 0 C--N 1.324 -0.527 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.351 -178.621 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 683' ' ' PRO . . . . . 0.448 ' HD2' ' HB ' ' A' ' 682' ' ' THR . 20.1 Cg_endo -60.42 -23.75 75.81 Favored 'Trans proline' 0 C--N 1.351 0.669 0 C-N-CA 122.519 2.146 . . . . 0.0 112.628 179.777 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 684' ' ' GLU . . . . . 0.41 ' HG2' ' OG1' ' A' ' 682' ' ' THR . 24.8 pt-20 -78.5 -18.04 55.36 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.017 0.436 . . . . 0.0 110.12 178.943 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 685' ' ' GLN . . . . . . . . . . . . . 95.0 mt-30 -99.65 -34.33 10.25 Favored 'General case' 0 CA--C 1.53 0.197 0 CA-C-N 115.88 -0.6 . . . . 0.0 111.012 179.81 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 686' ' ' LEU . . . . . 0.615 ' HB2' ' SG ' ' A' ' 681' ' ' CYS . 4.8 tt -134.09 124.59 26.41 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.94 -179.414 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 687' ' ' LYS . . . . . 0.42 ' O ' ' HA ' ' A' ' 658' ' ' ALA . 22.1 mtmm -94.46 147.01 23.68 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.2 0.524 . . . . 0.0 110.676 179.378 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 688' ' ' ILE . . . . . 0.568 HG22 HG12 ' A' ' 700' ' ' VAL . 78.0 mt -120.76 120.3 62.06 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.775 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.851 -179.325 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 689' ' ' PHE . . . . . . . . . . . . . 99.2 m-85 -119.42 145.94 45.81 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.289 -0.869 . . . . 0.0 110.091 179.327 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 690' ' ' ILE . . . . . 0.695 HD11 ' HZ ' ' A' ' 665' ' ' PHE . 19.5 tt -124.83 135.29 64.47 Favored 'Isoleucine or valine' 0 C--O 1.235 0.33 0 CA-C-O 121.267 0.556 . . . . 0.0 111.437 -179.662 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 691' ' ' LEU . . . . . 0.74 HD23 ' HB ' ' A' ' 704' ' ' ILE . 76.4 mt -107.11 126.89 52.95 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-N 115.53 -0.759 . . . . 0.0 110.219 179.93 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 692' ' ' GLY . . . . . 0.724 ' O ' ' HA ' ' A' ' 705' ' ' PRO . . . 162.72 -168.66 37.68 Favored Glycine 0 N--CA 1.447 -0.581 0 C-N-CA 120.651 -0.785 . . . . 0.0 112.125 -179.957 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 693' ' ' SER . . . . . . . . . . . . . 62.4 m -98.73 126.52 44.38 Favored 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 109.117 -0.697 . . . . 0.0 109.117 179.42 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 694' ' ' LYS . . . . . . . . . . . . . 99.3 mttt 59.67 59.35 2.56 Favored 'General case' 0 N--CA 1.465 0.291 0 O-C-N 123.772 0.67 . . . . 0.0 110.234 -179.075 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 695' ' ' GLY . . . . . . . . . . . . . . . -70.27 52.05 0.81 Allowed Glycine 0 CA--C 1.524 0.606 0 CA-C-N 115.559 -0.746 . . . . 0.0 114.219 -178.913 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 696' ' ' ASN . . . . . . . . . . . . . 66.0 t30 -89.4 78.3 7.2 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.938 0.399 . . . . 0.0 110.32 179.438 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 697' ' ' TYR . . . . . . . . . . . . . 97.6 m-85 -128.08 150.24 50.04 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.401 -179.668 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 698' ' ' GLN . . . . . . . . . . . . . 98.0 mt-30 -82.74 148.19 28.0 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.723 -0.671 . . . . 0.0 110.665 -179.626 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 699' ' ' GLY . . . . . 0.597 ' HA3' HG11 ' A' ' 674' ' ' VAL . . . 94.08 3.61 63.57 Favored Glycine 0 N--CA 1.449 -0.462 0 C-N-CA 120.579 -0.82 . . . . 0.0 113.707 179.449 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 700' ' ' VAL . . . . . 0.568 HG12 HG22 ' A' ' 688' ' ' ILE . 26.6 m -117.82 142.42 32.26 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.344 0 CA-C-N 117.594 0.697 . . . . 0.0 110.506 179.256 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 701' ' ' ASP . . . . . . . . . . . . . 36.9 t70 -72.8 -41.58 64.78 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.499 -0.773 . . . . 0.0 111.795 -179.787 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 702' ' ' ARG . . . . . . . . . . . . . 4.5 mmp_? -146.11 158.42 43.87 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.942 -178.92 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 703' ' ' TYR . . . . . . . . . . . . . 25.5 p90 -119.3 137.99 53.32 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.377 179.438 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 704' ' ' ILE . . . . . 0.74 ' HB ' HD23 ' A' ' 691' ' ' LEU . 31.2 mm -119.45 106.35 42.6 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 120.752 0.31 . . . . 0.0 110.63 -179.914 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 705' ' ' PRO . . . . . 0.724 ' HA ' ' O ' ' A' ' 692' ' ' GLY . 72.9 Cg_endo -72.93 149.08 46.63 Favored 'Trans proline' 0 C--N 1.346 0.441 0 C-N-CA 122.851 2.368 . . . . 0.0 113.791 -179.455 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 706' ' ' LEU . . . . . 0.621 HD23 HG23 ' A' ' 708' ' ' ILE . 91.0 mt -105.83 148.72 36.99 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-N 115.409 -0.814 . . . . 0.0 109.789 178.415 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 707' ' ' PRO . . . . . 0.519 ' C ' ' HA ' ' A' ' 706' ' ' LEU . 38.9 Cg_exo -64.29 137.91 30.3 Favored 'Cis proline' 0 C--N 1.35 0.615 0 C-N-CA 123.725 -1.365 . . . . 0.0 112.809 -1.137 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 708' ' ' ILE . . . . . 0.621 HG23 HD23 ' A' ' 706' ' ' LEU . 1.1 pt -66.36 139.24 21.5 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-O 121.227 0.537 . . . . 0.0 111.752 178.562 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 709' ' ' HIS . . . . . . . . . . . . . 70.5 m80 -105.65 111.53 64.72 Favored Pre-proline 0 C--N 1.319 -0.746 0 N-CA-C 108.637 -0.875 . . . . 0.0 108.637 177.676 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 710' ' ' PRO . . . . . . . . . . . . . 88.5 Cg_exo -52.95 -37.95 78.86 Favored 'Trans proline' 0 N--CA 1.478 0.582 0 C-N-CA 123.472 2.782 . . . . 0.0 114.31 -178.394 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 711' ' ' GLU . . . . . . . . . . . . . 42.5 tt0 -64.93 -42.36 94.75 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 112.277 0.473 . . . . 0.0 112.277 -178.611 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 712' ' ' SER . . . . . . . . . . . . . 46.3 m -89.64 -27.35 20.22 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 112.463 0.542 . . . . 0.0 112.463 -178.242 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 713' ' ' PHE . . . . . . . . . . . . . 88.6 t80 -59.32 -48.71 80.61 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-O 120.706 0.288 . . . . 0.0 110.988 -179.456 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 714' ' ' LEU . . . . . . . . . . . . . 59.1 tp -62.63 -41.89 99.28 Favored 'General case' 0 C--O 1.235 0.294 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.343 179.868 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 715' ' ' GLN . . . . . . . . . . . . . 59.3 mt-30 -63.69 -41.59 98.13 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.416 179.175 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 716' ' ' GLN . . . . . . . . . . . . . 82.9 mt-30 -64.29 -41.87 96.67 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-N 116.791 -0.186 . . . . 0.0 111.15 179.683 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 717' ' ' VAL . . . . . . . . . . . . . 68.2 t -63.84 -45.04 98.19 Favored 'Isoleucine or valine' 0 C--O 1.232 0.165 0 CA-C-O 121.057 0.455 . . . . 0.0 109.931 178.622 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 718' ' ' THR . . . . . . . . . . . . . 89.3 m -62.46 -44.27 96.82 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 115.517 -0.765 . . . . 0.0 110.858 179.521 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 719' ' ' MET . . . . . . . . . . . . . 63.5 tpp -59.98 -47.59 85.19 Favored 'General case' 0 N--CA 1.463 0.185 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.564 179.746 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 720' ' ' GLY . . . . . . . . . . . . . . . -62.64 -40.87 99.7 Favored Glycine 0 C--N 1.335 0.512 0 C-N-CA 120.638 -0.792 . . . . 0.0 111.752 178.738 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 721' ' ' LEU . . . . . . . . . . . . . 65.6 tp -62.7 -45.6 92.02 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.663 0.268 . . . . 0.0 111.315 179.156 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 722' ' ' THR . . . . . . . . . . . . . 73.1 p -70.95 -27.87 64.06 Favored 'General case' 0 N--CA 1.463 0.185 0 N-CA-C 112.539 0.57 . . . . 0.0 112.539 -179.834 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 723' ' ' SER . . . . . . . . . . . . . 73.0 p -71.57 -20.53 62.0 Favored 'General case' 0 CA--C 1.531 0.221 0 C-N-CA 121.194 -0.202 . . . . 0.0 111.467 179.967 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 724' ' ' LEU . . . . . . . . . . . . . 65.5 tp -63.0 -46.63 86.75 Favored 'General case' 0 CA--C 1.53 0.204 0 CA-C-N 116.471 -0.331 . . . . 0.0 111.348 179.984 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 725' ' ' ALA . . . . . . . . . . . . . . . -155.99 149.45 24.77 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.963 -179.879 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 726' ' ' THR . . . . . . . . . . . . . 72.7 p -81.01 159.96 24.69 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.398 -0.364 . . . . 0.0 111.243 179.951 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 727' ' ' SER . . . . . . . . . . . . . 98.3 p -153.08 162.54 41.19 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.566 -179.953 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 728' ' ' ALA . . . . . . . . . . . . . . . -148.24 154.06 39.55 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.652 179.987 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 729' ' ' GLN . . . . . . . . . . . . . 96.7 mt-30 . . . . . 0 C--O 1.248 1.0 0 CA-C-O 118.25 -0.881 . . . . 0.0 110.826 179.9 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 613' ' ' GLU . . . . . . . . . . . . . 3.3 mt-10 . . . . . 0 N--CA 1.488 1.469 0 CA-C-O 121.106 0.479 . . . . 0.0 110.626 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 614' ' ' GLY . . . . . . . . . . . . . . . 100.5 150.1 24.2 Favored Glycine 0 N--CA 1.451 -0.355 0 CA-C-N 115.664 -0.698 . . . . 0.0 112.163 -179.464 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 615' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -117.49 137.72 52.35 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.944 0.402 . . . . 0.0 111.271 -179.695 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 616' ' ' ILE . . . . . 0.467 ' O ' ' HA ' ' A' ' 640' ' ' VAL . 87.9 mt -122.71 133.23 69.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 115.73 -0.668 . . . . 0.0 109.669 178.943 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 617' ' ' VAL . . . . . 0.468 HG23 ' HB3' ' A' ' 656' ' ' PRO . 99.6 t -106.45 127.68 61.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-O 121.148 0.499 . . . . 0.0 110.235 -179.907 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 618' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -106.41 126.19 51.93 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.604 -178.771 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 619' ' ' VAL . . . . . 0.402 ' HA ' ' O ' ' A' ' 643' ' ' LEU . 59.6 t -115.78 118.46 58.86 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 N-CA-C 109.92 -0.4 . . . . 0.0 109.92 179.93 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 620' ' ' SER . . . . . 0.567 ' HB2' ' HB3' ' A' ' 662' ' ' ALA . 32.5 t -172.19 139.39 1.06 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.664 -0.698 . . . . 0.0 111.116 -179.472 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 621' ' ' GLU . . . . . 0.46 ' HB3' ' HB3' ' A' ' 666' ' ' SER . 25.9 pt-20 -84.05 -11.47 56.67 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.935 -0.575 . . . . 0.0 111.415 178.586 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 622' ' ' ASP . . . . . . . . . . . . . 62.5 t0 -91.4 107.48 19.24 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-O 120.854 0.359 . . . . 0.0 110.544 -179.051 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 623' ' ' GLU . . . . . . . . . . . . . 25.5 pm0 -67.2 -31.04 71.15 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.91 -0.587 . . . . 0.0 112.262 -179.884 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 624' ' ' ALA . . . . . . . . . . . . . . . -63.93 -45.35 89.62 Favored 'General case' 0 N--CA 1.464 0.23 0 N-CA-C 112.433 0.531 . . . . 0.0 112.433 -178.695 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 625' ' ' THR . . . . . . . . . . . . . 20.5 p -76.01 -36.13 59.27 Favored 'General case' 0 CA--C 1.517 -0.312 0 C-N-CA 120.95 -0.3 . . . . 0.0 111.34 179.943 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 626' ' ' SER . . . . . . . . . . . . . 68.5 m -63.44 -41.67 98.67 Favored 'General case' 0 N--CA 1.453 -0.286 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.324 -179.247 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 627' ' ' THR . . . . . . . . . . . . . 92.4 m -62.71 -47.05 85.27 Favored 'General case' 0 CA--C 1.532 0.286 0 CA-C-O 120.947 0.403 . . . . 0.0 111.506 179.846 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 628' ' ' LEU . . . . . . . . . . . . . 62.2 tp -66.77 -43.87 82.89 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.153 -0.476 . . . . 0.0 112.043 -179.736 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 629' ' ' ILE . . . . . . . . . . . . . 1.5 tp -70.21 -35.48 63.38 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.473 0 N-CA-C 113.236 0.828 . . . . 0.0 113.236 -177.965 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 630' ' ' CYS . . . . . . . . . . . . . 18.4 p -67.95 -29.48 68.54 Favored 'General case' 0 CA--C 1.521 -0.164 0 C-N-CA 121.071 -0.251 . . . . 0.0 111.202 -178.921 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 631' ' ' SER . . . . . . . . . . . . . 68.1 m -64.89 -41.81 95.3 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.887 179.558 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 632' ' ' ILE . . . . . . . . . . . . . 96.6 mt -63.54 -48.84 85.08 Favored 'Isoleucine or valine' 0 C--O 1.234 0.243 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.882 -179.972 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 633' ' ' LEU . . . . . . . . . . . . . 85.7 mt -65.36 -40.93 94.19 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-N 115.77 -0.65 . . . . 0.0 112.308 -179.492 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 634' ' ' THR . . . . . 0.523 ' HA ' ' O ' ' A' ' 638' ' ' TYR . 91.7 m -67.04 -40.5 87.2 Favored 'General case' 0 CA--C 1.531 0.222 0 CA-C-O 120.53 0.205 . . . . 0.0 111.207 -179.456 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 635' ' ' THR . . . . . . . . . . . . . 93.8 m -59.2 -38.59 80.27 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-O 120.845 0.355 . . . . 0.0 110.458 179.628 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 636' ' ' ALA . . . . . . . . . . . . . . . -63.87 -17.21 62.94 Favored 'General case' 0 CA--C 1.533 0.292 0 CA-C-N 115.922 -0.581 . . . . 0.0 111.453 178.981 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 637' ' ' GLY . . . . . . . . . . . . . . . 109.03 7.34 29.07 Favored Glycine 0 C--N 1.333 0.392 0 C-N-CA 120.888 -0.672 . . . . 0.0 113.077 179.866 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 638' ' ' TYR . . . . . 0.523 ' O ' ' HA ' ' A' ' 634' ' ' THR . 96.6 m-85 -100.26 140.56 34.33 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.828 0.347 . . . . 0.0 111.461 -179.936 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 639' ' ' GLN . . . . . . . . . . . . . 79.0 mt-30 -87.13 134.36 33.52 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 109.57 -0.53 . . . . 0.0 109.57 178.851 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 640' ' ' VAL . . . . . 0.467 ' HA ' ' O ' ' A' ' 616' ' ' ILE . 62.9 t -119.04 131.33 72.12 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 N-CA-C 112.756 0.651 . . . . 0.0 112.756 -178.62 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 641' ' ' ILE . . . . . 0.418 ' HB ' HG22 ' A' ' 617' ' ' VAL . 46.4 mm -109.87 118.58 57.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 N-CA-C 108.24 -1.022 . . . . 0.0 108.24 177.966 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 642' ' ' TRP . . . . . . . . . . . . . 22.1 t90 -90.79 125.77 35.81 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 112.558 0.577 . . . . 0.0 112.558 -177.981 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 643' ' ' LEU . . . . . 0.425 ' HA ' HD13 ' A' ' 643' ' ' LEU . 0.8 OUTLIER -122.03 133.96 54.8 Favored 'General case' 0 C--O 1.232 0.182 0 CA-C-N 115.477 -0.783 . . . . 0.0 109.713 178.73 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 644' ' ' VAL . . . . . . . . . . . . . 18.8 m -105.13 13.87 7.54 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 N-CA-C 112.915 0.709 . . . . 0.0 112.915 -179.109 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 645' ' ' ASP . . . . . . . . . . . . . 40.1 p30 -137.31 -18.17 1.31 Allowed 'General case' 0 N--CA 1.472 0.639 0 N-CA-C 114.292 1.219 . . . . 0.0 114.292 -178.191 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 646' ' ' GLY . . . . . . . . . . . . . . . 67.39 28.64 73.67 Favored Glycine 0 CA--C 1.522 0.508 0 C-N-CA 120.875 -0.679 . . . . 0.0 114.084 179.58 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 647' ' ' GLU . . . . . . . . . . . . . 48.1 mt-10 -67.67 125.16 25.35 Favored 'General case' 0 C--N 1.333 -0.123 0 CA-C-N 117.694 0.747 . . . . 0.0 111.389 -179.396 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 648' ' ' VAL . . . . . . . . . . . . . 78.5 t -61.53 -39.17 82.06 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-N 114.541 -1.209 . . . . 0.0 111.536 -179.718 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 649' ' ' GLU . . . . . . . . . . . . . 50.2 mp0 -60.26 -42.83 96.19 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 120.84 0.353 . . . . 0.0 110.204 -179.69 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 650' ' ' ARG . . . . . . . . . . . . . 11.3 mpt_? -72.07 -41.67 67.1 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.532 178.405 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 651' ' ' LEU . . . . . . . . . . . . . 87.2 mt -63.52 -41.41 98.5 Favored 'General case' 0 N--CA 1.463 0.182 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.508 179.413 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 652' ' ' LEU . . . . . . . . . . . . . 61.0 tp -65.17 -43.8 90.57 Favored 'General case' 0 CA--C 1.531 0.223 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.21 179.008 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 653' ' ' ALA . . . . . . . . . . . . . . . -62.72 -39.36 93.82 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-O 120.98 0.419 . . . . 0.0 111.828 179.825 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 654' ' ' LEU . . . . . . . . . . . . . 74.6 mt -101.36 30.32 4.28 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.986 -179.459 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 655' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -31.08 104.25 0.21 Allowed Pre-proline 0 N--CA 1.472 0.664 0 O-C-N 124.488 1.117 . . . . 0.0 113.86 -179.175 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 656' ' ' PRO . . . . . 0.468 ' HB3' HG23 ' A' ' 617' ' ' VAL . 35.5 Cg_endo -91.07 178.16 1.89 Allowed 'Trans proline' 0 C--N 1.345 0.365 0 C-N-CA 123.635 2.89 . . . . 0.0 112.711 178.782 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 657' ' ' ILE . . . . . . . . . . . . . 24.3 pt -84.82 -25.26 7.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-O 121.447 0.641 . . . . 0.0 109.65 177.77 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 658' ' ' ALA . . . . . 0.401 ' HA ' ' O ' ' A' ' 687' ' ' LYS . . . -157.72 153.16 26.17 Favored 'General case' 0 N--CA 1.449 -0.51 0 CA-C-N 115.035 -0.984 . . . . 0.0 110.718 179.894 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 659' ' ' VAL . . . . . . . . . . . . . 31.3 m -122.68 146.33 28.11 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-O 121.228 0.537 . . . . 0.0 110.889 179.054 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 660' ' ' LEU . . . . . . . . . . . . . 3.2 mp -115.86 118.39 32.86 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.453 -0.794 . . . . 0.0 109.785 179.141 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 661' ' ' LEU . . . . . . . . . . . . . 32.3 mt -108.37 112.96 25.66 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 109.549 -0.537 . . . . 0.0 109.549 -179.622 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 662' ' ' ALA . . . . . 0.567 ' HB3' ' HB2' ' A' ' 620' ' ' SER . . . -105.8 131.17 53.46 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 112.399 0.518 . . . . 0.0 112.399 -178.907 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 663' ' ' GLU . . . . . 0.519 ' HA ' ' C ' ' A' ' 664' ' ' PRO . 76.7 mm-40 -81.88 147.06 57.33 Favored Pre-proline 0 CA--C 1.535 0.373 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.549 178.811 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 664' ' ' PRO . . . . . 0.519 ' C ' ' HA ' ' A' ' 663' ' ' GLU . 35.9 Cg_exo -63.77 135.18 19.47 Favored 'Cis proline' 0 C--N 1.353 0.801 0 C-N-CA 123.95 -1.271 . . . . 0.0 112.354 -1.376 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 665' ' ' PHE . . . . . 0.686 ' CE2' ' HB3' ' A' ' 667' ' ' TYR . 4.4 t80 -81.63 119.77 24.23 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.332 -179.44 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 666' ' ' SER . . . . . 0.46 ' HB3' ' HB3' ' A' ' 621' ' ' GLU . 80.8 p -66.64 -38.35 86.71 Favored 'General case' 0 CA--C 1.53 0.186 0 N-CA-C 112.592 0.59 . . . . 0.0 112.592 -179.616 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 667' ' ' TYR . . . . . 0.686 ' HB3' ' CE2' ' A' ' 665' ' ' PHE . 67.8 t80 -66.58 -22.98 66.14 Favored 'General case' 0 CA--C 1.533 0.303 0 CA-C-O 120.927 0.394 . . . . 0.0 111.315 179.737 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 668' ' ' GLY . . . . . . . . . . . . . . . 101.67 -104.22 2.65 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.62 -0.8 . . . . 0.0 113.573 179.789 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 669' ' ' ASP . . . . . 0.406 ' OD2' ' HG3' ' A' ' 672' ' ' GLU . 23.9 t70 -81.82 110.77 17.44 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.076 0.465 . . . . 0.0 112.03 -177.96 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 670' ' ' VAL . . . . . . . . . . . . . 72.9 t -62.22 -39.59 84.59 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.419 0 CA-C-N 115.307 -0.861 . . . . 0.0 112.655 179.925 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 671' ' ' GLN . . . . . . . . . . . . . 20.8 mp0 -59.66 -41.81 91.44 Favored 'General case' 0 N--CA 1.465 0.286 0 N-CA-C 111.75 0.278 . . . . 0.0 111.75 -177.513 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 672' ' ' GLU . . . . . 0.406 ' HG3' ' OD2' ' A' ' 669' ' ' ASP . 95.5 mt-10 -64.3 -40.29 95.64 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-N 116.622 -0.263 . . . . 0.0 111.064 179.413 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 673' ' ' LEU . . . . . . . . . . . . . 62.4 tp -64.83 -42.88 94.59 Favored 'General case' 0 C--N 1.331 -0.204 0 N-CA-C 109.715 -0.476 . . . . 0.0 109.715 178.995 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 674' ' ' VAL . . . . . 0.62 HG11 ' HA3' ' A' ' 699' ' ' GLY . 53.7 t -62.24 -44.26 98.91 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.269 0 CA-C-N 115.463 -0.79 . . . . 0.0 109.736 179.439 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 675' ' ' ASP . . . . . 0.404 ' O ' ' HB2' ' A' ' 679' ' ' GLN . 34.9 t70 -59.21 -40.0 84.43 Favored 'General case' 0 CA--C 1.519 -0.222 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.229 178.876 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 676' ' ' GLN . . . . . . . . . . . . . 55.9 mt-30 -71.21 -41.58 70.07 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.941 179.719 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 677' ' ' LEU . . . . . . . . . . . . . 86.7 mt -68.18 -41.75 81.01 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.893 179.946 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 678' ' ' ARG . . . . . 0.544 ' HA ' ' O ' ' A' ' 681' ' ' CYS . 40.0 ptt180 -72.95 -25.13 60.92 Favored 'General case' 0 N--CA 1.467 0.382 0 CA-C-O 120.998 0.428 . . . . 0.0 110.844 -179.435 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 679' ' ' GLN . . . . . 0.404 ' HB2' ' O ' ' A' ' 675' ' ' ASP . 11.0 tp-100 -66.45 -38.67 87.88 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.62 -0.718 . . . . 0.0 110.121 178.809 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 680' ' ' ARG . . . . . . . . . . . . . 32.2 mmt180 -89.62 -43.54 10.69 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-N 115.882 -0.599 . . . . 0.0 111.338 -179.671 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 681' ' ' CYS . . . . . 0.544 ' O ' ' HA ' ' A' ' 678' ' ' ARG . 76.9 m -121.97 131.7 54.15 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.319 179.876 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 682' ' ' THR . . . . . 0.459 ' HB ' ' HD2' ' A' ' 683' ' ' PRO . 65.2 p -70.36 159.21 85.56 Favored Pre-proline 0 C--N 1.321 -0.634 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.597 -179.856 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 683' ' ' PRO . . . . . 0.459 ' HD2' ' HB ' ' A' ' 682' ' ' THR . 17.9 Cg_endo -59.39 -22.68 66.91 Favored 'Trans proline' 0 C--N 1.35 0.657 0 C-N-CA 122.569 2.18 . . . . 0.0 112.887 -179.724 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 684' ' ' GLU . . . . . 0.402 ' HG2' ' OG1' ' A' ' 682' ' ' THR . 24.8 pt-20 -81.31 -15.04 56.62 Favored 'General case' 0 CA--C 1.531 0.24 0 CA-C-O 120.893 0.378 . . . . 0.0 110.663 178.981 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 685' ' ' GLN . . . . . . . . . . . . . 90.9 mt-30 -99.19 -34.1 10.49 Favored 'General case' 0 C--N 1.333 -0.136 0 CA-C-N 116.057 -0.52 . . . . 0.0 111.869 -179.593 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 686' ' ' LEU . . . . . . . . . . . . . 3.1 tt -135.53 125.3 25.49 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.566 -0.288 . . . . 0.0 111.273 -178.932 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 687' ' ' LYS . . . . . 0.401 ' O ' ' HA ' ' A' ' 658' ' ' ALA . 75.6 mmtt -95.36 146.63 24.24 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 121.252 0.548 . . . . 0.0 110.377 179.087 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 688' ' ' ILE . . . . . 0.518 HG22 HG12 ' A' ' 700' ' ' VAL . 75.3 mt -122.62 121.01 62.47 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.781 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.194 -179.032 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 689' ' ' PHE . . . . . . . . . . . . . 97.7 m-85 -118.36 145.23 45.29 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.253 -0.885 . . . . 0.0 110.228 179.127 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 690' ' ' ILE . . . . . . . . . . . . . 18.8 tt -127.22 139.56 51.55 Favored 'Isoleucine or valine' 0 C--O 1.235 0.337 0 CA-C-O 121.196 0.522 . . . . 0.0 111.544 179.633 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 691' ' ' LEU . . . . . 0.49 HD23 ' HB ' ' A' ' 704' ' ' ILE . 81.9 mt -111.47 128.92 56.15 Favored 'General case' 0 C--O 1.235 0.327 0 CA-C-N 115.618 -0.719 . . . . 0.0 110.093 179.509 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 692' ' ' GLY . . . . . 0.611 ' O ' ' HA ' ' A' ' 705' ' ' PRO . . . -179.43 177.53 48.32 Favored Glycine 0 N--CA 1.446 -0.685 0 N-CA-C 111.48 -0.648 . . . . 0.0 111.48 -179.864 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 693' ' ' SER . . . . . . . . . . . . . 79.4 p -67.04 -39.72 87.0 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.786 0.293 . . . . 0.0 111.784 -179.794 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 694' ' ' LYS . . . . . . . . . . . . . 38.0 mtpt -133.48 133.87 42.8 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.201 0.524 . . . . 0.0 110.977 179.619 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 695' ' ' GLY . . . . . . . . . . . . . . . -124.1 108.83 1.19 Allowed Glycine 0 N--CA 1.446 -0.66 0 CA-C-N 115.473 -0.785 . . . . 0.0 112.076 178.983 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 696' ' ' ASN . . . . . . . . . . . . . 99.6 m-20 -109.41 -67.41 0.99 Allowed 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 120.826 0.346 . . . . 0.0 110.356 179.466 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 697' ' ' TYR . . . . . . . . . . . . . 53.9 p90 -157.09 155.86 31.81 Favored 'General case' 0 C--N 1.33 -0.247 0 N-CA-C 109.758 -0.46 . . . . 0.0 109.758 178.96 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 698' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER 174.58 25.42 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.284 0 O-C-N 124.062 0.851 . . . . 0.0 109.818 -179.978 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 699' ' ' GLY . . . . . 0.62 ' HA3' HG11 ' A' ' 674' ' ' VAL . . . 80.36 14.86 79.58 Favored Glycine 0 C--N 1.335 0.495 0 C-N-CA 120.337 -0.935 . . . . 0.0 111.865 -178.62 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 700' ' ' VAL . . . . . 0.518 HG12 HG22 ' A' ' 688' ' ' ILE . 23.7 m -101.92 147.58 8.53 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.502 0 CA-C-O 121.446 0.641 . . . . 0.0 111.43 -178.372 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 701' ' ' ASP . . . . . . . . . . . . . 36.7 t70 -72.46 -40.95 66.59 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 114.905 -1.043 . . . . 0.0 111.87 -179.697 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 702' ' ' ARG . . . . . . . . . . . . . 95.1 mtt-85 -143.5 157.91 44.07 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-O 121.06 0.457 . . . . 0.0 111.376 -178.573 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 703' ' ' TYR . . . . . . . . . . . . . 24.8 p90 -125.54 143.96 50.77 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.244 179.41 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 704' ' ' ILE . . . . . 0.49 ' HB ' HD23 ' A' ' 691' ' ' LEU . 56.5 mt -126.98 87.62 56.27 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-O 120.922 0.391 . . . . 0.0 110.484 179.915 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 705' ' ' PRO . . . . . 0.611 ' HA ' ' O ' ' A' ' 692' ' ' GLY . 31.4 Cg_exo -61.73 142.56 94.41 Favored 'Trans proline' 0 C--N 1.348 0.534 0 C-N-CA 123.492 2.795 . . . . 0.0 113.859 -179.462 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 706' ' ' LEU . . . . . . . . . . . . . 90.9 mt -79.22 151.36 75.4 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-N 115.443 -0.799 . . . . 0.0 110.276 178.384 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 707' ' ' PRO . . . . . . . . . . . . . 63.4 Cg_endo -72.65 139.83 63.12 Favored 'Cis proline' 0 C--N 1.347 0.475 0 C-N-CA 123.226 -1.573 . . . . 0.0 112.766 -0.297 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 708' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -69.81 116.51 10.96 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-N 115.773 -0.648 . . . . 0.0 111.639 179.108 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 709' ' ' HIS . . . . . . . . . . . . . 98.4 m-70 -91.96 118.16 68.08 Favored Pre-proline 0 C--N 1.324 -0.541 0 N-CA-C 108.379 -0.971 . . . . 0.0 108.379 177.679 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 710' ' ' PRO . . . . . . . . . . . . . 86.4 Cg_exo -52.34 -37.46 71.53 Favored 'Trans proline' 0 C--N 1.348 0.541 0 C-N-CA 123.166 2.578 . . . . 0.0 114.279 -178.173 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 711' ' ' GLU . . . . . . . . . . . . . 88.8 tt0 -64.1 -44.08 93.4 Favored 'General case' 0 CA--C 1.531 0.236 0 N-CA-C 111.954 0.353 . . . . 0.0 111.954 -179.077 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 712' ' ' SER . . . . . . . . . . . . . 50.7 m -86.66 -26.25 24.43 Favored 'General case' 0 C--N 1.331 -0.225 0 N-CA-C 111.99 0.367 . . . . 0.0 111.99 -178.824 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 713' ' ' PHE . . . . . . . . . . . . . 69.9 t80 -59.64 -49.94 75.81 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-O 120.658 0.266 . . . . 0.0 111.095 -179.769 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 714' ' ' LEU . . . . . . . . . . . . . 56.9 tp -65.05 -40.06 94.21 Favored 'General case' 0 C--O 1.235 0.308 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.323 179.741 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 715' ' ' GLN . . . . . . . . . . . . . 30.4 mm100 -62.02 -42.03 98.72 Favored 'General case' 0 N--CA 1.462 0.148 0 CA-C-N 115.904 -0.589 . . . . 0.0 111.568 179.525 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 716' ' ' GLN . . . . . . . . . . . . . 98.0 mm-40 -64.0 -41.92 97.33 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-O 120.691 0.281 . . . . 0.0 110.969 179.603 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 717' ' ' VAL . . . . . . . . . . . . . 74.7 t -64.0 -45.07 97.77 Favored 'Isoleucine or valine' 0 C--O 1.232 0.171 0 CA-C-O 121.007 0.432 . . . . 0.0 110.019 179.115 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 718' ' ' THR . . . . . . . . . . . . . 89.5 m -61.97 -45.44 93.65 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-N 115.685 -0.689 . . . . 0.0 111.005 179.573 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 719' ' ' MET . . . . . . . . . . . . . 38.5 mmt -62.84 -40.98 99.09 Favored 'General case' 0 N--CA 1.462 0.174 0 CA-C-N 116.502 -0.317 . . . . 0.0 110.641 179.385 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 720' ' ' GLY . . . . . . . . . . . . . . . -64.2 -42.13 98.07 Favored Glycine 0 CA--C 1.519 0.326 0 C-N-CA 120.828 -0.701 . . . . 0.0 112.509 178.758 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 721' ' ' LEU . . . . . . . . . . . . . 97.8 mt -67.7 -38.57 83.84 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-O 120.927 0.394 . . . . 0.0 111.933 179.95 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 722' ' ' THR . . . . . . . . . . . . . 60.3 p -89.39 2.17 54.81 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 112.905 0.706 . . . . 0.0 112.905 -178.659 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 723' ' ' SER . . . . . . . . . . . . . 91.1 p -65.12 -35.62 81.68 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.819 0.342 . . . . 0.0 110.953 179.502 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 724' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -70.24 -45.14 67.07 Favored 'General case' 0 CA--C 1.53 0.18 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.197 -179.973 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 725' ' ' ALA . . . . . . . . . . . . . . . -153.38 147.78 25.97 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.416 -0.356 . . . . 0.0 111.043 -179.865 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 726' ' ' THR . . . . . . . . . . . . . 15.3 t -151.04 159.33 44.6 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.341 179.974 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 727' ' ' SER . . . . . . . . . . . . . 40.7 t -148.85 144.82 27.17 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.562 0.22 . . . . 0.0 110.483 -179.809 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 728' ' ' ALA . . . . . . . . . . . . . . . -148.5 152.61 37.18 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.604 -179.895 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 729' ' ' GLN . . . . . . . . . . . . . 96.7 mt-30 . . . . . 0 C--O 1.25 1.098 0 CA-C-O 118.139 -0.934 . . . . 0.0 110.801 179.941 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 613' ' ' GLU . . . . . . . . . . . . . 39.9 mt-10 . . . . . 0 N--CA 1.487 1.387 0 CA-C-O 120.932 0.396 . . . . 0.0 110.73 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 614' ' ' GLY . . . . . . . . . . . . . . . -176.71 -178.19 46.27 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.819 -0.705 . . . . 0.0 112.509 -179.832 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 615' ' ' ARG . . . . . . . . . . . . . 78.4 mtp85 -114.99 131.81 56.8 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.779 0.323 . . . . 0.0 110.905 -179.737 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 616' ' ' ILE . . . . . 0.474 ' O ' ' HA ' ' A' ' 640' ' ' VAL . 83.8 mt -126.63 134.28 66.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.098 179.725 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 617' ' ' VAL . . . . . 0.644 HG12 HG12 ' A' ' 659' ' ' VAL . 0.5 OUTLIER -102.31 142.45 16.56 Favored 'Isoleucine or valine' 0 C--O 1.236 0.363 0 N-CA-C 109.656 -0.498 . . . . 0.0 109.656 -179.971 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 618' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -122.84 124.77 44.03 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.74 -178.91 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 619' ' ' VAL . . . . . . . . . . . . . 60.7 t -117.95 119.37 61.29 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 N-CA-C 109.321 -0.622 . . . . 0.0 109.321 179.825 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 620' ' ' SER . . . . . 0.647 ' HB2' ' HB3' ' A' ' 662' ' ' ALA . 32.4 t -166.31 140.09 4.17 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.942 -0.572 . . . . 0.0 111.505 -179.155 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 621' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -76.96 -28.23 55.1 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.446 -0.797 . . . . 0.0 111.034 178.884 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 622' ' ' ASP . . . . . . . . . . . . . 37.2 t70 -86.51 111.2 20.35 Favored 'General case' 0 CA--C 1.53 0.188 0 CA-C-O 121.102 0.477 . . . . 0.0 111.678 -178.646 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 623' ' ' GLU . . . . . . . . . . . . . 97.8 mt-10 -63.33 -39.15 93.75 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.342 -0.844 . . . . 0.0 112.647 -179.824 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 624' ' ' ALA . . . . . . . . . . . . . . . -60.53 -43.61 96.97 Favored 'General case' 0 N--CA 1.467 0.413 0 N-CA-C 112.662 0.615 . . . . 0.0 112.662 -178.068 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 625' ' ' THR . . . . . 0.437 ' O ' HG22 ' A' ' 629' ' ' ILE . 91.3 m -69.8 -40.24 76.08 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.113 0.483 . . . . 0.0 110.068 179.278 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 626' ' ' SER . . . . . . . . . . . . . 67.7 m -62.19 -41.53 98.44 Favored 'General case' 0 CA--C 1.531 0.236 0 CA-C-N 115.406 -0.815 . . . . 0.0 112.376 -178.774 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 627' ' ' THR . . . . . . . . . . . . . 48.8 p -68.14 -39.65 82.63 Favored 'General case' 0 N--CA 1.466 0.328 0 N-CA-C 112.427 0.529 . . . . 0.0 112.427 -179.587 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 628' ' ' LEU . . . . . . . . . . . . . 62.8 tp -65.09 -47.28 77.8 Favored 'General case' 0 N--CA 1.463 0.208 0 N-CA-C 111.983 0.364 . . . . 0.0 111.983 -179.384 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 629' ' ' ILE . . . . . 0.437 HG22 ' O ' ' A' ' 625' ' ' THR . 18.4 tt -71.93 -34.91 52.55 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.404 0 N-CA-C 112.402 0.519 . . . . 0.0 112.402 -179.119 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 630' ' ' CYS . . . . . . . . . . . . . 46.7 t -60.87 -43.01 98.98 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.143 -179.658 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 631' ' ' SER . . . . . . . . . . . . . 67.8 m -61.66 -41.29 97.32 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.047 -179.664 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 632' ' ' ILE . . . . . . . . . . . . . 97.2 mt -62.47 -48.17 89.52 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.249 0 CA-C-O 121.013 0.435 . . . . 0.0 110.725 179.638 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 633' ' ' LEU . . . . . . . . . . . . . 79.2 mt -66.48 -40.54 89.38 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.777 -0.647 . . . . 0.0 112.649 -179.699 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 634' ' ' THR . . . . . 0.499 ' HA ' ' O ' ' A' ' 638' ' ' TYR . 61.1 m -66.24 -40.36 90.17 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.628 0.251 . . . . 0.0 110.815 -179.276 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 635' ' ' THR . . . . . . . . . . . . . 92.4 m -59.29 -39.21 82.24 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.319 179.23 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 636' ' ' ALA . . . . . . . . . . . . . . . -65.06 -17.37 64.39 Favored 'General case' 0 CA--C 1.533 0.304 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.385 178.934 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 637' ' ' GLY . . . . . . . . . . . . . . . 108.9 7.05 29.71 Favored Glycine 0 C--N 1.333 0.411 0 C-N-CA 120.906 -0.664 . . . . 0.0 113.161 179.729 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 638' ' ' TYR . . . . . 0.499 ' O ' ' HA ' ' A' ' 634' ' ' THR . 96.3 m-85 -100.07 141.0 33.48 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.797 0.332 . . . . 0.0 111.265 -179.804 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 639' ' ' GLN . . . . . . . . . . . . . 98.3 mt-30 -88.88 133.59 34.23 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.086 179.378 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 640' ' ' VAL . . . . . 0.474 ' HA ' ' O ' ' A' ' 616' ' ' ILE . 60.6 t -119.99 131.52 72.16 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 N-CA-C 112.43 0.53 . . . . 0.0 112.43 -179.106 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 641' ' ' ILE . . . . . 0.564 ' HB ' HG23 ' A' ' 617' ' ' VAL . 1.2 mp -112.59 118.98 59.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 N-CA-C 108.45 -0.944 . . . . 0.0 108.45 178.073 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 642' ' ' TRP . . . . . . . . . . . . . 28.4 t90 -93.35 128.49 39.4 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 121.345 0.593 . . . . 0.0 112.392 -178.116 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 643' ' ' LEU . . . . . 0.589 HD11 ' HE ' ' A' ' 650' ' ' ARG . 1.0 OUTLIER -121.86 135.56 54.9 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-N 115.225 -0.898 . . . . 0.0 110.389 179.388 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 644' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -109.31 32.63 0.89 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 N-CA-C 111.778 0.288 . . . . 0.0 111.778 -179.826 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 645' ' ' ASP . . . . . . . . . . . . . 15.5 t0 -150.35 -25.87 0.24 Allowed 'General case' 0 N--CA 1.471 0.594 0 N-CA-C 113.626 0.973 . . . . 0.0 113.626 -178.421 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 646' ' ' GLY . . . . . . . . . . . . . . . 72.38 28.36 68.0 Favored Glycine 0 CA--C 1.522 0.482 0 C-N-CA 120.58 -0.819 . . . . 0.0 113.325 -179.273 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 647' ' ' GLU . . . . . . . . . . . . . 7.9 mm-40 -69.0 118.39 11.85 Favored 'General case' 0 C--O 1.232 0.144 0 CA-C-O 120.969 0.414 . . . . 0.0 110.788 179.732 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 648' ' ' VAL . . . . . . . . . . . . . 28.0 m -64.09 -30.34 49.78 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-N 115.508 -0.769 . . . . 0.0 112.163 -179.255 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 649' ' ' GLU . . . . . . . . . . . . . 98.1 mt-10 -64.14 -44.3 92.57 Favored 'General case' 0 C--N 1.333 -0.127 0 CA-C-O 121.014 0.435 . . . . 0.0 110.153 179.542 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 650' ' ' ARG . . . . . 0.589 ' HE ' HD11 ' A' ' 643' ' ' LEU . 78.7 mtp85 -72.01 -41.02 68.05 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.635 178.838 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 651' ' ' LEU . . . . . 0.556 HD22 HG11 ' A' ' 617' ' ' VAL . 95.4 mt -65.62 -40.48 92.62 Favored 'General case' 0 CA--C 1.523 -0.087 0 CA-C-N 115.952 -0.567 . . . . 0.0 111.049 179.952 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 652' ' ' LEU . . . . . . . . . . . . . 62.2 tp -64.46 -43.85 92.96 Favored 'General case' 0 CA--C 1.533 0.29 0 CA-C-N 116.396 -0.366 . . . . 0.0 111.311 179.209 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 653' ' ' ALA . . . . . . . . . . . . . . . -62.68 -39.83 95.21 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-O 121.11 0.481 . . . . 0.0 111.464 -179.868 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 654' ' ' LEU . . . . . . . . . . . . . 76.1 mt -102.03 30.84 4.22 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.67 -0.695 . . . . 0.0 109.965 179.809 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 655' ' ' THR . . . . . . . . . . . . . 5.5 t -42.12 110.99 0.87 Allowed Pre-proline 0 CA--C 1.537 0.458 0 CA-C-N 115.079 -0.964 . . . . 0.0 113.531 -178.132 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 656' ' ' PRO . . . . . 0.422 ' HG3' ' HB ' ' A' ' 617' ' ' VAL . 33.8 Cg_endo -91.01 -175.9 0.85 Allowed 'Trans proline' 0 C--N 1.346 0.435 0 C-N-CA 123.95 3.1 . . . . 0.0 112.343 178.956 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 657' ' ' ILE . . . . . . . . . . . . . 23.8 pt -82.82 -25.03 8.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 121.494 0.664 . . . . 0.0 109.991 177.912 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 658' ' ' ALA . . . . . 0.441 ' HB2' ' HB2' ' A' ' 687' ' ' LYS . . . -156.32 154.08 30.05 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 114.986 -1.006 . . . . 0.0 110.843 -179.706 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 659' ' ' VAL . . . . . 0.644 HG12 HG12 ' A' ' 617' ' ' VAL . 33.3 m -120.04 143.3 32.17 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-O 121.292 0.567 . . . . 0.0 110.982 179.378 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 660' ' ' LEU . . . . . . . . . . . . . 13.0 mt -115.16 114.91 25.9 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.418 -0.81 . . . . 0.0 109.666 178.727 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 661' ' ' LEU . . . . . . . . . . . . . 64.7 mt -106.49 112.57 25.62 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 109.125 -0.694 . . . . 0.0 109.125 -179.977 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 662' ' ' ALA . . . . . 0.647 ' HB3' ' HB2' ' A' ' 620' ' ' SER . . . -107.49 133.02 52.58 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 113.11 0.781 . . . . 0.0 113.11 -178.164 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 663' ' ' GLU . . . . . . . . . . . . . 97.8 mt-10 -80.23 146.45 62.51 Favored Pre-proline 0 C--N 1.326 -0.439 0 CA-C-N 115.276 -0.875 . . . . 0.0 110.087 178.365 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 664' ' ' PRO . . . . . . . . . . . . . 67.1 Cg_endo -72.93 139.57 62.04 Favored 'Cis proline' 0 C--N 1.349 0.553 0 C-N-CA 123.217 -1.576 . . . . 0.0 112.771 -0.893 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 665' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -87.63 144.08 26.86 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.747 -0.66 . . . . 0.0 111.409 179.306 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 666' ' ' SER . . . . . . . . . . . . . 77.9 p -98.48 -20.25 17.2 Favored 'General case' 0 CA--C 1.531 0.232 0 N-CA-C 112.035 0.383 . . . . 0.0 112.035 -179.99 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 667' ' ' TYR . . . . . . . . . . . . . 14.7 p90 -70.44 -17.18 62.99 Favored 'General case' 0 N--CA 1.466 0.373 0 N-CA-C 112.179 0.437 . . . . 0.0 112.179 179.548 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 668' ' ' GLY . . . . . . . . . . . . . . . 100.16 -109.16 3.65 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.518 -0.848 . . . . 0.0 113.734 179.119 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 669' ' ' ASP . . . . . . . . . . . . . 27.1 t70 -84.43 110.72 18.85 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.83 0.348 . . . . 0.0 111.278 -178.363 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 670' ' ' VAL . . . . . . . . . . . . . 14.5 p -64.21 -32.65 58.31 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.416 0 N-CA-C 112.983 0.734 . . . . 0.0 112.983 -179.3 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 671' ' ' GLN . . . . . . . . . . . . . 21.1 mp0 -61.93 -42.17 98.79 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-O 120.854 0.359 . . . . 0.0 110.758 -179.419 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 672' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 -65.8 -39.77 91.25 Favored 'General case' 0 N--CA 1.461 0.086 0 CA-C-N 116.048 -0.523 . . . . 0.0 111.043 179.159 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 673' ' ' LEU . . . . . . . . . . . . . 63.9 tp -62.49 -43.98 97.49 Favored 'General case' 0 C--N 1.333 -0.15 0 N-CA-C 109.639 -0.504 . . . . 0.0 109.639 179.149 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 674' ' ' VAL . . . . . 0.568 HG11 ' HA3' ' A' ' 699' ' ' GLY . 52.9 t -62.88 -44.57 99.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 115.419 -0.809 . . . . 0.0 109.606 178.825 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 675' ' ' ASP . . . . . . . . . . . . . 35.4 t70 -59.71 -40.61 88.53 Favored 'General case' 0 CA--C 1.522 -0.103 0 CA-C-N 115.745 -0.662 . . . . 0.0 110.773 179.314 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 676' ' ' GLN . . . . . . . . . . . . . 78.5 mt-30 -70.5 -41.29 72.85 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.903 0.382 . . . . 0.0 110.906 -179.866 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 677' ' ' LEU . . . . . . . . . . . . . 63.9 tp -68.16 -44.23 76.46 Favored 'General case' 0 N--CA 1.447 -0.578 0 CA-C-N 115.956 -0.566 . . . . 0.0 111.506 179.894 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 678' ' ' ARG . . . . . 0.582 ' HA ' ' O ' ' A' ' 681' ' ' CYS . 39.8 ptt180 -71.2 -24.8 62.29 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-O 120.983 0.421 . . . . 0.0 110.948 -179.208 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 679' ' ' GLN . . . . . . . . . . . . . 53.2 tt0 -65.92 -38.86 89.79 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.213 178.912 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 680' ' ' ARG . . . . . . . . . . . . . 31.7 mmt180 -89.37 -42.98 11.23 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.261 -179.781 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 681' ' ' CYS . . . . . 0.582 ' O ' ' HA ' ' A' ' 678' ' ' ARG . 77.3 m -122.87 133.26 54.43 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.275 179.787 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 682' ' ' THR . . . . . 0.424 ' HB ' ' HD2' ' A' ' 683' ' ' PRO . 61.3 p -68.33 158.53 84.37 Favored Pre-proline 0 C--N 1.323 -0.576 0 CA-C-N 116.407 -0.361 . . . . 0.0 110.391 -179.689 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 683' ' ' PRO . . . . . 0.424 ' HD2' ' HB ' ' A' ' 682' ' ' THR . 19.0 Cg_endo -58.89 -26.78 82.21 Favored 'Trans proline' 0 C--N 1.349 0.59 0 C-N-CA 122.226 1.951 . . . . 0.0 112.308 -179.952 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 684' ' ' GLU . . . . . . . . . . . . . 51.6 mp0 -71.61 -39.31 70.57 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 121.178 0.513 . . . . 0.0 109.94 178.36 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 685' ' ' GLN . . . . . . . . . . . . . 90.9 mt-30 -72.19 -40.36 67.95 Favored 'General case' 0 C--O 1.231 0.123 0 CA-C-N 115.414 -0.812 . . . . 0.0 112.032 179.471 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 686' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -126.22 114.19 17.99 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.209 -0.45 . . . . 0.0 112.006 -178.264 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 687' ' ' LYS . . . . . 0.441 ' HB2' ' HB2' ' A' ' 658' ' ' ALA . 75.7 mmtt -84.81 144.85 28.19 Favored 'General case' 0 C--N 1.331 -0.222 0 N-CA-C 109.488 -0.56 . . . . 0.0 109.488 178.125 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 688' ' ' ILE . . . . . . . . . . . . . 76.5 mt -123.35 121.74 63.54 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.757 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.501 -178.025 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 689' ' ' PHE . . . . . . . . . . . . . 98.9 m-85 -121.63 145.06 48.37 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.095 -0.957 . . . . 0.0 110.204 178.794 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 690' ' ' ILE . . . . . . . . . . . . . 19.1 tt -124.86 139.03 52.22 Favored 'Isoleucine or valine' 0 C--O 1.235 0.303 0 CA-C-O 121.055 0.455 . . . . 0.0 111.222 179.729 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 691' ' ' LEU . . . . . 0.597 HD12 ' HB2' ' A' ' 662' ' ' ALA . 48.2 mt -112.0 138.38 48.71 Favored 'General case' 0 C--O 1.235 0.301 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.806 -179.329 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 692' ' ' GLY . . . . . 0.626 ' O ' ' HA ' ' A' ' 705' ' ' PRO . . . 165.71 -176.95 41.1 Favored Glycine 0 N--CA 1.449 -0.471 0 CA-C-N 115.868 -0.605 . . . . 0.0 111.802 179.654 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 693' ' ' SER . . . . . . . . . . . . . 79.9 p -67.32 -37.43 83.31 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.196 0.522 . . . . 0.0 110.658 179.119 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 694' ' ' LYS . . . . . . . . . . . . . 64.2 tttm -133.06 127.88 35.02 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.686 -0.688 . . . . 0.0 109.198 178.756 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 695' ' ' GLY . . . . . 0.427 ' HA3' ' HB2' ' A' ' 703' ' ' TYR . . . -70.64 129.14 18.87 Favored Glycine 0 N--CA 1.447 -0.597 0 C-N-CA 120.419 -0.896 . . . . 0.0 112.866 -179.777 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 696' ' ' ASN . . . . . . . . . . . . . 67.1 t30 -91.8 91.61 8.01 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 109.637 -0.505 . . . . 0.0 109.637 179.122 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 697' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -71.03 53.84 0.17 Allowed 'General case' 0 CA--C 1.535 0.372 0 N-CA-C 113.034 0.753 . . . . 0.0 113.034 -178.652 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 698' ' ' GLN . . . . . . . . . . . . . 99.2 mm-40 -117.08 77.15 1.09 Allowed 'General case' 0 N--CA 1.453 -0.318 0 N-CA-C 109.887 -0.412 . . . . 0.0 109.887 178.795 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 699' ' ' GLY . . . . . 0.568 ' HA3' HG11 ' A' ' 674' ' ' VAL . . . 93.97 10.65 58.48 Favored Glycine 0 CA--C 1.52 0.403 0 C-N-CA 120.482 -0.866 . . . . 0.0 113.692 -179.971 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 700' ' ' VAL . . . . . . . . . . . . . 23.3 m -110.45 146.2 15.95 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.255 0 CA-C-N 117.595 0.698 . . . . 0.0 110.16 179.813 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 701' ' ' ASP . . . . . . . . . . . . . 32.0 t0 -72.85 -43.04 63.08 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.546 -0.752 . . . . 0.0 112.035 -179.047 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 702' ' ' ARG . . . . . . . . . . . . . 95.5 mtt-85 -146.91 162.32 38.94 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-O 120.813 0.339 . . . . 0.0 110.909 -178.663 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 703' ' ' TYR . . . . . 0.427 ' HB2' ' HA3' ' A' ' 695' ' ' GLY . 51.0 p90 -124.35 144.42 50.03 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.404 179.425 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 704' ' ' ILE . . . . . 0.55 ' HB ' HD23 ' A' ' 691' ' ' LEU . 39.8 mt -125.98 94.27 42.08 Favored Pre-proline 0 C--N 1.328 -0.36 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.046 -179.726 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 705' ' ' PRO . . . . . 0.626 ' HA ' ' O ' ' A' ' 692' ' ' GLY . 84.6 Cg_endo -74.92 151.24 39.71 Favored 'Trans proline' 0 C--N 1.346 0.42 0 C-N-CA 122.929 2.42 . . . . 0.0 114.069 -178.762 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 706' ' ' LEU . . . . . 0.785 HD23 HG13 ' A' ' 708' ' ' ILE . 79.4 mt -83.19 144.06 46.35 Favored Pre-proline 0 CA--C 1.532 0.269 0 CA-C-N 115.494 -0.775 . . . . 0.0 110.429 178.599 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 707' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -74.68 141.43 71.74 Favored 'Cis proline' 0 C--N 1.345 0.393 0 C-N-CA 123.052 -1.645 . . . . 0.0 112.191 -1.233 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 708' ' ' ILE . . . . . 0.785 HG13 HD23 ' A' ' 706' ' ' LEU . 74.1 mt -78.67 119.51 27.92 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-N 116.354 -0.384 . . . . 0.0 110.327 179.433 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 709' ' ' HIS . . . . . . . . . . . . . 70.1 m80 -85.77 122.11 73.08 Favored Pre-proline 0 C--N 1.327 -0.38 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.391 179.538 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 710' ' ' PRO . . . . . . . . . . . . . 27.4 Cg_endo -61.46 -30.73 87.29 Favored 'Trans proline' 0 C--N 1.349 0.596 0 C-N-CA 122.954 2.436 . . . . 0.0 113.913 -178.765 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 711' ' ' GLU . . . . . . . . . . . . . 88.7 tt0 -64.7 -43.5 93.29 Favored 'General case' 0 CA--C 1.531 0.231 0 N-CA-C 112.138 0.422 . . . . 0.0 112.138 -179.124 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 712' ' ' SER . . . . . . . . . . . . . 67.2 m -94.48 -18.44 21.48 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 111.979 0.363 . . . . 0.0 111.979 -178.763 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 713' ' ' PHE . . . . . 0.419 ' CZ ' HD11 ' A' ' 629' ' ' ILE . 75.4 t80 -60.51 -49.23 78.37 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.843 0.354 . . . . 0.0 110.692 179.768 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 714' ' ' LEU . . . . . . . . . . . . . 92.7 mt -63.81 -38.22 90.28 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.23 179.24 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 715' ' ' GLN . . . . . . . . . . . . . 97.3 mt-30 -62.05 -39.77 93.47 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.498 179.0 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 716' ' ' GLN . . . . . . . . . . . . . 86.5 mt-30 -63.4 -41.24 98.75 Favored 'General case' 0 C--O 1.233 0.22 0 N-CA-C 109.957 -0.386 . . . . 0.0 109.957 178.404 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 717' ' ' VAL . . . . . . . . . . . . . 74.7 t -65.01 -45.39 94.69 Favored 'Isoleucine or valine' 0 C--O 1.232 0.169 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.145 178.535 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 718' ' ' THR . . . . . . . . . . . . . 40.4 p -64.31 -36.4 83.99 Favored 'General case' 0 C--O 1.234 0.243 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.339 179.517 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 719' ' ' MET . . . . . . . . . . . . . 18.6 tpt -62.89 -46.89 85.69 Favored 'General case' 0 C--O 1.232 0.182 0 N-CA-C 109.872 -0.418 . . . . 0.0 109.872 178.575 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 720' ' ' GLY . . . . . . . . . . . . . . . -65.36 -40.72 96.62 Favored Glycine 0 C--N 1.331 0.301 0 C-N-CA 120.971 -0.633 . . . . 0.0 112.222 178.553 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 721' ' ' LEU . . . . . . . . . . . . . 60.5 tp -62.65 -43.98 97.43 Favored 'General case' 0 CA--C 1.53 0.193 0 N-CA-C 111.803 0.298 . . . . 0.0 111.803 -179.771 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 722' ' ' THR . . . . . . . . . . . . . 6.1 t -71.4 -16.23 62.39 Favored 'General case' 0 CA--C 1.532 0.257 0 CA-C-O 120.664 0.268 . . . . 0.0 111.427 -179.899 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 723' ' ' SER . . . . . . . . . . . . . 56.1 m -91.19 -10.15 42.74 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.739 0.304 . . . . 0.0 110.965 179.378 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 724' ' ' LEU . . . . . . . . . . . . . 2.9 tt -65.77 -42.63 90.58 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.012 -179.995 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 725' ' ' ALA . . . . . . . . . . . . . . . -150.73 149.98 30.47 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.635 179.951 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 726' ' ' THR . . . . . . . . . . . . . 66.5 p -128.25 157.61 40.43 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.385 -0.371 . . . . 0.0 110.825 179.99 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 727' ' ' SER . . . . . . . . . . . . . 59.9 m -128.01 149.02 50.55 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.544 -0.298 . . . . 0.0 110.802 -179.962 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 728' ' ' ALA . . . . . . . . . . . . . . . -147.4 153.52 39.73 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.594 179.969 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 729' ' ' GLN . . . . . . . . . . . . . 77.8 mt-30 . . . . . 0 C--O 1.25 1.097 0 CA-C-O 118.1 -0.952 . . . . 0.0 110.733 -179.998 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 613' ' ' GLU . . . . . . . . . . . . . 75.5 mm-40 . . . . . 0 N--CA 1.488 1.47 0 CA-C-O 121.052 0.453 . . . . 0.0 110.684 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 614' ' ' GLY . . . . . . . . . . . . . . . -82.24 72.67 2.76 Favored Glycine 0 N--CA 1.453 -0.23 0 C-N-CA 121.025 -0.607 . . . . 0.0 112.446 179.903 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 615' ' ' ARG . . . . . . . . . . . . . 92.1 mtm-85 -109.84 129.72 55.6 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.688 0.28 . . . . 0.0 110.726 -179.745 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 616' ' ' ILE . . . . . 0.424 ' O ' ' HA ' ' A' ' 640' ' ' VAL . 84.4 mt -124.14 132.75 70.87 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-N 116.243 -0.435 . . . . 0.0 109.904 178.74 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 617' ' ' VAL . . . . . . . . . . . . . 97.0 t -108.03 128.47 63.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 121.04 0.448 . . . . 0.0 110.46 -179.691 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 618' ' ' LEU . . . . . 0.468 HD11 HG21 ' A' ' 629' ' ' ILE . 1.5 tt -109.35 129.88 55.51 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.773 -0.648 . . . . 0.0 110.953 -179.005 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 619' ' ' VAL . . . . . . . . . . . . . 64.1 t -117.63 119.18 60.88 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 N-CA-C 109.397 -0.594 . . . . 0.0 109.397 179.328 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 620' ' ' SER . . . . . 0.607 ' HB2' ' HB3' ' A' ' 662' ' ' ALA . 30.6 t -169.41 147.59 3.67 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.827 -0.624 . . . . 0.0 111.452 -179.239 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 621' ' ' GLU . . . . . . . . . . . . . 98.0 mt-10 -87.09 -11.27 50.68 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.573 -0.74 . . . . 0.0 110.883 178.542 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 622' ' ' ASP . . . . . . . . . . . . . 44.7 t0 -99.21 107.84 20.27 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-O 120.982 0.42 . . . . 0.0 111.529 -179.01 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 623' ' ' GLU . . . . . . . . . . . . . 24.8 pt-20 -68.21 -30.23 69.26 Favored 'General case' 0 CA--C 1.534 0.353 0 CA-C-N 115.774 -0.648 . . . . 0.0 112.071 179.474 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 624' ' ' ALA . . . . . . . . . . . . . . . -62.91 -46.67 86.71 Favored 'General case' 0 N--CA 1.465 0.311 0 N-CA-C 112.67 0.619 . . . . 0.0 112.67 -178.983 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 625' ' ' THR . . . . . . . . . . . . . 94.3 m -70.31 -40.21 74.34 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-O 121.165 0.507 . . . . 0.0 110.473 179.916 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 626' ' ' SER . . . . . . . . . . . . . 70.8 m -61.82 -40.84 96.66 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.278 -0.874 . . . . 0.0 111.88 -178.985 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 627' ' ' THR . . . . . . . . . . . . . 92.9 m -61.59 -46.15 91.06 Favored 'General case' 0 CA--C 1.533 0.316 0 N-CA-C 112.01 0.374 . . . . 0.0 112.01 -179.774 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 628' ' ' LEU . . . . . . . . . . . . . 63.6 tp -62.55 -46.68 87.25 Favored 'General case' 0 CA--C 1.533 0.318 0 N-CA-C 112.682 0.623 . . . . 0.0 112.682 -178.953 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 629' ' ' ILE . . . . . 0.468 HG21 HD11 ' A' ' 618' ' ' LEU . 21.1 tt -68.98 -33.3 58.27 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.504 0 N-CA-C 113.027 0.751 . . . . 0.0 113.027 -178.58 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 630' ' ' CYS . . . . . . . . . . . . . 82.3 m -62.41 -39.93 94.87 Favored 'General case' 0 N--CA 1.466 0.348 0 N-CA-C 112.261 0.467 . . . . 0.0 112.261 -178.937 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 631' ' ' SER . . . . . . . . . . . . . 93.4 p -63.12 -39.51 94.89 Favored 'General case' 0 C--N 1.33 -0.26 0 C-N-CA 121.071 -0.252 . . . . 0.0 111.245 -179.492 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 632' ' ' ILE . . . . . . . . . . . . . 96.9 mt -65.06 -48.51 83.62 Favored 'Isoleucine or valine' 0 C--O 1.235 0.29 0 CA-C-O 121.015 0.436 . . . . 0.0 111.059 179.617 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 633' ' ' LEU . . . . . . . . . . . . . 83.1 mt -66.85 -40.11 87.81 Favored 'General case' 0 C--O 1.233 0.221 0 N-CA-C 112.726 0.639 . . . . 0.0 112.726 -179.374 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 634' ' ' THR . . . . . 0.499 ' HA ' ' O ' ' A' ' 638' ' ' TYR . 69.0 m -65.56 -40.12 92.44 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.663 0.268 . . . . 0.0 110.746 -179.604 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 635' ' ' THR . . . . . . . . . . . . . 93.7 m -59.23 -39.17 81.89 Favored 'General case' 0 N--CA 1.464 0.225 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.223 179.157 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 636' ' ' ALA . . . . . . . . . . . . . . . -64.7 -17.89 64.51 Favored 'General case' 0 CA--C 1.534 0.336 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.289 178.905 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 637' ' ' GLY . . . . . . . . . . . . . . . 108.94 6.23 30.29 Favored Glycine 0 C--N 1.333 0.372 0 C-N-CA 120.993 -0.622 . . . . 0.0 113.168 179.722 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 638' ' ' TYR . . . . . 0.499 ' O ' ' HA ' ' A' ' 634' ' ' THR . 96.5 m-85 -100.48 142.8 31.45 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.832 0.349 . . . . 0.0 111.469 -179.817 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 639' ' ' GLN . . . . . . . . . . . . . 78.5 mt-30 -91.61 134.83 34.34 Favored 'General case' 0 CA--C 1.517 -0.292 0 CA-C-N 116.227 -0.442 . . . . 0.0 109.965 179.237 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 640' ' ' VAL . . . . . 0.424 ' HA ' ' O ' ' A' ' 616' ' ' ILE . 58.3 t -117.92 130.4 72.85 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-O 121.065 0.46 . . . . 0.0 112.175 -179.333 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 641' ' ' ILE . . . . . . . . . . . . . 47.7 mm -111.99 119.43 60.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 N-CA-C 108.564 -0.902 . . . . 0.0 108.564 178.413 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 642' ' ' TRP . . . . . . . . . . . . . 61.9 t90 -97.6 127.4 43.53 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 112.509 0.559 . . . . 0.0 112.509 -178.49 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 643' ' ' LEU . . . . . . . . . . . . . 91.1 mt -120.74 137.12 54.66 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.406 -0.815 . . . . 0.0 109.999 178.6 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 644' ' ' VAL . . . . . . . . . . . . . 5.3 p -103.36 17.73 4.64 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.563 0 CA-C-O 121.228 0.537 . . . . 0.0 111.315 -179.52 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 645' ' ' ASP . . . . . . . . . . . . . 17.3 t0 -135.03 -39.84 0.76 Allowed 'General case' 0 N--CA 1.471 0.581 0 N-CA-C 112.707 0.632 . . . . 0.0 112.707 -178.087 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 646' ' ' GLY . . . . . . . . . . . . . . . 75.64 28.74 60.7 Favored Glycine 0 CA--C 1.523 0.553 0 N-CA-C 114.948 0.739 . . . . 0.0 114.948 179.441 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 647' ' ' GLU . . . . . . . . . . . . . 98.2 mt-10 -65.6 132.31 48.53 Favored 'General case' 0 N--CA 1.457 -0.081 0 CA-C-N 118.088 0.944 . . . . 0.0 110.875 179.495 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 648' ' ' VAL . . . . . . . . . . . . . 79.6 t -61.49 -39.99 84.84 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 CA-C-N 114.801 -1.09 . . . . 0.0 111.537 -179.408 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 649' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -61.03 -42.62 98.81 Favored 'General case' 0 C--N 1.331 -0.219 0 C-N-CA 120.701 -0.4 . . . . 0.0 110.307 179.906 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 650' ' ' ARG . . . . . . . . . . . . . 95.8 mtt-85 -70.24 -40.94 74.16 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-N 116.449 -0.341 . . . . 0.0 110.419 178.304 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 651' ' ' LEU . . . . . . . . . . . . . 81.8 mt -64.49 -41.4 96.47 Favored 'General case' 0 N--CA 1.463 0.176 0 CA-C-N 116.31 -0.404 . . . . 0.0 110.547 179.133 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 652' ' ' LEU . . . . . . . . . . . . . 61.8 tp -65.04 -44.31 89.5 Favored 'General case' 0 CA--C 1.531 0.238 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.11 178.853 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 653' ' ' ALA . . . . . . . . . . . . . . . -63.05 -40.21 97.02 Favored 'General case' 0 N--CA 1.466 0.354 0 CA-C-O 121.126 0.489 . . . . 0.0 111.58 -179.964 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 654' ' ' LEU . . . . . . . . . . . . . 75.1 mt -101.31 30.34 4.25 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.048 179.91 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 655' ' ' THR . . . . . . . . . . . . . 5.3 t -42.96 109.17 0.72 Allowed Pre-proline 0 CA--C 1.537 0.451 0 O-C-N 124.186 0.929 . . . . 0.0 113.444 -178.137 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 656' ' ' PRO . . . . . . . . . . . . . 26.3 Cg_endo -92.6 -176.07 0.64 Allowed 'Trans proline' 0 N--CA 1.461 -0.413 0 C-N-CA 123.963 3.109 . . . . 0.0 112.119 178.86 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 657' ' ' ILE . . . . . . . . . . . . . 24.9 pt -83.31 -24.6 8.04 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-O 121.324 0.583 . . . . 0.0 109.826 177.988 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 658' ' ' ALA . . . . . 0.445 ' HA ' ' O ' ' A' ' 687' ' ' LYS . . . -159.19 153.27 23.53 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.23 -0.895 . . . . 0.0 111.07 179.948 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 659' ' ' VAL . . . . . . . . . . . . . 27.8 m -123.27 147.67 27.48 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-O 121.281 0.562 . . . . 0.0 111.07 179.211 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 660' ' ' LEU . . . . . . . . . . . . . 17.8 mt -116.41 120.84 40.09 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.349 -0.841 . . . . 0.0 109.937 178.997 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 661' ' ' LEU . . . . . . . . . . . . . 73.1 mt -108.16 112.5 25.04 Favored 'General case' 0 C--N 1.327 -0.404 0 C-N-CA 120.644 -0.422 . . . . 0.0 109.956 179.969 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 662' ' ' ALA . . . . . 0.607 ' HB3' ' HB2' ' A' ' 620' ' ' SER . . . -107.09 113.78 27.44 Favored 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 120.985 -0.286 . . . . 0.0 111.378 -179.747 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 663' ' ' GLU . . . . . 0.573 ' HA ' ' C ' ' A' ' 664' ' ' PRO . 24.6 pt-20 -65.64 145.87 99.01 Favored Pre-proline 0 C--N 1.326 -0.451 0 CA-C-N 115.871 -0.604 . . . . 0.0 111.183 179.394 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 664' ' ' PRO . . . . . 0.573 ' C ' ' HA ' ' A' ' 663' ' ' GLU . 36.1 Cg_exo -61.47 137.95 22.17 Favored 'Cis proline' 0 C--N 1.355 0.892 0 C-N-CA 124.05 -1.229 . . . . 0.0 112.732 -1.017 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 665' ' ' PHE . . . . . 0.572 ' CZ ' HD11 ' A' ' 690' ' ' ILE . 33.7 m-85 -78.34 126.0 30.16 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.046 -0.525 . . . . 0.0 111.09 -179.15 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 666' ' ' SER . . . . . . . . . . . . . 67.8 m -63.95 -43.23 96.44 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.758 179.903 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 667' ' ' TYR . . . . . . . . . . . . . 62.1 t80 -69.63 -23.53 63.51 Favored 'General case' 0 CA--C 1.532 0.274 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.74 179.865 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 668' ' ' GLY . . . . . . . . . . . . . . . 100.38 -103.45 2.63 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.352 -0.928 . . . . 0.0 112.482 -179.166 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 669' ' ' ASP . . . . . . . . . . . . . 28.1 t70 -80.3 108.07 13.61 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-O 120.893 0.378 . . . . 0.0 110.281 -179.576 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 670' ' ' VAL . . . . . 0.428 ' O ' HG23 ' A' ' 674' ' ' VAL . 17.5 m -68.84 -27.31 35.28 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.225 0 N-CA-C 113.638 0.977 . . . . 0.0 113.638 -178.664 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 671' ' ' GLN . . . . . . . . . . . . . 24.1 mp0 -61.73 -42.26 98.72 Favored 'General case' 0 C--O 1.232 0.146 0 CA-C-N 117.995 0.361 . . . . 0.0 111.014 -179.392 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 672' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 -65.77 -39.83 91.4 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.393 178.448 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 673' ' ' LEU . . . . . . . . . . . . . 63.6 tp -63.62 -44.82 92.82 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 115.586 -0.734 . . . . 0.0 110.079 179.264 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 674' ' ' VAL . . . . . 0.567 HG11 ' HA3' ' A' ' 699' ' ' GLY . 56.0 t -63.1 -44.52 99.53 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.18 0 CA-C-N 115.606 -0.725 . . . . 0.0 109.917 179.376 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 675' ' ' ASP . . . . . 0.429 ' O ' ' HB2' ' A' ' 679' ' ' GLN . 36.4 t70 -59.53 -40.14 86.21 Favored 'General case' 0 CA--C 1.52 -0.176 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.699 179.346 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 676' ' ' GLN . . . . . . . . . . . . . 55.9 mt-30 -70.26 -40.0 74.63 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.884 0.373 . . . . 0.0 111.09 -179.753 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 677' ' ' LEU . . . . . . . . . . . . . 7.0 mp -70.0 -44.21 69.83 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.696 179.918 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 678' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -74.41 -19.74 60.31 Favored 'General case' 0 N--CA 1.469 0.478 0 N-CA-C 111.884 0.327 . . . . 0.0 111.884 -179.058 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 679' ' ' GLN . . . . . 0.429 ' HB2' ' O ' ' A' ' 675' ' ' ASP . 53.6 tt0 -64.61 -39.52 93.85 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.583 -179.659 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 680' ' ' ARG . . . . . 0.402 ' H ' ' HG2' ' A' ' 680' ' ' ARG . 0.0 OUTLIER -110.51 -20.26 12.63 Favored 'General case' 0 C--N 1.332 -0.174 0 N-CA-C 112.636 0.606 . . . . 0.0 112.636 -179.14 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 681' ' ' CYS . . . . . . . . . . . . . 76.7 m -119.52 132.42 55.76 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 120.877 0.37 . . . . 0.0 111.194 -179.985 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 682' ' ' THR . . . . . 0.456 ' HB ' ' HD2' ' A' ' 683' ' ' PRO . 57.3 p -74.9 159.95 81.82 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.168 179.421 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 683' ' ' PRO . . . . . 0.456 ' HD2' ' HB ' ' A' ' 682' ' ' THR . 17.9 Cg_endo -60.02 -28.55 87.32 Favored 'Trans proline' 0 C--N 1.35 0.652 0 C-N-CA 122.063 1.842 . . . . 0.0 112.312 179.527 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 684' ' ' GLU . . . . . 0.421 ' HG2' HD12 ' A' ' 724' ' ' LEU . 97.3 mt-10 -71.64 -39.33 70.44 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-O 121.047 0.451 . . . . 0.0 109.981 178.742 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 685' ' ' GLN . . . . . . . . . . . . . 65.4 tt0 -71.63 -42.46 67.58 Favored 'General case' 0 C--O 1.232 0.155 0 CA-C-N 115.386 -0.824 . . . . 0.0 111.756 179.745 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 686' ' ' LEU . . . . . . . . . . . . . 2.6 tt -137.74 121.93 18.04 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.114 -178.805 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 687' ' ' LYS . . . . . 0.445 ' O ' ' HA ' ' A' ' 658' ' ' ALA . 61.0 mttp -102.39 146.92 27.37 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.227 179.273 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 688' ' ' ILE . . . . . 0.583 HG22 HG12 ' A' ' 700' ' ' VAL . 76.9 mt -121.35 120.96 63.47 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.797 0 CA-C-O 121.317 0.579 . . . . 0.0 111.071 -178.416 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 689' ' ' PHE . . . . . . . . . . . . . 95.4 m-85 -121.16 146.82 46.37 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.081 -0.963 . . . . 0.0 109.653 178.8 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 690' ' ' ILE . . . . . 0.572 HD11 ' CZ ' ' A' ' 665' ' ' PHE . 19.8 tt -123.52 139.02 51.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-O 121.354 0.597 . . . . 0.0 112.096 -178.635 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 691' ' ' LEU . . . . . 0.629 HD23 ' HB ' ' A' ' 704' ' ' ILE . 73.2 mt -107.24 129.41 54.88 Favored 'General case' 0 C--O 1.235 0.33 0 CA-C-N 115.345 -0.843 . . . . 0.0 109.963 179.585 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 692' ' ' GLY . . . . . 0.655 ' O ' ' HA ' ' A' ' 705' ' ' PRO . . . 171.68 178.61 42.15 Favored Glycine 0 N--CA 1.444 -0.788 0 C-N-CA 120.341 -0.933 . . . . 0.0 113.156 179.832 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 693' ' ' SER . . . . . . . . . . . . . 80.2 p -69.49 -36.38 76.46 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 120.838 0.352 . . . . 0.0 111.216 179.628 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 694' ' ' LYS . . . . . . . . . . . . . 35.6 mmtp -119.54 137.36 53.88 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.114 0.483 . . . . 0.0 110.331 179.694 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 695' ' ' GLY . . . . . 0.488 ' HA3' ' CG ' ' A' ' 703' ' ' TYR . . . -102.35 16.46 55.21 Favored Glycine 0 N--CA 1.449 -0.483 0 CA-C-N 115.545 -0.752 . . . . 0.0 113.1 179.821 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 696' ' ' ASN . . . . . . . . . . . . . 64.4 t30 -81.33 68.39 7.63 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.092 0.472 . . . . 0.0 111.241 -179.315 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 697' ' ' TYR . . . . . . . . . . . . . 97.0 m-85 -131.03 142.03 50.27 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.889 -0.596 . . . . 0.0 109.942 179.107 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 698' ' ' GLN . . . . . . . . . . . . . 21.4 mp0 -90.98 149.43 21.86 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.923 -179.439 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 699' ' ' GLY . . . . . 0.567 ' HA3' HG11 ' A' ' 674' ' ' VAL . . . 92.88 4.12 65.41 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.704 -0.76 . . . . 0.0 113.995 179.167 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 700' ' ' VAL . . . . . 0.583 HG12 HG22 ' A' ' 688' ' ' ILE . 29.2 m -119.36 147.07 23.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 117.642 0.721 . . . . 0.0 110.662 179.42 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 701' ' ' ASP . . . . . . . . . . . . . 36.5 t70 -72.9 -43.63 62.22 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.442 -0.799 . . . . 0.0 111.996 -179.569 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 702' ' ' ARG . . . . . . . . . . . . . 69.0 mtp85 -146.73 163.63 35.34 Favored 'General case' 0 C--O 1.235 0.292 0 CA-C-O 120.795 0.331 . . . . 0.0 110.776 -179.056 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 703' ' ' TYR . . . . . 0.488 ' CG ' ' HA3' ' A' ' 695' ' ' GLY . 50.3 p90 -121.4 142.03 50.4 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.092 179.247 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 704' ' ' ILE . . . . . 0.629 ' HB ' HD23 ' A' ' 691' ' ' LEU . 58.9 mt -127.09 119.26 22.16 Favored Pre-proline 0 C--N 1.327 -0.402 0 CA-C-N 116.537 -0.301 . . . . 0.0 110.501 179.83 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 705' ' ' PRO . . . . . 0.655 ' HA ' ' O ' ' A' ' 692' ' ' GLY . 72.8 Cg_endo -72.56 156.42 53.92 Favored 'Trans proline' 0 C--N 1.345 0.357 0 C-N-CA 122.926 2.417 . . . . 0.0 113.775 -179.4 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 706' ' ' LEU . . . . . 0.687 HD23 HG23 ' A' ' 708' ' ' ILE . 87.8 mt -124.4 142.75 41.12 Favored Pre-proline 0 C--N 1.33 -0.253 0 CA-C-N 115.421 -0.809 . . . . 0.0 109.692 179.104 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 707' ' ' PRO . . . . . 0.539 ' C ' ' HA ' ' A' ' 706' ' ' LEU . 31.2 Cg_exo -62.85 137.92 25.87 Favored 'Cis proline' 0 C--N 1.349 0.584 0 C-N-CA 123.752 -1.353 . . . . 0.0 112.791 -1.303 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 708' ' ' ILE . . . . . 0.687 HG23 HD23 ' A' ' 706' ' ' LEU . 2.9 pt -63.93 147.6 12.18 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-O 121.577 0.703 . . . . 0.0 112.26 179.056 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 709' ' ' HIS . . . . . . . . . . . . . 97.6 m-70 -103.65 112.17 65.48 Favored Pre-proline 0 C--N 1.32 -0.685 0 N-CA-C 107.722 -1.214 . . . . 0.0 107.722 177.491 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 710' ' ' PRO . . . . . . . . . . . . . 21.4 Cg_endo -59.51 -30.31 92.17 Favored 'Trans proline' 0 N--CA 1.475 0.432 0 C-N-CA 122.782 2.321 . . . . 0.0 114.609 -176.956 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 711' ' ' GLU . . . . . . . . . . . . . 88.7 tt0 -65.28 -43.21 91.94 Favored 'General case' 0 CA--C 1.533 0.293 0 N-CA-C 112.141 0.423 . . . . 0.0 112.141 -179.164 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 712' ' ' SER . . . . . . . . . . . . . 67.4 m -99.05 -15.08 19.17 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 112.341 0.497 . . . . 0.0 112.341 -178.711 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 713' ' ' PHE . . . . . . . . . . . . . 90.0 t80 -59.32 -48.77 80.36 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.866 0.365 . . . . 0.0 110.469 -179.721 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 714' ' ' LEU . . . . . . . . . . . . . 90.6 mt -64.0 -37.86 88.98 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.223 178.986 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 715' ' ' GLN . . . . . . . . . . . . . 97.3 mt-30 -63.25 -43.07 99.05 Favored 'General case' 0 CA--C 1.531 0.214 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.893 179.536 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 716' ' ' GLN . . . . . . . . . . . . . 2.9 mp0 -65.95 -41.83 90.75 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 116.576 -0.284 . . . . 0.0 111.154 179.296 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 717' ' ' VAL . . . . . . . . . . . . . 66.3 t -62.36 -45.47 98.69 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.175 0 CA-C-O 120.68 0.276 . . . . 0.0 110.436 179.373 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 718' ' ' THR . . . . . . . . . . . . . 89.5 m -62.37 -45.64 92.27 Favored 'General case' 0 CA--C 1.531 0.228 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.202 179.65 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 719' ' ' MET . . . . . . . . . . . . . 1.4 mpp? -66.85 -40.56 87.93 Favored 'General case' 0 N--CA 1.464 0.262 0 C-N-CA 121.157 -0.217 . . . . 0.0 110.754 179.368 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 720' ' ' GLY . . . . . . . . . . . . . . . -63.86 -42.98 98.24 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.267 -0.968 . . . . 0.0 111.36 177.968 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 721' ' ' LEU . . . . . . . . . . . . . 63.3 tp -66.88 -48.15 69.65 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 122.501 0.32 . . . . 0.0 111.196 178.647 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 722' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER 37.29 37.95 0.11 Allowed 'General case' 0 N--CA 1.478 0.969 0 N-CA-C 114.175 1.176 . . . . 0.0 114.175 -179.894 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 723' ' ' SER . . . . . 0.558 ' HA ' ' O ' ' A' ' 726' ' ' THR . 58.2 m 57.37 27.26 13.56 Favored 'General case' 0 N--CA 1.47 0.541 0 N-CA-C 112.999 0.741 . . . . 0.0 112.999 179.428 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 724' ' ' LEU . . . . . 0.423 HD13 ' HA ' ' A' ' 724' ' ' LEU . 1.7 mm? -73.87 -39.16 64.14 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-O 120.78 0.324 . . . . 0.0 111.119 179.104 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 725' ' ' ALA . . . . . . . . . . . . . . . -103.72 -49.95 3.54 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.367 -0.378 . . . . 0.0 111.47 -179.868 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 726' ' ' THR . . . . . 0.558 ' O ' ' HA ' ' A' ' 723' ' ' SER . 72.2 p -129.13 158.48 38.86 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.997 -179.894 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 727' ' ' SER . . . . . . . . . . . . . 96.2 p -149.16 162.6 39.67 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.397 -179.974 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 728' ' ' ALA . . . . . . . . . . . . . . . -146.35 153.27 40.32 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.715 -179.94 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 729' ' ' GLN . . . . . . . . . . . . . 96.8 mt-30 . . . . . 0 C--O 1.25 1.108 0 CA-C-O 118.13 -0.938 . . . . 0.0 110.839 -179.987 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 613' ' ' GLU . . . . . . . . . . . . . 57.9 mt-10 . . . . . 0 N--CA 1.488 1.454 0 CA-C-O 121.107 0.48 . . . . 0.0 110.747 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 614' ' ' GLY . . . . . . . . . . . . . . . -86.69 69.91 3.02 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.911 -0.661 . . . . 0.0 112.545 -179.898 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 615' ' ' ARG . . . . . . . . . . . . . 33.7 mtp-105 -111.39 126.55 55.05 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.077 0.465 . . . . 0.0 111.102 -179.827 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 616' ' ' ILE . . . . . 0.453 ' O ' ' HA ' ' A' ' 640' ' ' VAL . 83.8 mt -124.89 133.85 68.4 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-N 115.568 -0.742 . . . . 0.0 110.113 179.577 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 617' ' ' VAL . . . . . 0.423 HG22 ' HB ' ' A' ' 641' ' ' ILE . 96.8 t -105.43 126.67 60.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 N-CA-C 109.5 -0.555 . . . . 0.0 109.5 179.615 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 618' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -108.54 126.74 53.26 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.856 -0.611 . . . . 0.0 111.1 -178.329 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 619' ' ' VAL . . . . . . . . . . . . . 61.0 t -112.9 117.07 54.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 N-CA-C 109.04 -0.726 . . . . 0.0 109.04 179.578 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 620' ' ' SER . . . . . 0.519 ' HB2' ' HB3' ' A' ' 662' ' ' ALA . 47.9 t -163.05 135.68 5.47 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.552 -179.14 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 621' ' ' GLU . . . . . . . . . . . . . 88.2 tt0 -77.69 -28.39 51.04 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.517 -0.765 . . . . 0.0 110.843 178.697 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 622' ' ' ASP . . . . . . . . . . . . . 56.1 t0 -85.18 110.64 19.15 Favored 'General case' 0 C--O 1.235 0.342 0 CA-C-O 121.01 0.433 . . . . 0.0 111.205 -178.593 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 623' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -63.59 -39.47 94.47 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 115.444 -0.798 . . . . 0.0 112.344 179.954 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 624' ' ' ALA . . . . . . . . . . . . . . . -61.56 -44.16 97.54 Favored 'General case' 0 N--CA 1.465 0.301 0 N-CA-C 112.088 0.403 . . . . 0.0 112.088 -178.869 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 625' ' ' THR . . . . . . . . . . . . . 86.5 m -69.3 -40.66 77.57 Favored 'General case' 0 N--CA 1.454 -0.265 0 CA-C-O 121.137 0.494 . . . . 0.0 110.126 179.852 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 626' ' ' SER . . . . . . . . . . . . . 69.3 m -61.92 -41.65 98.19 Favored 'General case' 0 N--CA 1.453 -0.278 0 CA-C-N 115.412 -0.813 . . . . 0.0 111.497 -179.307 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 627' ' ' THR . . . . . . . . . . . . . 92.0 m -61.81 -46.32 90.04 Favored 'General case' 0 CA--C 1.533 0.305 0 N-CA-C 112.241 0.46 . . . . 0.0 112.241 -179.292 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 628' ' ' LEU . . . . . . . . . . . . . 62.7 tp -63.77 -47.15 82.14 Favored 'General case' 0 CA--C 1.533 0.316 0 N-CA-C 112.693 0.627 . . . . 0.0 112.693 -178.826 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 629' ' ' ILE . . . . . . . . . . . . . 17.3 tt -70.49 -36.78 67.66 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.409 0 N-CA-C 112.914 0.709 . . . . 0.0 112.914 -178.579 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 630' ' ' CYS . . . . . . . . . . . . . 85.3 m -62.9 -39.57 94.92 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-O 120.572 0.225 . . . . 0.0 110.935 -179.877 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 631' ' ' SER . . . . . . . . . . . . . 68.4 m -62.23 -41.32 98.29 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.796 179.982 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 632' ' ' ILE . . . . . 0.536 ' O ' HG22 ' A' ' 635' ' ' THR . 96.9 mt -63.12 -47.36 92.88 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.296 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.739 179.677 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 633' ' ' LEU . . . . . . . . . . . . . 80.7 mt -67.64 -40.29 84.61 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 112.425 0.528 . . . . 0.0 112.425 179.997 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 634' ' ' THR . . . . . 0.56 ' HA ' ' O ' ' A' ' 638' ' ' TYR . 90.9 m -66.06 -42.67 89.13 Favored 'General case' 0 CA--C 1.531 0.232 0 N-CA-C 111.533 0.197 . . . . 0.0 111.533 -179.051 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 635' ' ' THR . . . . . 0.536 HG22 ' O ' ' A' ' 632' ' ' ILE . 2.1 t -62.9 -17.64 61.94 Favored 'General case' 0 CA--C 1.534 0.345 0 CA-C-O 120.699 0.285 . . . . 0.0 111.32 179.651 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 636' ' ' ALA . . . . . . . . . . . . . . . -85.75 -1.84 57.61 Favored 'General case' 0 CA--C 1.53 0.211 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.825 178.852 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 637' ' ' GLY . . . . . . . . . . . . . . . 95.33 6.03 60.18 Favored Glycine 0 C--N 1.334 0.433 0 C-N-CA 120.998 -0.62 . . . . 0.0 113.152 179.873 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 638' ' ' TYR . . . . . 0.56 ' O ' ' HA ' ' A' ' 634' ' ' THR . 90.8 m-85 -100.24 142.86 31.14 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.888 0.375 . . . . 0.0 111.408 -179.839 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 639' ' ' GLN . . . . . . . . . . . . . 97.9 mt-30 -92.94 133.36 36.19 Favored 'General case' 0 CA--C 1.517 -0.31 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.082 179.241 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 640' ' ' VAL . . . . . 0.453 ' HA ' ' O ' ' A' ' 616' ' ' ILE . 57.9 t -118.08 130.56 72.77 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-O 121.122 0.487 . . . . 0.0 112.029 -179.232 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 641' ' ' ILE . . . . . 0.423 ' HB ' HG22 ' A' ' 617' ' ' VAL . 38.3 mm -107.7 116.91 52.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 N-CA-C 108.483 -0.932 . . . . 0.0 108.483 178.599 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 642' ' ' TRP . . . . . . . . . . . . . 27.4 t90 -87.17 127.13 35.15 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 112.309 0.485 . . . . 0.0 112.309 -178.623 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 643' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -122.16 128.72 51.57 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.642 -0.708 . . . . 0.0 110.2 178.97 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 644' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -107.6 39.96 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.671 -0.24 . . . . 0.0 111.526 -179.725 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 645' ' ' ASP . . . . . . . . . . . . . 36.0 t70 -154.59 -35.9 0.1 Allowed 'General case' 0 N--CA 1.469 0.486 0 N-CA-C 112.426 0.528 . . . . 0.0 112.426 -178.879 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 646' ' ' GLY . . . . . . . . . . . . . . . 77.66 20.55 73.85 Favored Glycine 0 N--CA 1.453 -0.219 0 C-N-CA 120.67 -0.776 . . . . 0.0 112.913 -179.59 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 647' ' ' GLU . . . . . . . . . . . . . 37.2 tt0 -61.45 121.15 11.96 Favored 'General case' 0 N--CA 1.456 -0.149 0 CA-C-O 120.941 0.401 . . . . 0.0 110.305 -179.764 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 648' ' ' VAL . . . . . . . . . . . . . 13.4 p -63.14 -34.14 65.03 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-N 115.493 -0.776 . . . . 0.0 112.132 -178.954 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 649' ' ' GLU . . . . . . . . . . . . . 49.0 mp0 -63.9 -42.99 97.29 Favored 'General case' 0 C--O 1.231 0.104 0 CA-C-O 121.005 0.431 . . . . 0.0 109.921 178.914 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 650' ' ' ARG . . . . . . . . . . . . . 24.9 tpp180 -67.95 -43.36 79.25 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.0 178.321 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 651' ' ' LEU . . . . . . . . . . . . . 89.6 mt -63.43 -41.42 98.68 Favored 'General case' 0 N--CA 1.462 0.144 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.361 179.206 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 652' ' ' LEU . . . . . . . . . . . . . 61.1 tp -65.41 -43.19 91.34 Favored 'General case' 0 CA--C 1.531 0.243 0 CA-C-N 116.022 -0.535 . . . . 0.0 111.083 178.611 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 653' ' ' ALA . . . . . . . . . . . . . . . -62.8 -39.72 95.15 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-O 120.931 0.396 . . . . 0.0 111.935 179.96 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 654' ' ' LEU . . . . . . . . . . . . . 78.4 mt -101.16 29.21 4.81 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.843 -179.627 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 655' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -32.16 104.76 0.23 Allowed Pre-proline 0 N--CA 1.471 0.606 0 N-CA-C 114.483 1.29 . . . . 0.0 114.483 -178.881 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 656' ' ' PRO . . . . . . . . . . . . . 25.4 Cg_endo -92.65 -177.63 0.8 Allowed 'Trans proline' 0 C--N 1.346 0.403 0 C-N-CA 123.673 2.915 . . . . 0.0 111.636 177.509 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 657' ' ' ILE . . . . . 0.68 ' HB ' HD21 ' A' ' 724' ' ' LEU . 23.0 pt -81.54 -26.11 10.02 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-O 121.394 0.616 . . . . 0.0 109.757 177.83 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 658' ' ' ALA . . . . . 0.467 ' HA ' ' O ' ' A' ' 687' ' ' LYS . . . -158.93 154.44 25.93 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.109 -0.95 . . . . 0.0 111.152 -179.759 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 659' ' ' VAL . . . . . . . . . . . . . 28.6 m -124.04 147.63 28.43 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-O 121.048 0.451 . . . . 0.0 110.995 179.174 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 660' ' ' LEU . . . . . 0.406 HD22 HD21 ' A' ' 691' ' ' LEU . 17.5 mt -115.63 117.77 31.24 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.66 -0.7 . . . . 0.0 109.555 178.656 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 661' ' ' LEU . . . . . . . . . . . . . 17.5 mt -104.96 113.05 26.41 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 109.336 -0.616 . . . . 0.0 109.336 -179.536 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 662' ' ' ALA . . . . . 0.519 ' HB3' ' HB2' ' A' ' 620' ' ' SER . . . -102.27 128.81 48.64 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 112.591 0.589 . . . . 0.0 112.591 -179.064 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 663' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -71.48 143.5 87.78 Favored Pre-proline 0 CA--C 1.533 0.296 0 CA-C-N 115.359 -0.837 . . . . 0.0 110.749 178.315 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 664' ' ' PRO . . . . . . . . . . . . . 65.8 Cg_endo -72.95 142.53 74.99 Favored 'Cis proline' 0 C--N 1.348 0.516 0 C-N-CA 123.081 -1.633 . . . . 0.0 112.315 -0.931 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 665' ' ' PHE . . . . . . . . . . . . . 60.0 m-85 -69.91 118.13 12.37 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.524 179.98 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 666' ' ' SER . . . . . . . . . . . . . 78.7 p -65.26 -35.38 80.86 Favored 'General case' 0 CA--C 1.53 0.208 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.226 179.59 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 667' ' ' TYR . . . . . 0.439 ' CD2' ' HB2' ' A' ' 673' ' ' LEU . 75.0 t80 -65.33 -22.49 66.83 Favored 'General case' 0 CA--C 1.534 0.35 0 CA-C-N 115.982 -0.554 . . . . 0.0 111.491 178.83 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 668' ' ' GLY . . . . . . . . . . . . . . . 101.45 -103.24 2.51 Favored Glycine 0 N--CA 1.45 -0.412 0 C-N-CA 120.501 -0.857 . . . . 0.0 112.117 -178.83 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 669' ' ' ASP . . . . . . . . . . . . . 37.7 t70 -80.47 106.25 12.33 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 121.075 0.464 . . . . 0.0 110.427 -179.82 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 670' ' ' VAL . . . . . . . . . . . . . 13.5 p -63.04 -32.7 57.15 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.403 0 N-CA-C 113.122 0.786 . . . . 0.0 113.122 -179.002 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 671' ' ' GLN . . . . . . . . . . . . . 30.9 mm100 -62.79 -40.84 98.58 Favored 'General case' 0 N--CA 1.463 0.183 0 CA-C-O 120.664 0.268 . . . . 0.0 111.267 -178.844 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 672' ' ' GLU . . . . . . . . . . . . . 88.8 tt0 -63.58 -43.23 97.59 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.567 179.296 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 673' ' ' LEU . . . . . 0.439 ' HB2' ' CD2' ' A' ' 667' ' ' TYR . 62.4 tp -63.44 -44.63 93.99 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.462 179.873 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 674' ' ' VAL . . . . . 0.472 HG11 ' HA3' ' A' ' 699' ' ' GLY . 60.4 t -63.11 -44.89 99.72 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.177 0 CA-C-N 115.866 -0.606 . . . . 0.0 109.813 179.398 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 675' ' ' ASP . . . . . . . . . . . . . 35.4 t70 -60.14 -40.18 88.9 Favored 'General case' 0 CA--C 1.52 -0.195 0 CA-C-N 115.804 -0.635 . . . . 0.0 110.581 178.994 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 676' ' ' GLN . . . . . . . . . . . . . 96.8 mt-30 -70.07 -41.13 74.54 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.426 -0.352 . . . . 0.0 111.053 -179.742 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 677' ' ' LEU . . . . . . . . . . . . . 84.2 mt -68.16 -41.61 81.29 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.798 179.93 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 678' ' ' ARG . . . . . 0.426 ' HA ' ' O ' ' A' ' 681' ' ' CYS . 39.9 ptt180 -73.61 -26.59 60.87 Favored 'General case' 0 N--CA 1.469 0.494 0 CA-C-O 121.003 0.43 . . . . 0.0 110.98 -179.121 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 679' ' ' GLN . . . . . . . . . . . . . 53.3 tt0 -65.96 -39.25 90.27 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.328 179.157 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 680' ' ' ARG . . . . . . . . . . . . . 29.4 mmm180 -87.42 -42.67 12.65 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.944 -0.571 . . . . 0.0 111.685 -179.537 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 681' ' ' CYS . . . . . 0.426 ' O ' ' HA ' ' A' ' 678' ' ' ARG . 76.0 m -125.24 134.98 52.12 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 121.154 0.502 . . . . 0.0 111.429 -179.391 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 682' ' ' THR . . . . . . . . . . . . . 63.0 p -71.81 161.88 76.31 Favored Pre-proline 0 C--N 1.324 -0.514 0 CA-C-N 115.659 -0.7 . . . . 0.0 110.362 179.199 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 683' ' ' PRO . . . . . . . . . . . . . 79.3 Cg_exo -53.25 -34.29 69.12 Favored 'Trans proline' 0 C--N 1.351 0.71 0 C-N-CA 122.8 2.334 . . . . 0.0 112.943 -179.959 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 684' ' ' GLU . . . . . . . . . . . . . 51.2 mp0 -69.64 -38.91 77.34 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.99 0.424 . . . . 0.0 110.432 179.563 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 685' ' ' GLN . . . . . . . . . . . . . 91.2 mt-30 -71.7 -39.96 69.84 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.724 -0.671 . . . . 0.0 111.904 179.398 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 686' ' ' LEU . . . . . . . . . . . . . 3.3 tt -142.2 120.64 12.41 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.347 -178.7 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 687' ' ' LYS . . . . . 0.467 ' O ' ' HA ' ' A' ' 658' ' ' ALA . 68.7 mttm -94.32 146.35 24.1 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.319 0.581 . . . . 0.0 110.615 178.609 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 688' ' ' ILE . . . . . 0.4 HG22 HG12 ' A' ' 700' ' ' VAL . 80.4 mt -122.6 123.08 67.63 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.784 0 CA-C-N 115.563 -0.744 . . . . 0.0 111.16 -178.521 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 689' ' ' PHE . . . . . 0.467 ' CD2' ' HB2' ' A' ' 702' ' ' ARG . 61.3 m-85 -123.51 145.55 48.77 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.232 -0.895 . . . . 0.0 110.007 179.067 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 690' ' ' ILE . . . . . . . . . . . . . 96.6 mt -121.65 135.24 62.44 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.466 0 CA-C-O 121.313 0.578 . . . . 0.0 112.441 -179.15 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 691' ' ' LEU . . . . . 0.672 HD23 ' HB ' ' A' ' 704' ' ' ILE . 35.2 mt -106.68 128.16 53.96 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-N 115.052 -0.976 . . . . 0.0 109.491 179.629 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 692' ' ' GLY . . . . . 0.743 ' O ' ' HA ' ' A' ' 705' ' ' PRO . . . 165.48 -174.41 41.26 Favored Glycine 0 N--CA 1.447 -0.601 0 C-N-CA 120.335 -0.936 . . . . 0.0 112.204 179.899 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 693' ' ' SER . . . . . . . . . . . . . 80.1 p -67.56 -37.6 82.91 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 120.807 0.336 . . . . 0.0 111.446 179.837 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 694' ' ' LYS . . . . . . . . . . . . . 35.5 mmtp -124.69 133.99 53.01 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.217 0.532 . . . . 0.0 110.85 179.657 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 695' ' ' GLY . . . . . 0.534 ' HA3' ' CB ' ' A' ' 703' ' ' TYR . . . -111.68 19.32 23.83 Favored Glycine 0 N--CA 1.449 -0.482 0 CA-C-N 115.345 -0.843 . . . . 0.0 112.5 179.575 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 696' ' ' ASN . . . . . . . . . . . . . 65.1 t30 -81.93 73.33 8.97 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.023 0.44 . . . . 0.0 111.395 -179.081 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 697' ' ' TYR . . . . . . . . . . . . . 98.9 m-85 -130.51 145.03 51.78 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.928 -0.578 . . . . 0.0 109.707 179.116 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 698' ' ' GLN . . . . . . . . . . . . . 98.2 mt-30 -84.3 145.62 28.18 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.959 -179.91 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 699' ' ' GLY . . . . . 0.472 ' HA3' HG11 ' A' ' 674' ' ' VAL . . . 94.58 5.73 61.41 Favored Glycine 0 CA--C 1.519 0.294 0 C-N-CA 120.552 -0.832 . . . . 0.0 113.776 179.481 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 700' ' ' VAL . . . . . 0.4 HG12 HG22 ' A' ' 688' ' ' ILE . 21.4 m -119.46 152.61 21.98 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.271 0 CA-C-N 117.394 0.597 . . . . 0.0 109.947 179.268 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 701' ' ' ASP . . . . . . . . . . . . . 67.8 m-20 -88.93 -39.74 13.55 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 116.006 -0.543 . . . . 0.0 112.259 -178.926 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 702' ' ' ARG . . . . . 0.467 ' HB2' ' CD2' ' A' ' 689' ' ' PHE . 91.3 mmt-85 -144.69 161.74 38.45 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-O 120.805 0.336 . . . . 0.0 110.594 -178.611 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 703' ' ' TYR . . . . . 0.534 ' CB ' ' HA3' ' A' ' 695' ' ' GLY . 53.1 p90 -133.03 147.96 52.23 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.021 -0.536 . . . . 0.0 109.617 178.596 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 704' ' ' ILE . . . . . 0.672 ' HB ' HD23 ' A' ' 691' ' ' LEU . 58.8 mt -126.05 101.13 29.31 Favored Pre-proline 0 C--N 1.324 -0.528 0 CA-C-O 120.81 0.338 . . . . 0.0 110.846 -179.651 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 705' ' ' PRO . . . . . 0.743 ' HA ' ' O ' ' A' ' 692' ' ' GLY . 73.5 Cg_endo -73.52 152.58 48.89 Favored 'Trans proline' 0 C--N 1.347 0.454 0 C-N-CA 122.927 2.418 . . . . 0.0 113.34 -179.727 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 706' ' ' LEU . . . . . 0.57 ' HA ' ' C ' ' A' ' 707' ' ' PRO . 0.7 OUTLIER -105.21 151.86 39.67 Favored Pre-proline 0 CA--C 1.534 0.355 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.835 179.017 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 707' ' ' PRO . . . . . 0.57 ' C ' ' HA ' ' A' ' 706' ' ' LEU . 37.9 Cg_endo -65.68 136.84 29.78 Favored 'Cis proline' 0 C--N 1.35 0.63 0 C-N-CA 123.026 -1.656 . . . . 0.0 112.316 0.122 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 708' ' ' ILE . . . . . 0.454 HG12 HG22 ' A' ' 704' ' ' ILE . 69.1 mt -80.7 120.33 32.07 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-N 115.606 -0.724 . . . . 0.0 110.785 -179.398 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 709' ' ' HIS . . . . . . . . . . . . . 70.1 m80 -84.85 124.04 73.2 Favored Pre-proline 0 C--N 1.327 -0.386 0 CA-C-N 116.037 -0.528 . . . . 0.0 110.148 179.174 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 710' ' ' PRO . . . . . . . . . . . . . 24.0 Cg_endo -60.74 -31.56 92.05 Favored 'Trans proline' 0 C--N 1.348 0.545 0 C-N-CA 123.043 2.495 . . . . 0.0 114.014 -178.771 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 711' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -66.43 -40.1 89.31 Favored 'General case' 0 C--N 1.331 -0.233 0 N-CA-C 112.143 0.423 . . . . 0.0 112.143 -179.343 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 712' ' ' SER . . . . . . . . . . . . . 51.0 m -95.76 -15.96 22.24 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.513 -0.312 . . . . 0.0 111.733 -178.854 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 713' ' ' PHE . . . . . . . . . . . . . 85.1 t80 -60.38 -49.74 76.4 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 120.874 0.369 . . . . 0.0 110.732 -179.994 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 714' ' ' LEU . . . . . . . . . . . . . 91.2 mt -64.39 -37.83 88.9 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.372 179.555 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 715' ' ' GLN . . . . . . . . . . . . . 99.3 mm-40 -63.68 -42.16 98.05 Favored 'General case' 0 CA--C 1.53 0.187 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.672 179.317 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 716' ' ' GLN . . . . . . . . . . . . . 30.6 mm100 -65.8 -40.39 91.85 Favored 'General case' 0 C--O 1.234 0.259 0 CA-C-N 116.431 -0.35 . . . . 0.0 110.652 179.19 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 717' ' ' VAL . . . . . . . . . . . . . 65.7 t -62.9 -44.14 99.41 Favored 'Isoleucine or valine' 0 C--O 1.232 0.152 0 N-CA-C 109.831 -0.433 . . . . 0.0 109.831 178.934 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 718' ' ' THR . . . . . . . . . . . . . 90.7 m -61.73 -45.19 94.99 Favored 'General case' 0 CA--C 1.531 0.216 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.677 179.255 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 719' ' ' MET . . . . . . . . . . . . . 39.0 mmt -63.84 -41.09 97.9 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-N 116.727 -0.215 . . . . 0.0 110.482 178.839 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 720' ' ' GLY . . . . . . . . . . . . . . . -64.5 -42.76 97.36 Favored Glycine 0 N--CA 1.452 -0.26 0 C-N-CA 120.342 -0.932 . . . . 0.0 111.248 177.941 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 721' ' ' LEU . . . . . 0.698 HD12 ' HB3' ' A' ' 724' ' ' LEU . 64.4 tp -64.75 -48.88 72.94 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 122.935 0.494 . . . . 0.0 111.163 179.002 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 722' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 33.69 -96.76 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.783 0 N-CA-C 115.132 1.531 . . . . 0.0 115.132 -179.784 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 723' ' ' SER . . . . . . . . . . . . . 57.4 m -93.39 -2.72 54.38 Favored 'General case' 0 N--CA 1.467 0.42 0 N-CA-C 114.12 1.156 . . . . 0.0 114.12 -176.942 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 724' ' ' LEU . . . . . 0.698 ' HB3' HD12 ' A' ' 721' ' ' LEU . 64.9 tp -62.35 -45.74 91.83 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-O 120.891 0.376 . . . . 0.0 111.194 179.771 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 725' ' ' ALA . . . . . . . . . . . . . . . -152.46 153.19 33.04 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.678 -179.888 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 726' ' ' THR . . . . . . . . . . . . . 67.0 p -127.52 159.27 35.08 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.823 179.921 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 727' ' ' SER . . . . . . . . . . . . . 90.1 p -72.55 159.39 33.99 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.081 179.838 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 728' ' ' ALA . . . . . . . . . . . . . . . -147.88 153.82 39.61 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.645 -179.908 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 729' ' ' GLN . . . . . . . . . . . . . 96.7 mt-30 . . . . . 0 C--O 1.248 1.025 0 CA-C-O 118.29 -0.862 . . . . 0.0 110.781 -179.999 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 613' ' ' GLU . . . . . . . . . . . . . 93.6 mt-10 . . . . . 0 N--CA 1.488 1.427 0 CA-C-O 121.051 0.453 . . . . 0.0 110.465 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 614' ' ' GLY . . . . . . . . . . . . . . . -175.71 169.22 41.89 Favored Glycine 0 N--CA 1.449 -0.446 0 CA-C-N 115.808 -0.633 . . . . 0.0 111.991 179.768 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 615' ' ' ARG . . . . . . . . . . . . . 83.9 mtp180 -117.29 132.63 56.57 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.011 0.434 . . . . 0.0 111.066 -179.971 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 616' ' ' ILE . . . . . . . . . . . . . 87.0 mt -125.18 134.31 67.19 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 115.537 -0.756 . . . . 0.0 109.995 179.361 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 617' ' ' VAL . . . . . . . . . . . . . 95.3 t -105.91 126.26 61.35 Favored 'Isoleucine or valine' 0 C--O 1.235 0.305 0 CA-C-O 121.043 0.449 . . . . 0.0 109.832 179.878 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 618' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -109.2 126.01 52.82 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.773 -0.648 . . . . 0.0 110.624 -178.536 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 619' ' ' VAL . . . . . . . . . . . . . 62.4 t -117.95 119.59 61.97 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 N-CA-C 109.492 -0.559 . . . . 0.0 109.492 179.704 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 620' ' ' SER . . . . . 0.521 ' HB2' ' HB3' ' A' ' 662' ' ' ALA . 26.9 t -166.27 139.72 4.11 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.399 -179.351 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 621' ' ' GLU . . . . . . . . . . . . . 88.2 tt0 -77.11 -28.24 54.35 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.579 -0.737 . . . . 0.0 111.125 178.977 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 622' ' ' ASP . . . . . . . . . . . . . 56.8 t0 -83.43 110.14 17.92 Favored 'General case' 0 C--O 1.234 0.287 0 CA-C-O 120.946 0.403 . . . . 0.0 111.135 -178.473 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 623' ' ' GLU . . . . . . . . . . . . . 51.3 mp0 -63.62 -39.71 95.05 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-N 115.606 -0.725 . . . . 0.0 112.206 -179.776 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 624' ' ' ALA . . . . . . . . . . . . . . . -61.27 -43.95 98.03 Favored 'General case' 0 N--CA 1.463 0.179 0 N-CA-C 112.03 0.382 . . . . 0.0 112.03 -178.668 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 625' ' ' THR . . . . . 0.439 ' O ' HG22 ' A' ' 629' ' ' ILE . 85.4 m -70.26 -41.14 73.87 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.86 0.362 . . . . 0.0 110.291 179.542 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 626' ' ' SER . . . . . . . . . . . . . 66.7 m -62.46 -41.92 99.1 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.628 -0.714 . . . . 0.0 112.342 -178.564 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 627' ' ' THR . . . . . . . . . . . . . 40.1 p -68.56 -40.49 80.6 Favored 'General case' 0 N--CA 1.464 0.248 0 N-CA-C 112.614 0.598 . . . . 0.0 112.614 -179.729 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 628' ' ' LEU . . . . . . . . . . . . . 63.0 tp -64.41 -47.07 80.56 Favored 'General case' 0 N--CA 1.464 0.227 0 N-CA-C 111.952 0.353 . . . . 0.0 111.952 -179.509 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 629' ' ' ILE . . . . . 0.439 HG22 ' O ' ' A' ' 625' ' ' THR . 20.2 tt -70.6 -34.0 55.45 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.425 0 N-CA-C 112.36 0.504 . . . . 0.0 112.36 -179.273 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 630' ' ' CYS . . . . . . . . . . . . . 51.1 t -60.63 -44.93 95.79 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.427 -179.434 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 631' ' ' SER . . . . . . . . . . . . . 47.2 t -61.64 -42.36 98.79 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.079 -179.663 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 632' ' ' ILE . . . . . . . . . . . . . 97.2 mt -61.58 -48.1 90.31 Favored 'Isoleucine or valine' 0 C--O 1.235 0.312 0 CA-C-N 116.472 -0.331 . . . . 0.0 110.857 179.98 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 633' ' ' LEU . . . . . . . . . . . . . 80.6 mt -66.07 -39.81 90.37 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.92 179.654 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 634' ' ' THR . . . . . 0.518 ' HA ' ' O ' ' A' ' 638' ' ' TYR . 89.5 m -65.25 -40.44 94.01 Favored 'General case' 0 CA--C 1.529 0.151 0 CA-C-O 120.708 0.289 . . . . 0.0 110.671 -179.946 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 635' ' ' THR . . . . . . . . . . . . . 91.9 m -59.44 -38.4 80.63 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.226 179.149 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 636' ' ' ALA . . . . . . . . . . . . . . . -63.34 -17.62 62.77 Favored 'General case' 0 CA--C 1.534 0.327 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.465 178.963 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 637' ' ' GLY . . . . . . . . . . . . . . . 109.33 4.85 30.56 Favored Glycine 0 C--N 1.333 0.403 0 C-N-CA 121.06 -0.591 . . . . 0.0 113.332 179.695 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 638' ' ' TYR . . . . . 0.518 ' O ' ' HA ' ' A' ' 634' ' ' THR . 93.5 m-85 -100.9 142.61 32.13 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.739 0.304 . . . . 0.0 111.582 179.879 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 639' ' ' GLN . . . . . . . . . . . . . 75.1 mt-30 -86.25 135.27 33.62 Favored 'General case' 0 CA--C 1.519 -0.233 0 N-CA-C 109.829 -0.434 . . . . 0.0 109.829 179.206 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 640' ' ' VAL . . . . . . . . . . . . . 60.6 t -118.04 129.96 73.63 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 N-CA-C 112.333 0.494 . . . . 0.0 112.333 -179.159 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 641' ' ' ILE . . . . . . . . . . . . . 42.4 mm -109.83 117.3 54.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 N-CA-C 108.174 -1.047 . . . . 0.0 108.174 178.308 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 642' ' ' TRP . . . . . . . . . . . . . 26.9 t90 -92.25 128.08 37.97 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.318 0.58 . . . . 0.0 112.439 -178.321 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 643' ' ' LEU . . . . . . . . . . . . . 2.8 mp -122.04 134.46 54.79 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.304 -0.862 . . . . 0.0 110.492 179.014 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 644' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -111.61 36.26 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.592 -0.276 . . . . 0.0 111.226 179.952 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 645' ' ' ASP . . . . . . . . . . . . . 20.3 t0 -151.32 -34.66 0.14 Allowed 'General case' 0 N--CA 1.469 0.515 0 N-CA-C 112.508 0.558 . . . . 0.0 112.508 -178.502 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 646' ' ' GLY . . . . . . . . . . . . . . . 74.64 28.49 63.14 Favored Glycine 0 CA--C 1.521 0.443 0 C-N-CA 120.775 -0.726 . . . . 0.0 113.934 179.821 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 647' ' ' GLU . . . . . . . . . . . . . 58.9 mm-40 -65.16 120.56 12.93 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 117.329 0.564 . . . . 0.0 110.837 179.655 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 648' ' ' VAL . . . . . . . . . . . . . 79.3 t -61.33 -41.26 89.09 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-N 115.168 -0.924 . . . . 0.0 111.824 -179.097 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 649' ' ' GLU . . . . . . . . . . . . . 79.5 mm-40 -61.15 -42.41 98.49 Favored 'General case' 0 C--N 1.332 -0.183 0 C-N-CA 120.76 -0.376 . . . . 0.0 110.148 179.968 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 650' ' ' ARG . . . . . . . . . . . . . 89.9 mmt-85 -70.91 -40.71 72.0 Favored 'General case' 0 CA--C 1.53 0.175 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.47 178.513 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 651' ' ' LEU . . . . . . . . . . . . . 84.3 mt -64.3 -41.12 97.01 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.459 179.01 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 652' ' ' LEU . . . . . . . . . . . . . 61.6 tp -64.19 -43.3 95.52 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.838 178.765 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 653' ' ' ALA . . . . . . . . . . . . . . . -63.29 -39.87 95.79 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.396 -179.862 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 654' ' ' LEU . . . . . . . . . . . . . 75.3 mt -100.76 30.36 4.04 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.679 -0.691 . . . . 0.0 110.02 179.925 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 655' ' ' THR . . . . . . . . . . . . . 6.7 t -46.4 109.89 1.1 Allowed Pre-proline 0 CA--C 1.536 0.436 0 CA-C-O 121.982 0.896 . . . . 0.0 113.314 -177.949 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 656' ' ' PRO . . . . . . . . . . . . . 27.8 Cg_endo -92.3 -174.8 0.55 Allowed 'Trans proline' 0 C--N 1.344 0.339 0 C-N-CA 124.028 3.152 . . . . 0.0 111.765 178.636 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 657' ' ' ILE . . . . . . . . . . . . . 21.5 pt -80.45 -25.45 11.36 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-O 121.237 0.541 . . . . 0.0 109.82 178.158 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 658' ' ' ALA . . . . . 0.413 ' HA ' ' O ' ' A' ' 687' ' ' LYS . . . -157.43 151.67 24.81 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.321 -0.854 . . . . 0.0 111.245 -179.816 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 659' ' ' VAL . . . . . 0.596 HG13 HD11 ' A' ' 686' ' ' LEU . 16.3 m -121.44 145.72 27.58 Favored 'Isoleucine or valine' 0 C--O 1.235 0.33 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.737 178.833 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 660' ' ' LEU . . . . . . . . . . . . . 6.0 mp -116.72 119.83 36.69 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.227 179.577 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 661' ' ' LEU . . . . . . . . . . . . . 69.0 mt -109.18 114.25 27.79 Favored 'General case' 0 C--N 1.328 -0.355 0 C-N-CA 120.624 -0.43 . . . . 0.0 109.946 -179.932 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 662' ' ' ALA . . . . . 0.521 ' HB3' ' HB2' ' A' ' 620' ' ' SER . . . -109.71 116.93 32.61 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 111.972 0.36 . . . . 0.0 111.972 -179.335 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 663' ' ' GLU . . . . . 0.517 ' HA ' ' C ' ' A' ' 664' ' ' PRO . 24.4 pt-20 -68.67 148.7 98.06 Favored Pre-proline 0 CA--C 1.538 0.488 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.747 178.782 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 664' ' ' PRO . . . . . 0.517 ' C ' ' HA ' ' A' ' 663' ' ' GLU . 43.4 Cg_endo -66.99 139.71 47.29 Favored 'Cis proline' 0 C--N 1.35 0.632 0 C-N-CA 123.351 -1.52 . . . . 0.0 112.451 -0.286 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 665' ' ' PHE . . . . . 0.486 ' HZ ' HD11 ' A' ' 690' ' ' ILE . 56.1 m-85 -80.72 124.72 29.27 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.774 -179.234 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 666' ' ' SER . . . . . . . . . . . . . 78.6 p -64.48 -35.25 80.35 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.214 179.619 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 667' ' ' TYR . . . . . . . . . . . . . 53.4 t80 -67.58 -22.05 65.4 Favored 'General case' 0 CA--C 1.535 0.37 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.207 179.206 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 668' ' ' GLY . . . . . . . . . . . . . . . 101.91 -103.79 2.55 Favored Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.672 -0.775 . . . . 0.0 112.469 -179.187 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 669' ' ' ASP . . . . . . . . . . . . . 37.5 t70 -80.46 109.53 15.05 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.033 0.444 . . . . 0.0 110.738 -179.489 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 670' ' ' VAL . . . . . . . . . . . . . 11.1 p -63.94 -30.96 51.37 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.449 0 N-CA-C 113.208 0.818 . . . . 0.0 113.208 -179.201 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 671' ' ' GLN . . . . . . . . . . . . . 57.3 mt-30 -62.06 -42.83 99.6 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-O 120.755 0.312 . . . . 0.0 111.471 -178.815 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 672' ' ' GLU . . . . . . . . . . . . . 95.2 mt-10 -65.14 -40.35 94.3 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.906 179.265 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 673' ' ' LEU . . . . . . . . . . . . . 61.8 tp -63.49 -45.35 91.13 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.127 179.518 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 674' ' ' VAL . . . . . 0.471 HG11 ' HA3' ' A' ' 699' ' ' GLY . 62.5 t -64.16 -44.98 97.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 115.59 -0.732 . . . . 0.0 110.103 179.521 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 675' ' ' ASP . . . . . . . . . . . . . 37.2 t70 -60.06 -41.34 92.15 Favored 'General case' 0 CA--C 1.52 -0.189 0 CA-C-N 116.086 -0.507 . . . . 0.0 110.912 179.344 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 676' ' ' GLN . . . . . 0.451 ' O ' ' HG3' ' A' ' 680' ' ' ARG . 55.9 mt-30 -68.52 -41.47 79.91 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.485 -0.325 . . . . 0.0 111.119 -179.485 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 677' ' ' LEU . . . . . . . . . . . . . 87.7 mt -69.87 -42.26 73.71 Favored 'General case' 0 C--O 1.22 -0.479 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.078 179.952 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 678' ' ' ARG . . . . . . . . . . . . . 80.2 ttt180 -64.67 -38.67 91.79 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-O 121.296 0.569 . . . . 0.0 110.667 -179.701 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 679' ' ' GLN . . . . . . . . . . . . . 53.1 tt0 -63.06 -38.57 91.71 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.57 -0.741 . . . . 0.0 110.256 179.307 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 680' ' ' ARG . . . . . 0.451 ' HG3' ' O ' ' A' ' 676' ' ' GLN . 91.5 mtt-85 -85.12 -35.04 22.02 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 115.983 -0.553 . . . . 0.0 112.306 -179.326 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 681' ' ' CYS . . . . . 0.481 ' SG ' ' HB3' ' A' ' 686' ' ' LEU . 18.0 p -133.11 136.79 46.03 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 121.321 0.582 . . . . 0.0 111.202 -179.185 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 682' ' ' THR . . . . . . . . . . . . . 52.6 p -73.09 159.09 86.01 Favored Pre-proline 0 C--N 1.32 -0.684 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.367 179.34 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 683' ' ' PRO . . . . . . . . . . . . . 76.9 Cg_exo -55.3 -32.29 80.5 Favored 'Trans proline' 0 C--N 1.349 0.556 0 C-N-CA 122.708 2.272 . . . . 0.0 112.408 179.32 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 684' ' ' GLU . . . . . 0.416 ' O ' HD13 ' A' ' 724' ' ' LEU . 97.5 mt-10 -70.34 -38.15 74.78 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.95 179.739 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 685' ' ' GLN . . . . . . . . . . . . . 64.7 tt0 -70.66 -41.88 71.53 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.787 -179.48 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 686' ' ' LEU . . . . . 0.596 HD11 HG13 ' A' ' 659' ' ' VAL . 60.2 tp -135.04 120.82 19.58 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.526 -179.204 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 687' ' ' LYS . . . . . 0.413 ' O ' ' HA ' ' A' ' 658' ' ' ALA . 0.9 OUTLIER -85.11 143.59 28.75 Favored 'General case' 0 CA--C 1.52 -0.206 0 N-CA-C 109.576 -0.528 . . . . 0.0 109.576 178.534 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 688' ' ' ILE . . . . . 0.47 HG22 HG12 ' A' ' 700' ' ' VAL . 76.1 mt -123.36 121.08 61.91 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.77 0 CA-C-O 121.318 0.58 . . . . 0.0 111.327 -178.638 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 689' ' ' PHE . . . . . . . . . . . . . 98.6 m-85 -116.68 141.12 48.61 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 114.965 -1.016 . . . . 0.0 109.523 178.541 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 690' ' ' ILE . . . . . 0.486 HD11 ' HZ ' ' A' ' 665' ' ' PHE . 19.9 tt -122.32 136.27 59.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-O 121.25 0.548 . . . . 0.0 111.369 -179.625 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 691' ' ' LEU . . . . . 0.437 HD21 HD12 ' A' ' 629' ' ' ILE . 1.3 mp -105.22 127.86 53.14 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.609 -0.723 . . . . 0.0 111.053 -179.712 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 692' ' ' GLY . . . . . 0.599 ' O ' ' HA ' ' A' ' 705' ' ' PRO . . . 168.55 179.66 40.97 Favored Glycine 0 N--CA 1.443 -0.857 0 CA-C-N 115.492 -0.776 . . . . 0.0 113.122 179.64 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 693' ' ' SER . . . . . . . . . . . . . 90.0 p -73.24 -21.63 60.59 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.058 0.456 . . . . 0.0 110.955 179.423 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 694' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -126.4 126.88 44.58 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.319 -179.923 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 695' ' ' GLY . . . . . 0.55 ' HA3' ' CB ' ' A' ' 703' ' ' TYR . . . -109.35 10.48 33.37 Favored Glycine 0 N--CA 1.448 -0.533 0 C-N-CA 120.692 -0.766 . . . . 0.0 113.152 -179.958 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 696' ' ' ASN . . . . . . . . . . . . . 65.7 t30 -84.12 73.1 10.44 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.144 0.497 . . . . 0.0 111.444 -179.236 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 697' ' ' TYR . . . . . . . . . . . . . 97.5 m-85 -129.91 148.28 51.76 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.827 -0.624 . . . . 0.0 109.737 179.152 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 698' ' ' GLN . . . . . . . . . . . . . 99.7 mm-40 -85.96 146.94 26.46 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.127 -179.365 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 699' ' ' GLY . . . . . 0.471 ' HA3' HG11 ' A' ' 674' ' ' VAL . . . 92.96 3.65 65.62 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.799 -0.715 . . . . 0.0 113.864 179.356 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 700' ' ' VAL . . . . . 0.47 HG12 HG22 ' A' ' 688' ' ' ILE . 26.1 m -119.46 147.77 22.86 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 117.467 0.634 . . . . 0.0 109.985 179.25 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 701' ' ' ASP . . . . . 0.538 ' O ' ' HD2' ' A' ' 702' ' ' ARG . 28.1 t0 -81.91 -41.31 21.06 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.764 -0.653 . . . . 0.0 111.739 -179.746 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 702' ' ' ARG . . . . . 0.538 ' HD2' ' O ' ' A' ' 701' ' ' ASP . 1.2 mpt_? -141.98 169.35 17.75 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.63 -178.592 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 703' ' ' TYR . . . . . 0.55 ' CB ' ' HA3' ' A' ' 695' ' ' GLY . 53.1 p90 -129.02 147.16 50.86 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.038 179.384 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 704' ' ' ILE . . . . . 0.437 ' HB ' ' HG ' ' A' ' 691' ' ' LEU . 44.5 mm -122.19 100.66 42.16 Favored Pre-proline 0 C--N 1.326 -0.448 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.868 -179.929 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 705' ' ' PRO . . . . . 0.599 ' HA ' ' O ' ' A' ' 692' ' ' GLY . 88.3 Cg_endo -76.55 149.24 30.38 Favored 'Trans proline' 0 CA--C 1.531 0.373 0 C-N-CA 122.63 2.22 . . . . 0.0 113.375 179.899 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 706' ' ' LEU . . . . . 0.584 ' HA ' ' C ' ' A' ' 707' ' ' PRO . 7.2 mp -112.13 151.52 43.7 Favored Pre-proline 0 C--N 1.33 -0.249 0 CA-C-N 115.887 -0.597 . . . . 0.0 109.539 178.509 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 707' ' ' PRO . . . . . 0.584 ' C ' ' HA ' ' A' ' 706' ' ' LEU . 43.3 Cg_exo -60.42 135.88 14.77 Favored 'Cis proline' 0 C--N 1.352 0.722 0 C-N-CA 123.849 -1.313 . . . . 0.0 113.071 -0.11 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 708' ' ' ILE . . . . . . . . . . . . . 2.8 pt -69.97 128.29 33.1 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-N 115.64 -0.709 . . . . 0.0 112.243 179.368 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 709' ' ' HIS . . . . . . . . . . . . . 67.3 m80 -99.86 115.56 65.46 Favored Pre-proline 0 C--N 1.322 -0.625 0 N-CA-C 108.208 -1.034 . . . . 0.0 108.208 177.374 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 710' ' ' PRO . . . . . . . . . . . . . 21.5 Cg_endo -59.55 -29.94 91.17 Favored 'Trans proline' 0 C--N 1.345 0.377 0 C-N-CA 122.842 2.361 . . . . 0.0 114.349 -177.297 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 711' ' ' GLU . . . . . . . . . . . . . 24.5 pt-20 -70.3 -32.21 69.88 Favored 'General case' 0 CA--C 1.532 0.268 0 N-CA-C 112.149 0.426 . . . . 0.0 112.149 -179.443 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 712' ' ' SER . . . . . . . . . . . . . 36.8 m -99.9 -24.02 14.78 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.759 -0.201 . . . . 0.0 111.395 -179.382 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 713' ' ' PHE . . . . . . . . . . . . . 72.6 t80 -59.88 -49.17 78.74 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.262 -179.473 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 714' ' ' LEU . . . . . . . . . . . . . 8.1 mp -64.12 -39.86 94.95 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-O 120.842 0.353 . . . . 0.0 110.577 179.626 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 715' ' ' GLN . . . . . . . . . . . . . 24.1 tm0? -62.08 -44.09 97.43 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.694 -0.685 . . . . 0.0 110.928 179.449 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 716' ' ' GLN . . . . . . . . . . . . . 91.2 mm-40 -66.09 -41.89 90.05 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 116.566 -0.288 . . . . 0.0 111.496 179.426 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 717' ' ' VAL . . . . . 0.716 ' O ' ' HG ' ' A' ' 721' ' ' LEU . 68.4 t -63.99 -45.26 97.27 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.1 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.505 179.474 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 718' ' ' THR . . . . . . . . . . . . . 89.2 m -60.94 -42.7 98.69 Favored 'General case' 0 C--O 1.232 0.178 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.663 179.598 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 719' ' ' MET . . . . . . . . . . . . . 11.0 tpt -60.93 -41.55 96.43 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.342 179.299 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 720' ' ' GLY . . . . . . . . . . . . . . . -72.76 -17.51 78.29 Favored Glycine 0 CA--C 1.522 0.501 0 C-N-CA 120.938 -0.648 . . . . 0.0 113.345 179.493 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 721' ' ' LEU . . . . . 0.716 ' HG ' ' O ' ' A' ' 717' ' ' VAL . 92.9 mt -84.84 -11.08 56.43 Favored 'General case' 0 N--CA 1.467 0.423 0 CA-C-N 117.038 0.419 . . . . 0.0 111.539 179.964 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 722' ' ' THR . . . . . . . . . . . . . 68.7 p -68.63 162.34 26.17 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.052 -179.687 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 723' ' ' SER . . . . . . . . . . . . . 50.5 m 63.7 28.43 14.94 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-N 115.674 -0.694 . . . . 0.0 111.038 -178.901 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 724' ' ' LEU . . . . . 0.416 HD13 ' O ' ' A' ' 684' ' ' GLU . 39.9 tp -135.96 -70.93 0.47 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.288 179.542 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 725' ' ' ALA . . . . . . . . . . . . . . . -153.44 156.71 38.71 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.498 -179.965 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 726' ' ' THR . . . . . . . . . . . . . 72.1 p -81.01 159.09 24.93 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.729 0.3 . . . . 0.0 111.087 179.664 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 727' ' ' SER . . . . . . . . . . . . . 40.3 t -150.85 146.3 26.25 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.49 -0.323 . . . . 0.0 110.254 -179.963 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 728' ' ' ALA . . . . . . . . . . . . . . . -149.14 152.6 36.37 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.461 -0.336 . . . . 0.0 110.761 -179.908 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 729' ' ' GLN . . . . . . . . . . . . . 96.2 mt-30 . . . . . 0 C--O 1.25 1.083 0 CA-C-O 118.205 -0.902 . . . . 0.0 110.724 179.887 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 613' ' ' GLU . . . . . . . . . . . . . 58.1 mt-10 . . . . . 0 N--CA 1.487 1.391 0 CA-C-O 121.045 0.45 . . . . 0.0 110.799 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 614' ' ' GLY . . . . . . . . . . . . . . . -83.64 65.19 4.16 Favored Glycine 0 N--CA 1.453 -0.182 0 C-N-CA 120.961 -0.638 . . . . 0.0 112.605 -179.865 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 615' ' ' ARG . . . . . . . . . . . . . 88.1 mtm180 -111.98 130.16 55.95 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.91 0.386 . . . . 0.0 110.722 -179.99 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 616' ' ' ILE . . . . . . . . . . . . . 84.3 mt -123.48 133.64 68.61 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.034 179.562 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 617' ' ' VAL . . . . . . . . . . . . . 90.9 t -107.24 127.72 62.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-O 120.954 0.407 . . . . 0.0 110.039 179.999 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 618' ' ' LEU . . . . . 0.446 HD11 HG21 ' A' ' 629' ' ' ILE . 0.9 OUTLIER -109.65 130.72 55.49 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.919 -0.582 . . . . 0.0 111.117 -178.714 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 619' ' ' VAL . . . . . . . . . . . . . 67.4 t -118.88 118.24 57.06 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-N 115.986 -0.552 . . . . 0.0 109.718 179.447 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 620' ' ' SER . . . . . 0.573 ' HB3' ' HB3' ' A' ' 662' ' ' ALA . 82.7 p -168.09 165.33 13.44 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.524 -0.762 . . . . 0.0 111.118 -179.418 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 621' ' ' GLU . . . . . 0.423 ' OE2' ' HA ' ' A' ' 666' ' ' SER . 99.4 mt-10 -104.65 -9.92 17.88 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.472 -0.786 . . . . 0.0 111.278 178.205 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 622' ' ' ASP . . . . . . . . . . . . . 57.2 t0 -96.81 108.17 20.79 Favored 'General case' 0 CA--C 1.53 0.186 0 CA-C-O 121.097 0.475 . . . . 0.0 111.577 -177.923 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 623' ' ' GLU . . . . . . . . . . . . . 51.1 mp0 -65.56 -38.27 89.08 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-N 115.51 -0.768 . . . . 0.0 111.944 179.199 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 624' ' ' ALA . . . . . . . . . . . . . . . -60.33 -45.17 94.38 Favored 'General case' 0 N--CA 1.465 0.318 0 N-CA-C 112.825 0.676 . . . . 0.0 112.825 -178.029 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 625' ' ' THR . . . . . . . . . . . . . 21.9 p -72.04 -32.61 67.27 Favored 'General case' 0 CA--C 1.516 -0.344 0 C-N-CA 120.491 -0.484 . . . . 0.0 110.616 179.464 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 626' ' ' SER . . . . . . . . . . . . . 68.0 m -64.83 -41.54 95.67 Favored 'General case' 0 N--CA 1.451 -0.41 0 CA-C-N 115.473 -0.785 . . . . 0.0 111.731 -179.425 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 627' ' ' THR . . . . . . . . . . . . . 72.7 p -65.41 -40.69 93.69 Favored 'General case' 0 N--CA 1.465 0.309 0 N-CA-C 112.033 0.383 . . . . 0.0 112.033 -179.654 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 628' ' ' LEU . . . . . . . . . . . . . 61.7 tp -69.55 -43.44 72.94 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.929 0.395 . . . . 0.0 111.507 179.588 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 629' ' ' ILE . . . . . 0.446 HG21 HD11 ' A' ' 618' ' ' LEU . 1.2 tp -70.03 -37.53 72.61 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.521 0 CA-C-N 115.968 -0.56 . . . . 0.0 112.375 -178.417 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 630' ' ' CYS . . . . . . . . . . . . . 88.3 m -64.55 -39.3 93.5 Favored 'General case' 0 N--CA 1.464 0.239 0 N-CA-C 111.706 0.261 . . . . 0.0 111.706 -179.618 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 631' ' ' SER . . . . . . . . . . . . . 67.4 m -61.7 -42.9 99.56 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.447 -0.342 . . . . 0.0 111.036 -179.169 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 632' ' ' ILE . . . . . . . . . . . . . 97.0 mt -63.8 -47.85 89.04 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.253 0 CA-C-O 121.057 0.456 . . . . 0.0 110.759 179.573 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 633' ' ' LEU . . . . . . . . . . . . . 83.9 mt -66.34 -40.43 89.84 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-N 115.697 -0.683 . . . . 0.0 112.372 -179.499 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 634' ' ' THR . . . . . 0.519 ' HA ' ' O ' ' A' ' 638' ' ' TYR . 91.0 m -65.93 -39.83 90.86 Favored 'General case' 0 CA--C 1.53 0.182 0 CA-C-O 120.682 0.277 . . . . 0.0 110.999 -179.741 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 635' ' ' THR . . . . . . . . . . . . . 93.6 m -58.57 -38.19 77.36 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.518 179.356 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 636' ' ' ALA . . . . . . . . . . . . . . . -68.66 -9.69 51.68 Favored 'General case' 0 CA--C 1.535 0.387 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.466 179.228 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 637' ' ' GLY . . . . . . . . . . . . . . . 101.91 8.48 45.09 Favored Glycine 0 C--N 1.334 0.437 0 C-N-CA 121.049 -0.596 . . . . 0.0 113.494 179.321 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 638' ' ' TYR . . . . . 0.519 ' O ' ' HA ' ' A' ' 634' ' ' THR . 98.8 m-85 -100.56 142.7 31.67 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.956 0.378 . . . . 0.0 111.592 -179.796 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 639' ' ' GLN . . . . . . . . . . . . . 78.5 mt-30 -92.58 134.91 34.54 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 109.525 -0.546 . . . . 0.0 109.525 178.936 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 640' ' ' VAL . . . . . . . . . . . . . 58.5 t -118.24 130.51 73.0 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 N-CA-C 112.391 0.515 . . . . 0.0 112.391 -178.963 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 641' ' ' ILE . . . . . . . . . . . . . 47.9 mm -111.6 118.99 58.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 N-CA-C 108.249 -1.019 . . . . 0.0 108.249 178.066 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 642' ' ' TRP . . . . . . . . . . . . . 75.5 t90 -99.68 128.04 45.79 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 112.689 0.626 . . . . 0.0 112.689 -178.046 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 643' ' ' LEU . . . . . . . . . . . . . 89.0 mt -119.47 136.76 54.18 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.332 -0.849 . . . . 0.0 110.264 178.97 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 644' ' ' VAL . . . . . . . . . . . . . 7.5 p -103.91 23.31 2.17 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.572 0 CA-C-O 121.4 0.619 . . . . 0.0 111.348 -179.409 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 645' ' ' ASP . . . . . . . . . . . . . 16.8 t0 -143.17 -33.75 0.44 Allowed 'General case' 0 N--CA 1.471 0.596 0 N-CA-C 113.012 0.745 . . . . 0.0 113.012 -178.239 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 646' ' ' GLY . . . . . . . . . . . . . . . 74.6 29.26 61.83 Favored Glycine 0 CA--C 1.523 0.532 0 C-N-CA 120.846 -0.692 . . . . 0.0 114.805 179.41 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 647' ' ' GLU . . . . . . . . . . . . . 93.8 mt-10 -63.45 126.5 27.68 Favored 'General case' 0 N--CA 1.461 0.081 0 CA-C-N 117.753 0.776 . . . . 0.0 111.102 179.68 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 648' ' ' VAL . . . . . . . . . . . . . 79.5 t -61.86 -39.74 84.59 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-N 114.826 -1.079 . . . . 0.0 111.504 -179.637 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 649' ' ' GLU . . . . . . . . . . . . . 50.4 mp0 -60.64 -42.52 97.09 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.872 0.368 . . . . 0.0 110.017 179.996 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 650' ' ' ARG . . . . . . . . . . . . . 16.2 mmp_? -70.39 -40.69 73.8 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.394 178.486 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 651' ' ' LEU . . . . . . . . . . . . . 81.0 mt -64.17 -41.63 97.05 Favored 'General case' 0 N--CA 1.462 0.173 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.395 178.977 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 652' ' ' LEU . . . . . . . . . . . . . 61.4 tp -65.29 -43.12 92.17 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.911 178.855 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 653' ' ' ALA . . . . . . . . . . . . . . . -62.86 -39.57 94.81 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.917 -179.969 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 654' ' ' LEU . . . . . . . . . . . . . 75.1 mt -101.24 29.8 4.53 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.094 -179.468 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 655' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -35.03 105.05 0.27 Allowed Pre-proline 0 N--CA 1.471 0.613 0 O-C-N 124.495 1.122 . . . . 0.0 113.71 -179.371 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 656' ' ' PRO . . . . . . . . . . . . . 29.7 Cg_endo -92.95 -176.29 0.6 Allowed 'Trans proline' 0 C--N 1.344 0.339 0 C-N-CA 123.732 2.955 . . . . 0.0 112.173 178.758 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 657' ' ' ILE . . . . . . . . . . . . . 19.7 pt -83.16 -26.51 7.88 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-O 121.303 0.573 . . . . 0.0 109.928 178.042 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 658' ' ' ALA . . . . . 0.424 ' HB2' ' HB2' ' A' ' 687' ' ' LYS . . . -158.33 152.97 24.7 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.171 -0.922 . . . . 0.0 111.033 -179.738 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 659' ' ' VAL . . . . . 0.4 HG13 HD11 ' A' ' 686' ' ' LEU . 20.5 m -122.34 146.55 27.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-O 121.191 0.52 . . . . 0.0 110.964 178.966 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 660' ' ' LEU . . . . . . . . . . . . . 14.4 mt -115.06 119.45 36.5 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.42 -0.809 . . . . 0.0 110.17 179.403 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 661' ' ' LEU . . . . . . . . . . . . . 70.8 mt -106.36 111.34 23.88 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 109.018 -0.734 . . . . 0.0 109.018 179.408 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 662' ' ' ALA . . . . . 0.573 ' HB3' ' HB3' ' A' ' 620' ' ' SER . . . -107.03 130.93 54.58 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 112.943 0.72 . . . . 0.0 112.943 -178.394 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 663' ' ' GLU . . . . . . . . . . . . . 8.9 mm-40 -68.37 139.08 91.87 Favored Pre-proline 0 CA--C 1.533 0.32 0 CA-C-N 115.635 -0.711 . . . . 0.0 110.889 177.768 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 664' ' ' PRO . . . . . . . . . . . . . 81.0 Cg_endo -77.57 142.0 69.58 Favored 'Cis proline' 0 C--N 1.349 0.569 0 C-N-CA 123.403 -1.499 . . . . 0.0 112.334 -1.366 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 665' ' ' PHE . . . . . 0.594 ' HZ ' HD11 ' A' ' 690' ' ' ILE . 29.0 m-85 -74.58 127.35 32.89 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.399 -179.908 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 666' ' ' SER . . . . . 0.423 ' HA ' ' OE2' ' A' ' 621' ' ' GLU . 78.1 p -69.47 -38.19 77.62 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.568 179.266 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 667' ' ' TYR . . . . . . . . . . . . . 55.4 t80 -68.8 -23.64 64.31 Favored 'General case' 0 CA--C 1.534 0.331 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.506 179.626 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 668' ' ' GLY . . . . . . . . . . . . . . . 100.29 -104.33 2.78 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.602 -0.809 . . . . 0.0 112.331 -179.404 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 669' ' ' ASP . . . . . . . . . . . . . 37.6 t70 -82.19 109.26 16.32 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.874 0.369 . . . . 0.0 110.61 -179.868 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 670' ' ' VAL . . . . . 0.436 ' O ' HG23 ' A' ' 674' ' ' VAL . 7.5 m -70.81 -23.28 23.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 N-CA-C 113.675 0.991 . . . . 0.0 113.675 -179.048 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 671' ' ' GLN . . . . . . . . . . . . . 55.3 mt-30 -61.33 -42.86 99.38 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 118.149 0.431 . . . . 0.0 110.439 -179.366 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 672' ' ' GLU . . . . . . . . . . . . . 95.8 mt-10 -66.57 -39.85 88.67 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.347 178.386 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 673' ' ' LEU . . . . . . . . . . . . . 62.8 tp -63.51 -44.83 93.18 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.646 -0.706 . . . . 0.0 110.107 179.237 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 674' ' ' VAL . . . . . 0.707 HG11 ' HA3' ' A' ' 699' ' ' GLY . 53.1 t -63.05 -43.68 99.14 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.21 0 CA-C-N 115.587 -0.733 . . . . 0.0 109.796 179.306 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 675' ' ' ASP . . . . . . . . . . . . . 37.3 t70 -59.91 -40.94 90.53 Favored 'General case' 0 CA--C 1.52 -0.178 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.335 178.955 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 676' ' ' GLN . . . . . 0.416 ' O ' ' HG2' ' A' ' 680' ' ' ARG . 55.6 mt-30 -70.32 -41.67 72.95 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.892 179.832 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 677' ' ' LEU . . . . . . . . . . . . . 85.3 mt -66.94 -42.0 86.01 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.888 179.394 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 678' ' ' ARG . . . . . . . . . . . . . 62.5 ttp180 -66.32 -38.66 88.2 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-O 121.333 0.587 . . . . 0.0 110.659 179.792 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 679' ' ' GLN . . . . . . . . . . . . . 53.6 tt0 -62.43 -38.93 91.62 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.215 -0.902 . . . . 0.0 110.674 -179.927 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 680' ' ' ARG . . . . . 0.416 ' HG2' ' O ' ' A' ' 676' ' ' GLN . 37.9 mmt180 -84.64 -43.29 14.53 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.384 -0.371 . . . . 0.0 111.24 -179.882 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 681' ' ' CYS . . . . . . . . . . . . . 73.8 m -127.89 130.31 48.33 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 120.89 0.376 . . . . 0.0 110.242 179.644 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 682' ' ' THR . . . . . 0.44 ' OG1' ' HG2' ' A' ' 684' ' ' GLU . 63.0 p -71.84 160.01 83.85 Favored Pre-proline 0 C--N 1.322 -0.607 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.854 -179.552 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 683' ' ' PRO . . . . . . . . . . . . . 76.5 Cg_exo -55.0 -30.07 67.88 Favored 'Trans proline' 0 C--N 1.35 0.642 0 C-N-CA 122.858 2.372 . . . . 0.0 112.811 179.877 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 684' ' ' GLU . . . . . 0.44 ' HG2' ' OG1' ' A' ' 682' ' ' THR . 10.8 pt-20 -75.83 -14.25 60.29 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.809 0.338 . . . . 0.0 110.998 179.817 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 685' ' ' GLN . . . . . . . . . . . . . 90.8 mt-30 -101.15 -40.04 7.38 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.505 -179.799 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 686' ' ' LEU . . . . . 0.4 HD11 HG13 ' A' ' 659' ' ' VAL . 59.9 tp -131.83 122.64 26.08 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.631 -179.145 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 687' ' ' LYS . . . . . 0.424 ' HB2' ' HB2' ' A' ' 658' ' ' ALA . 46.9 mmtm -91.89 146.56 23.65 Favored 'General case' 0 CA--C 1.521 -0.147 0 CA-C-O 121.332 0.587 . . . . 0.0 110.917 178.736 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 688' ' ' ILE . . . . . 0.592 HG22 HG12 ' A' ' 700' ' ' VAL . 78.6 mt -123.18 122.58 65.76 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.761 0 CA-C-N 115.494 -0.776 . . . . 0.0 110.543 -179.385 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 689' ' ' PHE . . . . . . . . . . . . . 71.1 m-85 -122.51 147.23 46.61 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.34 -0.845 . . . . 0.0 110.197 179.561 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 690' ' ' ILE . . . . . 0.594 HD11 ' HZ ' ' A' ' 665' ' ' PHE . 16.7 tt -122.3 135.96 60.7 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.326 0 CA-C-O 121.377 0.608 . . . . 0.0 112.26 -178.895 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 691' ' ' LEU . . . . . 0.634 HD23 ' HB ' ' A' ' 704' ' ' ILE . 79.8 mt -110.23 129.44 55.73 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-N 115.352 -0.84 . . . . 0.0 110.281 179.479 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 692' ' ' GLY . . . . . 0.72 ' O ' ' HA ' ' A' ' 705' ' ' PRO . . . 162.66 -178.09 38.54 Favored Glycine 0 N--CA 1.446 -0.68 0 C-N-CA 120.532 -0.842 . . . . 0.0 112.239 179.618 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 693' ' ' SER . . . . . . . . . . . . . 79.8 p -66.26 -36.54 83.25 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.973 0.416 . . . . 0.0 110.986 179.345 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 694' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -126.25 123.01 37.17 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.045 179.666 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 695' ' ' GLY . . . . . 0.431 ' HA3' ' HB2' ' A' ' 703' ' ' TYR . . . -112.52 18.12 22.99 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.8 -179.793 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 696' ' ' ASN . . . . . . . . . . . . . 65.2 t30 -82.05 72.94 9.11 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.189 0.519 . . . . 0.0 111.026 -179.46 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 697' ' ' TYR . . . . . . . . . . . . . 96.8 m-85 -130.71 149.81 52.18 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.632 -0.713 . . . . 0.0 109.66 179.527 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 698' ' ' GLN . . . . . . . . . . . . . 29.4 pt20 -79.93 150.05 30.65 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.959 -179.552 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 699' ' ' GLY . . . . . 0.707 ' HA3' HG11 ' A' ' 674' ' ' VAL . . . 93.34 2.42 65.83 Favored Glycine 0 N--CA 1.45 -0.425 0 C-N-CA 120.532 -0.842 . . . . 0.0 114.037 179.215 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 700' ' ' VAL . . . . . 0.592 HG12 HG22 ' A' ' 688' ' ' ILE . 24.3 m -117.58 141.94 34.06 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.255 0 CA-C-N 117.945 0.872 . . . . 0.0 110.503 179.359 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 701' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -74.28 -44.38 52.98 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.404 -0.816 . . . . 0.0 112.262 -179.34 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 702' ' ' ARG . . . . . . . . . . . . . 91.0 mmt-85 -141.67 157.29 45.25 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.737 0.303 . . . . 0.0 110.569 -178.636 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 703' ' ' TYR . . . . . 0.431 ' HB2' ' HA3' ' A' ' 695' ' ' GLY . 26.6 p90 -119.35 136.57 54.2 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.371 179.151 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 704' ' ' ILE . . . . . 0.634 ' HB ' HD23 ' A' ' 691' ' ' LEU . 60.3 mt -122.82 98.81 42.33 Favored Pre-proline 0 C--O 1.236 0.39 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.697 179.914 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 705' ' ' PRO . . . . . 0.72 ' HA ' ' O ' ' A' ' 692' ' ' GLY . 73.4 Cg_endo -73.66 154.67 49.54 Favored 'Trans proline' 0 C--N 1.345 0.393 0 C-N-CA 122.899 2.4 . . . . 0.0 113.24 -179.739 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 706' ' ' LEU . . . . . 0.655 ' HA ' ' C ' ' A' ' 707' ' ' PRO . 2.4 pp -119.99 154.97 55.77 Favored Pre-proline 0 C--N 1.328 -0.367 0 CA-C-N 115.793 -0.639 . . . . 0.0 110.566 178.981 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 707' ' ' PRO . . . . . 0.655 ' C ' ' HA ' ' A' ' 706' ' ' LEU . 53.0 Cg_exo -58.71 133.98 9.01 Favored 'Cis proline' 0 C--N 1.353 0.773 0 C-N-CA 123.698 -1.376 . . . . 0.0 112.865 -0.195 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 708' ' ' ILE . . . . . 0.413 HD13 HD12 ' A' ' 629' ' ' ILE . 12.8 pt -70.64 149.83 10.01 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-O 121.732 0.777 . . . . 0.0 112.654 -179.988 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 709' ' ' HIS . . . . . . . . . . . . . 68.4 m80 -108.13 112.19 61.54 Favored Pre-proline 0 C--N 1.317 -0.807 0 N-CA-C 107.154 -1.424 . . . . 0.0 107.154 176.864 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 710' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_endo -58.67 -30.81 93.33 Favored 'Trans proline' 0 C--N 1.345 0.386 0 C-N-CA 122.513 2.142 . . . . 0.0 113.931 -177.029 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 711' ' ' GLU . . . . . . . . . . . . . 42.6 tt0 -64.77 -42.42 95.11 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.796 0.331 . . . . 0.0 111.792 -179.927 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 712' ' ' SER . . . . . . . . . . . . . 56.8 m -96.62 -14.21 22.33 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 112.252 0.464 . . . . 0.0 112.252 -178.786 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 713' ' ' PHE . . . . . . . . . . . . . 92.3 t80 -60.66 -49.11 78.82 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-O 121.092 0.472 . . . . 0.0 110.226 179.796 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 714' ' ' LEU . . . . . 0.467 ' O ' HG12 ' A' ' 717' ' ' VAL . 91.0 mt -65.97 -36.92 84.65 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.64 -0.709 . . . . 0.0 110.143 178.885 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 715' ' ' GLN . . . . . . . . . . . . . 65.6 tt0 -62.14 -42.36 99.17 Favored 'General case' 0 CA--C 1.532 0.26 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.678 179.358 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 716' ' ' GLN . . . . . . . . . . . . . 87.7 mt-30 -64.35 -41.03 96.96 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 116.447 -0.342 . . . . 0.0 111.903 -179.874 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 717' ' ' VAL . . . . . 0.467 HG12 ' O ' ' A' ' 714' ' ' LEU . 5.5 p -69.81 -32.98 54.0 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.263 0 C-N-CA 120.414 -0.514 . . . . 0.0 110.183 179.592 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 718' ' ' THR . . . . . . . . . . . . . 93.8 m -62.15 -43.76 98.12 Favored 'General case' 0 C--O 1.232 0.168 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.436 178.285 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 719' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -61.66 -43.93 97.93 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-N 116.337 -0.392 . . . . 0.0 109.978 179.034 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 720' ' ' GLY . . . . . . . . . . . . . . . -64.26 -39.98 97.53 Favored Glycine 0 C--N 1.33 0.235 0 N-CA-C 111.389 -0.684 . . . . 0.0 111.389 177.915 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 721' ' ' LEU . . . . . . . . . . . . . 65.7 tp -62.25 -44.38 96.68 Favored 'General case' 0 CA--C 1.528 0.119 0 CA-C-N 115.456 -0.372 . . . . 0.0 111.3 179.486 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 722' ' ' THR . . . . . . . . . . . . . 67.8 p -65.86 -30.78 71.45 Favored 'General case' 0 N--CA 1.463 0.195 0 CA-C-O 120.823 0.344 . . . . 0.0 110.745 179.765 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 723' ' ' SER . . . . . . . . . . . . . 67.0 m -68.33 -40.69 81.54 Favored 'General case' 0 C--N 1.332 -0.195 0 N-CA-C 109.349 -0.611 . . . . 0.0 109.349 177.468 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 724' ' ' LEU . . . . . . . . . . . . . 67.6 tp -65.21 -46.48 80.51 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-N 115.089 -0.959 . . . . 0.0 111.567 179.139 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 725' ' ' ALA . . . . . . . . . . . . . . . -150.49 153.85 36.59 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.106 -179.483 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 726' ' ' THR . . . . . . . . . . . . . 71.2 p -72.24 -18.02 61.85 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.213 -0.449 . . . . 0.0 112.181 -179.67 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 727' ' ' SER . . . . . . . . . . . . . 90.6 p -71.71 157.19 38.38 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.767 0.318 . . . . 0.0 111.143 -179.99 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 728' ' ' ALA . . . . . . . . . . . . . . . -153.04 159.49 42.86 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.321 -0.399 . . . . 0.0 110.755 -179.792 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 729' ' ' GLN . . . . . . . . . . . . . 78.4 mt-30 . . . . . 0 C--O 1.25 1.112 0 CA-C-O 118.209 -0.9 . . . . 0.0 110.994 179.756 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 613' ' ' GLU . . . . . . . . . . . . . 57.4 mt-10 . . . . . 0 N--CA 1.487 1.421 0 CA-C-O 120.905 0.383 . . . . 0.0 110.736 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 614' ' ' GLY . . . . . . . . . . . . . . . -174.28 176.48 46.65 Favored Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.458 -179.996 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 615' ' ' ARG . . . . . . . . . . . . . 47.2 mtm105 -116.63 136.42 52.99 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.641 0.258 . . . . 0.0 110.964 -179.838 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 616' ' ' ILE . . . . . 0.409 ' O ' ' HA ' ' A' ' 640' ' ' VAL . 84.6 mt -123.04 132.58 71.14 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-N 116.116 -0.493 . . . . 0.0 109.853 178.953 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 617' ' ' VAL . . . . . . . . . . . . . 96.0 t -106.82 126.43 62.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-O 120.919 0.39 . . . . 0.0 110.078 -179.916 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 618' ' ' LEU . . . . . 0.446 HD11 HD13 ' A' ' 629' ' ' ILE . 0.9 OUTLIER -109.12 128.3 54.89 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.6 -178.727 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 619' ' ' VAL . . . . . . . . . . . . . 65.6 t -117.8 120.01 63.32 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-O 121.002 0.43 . . . . 0.0 110.04 179.952 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 620' ' ' SER . . . . . 0.643 ' HB3' ' HB3' ' A' ' 662' ' ' ALA . 90.4 p -165.37 161.72 19.12 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.391 -0.822 . . . . 0.0 110.97 -179.645 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 621' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -99.49 -12.19 20.4 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.821 -0.627 . . . . 0.0 111.423 178.456 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 622' ' ' ASP . . . . . . . . . . . . . 57.8 t0 -100.6 108.35 20.24 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-O 120.795 0.331 . . . . 0.0 111.234 -178.512 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 623' ' ' GLU . . . . . . . . . . . . . 25.4 pm0 -65.94 -30.83 71.47 Favored 'General case' 0 CA--C 1.534 0.331 0 CA-C-N 115.754 -0.657 . . . . 0.0 112.394 179.948 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 624' ' ' ALA . . . . . . . . . . . . . . . -62.53 -43.86 97.78 Favored 'General case' 0 N--CA 1.464 0.275 0 CA-C-O 120.857 0.361 . . . . 0.0 111.825 -179.2 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 625' ' ' THR . . . . . . . . . . . . . 85.5 m -68.31 -39.96 81.84 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.109 0.481 . . . . 0.0 109.976 179.669 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 626' ' ' SER . . . . . . . . . . . . . 73.1 m -61.39 -40.39 94.19 Favored 'General case' 0 N--CA 1.455 -0.21 0 CA-C-N 115.35 -0.841 . . . . 0.0 112.35 -178.878 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 627' ' ' THR . . . . . . . . . . . . . 74.9 p -65.07 -35.77 82.22 Favored 'General case' 0 N--CA 1.466 0.337 0 N-CA-C 112.381 0.511 . . . . 0.0 112.381 -179.422 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 628' ' ' LEU . . . . . . . . . . . . . 1.8 mm? -74.02 -48.13 32.23 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 112.008 0.373 . . . . 0.0 112.008 -179.673 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 629' ' ' ILE . . . . . 0.446 HD13 HD11 ' A' ' 618' ' ' LEU . 21.2 tt -69.27 -36.73 73.9 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.399 0 N-CA-C 112.456 0.539 . . . . 0.0 112.456 -178.932 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 630' ' ' CYS . . . . . . . . . . . . . 45.1 t -61.42 -42.74 99.21 Favored 'General case' 0 CA--C 1.52 -0.206 0 CA-C-O 120.606 0.241 . . . . 0.0 110.925 -179.792 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 631' ' ' SER . . . . . . . . . . . . . 69.2 m -61.64 -41.64 97.79 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.833 -179.576 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 632' ' ' ILE . . . . . . . . . . . . . 97.2 mt -63.14 -48.69 86.54 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.323 0 CA-C-O 120.981 0.419 . . . . 0.0 111.021 179.693 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 633' ' ' LEU . . . . . . . . . . . . . 87.9 mt -67.67 -39.23 84.54 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-N 115.915 -0.584 . . . . 0.0 112.381 -179.636 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 634' ' ' THR . . . . . 0.488 ' HA ' ' O ' ' A' ' 638' ' ' TYR . 86.4 m -64.93 -39.95 94.3 Favored 'General case' 0 N--CA 1.463 0.187 0 CA-C-O 120.697 0.284 . . . . 0.0 110.686 -179.746 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 635' ' ' THR . . . . . . . . . . . . . 93.2 m -58.79 -38.75 79.25 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.191 179.273 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 636' ' ' ALA . . . . . . . . . . . . . . . -64.34 -17.91 64.14 Favored 'General case' 0 CA--C 1.534 0.329 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.308 178.794 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 637' ' ' GLY . . . . . . . . . . . . . . . 108.94 4.69 31.38 Favored Glycine 0 C--N 1.334 0.437 0 C-N-CA 121.072 -0.585 . . . . 0.0 113.321 179.631 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 638' ' ' TYR . . . . . 0.488 ' O ' ' HA ' ' A' ' 634' ' ' THR . 92.6 m-85 -100.48 141.72 32.95 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.846 0.355 . . . . 0.0 111.636 -179.822 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 639' ' ' GLN . . . . . . . . . . . . . 98.6 mm-40 -88.2 136.52 32.94 Favored 'General case' 0 CA--C 1.518 -0.266 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.224 179.64 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 640' ' ' VAL . . . . . 0.409 ' HA ' ' O ' ' A' ' 616' ' ' ILE . 60.1 t -118.12 129.99 73.65 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 CA-C-O 121.098 0.475 . . . . 0.0 112.025 -179.62 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 641' ' ' ILE . . . . . . . . . . . . . 47.5 mm -111.21 119.52 59.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 N-CA-C 108.578 -0.897 . . . . 0.0 108.578 178.503 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 642' ' ' TRP . . . . . . . . . . . . . 25.1 t90 -92.66 127.51 38.19 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.178 0.514 . . . . 0.0 112.329 -178.353 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 643' ' ' LEU . . . . . 0.411 ' HA ' HD13 ' A' ' 643' ' ' LEU . 0.7 OUTLIER -119.55 130.31 55.1 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 115.495 -0.775 . . . . 0.0 110.142 178.827 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 644' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -107.73 37.79 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.718 -0.219 . . . . 0.0 111.403 -179.477 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 645' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -150.58 -37.14 0.14 Allowed 'General case' 0 N--CA 1.469 0.497 0 N-CA-C 112.544 0.572 . . . . 0.0 112.544 -178.768 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 646' ' ' GLY . . . . . . . . . . . . . . . 74.57 28.25 63.76 Favored Glycine 0 CA--C 1.519 0.308 0 C-N-CA 120.749 -0.738 . . . . 0.0 113.86 -179.856 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 647' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -70.49 128.64 36.84 Favored 'General case' 0 N--CA 1.456 -0.164 0 CA-C-N 117.263 0.532 . . . . 0.0 110.544 179.59 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 648' ' ' VAL . . . . . . . . . . . . . 76.6 t -61.42 -40.33 85.9 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 CA-C-N 115.101 -0.954 . . . . 0.0 111.237 -179.628 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 649' ' ' GLU . . . . . . . . . . . . . 50.3 mp0 -61.29 -43.48 98.8 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.743 0.306 . . . . 0.0 110.38 -179.856 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 650' ' ' ARG . . . . . . . . . . . . . 95.8 mtt-85 -69.55 -41.61 75.7 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.655 178.707 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 651' ' ' LEU . . . . . . . . . . . . . 88.4 mt -65.34 -41.18 94.15 Favored 'General case' 0 N--CA 1.462 0.15 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.648 179.379 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 652' ' ' LEU . . . . . . . . . . . . . 62.4 tp -65.95 -42.98 89.3 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.226 178.895 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 653' ' ' ALA . . . . . . . . . . . . . . . -62.89 -40.11 96.54 Favored 'General case' 0 N--CA 1.467 0.418 0 CA-C-O 121.082 0.468 . . . . 0.0 111.591 -179.645 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 654' ' ' LEU . . . . . . . . . . . . . 75.7 mt -101.6 29.63 4.76 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.103 179.849 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 655' ' ' THR . . . . . . . . . . . . . 6.2 t -43.36 109.72 0.83 Allowed Pre-proline 0 N--CA 1.467 0.399 0 O-C-N 124.24 0.963 . . . . 0.0 113.353 -177.899 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 656' ' ' PRO . . . . . . . . . . . . . 22.5 Cg_endo -93.07 -174.37 0.44 Allowed 'Trans proline' 0 C--N 1.345 0.373 0 C-N-CA 124.217 3.278 . . . . 0.0 111.852 178.744 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 657' ' ' ILE . . . . . . . . . . . . . 18.5 pt -81.13 -24.32 10.56 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-O 121.447 0.641 . . . . 0.0 109.791 177.903 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 658' ' ' ALA . . . . . 0.436 ' HB2' ' HB2' ' A' ' 687' ' ' LYS . . . -158.62 151.18 21.92 Favored 'General case' 0 N--CA 1.452 -0.332 0 CA-C-N 115.142 -0.935 . . . . 0.0 111.198 179.77 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 659' ' ' VAL . . . . . 0.463 HG13 HD11 ' A' ' 686' ' ' LEU . 19.3 m -120.86 145.19 27.7 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-O 121.325 0.583 . . . . 0.0 110.406 178.825 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 660' ' ' LEU . . . . . 0.683 HD21 HD12 ' A' ' 691' ' ' LEU . 2.0 tt -119.08 116.79 27.12 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.457 -0.792 . . . . 0.0 109.651 179.535 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 661' ' ' LEU . . . . . . . . . . . . . 41.3 mt -104.04 111.27 23.77 Favored 'General case' 0 C--N 1.323 -0.587 0 N-CA-C 109.307 -0.627 . . . . 0.0 109.307 -179.334 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 662' ' ' ALA . . . . . 0.643 ' HB3' ' HB3' ' A' ' 620' ' ' SER . . . -104.83 130.1 53.01 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 112.402 0.519 . . . . 0.0 112.402 -178.381 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 663' ' ' GLU . . . . . . . . . . . . . 98.5 mt-10 -75.19 144.74 79.24 Favored Pre-proline 0 C--N 1.325 -0.471 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.288 178.294 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 664' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -72.26 139.43 60.18 Favored 'Cis proline' 0 C--N 1.349 0.563 0 C-N-CA 123.318 -1.534 . . . . 0.0 112.825 -0.573 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 665' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -85.87 153.11 22.46 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.495 -0.775 . . . . 0.0 111.809 179.955 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 666' ' ' SER . . . . . . . . . . . . . 5.5 p -104.88 -25.12 12.74 Favored 'General case' 0 CA--C 1.53 0.207 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.894 179.938 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 667' ' ' TYR . . . . . . . . . . . . . 18.0 p90 -68.59 -20.64 64.52 Favored 'General case' 0 N--CA 1.467 0.407 0 N-CA-C 112.102 0.408 . . . . 0.0 112.102 179.756 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 668' ' ' GLY . . . . . . . . . . . . . . . 100.13 -106.37 3.14 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.611 -0.804 . . . . 0.0 113.253 179.786 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 669' ' ' ASP . . . . . . . . . . . . . 25.5 t70 -84.67 112.15 20.21 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.728 0.299 . . . . 0.0 111.007 -178.863 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 670' ' ' VAL . . . . . 0.438 ' O ' HG23 ' A' ' 674' ' ' VAL . 14.3 p -64.37 -34.66 70.74 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.333 0 N-CA-C 113.122 0.786 . . . . 0.0 113.122 -179.031 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 671' ' ' GLN . . . . . . . . . . . . . 27.7 mp0 -62.4 -42.21 99.26 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.843 0.354 . . . . 0.0 110.904 -178.936 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 672' ' ' GLU . . . . . . . . . . . . . 95.8 mt-10 -66.4 -39.6 89.13 Favored 'General case' 0 N--CA 1.462 0.169 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.95 179.061 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 673' ' ' LEU . . . . . . . . . . . . . 62.6 tp -62.48 -43.36 99.01 Favored 'General case' 0 C--N 1.331 -0.229 0 N-CA-C 109.495 -0.557 . . . . 0.0 109.495 178.864 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 674' ' ' VAL . . . . . 0.698 HG11 ' HA3' ' A' ' 699' ' ' GLY . 55.1 t -61.75 -44.83 99.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 115.256 -0.883 . . . . 0.0 109.913 178.945 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 675' ' ' ASP . . . . . . . . . . . . . 37.2 t70 -60.57 -40.11 90.48 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.396 179.058 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 676' ' ' GLN . . . . . . . . . . . . . 56.9 mt-30 -70.26 -41.29 73.66 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.006 -179.733 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 677' ' ' LEU . . . . . . . . . . . . . 85.7 mt -66.68 -42.43 86.53 Favored 'General case' 0 C--N 1.334 -0.1 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.373 179.346 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 678' ' ' ARG . . . . . 0.599 ' HA ' ' O ' ' A' ' 681' ' ' CYS . 83.6 mtp180 -72.14 -26.37 62.07 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-O 120.989 0.423 . . . . 0.0 111.371 -179.95 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 679' ' ' GLN . . . . . . . . . . . . . 52.7 tt0 -62.69 -39.01 92.64 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.589 -0.732 . . . . 0.0 110.459 179.491 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 680' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -95.41 -42.45 8.48 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.709 -179.701 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 681' ' ' CYS . . . . . 0.599 ' O ' ' HA ' ' A' ' 678' ' ' ARG . 76.7 m -121.14 131.31 54.17 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 120.774 0.321 . . . . 0.0 110.615 179.873 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 682' ' ' THR . . . . . . . . . . . . . 68.5 p -71.49 159.46 85.45 Favored Pre-proline 0 C--N 1.324 -0.506 0 CA-C-N 116.374 -0.376 . . . . 0.0 110.674 -179.978 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 683' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_exo -54.6 -31.79 71.87 Favored 'Trans proline' 0 C--N 1.35 0.643 0 C-N-CA 122.81 2.34 . . . . 0.0 112.715 179.611 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 684' ' ' GLU . . . . . . . . . . . . . 80.1 mm-40 -70.01 -39.1 76.05 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 121.084 0.469 . . . . 0.0 110.512 179.583 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 685' ' ' GLN . . . . . . . . . . . . . 91.0 mt-30 -72.85 -40.99 65.25 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.442 -0.799 . . . . 0.0 112.103 179.707 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 686' ' ' LEU . . . . . 0.463 HD11 HG13 ' A' ' 659' ' ' VAL . 60.6 tp -134.95 119.97 18.64 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.957 -178.373 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 687' ' ' LYS . . . . . 0.436 ' HB2' ' HB2' ' A' ' 658' ' ' ALA . 45.1 mmtm -89.14 146.4 24.82 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 121.356 0.598 . . . . 0.0 110.594 178.367 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 688' ' ' ILE . . . . . . . . . . . . . 75.5 mt -123.7 121.61 62.82 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.739 0 CA-C-N 115.635 -0.711 . . . . 0.0 110.663 -179.222 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 689' ' ' PHE . . . . . . . . . . . . . 91.1 m-85 -119.93 144.5 47.41 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.463 -0.789 . . . . 0.0 110.335 179.391 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 690' ' ' ILE . . . . . . . . . . . . . 19.6 tt -123.93 137.35 57.28 Favored 'Isoleucine or valine' 0 C--O 1.235 0.331 0 CA-C-O 121.361 0.601 . . . . 0.0 111.599 179.906 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 691' ' ' LEU . . . . . 0.683 HD12 HD21 ' A' ' 660' ' ' LEU . 0.5 OUTLIER -110.84 129.3 55.9 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-N 115.434 -0.803 . . . . 0.0 111.057 -179.825 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 692' ' ' GLY . . . . . 0.638 ' O ' ' HA ' ' A' ' 705' ' ' PRO . . . 177.68 -178.61 48.41 Favored Glycine 0 N--CA 1.446 -0.634 0 CA-C-N 115.613 -0.721 . . . . 0.0 111.678 179.764 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 693' ' ' SER . . . . . . . . . . . . . 80.1 p -66.47 -37.22 84.62 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.947 0.403 . . . . 0.0 110.935 179.379 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 694' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -138.87 128.1 24.12 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.88 -0.6 . . . . 0.0 109.879 179.207 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 695' ' ' GLY . . . . . 0.426 ' HA3' ' HB2' ' A' ' 703' ' ' TYR . . . -82.64 122.36 5.72 Favored Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.44 -0.886 . . . . 0.0 112.135 179.771 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 696' ' ' ASN . . . . . . . . . . . . . 99.5 m-20 -63.32 -38.15 90.05 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-O 120.782 0.325 . . . . 0.0 111.14 179.7 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 697' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER 64.94 38.23 6.51 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 115.47 -0.786 . . . . 0.0 112.156 179.641 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 698' ' ' GLN . . . . . . . . . . . . . 97.6 mt-30 -115.01 94.66 4.84 Favored 'General case' 0 N--CA 1.451 -0.403 0 N-CA-C 109.709 -0.478 . . . . 0.0 109.709 178.972 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 699' ' ' GLY . . . . . 0.698 ' HA3' HG11 ' A' ' 674' ' ' VAL . . . 90.8 8.09 65.66 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.684 -0.77 . . . . 0.0 113.295 -179.783 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 700' ' ' VAL . . . . . . . . . . . . . 33.1 m -118.38 148.94 20.91 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.333 0 O-C-N 122.246 -0.561 . . . . 0.0 110.038 179.792 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 701' ' ' ASP . . . . . . . . . . . . . 37.6 t70 -71.7 -43.96 65.05 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.593 -0.73 . . . . 0.0 112.307 -178.81 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 702' ' ' ARG . . . . . . . . . . . . . 94.4 mtt-85 -144.92 162.55 36.6 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.572 -0.285 . . . . 0.0 110.612 -178.606 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 703' ' ' TYR . . . . . 0.426 ' HB2' ' HA3' ' A' ' 695' ' ' GLY . 45.8 p90 -123.59 147.36 47.39 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 109.826 -0.435 . . . . 0.0 109.826 179.072 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 704' ' ' ILE . . . . . 0.422 ' O ' HD23 ' A' ' 691' ' ' LEU . 46.2 mt -121.98 99.28 44.13 Favored Pre-proline 0 C--N 1.327 -0.39 0 CA-C-N 116.594 -0.276 . . . . 0.0 110.927 -179.664 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 705' ' ' PRO . . . . . 0.638 ' HA ' ' O ' ' A' ' 692' ' ' GLY . 85.2 Cg_endo -79.99 141.74 15.1 Favored 'Trans proline' 0 CA--C 1.531 0.359 0 C-N-CA 122.633 2.222 . . . . 0.0 113.574 -179.941 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 706' ' ' LEU . . . . . . . . . . . . . 92.3 mt -81.76 151.27 67.59 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.412 178.03 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 707' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -75.46 142.78 75.28 Favored 'Cis proline' 0 C--N 1.346 0.416 0 C-N-CA 123.112 -1.62 . . . . 0.0 112.851 -0.776 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 708' ' ' ILE . . . . . 0.417 HG23 HD21 ' A' ' 691' ' ' LEU . 0.5 OUTLIER -69.86 106.87 1.57 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.817 178.671 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 709' ' ' HIS . . . . . . . . . . . . . 71.5 m80 -82.47 121.45 78.25 Favored Pre-proline 0 C--N 1.33 -0.277 0 N-CA-C 108.78 -0.822 . . . . 0.0 108.78 177.796 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 710' ' ' PRO . . . . . . . . . . . . . 22.6 Cg_endo -60.34 -30.4 90.94 Favored 'Trans proline' 0 C--N 1.346 0.419 0 C-N-CA 122.689 2.259 . . . . 0.0 114.081 -177.875 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 711' ' ' GLU . . . . . . . . . . . . . 51.4 mp0 -66.23 -40.48 90.3 Favored 'General case' 0 C--N 1.331 -0.23 0 N-CA-C 112.119 0.415 . . . . 0.0 112.119 -179.327 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 712' ' ' SER . . . . . . . . . . . . . 63.0 m -99.0 -17.74 18.14 Favored 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 112.194 0.442 . . . . 0.0 112.194 -178.64 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 713' ' ' PHE . . . . . . . . . . . . . 85.0 t80 -60.2 -48.65 80.84 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-O 120.744 0.307 . . . . 0.0 110.552 179.909 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 714' ' ' LEU . . . . . 0.444 ' O ' HG12 ' A' ' 717' ' ' VAL . 85.9 mt -62.9 -39.27 93.99 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.188 179.492 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 715' ' ' GLN . . . . . . . . . . . . . 97.0 mt-30 -63.57 -40.16 96.25 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.684 179.229 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 716' ' ' GLN . . . . . . . . . . . . . 96.7 mt-30 -63.72 -41.14 98.12 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-N 116.69 -0.232 . . . . 0.0 111.109 179.594 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 717' ' ' VAL . . . . . 0.504 ' O ' ' HG ' ' A' ' 721' ' ' LEU . 4.8 p -73.68 -36.07 45.83 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.34 0 C-N-CA 120.574 -0.45 . . . . 0.0 110.847 179.506 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 718' ' ' THR . . . . . . . . . . . . . 35.2 p -64.57 -36.49 84.39 Favored 'General case' 0 C--N 1.341 0.238 0 N-CA-C 111.593 0.22 . . . . 0.0 111.593 179.242 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 719' ' ' MET . . . . . . . . . . . . . 98.3 mtp -63.8 -42.31 97.73 Favored 'General case' 0 C--O 1.235 0.303 0 CA-C-O 121.199 0.523 . . . . 0.0 109.753 178.579 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 720' ' ' GLY . . . . . . . . . . . . . . . -66.9 -39.6 93.4 Favored Glycine 0 N--CA 1.451 -0.32 0 CA-C-N 115.589 -0.732 . . . . 0.0 112.402 178.305 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 721' ' ' LEU . . . . . 0.504 ' HG ' ' O ' ' A' ' 717' ' ' VAL . 97.5 mt -63.42 -39.39 94.36 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-O 120.827 0.346 . . . . 0.0 111.455 -179.726 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 722' ' ' THR . . . . . . . . . . . . . 73.4 p -71.23 -11.33 60.87 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.921 0.391 . . . . 0.0 111.401 179.582 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 723' ' ' SER . . . . . . . . . . . . . 59.5 m -91.27 -1.99 57.53 Favored 'General case' 0 CA--C 1.532 0.255 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.01 179.588 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 724' ' ' LEU . . . . . . . . . . . . . 74.8 mt -73.03 141.09 47.66 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-N 116.51 -0.313 . . . . 0.0 111.159 179.672 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 725' ' ' ALA . . . . . . . . . . . . . . . -62.67 -39.77 94.98 Favored 'General case' 0 N--CA 1.461 0.111 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.123 179.192 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 726' ' ' THR . . . . . . . . . . . . . 87.8 m -121.55 128.92 52.51 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.21 179.571 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 727' ' ' SER . . . . . . . . . . . . . 63.6 m -123.31 149.37 44.93 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.67 0.271 . . . . 0.0 110.715 -179.728 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 728' ' ' ALA . . . . . . . . . . . . . . . -130.17 145.8 51.75 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.794 179.95 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 729' ' ' GLN . . . . . . . . . . . . . 10.2 tm0? . . . . . 0 C--O 1.248 1.01 0 CA-C-O 118.137 -0.935 . . . . 0.0 110.524 179.986 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 613' ' ' GLU . . . . . . . . . . . . . 77.8 mm-40 . . . . . 0 N--CA 1.485 1.294 0 CA-C-O 120.539 0.209 . . . . 0.0 110.817 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 614' ' ' GLY . . . . . . . . . . . . . . . 178.92 178.56 48.27 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.837 -0.697 . . . . 0.0 112.058 179.958 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 615' ' ' ARG . . . . . . . . . . . . . 27.5 ptt85 -117.54 148.23 42.07 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.219 0.533 . . . . 0.0 111.503 -179.946 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 616' ' ' ILE . . . . . . . . . . . . . 84.1 mt -124.01 135.87 62.17 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-N 115.268 -0.878 . . . . 0.0 110.644 -179.077 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 617' ' ' VAL . . . . . . . . . . . . . 79.9 t -105.28 127.14 60.21 Favored 'Isoleucine or valine' 0 C--O 1.234 0.285 0 N-CA-C 109.692 -0.484 . . . . 0.0 109.692 179.507 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 618' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -110.65 125.21 53.2 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.719 -0.673 . . . . 0.0 111.004 -178.421 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 619' ' ' VAL . . . . . 0.459 ' HA ' ' O ' ' A' ' 643' ' ' LEU . 59.3 t -118.39 117.99 56.5 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 N-CA-C 109.074 -0.713 . . . . 0.0 109.074 179.135 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 620' ' ' SER . . . . . 0.57 ' HB2' ' HB3' ' A' ' 662' ' ' ALA . 31.5 t -163.69 140.9 7.18 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.929 -179.039 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 621' ' ' GLU . . . . . . . . . . . . . 88.1 tt0 -77.47 -28.22 52.23 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.315 -0.857 . . . . 0.0 111.33 178.628 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 622' ' ' ASP . . . . . . . . . . . . . 62.9 t0 -85.71 108.82 18.22 Favored 'General case' 0 C--O 1.232 0.137 0 CA-C-O 121.167 0.508 . . . . 0.0 111.349 -178.279 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 623' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -64.7 -37.71 88.52 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.272 -0.876 . . . . 0.0 112.03 179.606 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 624' ' ' ALA . . . . . . . . . . . . . . . -60.82 -45.34 94.81 Favored 'General case' 0 N--CA 1.466 0.351 0 N-CA-C 112.739 0.644 . . . . 0.0 112.739 -178.2 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 625' ' ' THR . . . . . . . . . . . . . 18.5 p -73.4 -35.88 65.92 Favored 'General case' 0 CA--C 1.517 -0.324 0 C-N-CA 120.702 -0.399 . . . . 0.0 110.883 179.546 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 626' ' ' SER . . . . . 0.429 ' O ' HG22 ' A' ' 629' ' ' ILE . 68.1 m -63.77 -42.73 97.73 Favored 'General case' 0 N--CA 1.451 -0.42 0 CA-C-N 115.73 -0.668 . . . . 0.0 111.151 -179.676 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 627' ' ' THR . . . . . . . . . . . . . 91.3 m -62.31 -47.23 85.21 Favored 'General case' 0 CA--C 1.532 0.263 0 CA-C-O 120.848 0.356 . . . . 0.0 111.602 -179.93 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 628' ' ' LEU . . . . . . . . . . . . . 62.1 tp -65.04 -44.67 88.33 Favored 'General case' 0 CA--C 1.531 0.225 0 CA-C-N 116.128 -0.487 . . . . 0.0 112.1 -179.528 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 629' ' ' ILE . . . . . 0.429 HG22 ' O ' ' A' ' 626' ' ' SER . 1.4 tp -67.13 -32.48 57.93 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.548 0 N-CA-C 112.606 0.595 . . . . 0.0 112.606 -178.291 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 630' ' ' CYS . . . . . . . . . . . . . 76.8 m -63.95 -38.74 92.21 Favored 'General case' 0 N--CA 1.466 0.335 0 N-CA-C 112.54 0.57 . . . . 0.0 112.54 -179.361 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 631' ' ' SER . . . . . . . . . . . . . 95.4 p -62.25 -39.14 91.88 Favored 'General case' 0 C--N 1.33 -0.256 0 C-N-CA 121.149 -0.22 . . . . 0.0 111.565 -178.667 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 632' ' ' ILE . . . . . 0.543 ' O ' HG22 ' A' ' 635' ' ' THR . 96.5 mt -65.09 -48.01 85.53 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.279 0 CA-C-O 121.068 0.461 . . . . 0.0 110.961 179.635 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 633' ' ' LEU . . . . . . . . . . . . . 89.2 mt -67.67 -40.44 84.45 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.879 -0.601 . . . . 0.0 112.107 -179.631 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 634' ' ' THR . . . . . 0.521 ' HA ' ' O ' ' A' ' 638' ' ' TYR . 91.6 m -67.21 -41.65 85.41 Favored 'General case' 0 CA--C 1.53 0.195 0 CA-C-O 120.532 0.206 . . . . 0.0 111.338 -179.108 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 635' ' ' THR . . . . . 0.543 HG22 ' O ' ' A' ' 632' ' ' ILE . 0.9 OUTLIER -61.21 -18.96 60.91 Favored 'General case' 0 CA--C 1.535 0.389 0 CA-C-O 120.871 0.367 . . . . 0.0 111.248 179.789 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 636' ' ' ALA . . . . . . . . . . . . . . . -82.9 -3.33 56.84 Favored 'General case' 0 CA--C 1.53 0.211 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.837 178.841 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 637' ' ' GLY . . . . . . . . . . . . . . . 95.34 5.02 60.72 Favored Glycine 0 C--N 1.331 0.299 0 C-N-CA 121.118 -0.563 . . . . 0.0 113.05 179.778 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 638' ' ' TYR . . . . . 0.521 ' O ' ' HA ' ' A' ' 634' ' ' THR . 91.8 m-85 -100.7 139.3 36.58 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.85 0.357 . . . . 0.0 111.283 -179.971 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 639' ' ' GLN . . . . . . . . . . . . . 24.4 mp0 -85.97 138.0 32.31 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 109.929 -0.397 . . . . 0.0 109.929 179.197 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 640' ' ' VAL . . . . . . . . . . . . . 58.3 t -117.28 129.87 73.09 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-O 121.054 0.454 . . . . 0.0 111.926 -179.482 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 641' ' ' ILE . . . . . . . . . . . . . 31.1 mm -107.65 115.2 48.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 N-CA-C 108.349 -0.982 . . . . 0.0 108.349 178.611 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 642' ' ' TRP . . . . . . . . . . . . . 74.8 t90 -93.95 124.66 38.1 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.251 0.548 . . . . 0.0 112.418 -178.495 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 643' ' ' LEU . . . . . 0.459 ' O ' ' HA ' ' A' ' 619' ' ' VAL . 93.1 mt -127.87 145.48 50.93 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.151 -0.931 . . . . 0.0 110.703 179.412 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 644' ' ' VAL . . . . . . . . . . . . . 3.4 p -130.9 81.86 0.66 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.44 0 CA-C-O 121.609 0.719 . . . . 0.0 110.314 178.009 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 645' ' ' ASP . . . . . . . . . . . . . 19.1 t0 -179.41 -31.68 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.609 0 CA-C-N 115.559 -0.746 . . . . 0.0 111.651 -179.654 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 646' ' ' GLY . . . . . 0.43 ' HA3' ' HB3' ' A' ' 667' ' ' TYR . . . 73.06 28.72 65.97 Favored Glycine 0 CA--C 1.519 0.314 0 C-N-CA 121.077 -0.582 . . . . 0.0 113.428 -179.472 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 647' ' ' GLU . . . . . . . . . . . . . 7.3 mm-40 -69.31 115.55 8.72 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-O 121.084 0.469 . . . . 0.0 111.239 179.882 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 648' ' ' VAL . . . . . . . . . . . . . 79.0 t -61.33 -40.38 85.95 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-N 115.273 -0.876 . . . . 0.0 111.283 -179.71 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 649' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -61.16 -42.28 98.27 Favored 'General case' 0 C--N 1.332 -0.158 0 C-N-CA 120.769 -0.372 . . . . 0.0 110.213 -179.894 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 650' ' ' ARG . . . . . . . . . . . . . 90.4 mmt-85 -70.75 -41.2 72.08 Favored 'General case' 0 C--O 1.232 0.159 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.43 178.576 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 651' ' ' LEU . . . . . . . . . . . . . 84.1 mt -64.81 -41.59 95.67 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.745 179.403 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 652' ' ' LEU . . . . . . . . . . . . . 62.6 tp -65.27 -43.76 90.21 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.213 179.017 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 653' ' ' ALA . . . . . . . . . . . . . . . -63.2 -39.91 95.99 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-O 121.081 0.467 . . . . 0.0 111.412 -179.791 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 654' ' ' LEU . . . . . . . . . . . . . 75.7 mt -100.65 30.67 3.84 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.547 -0.751 . . . . 0.0 110.094 179.914 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 655' ' ' THR . . . . . . . . . . . . . 5.8 t -44.79 109.92 0.97 Allowed Pre-proline 0 CA--C 1.539 0.557 0 N-CA-C 113.418 0.896 . . . . 0.0 113.418 -178.283 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 656' ' ' PRO . . . . . . . . . . . . . 27.4 Cg_endo -92.59 -174.68 0.51 Allowed 'Trans proline' 0 C--N 1.347 0.487 0 C-N-CA 124.369 3.379 . . . . 0.0 111.897 178.963 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 657' ' ' ILE . . . . . . . . . . . . . 23.1 pt -81.16 -25.1 10.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 121.423 0.63 . . . . 0.0 109.715 177.573 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 658' ' ' ALA . . . . . . . . . . . . . . . -157.7 152.66 25.51 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.157 -0.929 . . . . 0.0 110.993 -179.716 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 659' ' ' VAL . . . . . . . . . . . . . 24.9 m -120.93 145.33 27.58 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-O 121.116 0.484 . . . . 0.0 110.92 179.146 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 660' ' ' LEU . . . . . . . . . . . . . 2.9 mp -115.18 119.31 35.95 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.6 -0.727 . . . . 0.0 110.006 179.288 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 661' ' ' LEU . . . . . . . . . . . . . 69.2 mt -109.47 112.86 25.22 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 109.371 -0.603 . . . . 0.0 109.371 179.942 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 662' ' ' ALA . . . . . 0.67 ' HB2' HD12 ' A' ' 691' ' ' LEU . . . -110.41 131.93 54.62 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 113.431 0.9 . . . . 0.0 113.431 -178.23 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 663' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -73.12 147.0 87.8 Favored Pre-proline 0 C--N 1.326 -0.428 0 CA-C-N 115.484 -0.78 . . . . 0.0 110.208 178.11 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 664' ' ' PRO . . . . . . . . . . . . . 70.1 Cg_endo -73.89 142.86 76.02 Favored 'Cis proline' 0 C--N 1.348 0.523 0 C-N-CA 123.237 -1.568 . . . . 0.0 112.677 -0.879 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 665' ' ' PHE . . . . . 0.402 ' HZ ' HD11 ' A' ' 690' ' ' ILE . 22.1 m-85 -77.6 136.96 38.32 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.72 -0.673 . . . . 0.0 111.002 179.351 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 666' ' ' SER . . . . . . . . . . . . . 78.2 p -91.29 -23.09 20.25 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.468 -0.333 . . . . 0.0 111.551 179.619 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 667' ' ' TYR . . . . . 0.43 ' HB3' ' HA3' ' A' ' 646' ' ' GLY . 12.7 p90 -80.91 -16.13 54.42 Favored 'General case' 0 CA--C 1.531 0.218 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.956 179.651 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 668' ' ' GLY . . . . . . . . . . . . . . . 100.18 -106.83 3.22 Favored Glycine 0 CA--C 1.521 0.414 0 C-N-CA 120.601 -0.809 . . . . 0.0 113.878 179.247 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 669' ' ' ASP . . . . . . . . . . . . . 35.2 t70 -82.88 111.21 18.57 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-O 120.941 0.401 . . . . 0.0 111.977 -178.049 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 670' ' ' VAL . . . . . . . . . . . . . 9.0 p -65.9 -30.03 48.73 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.449 0 N-CA-C 113.302 0.853 . . . . 0.0 113.302 -179.742 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 671' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -61.79 -41.71 98.08 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-N 117.888 0.313 . . . . 0.0 111.108 -179.078 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 672' ' ' GLU . . . . . . . . . . . . . 95.4 mt-10 -65.27 -40.2 93.62 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.839 179.112 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 673' ' ' LEU . . . . . . . . . . . . . 65.2 tp -64.19 -44.82 90.8 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.131 179.234 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 674' ' ' VAL . . . . . 0.678 HG11 ' HA3' ' A' ' 699' ' ' GLY . 59.1 t -62.99 -43.92 99.35 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.188 0 CA-C-N 115.777 -0.647 . . . . 0.0 109.859 179.642 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 675' ' ' ASP . . . . . . . . . . . . . 37.3 t70 -59.5 -41.02 88.93 Favored 'General case' 0 CA--C 1.518 -0.285 0 CA-C-N 115.87 -0.604 . . . . 0.0 110.476 178.93 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 676' ' ' GLN . . . . . . . . . . . . . 56.9 mt-30 -71.11 -41.17 70.93 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.015 179.958 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 677' ' ' LEU . . . . . . . . . . . . . 86.2 mt -67.2 -41.83 85.16 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 116.141 -0.482 . . . . 0.0 111.88 179.973 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 678' ' ' ARG . . . . . 0.539 ' HA ' ' O ' ' A' ' 681' ' ' CYS . 14.0 ptm180 -74.23 -24.66 59.35 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-O 121.106 0.479 . . . . 0.0 110.686 -179.296 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 679' ' ' GLN . . . . . . . . . . . . . 64.6 tt0 -65.71 -39.0 90.76 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.624 -0.716 . . . . 0.0 110.152 178.792 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 680' ' ' ARG . . . . . . . . . . . . . 33.1 mmt180 -89.37 -44.15 10.4 Favored 'General case' 0 C--N 1.333 -0.136 0 CA-C-N 115.8 -0.636 . . . . 0.0 111.377 -179.554 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 681' ' ' CYS . . . . . 0.539 ' O ' ' HA ' ' A' ' 678' ' ' ARG . 77.5 m -122.73 131.43 53.78 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.576 179.996 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 682' ' ' THR . . . . . 0.471 ' HB ' ' HD2' ' A' ' 683' ' ' PRO . 63.6 p -71.29 159.54 85.24 Favored Pre-proline 0 C--N 1.322 -0.619 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.575 -179.664 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 683' ' ' PRO . . . . . 0.471 ' HD2' ' HB ' ' A' ' 682' ' ' THR . 17.8 Cg_endo -59.41 -23.95 72.58 Favored 'Trans proline' 0 C--N 1.352 0.732 0 C-N-CA 122.483 2.122 . . . . 0.0 112.823 -179.829 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 684' ' ' GLU . . . . . 0.411 ' HG2' ' OG1' ' A' ' 682' ' ' THR . 24.8 pt-20 -79.4 -15.8 57.26 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.977 0.418 . . . . 0.0 110.397 179.074 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 685' ' ' GLN . . . . . . . . . . . . . 90.8 mt-30 -98.8 -36.34 9.84 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.013 -0.539 . . . . 0.0 111.355 179.954 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 686' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -128.03 115.27 18.23 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.696 -178.946 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 687' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -84.97 142.49 29.6 Favored 'General case' 0 CA--C 1.52 -0.187 0 N-CA-C 109.553 -0.536 . . . . 0.0 109.553 178.057 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 688' ' ' ILE . . . . . 0.403 HG22 HG12 ' A' ' 700' ' ' VAL . 78.7 mt -122.03 119.74 59.41 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.768 0 CA-C-O 121.336 0.589 . . . . 0.0 111.396 -178.96 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 689' ' ' PHE . . . . . . . . . . . . . 98.5 m-85 -117.09 141.89 47.69 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 114.906 -1.043 . . . . 0.0 109.59 178.779 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 690' ' ' ILE . . . . . 0.402 HD11 ' HZ ' ' A' ' 665' ' ' PHE . 18.2 tt -123.1 135.91 61.57 Favored 'Isoleucine or valine' 0 C--O 1.237 0.398 0 CA-C-O 121.171 0.51 . . . . 0.0 111.415 -179.647 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 691' ' ' LEU . . . . . 0.67 HD12 ' HB2' ' A' ' 662' ' ' ALA . 39.6 mt -109.35 125.91 52.85 Favored 'General case' 0 C--O 1.234 0.266 0 CA-C-N 115.741 -0.663 . . . . 0.0 109.679 179.831 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 692' ' ' GLY . . . . . 0.604 ' O ' ' HA ' ' A' ' 705' ' ' PRO . . . 175.32 -179.48 46.52 Favored Glycine 0 N--CA 1.446 -0.668 0 C-N-CA 120.676 -0.774 . . . . 0.0 112.199 -179.91 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 693' ' ' SER . . . . . . . . . . . . . 80.3 p -67.09 -36.37 81.82 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 120.715 0.293 . . . . 0.0 111.632 179.776 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 694' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -123.73 137.51 54.69 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.242 0.544 . . . . 0.0 110.97 179.948 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 695' ' ' GLY . . . . . 0.415 ' HA3' ' CB ' ' A' ' 703' ' ' TYR . . . -102.9 14.72 55.94 Favored Glycine 0 N--CA 1.449 -0.436 0 CA-C-N 115.327 -0.851 . . . . 0.0 112.882 179.543 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 696' ' ' ASN . . . . . . . . . . . . . 64.7 t30 -81.23 69.74 7.91 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 121.148 0.499 . . . . 0.0 111.284 -179.217 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 697' ' ' TYR . . . . . . . . . . . . . 97.0 m-85 -131.93 146.38 52.07 Favored 'General case' 0 N--CA 1.453 -0.316 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.027 179.174 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 698' ' ' GLN . . . . . . . . . . . . . 78.4 mt-30 -93.16 147.91 22.48 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.525 -179.831 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 699' ' ' GLY . . . . . 0.678 ' HA3' HG11 ' A' ' 674' ' ' VAL . . . 94.83 4.11 61.92 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.559 -0.829 . . . . 0.0 113.576 179.687 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 700' ' ' VAL . . . . . 0.403 HG12 HG22 ' A' ' 688' ' ' ILE . 29.5 m -119.16 148.92 21.79 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.272 0 CA-C-N 117.412 0.606 . . . . 0.0 110.142 179.149 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 701' ' ' ASP . . . . . 0.41 ' O ' ' HD2' ' A' ' 702' ' ' ARG . 34.4 t0 -80.75 -42.29 22.06 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.752 -0.658 . . . . 0.0 111.92 -179.177 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 702' ' ' ARG . . . . . 0.41 ' HD2' ' O ' ' A' ' 701' ' ' ASP . 2.0 mpt_? -141.02 164.37 30.47 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.763 0.316 . . . . 0.0 110.657 -178.486 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 703' ' ' TYR . . . . . 0.415 ' CB ' ' HA3' ' A' ' 695' ' ' GLY . 52.5 p90 -131.36 144.58 51.34 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.496 179.3 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 704' ' ' ILE . . . . . 0.454 HG22 HG22 ' A' ' 708' ' ' ILE . 31.2 mm -123.41 101.46 37.49 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-N 116.056 -0.52 . . . . 0.0 109.69 179.397 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 705' ' ' PRO . . . . . 0.604 ' HA ' ' O ' ' A' ' 692' ' ' GLY . 69.0 Cg_endo -72.41 145.67 43.29 Favored 'Trans proline' 0 C--N 1.345 0.355 0 C-N-CA 122.304 2.003 . . . . 0.0 113.788 -179.093 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 706' ' ' LEU . . . . . 0.702 HD23 HG23 ' A' ' 708' ' ' ILE . 81.5 mt -98.0 148.02 33.9 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-N 115.361 -0.836 . . . . 0.0 109.899 178.317 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 707' ' ' PRO . . . . . 0.51 ' C ' ' HA ' ' A' ' 706' ' ' LEU . 38.5 Cg_exo -64.34 138.22 31.72 Favored 'Cis proline' 0 C--N 1.348 0.551 0 C-N-CA 123.922 -1.283 . . . . 0.0 112.71 -1.219 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 708' ' ' ILE . . . . . 0.702 HG23 HD23 ' A' ' 706' ' ' LEU . 1.7 pt -68.04 137.42 24.6 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-O 121.383 0.611 . . . . 0.0 111.985 178.812 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 709' ' ' HIS . . . . . . . . . . . . . 69.8 m80 -107.15 111.2 63.54 Favored Pre-proline 0 C--N 1.321 -0.647 0 N-CA-C 108.377 -0.972 . . . . 0.0 108.377 177.297 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 710' ' ' PRO . . . . . . . . . . . . . 84.3 Cg_exo -53.03 -37.84 79.46 Favored 'Trans proline' 0 N--CA 1.479 0.636 0 C-N-CA 123.31 2.673 . . . . 0.0 114.381 -178.104 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 711' ' ' GLU . . . . . . . . . . . . . 88.7 tt0 -63.65 -42.88 98.06 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 112.208 0.447 . . . . 0.0 112.208 -178.903 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 712' ' ' SER . . . . . . . . . . . . . 51.1 m -90.64 -25.43 20.12 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 112.287 0.477 . . . . 0.0 112.287 -178.458 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 713' ' ' PHE . . . . . . . . . . . . . 68.1 t80 -59.25 -49.61 77.18 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-O 120.729 0.3 . . . . 0.0 111.228 -179.492 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 714' ' ' LEU . . . . . . . . . . . . . 58.3 tp -64.44 -41.28 96.66 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.259 179.731 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 715' ' ' GLN . . . . . . . . . . . . . 98.6 mm-40 -63.11 -42.55 99.58 Favored 'General case' 0 CA--C 1.531 0.245 0 CA-C-N 115.922 -0.581 . . . . 0.0 111.66 179.699 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 716' ' ' GLN . . . . . . . . . . . . . 79.6 mt-30 -64.13 -41.72 97.12 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-O 120.493 0.187 . . . . 0.0 111.349 179.947 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 717' ' ' VAL . . . . . . . . . . . . . 69.3 t -64.11 -44.16 97.59 Favored 'Isoleucine or valine' 0 C--O 1.234 0.248 0 CA-C-O 121.007 0.432 . . . . 0.0 109.945 178.758 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 718' ' ' THR . . . . . . . . . . . . . 90.3 m -61.88 -44.73 96.22 Favored 'General case' 0 CA--C 1.529 0.166 0 CA-C-N 115.673 -0.694 . . . . 0.0 111.041 179.708 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 719' ' ' MET . . . . . . . . . . . . . 38.7 mmt -61.31 -43.37 98.99 Favored 'General case' 0 N--CA 1.464 0.225 0 CA-C-O 120.545 0.212 . . . . 0.0 110.768 179.833 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 720' ' ' GLY . . . . . . . . . . . . . . . -64.03 -40.82 98.55 Favored Glycine 0 C--N 1.333 0.368 0 C-N-CA 120.747 -0.739 . . . . 0.0 111.624 178.235 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 721' ' ' LEU . . . . . . . . . . . . . 60.5 tp -64.64 -43.94 92.07 Favored 'General case' 0 CA--C 1.534 0.329 0 CA-C-N 115.349 -0.426 . . . . 0.0 111.353 179.327 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 722' ' ' THR . . . . . . . . . . . . . 70.4 p -70.74 -19.37 62.74 Favored 'General case' 0 N--CA 1.463 0.223 0 N-CA-C 112.127 0.418 . . . . 0.0 112.127 -179.958 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 723' ' ' SER . . . . . . . . . . . . . 73.3 m -63.65 -39.77 95.18 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-O 120.684 0.278 . . . . 0.0 110.582 179.111 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 724' ' ' LEU . . . . . . . . . . . . . 64.0 tp -63.56 -46.95 83.57 Favored 'General case' 0 C--O 1.232 0.153 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.232 179.526 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 725' ' ' ALA . . . . . . . . . . . . . . . -155.15 146.39 22.82 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.735 179.998 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 726' ' ' THR . . . . . . . . . . . . . 9.8 t -150.63 152.16 33.6 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.4 -0.364 . . . . 0.0 110.855 -179.806 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 727' ' ' SER . . . . . . . . . . . . . 90.2 p -87.99 -11.98 45.82 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.305 179.85 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 728' ' ' ALA . . . . . . . . . . . . . . . -149.15 150.57 32.89 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.445 -0.343 . . . . 0.0 110.89 -179.97 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 729' ' ' GLN . . . . . . . . . . . . . 9.1 tm0? . . . . . 0 C--O 1.249 1.052 0 CA-C-O 118.355 -0.831 . . . . 0.0 110.468 -179.874 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 613' ' ' GLU . . . . . 0.434 ' HA ' ' OXT' ' A' ' 729' ' ' GLN . 3.0 pt-20 . . . . . 0 N--CA 1.488 1.436 0 CA-C-O 121.084 0.469 . . . . 0.0 110.914 . . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 614' ' ' GLY . . . . . . . . . . . . . . . 108.42 131.52 6.46 Favored Glycine 0 N--CA 1.453 -0.229 0 CA-C-N 115.706 -0.679 . . . . 0.0 112.348 -179.94 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 615' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -117.23 125.23 50.81 Favored 'General case' 0 C--O 1.234 0.271 0 CA-C-O 120.802 0.334 . . . . 0.0 111.448 -179.394 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 616' ' ' ILE . . . . . 0.466 ' O ' ' HA ' ' A' ' 640' ' ' VAL . 85.9 mt -126.11 133.83 67.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 115.832 -0.622 . . . . 0.0 109.789 178.994 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 617' ' ' VAL . . . . . . . . . . . . . 91.5 t -106.78 127.94 61.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 121.055 0.455 . . . . 0.0 110.309 179.999 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 618' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -109.61 127.01 54.22 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.749 -0.66 . . . . 0.0 110.617 -178.93 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 619' ' ' VAL . . . . . . . . . . . . . 68.4 t -117.75 119.5 61.81 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-O 120.897 0.379 . . . . 0.0 110.186 179.979 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 620' ' ' SER . . . . . 0.646 ' HB2' ' HB3' ' A' ' 662' ' ' ALA . 32.1 t -171.36 137.9 1.14 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.638 -0.71 . . . . 0.0 110.923 -179.715 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 621' ' ' GLU . . . . . . . . . . . . . 26.3 pt-20 -82.99 -12.8 56.97 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.002 -0.545 . . . . 0.0 111.689 178.998 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 622' ' ' ASP . . . . . . . . . . . . . 35.8 t70 -91.22 110.06 21.33 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-O 120.884 0.373 . . . . 0.0 110.676 -179.333 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 623' ' ' GLU . . . . . . . . . . . . . 51.2 mp0 -63.16 -39.78 95.65 Favored 'General case' 0 CA--C 1.531 0.243 0 N-CA-C 112.763 0.653 . . . . 0.0 112.763 -178.854 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 624' ' ' ALA . . . . . . . . . . . . . . . -61.32 -45.73 93.22 Favored 'General case' 0 N--CA 1.464 0.246 0 N-CA-C 112.739 0.644 . . . . 0.0 112.739 -177.994 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 625' ' ' THR . . . . . 0.416 ' O ' HG22 ' A' ' 629' ' ' ILE . 89.7 m -70.84 -41.26 71.7 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.928 0.394 . . . . 0.0 110.623 179.629 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 626' ' ' SER . . . . . . . . . . . . . 66.7 m -62.47 -42.78 99.72 Favored 'General case' 0 CA--C 1.53 0.203 0 CA-C-N 115.713 -0.676 . . . . 0.0 112.468 -178.29 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 627' ' ' THR . . . . . . . . . . . . . 35.7 p -66.96 -39.65 87.31 Favored 'General case' 0 N--CA 1.466 0.345 0 N-CA-C 112.545 0.572 . . . . 0.0 112.545 -179.463 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 628' ' ' LEU . . . . . . . . . . . . . 62.9 tp -64.94 -47.07 78.99 Favored 'General case' 0 CA--C 1.533 0.322 0 N-CA-C 112.215 0.45 . . . . 0.0 112.215 -179.614 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 629' ' ' ILE . . . . . 0.431 HD13 HD11 ' A' ' 691' ' ' LEU . 16.0 tt -71.83 -36.55 58.83 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.395 0 N-CA-C 112.991 0.738 . . . . 0.0 112.991 -178.814 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 630' ' ' CYS . . . . . . . . . . . . . 85.8 m -62.63 -39.59 94.32 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-O 120.6 0.238 . . . . 0.0 111.242 -179.692 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 631' ' ' SER . . . . . . . . . . . . . 67.0 m -62.12 -41.23 98.02 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.684 179.7 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 632' ' ' ILE . . . . . . . . . . . . . 97.1 mt -63.02 -47.79 91.05 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.269 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.685 179.548 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 633' ' ' LEU . . . . . . . . . . . . . 79.8 mt -66.29 -40.34 89.97 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-N 115.902 -0.59 . . . . 0.0 112.335 -179.701 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 634' ' ' THR . . . . . 0.495 ' HA ' ' O ' ' A' ' 638' ' ' TYR . 77.1 m -65.94 -40.5 91.42 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 120.749 0.309 . . . . 0.0 110.629 -179.667 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 635' ' ' THR . . . . . . . . . . . . . 92.8 m -59.12 -38.82 80.5 Favored 'General case' 0 CA--C 1.529 0.161 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.248 178.983 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 636' ' ' ALA . . . . . . . . . . . . . . . -64.3 -17.48 63.69 Favored 'General case' 0 CA--C 1.533 0.294 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.363 178.759 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 637' ' ' GLY . . . . . . . . . . . . . . . 108.98 6.6 29.92 Favored Glycine 0 C--N 1.335 0.488 0 C-N-CA 121.063 -0.589 . . . . 0.0 113.331 179.61 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 638' ' ' TYR . . . . . 0.495 ' O ' ' HA ' ' A' ' 634' ' ' THR . 91.8 m-85 -100.35 141.72 32.81 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.913 0.356 . . . . 0.0 111.516 -179.862 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 639' ' ' GLN . . . . . . . . . . . . . 97.5 mt-30 -87.56 133.86 33.72 Favored 'General case' 0 CA--C 1.517 -0.307 0 N-CA-C 109.84 -0.43 . . . . 0.0 109.84 178.959 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 640' ' ' VAL . . . . . 0.466 ' HA ' ' O ' ' A' ' 616' ' ' ILE . 58.4 t -119.71 131.52 71.99 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 N-CA-C 112.69 0.626 . . . . 0.0 112.69 -179.022 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 641' ' ' ILE . . . . . . . . . . . . . 4.1 mp -109.57 116.35 51.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 N-CA-C 107.815 -1.18 . . . . 0.0 107.815 177.891 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 642' ' ' TRP . . . . . . . . . . . . . 20.9 t90 -96.64 125.77 41.34 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 112.549 0.574 . . . . 0.0 112.549 -177.695 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 643' ' ' LEU . . . . . . . . . . . . . 89.3 mt -122.61 143.48 49.73 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-N 115.417 -0.811 . . . . 0.0 110.594 179.304 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 644' ' ' VAL . . . . . . . . . . . . . 6.3 m -110.14 23.36 4.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 N-CA-C 112.565 0.58 . . . . 0.0 112.565 -179.799 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 645' ' ' ASP . . . . . . . . . . . . . 20.4 t0 -137.15 -34.71 0.71 Allowed 'General case' 0 N--CA 1.469 0.503 0 N-CA-C 113.221 0.823 . . . . 0.0 113.221 -178.24 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 646' ' ' GLY . . . . . . . . . . . . . . . 80.37 22.69 62.17 Favored Glycine 0 CA--C 1.522 0.476 0 C-N-CA 120.624 -0.798 . . . . 0.0 113.953 -179.683 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 647' ' ' GLU . . . . . . . . . . . . . 57.6 mm-40 -62.58 120.11 10.52 Favored 'General case' 0 C--O 1.231 0.124 0 CA-C-O 121.298 0.571 . . . . 0.0 111.104 179.98 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 648' ' ' VAL . . . . . . . . . . . . . 10.9 p -64.0 -31.02 51.62 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-N 114.941 -1.027 . . . . 0.0 111.974 -179.416 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 649' ' ' GLU . . . . . . . . . . . . . 78.8 mm-40 -63.54 -43.75 96.2 Favored 'General case' 0 C--O 1.232 0.144 0 N-CA-C 109.997 -0.371 . . . . 0.0 109.997 179.775 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 650' ' ' ARG . . . . . . . . . . . . . 74.6 mtm180 -71.63 -39.43 70.43 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.332 178.389 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 651' ' ' LEU . . . . . . . . . . . . . 85.8 mt -63.49 -41.7 98.56 Favored 'General case' 0 N--CA 1.462 0.172 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.187 179.027 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 652' ' ' LEU . . . . . . . . . . . . . 61.2 tp -64.61 -43.81 92.6 Favored 'General case' 0 CA--C 1.53 0.185 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.913 178.576 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 653' ' ' ALA . . . . . . . . . . . . . . . -62.97 -39.39 94.55 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.705 179.732 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 654' ' ' LEU . . . . . . . . . . . . . 75.2 mt -100.05 29.63 4.16 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.084 -179.413 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 655' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -31.59 104.33 0.22 Allowed Pre-proline 0 N--CA 1.473 0.718 0 O-C-N 124.527 1.142 . . . . 0.0 113.637 -179.516 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 656' ' ' PRO . . . . . . . . . . . . . 28.6 Cg_endo -93.56 177.91 1.19 Allowed 'Trans proline' 0 N--CA 1.461 -0.408 0 C-N-CA 123.634 2.889 . . . . 0.0 112.739 179.211 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 657' ' ' ILE . . . . . . . . . . . . . 89.6 mt -72.98 -38.49 56.12 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 N-CA-C 108.5 -0.926 . . . . 0.0 108.5 177.831 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 658' ' ' ALA . . . . . 0.443 ' HB2' ' HB2' ' A' ' 687' ' ' LYS . . . -151.66 155.06 37.6 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 114.216 -1.356 . . . . 0.0 111.609 -178.844 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 659' ' ' VAL . . . . . . . . . . . . . 17.5 m -122.06 146.38 27.29 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.897 178.924 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 660' ' ' LEU . . . . . . . . . . . . . 5.9 mt -117.85 116.99 28.08 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.525 -0.761 . . . . 0.0 110.277 179.263 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 661' ' ' LEU . . . . . . . . . . . . . 76.3 mt -106.22 113.6 27.23 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 179.44 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 662' ' ' ALA . . . . . 0.646 ' HB3' ' HB2' ' A' ' 620' ' ' SER . . . -106.3 130.85 54.07 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 112.536 0.569 . . . . 0.0 112.536 -178.679 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 663' ' ' GLU . . . . . 0.463 ' HA ' ' C ' ' A' ' 664' ' ' PRO . 96.9 mt-10 -73.22 145.93 86.31 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-N 115.4 -0.818 . . . . 0.0 110.881 178.816 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 664' ' ' PRO . . . . . 0.463 ' C ' ' HA ' ' A' ' 663' ' ' GLU . 23.9 Cg_exo -67.38 136.8 34.27 Favored 'Cis proline' 0 C--N 1.349 0.57 0 C-N-CA 123.769 -1.346 . . . . 0.0 112.348 -1.697 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 665' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -72.79 116.15 12.93 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.921 179.66 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 666' ' ' SER . . . . . . . . . . . . . 80.2 p -64.83 -38.37 90.76 Favored 'General case' 0 CA--C 1.531 0.224 0 CA-C-N 116.131 -0.486 . . . . 0.0 112.257 -179.448 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 667' ' ' TYR . . . . . . . . . . . . . 69.1 t80 -65.67 -24.03 66.92 Favored 'General case' 0 CA--C 1.534 0.346 0 CA-C-O 120.766 0.317 . . . . 0.0 111.671 179.629 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 668' ' ' GLY . . . . . . . . . . . . . . . 100.27 -103.57 2.66 Favored Glycine 0 N--CA 1.45 -0.411 0 C-N-CA 120.395 -0.907 . . . . 0.0 112.283 -179.175 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 669' ' ' ASP . . . . . 0.428 ' OD2' ' HG3' ' A' ' 672' ' ' GLU . 27.6 t70 -82.52 103.99 12.47 Favored 'General case' 0 C--N 1.327 -0.402 0 O-C-N 122.671 -0.311 . . . . 0.0 110.246 -179.467 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 670' ' ' VAL . . . . . . . . . . . . . 16.9 m -66.46 -24.45 33.24 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.326 0 N-CA-C 113.116 0.784 . . . . 0.0 113.116 -179.126 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 671' ' ' GLN . . . . . 0.473 ' HA ' HG22 ' A' ' 674' ' ' VAL . 23.7 mp0 -62.35 -39.71 93.99 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.882 0.372 . . . . 0.0 110.723 179.837 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 672' ' ' GLU . . . . . 0.428 ' HG3' ' OD2' ' A' ' 669' ' ' ASP . 95.6 mt-10 -64.89 -38.79 92.14 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.323 178.342 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 673' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -68.23 -46.67 69.89 Favored 'General case' 0 CA--C 1.519 -0.231 0 CA-C-N 115.925 -0.58 . . . . 0.0 111.322 179.981 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 674' ' ' VAL . . . . . 0.473 HG22 ' HA ' ' A' ' 671' ' ' GLN . 34.3 m -65.37 -36.92 78.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 N-CA-C 109.977 -0.379 . . . . 0.0 109.977 -179.631 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 675' ' ' ASP . . . . . 0.433 ' O ' ' HB2' ' A' ' 679' ' ' GLN . 36.9 t70 -62.58 -40.86 98.22 Favored 'General case' 0 C--O 1.225 -0.232 0 N-CA-C 109.827 -0.435 . . . . 0.0 109.827 177.388 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 676' ' ' GLN . . . . . . . . . . . . . 55.3 mt-30 -70.64 -40.77 72.88 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.74 179.551 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 677' ' ' LEU . . . . . . . . . . . . . 85.2 mt -64.85 -41.17 95.92 Favored 'General case' 0 C--N 1.333 -0.113 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.28 179.559 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 678' ' ' ARG . . . . . 0.635 ' HA ' ' O ' ' A' ' 681' ' ' CYS . 84.9 mtp180 -81.9 -15.18 54.78 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-N 116.465 -0.334 . . . . 0.0 111.655 -179.312 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 679' ' ' GLN . . . . . 0.433 ' HB2' ' O ' ' A' ' 675' ' ' ASP . 53.1 tt0 -65.74 -39.9 91.57 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.154 179.835 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 680' ' ' ARG . . . . . 0.414 ' H ' ' HG2' ' A' ' 680' ' ' ARG . 0.0 OUTLIER -107.49 -29.12 9.4 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.405 -0.361 . . . . 0.0 111.909 -179.744 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 681' ' ' CYS . . . . . 0.635 ' O ' ' HA ' ' A' ' 678' ' ' ARG . 76.0 m -118.95 131.02 56.01 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.71 0.29 . . . . 0.0 110.563 179.684 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 682' ' ' THR . . . . . 0.411 ' HB ' ' HD2' ' A' ' 683' ' ' PRO . 63.4 p -72.69 158.08 87.87 Favored Pre-proline 0 C--N 1.325 -0.483 0 N-CA-C 110.09 -0.337 . . . . 0.0 110.09 179.859 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 683' ' ' PRO . . . . . 0.411 ' HD2' ' HB ' ' A' ' 682' ' ' THR . 18.0 Cg_endo -60.02 -26.46 82.48 Favored 'Trans proline' 0 C--N 1.348 0.543 0 C-N-CA 122.169 1.913 . . . . 0.0 112.032 179.516 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 684' ' ' GLU . . . . . . . . . . . . . 51.6 mp0 -71.3 -38.74 71.75 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 121.063 0.459 . . . . 0.0 110.352 178.571 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 685' ' ' GLN . . . . . . . . . . . . . 90.1 mt-30 -72.42 -40.73 66.89 Favored 'General case' 0 N--CA 1.462 0.127 0 CA-C-N 115.611 -0.722 . . . . 0.0 111.942 179.516 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 686' ' ' LEU . . . . . . . . . . . . . 51.5 tp -131.31 119.25 21.48 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.501 -178.81 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 687' ' ' LYS . . . . . 0.443 ' HB2' ' HB2' ' A' ' 658' ' ' ALA . 75.2 mmtt -88.4 145.4 25.81 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.381 0.61 . . . . 0.0 110.647 179.191 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 688' ' ' ILE . . . . . 0.529 HG22 HG12 ' A' ' 700' ' ' VAL . 78.1 mt -123.78 120.91 61.05 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.679 0 CA-C-N 115.572 -0.74 . . . . 0.0 110.855 -179.072 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 689' ' ' PHE . . . . . 0.471 ' CD2' ' HB2' ' A' ' 702' ' ' ARG . 97.9 m-85 -118.76 144.78 46.06 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.09 -0.959 . . . . 0.0 110.096 179.418 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 690' ' ' ILE . . . . . . . . . . . . . 18.7 tt -127.01 139.96 50.42 Favored 'Isoleucine or valine' 0 C--O 1.236 0.363 0 CA-C-O 121.113 0.482 . . . . 0.0 111.196 179.518 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 691' ' ' LEU . . . . . 0.563 HD12 ' HB2' ' A' ' 662' ' ' ALA . 58.5 mt -110.37 133.23 53.46 Favored 'General case' 0 C--O 1.234 0.272 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.142 179.94 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 692' ' ' GLY . . . . . 0.592 ' O ' ' HA ' ' A' ' 705' ' ' PRO . . . 168.31 -176.56 42.71 Favored Glycine 0 N--CA 1.446 -0.666 0 CA-C-N 115.814 -0.63 . . . . 0.0 111.836 179.933 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 693' ' ' SER . . . . . . . . . . . . . 80.1 p -67.97 -36.62 80.35 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.811 0.339 . . . . 0.0 111.19 179.497 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 694' ' ' LYS . . . . . . . . . . . . . 64.7 mttp -124.39 136.77 54.33 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.045 0.45 . . . . 0.0 110.604 179.44 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 695' ' ' GLY . . . . . 0.522 ' HA3' ' CB ' ' A' ' 703' ' ' TYR . . . -103.56 14.01 53.98 Favored Glycine 0 N--CA 1.449 -0.438 0 CA-C-N 115.512 -0.767 . . . . 0.0 112.956 179.587 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 696' ' ' ASN . . . . . . . . . . . . . 64.9 t30 -82.03 72.29 9.08 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.958 0.408 . . . . 0.0 111.531 -179.091 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 697' ' ' TYR . . . . . . . . . . . . . 97.4 m-85 -131.37 144.92 51.58 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.175 178.959 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 698' ' ' GLN . . . . . . . . . . . . . 22.2 mp0 -82.4 147.21 28.91 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.747 179.81 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 699' ' ' GLY . . . . . 0.472 ' HA3' HG21 ' A' ' 674' ' ' VAL . . . 94.21 2.55 64.0 Favored Glycine 0 C--O 1.228 -0.224 0 C-N-CA 120.722 -0.752 . . . . 0.0 114.02 179.267 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 700' ' ' VAL . . . . . 0.529 HG12 HG22 ' A' ' 688' ' ' ILE . 24.9 m -119.61 150.51 22.1 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.298 0 CA-C-N 117.706 0.753 . . . . 0.0 110.165 179.283 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 701' ' ' ASP . . . . . . . . . . . . . 28.8 t0 -88.01 -39.79 14.39 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.958 -179.387 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 702' ' ' ARG . . . . . 0.471 ' HB2' ' CD2' ' A' ' 689' ' ' PHE . 90.7 mmt-85 -140.95 161.48 37.73 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.705 -178.394 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 703' ' ' TYR . . . . . 0.522 ' CB ' ' HA3' ' A' ' 695' ' ' GLY . 52.6 p90 -130.45 146.58 52.03 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.562 179.378 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 704' ' ' ILE . . . . . 0.514 ' HB ' ' CD2' ' A' ' 691' ' ' LEU . 52.9 mt -129.1 97.19 26.78 Favored Pre-proline 0 C--O 1.234 0.258 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.317 -179.982 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 705' ' ' PRO . . . . . 0.592 ' HA ' ' O ' ' A' ' 692' ' ' GLY . 74.5 Cg_endo -74.59 154.31 44.5 Favored 'Trans proline' 0 C--N 1.347 0.456 0 C-N-CA 122.92 2.413 . . . . 0.0 113.626 -179.126 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 706' ' ' LEU . . . . . 0.467 ' HA ' ' C ' ' A' ' 707' ' ' PRO . 7.2 mp -97.1 148.6 34.63 Favored Pre-proline 0 CA--C 1.531 0.25 0 CA-C-N 115.738 -0.664 . . . . 0.0 110.041 178.892 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 707' ' ' PRO . . . . . 0.467 ' C ' ' HA ' ' A' ' 706' ' ' LEU . 55.3 Cg_endo -69.48 138.41 48.19 Favored 'Cis proline' 0 C--N 1.347 0.495 0 C-N-CA 123.001 -1.666 . . . . 0.0 112.435 -0.293 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 708' ' ' ILE . . . . . 0.469 HG12 HG22 ' A' ' 704' ' ' ILE . 71.9 mt -81.16 118.94 29.81 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-N 115.859 -0.609 . . . . 0.0 110.55 -179.94 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 709' ' ' HIS . . . . . . . . . . . . . 68.6 m80 -89.45 122.55 68.29 Favored Pre-proline 0 C--N 1.327 -0.41 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.31 179.35 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 710' ' ' PRO . . . . . . . . . . . . . 88.2 Cg_exo -52.72 -38.65 77.38 Favored 'Trans proline' 0 N--CA 1.481 0.742 0 C-N-CA 123.474 2.782 . . . . 0.0 114.7 -178.622 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 711' ' ' GLU . . . . . . . . . . . . . 88.8 tt0 -64.03 -45.55 88.38 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-O 120.946 0.403 . . . . 0.0 111.59 -178.839 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 712' ' ' SER . . . . . . . . . . . . . 50.5 m -80.59 -26.67 37.73 Favored 'General case' 0 CA--C 1.516 -0.355 0 CA-C-N 116.09 -0.505 . . . . 0.0 111.181 -179.711 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 713' ' ' PHE . . . . . 0.477 ' O ' HG23 ' A' ' 717' ' ' VAL . 86.7 t80 -60.2 -50.0 75.4 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.668 -0.242 . . . . 0.0 111.069 -179.533 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 714' ' ' LEU . . . . . 0.464 HD13 ' HA ' ' A' ' 714' ' ' LEU . 1.5 mm? -66.31 -42.88 87.65 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-O 120.853 0.358 . . . . 0.0 110.746 179.876 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 715' ' ' GLN . . . . . . . . . . . . . 72.1 tp60 -63.19 -42.26 99.3 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.924 179.525 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 716' ' ' GLN . . . . . . . . . . . . . 12.5 tp-100 -65.84 -41.51 91.64 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.852 179.694 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 717' ' ' VAL . . . . . 0.477 HG23 ' O ' ' A' ' 713' ' ' PHE . 55.7 t -63.41 -42.72 97.29 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.107 0 N-CA-C 109.875 -0.417 . . . . 0.0 109.875 178.524 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 718' ' ' THR . . . . . . . . . . . . . 91.9 m -61.09 -43.85 98.25 Favored 'General case' 0 C--O 1.235 0.298 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.364 179.13 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 719' ' ' MET . . . . . 0.552 ' O ' HG22 ' A' ' 722' ' ' THR . 18.3 tpt -61.17 -45.88 92.79 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.001 178.987 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 720' ' ' GLY . . . . . . . . . . . . . . . -65.27 -37.81 94.38 Favored Glycine 0 CA--C 1.52 0.364 0 CA-C-N 116.012 -0.54 . . . . 0.0 112.294 178.286 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 721' ' ' LEU . . . . . 0.422 ' O ' HD22 ' A' ' 724' ' ' LEU . 63.9 tp -60.99 -43.42 98.86 Favored 'General case' 0 N--CA 1.463 0.223 0 C-N-CA 123.255 0.622 . . . . 0.0 112.568 -179.359 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 722' ' ' THR . . . . . 0.552 HG22 ' O ' ' A' ' 719' ' ' MET . 5.4 t -64.99 161.68 18.16 Favored 'General case' 0 CA--C 1.534 0.345 0 CA-C-O 120.756 0.312 . . . . 0.0 111.595 -179.326 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 723' ' ' SER . . . . . . . . . . . . . 50.1 m 62.49 46.79 5.44 Favored 'General case' 0 N--CA 1.467 0.423 0 CA-C-N 115.946 -0.57 . . . . 0.0 111.227 -179.215 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 724' ' ' LEU . . . . . 0.723 HD11 ' HB3' ' A' ' 727' ' ' SER . 1.3 pt? -119.87 -179.57 3.95 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.362 179.828 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 725' ' ' ALA . . . . . . . . . . . . . . . -78.41 -71.75 0.41 Allowed 'General case' 0 N--CA 1.462 0.154 0 N-CA-C 111.814 0.301 . . . . 0.0 111.814 -179.229 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 726' ' ' THR . . . . . . . . . . . . . 77.8 p -130.75 149.98 52.14 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.585 0.231 . . . . 0.0 111.206 180.0 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 727' ' ' SER . . . . . 0.723 ' HB3' HD11 ' A' ' 724' ' ' LEU . 95.6 p -157.12 161.06 39.38 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.42 -0.355 . . . . 0.0 110.513 179.799 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 728' ' ' ALA . . . . . . . . . . . . . . . -149.61 147.14 27.77 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.374 -0.376 . . . . 0.0 110.527 179.519 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 729' ' ' GLN . . . . . 0.434 ' OXT' ' HA ' ' A' ' 613' ' ' GLU . 6.4 tm0? . . . . . 0 C--O 1.25 1.08 0 CA-C-O 118.063 -0.97 . . . . 0.0 110.377 179.885 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 613' ' ' GLU . . . . . . . . . . . . . 75.6 mm-40 . . . . . 0 N--CA 1.487 1.379 0 CA-C-O 120.895 0.379 . . . . 0.0 110.698 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 614' ' ' GLY . . . . . . . . . . . . . . . -178.85 173.34 45.61 Favored Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.662 -0.78 . . . . 0.0 112.534 179.863 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 615' ' ' ARG . . . . . . . . . . . . . 35.7 mtp-105 -117.32 126.55 52.9 Favored 'General case' 0 C--O 1.234 0.271 0 CA-C-O 120.72 0.295 . . . . 0.0 111.088 -179.873 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 616' ' ' ILE . . . . . 0.447 ' O ' ' HA ' ' A' ' 640' ' ' VAL . 84.7 mt -126.35 133.96 67.53 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.29 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.398 179.483 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 617' ' ' VAL . . . . . . . . . . . . . 77.2 t -104.53 127.67 58.73 Favored 'Isoleucine or valine' 0 C--O 1.234 0.289 0 CA-C-O 120.995 0.426 . . . . 0.0 109.887 179.658 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 618' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -111.92 127.44 55.85 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.809 -0.632 . . . . 0.0 111.02 -178.456 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 619' ' ' VAL . . . . . . . . . . . . . 80.4 t -115.73 117.75 56.58 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 N-CA-C 109.262 -0.644 . . . . 0.0 109.262 179.405 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 620' ' ' SER . . . . . 0.49 ' HB2' ' HB3' ' A' ' 662' ' ' ALA . 47.2 t -162.23 139.8 8.48 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.944 -0.571 . . . . 0.0 111.554 -178.838 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 621' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -82.15 -26.89 33.05 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.747 -0.661 . . . . 0.0 111.182 178.705 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 622' ' ' ASP . . . . . . . . . . . . . 36.9 t70 -86.08 112.74 21.55 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.921 0.391 . . . . 0.0 111.64 -178.32 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 623' ' ' GLU . . . . . . . . . . . . . 50.9 mp0 -62.9 -40.02 96.3 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.438 -0.801 . . . . 0.0 112.447 -179.593 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 624' ' ' ALA . . . . . . . . . . . . . . . -60.8 -45.53 94.04 Favored 'General case' 0 N--CA 1.466 0.337 0 N-CA-C 112.592 0.59 . . . . 0.0 112.592 -178.283 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 625' ' ' THR . . . . . 0.446 ' O ' HG22 ' A' ' 629' ' ' ILE . 90.6 m -68.8 -39.86 79.87 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.965 0.412 . . . . 0.0 110.021 179.538 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 626' ' ' SER . . . . . . . . . . . . . 69.1 m -61.44 -41.13 96.73 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.494 -0.775 . . . . 0.0 111.866 -178.937 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 627' ' ' THR . . . . . . . . . . . . . 65.9 p -67.37 -35.23 78.92 Favored 'General case' 0 N--CA 1.466 0.336 0 N-CA-C 112.382 0.512 . . . . 0.0 112.382 -179.812 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 628' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -71.72 -49.42 39.55 Favored 'General case' 0 N--CA 1.463 0.22 0 N-CA-C 111.925 0.343 . . . . 0.0 111.925 -179.47 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 629' ' ' ILE . . . . . 0.446 HG22 ' O ' ' A' ' 625' ' ' THR . 18.7 tt -68.34 -37.52 78.05 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.384 0 N-CA-C 112.19 0.441 . . . . 0.0 112.19 -179.124 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 630' ' ' CYS . . . . . . . . . . . . . 48.2 t -61.61 -43.66 98.44 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.857 179.776 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 631' ' ' SER . . . . . . . . . . . . . 70.2 m -61.91 -41.51 98.0 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.962 -179.611 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 632' ' ' ILE . . . . . . . . . . . . . 97.4 mt -62.45 -48.54 87.8 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.283 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.863 179.819 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 633' ' ' LEU . . . . . . . . . . . . . 84.3 mt -67.2 -40.0 86.4 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-N 115.867 -0.606 . . . . 0.0 112.395 -179.708 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 634' ' ' THR . . . . . 0.53 ' HA ' ' O ' ' A' ' 638' ' ' TYR . 77.7 m -65.74 -40.08 91.76 Favored 'General case' 0 CA--C 1.529 0.168 0 CA-C-O 120.701 0.286 . . . . 0.0 110.852 -179.458 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 635' ' ' THR . . . . . . . . . . . . . 93.2 m -59.09 -38.95 80.71 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.261 179.28 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 636' ' ' ALA . . . . . . . . . . . . . . . -64.67 -16.84 63.44 Favored 'General case' 0 CA--C 1.533 0.305 0 CA-C-N 115.931 -0.577 . . . . 0.0 111.329 178.905 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 637' ' ' GLY . . . . . . . . . . . . . . . 108.67 7.34 29.82 Favored Glycine 0 C--N 1.333 0.413 0 C-N-CA 120.929 -0.653 . . . . 0.0 113.182 179.681 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 638' ' ' TYR . . . . . 0.53 ' O ' ' HA ' ' A' ' 634' ' ' THR . 96.5 m-85 -100.23 141.46 33.05 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.803 0.302 . . . . 0.0 111.415 -179.847 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 639' ' ' GLN . . . . . . . . . . . . . 78.5 mt-30 -87.91 133.26 33.96 Favored 'General case' 0 CA--C 1.517 -0.325 0 N-CA-C 109.796 -0.446 . . . . 0.0 109.796 179.199 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 640' ' ' VAL . . . . . 0.447 ' HA ' ' O ' ' A' ' 616' ' ' ILE . 60.1 t -118.11 130.47 72.93 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 N-CA-C 112.547 0.573 . . . . 0.0 112.547 -179.161 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 641' ' ' ILE . . . . . . . . . . . . . 4.0 mp -109.36 115.37 49.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 N-CA-C 108.013 -1.106 . . . . 0.0 108.013 178.09 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 642' ' ' TRP . . . . . . . . . . . . . 22.0 t90 -94.47 126.03 39.49 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 121.237 0.541 . . . . 0.0 112.26 -177.986 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 643' ' ' LEU . . . . . . . . . . . . . 89.6 mt -121.15 142.89 49.45 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-N 115.407 -0.815 . . . . 0.0 110.779 179.531 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 644' ' ' VAL . . . . . . . . . . . . . 5.7 m -102.93 27.26 1.01 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.81 179.711 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 645' ' ' ASP . . . . . 0.426 ' O ' ' HB2' ' A' ' 666' ' ' SER . 33.6 t70 -142.48 -73.86 0.3 Allowed 'General case' 0 N--CA 1.465 0.296 0 CA-C-O 120.736 0.303 . . . . 0.0 111.76 -179.458 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 646' ' ' GLY . . . . . . . . . . . . . . . 104.93 27.14 6.06 Favored Glycine 0 CA--C 1.518 0.278 0 C-N-CA 120.819 -0.705 . . . . 0.0 113.612 -179.894 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 647' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -71.07 143.35 50.72 Favored 'General case' 0 N--CA 1.453 -0.302 0 CA-C-O 121.529 0.681 . . . . 0.0 110.93 179.436 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 648' ' ' VAL . . . . . . . . . . . . . 78.5 t -61.22 -40.13 84.9 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 CA-C-N 114.553 -1.203 . . . . 0.0 112.666 -178.231 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 649' ' ' GLU . . . . . . . . . . . . . 98.3 mt-10 -60.31 -45.03 94.83 Favored 'General case' 0 C--O 1.232 0.157 0 C-N-CA 120.58 -0.448 . . . . 0.0 111.339 -178.531 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 650' ' ' ARG . . . . . . . . . . . . . 54.8 mmm-85 -71.02 -40.6 71.68 Favored 'General case' 0 C--N 1.33 -0.25 0 C-N-CA 121.02 -0.272 . . . . 0.0 110.987 178.682 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 651' ' ' LEU . . . . . . . . . . . . . 86.4 mt -64.52 -41.65 96.26 Favored 'General case' 0 N--CA 1.461 0.105 0 CA-C-N 116.438 -0.346 . . . . 0.0 110.615 179.393 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 652' ' ' LEU . . . . . . . . . . . . . 60.8 tp -65.81 -43.37 88.84 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.226 178.751 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 653' ' ' ALA . . . . . . . . . . . . . . . -63.02 -39.72 95.6 Favored 'General case' 0 N--CA 1.466 0.332 0 N-CA-C 112.075 0.398 . . . . 0.0 112.075 -179.802 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 654' ' ' LEU . . . . . . . . . . . . . 75.3 mt -101.74 29.15 5.1 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.091 -179.354 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 655' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -33.92 104.96 0.25 Allowed Pre-proline 0 N--CA 1.472 0.651 0 O-C-N 124.571 1.169 . . . . 0.0 114.095 -179.094 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 656' ' ' PRO . . . . . . . . . . . . . 22.8 Cg_endo -93.72 -179.35 0.81 Allowed 'Trans proline' 0 C--N 1.345 0.385 0 C-N-CA 123.814 3.009 . . . . 0.0 112.473 178.271 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 657' ' ' ILE . . . . . 0.462 ' O ' ' HA ' ' A' ' 686' ' ' LEU . 94.9 mt -72.04 -38.17 62.79 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 N-CA-C 108.557 -0.905 . . . . 0.0 108.557 177.765 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 658' ' ' ALA . . . . . . . . . . . . . . . -152.61 155.73 37.92 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 114.282 -1.326 . . . . 0.0 111.552 -178.598 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 659' ' ' VAL . . . . . 0.457 HG13 HD11 ' A' ' 686' ' ' LEU . 18.3 m -122.05 145.45 28.73 Favored 'Isoleucine or valine' 0 C--O 1.235 0.316 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.942 178.971 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 660' ' ' LEU . . . . . . . . . . . . . 5.4 mt -116.44 115.02 25.06 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.507 -0.77 . . . . 0.0 109.215 178.435 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 661' ' ' LEU . . . . . . . . . . . . . 62.0 mt -104.24 115.6 30.7 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 109.813 -0.44 . . . . 0.0 109.813 -179.088 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 662' ' ' ALA . . . . . 0.49 ' HB3' ' HB2' ' A' ' 620' ' ' SER . . . -108.42 132.23 53.98 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 112.763 0.653 . . . . 0.0 112.763 -178.973 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 663' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -76.65 146.14 76.23 Favored Pre-proline 0 C--N 1.326 -0.421 0 CA-C-N 115.376 -0.829 . . . . 0.0 109.978 178.081 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 664' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -72.43 139.97 63.59 Favored 'Cis proline' 0 C--N 1.348 0.551 0 C-N-CA 123.446 -1.481 . . . . 0.0 112.897 -0.751 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 665' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -83.87 144.52 29.18 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.366 -0.833 . . . . 0.0 112.27 -179.816 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 666' ' ' SER . . . . . 0.426 ' HB2' ' O ' ' A' ' 645' ' ' ASP . 47.9 m -98.04 -33.74 11.06 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.251 179.301 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 667' ' ' TYR . . . . . . . . . . . . . 18.9 p90 -61.67 -16.11 45.84 Favored 'General case' 0 CA--C 1.536 0.409 0 N-CA-C 112.7 0.63 . . . . 0.0 112.7 179.863 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 668' ' ' GLY . . . . . . . . . . . . . . . 101.47 -120.38 6.84 Favored Glycine 0 N--CA 1.449 -0.489 0 C-N-CA 120.614 -0.803 . . . . 0.0 113.523 179.228 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 669' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -76.26 118.52 19.06 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.995 0.426 . . . . 0.0 111.849 -178.07 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 670' ' ' VAL . . . . . 0.426 ' O ' HG23 ' A' ' 674' ' ' VAL . 77.8 t -61.78 -43.15 96.85 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.289 0 CA-C-N 115.446 -0.797 . . . . 0.0 112.345 -179.469 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 671' ' ' GLN . . . . . . . . . . . . . 20.8 mp0 -60.76 -42.53 97.65 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.562 0.22 . . . . 0.0 111.447 -178.029 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 672' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -65.11 -40.32 94.35 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.515 -0.311 . . . . 0.0 110.957 179.408 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 673' ' ' LEU . . . . . . . . . . . . . 63.1 tp -63.4 -43.52 97.3 Favored 'General case' 0 C--N 1.331 -0.23 0 N-CA-C 109.561 -0.533 . . . . 0.0 109.561 178.754 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 674' ' ' VAL . . . . . 0.734 HG11 ' HA3' ' A' ' 699' ' ' GLY . 55.0 t -61.83 -44.86 99.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 115.18 -0.918 . . . . 0.0 110.107 179.438 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 675' ' ' ASP . . . . . . . . . . . . . 99.5 m-20 -60.91 -39.61 89.99 Favored 'General case' 0 CA--C 1.519 -0.226 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.47 179.015 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 676' ' ' GLN . . . . . 0.42 ' O ' ' HG2' ' A' ' 680' ' ' ARG . 57.2 mt-30 -70.77 -41.85 71.19 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.396 -0.366 . . . . 0.0 110.709 179.788 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 677' ' ' LEU . . . . . . . . . . . . . 84.8 mt -65.21 -42.67 93.25 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.113 179.457 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 678' ' ' ARG . . . . . 0.485 ' HA ' ' O ' ' A' ' 681' ' ' CYS . 82.9 mtp180 -69.66 -35.71 75.4 Favored 'General case' 0 N--CA 1.468 0.444 0 CA-C-O 120.958 0.409 . . . . 0.0 111.194 179.677 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 679' ' ' GLN . . . . . . . . . . . . . 55.1 tt0 -63.93 -37.67 88.26 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.739 -0.664 . . . . 0.0 110.247 179.444 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 680' ' ' ARG . . . . . 0.42 ' HG2' ' O ' ' A' ' 676' ' ' GLN . 88.2 mmt-85 -84.47 -45.18 12.92 Favored 'General case' 0 N--CA 1.461 0.109 0 CA-C-N 116.321 -0.399 . . . . 0.0 110.97 179.749 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 681' ' ' CYS . . . . . 0.485 ' O ' ' HA ' ' A' ' 678' ' ' ARG . 76.8 m -127.99 132.19 49.19 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.408 179.944 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 682' ' ' THR . . . . . . . . . . . . . 69.3 p -67.55 157.5 85.72 Favored Pre-proline 0 C--N 1.322 -0.618 0 CA-C-N 116.49 -0.323 . . . . 0.0 110.233 179.891 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 683' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -59.41 -26.52 82.23 Favored 'Trans proline' 0 C--N 1.348 0.507 0 C-N-CA 122.167 1.912 . . . . 0.0 111.918 179.751 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 684' ' ' GLU . . . . . . . . . . . . . 51.9 mp0 -71.75 -38.59 70.39 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.278 0.561 . . . . 0.0 109.977 178.348 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 685' ' ' GLN . . . . . . . . . . . . . 64.9 tt0 -71.61 -41.55 68.76 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-N 115.35 -0.841 . . . . 0.0 111.418 -179.943 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 686' ' ' LEU . . . . . 0.462 ' HA ' ' O ' ' A' ' 657' ' ' ILE . 0.1 OUTLIER -138.92 127.4 23.06 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.727 -178.867 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 687' ' ' LYS . . . . . . . . . . . . . 21.2 mtmm -91.92 146.59 23.62 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.344 0.592 . . . . 0.0 110.661 179.242 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 688' ' ' ILE . . . . . 0.484 HG22 HG12 ' A' ' 700' ' ' VAL . 77.3 mt -122.75 123.56 68.55 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 CA-C-N 115.733 -0.667 . . . . 0.0 111.021 -179.277 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 689' ' ' PHE . . . . . . . . . . . . . 93.3 m-85 -122.75 147.29 46.67 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.409 -0.814 . . . . 0.0 110.408 179.166 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 690' ' ' ILE . . . . . . . . . . . . . 19.7 tt -126.66 140.88 47.66 Favored 'Isoleucine or valine' 0 C--O 1.235 0.326 0 CA-C-O 121.332 0.587 . . . . 0.0 111.965 -179.481 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 691' ' ' LEU . . . . . 0.541 HD23 ' HB ' ' A' ' 704' ' ' ILE . 77.6 mt -112.42 140.32 47.26 Favored 'General case' 0 C--O 1.234 0.263 0 CA-C-N 115.376 -0.829 . . . . 0.0 109.886 179.498 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 692' ' ' GLY . . . . . 0.474 ' O ' ' HA ' ' A' ' 705' ' ' PRO . . . 179.14 -167.64 37.92 Favored Glycine 0 N--CA 1.446 -0.658 0 C-N-CA 120.84 -0.695 . . . . 0.0 111.818 -179.675 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 693' ' ' SER . . . . . . . . . . . . . 79.9 p -63.24 -37.26 86.55 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.987 0.422 . . . . 0.0 111.019 179.836 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 694' ' ' LYS . . . . . . . . . . . . . 2.6 mmmt -143.35 -47.44 0.3 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.716 179.383 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 695' ' ' GLY . . . . . . . . . . . . . . . 114.78 129.26 4.66 Favored Glycine 0 N--CA 1.451 -0.302 0 N-CA-C 111.461 -0.656 . . . . 0.0 111.461 -179.442 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 696' ' ' ASN . . . . . . . . . . . . . 48.6 p-10 -81.11 -15.88 54.67 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 116.899 0.349 . . . . 0.0 111.822 -179.215 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 697' ' ' TYR . . . . . . . . . . . . . 2.6 t80 48.46 48.49 19.27 Favored 'General case' 0 N--CA 1.467 0.411 0 N-CA-C 112.774 0.657 . . . . 0.0 112.774 179.688 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 698' ' ' GLN . . . . . . . . . . . . . 98.5 mm-40 -111.41 96.96 6.42 Favored 'General case' 0 N--CA 1.454 -0.266 0 O-C-N 122.168 -0.333 . . . . 0.0 110.809 179.634 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 699' ' ' GLY . . . . . 0.734 ' HA3' HG11 ' A' ' 674' ' ' VAL . . . 81.42 14.34 78.67 Favored Glycine 0 CA--C 1.521 0.447 0 C-N-CA 120.49 -0.862 . . . . 0.0 113.837 179.339 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 700' ' ' VAL . . . . . 0.484 HG12 HG22 ' A' ' 688' ' ' ILE . 33.1 m -116.08 151.66 17.84 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 117.378 0.589 . . . . 0.0 110.502 -179.757 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 701' ' ' ASP . . . . . . . . . . . . . 37.4 t70 -70.37 -42.86 71.21 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.483 -0.781 . . . . 0.0 111.891 -179.052 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 702' ' ' ARG . . . . . . . . . . . . . 77.5 mtp85 -145.66 158.47 43.84 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.904 0.383 . . . . 0.0 111.167 -178.795 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 703' ' ' TYR . . . . . . . . . . . . . 50.4 p90 -120.48 136.2 54.83 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 108.918 -0.771 . . . . 0.0 108.918 178.539 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 704' ' ' ILE . . . . . 0.541 ' HB ' HD23 ' A' ' 691' ' ' LEU . 42.5 mt -125.36 98.91 34.35 Favored Pre-proline 0 C--N 1.328 -0.366 0 C-N-CA 120.512 -0.475 . . . . 0.0 111.851 -179.115 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 705' ' ' PRO . . . . . 0.474 ' HA ' ' O ' ' A' ' 692' ' ' GLY . 32.5 Cg_exo -61.59 142.96 96.43 Favored 'Trans proline' 0 C--N 1.345 0.382 0 C-N-CA 123.304 2.669 . . . . 0.0 113.226 179.239 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 706' ' ' LEU . . . . . 0.563 HD23 HG23 ' A' ' 708' ' ' ILE . 87.7 mt -98.35 149.91 36.21 Favored Pre-proline 0 C--N 1.328 -0.359 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.028 178.796 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 707' ' ' PRO . . . . . 0.4 ' C ' ' HA ' ' A' ' 706' ' ' LEU . 60.7 Cg_endo -72.35 139.84 62.71 Favored 'Cis proline' 0 C--N 1.345 0.388 0 C-N-CA 123.112 -1.62 . . . . 0.0 112.866 -0.138 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 708' ' ' ILE . . . . . 0.563 HG23 HD23 ' A' ' 706' ' ' LEU . 4.1 pt -63.67 145.13 13.96 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-N 115.538 -0.755 . . . . 0.0 112.071 178.843 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 709' ' ' HIS . . . . . 0.401 ' HA ' ' HD2' ' A' ' 710' ' ' PRO . 69.9 m80 -103.17 112.34 65.67 Favored Pre-proline 0 C--N 1.321 -0.668 0 N-CA-C 107.771 -1.196 . . . . 0.0 107.771 177.496 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 710' ' ' PRO . . . . . 0.401 ' HD2' ' HA ' ' A' ' 709' ' ' HIS . 20.1 Cg_endo -59.3 -30.18 92.2 Favored 'Trans proline' 0 N--CA 1.474 0.332 0 C-N-CA 122.658 2.238 . . . . 0.0 114.305 -177.31 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 711' ' ' GLU . . . . . . . . . . . . . 51.5 mp0 -66.67 -40.67 88.71 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 112.159 0.429 . . . . 0.0 112.159 -179.249 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 712' ' ' SER . . . . . . . . . . . . . 80.8 p -99.22 -17.91 17.89 Favored 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 112.401 0.519 . . . . 0.0 112.401 -178.701 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 713' ' ' PHE . . . . . . . . . . . . . 91.4 t80 -60.33 -49.08 79.0 Favored 'General case' 0 C--O 1.232 0.167 0 CA-C-O 120.789 0.328 . . . . 0.0 110.66 179.96 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 714' ' ' LEU . . . . . . . . . . . . . 87.9 mt -64.62 -38.45 91.06 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.524 179.311 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 715' ' ' GLN . . . . . . . . . . . . . 97.8 mt-30 -62.93 -42.61 99.86 Favored 'General case' 0 N--CA 1.461 0.096 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.144 179.541 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 716' ' ' GLN . . . . . . . . . . . . . 57.1 mt-30 -65.23 -41.0 94.82 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-N 116.584 -0.28 . . . . 0.0 111.027 179.956 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 717' ' ' VAL . . . . . . . . . . . . . 67.0 t -62.98 -44.78 99.86 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.171 0 N-CA-C 109.83 -0.433 . . . . 0.0 109.83 178.887 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 718' ' ' THR . . . . . . . . . . . . . 90.3 m -62.14 -45.24 94.3 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 115.586 -0.734 . . . . 0.0 110.853 179.472 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 719' ' ' MET . . . . . . . . . . . . . 38.6 mmt -62.05 -43.39 98.94 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 116.722 -0.217 . . . . 0.0 110.719 179.64 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 720' ' ' GLY . . . . . . . . . . . . . . . -63.68 -41.01 99.15 Favored Glycine 0 C--N 1.333 0.378 0 C-N-CA 120.693 -0.765 . . . . 0.0 111.482 178.232 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 721' ' ' LEU . . . . . . . . . . . . . 62.7 tp -63.4 -44.81 93.59 Favored 'General case' 0 CA--C 1.532 0.255 0 CA-C-N 115.329 -0.436 . . . . 0.0 111.137 179.118 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 722' ' ' THR . . . . . . . . . . . . . 71.5 p -69.66 -24.0 63.55 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-N 116.556 -0.293 . . . . 0.0 111.598 179.91 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 723' ' ' SER . . . . . . . . . . . . . 74.3 m -63.83 -39.61 94.64 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.82 0.343 . . . . 0.0 110.258 178.692 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 724' ' ' LEU . . . . . . . . . . . . . 65.1 tp -62.99 -47.08 84.66 Favored 'General case' 0 C--O 1.233 0.237 0 CA-C-N 115.827 -0.624 . . . . 0.0 111.338 179.539 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 725' ' ' ALA . . . . . . . . . . . . . . . -155.25 147.44 23.72 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.926 179.967 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 726' ' ' THR . . . . . . . . . . . . . 70.0 p -70.51 -28.04 64.66 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.594 -179.911 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 727' ' ' SER . . . . . . . . . . . . . 50.2 m 58.26 38.06 26.09 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-N 115.934 -0.575 . . . . 0.0 111.483 -179.938 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 728' ' ' ALA . . . . . . . . . . . . . . . -147.82 153.15 38.8 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.757 -179.989 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 729' ' ' GLN . . . . . . . . . . . . . 98.5 mm-40 . . . . . 0 C--O 1.247 0.961 0 CA-C-O 118.337 -0.84 . . . . 0.0 110.858 179.971 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 613' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 . . . . . 0 N--CA 1.484 1.269 0 CA-C-O 120.779 0.324 . . . . 0.0 110.704 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 614' ' ' GLY . . . . . . . . . . . . . . . -158.69 165.06 33.91 Favored Glycine 0 N--CA 1.449 -0.466 0 C-N-CA 121.046 -0.597 . . . . 0.0 111.659 179.704 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 615' ' ' ARG . . . . . . . . . . . . . 89.7 mtm180 -116.8 129.4 56.07 Favored 'General case' 0 C--O 1.235 0.328 0 CA-C-O 120.929 0.395 . . . . 0.0 111.278 -179.547 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 616' ' ' ILE . . . . . 0.418 ' O ' ' HA ' ' A' ' 640' ' ' VAL . 86.0 mt -126.92 134.15 66.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 115.808 -0.633 . . . . 0.0 109.882 178.929 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 617' ' ' VAL . . . . . . . . . . . . . 99.4 t -107.35 126.66 63.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 120.955 0.407 . . . . 0.0 110.253 -179.862 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 618' ' ' LEU . . . . . . . . . . . . . 1.1 tt -108.91 126.52 53.16 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.534 -179.076 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 619' ' ' VAL . . . . . 0.428 ' HA ' ' O ' ' A' ' 643' ' ' LEU . 79.8 t -116.39 118.14 57.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-O 121.197 0.522 . . . . 0.0 110.355 -179.861 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 620' ' ' SER . . . . . 0.559 ' HB3' ' HB3' ' A' ' 662' ' ' ALA . 84.6 p -166.64 164.2 16.83 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.006 -0.997 . . . . 0.0 110.506 -179.52 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 621' ' ' GLU . . . . . . . . . . . . . 61.1 mt-10 -104.29 -12.52 16.58 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.911 -0.586 . . . . 0.0 111.787 178.606 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 622' ' ' ASP . . . . . . . . . . . . . 36.3 t70 -96.33 110.33 22.68 Favored 'General case' 0 C--O 1.232 0.136 0 CA-C-O 121.123 0.487 . . . . 0.0 111.895 -178.442 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 623' ' ' GLU . . . . . 0.407 ' O ' HG23 ' A' ' 627' ' ' THR . 88.5 tt0 -63.62 -40.04 95.89 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.292 -0.867 . . . . 0.0 112.606 179.977 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 624' ' ' ALA . . . . . . . . . . . . . . . -60.74 -45.52 93.99 Favored 'General case' 0 N--CA 1.466 0.371 0 N-CA-C 112.908 0.707 . . . . 0.0 112.908 -177.596 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 625' ' ' THR . . . . . . . . . . . . . 92.2 m -68.37 -39.11 81.89 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.199 0.523 . . . . 0.0 109.837 179.547 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 626' ' ' SER . . . . . . . . . . . . . 66.7 m -61.16 -40.55 94.28 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.124 -0.944 . . . . 0.0 112.435 -178.873 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 627' ' ' THR . . . . . 0.407 HG23 ' O ' ' A' ' 623' ' ' GLU . 72.3 p -64.3 -39.29 93.63 Favored 'General case' 0 N--CA 1.465 0.288 0 N-CA-C 112.388 0.514 . . . . 0.0 112.388 -179.015 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 628' ' ' LEU . . . . . . . . . . . . . 62.2 tp -69.9 -45.89 66.62 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 112.229 0.455 . . . . 0.0 112.229 -179.636 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 629' ' ' ILE . . . . . . . . . . . . . 19.6 tt -71.51 -37.15 63.09 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.451 0 N-CA-C 112.885 0.698 . . . . 0.0 112.885 -178.391 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 630' ' ' CYS . . . . . . . . . . . . . 87.7 m -63.21 -38.8 92.59 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-O 120.711 0.291 . . . . 0.0 111.002 179.927 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 631' ' ' SER . . . . . . . . . . . . . 71.8 m -61.72 -40.25 94.39 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.73 -179.909 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 632' ' ' ILE . . . . . . . . . . . . . 96.8 mt -62.32 -49.57 83.41 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.314 0 CA-C-O 121.093 0.473 . . . . 0.0 110.725 179.895 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 633' ' ' LEU . . . . . . . . . . . . . 90.6 mt -66.99 -40.21 87.31 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-N 115.652 -0.704 . . . . 0.0 112.522 -179.507 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 634' ' ' THR . . . . . 0.545 ' HA ' ' O ' ' A' ' 638' ' ' TYR . 82.7 m -65.83 -40.68 92.02 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-O 120.699 0.285 . . . . 0.0 111.103 -179.389 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 635' ' ' THR . . . . . . . . . . . . . 92.2 m -58.85 -38.57 79.06 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.351 179.208 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 636' ' ' ALA . . . . . . . . . . . . . . . -64.7 -17.12 63.81 Favored 'General case' 0 CA--C 1.532 0.288 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.357 178.837 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 637' ' ' GLY . . . . . . . . . . . . . . . 108.91 6.9 29.84 Favored Glycine 0 C--N 1.334 0.467 0 C-N-CA 120.973 -0.632 . . . . 0.0 113.21 179.767 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 638' ' ' TYR . . . . . 0.545 ' O ' ' HA ' ' A' ' 634' ' ' THR . 97.1 m-85 -100.74 142.27 32.44 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.878 0.37 . . . . 0.0 111.479 -179.802 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 639' ' ' GLN . . . . . . . . . . . . . 78.9 mt-30 -89.32 135.81 33.38 Favored 'General case' 0 CA--C 1.519 -0.226 0 CA-C-N 116.243 -0.435 . . . . 0.0 109.96 179.308 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 640' ' ' VAL . . . . . 0.418 ' HA ' ' O ' ' A' ' 616' ' ' ILE . 57.8 t -118.63 131.04 72.55 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-O 121.121 0.486 . . . . 0.0 112.272 -179.123 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 641' ' ' ILE . . . . . . . . . . . . . 46.0 mm -110.14 118.62 57.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 N-CA-C 108.348 -0.982 . . . . 0.0 108.348 178.248 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 642' ' ' TRP . . . . . . . . . . . . . 24.2 t90 -92.83 127.11 38.22 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 112.534 0.568 . . . . 0.0 112.534 -178.104 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 643' ' ' LEU . . . . . 0.428 ' O ' ' HA ' ' A' ' 619' ' ' VAL . 4.0 mp -123.6 137.55 54.72 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.471 -0.786 . . . . 0.0 110.109 178.886 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 644' ' ' VAL . . . . . . . . . . . . . 19.1 m -101.56 12.4 6.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 N-CA-C 112.03 0.382 . . . . 0.0 112.03 -179.798 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 645' ' ' ASP . . . . . 0.51 ' O ' ' HB2' ' A' ' 666' ' ' SER . 12.0 t0 -126.87 -72.99 0.62 Allowed 'General case' 0 N--CA 1.466 0.355 0 N-CA-C 111.98 0.363 . . . . 0.0 111.98 -178.82 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 646' ' ' GLY . . . . . . . . . . . . . . . 105.45 29.13 5.19 Favored Glycine 0 CA--C 1.519 0.328 0 C-N-CA 120.61 -0.805 . . . . 0.0 113.898 -179.939 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 647' ' ' GLU . . . . . . . . . . . . . 79.4 mm-40 -67.95 133.53 49.23 Favored 'General case' 0 N--CA 1.454 -0.255 0 CA-C-N 117.161 0.481 . . . . 0.0 110.236 179.243 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 648' ' ' VAL . . . . . . . . . . . . . 11.2 p -62.94 -32.76 57.17 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.587 0 CA-C-N 115.139 -0.937 . . . . 0.0 112.283 -178.594 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 649' ' ' GLU . . . . . . . . . . . . . 95.4 mt-10 -63.45 -44.96 93.01 Favored 'General case' 0 C--O 1.232 0.178 0 CA-C-O 120.982 0.42 . . . . 0.0 110.251 179.883 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 650' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -72.65 -40.97 65.96 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.918 178.775 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 651' ' ' LEU . . . . . . . . . . . . . 88.3 mt -63.95 -40.9 97.48 Favored 'General case' 0 N--CA 1.462 0.174 0 CA-C-N 116.428 -0.351 . . . . 0.0 110.786 179.339 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 652' ' ' LEU . . . . . . . . . . . . . 63.0 tp -65.04 -43.77 91.27 Favored 'General case' 0 CA--C 1.534 0.334 0 CA-C-N 116.488 -0.324 . . . . 0.0 110.985 178.719 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 653' ' ' ALA . . . . . . . . . . . . . . . -63.29 -39.99 96.11 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-O 121.129 0.49 . . . . 0.0 111.553 -179.93 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 654' ' ' LEU . . . . . . . . . . . . . 76.2 mt -100.63 30.12 4.13 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.591 -0.731 . . . . 0.0 110.023 179.916 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 655' ' ' THR . . . . . . . . . . . . . 5.1 t -44.03 108.16 0.68 Allowed Pre-proline 0 CA--C 1.537 0.461 0 O-C-N 124.197 0.936 . . . . 0.0 113.249 -178.263 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 656' ' ' PRO . . . . . . . . . . . . . 26.9 Cg_endo -91.97 -176.96 0.84 Allowed 'Trans proline' 0 N--CA 1.462 -0.375 0 C-N-CA 123.861 3.041 . . . . 0.0 112.567 178.94 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 657' ' ' ILE . . . . . 0.41 ' O ' ' HA ' ' A' ' 686' ' ' LEU . 96.9 mt -71.52 -37.97 66.13 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 N-CA-C 108.268 -1.012 . . . . 0.0 108.268 177.952 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 658' ' ' ALA . . . . . 0.487 ' HB2' ' HB2' ' A' ' 687' ' ' LYS . . . -151.11 153.53 35.21 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 114.214 -1.357 . . . . 0.0 111.566 -178.808 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 659' ' ' VAL . . . . . . . . . . . . . 22.5 m -121.05 143.7 32.46 Favored 'Isoleucine or valine' 0 C--O 1.235 0.325 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.578 178.72 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 660' ' ' LEU . . . . . . . . . . . . . 4.9 mp -115.08 111.42 21.03 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 108.713 -0.847 . . . . 0.0 108.713 178.541 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 661' ' ' LEU . . . . . . . . . . . . . 66.6 mt -103.82 116.6 32.59 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 110.051 -0.351 . . . . 0.0 110.051 -178.472 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 662' ' ' ALA . . . . . 0.559 ' HB3' ' HB3' ' A' ' 620' ' ' SER . . . -107.68 135.37 49.23 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 112.412 0.523 . . . . 0.0 112.412 -178.903 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 663' ' ' GLU . . . . . . . . . . . . . 98.1 mt-10 -76.31 146.75 78.4 Favored Pre-proline 0 C--N 1.327 -0.399 0 CA-C-N 115.58 -0.737 . . . . 0.0 110.222 178.327 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 664' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -72.43 140.19 64.87 Favored 'Cis proline' 0 C--N 1.35 0.609 0 C-N-CA 123.403 -1.499 . . . . 0.0 112.802 -0.41 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 665' ' ' PHE . . . . . 0.509 ' HB3' ' CZ ' ' A' ' 667' ' ' TYR . 0.1 OUTLIER -76.71 112.36 13.2 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.451 -0.795 . . . . 0.0 112.321 179.868 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 666' ' ' SER . . . . . 0.51 ' HB2' ' O ' ' A' ' 645' ' ' ASP . 68.5 m -65.07 -40.97 95.42 Favored 'General case' 0 N--CA 1.468 0.469 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.464 179.306 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 667' ' ' TYR . . . . . 0.509 ' CZ ' ' HB3' ' A' ' 665' ' ' PHE . 19.2 p90 -60.51 -16.64 39.12 Favored 'General case' 0 CA--C 1.537 0.464 0 N-CA-C 112.896 0.702 . . . . 0.0 112.896 -179.933 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 668' ' ' GLY . . . . . . . . . . . . . . . 100.67 -112.67 4.48 Favored Glycine 0 N--CA 1.452 -0.245 0 C-N-CA 120.547 -0.835 . . . . 0.0 113.667 179.167 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 669' ' ' ASP . . . . . . . . . . . . . 49.8 t0 -81.87 110.19 16.93 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.044 0.449 . . . . 0.0 111.547 -178.386 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 670' ' ' VAL . . . . . 0.402 ' O ' HG23 ' A' ' 674' ' ' VAL . 13.4 p -65.11 -31.93 56.08 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.307 0 CA-C-N 115.546 -0.752 . . . . 0.0 112.642 -179.821 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 671' ' ' GLN . . . . . . . . . . . . . 52.2 tt0 -61.51 -43.36 99.0 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-O 120.812 0.339 . . . . 0.0 110.93 -179.307 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 672' ' ' GLU . . . . . . . . . . . . . 95.1 mt-10 -65.56 -40.6 92.98 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.723 179.165 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 673' ' ' LEU . . . . . . . . . . . . . 61.9 tp -64.04 -44.81 91.37 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.216 179.35 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 674' ' ' VAL . . . . . 0.402 HG23 ' O ' ' A' ' 670' ' ' VAL . 59.9 t -63.28 -43.83 98.86 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.21 0 CA-C-N 115.864 -0.607 . . . . 0.0 109.597 179.381 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 675' ' ' ASP . . . . . . . . . . . . . 37.4 t70 -60.36 -41.13 93.04 Favored 'General case' 0 CA--C 1.521 -0.141 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.521 178.81 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 676' ' ' GLN . . . . . 0.414 ' O ' ' HG2' ' A' ' 680' ' ' ARG . 76.7 mt-30 -69.94 -41.76 74.15 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-N 116.668 -0.242 . . . . 0.0 110.898 179.986 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 677' ' ' LEU . . . . . . . . . . . . . 85.6 mt -66.8 -41.83 86.94 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.641 179.456 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 678' ' ' ARG . . . . . . . . . . . . . 70.4 ttp85 -67.36 -38.97 85.63 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.927 179.834 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 679' ' ' GLN . . . . . . . . . . . . . 10.6 tp-100 -64.36 -38.13 89.96 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.486 -0.779 . . . . 0.0 110.785 179.893 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 680' ' ' ARG . . . . . 0.414 ' HG2' ' O ' ' A' ' 676' ' ' GLN . 89.3 mmt-85 -83.91 -42.88 15.85 Favored 'General case' 0 C--N 1.333 -0.131 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.203 -179.541 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 681' ' ' CYS . . . . . . . . . . . . . 76.0 m -127.86 133.65 49.36 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.33 179.687 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 682' ' ' THR . . . . . 0.428 ' HB ' ' HD2' ' A' ' 683' ' ' PRO . 65.0 p -67.18 158.35 81.84 Favored Pre-proline 0 C--N 1.321 -0.66 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.12 179.802 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 683' ' ' PRO . . . . . 0.428 ' HD2' ' HB ' ' A' ' 682' ' ' THR . 19.8 Cg_endo -58.38 -26.97 79.83 Favored 'Trans proline' 0 C--N 1.349 0.577 0 C-N-CA 122.139 1.893 . . . . 0.0 112.291 -179.819 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 684' ' ' GLU . . . . . . . . . . . . . 51.4 mp0 -71.43 -39.1 71.26 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 121.165 0.507 . . . . 0.0 110.087 178.478 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 685' ' ' GLN . . . . . . . . . . . . . 91.0 mt-30 -71.88 -39.91 69.29 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.322 -0.854 . . . . 0.0 112.183 179.612 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 686' ' ' LEU . . . . . 0.41 ' HA ' ' O ' ' A' ' 657' ' ' ILE . 2.8 tt -135.79 119.08 16.68 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.547 -178.371 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 687' ' ' LYS . . . . . 0.487 ' HB2' ' HB2' ' A' ' 658' ' ' ALA . 74.6 mmtt -88.12 144.82 26.26 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 121.191 0.519 . . . . 0.0 110.241 178.649 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 688' ' ' ILE . . . . . . . . . . . . . 79.9 mt -124.0 122.49 64.62 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.751 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.986 -179.293 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 689' ' ' PHE . . . . . . . . . . . . . 97.8 m-85 -121.99 147.06 46.53 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.482 -0.781 . . . . 0.0 110.291 179.134 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 690' ' ' ILE . . . . . . . . . . . . . 19.0 tt -123.58 137.69 55.92 Favored 'Isoleucine or valine' 0 C--O 1.235 0.331 0 CA-C-O 121.325 0.583 . . . . 0.0 111.186 -179.768 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 691' ' ' LEU . . . . . 0.439 HD23 ' HB ' ' A' ' 704' ' ' ILE . 69.0 mt -112.28 136.35 51.83 Favored 'General case' 0 C--O 1.235 0.313 0 CA-C-N 115.522 -0.763 . . . . 0.0 110.661 -179.429 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 692' ' ' GLY . . . . . 0.655 ' O ' ' HA ' ' A' ' 705' ' ' PRO . . . 168.37 -178.61 41.87 Favored Glycine 0 N--CA 1.446 -0.672 0 C-N-CA 120.876 -0.678 . . . . 0.0 111.706 179.709 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 693' ' ' SER . . . . . . . . . . . . . 80.0 p -67.64 -36.14 80.2 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 120.98 0.419 . . . . 0.0 110.836 179.35 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 694' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -128.98 135.36 48.88 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.913 -0.585 . . . . 0.0 109.919 179.274 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 695' ' ' GLY . . . . . . . . . . . . . . . -73.12 108.57 2.54 Favored Glycine 0 N--CA 1.45 -0.412 0 C-N-CA 120.646 -0.788 . . . . 0.0 112.626 179.963 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 696' ' ' ASN . . . . . . . . . . . . . 62.9 t30 -86.99 91.39 8.68 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 109.994 -0.373 . . . . 0.0 109.994 179.482 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 697' ' ' TYR . . . . . . . . . . . . . 53.0 t80 -71.49 97.13 1.6 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.913 -0.585 . . . . 0.0 111.726 -178.845 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 698' ' ' GLN . . . . . . . . . . . . . 95.9 mm-40 -122.97 35.86 4.78 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.532 -0.758 . . . . 0.0 109.564 178.618 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 699' ' ' GLY . . . . . . . . . . . . . . . 103.87 10.15 35.64 Favored Glycine 0 N--CA 1.453 -0.171 0 C-N-CA 120.781 -0.723 . . . . 0.0 112.006 -178.628 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 700' ' ' VAL . . . . . . . . . . . . . 31.5 m -81.84 150.58 4.45 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.365 0 CA-C-O 121.282 0.563 . . . . 0.0 110.53 179.804 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 701' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -70.08 -40.36 75.05 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 115.365 -0.834 . . . . 0.0 112.151 -179.319 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 702' ' ' ARG . . . . . . . . . . . . . 58.1 ttm-85 -158.08 149.69 21.5 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.826 0.346 . . . . 0.0 111.354 -179.07 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 703' ' ' TYR . . . . . . . . . . . . . 23.7 p90 -107.79 141.59 39.11 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.162 179.125 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 704' ' ' ILE . . . . . 0.498 HG22 HG12 ' A' ' 708' ' ' ILE . 44.9 mt -125.57 85.79 58.26 Favored Pre-proline 0 C--N 1.328 -0.364 0 CA-C-O 121.044 0.449 . . . . 0.0 110.293 -179.655 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 705' ' ' PRO . . . . . 0.655 ' HA ' ' O ' ' A' ' 692' ' ' GLY . 38.5 Cg_exo -63.15 144.34 92.0 Favored 'Trans proline' 0 C--N 1.35 0.61 0 C-N-CA 123.781 2.987 . . . . 0.0 114.272 -179.235 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 706' ' ' LEU . . . . . 0.825 HD23 HG13 ' A' ' 708' ' ' ILE . 80.6 mt -80.88 145.82 58.26 Favored Pre-proline 0 CA--C 1.533 0.291 0 CA-C-N 115.527 -0.761 . . . . 0.0 110.276 178.076 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 707' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -74.88 141.49 71.92 Favored 'Cis proline' 0 C--N 1.345 0.357 0 C-N-CA 123.121 -1.616 . . . . 0.0 112.051 -1.086 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 708' ' ' ILE . . . . . 0.825 HG13 HD23 ' A' ' 706' ' ' LEU . 72.1 mt -78.97 119.8 28.9 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.399 179.513 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 709' ' ' HIS . . . . . . . . . . . . . 71.1 m80 -84.65 123.1 74.75 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.34 179.644 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 710' ' ' PRO . . . . . . . . . . . . . 24.9 Cg_endo -61.59 -31.92 87.29 Favored 'Trans proline' 0 C--N 1.349 0.566 0 C-N-CA 122.869 2.379 . . . . 0.0 113.958 -178.886 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 711' ' ' GLU . . . . . . . . . . . . . 42.6 tt0 -66.08 -41.66 90.42 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 112.179 0.437 . . . . 0.0 112.179 -179.193 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 712' ' ' SER . . . . . . . . . . . . . 80.7 p -95.2 -20.43 19.24 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 112.44 0.533 . . . . 0.0 112.44 -178.266 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 713' ' ' PHE . . . . . . . . . . . . . 77.9 t80 -60.17 -49.89 75.86 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-O 120.759 0.314 . . . . 0.0 111.406 -179.694 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 714' ' ' LEU . . . . . . . . . . . . . 52.6 tp -64.25 -39.45 93.97 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.064 -0.517 . . . . 0.0 109.651 179.799 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 715' ' ' GLN . . . . . . . . . . . . . 64.4 tt0 -61.99 -43.77 98.14 Favored 'General case' 0 CA--C 1.532 0.262 0 CA-C-N 115.534 -0.757 . . . . 0.0 110.827 179.034 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 716' ' ' GLN . . . . . . . . . . . . . 96.5 mt-30 -63.78 -41.39 97.95 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 116.583 -0.28 . . . . 0.0 111.135 179.656 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 717' ' ' VAL . . . . . . . . . . . . . 68.7 t -63.08 -45.28 99.13 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 N-CA-C 109.947 -0.39 . . . . 0.0 109.947 179.097 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 718' ' ' THR . . . . . . . . . . . . . 89.4 m -62.88 -44.55 95.8 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.887 179.425 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 719' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -63.18 -43.57 97.87 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 116.523 -0.308 . . . . 0.0 110.776 179.555 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 720' ' ' GLY . . . . . . . . . . . . . . . -64.48 -40.96 98.14 Favored Glycine 0 C--N 1.332 0.361 0 C-N-CA 120.509 -0.853 . . . . 0.0 111.631 178.15 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 721' ' ' LEU . . . . . . . . . . . . . 61.3 tp -65.87 -42.52 90.26 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 122.81 0.444 . . . . 0.0 112.189 179.656 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 722' ' ' THR . . . . . . . . . . . . . 4.9 t -71.28 -3.55 21.07 Favored 'General case' 0 CA--C 1.535 0.396 0 N-CA-C 113.032 0.752 . . . . 0.0 113.032 -178.607 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 723' ' ' SER . . . . . . . . . . . . . 83.0 p -69.35 -20.29 63.85 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.682 0.277 . . . . 0.0 110.973 179.495 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 724' ' ' LEU . . . . . . . . . . . . . 91.8 mt -64.22 -40.96 97.13 Favored 'General case' 0 CA--C 1.529 0.171 0 CA-C-N 116.077 -0.51 . . . . 0.0 111.989 -179.872 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 725' ' ' ALA . . . . . . . . . . . . . . . -156.75 148.39 22.57 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.661 -0.245 . . . . 0.0 111.182 -179.837 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 726' ' ' THR . . . . . . . . . . . . . 63.6 p -70.64 -28.73 65.04 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.341 -0.39 . . . . 0.0 111.591 179.943 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 727' ' ' SER . . . . . . . . . . . . . 7.4 m -86.86 67.43 9.81 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.904 -179.981 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 728' ' ' ALA . . . . . . . . . . . . . . . -62.32 -39.89 94.52 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.482 179.745 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 729' ' ' GLN . . . . . . . . . . . . . 96.6 mt-30 . . . . . 0 C--O 1.25 1.108 0 CA-C-O 118.225 -0.893 . . . . 0.0 110.662 179.954 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 613' ' ' GLU . . . . . . . . . . . . . 3.9 pt-20 . . . . . 0 N--CA 1.489 1.483 0 CA-C-O 120.975 0.417 . . . . 0.0 110.841 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 614' ' ' GLY . . . . . . . . . . . . . . . -84.0 64.97 4.19 Favored Glycine 0 N--CA 1.453 -0.169 0 C-N-CA 120.887 -0.673 . . . . 0.0 112.628 -179.882 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 615' ' ' ARG . . . . . 0.405 HH22 ' HB3' ' A' ' 654' ' ' LEU . 35.5 mtp-105 -115.01 130.32 56.91 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.04 0.448 . . . . 0.0 111.029 -179.96 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 616' ' ' ILE . . . . . 0.446 ' O ' ' HA ' ' A' ' 640' ' ' VAL . 84.7 mt -124.12 134.08 67.55 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-N 115.578 -0.737 . . . . 0.0 109.89 179.835 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 617' ' ' VAL . . . . . 0.413 HG23 ' HB3' ' A' ' 656' ' ' PRO . 93.4 t -106.6 127.15 62.26 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-O 121.108 0.48 . . . . 0.0 109.786 -179.923 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 618' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -107.01 127.13 53.18 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.821 -178.501 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 619' ' ' VAL . . . . . . . . . . . . . 58.8 t -116.65 118.66 59.51 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 N-CA-C 109.624 -0.51 . . . . 0.0 109.624 179.898 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 620' ' ' SER . . . . . 0.532 ' HB2' ' HB3' ' A' ' 662' ' ' ALA . 25.2 t -169.59 139.55 2.06 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.693 -0.685 . . . . 0.0 111.039 -179.536 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 621' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -77.02 -27.7 54.68 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.624 -0.716 . . . . 0.0 111.118 179.002 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 622' ' ' ASP . . . . . . . . . . . . . 44.1 t0 -84.02 110.63 18.6 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-O 121.173 0.511 . . . . 0.0 111.97 -178.433 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 623' ' ' GLU . . . . . . . . . . . . . 88.6 tt0 -63.43 -40.05 96.13 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.031 -0.986 . . . . 0.0 112.112 179.495 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 624' ' ' ALA . . . . . . . . . . . . . . . -61.14 -45.44 94.66 Favored 'General case' 0 N--CA 1.466 0.351 0 N-CA-C 112.902 0.704 . . . . 0.0 112.902 -177.831 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 625' ' ' THR . . . . . . . . . . . . . 95.6 m -69.77 -40.69 75.94 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-O 121.149 0.5 . . . . 0.0 110.348 -179.977 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 626' ' ' SER . . . . . . . . . . . . . 67.5 m -62.25 -41.03 98.07 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.492 -0.776 . . . . 0.0 111.653 -179.405 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 627' ' ' THR . . . . . . . . . . . . . 92.2 m -61.56 -46.1 91.32 Favored 'General case' 0 CA--C 1.534 0.351 0 N-CA-C 112.384 0.513 . . . . 0.0 112.384 -179.3 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 628' ' ' LEU . . . . . . . . . . . . . 62.9 tp -62.79 -47.31 84.05 Favored 'General case' 0 CA--C 1.533 0.322 0 N-CA-C 112.626 0.602 . . . . 0.0 112.626 -178.714 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 629' ' ' ILE . . . . . . . . . . . . . 16.3 tt -70.87 -35.77 61.37 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.434 0 N-CA-C 112.964 0.727 . . . . 0.0 112.964 -178.648 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 630' ' ' CYS . . . . . . . . . . . . . 87.2 m -62.4 -39.69 94.09 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-O 120.668 0.27 . . . . 0.0 111.148 -179.863 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 631' ' ' SER . . . . . . . . . . . . . 67.8 m -62.29 -41.17 98.28 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.74 179.908 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 632' ' ' ILE . . . . . . . . . . . . . 97.1 mt -62.72 -48.14 89.58 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.272 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.754 179.705 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 633' ' ' LEU . . . . . . . . . . . . . 79.4 mt -66.36 -40.39 89.76 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-N 115.835 -0.621 . . . . 0.0 112.582 -179.733 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 634' ' ' THR . . . . . 0.504 ' HA ' ' O ' ' A' ' 638' ' ' TYR . 73.4 m -65.58 -40.35 92.66 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.713 0.292 . . . . 0.0 110.668 -179.54 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 635' ' ' THR . . . . . . . . . . . . . 92.1 m -59.54 -38.92 82.3 Favored 'General case' 0 CA--C 1.531 0.232 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.222 179.075 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 636' ' ' ALA . . . . . . . . . . . . . . . -64.56 -17.65 64.14 Favored 'General case' 0 CA--C 1.532 0.288 0 CA-C-N 115.918 -0.583 . . . . 0.0 111.396 178.882 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 637' ' ' GLY . . . . . . . . . . . . . . . 109.2 6.06 29.92 Favored Glycine 0 C--N 1.334 0.435 0 C-N-CA 121.004 -0.617 . . . . 0.0 113.233 179.684 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 638' ' ' TYR . . . . . 0.504 ' O ' ' HA ' ' A' ' 634' ' ' THR . 93.9 m-85 -100.31 142.49 31.71 Favored 'General case' 0 C--N 1.329 -0.318 0 O-C-N 122.581 -0.364 . . . . 0.0 111.497 179.93 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 639' ' ' GLN . . . . . . . . . . . . . 78.3 mt-30 -88.9 134.14 34.05 Favored 'General case' 0 CA--C 1.518 -0.254 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.052 179.376 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 640' ' ' VAL . . . . . 0.446 ' HA ' ' O ' ' A' ' 616' ' ' ILE . 58.5 t -118.8 130.87 73.03 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.5 0 CA-C-O 121.016 0.436 . . . . 0.0 111.985 -179.336 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 641' ' ' ILE . . . . . . . . . . . . . 37.8 mm -108.86 117.57 54.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 N-CA-C 108.444 -0.947 . . . . 0.0 108.444 178.603 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 642' ' ' TRP . . . . . . . . . . . . . 23.9 t90 -89.24 125.68 35.18 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.165 0.507 . . . . 0.0 112.025 -178.517 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 643' ' ' LEU . . . . . . . . . . . . . 3.1 mp -120.13 134.22 55.31 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.581 -0.736 . . . . 0.0 110.698 179.263 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 644' ' ' VAL . . . . . . . . . . . . . 8.4 m -106.72 23.4 3.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.942 -179.789 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 645' ' ' ASP . . . . . . . . . . . . . 18.2 t0 -145.51 -32.62 0.37 Allowed 'General case' 0 N--CA 1.469 0.521 0 N-CA-C 113.193 0.812 . . . . 0.0 113.193 -178.211 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 646' ' ' GLY . . . . . . . . . . . . . . . 74.44 27.33 65.83 Favored Glycine 0 CA--C 1.52 0.402 0 C-N-CA 120.757 -0.735 . . . . 0.0 113.761 -179.692 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 647' ' ' GLU . . . . . . . . . . . . . 8.3 mm-40 -63.85 122.32 16.17 Favored 'General case' 0 C--O 1.232 0.137 0 CA-C-O 121.087 0.47 . . . . 0.0 110.938 179.745 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 648' ' ' VAL . . . . . . . . . . . . . 27.8 m -64.62 -30.24 49.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 115.458 -0.792 . . . . 0.0 112.013 -179.287 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 649' ' ' GLU . . . . . . . . . . . . . 97.9 mt-10 -64.27 -43.74 93.88 Favored 'General case' 0 C--O 1.231 0.123 0 N-CA-C 109.773 -0.454 . . . . 0.0 109.773 179.182 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 650' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -71.68 -40.35 69.62 Favored 'General case' 0 N--CA 1.455 -0.178 0 CA-C-N 115.676 -0.693 . . . . 0.0 110.404 178.569 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 651' ' ' LEU . . . . . . . . . . . . . 83.7 mt -64.0 -41.07 97.6 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.185 179.155 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 652' ' ' LEU . . . . . . . . . . . . . 60.2 tp -64.01 -44.67 91.9 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.909 178.896 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 653' ' ' ALA . . . . . . . . . . . . . . . -63.35 -39.66 95.16 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-O 121.034 0.445 . . . . 0.0 111.704 179.611 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 654' ' ' LEU . . . . . 0.405 ' HB3' HH22 ' A' ' 615' ' ' ARG . 76.3 mt -100.28 29.35 4.39 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.828 -179.66 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 655' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -31.38 103.84 0.21 Allowed Pre-proline 0 N--CA 1.471 0.602 0 N-CA-C 114.311 1.226 . . . . 0.0 114.311 -178.268 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 656' ' ' PRO . . . . . 0.413 ' HB3' HG23 ' A' ' 617' ' ' VAL . 41.4 Cg_endo -90.22 177.37 2.42 Favored 'Trans proline' 0 C--N 1.346 0.411 0 C-N-CA 123.739 2.959 . . . . 0.0 112.068 177.959 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 657' ' ' ILE . . . . . . . . . . . . . 19.4 pt -83.6 -26.24 7.63 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-O 121.389 0.614 . . . . 0.0 109.871 177.868 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 658' ' ' ALA . . . . . 0.401 ' HA ' ' O ' ' A' ' 687' ' ' LYS . . . -158.16 154.11 26.85 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.209 -0.905 . . . . 0.0 111.0 -179.967 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 659' ' ' VAL . . . . . . . . . . . . . 30.4 m -124.38 148.08 28.73 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-O 121.27 0.557 . . . . 0.0 111.104 179.119 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 660' ' ' LEU . . . . . . . . . . . . . 11.9 mt -116.64 118.81 33.62 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.444 -0.798 . . . . 0.0 110.271 179.174 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 661' ' ' LEU . . . . . . . . . . . . . 63.3 mt -105.9 112.15 25.08 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 108.774 -0.824 . . . . 0.0 108.774 179.24 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 662' ' ' ALA . . . . . 0.631 ' HB2' HD12 ' A' ' 691' ' ' LEU . . . -109.75 135.68 50.29 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 113.159 0.8 . . . . 0.0 113.159 -178.119 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 663' ' ' GLU . . . . . 0.444 ' HG2' ' CE1' ' A' ' 665' ' ' PHE . 48.6 mt-10 -69.23 137.49 89.18 Favored Pre-proline 0 CA--C 1.535 0.384 0 CA-C-N 115.309 -0.859 . . . . 0.0 110.516 177.923 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 664' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -76.44 141.97 71.7 Favored 'Cis proline' 0 C--N 1.348 0.543 0 C-N-CA 123.533 -1.444 . . . . 0.0 112.506 -0.974 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 665' ' ' PHE . . . . . 0.504 ' HZ ' HD11 ' A' ' 690' ' ' ILE . 49.9 m-85 -77.64 119.72 21.59 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.942 -0.572 . . . . 0.0 111.031 -179.742 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 666' ' ' SER . . . . . . . . . . . . . 79.3 p -67.41 -37.93 83.84 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.224 -0.443 . . . . 0.0 111.614 179.652 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 667' ' ' TYR . . . . . . . . . . . . . 56.3 t80 -67.29 -24.36 65.76 Favored 'General case' 0 CA--C 1.533 0.301 0 CA-C-O 120.704 0.288 . . . . 0.0 111.718 179.424 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 668' ' ' GLY . . . . . . . . . . . . . . . 100.66 -103.82 2.67 Favored Glycine 0 CA--C 1.52 0.372 0 C-N-CA 120.246 -0.978 . . . . 0.0 113.324 -179.844 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 669' ' ' ASP . . . . . 0.447 ' OD1' ' HG2' ' A' ' 671' ' ' GLN . 47.6 t0 -80.25 109.85 15.12 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-O 121.218 0.532 . . . . 0.0 111.65 -178.369 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 670' ' ' VAL . . . . . . . . . . . . . 67.7 t -63.25 -42.2 95.57 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.357 0 N-CA-C 113.805 1.039 . . . . 0.0 113.805 -179.181 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 671' ' ' GLN . . . . . 0.47 ' HA ' HG22 ' A' ' 674' ' ' VAL . 19.2 pt20 -59.1 -34.6 72.2 Favored 'General case' 0 N--CA 1.466 0.331 0 N-CA-C 111.81 0.3 . . . . 0.0 111.81 -177.605 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 672' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 -70.53 -40.72 73.27 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.963 0.411 . . . . 0.0 110.57 178.134 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 673' ' ' LEU . . . . . . . . . . . . . 59.8 tp -65.19 -44.55 88.07 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.672 -0.694 . . . . 0.0 111.141 -179.887 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 674' ' ' VAL . . . . . 0.47 HG22 ' HA ' ' A' ' 671' ' ' GLN . 34.4 m -66.99 -36.78 77.97 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.197 0 CA-C-N 116.4 -0.363 . . . . 0.0 110.056 179.964 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 675' ' ' ASP . . . . . . . . . . . . . 36.9 t70 -62.83 -41.19 99.24 Favored 'General case' 0 CA--C 1.518 -0.252 0 CA-C-N 116.266 -0.425 . . . . 0.0 109.929 177.626 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 676' ' ' GLN . . . . . . . . . . . . . 96.4 mt-30 -69.32 -41.5 76.62 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.978 -179.783 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 677' ' ' LEU . . . . . . . . . . . . . 84.8 mt -68.33 -41.59 80.57 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.055 179.408 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 678' ' ' ARG . . . . . . . . . . . . . 79.6 ttt-85 -66.51 -38.25 86.81 Favored 'General case' 0 N--CA 1.468 0.467 0 CA-C-O 121.321 0.581 . . . . 0.0 110.844 -179.851 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 679' ' ' GLN . . . . . . . . . . . . . 71.2 tp60 -62.33 -38.64 90.25 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.36 -0.836 . . . . 0.0 110.852 -179.961 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 680' ' ' ARG . . . . . . . . . . . . . 31.3 mmm180 -84.8 -42.47 15.11 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.369 179.979 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 681' ' ' CYS . . . . . . . . . . . . . 77.4 m -127.12 130.5 49.94 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 120.903 0.383 . . . . 0.0 110.6 179.919 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 682' ' ' THR . . . . . 0.472 ' HB ' ' HD2' ' A' ' 683' ' ' PRO . 59.6 p -71.06 160.03 83.73 Favored Pre-proline 0 C--N 1.323 -0.578 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.708 -179.846 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 683' ' ' PRO . . . . . 0.472 ' HD2' ' HB ' ' A' ' 682' ' ' THR . 18.1 Cg_endo -59.13 -23.65 70.08 Favored 'Trans proline' 0 C--N 1.352 0.725 0 C-N-CA 122.536 2.158 . . . . 0.0 112.944 -179.915 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 684' ' ' GLU . . . . . 0.423 ' HG2' ' OG1' ' A' ' 682' ' ' THR . 24.8 pt-20 -79.5 -14.56 58.8 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.981 0.419 . . . . 0.0 110.286 178.871 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 685' ' ' GLN . . . . . . . . . . . . . 91.1 mt-30 -101.73 -34.83 9.3 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.959 -0.564 . . . . 0.0 111.624 -179.741 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 686' ' ' LEU . . . . . . . . . . . . . 2.9 tt -139.75 129.32 24.36 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.457 -0.338 . . . . 0.0 111.33 -178.809 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 687' ' ' LYS . . . . . 0.401 ' O ' ' HA ' ' A' ' 658' ' ' ALA . 0.1 OUTLIER -99.13 144.07 28.68 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 121.348 0.594 . . . . 0.0 110.566 178.744 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 688' ' ' ILE . . . . . 0.549 HG22 HG12 ' A' ' 700' ' ' VAL . 75.6 mt -121.58 122.21 66.49 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.81 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.66 -179.135 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 689' ' ' PHE . . . . . . . . . . . . . 95.8 m-85 -120.1 147.06 45.32 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.497 -0.774 . . . . 0.0 110.567 179.411 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 690' ' ' ILE . . . . . 0.504 HD11 ' HZ ' ' A' ' 665' ' ' PHE . 18.3 tt -123.52 137.19 57.59 Favored 'Isoleucine or valine' 0 C--O 1.236 0.37 0 CA-C-O 121.248 0.546 . . . . 0.0 111.418 -179.349 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 691' ' ' LEU . . . . . 0.631 HD12 ' HB2' ' A' ' 662' ' ' ALA . 51.3 mt -111.85 136.15 51.53 Favored 'General case' 0 C--O 1.235 0.312 0 CA-C-N 115.618 -0.719 . . . . 0.0 110.644 -179.638 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 692' ' ' GLY . . . . . 0.666 ' O ' ' HA ' ' A' ' 705' ' ' PRO . . . 165.99 -178.17 40.77 Favored Glycine 0 N--CA 1.446 -0.679 0 C-N-CA 121.01 -0.614 . . . . 0.0 112.019 179.697 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 693' ' ' SER . . . . . . . . . . . . . 79.8 p -67.27 -36.86 82.45 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.021 0.439 . . . . 0.0 110.808 179.393 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 694' ' ' LYS . . . . . . . . . . . . . 64.7 tttp -129.91 128.84 42.98 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.891 -0.595 . . . . 0.0 109.666 179.239 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 695' ' ' GLY . . . . . . . . . . . . . . . -74.56 119.32 6.08 Favored Glycine 0 N--CA 1.445 -0.764 0 C-N-CA 120.54 -0.838 . . . . 0.0 112.993 -179.526 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 696' ' ' ASN . . . . . . . . . . . . . 65.5 t30 -88.19 92.23 9.08 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 109.433 -0.58 . . . . 0.0 109.433 179.003 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 697' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -71.77 61.98 0.4 Allowed 'General case' 0 CA--C 1.532 0.277 0 N-CA-C 112.994 0.739 . . . . 0.0 112.994 -178.205 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 698' ' ' GLN . . . . . . . . . . . . . 97.2 mt-30 -124.34 91.56 3.48 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 109.511 -0.552 . . . . 0.0 109.511 177.943 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 699' ' ' GLY . . . . . 0.428 ' HA3' HG21 ' A' ' 674' ' ' VAL . . . 83.03 13.89 76.29 Favored Glycine 0 CA--C 1.521 0.419 0 C-N-CA 120.542 -0.837 . . . . 0.0 113.394 -179.963 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 700' ' ' VAL . . . . . 0.549 HG12 HG22 ' A' ' 688' ' ' ILE . 29.0 m -118.97 147.3 22.58 Favored 'Isoleucine or valine' 0 C--O 1.234 0.257 0 CA-C-N 117.234 0.517 . . . . 0.0 110.246 179.854 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 701' ' ' ASP . . . . . . . . . . . . . 36.0 t70 -75.38 -42.41 54.01 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.684 -0.689 . . . . 0.0 112.625 -179.166 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 702' ' ' ARG . . . . . . . . . . . . . 67.8 mtp85 -146.01 165.84 27.85 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-O 120.737 0.303 . . . . 0.0 110.827 -178.232 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 703' ' ' TYR . . . . . . . . . . . . . 52.2 p90 -125.38 144.82 50.33 Favored 'General case' 0 C--O 1.234 0.255 0 CA-C-N 116.312 -0.403 . . . . 0.0 110.612 179.427 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 704' ' ' ILE . . . . . 0.546 ' HB ' HD23 ' A' ' 691' ' ' LEU . 49.2 mt -126.15 96.84 35.99 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-N 116.144 -0.48 . . . . 0.0 109.884 179.77 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 705' ' ' PRO . . . . . 0.666 ' HA ' ' O ' ' A' ' 692' ' ' GLY . 71.9 Cg_endo -73.85 150.42 44.15 Favored 'Trans proline' 0 C--N 1.348 0.517 0 C-N-CA 123.005 2.47 . . . . 0.0 114.47 -178.433 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 706' ' ' LEU . . . . . 0.864 HD23 HG13 ' A' ' 708' ' ' ILE . 76.2 mt -87.69 145.38 36.89 Favored Pre-proline 0 CA--C 1.531 0.245 0 CA-C-N 115.217 -0.901 . . . . 0.0 110.358 178.386 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 707' ' ' PRO . . . . . . . . . . . . . 15.4 Cg_exo -71.34 139.0 56.15 Favored 'Cis proline' 0 C--N 1.346 0.399 0 C-N-CA 123.746 -1.356 . . . . 0.0 111.965 -1.744 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 708' ' ' ILE . . . . . 0.864 HG13 HD23 ' A' ' 706' ' ' LEU . 74.2 mt -78.64 118.69 26.34 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 N-CA-C 109.932 -0.395 . . . . 0.0 109.932 179.13 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 709' ' ' HIS . . . . . . . . . . . . . 67.8 m80 -87.44 121.54 71.13 Favored Pre-proline 0 C--N 1.328 -0.364 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.439 179.529 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 710' ' ' PRO . . . . . . . . . . . . . 81.8 Cg_exo -53.72 -38.49 84.86 Favored 'Trans proline' 0 C--N 1.35 0.652 0 C-N-CA 123.579 2.853 . . . . 0.0 114.44 -178.895 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 711' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -64.99 -42.61 94.36 Favored 'General case' 0 N--CA 1.463 0.221 0 N-CA-C 112.034 0.383 . . . . 0.0 112.034 -178.754 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 712' ' ' SER . . . . . . . . . . . . . 49.4 m -82.34 -29.57 30.92 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.513 -0.312 . . . . 0.0 111.248 -179.703 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 713' ' ' PHE . . . . . . . . . . . . . 84.4 t80 -60.38 -50.3 74.14 Favored 'General case' 0 C--N 1.328 -0.34 0 O-C-N 123.175 0.297 . . . . 0.0 111.483 -179.394 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 714' ' ' LEU . . . . . . . . . . . . . 91.4 mt -65.88 -40.64 91.79 Favored 'General case' 0 C--O 1.234 0.272 0 CA-C-N 116.503 -0.317 . . . . 0.0 110.889 179.848 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 715' ' ' GLN . . . . . . . . . . . . . 98.8 mm-40 -65.36 -40.95 94.22 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.055 178.897 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 716' ' ' GLN . . . . . . . . . . . . . 61.5 tt0 -63.86 -42.31 97.56 Favored 'General case' 0 C--O 1.233 0.185 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.7 -179.899 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 717' ' ' VAL . . . . . . . . . . . . . 66.1 t -63.69 -43.77 98.18 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.135 0 N-CA-C 109.843 -0.429 . . . . 0.0 109.843 178.582 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 718' ' ' THR . . . . . . . . . . . . . 89.9 m -61.86 -43.94 97.83 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-N 115.57 -0.741 . . . . 0.0 110.922 179.394 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 719' ' ' MET . . . . . . . . . . . . . 98.0 mtp -61.5 -43.62 98.54 Favored 'General case' 0 N--CA 1.462 0.167 0 CA-C-O 120.578 0.228 . . . . 0.0 110.542 179.547 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 720' ' ' GLY . . . . . . . . . . . . . . . -65.52 -41.61 96.14 Favored Glycine 0 C--N 1.333 0.369 0 C-N-CA 120.621 -0.8 . . . . 0.0 111.88 178.421 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 721' ' ' LEU . . . . . . . . . . . . . 62.1 tp -63.95 -43.86 94.55 Favored 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 122.789 0.436 . . . . 0.0 111.827 179.798 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 722' ' ' THR . . . . . . . . . . . . . 41.0 p -73.56 -10.31 59.57 Favored 'General case' 0 N--CA 1.465 0.277 0 N-CA-C 112.243 0.46 . . . . 0.0 112.243 -179.379 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 723' ' ' SER . . . . . . . . . . . . . 74.6 m -84.18 -4.29 58.71 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.844 0.354 . . . . 0.0 110.651 179.137 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 724' ' ' LEU . . . . . . . . . . . . . 67.3 tp -99.9 121.4 41.27 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.533 179.796 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 725' ' ' ALA . . . . . . . . . . . . . . . -146.82 152.65 39.1 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.637 179.918 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 726' ' ' THR . . . . . . . . . . . . . 72.5 p -128.04 159.2 35.77 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.816 -179.962 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 727' ' ' SER . . . . . . . . . . . . . 87.3 p -70.07 -23.74 63.12 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-N 116.361 -0.381 . . . . 0.0 111.591 179.851 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 728' ' ' ALA . . . . . . . . . . . . . . . -147.79 152.25 37.38 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.545 179.919 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 729' ' ' GLN . . . . . . . . . . . . . 96.7 mt-30 . . . . . 0 C--O 1.25 1.088 0 CA-C-O 118.291 -0.861 . . . . 0.0 110.752 -179.962 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 613' ' ' GLU . . . . . 0.499 ' HA ' ' O ' ' A' ' 637' ' ' GLY . 2.1 mp0 . . . . . 0 N--CA 1.487 1.39 0 CA-C-O 121.009 0.433 . . . . 0.0 110.656 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 614' ' ' GLY . . . . . . . . . . . . . . . -82.42 176.78 53.65 Favored Glycine 0 C--N 1.33 0.202 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.604 179.968 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 615' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -115.27 131.39 56.95 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.942 0.401 . . . . 0.0 111.163 -179.813 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 616' ' ' ILE . . . . . 0.592 ' O ' ' HA ' ' A' ' 640' ' ' VAL . 85.2 mt -130.76 138.56 53.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 115.624 -0.716 . . . . 0.0 109.354 179.078 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 617' ' ' VAL . . . . . 0.541 HG22 HG12 ' A' ' 659' ' ' VAL . 33.0 m -110.61 146.72 15.4 Favored 'Isoleucine or valine' 0 C--O 1.235 0.334 0 C-N-CA 119.89 -0.724 . . . . 0.0 110.962 -179.931 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 618' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -116.48 126.87 53.99 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.857 -0.611 . . . . 0.0 110.716 179.895 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 619' ' ' VAL . . . . . . . . . . . . . 96.7 t -117.07 117.82 56.66 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 N-CA-C 109.537 -0.542 . . . . 0.0 109.537 179.512 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 620' ' ' SER . . . . . 0.544 ' HB3' ' HB3' ' A' ' 662' ' ' ALA . 83.3 p -170.06 163.8 9.29 Favored 'General case' 0 N--CA 1.453 -0.32 0 CA-C-N 115.521 -0.763 . . . . 0.0 111.145 -178.991 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 621' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -103.87 -5.52 22.26 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.315 -0.857 . . . . 0.0 111.17 178.584 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 622' ' ' ASP . . . . . . . . . . . . . 52.7 t0 -102.63 107.52 18.47 Favored 'General case' 0 C--O 1.233 0.234 0 CA-C-O 121.035 0.445 . . . . 0.0 111.076 -178.723 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 623' ' ' GLU . . . . . 0.413 ' O ' HG23 ' A' ' 627' ' ' THR . 98.0 mt-10 -64.58 -39.31 93.51 Favored 'General case' 0 CA--C 1.532 0.281 0 CA-C-N 115.591 -0.732 . . . . 0.0 112.415 179.834 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 624' ' ' ALA . . . . . . . . . . . . . . . -61.41 -43.99 97.92 Favored 'General case' 0 N--CA 1.466 0.339 0 N-CA-C 112.361 0.504 . . . . 0.0 112.361 -178.355 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 625' ' ' THR . . . . . . . . . . . . . 85.8 m -68.28 -39.48 82.13 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.385 0.612 . . . . 0.0 109.893 179.629 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 626' ' ' SER . . . . . . . . . . . . . 67.0 m -61.66 -40.35 94.6 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 114.899 -1.046 . . . . 0.0 112.577 -178.832 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 627' ' ' THR . . . . . 0.413 HG23 ' O ' ' A' ' 623' ' ' GLU . 77.0 p -63.03 -39.31 94.36 Favored 'General case' 0 N--CA 1.466 0.336 0 N-CA-C 112.316 0.487 . . . . 0.0 112.316 -179.026 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 628' ' ' LEU . . . . . . . . . . . . . 62.4 tp -67.91 -46.32 71.89 Favored 'General case' 0 CA--C 1.533 0.293 0 N-CA-C 112.138 0.422 . . . . 0.0 112.138 -179.816 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 629' ' ' ILE . . . . . . . . . . . . . 20.6 tt -71.98 -36.76 58.57 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.417 0 N-CA-C 112.822 0.675 . . . . 0.0 112.822 -178.586 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 630' ' ' CYS . . . . . . . . . . . . . 81.1 m -62.64 -40.0 95.63 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-O 120.673 0.273 . . . . 0.0 110.95 -179.808 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 631' ' ' SER . . . . . . . . . . . . . 66.1 m -63.11 -41.21 99.31 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.738 179.768 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 632' ' ' ILE . . . . . . . . . . . . . 97.0 mt -62.54 -48.89 86.1 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.324 0 CA-C-O 120.962 0.411 . . . . 0.0 110.921 179.969 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 633' ' ' LEU . . . . . . . . . . . . . 82.2 mt -67.21 -40.73 86.5 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-N 115.853 -0.612 . . . . 0.0 112.461 -179.412 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 634' ' ' THR . . . . . 0.531 ' HA ' ' O ' ' A' ' 638' ' ' TYR . 86.0 m -66.35 -40.75 90.0 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.6 0.238 . . . . 0.0 111.054 -179.602 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 635' ' ' THR . . . . . . . . . . . . . 93.5 m -59.66 -38.95 82.86 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-O 120.885 0.374 . . . . 0.0 110.351 179.168 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 636' ' ' ALA . . . . . . . . . . . . . . . -64.21 -16.92 62.98 Favored 'General case' 0 CA--C 1.532 0.282 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.538 179.012 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 637' ' ' GLY . . . . . 0.499 ' O ' ' HA ' ' A' ' 613' ' ' GLU . . . 108.91 6.81 29.91 Favored Glycine 0 C--N 1.334 0.441 0 C-N-CA 120.996 -0.621 . . . . 0.0 113.115 179.781 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 638' ' ' TYR . . . . . 0.531 ' O ' ' HA ' ' A' ' 634' ' ' THR . 91.4 m-85 -100.16 142.53 31.51 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 120.843 0.354 . . . . 0.0 111.387 -179.95 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 639' ' ' GLN . . . . . . . . . . . . . 98.6 mm-40 -90.06 133.57 34.76 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.215 -0.448 . . . . 0.0 109.806 179.397 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 640' ' ' VAL . . . . . 0.592 ' HA ' ' O ' ' A' ' 616' ' ' ILE . 0.9 OUTLIER -122.21 138.97 50.62 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 N-CA-C 113.336 0.865 . . . . 0.0 113.336 -179.376 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 641' ' ' ILE . . . . . . . . . . . . . 48.6 mm -119.73 123.82 71.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 N-CA-C 108.533 -0.914 . . . . 0.0 108.533 178.041 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 642' ' ' TRP . . . . . 0.406 ' CH2' ' HB ' ' A' ' 644' ' ' VAL . 67.8 t90 -96.68 128.71 43.88 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 112.531 0.567 . . . . 0.0 112.531 -178.452 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 643' ' ' LEU . . . . . 0.408 HD13 ' HA ' ' A' ' 643' ' ' LEU . 0.7 OUTLIER -119.42 124.02 45.51 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 115.283 -0.871 . . . . 0.0 110.073 179.144 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 644' ' ' VAL . . . . . 0.406 ' HB ' ' CH2' ' A' ' 642' ' ' TRP . 7.8 p -93.09 3.62 8.11 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.475 0 CA-C-O 121.054 0.454 . . . . 0.0 111.531 -179.453 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 645' ' ' ASP . . . . . . . . . . . . . 15.4 t0 -125.74 -28.49 3.24 Favored 'General case' 0 N--CA 1.47 0.558 0 N-CA-C 113.089 0.774 . . . . 0.0 113.089 -177.471 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 646' ' ' GLY . . . . . . . . . . . . . . . 73.37 28.8 65.16 Favored Glycine 0 CA--C 1.52 0.377 0 C-N-CA 120.664 -0.779 . . . . 0.0 114.084 179.948 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 647' ' ' GLU . . . . . . . . . . . . . 33.7 mt-10 -65.6 123.13 18.86 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 121.384 0.611 . . . . 0.0 111.012 179.757 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 648' ' ' VAL . . . . . . . . . . . . . 77.3 t -61.36 -39.63 83.41 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-N 114.797 -1.092 . . . . 0.0 111.592 -179.396 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 649' ' ' GLU . . . . . . . . . . . . . 50.5 mp0 -60.53 -43.43 97.17 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.691 0.281 . . . . 0.0 110.439 -179.614 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 650' ' ' ARG . . . . . . . . . . . . . 95.6 mtt-85 -70.56 -41.6 72.23 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.731 178.686 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 651' ' ' LEU . . . . . 0.478 HD22 HG21 ' A' ' 617' ' ' VAL . 94.2 mt -65.89 -40.44 91.56 Favored 'General case' 0 N--CA 1.462 0.14 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.895 179.631 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 652' ' ' LEU . . . . . . . . . . . . . 63.3 tp -64.25 -43.21 95.58 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.102 179.028 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 653' ' ' ALA . . . . . . . . . . . . . . . -62.4 -39.67 94.0 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-O 121.164 0.507 . . . . 0.0 111.247 179.967 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 654' ' ' LEU . . . . . . . . . . . . . 76.6 mt -101.22 30.78 3.98 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.572 -0.74 . . . . 0.0 109.97 179.81 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 655' ' ' THR . . . . . . . . . . . . . 5.6 t -42.73 110.74 0.9 Allowed Pre-proline 0 N--CA 1.468 0.471 0 O-C-N 124.189 0.931 . . . . 0.0 113.276 -178.13 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 656' ' ' PRO . . . . . 0.437 ' HG3' HG22 ' A' ' 617' ' ' VAL . 23.5 Cg_endo -92.53 -175.61 0.6 Allowed 'Trans proline' 0 C--N 1.345 0.352 0 C-N-CA 124.069 3.179 . . . . 0.0 112.513 179.374 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 657' ' ' ILE . . . . . . . . . . . . . 27.2 pt -83.23 -24.11 8.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-O 121.239 0.542 . . . . 0.0 110.171 178.041 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 658' ' ' ALA . . . . . 0.408 ' HA ' ' O ' ' A' ' 687' ' ' LYS . . . -156.37 152.9 28.14 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.368 -0.833 . . . . 0.0 111.165 -179.756 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 659' ' ' VAL . . . . . 0.724 HG13 HD11 ' A' ' 686' ' ' LEU . 35.4 m -122.73 147.08 27.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-O 121.178 0.514 . . . . 0.0 111.266 179.49 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 660' ' ' LEU . . . . . . . . . . . . . 11.8 mt -116.69 115.39 25.56 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.436 -0.802 . . . . 0.0 109.814 178.646 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 661' ' ' LEU . . . . . . . . . . . . . 73.1 mt -106.11 114.57 28.79 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 109.557 -0.534 . . . . 0.0 109.557 -179.985 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 662' ' ' ALA . . . . . 0.544 ' HB3' ' HB3' ' A' ' 620' ' ' SER . . . -106.07 131.22 53.6 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 112.57 0.581 . . . . 0.0 112.57 -178.873 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 663' ' ' GLU . . . . . . . . . . . . . 57.5 mt-10 -71.59 139.28 83.59 Favored Pre-proline 0 CA--C 1.535 0.396 0 CA-C-N 115.506 -0.77 . . . . 0.0 110.56 178.24 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 664' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -74.62 141.91 73.19 Favored 'Cis proline' 0 C--N 1.349 0.605 0 C-N-CA 123.367 -1.514 . . . . 0.0 112.448 -0.911 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 665' ' ' PHE . . . . . 0.467 ' HZ ' HD11 ' A' ' 690' ' ' ILE . 40.8 m-85 -66.15 126.21 27.95 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.87 -179.892 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 666' ' ' SER . . . . . . . . . . . . . 66.7 m -64.01 -41.17 97.55 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.313 179.719 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 667' ' ' TYR . . . . . . . . . . . . . 53.1 t80 -68.63 -21.06 64.5 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-N 115.815 -0.63 . . . . 0.0 111.413 179.82 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 668' ' ' GLY . . . . . . . . . . . . . . . 102.52 -102.75 2.33 Favored Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 120.54 -0.838 . . . . 0.0 112.121 -178.712 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 669' ' ' ASP . . . . . . . . . . . . . 51.1 t0 -77.29 108.2 10.24 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.049 0.452 . . . . 0.0 110.399 -179.836 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 670' ' ' VAL . . . . . . . . . . . . . 11.2 p -62.7 -32.26 54.99 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.332 0 CA-C-N 115.472 -0.786 . . . . 0.0 112.918 -179.064 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 671' ' ' GLN . . . . . . . . . . . . . 97.2 mt-30 -62.56 -40.88 98.26 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-O 120.898 0.38 . . . . 0.0 111.246 -179.179 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 672' ' ' GLU . . . . . . . . . . . . . 95.3 mt-10 -67.46 -40.58 85.38 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.917 0.389 . . . . 0.0 110.395 178.706 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 673' ' ' LEU . . . . . . . . . . . . . 63.3 tp -64.42 -45.34 87.99 Favored 'General case' 0 CA--C 1.53 0.193 0 CA-C-N 115.665 -0.698 . . . . 0.0 111.254 -179.924 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 674' ' ' VAL . . . . . . . . . . . . . 27.2 m -67.77 -36.69 76.74 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.172 0 N-CA-C 110.211 -0.292 . . . . 0.0 110.211 179.813 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 675' ' ' ASP . . . . . . . . . . . . . 37.0 t70 -63.48 -40.62 97.58 Favored 'General case' 0 CA--C 1.521 -0.167 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.343 177.896 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 676' ' ' GLN . . . . . . . . . . . . . 76.9 mt-30 -69.51 -40.84 76.73 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.042 -179.533 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 677' ' ' LEU . . . . . . . . . . . . . 7.3 mp -69.21 -43.31 74.36 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.901 179.485 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 678' ' ' ARG . . . . . . . . . . . . . 61.9 ttp180 -64.62 -38.46 91.07 Favored 'General case' 0 N--CA 1.468 0.428 0 CA-C-O 121.248 0.546 . . . . 0.0 110.804 179.868 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 679' ' ' GLN . . . . . . . . . . . . . 71.3 tp60 -62.76 -38.87 92.26 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.512 -0.767 . . . . 0.0 111.036 -179.965 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 680' ' ' ARG . . . . . . . . . . . . . 31.4 mmm180 -84.54 -42.59 15.34 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 120.814 0.34 . . . . 0.0 111.431 -179.801 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 681' ' ' CYS . . . . . . . . . . . . . 74.3 m -126.47 130.69 51.13 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.343 -0.389 . . . . 0.0 110.307 179.727 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 682' ' ' THR . . . . . . . . . . . . . 68.2 p -68.88 158.95 84.73 Favored Pre-proline 0 C--N 1.325 -0.49 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.583 -179.709 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 683' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_exo -54.46 -32.25 72.44 Favored 'Trans proline' 0 C--N 1.349 0.588 0 C-N-CA 122.614 2.209 . . . . 0.0 112.389 179.636 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 684' ' ' GLU . . . . . . . . . . . . . 51.9 mp0 -70.65 -39.34 73.67 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.691 179.599 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 685' ' ' GLN . . . . . . . . . . . . . 71.8 tp60 -71.95 -41.64 67.55 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.829 -0.623 . . . . 0.0 111.852 179.888 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 686' ' ' LEU . . . . . 0.724 HD11 HG13 ' A' ' 659' ' ' VAL . 62.6 tp -129.72 119.89 24.21 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.759 -178.476 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 687' ' ' LYS . . . . . 0.408 ' O ' ' HA ' ' A' ' 658' ' ' ALA . 3.0 mptp? -85.13 145.01 27.84 Favored 'General case' 0 C--N 1.331 -0.229 0 N-CA-C 109.916 -0.401 . . . . 0.0 109.916 178.603 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 688' ' ' ILE . . . . . 0.428 HG22 HG12 ' A' ' 700' ' ' VAL . 80.0 mt -123.38 119.87 58.63 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.808 0 CA-C-O 121.328 0.585 . . . . 0.0 111.341 -178.977 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 689' ' ' PHE . . . . . 0.415 ' CD2' ' HB2' ' A' ' 702' ' ' ARG . 98.3 m-85 -117.61 144.86 44.76 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 114.958 -1.019 . . . . 0.0 109.934 178.983 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 690' ' ' ILE . . . . . 0.467 HD11 ' HZ ' ' A' ' 665' ' ' PHE . 17.4 tt -124.97 137.76 56.5 Favored 'Isoleucine or valine' 0 C--O 1.237 0.398 0 CA-C-O 121.276 0.56 . . . . 0.0 111.751 -179.768 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 691' ' ' LEU . . . . . 0.5 HD23 ' HB ' ' A' ' 704' ' ' ILE . 58.7 mt -110.18 130.15 55.59 Favored 'General case' 0 C--O 1.234 0.269 0 CA-C-N 115.525 -0.761 . . . . 0.0 109.7 179.544 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 692' ' ' GLY . . . . . 0.631 ' O ' ' HA ' ' A' ' 705' ' ' PRO . . . 167.3 -166.73 39.45 Favored Glycine 0 N--CA 1.446 -0.673 0 C-N-CA 120.628 -0.796 . . . . 0.0 112.051 -179.714 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 693' ' ' SER . . . . . . . . . . . . . 89.6 p -87.52 -14.41 40.38 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 120.616 0.246 . . . . 0.0 111.623 179.93 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 694' ' ' LYS . . . . . . . . . . . . . 68.9 mttm -128.86 136.18 50.1 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.217 0.532 . . . . 0.0 111.384 -179.947 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 695' ' ' GLY . . . . . 0.414 ' HA3' ' CB ' ' A' ' 703' ' ' TYR . . . -117.27 22.97 10.04 Favored Glycine 0 N--CA 1.45 -0.428 0 CA-C-N 115.384 -0.826 . . . . 0.0 112.383 179.493 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 696' ' ' ASN . . . . . . . . . . . . . 21.5 p-10 -93.41 11.48 28.22 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 111.865 0.32 . . . . 0.0 111.865 -179.231 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 697' ' ' TYR . . . . . . . . . . . . . 81.6 m-85 -73.25 142.9 47.24 Favored 'General case' 0 N--CA 1.45 -0.439 0 CA-C-O 121.376 0.607 . . . . 0.0 110.84 179.914 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 698' ' ' GLN . . . . . . . . . . . . . 98.3 mm-40 -88.54 151.98 22.16 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-N 115.1 -0.955 . . . . 0.0 110.729 -179.653 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 699' ' ' GLY . . . . . . . . . . . . . . . 93.4 3.09 65.17 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.641 -0.79 . . . . 0.0 112.897 -179.725 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 700' ' ' VAL . . . . . 0.428 HG12 HG22 ' A' ' 688' ' ' ILE . 21.8 m -119.76 152.46 22.4 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.303 0 CA-C-O 120.859 0.362 . . . . 0.0 110.055 179.363 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 701' ' ' ASP . . . . . . . . . . . . . 66.5 m-20 -89.56 -36.59 15.25 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.114 -0.493 . . . . 0.0 112.25 -178.861 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 702' ' ' ARG . . . . . 0.415 ' HB2' ' CD2' ' A' ' 689' ' ' PHE . 2.3 mpt_? -141.2 163.84 31.88 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.812 0.339 . . . . 0.0 110.62 -178.689 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 703' ' ' TYR . . . . . 0.414 ' CB ' ' HA3' ' A' ' 695' ' ' GLY . 50.2 p90 -131.3 144.32 51.18 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.779 179.576 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 704' ' ' ILE . . . . . 0.5 ' HB ' HD23 ' A' ' 691' ' ' LEU . 52.3 mt -129.64 87.98 51.07 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.45 -179.774 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 705' ' ' PRO . . . . . 0.631 ' HA ' ' O ' ' A' ' 692' ' ' GLY . 31.2 Cg_exo -61.88 142.59 93.81 Favored 'Trans proline' 0 C--N 1.348 0.535 0 C-N-CA 123.511 2.807 . . . . 0.0 114.025 -179.236 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 706' ' ' LEU . . . . . 0.76 HD23 HG13 ' A' ' 708' ' ' ILE . 82.3 mt -80.52 145.22 58.52 Favored Pre-proline 0 CA--C 1.531 0.242 0 CA-C-N 115.544 -0.753 . . . . 0.0 110.336 178.28 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 707' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -74.48 142.88 76.09 Favored 'Cis proline' 0 C--N 1.345 0.382 0 C-N-CA 123.051 -1.645 . . . . 0.0 112.115 -1.31 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 708' ' ' ILE . . . . . 0.76 HG13 HD23 ' A' ' 706' ' ' LEU . 68.8 mt -75.46 121.28 26.84 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.305 179.469 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 709' ' ' HIS . . . . . . . . . . . . . 69.1 m80 -90.39 119.96 69.09 Favored Pre-proline 0 C--N 1.328 -0.355 0 CA-C-N 116.345 -0.388 . . . . 0.0 110.074 179.145 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 710' ' ' PRO . . . . . . . . . . . . . 82.8 Cg_exo -53.59 -38.27 83.83 Favored 'Trans proline' 0 N--CA 1.48 0.718 0 C-N-CA 123.471 2.781 . . . . 0.0 114.433 -178.961 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 711' ' ' GLU . . . . . . . . . . . . . 42.8 tt0 -64.28 -43.66 94.08 Favored 'General case' 0 CA--C 1.531 0.222 0 N-CA-C 112.13 0.418 . . . . 0.0 112.13 -178.746 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 712' ' ' SER . . . . . . . . . . . . . 48.9 m -87.29 -22.52 25.1 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 111.856 0.317 . . . . 0.0 111.856 -178.89 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 713' ' ' PHE . . . . . . . . . . . . . 82.4 t80 -60.0 -49.7 76.65 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.808 0.337 . . . . 0.0 110.899 -179.672 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 714' ' ' LEU . . . . . . . . . . . . . 89.8 mt -64.84 -38.51 91.22 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.348 179.29 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 715' ' ' GLN . . . . . . . . . . . . . 30.6 mm100 -63.48 -41.96 98.56 Favored 'General case' 0 CA--C 1.529 0.162 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.187 179.528 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 716' ' ' GLN . . . . . . . . . . . . . 87.3 mt-30 -64.43 -41.29 96.66 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-O 120.53 0.205 . . . . 0.0 111.072 179.53 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 717' ' ' VAL . . . . . . . . . . . . . 73.4 t -63.79 -44.34 98.2 Favored 'Isoleucine or valine' 0 C--O 1.233 0.2 0 CA-C-O 121.06 0.457 . . . . 0.0 109.822 178.919 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 718' ' ' THR . . . . . . . . . . . . . 91.3 m -62.29 -45.37 93.57 Favored 'General case' 0 CA--C 1.53 0.203 0 CA-C-N 115.479 -0.782 . . . . 0.0 110.826 179.427 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 719' ' ' MET . . . . . . . . . . . . . 95.3 mmm -62.27 -40.54 96.56 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-N 116.452 -0.34 . . . . 0.0 110.573 179.58 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 720' ' ' GLY . . . . . . . . . . . . . . . -62.36 -41.33 99.76 Favored Glycine 0 C--N 1.332 0.317 0 C-N-CA 120.644 -0.788 . . . . 0.0 111.793 178.596 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 721' ' ' LEU . . . . . . . . . . . . . 98.6 mt -65.96 -40.56 91.42 Favored 'General case' 0 N--CA 1.461 0.116 0 CA-C-O 120.737 0.303 . . . . 0.0 111.082 179.299 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 722' ' ' THR . . . . . . . . . . . . . 75.9 p -70.78 -24.81 62.66 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.451 179.804 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 723' ' ' SER . . . . . . . . . . . . . 75.0 m -64.37 -40.06 95.09 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-O 120.861 0.362 . . . . 0.0 110.196 178.732 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 724' ' ' LEU . . . . . . . . . . . . . 64.7 tp -63.81 -46.84 83.32 Favored 'General case' 0 CA--C 1.53 0.187 0 CA-C-N 115.714 -0.676 . . . . 0.0 111.356 179.525 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 725' ' ' ALA . . . . . . . . . . . . . . . -154.92 148.88 25.72 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.943 -179.817 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 726' ' ' THR . . . . . . . . . . . . . 73.5 p -80.72 160.54 24.92 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.255 179.919 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 727' ' ' SER . . . . . . . . . . . . . 97.4 p -153.19 162.93 40.75 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.279 -0.418 . . . . 0.0 110.451 179.97 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 728' ' ' ALA . . . . . . . . . . . . . . . -147.1 153.46 39.96 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.4 -0.364 . . . . 0.0 110.634 -179.863 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 729' ' ' GLN . . . . . . . . . . . . . 96.7 mt-30 . . . . . 0 C--O 1.249 1.076 0 CA-C-O 118.283 -0.865 . . . . 0.0 110.8 -179.971 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 613' ' ' GLU . . . . . . . . . . . . . 15.6 mt-10 . . . . . 0 N--CA 1.485 1.294 0 CA-C-O 120.814 0.34 . . . . 0.0 110.624 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 614' ' ' GLY . . . . . . . . . . . . . . . -161.87 165.48 35.79 Favored Glycine 0 N--CA 1.45 -0.386 0 N-CA-C 111.495 -0.642 . . . . 0.0 111.495 179.677 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 615' ' ' ARG . . . . . . . . . . . . . 83.7 mtp180 -116.58 130.08 56.54 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.011 0.434 . . . . 0.0 111.087 -179.743 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 616' ' ' ILE . . . . . 0.406 ' O ' ' HA ' ' A' ' 640' ' ' VAL . 83.7 mt -124.75 134.26 67.3 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-N 115.54 -0.755 . . . . 0.0 109.746 179.393 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 617' ' ' VAL . . . . . . . . . . . . . 96.2 t -105.77 127.04 61.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-O 121.046 0.45 . . . . 0.0 110.044 -179.908 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 618' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -109.22 129.08 55.5 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.703 -0.68 . . . . 0.0 111.045 -178.58 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 619' ' ' VAL . . . . . . . . . . . . . 80.0 t -117.87 118.67 59.07 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.124 179.905 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 620' ' ' SER . . . . . 0.483 ' HB2' ' HB3' ' A' ' 662' ' ' ALA . 22.8 t -172.36 137.34 0.86 Allowed 'General case' 0 C--O 1.232 0.176 0 CA-C-N 115.621 -0.718 . . . . 0.0 110.826 -179.899 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 621' ' ' GLU . . . . . . . . . . . . . 25.7 pt-20 -85.3 -10.49 56.37 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.804 179.206 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 622' ' ' ASP . . . . . . . . . . . . . 36.0 t70 -90.63 109.67 20.83 Favored 'General case' 0 C--O 1.232 0.179 0 CA-C-O 120.894 0.378 . . . . 0.0 110.62 -179.528 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 623' ' ' GLU . . . . . . . . . . . . . 51.1 mp0 -63.0 -39.77 95.77 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.597 -0.729 . . . . 0.0 112.755 -178.776 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 624' ' ' ALA . . . . . . . . . . . . . . . -61.04 -45.95 92.71 Favored 'General case' 0 N--CA 1.466 0.357 0 N-CA-C 112.674 0.62 . . . . 0.0 112.674 -178.033 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 625' ' ' THR . . . . . . . . . . . . . 89.2 m -71.27 -41.36 70.14 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.011 0.434 . . . . 0.0 110.665 179.752 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 626' ' ' SER . . . . . . . . . . . . . 66.9 m -63.16 -41.94 99.34 Favored 'General case' 0 CA--C 1.531 0.246 0 CA-C-N 115.707 -0.679 . . . . 0.0 112.674 -178.215 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 627' ' ' THR . . . . . . . . . . . . . 34.4 p -66.34 -40.89 90.13 Favored 'General case' 0 N--CA 1.466 0.373 0 N-CA-C 112.047 0.388 . . . . 0.0 112.047 -179.868 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 628' ' ' LEU . . . . . . . . . . . . . 61.8 tp -66.46 -44.39 82.89 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.647 179.612 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 629' ' ' ILE . . . . . . . . . . . . . 2.5 tp -69.25 -37.09 75.49 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.555 0 N-CA-C 112.705 0.631 . . . . 0.0 112.705 -178.574 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 630' ' ' CYS . . . . . . . . . . . . . 89.6 m -64.08 -39.46 94.12 Favored 'General case' 0 N--CA 1.465 0.297 0 N-CA-C 111.624 0.231 . . . . 0.0 111.624 -179.527 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 631' ' ' SER . . . . . . . . . . . . . 68.7 m -61.95 -41.61 98.18 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.162 -179.321 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 632' ' ' ILE . . . . . . . . . . . . . 97.1 mt -62.85 -48.15 89.43 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.306 0 CA-C-O 120.987 0.422 . . . . 0.0 110.912 179.836 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 633' ' ' LEU . . . . . . . . . . . . . 80.7 mt -66.47 -40.47 89.38 Favored 'General case' 0 C--O 1.234 0.255 0 CA-C-N 115.907 -0.588 . . . . 0.0 112.432 -179.565 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 634' ' ' THR . . . . . 0.488 ' HA ' ' O ' ' A' ' 638' ' ' TYR . 78.7 m -65.68 -40.16 92.07 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.652 0.263 . . . . 0.0 110.858 -179.373 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 635' ' ' THR . . . . . . . . . . . . . 92.9 m -59.05 -38.88 80.4 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.331 179.24 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 636' ' ' ALA . . . . . . . . . . . . . . . -64.69 -17.72 64.35 Favored 'General case' 0 CA--C 1.533 0.307 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.412 178.932 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 637' ' ' GLY . . . . . . . . . . . . . . . 109.01 6.61 29.85 Favored Glycine 0 C--N 1.333 0.381 0 C-N-CA 120.918 -0.658 . . . . 0.0 113.102 179.836 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 638' ' ' TYR . . . . . 0.488 ' O ' ' HA ' ' A' ' 634' ' ' THR . 93.1 m-85 -100.49 141.84 32.79 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.841 0.353 . . . . 0.0 111.46 -179.935 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 639' ' ' GLN . . . . . . . . . . . . . 78.7 mt-30 -89.18 134.55 33.98 Favored 'General case' 0 CA--C 1.517 -0.309 0 CA-C-N 116.229 -0.441 . . . . 0.0 109.894 179.172 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 640' ' ' VAL . . . . . 0.406 ' HA ' ' O ' ' A' ' 616' ' ' ILE . 57.3 t -118.9 131.58 71.27 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 N-CA-C 112.6 0.593 . . . . 0.0 112.6 -178.726 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 641' ' ' ILE . . . . . . . . . . . . . 42.7 mm -107.72 114.4 46.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 N-CA-C 108.116 -1.068 . . . . 0.0 108.116 177.926 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 642' ' ' TRP . . . . . . . . . . . . . 22.6 t90 -93.92 124.42 37.91 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.203 0.525 . . . . 0.0 112.225 -178.193 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 643' ' ' LEU . . . . . . . . . . . . . 90.0 mt -121.34 141.44 50.94 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-N 115.558 -0.746 . . . . 0.0 110.73 179.239 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 644' ' ' VAL . . . . . . . . . . . . . 5.8 m -108.79 23.6 3.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 N-CA-C 112.07 0.396 . . . . 0.0 112.07 -179.818 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 645' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -136.84 -37.21 0.67 Allowed 'General case' 0 N--CA 1.47 0.565 0 N-CA-C 112.934 0.716 . . . . 0.0 112.934 -178.301 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 646' ' ' GLY . . . . . . . . . . . . . . . 76.56 21.27 75.35 Favored Glycine 0 CA--C 1.52 0.345 0 C-N-CA 120.76 -0.734 . . . . 0.0 113.359 -179.485 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 647' ' ' GLU . . . . . . . . . . . . . 86.5 tt0 -62.49 123.47 18.41 Favored 'General case' 0 N--CA 1.456 -0.173 0 CA-C-O 121.261 0.553 . . . . 0.0 110.411 -179.718 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 648' ' ' VAL . . . . . . . . . . . . . 9.3 p -63.2 -31.75 53.87 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-N 114.981 -1.009 . . . . 0.0 112.661 -178.459 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 649' ' ' GLU . . . . . . . . . . . . . 99.1 mt-10 -63.46 -41.81 98.61 Favored 'General case' 0 N--CA 1.461 0.116 0 C-N-CA 120.71 -0.396 . . . . 0.0 110.107 179.615 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 650' ' ' ARG . . . . . . . . . . . . . 2.2 mpt_? -73.13 -40.04 65.24 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.254 178.482 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 651' ' ' LEU . . . . . . . . . . . . . 84.9 mt -63.09 -41.75 99.46 Favored 'General case' 0 CA--C 1.521 -0.157 0 CA-C-N 116.361 -0.381 . . . . 0.0 109.982 178.848 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 652' ' ' LEU . . . . . . . . . . . . . 62.1 tp -65.32 -43.29 91.48 Favored 'General case' 0 CA--C 1.53 0.203 0 CA-C-N 115.882 -0.599 . . . . 0.0 111.111 178.597 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 653' ' ' ALA . . . . . . . . . . . . . . . -62.76 -39.56 94.56 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-O 121.007 0.432 . . . . 0.0 111.988 179.966 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 654' ' ' LEU . . . . . . . . . . . . . 76.1 mt -101.94 29.78 4.81 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.2 -179.275 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 655' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -33.58 104.8 0.24 Allowed Pre-proline 0 N--CA 1.47 0.537 0 O-C-N 124.537 1.148 . . . . 0.0 113.925 -179.459 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 656' ' ' PRO . . . . . . . . . . . . . 34.0 Cg_endo -91.5 -176.56 0.87 Allowed 'Trans proline' 0 C--N 1.345 0.347 0 C-N-CA 123.456 2.77 . . . . 0.0 111.789 178.31 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 657' ' ' ILE . . . . . . . . . . . . . 22.8 pt -81.57 -25.06 9.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 121.333 0.587 . . . . 0.0 109.758 178.205 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 658' ' ' ALA . . . . . 0.439 ' HA ' ' O ' ' A' ' 687' ' ' LYS . . . -159.43 153.81 23.93 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.15 -0.932 . . . . 0.0 111.25 -179.825 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 659' ' ' VAL . . . . . 0.513 HG13 HD11 ' A' ' 686' ' ' LEU . 18.2 m -121.44 145.29 28.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-O 121.09 0.472 . . . . 0.0 110.633 178.816 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 660' ' ' LEU . . . . . 0.509 HD22 HD11 ' A' ' 691' ' ' LEU . 14.8 mt -117.13 120.37 38.11 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.498 -0.774 . . . . 0.0 110.355 179.646 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 661' ' ' LEU . . . . . . . . . . . . . 72.5 mt -107.78 110.79 22.69 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 109.177 -0.675 . . . . 0.0 109.177 179.397 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 662' ' ' ALA . . . . . 0.533 ' HB2' HD13 ' A' ' 691' ' ' LEU . . . -107.76 128.26 54.42 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 112.533 0.568 . . . . 0.0 112.533 -178.467 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 663' ' ' GLU . . . . . . . . . . . . . 99.7 mt-10 -70.06 145.28 93.77 Favored Pre-proline 0 C--N 1.326 -0.427 0 CA-C-N 115.623 -0.717 . . . . 0.0 110.482 177.903 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 664' ' ' PRO . . . . . . . . . . . . . 64.1 Cg_endo -73.92 140.59 68.1 Favored 'Cis proline' 0 C--N 1.347 0.492 0 C-N-CA 123.364 -1.515 . . . . 0.0 112.543 -1.204 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 665' ' ' PHE . . . . . 0.762 ' HZ ' HD11 ' A' ' 690' ' ' ILE . 41.0 m-85 -74.06 142.82 45.65 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.914 -0.585 . . . . 0.0 111.509 -179.756 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 666' ' ' SER . . . . . . . . . . . . . 65.7 p -93.56 -32.75 14.01 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.09 179.203 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 667' ' ' TYR . . . . . . . . . . . . . 65.7 t80 -68.88 -24.19 64.3 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 116.246 -0.433 . . . . 0.0 111.662 179.129 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 668' ' ' GLY . . . . . . . . . . . . . . . 99.91 -103.96 2.75 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.58 -0.819 . . . . 0.0 112.087 -179.197 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 669' ' ' ASP . . . . . . . . . . . . . 50.1 t0 -82.7 105.85 14.07 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.802 0.334 . . . . 0.0 110.179 179.889 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 670' ' ' VAL . . . . . 0.452 ' O ' HG23 ' A' ' 674' ' ' VAL . 12.4 m -71.08 -23.74 23.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 N-CA-C 113.589 0.959 . . . . 0.0 113.589 -178.884 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 671' ' ' GLN . . . . . . . . . . . . . 77.5 mt-30 -61.47 -42.21 98.43 Favored 'General case' 0 N--CA 1.462 0.15 0 CA-C-N 118.259 0.481 . . . . 0.0 110.563 -179.424 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 672' ' ' GLU . . . . . . . . . . . . . 95.1 mt-10 -65.84 -40.78 92.08 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.42 178.548 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 673' ' ' LEU . . . . . . . . . . . . . 61.8 tp -64.48 -43.81 92.98 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.076 179.384 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 674' ' ' VAL . . . . . 0.547 HG11 ' HA3' ' A' ' 699' ' ' GLY . 54.7 t -62.59 -44.61 99.53 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 CA-C-N 115.762 -0.654 . . . . 0.0 109.65 179.34 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 675' ' ' ASP . . . . . . . . . . . . . 37.4 t70 -60.46 -41.01 93.28 Favored 'General case' 0 CA--C 1.522 -0.133 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.291 178.512 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 676' ' ' GLN . . . . . 0.41 ' O ' ' HG2' ' A' ' 680' ' ' ARG . 96.6 mt-30 -68.12 -41.67 81.38 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.251 -0.432 . . . . 0.0 110.521 179.816 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 677' ' ' LEU . . . . . . . . . . . . . 84.0 mt -65.77 -42.39 90.89 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.139 179.568 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 678' ' ' ARG . . . . . 0.417 ' HA ' ' O ' ' A' ' 681' ' ' CYS . 37.1 mtp-105 -70.01 -36.29 75.0 Favored 'General case' 0 N--CA 1.468 0.466 0 CA-C-O 121.072 0.463 . . . . 0.0 111.092 179.72 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 679' ' ' GLN . . . . . . . . . . . . . 50.1 tt0 -64.27 -37.0 85.94 Favored 'General case' 0 N--CA 1.451 -0.388 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.211 179.592 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 680' ' ' ARG . . . . . 0.41 ' HG2' ' O ' ' A' ' 676' ' ' GLN . 89.6 mmt-85 -83.92 -44.32 14.37 Favored 'General case' 0 C--N 1.333 -0.122 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.041 179.678 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 681' ' ' CYS . . . . . 0.417 ' O ' ' HA ' ' A' ' 678' ' ' ARG . 73.8 m -128.95 131.79 47.53 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.563 179.895 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 682' ' ' THR . . . . . . . . . . . . . 68.9 p -70.69 159.62 84.56 Favored Pre-proline 0 C--N 1.321 -0.651 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.577 -179.96 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 683' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_exo -53.87 -32.78 68.7 Favored 'Trans proline' 0 C--N 1.351 0.672 0 C-N-CA 122.718 2.279 . . . . 0.0 112.781 179.918 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 684' ' ' GLU . . . . . . . . . . . . . 98.3 mt-10 -69.34 -38.78 78.32 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.052 0.454 . . . . 0.0 110.49 179.721 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 685' ' ' GLN . . . . . . . . . . . . . 91.1 mt-30 -71.75 -40.19 69.5 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.454 -0.794 . . . . 0.0 111.837 179.996 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 686' ' ' LEU . . . . . 0.513 HD11 HG13 ' A' ' 659' ' ' VAL . 0.1 OUTLIER -142.88 128.31 18.95 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.996 0.427 . . . . 0.0 111.788 -178.72 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 687' ' ' LYS . . . . . 0.439 ' O ' ' HA ' ' A' ' 658' ' ' ALA . 46.7 mmtm -90.83 147.18 23.36 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.401 0.619 . . . . 0.0 111.341 179.195 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 688' ' ' ILE . . . . . 0.526 HG22 HG12 ' A' ' 700' ' ' VAL . 79.3 mt -121.81 121.07 63.35 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.742 0 CA-C-N 115.472 -0.786 . . . . 0.0 110.4 -179.868 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 689' ' ' PHE . . . . . . . . . . . . . 92.1 m-85 -121.82 145.4 48.1 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.534 -0.757 . . . . 0.0 110.276 179.386 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 690' ' ' ILE . . . . . 0.762 HD11 ' HZ ' ' A' ' 665' ' ' PHE . 19.2 tt -127.28 138.74 53.92 Favored 'Isoleucine or valine' 0 C--O 1.236 0.363 0 CA-C-O 121.259 0.552 . . . . 0.0 111.802 -178.912 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 691' ' ' LEU . . . . . 0.533 HD13 ' HB2' ' A' ' 662' ' ' ALA . 0.8 OUTLIER -118.88 116.02 25.62 Favored 'General case' 0 C--O 1.234 0.288 0 CA-C-N 115.551 -0.749 . . . . 0.0 110.434 179.887 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 692' ' ' GLY . . . . . . . . . . . . . . . 161.94 129.09 0.99 Allowed Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.62 -0.8 . . . . 0.0 112.994 179.46 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 693' ' ' SER . . . . . . . . . . . . . 48.2 m 49.82 -114.68 0.74 Allowed 'General case' 0 CA--C 1.529 0.145 0 C-N-CA 123.101 0.56 . . . . 0.0 111.444 179.914 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 694' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -100.02 -12.17 19.96 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.26 -179.862 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 695' ' ' GLY . . . . . 0.466 ' HA3' ' HB2' ' A' ' 703' ' ' TYR . . . 69.76 28.7 71.75 Favored Glycine 0 CA--C 1.519 0.309 0 C-N-CA 120.979 -0.629 . . . . 0.0 113.263 -179.93 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 696' ' ' ASN . . . . . . . . . . . . . 65.4 t30 -81.24 74.34 8.24 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.205 0.526 . . . . 0.0 110.978 -179.681 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 697' ' ' TYR . . . . . 0.426 ' CD1' HD13 ' A' ' 690' ' ' ILE . 97.5 m-85 -131.36 148.31 52.66 Favored 'General case' 0 N--CA 1.453 -0.294 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.283 179.792 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 698' ' ' GLN . . . . . . . . . . . . . 19.3 pt20 -89.76 153.87 20.36 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.906 -179.439 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 699' ' ' GLY . . . . . 0.547 ' HA3' HG11 ' A' ' 674' ' ' VAL . . . 90.46 4.46 70.65 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.596 -0.811 . . . . 0.0 113.524 179.636 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 700' ' ' VAL . . . . . 0.526 HG12 HG22 ' A' ' 688' ' ' ILE . 28.9 m -116.03 145.05 22.3 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.335 0 CA-C-N 117.489 0.644 . . . . 0.0 110.537 179.4 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 701' ' ' ASP . . . . . . . . . . . . . 36.8 t70 -71.61 -40.81 69.58 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.347 -0.842 . . . . 0.0 112.111 -179.615 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 702' ' ' ARG . . . . . . . . . . . . . 36.4 ttm180 -155.13 148.8 25.36 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.782 0.325 . . . . 0.0 110.548 -179.192 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 703' ' ' TYR . . . . . 0.466 ' HB2' ' HA3' ' A' ' 695' ' ' GLY . 25.7 p90 -106.58 146.93 30.07 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.693 -179.486 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 704' ' ' ILE . . . . . 0.412 HD13 ' CE1' ' A' ' 713' ' ' PHE . 54.6 mt -121.41 95.56 48.27 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-N 115.783 -0.644 . . . . 0.0 109.836 179.504 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 705' ' ' PRO . . . . . . . . . . . . . 81.2 Cg_endo -74.95 154.89 43.06 Favored 'Trans proline' 0 C--N 1.347 0.469 0 C-N-CA 122.981 2.454 . . . . 0.0 113.901 -178.766 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 706' ' ' LEU . . . . . 0.521 ' HA ' ' C ' ' A' ' 707' ' ' PRO . 6.4 mp -103.14 147.84 34.75 Favored Pre-proline 0 CA--C 1.532 0.263 0 CA-C-N 115.403 -0.817 . . . . 0.0 109.781 178.68 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 707' ' ' PRO . . . . . 0.521 ' C ' ' HA ' ' A' ' 706' ' ' LEU . 32.6 Cg_exo -63.2 136.79 23.21 Favored 'Cis proline' 0 C--N 1.35 0.641 0 C-N-CA 123.848 -1.313 . . . . 0.0 112.424 -1.159 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 708' ' ' ILE . . . . . 0.48 HG13 ' HG ' ' A' ' 706' ' ' LEU . 72.0 mt -81.54 119.37 31.01 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.353 179.44 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 709' ' ' HIS . . . . . . . . . . . . . 68.8 m80 -87.37 122.88 70.53 Favored Pre-proline 0 C--N 1.325 -0.469 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.17 179.348 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 710' ' ' PRO . . . . . . . . . . . . . 20.5 Cg_endo -60.41 -31.43 92.63 Favored 'Trans proline' 0 C--N 1.349 0.578 0 C-N-CA 122.944 2.429 . . . . 0.0 113.511 -178.92 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 711' ' ' GLU . . . . . . . . . . . . . 88.7 tt0 -64.7 -43.68 92.69 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.83 -179.753 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 712' ' ' SER . . . . . . . . . . . . . 68.2 m -91.65 -20.45 21.6 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 112.06 0.393 . . . . 0.0 112.06 -178.669 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 713' ' ' PHE . . . . . 0.412 ' CE1' HD13 ' A' ' 704' ' ' ILE . 85.3 t80 -60.22 -49.36 77.92 Favored 'General case' 0 C--O 1.234 0.256 0 CA-C-O 120.814 0.34 . . . . 0.0 110.584 179.935 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 714' ' ' LEU . . . . . . . . . . . . . 96.2 mt -65.07 -37.7 88.38 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.189 179.254 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 715' ' ' GLN . . . . . . . . . . . . . 97.4 mt-30 -62.18 -41.85 98.72 Favored 'General case' 0 C--N 1.333 -0.125 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.973 179.083 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 716' ' ' GLN . . . . . . . . . . . . . 86.3 mt-30 -63.81 -42.59 97.66 Favored 'General case' 0 N--CA 1.463 0.187 0 CA-C-N 116.669 -0.241 . . . . 0.0 111.112 179.49 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 717' ' ' VAL . . . . . . . . . . . . . 77.5 t -64.64 -45.36 95.6 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 CA-C-O 120.929 0.395 . . . . 0.0 110.309 179.413 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 718' ' ' THR . . . . . . . . . . . . . 89.8 m -61.14 -48.18 82.82 Favored 'General case' 0 C--O 1.224 -0.271 0 CA-C-N 115.655 -0.702 . . . . 0.0 110.911 179.848 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 719' ' ' MET . . . . . . . . . . . . . 38.5 mmt -62.84 -39.26 93.8 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-O 120.796 0.331 . . . . 0.0 110.634 179.729 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 720' ' ' GLY . . . . . . . . . . . . . . . -61.65 -39.78 97.86 Favored Glycine 0 CA--C 1.522 0.528 0 CA-C-N 115.767 -0.651 . . . . 0.0 113.26 179.582 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 721' ' ' LEU . . . . . . . . . . . . . 1.7 pp -88.65 -33.91 17.44 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 117.33 0.565 . . . . 0.0 111.954 -179.358 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 722' ' ' THR . . . . . . . . . . . . . 95.2 m -63.86 -39.83 95.13 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.506 -0.315 . . . . 0.0 111.606 -179.675 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 723' ' ' SER . . . . . . . . . . . . . 80.5 p -61.84 -35.68 78.98 Favored 'General case' 0 CA--C 1.533 0.291 0 CA-C-N 116.696 -0.229 . . . . 0.0 111.207 179.627 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 724' ' ' LEU . . . . . . . . . . . . . 1.5 tm? -69.45 -45.71 68.43 Favored 'General case' 0 CA--C 1.532 0.266 0 CA-C-N 116.452 -0.34 . . . . 0.0 110.69 179.094 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 725' ' ' ALA . . . . . . . . . . . . . . . -155.89 148.11 23.52 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.1 -179.951 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 726' ' ' THR . . . . . . . . . . . . . 73.6 p -80.93 160.31 24.7 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.295 179.899 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 727' ' ' SER . . . . . . . . . . . . . 60.5 m -126.98 148.83 50.08 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.424 -0.353 . . . . 0.0 110.615 179.864 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 728' ' ' ALA . . . . . . . . . . . . . . . -147.28 153.97 40.4 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.734 -179.899 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 729' ' ' GLN . . . . . . . . . . . . . 96.7 mt-30 . . . . . 0 C--O 1.248 1.024 0 CA-C-O 118.375 -0.822 . . . . 0.0 110.758 -179.957 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 613' ' ' GLU . . . . . 0.498 ' HA ' ' O ' ' A' ' 637' ' ' GLY . 4.1 pt-20 . . . . . 0 N--CA 1.49 1.535 0 CA-C-O 121.103 0.477 . . . . 0.0 110.765 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 614' ' ' GLY . . . . . . . . . . . . . . . -82.93 177.64 53.26 Favored Glycine 0 CA--C 1.519 0.325 0 C-N-CA 120.939 -0.648 . . . . 0.0 112.85 -179.939 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 615' ' ' ARG . . . . . . . . . . . . . 48.6 mtm105 -108.74 128.25 54.71 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.721 0.296 . . . . 0.0 110.902 -179.709 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 616' ' ' ILE . . . . . 0.453 ' O ' ' HA ' ' A' ' 640' ' ' VAL . 85.4 mt -124.68 133.43 69.44 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.328 179.099 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 617' ' ' VAL . . . . . . . . . . . . . 86.2 t -105.73 127.63 60.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 121.042 0.449 . . . . 0.0 110.095 179.808 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 618' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -109.27 127.27 54.14 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.75 -178.73 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 619' ' ' VAL . . . . . . . . . . . . . 67.9 t -116.66 118.88 60.24 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 N-CA-C 109.463 -0.569 . . . . 0.0 109.463 179.585 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 620' ' ' SER . . . . . 0.795 ' HB2' ' HB3' ' A' ' 662' ' ' ALA . 34.9 t -168.63 144.94 3.67 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.599 -0.728 . . . . 0.0 111.297 -179.068 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 621' ' ' GLU . . . . . . . . . . . . . 99.2 mt-10 -91.05 -11.79 37.67 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.797 -0.638 . . . . 0.0 111.378 178.867 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 622' ' ' ASP . . . . . . . . . . . . . 29.0 t70 -93.3 111.56 23.25 Favored 'General case' 0 C--O 1.231 0.131 0 CA-C-O 120.877 0.37 . . . . 0.0 111.243 -178.766 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 623' ' ' GLU . . . . . . . . . . . . . 51.3 mp0 -63.8 -38.92 92.89 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.729 -0.669 . . . . 0.0 112.52 -179.611 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 624' ' ' ALA . . . . . . . . . . . . . . . -60.76 -45.61 93.67 Favored 'General case' 0 N--CA 1.465 0.315 0 N-CA-C 112.947 0.721 . . . . 0.0 112.947 -177.822 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 625' ' ' THR . . . . . . . . . . . . . 25.0 p -75.24 -36.31 61.31 Favored 'General case' 0 C--N 1.33 -0.242 0 C-N-CA 120.503 -0.479 . . . . 0.0 111.167 179.414 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 626' ' ' SER . . . . . . . . . . . . . 66.5 m -64.38 -42.78 95.97 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.99 -178.79 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 627' ' ' THR . . . . . . . . . . . . . 34.6 p -67.17 -41.46 85.92 Favored 'General case' 0 N--CA 1.465 0.29 0 N-CA-C 111.917 0.34 . . . . 0.0 111.917 -179.904 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 628' ' ' LEU . . . . . . . . . . . . . 61.7 tp -67.42 -44.06 79.69 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.519 179.64 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 629' ' ' ILE . . . . . . . . . . . . . 1.7 tp -69.67 -37.37 73.9 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.562 0 N-CA-C 112.586 0.587 . . . . 0.0 112.586 -178.389 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 630' ' ' CYS . . . . . . . . . . . . . 87.2 m -64.27 -39.18 93.4 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-O 120.747 0.308 . . . . 0.0 111.32 -179.83 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 631' ' ' SER . . . . . . . . . . . . . 68.3 m -62.02 -41.75 98.42 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.031 -0.532 . . . . 0.0 110.934 -179.42 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 632' ' ' ILE . . . . . . . . . . . . . 97.0 mt -63.29 -48.4 87.58 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.282 0 CA-C-O 120.844 0.354 . . . . 0.0 110.846 179.736 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 633' ' ' LEU . . . . . . . . . . . . . 83.5 mt -66.41 -40.36 89.56 Favored 'General case' 0 C--O 1.234 0.28 0 CA-C-N 116.075 -0.511 . . . . 0.0 112.314 -179.673 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 634' ' ' THR . . . . . 0.515 ' HA ' ' O ' ' A' ' 638' ' ' TYR . 84.7 m -65.81 -40.17 91.62 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.679 0.276 . . . . 0.0 110.919 -179.471 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 635' ' ' THR . . . . . . . . . . . . . 93.6 m -58.97 -38.75 79.83 Favored 'General case' 0 CA--C 1.53 0.205 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.498 179.43 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 636' ' ' ALA . . . . . . . . . . . . . . . -64.37 -17.23 63.54 Favored 'General case' 0 CA--C 1.533 0.318 0 CA-C-N 115.95 -0.568 . . . . 0.0 111.518 178.852 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 637' ' ' GLY . . . . . 0.498 ' O ' ' HA ' ' A' ' 613' ' ' GLU . . . 108.92 7.38 29.24 Favored Glycine 0 C--N 1.333 0.374 0 C-N-CA 120.94 -0.647 . . . . 0.0 113.1 179.836 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 638' ' ' TYR . . . . . 0.515 ' O ' ' HA ' ' A' ' 634' ' ' THR . 93.4 m-85 -100.01 141.31 32.99 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.837 0.351 . . . . 0.0 111.417 -179.886 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 639' ' ' GLN . . . . . . . . . . . . . 98.3 mt-30 -88.05 132.92 34.1 Favored 'General case' 0 CA--C 1.518 -0.283 0 N-CA-C 109.625 -0.509 . . . . 0.0 109.625 178.981 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 640' ' ' VAL . . . . . 0.453 ' HA ' ' O ' ' A' ' 616' ' ' ILE . 58.0 t -119.3 131.15 72.78 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 N-CA-C 112.653 0.612 . . . . 0.0 112.653 -178.823 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 641' ' ' ILE . . . . . . . . . . . . . 4.0 mp -110.23 116.41 52.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 N-CA-C 107.907 -1.146 . . . . 0.0 107.907 177.787 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 642' ' ' TRP . . . . . . . . . . . . . 19.7 t90 -96.03 124.53 40.08 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 121.222 0.535 . . . . 0.0 112.222 -177.879 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 643' ' ' LEU . . . . . . . . . . . . . 89.8 mt -121.77 142.14 50.51 Favored 'General case' 0 C--O 1.232 0.157 0 CA-C-N 115.413 -0.812 . . . . 0.0 110.647 179.332 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 644' ' ' VAL . . . . . . . . . . . . . 7.1 m -109.63 22.11 4.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.25 179.731 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 645' ' ' ASP . . . . . . . . . . . . . 11.5 t0 -128.45 -48.2 1.29 Allowed 'General case' 0 N--CA 1.468 0.472 0 N-CA-C 112.929 0.714 . . . . 0.0 112.929 -177.308 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 646' ' ' GLY . . . . . . . . . . . . . . . 80.69 23.95 59.21 Favored Glycine 0 CA--C 1.523 0.557 0 C-N-CA 120.665 -0.779 . . . . 0.0 113.928 -179.786 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 647' ' ' GLU . . . . . . . . . . . . . 77.5 mm-40 -68.24 131.43 45.35 Favored 'General case' 0 C--N 1.333 -0.125 0 CA-C-N 117.303 0.551 . . . . 0.0 110.928 179.697 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 648' ' ' VAL . . . . . . . . . . . . . 77.8 t -61.17 -41.52 89.81 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 CA-C-N 114.821 -1.081 . . . . 0.0 111.669 -179.398 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 649' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -61.59 -42.82 99.41 Favored 'General case' 0 C--N 1.331 -0.203 0 C-N-CA 120.772 -0.371 . . . . 0.0 110.496 -179.791 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 650' ' ' ARG . . . . . . . . . . . . . 80.8 mtp180 -70.5 -40.82 73.33 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.466 -0.334 . . . . 0.0 110.621 178.775 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 651' ' ' LEU . . . . . . . . . . . . . 84.3 mt -65.17 -41.09 94.97 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.558 178.863 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 652' ' ' LEU . . . . . . . . . . . . . 62.8 tp -65.2 -42.99 93.02 Favored 'General case' 0 CA--C 1.532 0.263 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.133 178.985 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 653' ' ' ALA . . . . . . . . . . . . . . . -62.7 -40.0 95.76 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-O 121.049 0.452 . . . . 0.0 111.58 -179.762 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 654' ' ' LEU . . . . . . . . . . . . . 76.1 mt -101.91 30.09 4.62 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.76 -0.654 . . . . 0.0 109.969 179.813 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 655' ' ' THR . . . . . . . . . . . . . 6.1 t -43.86 109.84 0.88 Allowed Pre-proline 0 CA--C 1.538 0.498 0 O-C-N 124.159 0.912 . . . . 0.0 113.416 -177.877 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 656' ' ' PRO . . . . . . . . . . . . . 27.4 Cg_endo -92.72 -175.36 0.55 Allowed 'Trans proline' 0 C--N 1.344 0.321 0 C-N-CA 124.008 3.138 . . . . 0.0 112.281 178.918 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 657' ' ' ILE . . . . . 0.433 ' O ' ' HA ' ' A' ' 686' ' ' LEU . 24.8 pt -82.19 -23.1 9.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-O 121.278 0.561 . . . . 0.0 109.824 178.223 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 658' ' ' ALA . . . . . 0.421 ' HB2' ' HB2' ' A' ' 687' ' ' LYS . . . -158.72 151.81 22.52 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.271 -0.877 . . . . 0.0 110.853 179.725 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 659' ' ' VAL . . . . . . . . . . . . . 29.1 m -121.39 145.0 28.64 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-O 121.316 0.579 . . . . 0.0 110.774 178.952 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 660' ' ' LEU . . . . . 0.508 HD23 HD11 ' A' ' 691' ' ' LEU . 4.6 mp -113.94 116.19 28.86 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.455 -0.793 . . . . 0.0 109.172 178.943 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 661' ' ' LEU . . . . . . . . . . . . . 50.6 mt -103.6 110.27 22.27 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 109.387 -0.597 . . . . 0.0 109.387 -179.102 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 662' ' ' ALA . . . . . 0.795 ' HB3' ' HB2' ' A' ' 620' ' ' SER . . . -107.71 136.19 47.87 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 112.523 0.564 . . . . 0.0 112.523 -178.595 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 663' ' ' GLU . . . . . . . . . . . . . 95.1 mt-10 -70.88 145.77 92.27 Favored Pre-proline 0 C--N 1.327 -0.39 0 CA-C-N 115.596 -0.729 . . . . 0.0 110.359 178.116 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 664' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -76.42 142.68 73.94 Favored 'Cis proline' 0 C--N 1.349 0.599 0 C-N-CA 123.363 -1.515 . . . . 0.0 112.621 -1.083 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 665' ' ' PHE . . . . . 0.471 ' CZ ' HD11 ' A' ' 690' ' ' ILE . 20.1 m-85 -68.87 134.82 50.15 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.997 179.602 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 666' ' ' SER . . . . . . . . . . . . . 56.8 p -96.85 -33.99 11.44 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.845 0.355 . . . . 0.0 111.536 179.579 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 667' ' ' TYR . . . . . . . . . . . . . 16.7 p90 -69.42 -17.94 63.7 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-N 116.042 -0.526 . . . . 0.0 112.049 179.446 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 668' ' ' GLY . . . . . . . . . . . . . . . 101.05 -107.9 3.35 Favored Glycine 0 CA--C 1.521 0.447 0 C-N-CA 120.664 -0.779 . . . . 0.0 113.918 179.445 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 669' ' ' ASP . . . . . . . . . . . . . 28.9 t70 -82.22 115.31 21.25 Favored 'General case' 0 N--CA 1.465 0.3 0 N-CA-C 112.258 0.466 . . . . 0.0 112.258 -177.901 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 670' ' ' VAL . . . . . . . . . . . . . 73.1 t -61.55 -42.3 93.51 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.36 0 CA-C-N 115.413 -0.812 . . . . 0.0 112.712 -179.807 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 671' ' ' GLN . . . . . . . . . . . . . 26.6 mp0 -60.87 -41.27 95.6 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 111.989 0.366 . . . . 0.0 111.989 -177.598 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 672' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 -65.0 -40.78 95.45 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.795 0.331 . . . . 0.0 110.862 178.959 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 673' ' ' LEU . . . . . . . . . . . . . 66.9 tp -64.47 -44.57 90.63 Favored 'General case' 0 C--N 1.333 -0.137 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.117 178.923 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 674' ' ' VAL . . . . . 0.57 HG11 ' HA3' ' A' ' 699' ' ' GLY . 53.2 t -62.86 -43.63 99.01 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 CA-C-N 115.46 -0.791 . . . . 0.0 110.158 179.875 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 675' ' ' ASP . . . . . . . . . . . . . 37.3 t70 -59.71 -40.65 88.67 Favored 'General case' 0 CA--C 1.521 -0.165 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.156 178.81 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 676' ' ' GLN . . . . . 0.408 ' O ' ' HG2' ' A' ' 680' ' ' ARG . 56.6 mt-30 -70.67 -41.44 72.05 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.861 179.875 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 677' ' ' LEU . . . . . . . . . . . . . 86.1 mt -65.8 -42.06 91.14 Favored 'General case' 0 C--N 1.334 -0.089 0 CA-C-N 116.538 -0.301 . . . . 0.0 111.013 179.376 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 678' ' ' ARG . . . . . . . . . . . . . 7.7 mmm180 -68.98 -37.07 78.56 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-O 121.03 0.443 . . . . 0.0 111.534 179.657 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 679' ' ' GLN . . . . . . . . . . . . . 49.5 tt0 -65.36 -37.09 85.97 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.468 179.621 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 680' ' ' ARG . . . . . 0.408 ' HG2' ' O ' ' A' ' 676' ' ' GLN . 89.4 mmt-85 -84.36 -44.2 13.98 Favored 'General case' 0 N--CA 1.461 0.116 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.783 -179.952 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 681' ' ' CYS . . . . . . . . . . . . . 71.9 m -126.65 138.03 53.37 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 121.258 0.551 . . . . 0.0 111.631 -179.071 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 682' ' ' THR . . . . . . . . . . . . . 54.0 p -71.18 162.28 73.45 Favored Pre-proline 0 C--N 1.323 -0.55 0 CA-C-N 115.647 -0.706 . . . . 0.0 109.941 178.934 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 683' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_exo -53.85 -33.99 73.7 Favored 'Trans proline' 0 C--N 1.35 0.615 0 C-N-CA 122.661 2.241 . . . . 0.0 112.849 -179.535 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 684' ' ' GLU . . . . . . . . . . . . . 51.8 mp0 -68.34 -38.55 81.6 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.996 0.427 . . . . 0.0 110.672 -179.988 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 685' ' ' GLN . . . . . . . . . . . . . 79.0 mt-30 -71.65 -39.57 70.26 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.511 -0.768 . . . . 0.0 112.49 -179.639 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 686' ' ' LEU . . . . . 0.433 ' HA ' ' O ' ' A' ' 657' ' ' ILE . 2.4 tt -139.0 120.01 14.48 Favored 'General case' 0 CA--C 1.531 0.23 0 N-CA-C 112.706 0.632 . . . . 0.0 112.706 -177.654 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 687' ' ' LYS . . . . . 0.421 ' HB2' ' HB2' ' A' ' 658' ' ' ALA . 47.4 mmtm -93.94 147.49 23.05 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.083 177.718 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 688' ' ' ILE . . . . . . . . . . . . . 79.6 mt -121.62 120.85 62.92 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 CA-C-O 121.393 0.616 . . . . 0.0 111.902 -178.67 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 689' ' ' PHE . . . . . . . . . . . . . 98.4 m-85 -121.1 146.86 46.29 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 114.864 -1.062 . . . . 0.0 109.79 178.838 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 690' ' ' ILE . . . . . 0.471 HD11 ' CZ ' ' A' ' 665' ' ' PHE . 18.7 tt -125.7 136.74 59.9 Favored 'Isoleucine or valine' 0 C--O 1.235 0.307 0 CA-C-O 121.438 0.637 . . . . 0.0 111.934 -179.518 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 691' ' ' LEU . . . . . 0.524 HD23 ' HB ' ' A' ' 704' ' ' ILE . 76.2 mt -113.48 134.54 54.62 Favored 'General case' 0 C--O 1.235 0.306 0 CA-C-N 115.243 -0.889 . . . . 0.0 110.441 179.998 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 692' ' ' GLY . . . . . 0.666 ' O ' ' HA ' ' A' ' 705' ' ' PRO . . . 163.04 -173.85 39.28 Favored Glycine 0 N--CA 1.447 -0.575 0 C-N-CA 120.461 -0.876 . . . . 0.0 112.202 179.778 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 693' ' ' SER . . . . . . . . . . . . . 80.2 p -68.38 -37.66 80.62 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 120.94 0.4 . . . . 0.0 111.026 179.42 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 694' ' ' LYS . . . . . . . . . . . . . 64.5 mttp -126.37 134.15 51.13 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.193 179.317 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 695' ' ' GLY . . . . . 0.497 ' HA3' ' HB2' ' A' ' 703' ' ' TYR . . . -108.65 17.13 33.58 Favored Glycine 0 N--CA 1.449 -0.451 0 C-N-CA 120.921 -0.657 . . . . 0.0 112.825 179.585 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 696' ' ' ASN . . . . . . . . . . . . . 64.8 t30 -81.61 70.98 8.61 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 121.044 0.45 . . . . 0.0 111.088 -179.418 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 697' ' ' TYR . . . . . . . . . . . . . 97.1 m-85 -130.18 143.04 50.55 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.018 179.299 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 698' ' ' GLN . . . . . . . . . . . . . 22.0 mp0 -81.57 146.02 30.34 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.665 -179.933 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 699' ' ' GLY . . . . . 0.57 ' HA3' HG11 ' A' ' 674' ' ' VAL . . . 96.05 5.85 59.37 Favored Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.45 -0.881 . . . . 0.0 114.155 179.1 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 700' ' ' VAL . . . . . . . . . . . . . 22.9 m -118.16 152.25 20.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 117.773 0.786 . . . . 0.0 109.868 179.075 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 701' ' ' ASP . . . . . . . . . . . . . 65.1 m-20 -83.92 -39.96 19.15 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 116.024 -0.534 . . . . 0.0 112.107 -178.458 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 702' ' ' ARG . . . . . . . . . . . . . 63.1 mtp85 -146.58 160.68 41.85 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.736 0.303 . . . . 0.0 110.728 -179.356 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 703' ' ' TYR . . . . . 0.497 ' HB2' ' HA3' ' A' ' 695' ' ' GLY . 16.6 p90 -122.49 140.35 52.84 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.072 0.463 . . . . 0.0 111.193 179.673 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 704' ' ' ILE . . . . . 0.543 HG22 HG12 ' A' ' 708' ' ' ILE . 53.7 mt -127.4 86.26 59.01 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-N 115.946 -0.57 . . . . 0.0 109.54 179.487 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 705' ' ' PRO . . . . . 0.666 ' HA ' ' O ' ' A' ' 692' ' ' GLY . 73.4 Cg_endo -73.03 152.16 50.97 Favored 'Trans proline' 0 C--N 1.349 0.562 0 C-N-CA 123.158 2.572 . . . . 0.0 114.384 -178.425 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 706' ' ' LEU . . . . . 0.761 HD23 HG13 ' A' ' 708' ' ' ILE . 76.7 mt -79.9 145.71 62.28 Favored Pre-proline 0 CA--C 1.531 0.246 0 CA-C-N 115.169 -0.923 . . . . 0.0 110.645 178.681 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 707' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -74.36 139.78 63.59 Favored 'Cis proline' 0 C--N 1.345 0.371 0 C-N-CA 123.081 -1.633 . . . . 0.0 112.112 -1.27 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 708' ' ' ILE . . . . . 0.761 HG13 HD23 ' A' ' 706' ' ' LEU . 78.4 mt -83.41 119.5 32.87 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 CA-C-O 120.983 0.42 . . . . 0.0 110.445 179.646 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 709' ' ' HIS . . . . . . . . . . . . . 70.0 m80 -86.81 124.05 69.69 Favored Pre-proline 0 C--N 1.328 -0.366 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.5 179.517 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 710' ' ' PRO . . . . . . . . . . . . . 23.2 Cg_endo -60.99 -30.3 89.61 Favored 'Trans proline' 0 C--N 1.348 0.535 0 C-N-CA 122.993 2.462 . . . . 0.0 113.63 -179.308 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 711' ' ' GLU . . . . . . . . . . . . . 51.5 mp0 -66.11 -39.87 90.26 Favored 'General case' 0 C--N 1.331 -0.225 0 N-CA-C 112.208 0.448 . . . . 0.0 112.208 -179.381 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 712' ' ' SER . . . . . . . . . . . . . 79.9 p -98.5 -17.08 18.92 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 112.28 0.474 . . . . 0.0 112.28 -178.648 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 713' ' ' PHE . . . . . . . . . . . . . 86.2 t80 -59.99 -49.68 76.74 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.669 0.271 . . . . 0.0 110.911 -179.82 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 714' ' ' LEU . . . . . . . . . . . . . 93.0 mt -64.74 -38.66 91.73 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.434 179.372 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 715' ' ' GLN . . . . . . . . . . . . . 22.6 tm0? -63.67 -43.34 96.99 Favored 'General case' 0 CA--C 1.534 0.344 0 CA-C-N 115.514 -0.766 . . . . 0.0 111.13 179.616 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 716' ' ' GLN . . . . . . . . . . . . . 84.7 mm-40 -66.15 -41.45 90.39 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-O 120.712 0.292 . . . . 0.0 111.156 179.773 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 717' ' ' VAL . . . . . . . . . . . . . 65.3 t -63.31 -44.95 99.35 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.158 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.692 179.55 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 718' ' ' THR . . . . . . . . . . . . . 89.9 m -62.12 -44.91 95.6 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.141 179.929 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 719' ' ' MET . . . . . 0.405 ' O ' HG22 ' A' ' 722' ' ' THR . 24.8 mmt -63.71 -40.34 96.52 Favored 'General case' 0 C--O 1.224 -0.275 0 C-N-CA 121.188 -0.205 . . . . 0.0 110.824 179.403 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 720' ' ' GLY . . . . . . . . . . . . . . . -68.36 -42.37 82.61 Favored Glycine 0 C--N 1.332 0.327 0 C-N-CA 120.314 -0.946 . . . . 0.0 112.124 177.976 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 721' ' ' LEU . . . . . . . . . . . . . 59.7 tp -67.99 -42.88 80.12 Favored 'General case' 0 CA--C 1.531 0.212 0 C-N-CA 122.628 0.371 . . . . 0.0 111.793 179.512 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 722' ' ' THR . . . . . 0.405 HG22 ' O ' ' A' ' 719' ' ' MET . 4.1 p 59.27 20.77 8.91 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 123.437 0.695 . . . . 0.0 111.92 -179.607 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 723' ' ' SER . . . . . . . . . . . . . 49.8 m 61.08 32.66 19.72 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-N 115.855 -0.611 . . . . 0.0 111.421 -179.218 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 724' ' ' LEU . . . . . . . . . . . . . 85.0 mt 57.79 -102.18 0.14 Allowed 'General case' 0 N--CA 1.467 0.393 0 CA-C-N 115.706 -0.679 . . . . 0.0 111.978 179.298 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 725' ' ' ALA . . . . . . . . . . . . . . . -121.24 24.56 9.97 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.713 0.292 . . . . 0.0 111.341 -179.529 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 726' ' ' THR . . . . . . . . . . . . . 74.4 p -125.9 159.67 31.96 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.867 0.365 . . . . 0.0 111.089 -179.71 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 727' ' ' SER . . . . . . . . . . . . . 60.1 m -128.23 148.48 50.63 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.568 179.861 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 728' ' ' ALA . . . . . . . . . . . . . . . -62.44 -40.01 95.2 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.581 179.88 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 729' ' ' GLN . . . . . . . . . . . . . 96.6 mt-30 . . . . . 0 C--O 1.249 1.052 0 CA-C-O 118.073 -0.965 . . . . 0.0 110.682 179.911 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 613' ' ' GLU . . . . . . . . . . . . . 75.6 mm-40 . . . . . 0 N--CA 1.486 1.328 0 CA-C-O 120.878 0.371 . . . . 0.0 110.804 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 614' ' ' GLY . . . . . . . . . . . . . . . -169.96 166.97 40.14 Favored Glycine 0 N--CA 1.45 -0.411 0 C-N-CA 120.601 -0.809 . . . . 0.0 112.598 -179.965 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 615' ' ' ARG . . . . . . . . . . . . . 13.6 tpt180 -115.83 118.69 33.69 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 109.986 -0.375 . . . . 0.0 109.986 179.927 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 616' ' ' ILE . . . . . 0.442 ' O ' ' HA ' ' A' ' 640' ' ' VAL . 83.4 mt -124.04 134.42 66.61 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 116.473 -0.331 . . . . 0.0 110.883 -179.679 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 617' ' ' VAL . . . . . 0.441 HG23 ' HB3' ' A' ' 656' ' ' PRO . 91.9 t -108.6 128.65 64.1 Favored 'Isoleucine or valine' 0 C--O 1.234 0.276 0 CA-C-O 120.943 0.401 . . . . 0.0 110.036 179.479 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 618' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -108.78 129.03 55.38 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.944 -0.571 . . . . 0.0 111.001 -178.546 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 619' ' ' VAL . . . . . . . . . . . . . 61.7 t -116.72 117.51 55.69 Favored 'Isoleucine or valine' 0 C--O 1.235 0.324 0 CA-C-O 121.03 0.443 . . . . 0.0 109.827 179.748 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 620' ' ' SER . . . . . 0.55 ' HB2' ' HB3' ' A' ' 662' ' ' ALA . 23.3 t -172.44 148.27 2.01 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.395 -0.82 . . . . 0.0 110.686 -179.633 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 621' ' ' GLU . . . . . . . . . . . . . 4.4 mm-40 -96.21 -4.9 41.63 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.931 178.652 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 622' ' ' ASP . . . . . . . . . . . . . 61.0 t0 -92.42 107.3 19.11 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-O 120.747 0.308 . . . . 0.0 110.17 -179.67 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 623' ' ' GLU . . . . . . . . . . . . . 51.1 mp0 -63.57 -40.15 96.23 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.836 -0.62 . . . . 0.0 112.514 -179.003 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 624' ' ' ALA . . . . . . . . . . . . . . . -61.6 -45.18 95.17 Favored 'General case' 0 N--CA 1.463 0.214 0 N-CA-C 112.423 0.527 . . . . 0.0 112.423 -178.306 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 625' ' ' THR . . . . . 0.45 ' O ' HG22 ' A' ' 629' ' ' ILE . 94.8 m -71.43 -41.17 69.85 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.721 0.296 . . . . 0.0 110.82 179.708 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 626' ' ' SER . . . . . . . . . . . . . 66.4 m -62.56 -41.49 98.94 Favored 'General case' 0 CA--C 1.53 0.179 0 CA-C-N 115.915 -0.584 . . . . 0.0 112.438 -178.489 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 627' ' ' THR . . . . . . . . . . . . . 35.3 p -68.66 -40.43 80.21 Favored 'General case' 0 N--CA 1.465 0.294 0 N-CA-C 112.511 0.56 . . . . 0.0 112.511 -179.935 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 628' ' ' LEU . . . . . . . . . . . . . 63.5 tp -64.17 -47.02 81.45 Favored 'General case' 0 CA--C 1.532 0.253 0 N-CA-C 112.052 0.39 . . . . 0.0 112.052 -179.602 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 629' ' ' ILE . . . . . 0.45 HG22 ' O ' ' A' ' 625' ' ' THR . 20.2 tt -70.79 -34.55 56.75 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.399 0 N-CA-C 112.483 0.549 . . . . 0.0 112.483 -179.221 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 630' ' ' CYS . . . . . . . . . . . . . 48.9 t -60.49 -44.68 95.69 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.484 -179.238 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 631' ' ' SER . . . . . . . . . . . . . 47.2 t -61.77 -42.62 99.23 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.141 -179.694 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 632' ' ' ILE . . . . . . . . . . . . . 97.4 mt -61.81 -48.17 89.87 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.289 0 CA-C-O 120.852 0.358 . . . . 0.0 110.65 179.974 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 633' ' ' LEU . . . . . . . . . . . . . 80.8 mt -66.35 -40.23 89.68 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.005 -0.543 . . . . 0.0 112.04 179.845 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 634' ' ' THR . . . . . 0.525 ' HA ' ' O ' ' A' ' 638' ' ' TYR . 89.9 m -65.84 -40.17 91.48 Favored 'General case' 0 CA--C 1.531 0.231 0 CA-C-O 120.685 0.279 . . . . 0.0 110.931 -179.612 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 635' ' ' THR . . . . . . . . . . . . . 92.2 m -59.01 -38.55 79.47 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.34 179.249 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 636' ' ' ALA . . . . . . . . . . . . . . . -67.31 -11.95 58.9 Favored 'General case' 0 CA--C 1.534 0.364 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.371 179.104 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 637' ' ' GLY . . . . . . . . . . . . . . . 103.5 7.69 42.09 Favored Glycine 0 C--N 1.334 0.421 0 C-N-CA 120.972 -0.632 . . . . 0.0 113.333 179.617 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 638' ' ' TYR . . . . . 0.525 ' O ' ' HA ' ' A' ' 634' ' ' THR . 96.0 m-85 -99.89 141.73 32.32 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.823 0.344 . . . . 0.0 111.319 -179.738 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 639' ' ' GLN . . . . . . . . . . . . . 98.4 mm-40 -90.69 134.32 34.49 Favored 'General case' 0 CA--C 1.517 -0.326 0 CA-C-N 116.309 -0.405 . . . . 0.0 109.911 179.537 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 640' ' ' VAL . . . . . 0.442 ' HA ' ' O ' ' A' ' 616' ' ' ILE . 60.6 t -118.91 130.36 73.84 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-O 121.008 0.432 . . . . 0.0 112.151 -179.318 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 641' ' ' ILE . . . . . . . . . . . . . 47.5 mm -109.28 117.93 55.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 N-CA-C 108.468 -0.938 . . . . 0.0 108.468 178.197 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 642' ' ' TRP . . . . . . . . . . . . . 24.6 t90 -90.63 124.31 34.95 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 112.405 0.52 . . . . 0.0 112.405 -178.237 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 643' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -119.54 132.94 55.85 Favored 'General case' 0 CA--C 1.53 0.204 0 CA-C-N 115.596 -0.729 . . . . 0.0 110.048 178.907 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 644' ' ' VAL . . . . . . . . . . . . . 19.0 m -103.0 18.0 4.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 N-CA-C 112.426 0.528 . . . . 0.0 112.426 -179.049 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 645' ' ' ASP . . . . . . . . . . . . . 16.4 t0 -144.17 -28.32 0.51 Allowed 'General case' 0 N--CA 1.47 0.562 0 N-CA-C 113.382 0.882 . . . . 0.0 113.382 -178.023 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 646' ' ' GLY . . . . . . . . . . . . . . . 73.88 28.75 64.22 Favored Glycine 0 CA--C 1.523 0.543 0 C-N-CA 120.734 -0.746 . . . . 0.0 114.461 179.76 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 647' ' ' GLU . . . . . . . . . . . . . 92.7 mt-10 -63.77 126.38 27.41 Favored 'General case' 0 C--N 1.334 -0.106 0 CA-C-N 117.683 0.742 . . . . 0.0 111.167 179.606 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 648' ' ' VAL . . . . . . . . . . . . . 75.0 t -61.59 -39.42 83.03 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-N 114.752 -1.113 . . . . 0.0 111.543 -179.653 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 649' ' ' GLU . . . . . . . . . . . . . 50.5 mp0 -60.7 -43.18 98.1 Favored 'General case' 0 C--N 1.331 -0.198 0 N-CA-C 110.038 -0.356 . . . . 0.0 110.038 -179.908 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 650' ' ' ARG . . . . . . . . . . . . . 16.2 mmp_? -70.21 -40.8 74.35 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.49 178.412 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 651' ' ' LEU . . . . . . . . . . . . . 89.2 mt -64.72 -41.03 96.27 Favored 'General case' 0 N--CA 1.462 0.171 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.413 179.2 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 652' ' ' LEU . . . . . . . . . . . . . 60.8 tp -65.23 -42.91 92.94 Favored 'General case' 0 CA--C 1.531 0.213 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.114 178.89 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 653' ' ' ALA . . . . . . . . . . . . . . . -62.56 -39.44 93.67 Favored 'General case' 0 N--CA 1.463 0.209 0 CA-C-O 120.989 0.423 . . . . 0.0 111.796 179.947 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 654' ' ' LEU . . . . . . . . . . . . . 75.8 mt -102.59 30.25 4.78 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.897 -179.447 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 655' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -31.1 104.02 0.21 Allowed Pre-proline 0 N--CA 1.471 0.624 0 O-C-N 124.595 1.185 . . . . 0.0 114.081 -179.129 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 656' ' ' PRO . . . . . 0.441 ' HB3' HG23 ' A' ' 617' ' ' VAL . 37.5 Cg_endo -90.75 177.11 2.24 Favored 'Trans proline' 0 C--N 1.345 0.356 0 C-N-CA 123.617 2.878 . . . . 0.0 112.37 178.557 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 657' ' ' ILE . . . . . . . . . . . . . 19.4 pt -83.81 -24.83 7.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-O 121.271 0.558 . . . . 0.0 109.649 177.85 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 658' ' ' ALA . . . . . 0.482 ' HA ' ' O ' ' A' ' 687' ' ' LYS . . . -157.18 153.23 27.33 Favored 'General case' 0 N--CA 1.449 -0.507 0 CA-C-N 115.21 -0.905 . . . . 0.0 111.006 -179.959 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 659' ' ' VAL . . . . . . . . . . . . . 31.5 m -122.96 147.16 27.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-O 121.138 0.494 . . . . 0.0 111.039 179.109 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 660' ' ' LEU . . . . . . . . . . . . . 12.1 mt -116.59 119.95 37.16 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.414 -0.812 . . . . 0.0 110.125 179.105 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 661' ' ' LEU . . . . . . . . . . . . . 75.5 mt -108.39 113.35 26.35 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 109.794 -0.447 . . . . 0.0 109.794 179.744 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 662' ' ' ALA . . . . . 0.55 ' HB3' ' HB2' ' A' ' 620' ' ' SER . . . -108.47 113.8 27.13 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 111.962 0.356 . . . . 0.0 111.962 -179.474 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 663' ' ' GLU . . . . . 0.59 ' HA ' ' C ' ' A' ' 664' ' ' PRO . 23.5 pt-20 -67.62 148.74 98.55 Favored Pre-proline 0 CA--C 1.537 0.477 0 CA-C-N 115.78 -0.645 . . . . 0.0 111.054 178.931 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 664' ' ' PRO . . . . . 0.59 ' C ' ' HA ' ' A' ' 663' ' ' GLU . 40.3 Cg_exo -60.91 138.26 21.51 Favored 'Cis proline' 0 C--N 1.353 0.775 0 C-N-CA 124.082 -1.216 . . . . 0.0 112.491 -0.891 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 665' ' ' PHE . . . . . 0.476 ' HZ ' HD11 ' A' ' 690' ' ' ILE . 59.3 m-85 -82.64 121.78 27.28 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.979 -179.175 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 666' ' ' SER . . . . . . . . . . . . . 79.0 p -66.27 -38.45 87.83 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.954 -0.567 . . . . 0.0 111.924 -179.867 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 667' ' ' TYR . . . . . . . . . . . . . 63.2 t80 -65.93 -23.99 66.73 Favored 'General case' 0 CA--C 1.534 0.342 0 CA-C-O 120.804 0.335 . . . . 0.0 111.551 179.328 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 668' ' ' GLY . . . . . . . . . . . . . . . 99.96 -104.03 2.76 Favored Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.518 -0.849 . . . . 0.0 112.291 -179.524 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 669' ' ' ASP . . . . . . . . . . . . . 49.5 t0 -83.15 106.27 14.81 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.916 0.389 . . . . 0.0 110.412 -179.887 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 670' ' ' VAL . . . . . 0.407 ' O ' HG23 ' A' ' 674' ' ' VAL . 11.5 m -70.23 -23.13 24.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 N-CA-C 113.25 0.833 . . . . 0.0 113.25 -179.122 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 671' ' ' GLN . . . . . . . . . . . . . 77.8 mt-30 -61.63 -42.33 98.74 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-O 121.073 0.463 . . . . 0.0 110.22 179.943 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 672' ' ' GLU . . . . . . . . . . . . . 95.1 mt-10 -66.51 -40.42 89.2 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.657 -0.701 . . . . 0.0 110.462 178.634 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 673' ' ' LEU . . . . . . . . . . . . . 62.7 tp -63.03 -44.56 95.6 Favored 'General case' 0 N--CA 1.462 0.129 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.148 179.443 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 674' ' ' VAL . . . . . 0.618 HG11 ' HA3' ' A' ' 699' ' ' GLY . 55.6 t -63.0 -43.87 99.34 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.15 0 CA-C-N 115.805 -0.634 . . . . 0.0 109.557 179.111 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 675' ' ' ASP . . . . . . . . . . . . . 37.3 t70 -60.5 -40.91 93.07 Favored 'General case' 0 CA--C 1.521 -0.155 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.38 178.771 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 676' ' ' GLN . . . . . 0.408 ' O ' ' HG2' ' A' ' 680' ' ' ARG . 95.4 mt-30 -69.88 -41.89 74.19 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.083 -179.937 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 677' ' ' LEU . . . . . . . . . . . . . 86.3 mt -67.09 -41.52 86.19 Favored 'General case' 0 C--O 1.226 -0.174 0 CA-C-N 116.443 -0.344 . . . . 0.0 110.801 178.999 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 678' ' ' ARG . . . . . . . . . . . . . 62.4 ttp180 -66.43 -38.6 87.79 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-O 121.304 0.574 . . . . 0.0 110.588 179.689 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 679' ' ' GLN . . . . . . . . . . . . . 53.7 tt0 -62.62 -39.13 92.82 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.25 -0.886 . . . . 0.0 110.781 179.915 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 680' ' ' ARG . . . . . 0.408 ' HG2' ' O ' ' A' ' 676' ' ' GLN . 38.2 mmt180 -84.82 -42.41 15.14 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.385 -0.37 . . . . 0.0 111.462 -179.739 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 681' ' ' CYS . . . . . . . . . . . . . 76.6 m -126.5 131.63 51.58 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.374 -0.375 . . . . 0.0 110.254 179.744 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 682' ' ' THR . . . . . 0.47 ' HB ' ' HD2' ' A' ' 683' ' ' PRO . 65.4 p -68.81 159.04 84.16 Favored Pre-proline 0 C--N 1.322 -0.607 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.854 -179.614 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 683' ' ' PRO . . . . . 0.47 ' HD2' ' HB ' ' A' ' 682' ' ' THR . 19.3 Cg_endo -59.91 -18.88 52.14 Favored 'Trans proline' 0 C--N 1.351 0.687 0 C-N-CA 122.75 2.3 . . . . 0.0 112.963 -179.793 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 684' ' ' GLU . . . . . . . . . . . . . 51.5 mt-10 -87.74 -12.1 46.21 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.751 0.31 . . . . 0.0 110.584 178.959 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 685' ' ' GLN . . . . . . . . . . . . . 91.6 mt-30 -100.79 -34.22 9.92 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.341 -0.39 . . . . 0.0 111.571 -179.889 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 686' ' ' LEU . . . . . . . . . . . . . 3.1 tt -135.44 125.23 25.5 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.874 -179.298 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 687' ' ' LYS . . . . . 0.482 ' O ' ' HA ' ' A' ' 658' ' ' ALA . 74.2 mmtt -94.35 146.56 23.97 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.148 0.499 . . . . 0.0 110.194 179.47 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 688' ' ' ILE . . . . . 0.529 HG22 HG12 ' A' ' 700' ' ' VAL . 78.7 mt -122.77 121.35 63.17 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.767 0 CA-C-O 121.246 0.546 . . . . 0.0 110.981 -179.199 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 689' ' ' PHE . . . . . . . . . . . . . 98.3 m-85 -117.65 142.16 47.55 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.036 -0.983 . . . . 0.0 110.094 179.102 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 690' ' ' ILE . . . . . 0.476 HD11 ' HZ ' ' A' ' 665' ' ' PHE . 18.0 tt -121.18 136.5 57.93 Favored 'Isoleucine or valine' 0 C--O 1.237 0.395 0 CA-C-O 121.122 0.487 . . . . 0.0 111.095 179.795 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 691' ' ' LEU . . . . . 0.617 HD23 ' HB ' ' A' ' 704' ' ' ILE . 72.2 mt -107.86 135.28 49.52 Favored 'General case' 0 C--O 1.233 0.237 0 CA-C-N 115.8 -0.637 . . . . 0.0 110.566 -179.897 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 692' ' ' GLY . . . . . 0.637 ' O ' ' HA ' ' A' ' 705' ' ' PRO . . . 161.95 -163.33 34.74 Favored Glycine 0 N--CA 1.449 -0.488 0 C-N-CA 120.449 -0.882 . . . . 0.0 112.97 179.859 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 693' ' ' SER . . . . . . . . . . . . . 60.4 m -97.18 111.1 23.49 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 109.155 -0.683 . . . . 0.0 109.155 179.328 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 694' ' ' LYS . . . . . . . . . . . . . 88.5 tttt 63.2 83.1 0.17 Allowed 'General case' 0 N--CA 1.465 0.289 0 O-C-N 123.871 0.732 . . . . 0.0 109.648 -178.713 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 695' ' ' GLY . . . . . 0.409 ' HA3' ' HB2' ' A' ' 703' ' ' TYR . . . -75.77 58.02 3.03 Favored Glycine 0 CA--C 1.519 0.314 0 CA-C-N 115.776 -0.647 . . . . 0.0 113.726 -178.603 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 696' ' ' ASN . . . . . . . . . . . . . 66.4 t30 -89.5 88.91 7.62 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 109.611 -0.515 . . . . 0.0 109.611 179.058 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 697' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -140.97 -171.45 3.26 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.814 -179.181 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 698' ' ' GLN . . . . . . . . . . . . . 27.1 pt20 -127.33 152.67 47.16 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.869 -0.605 . . . . 0.0 109.755 -179.882 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 699' ' ' GLY . . . . . 0.618 ' HA3' HG11 ' A' ' 674' ' ' VAL . . . 91.6 -6.67 80.17 Favored Glycine 0 N--CA 1.449 -0.464 0 C-N-CA 120.337 -0.935 . . . . 0.0 112.432 -179.436 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 700' ' ' VAL . . . . . 0.529 HG12 HG22 ' A' ' 688' ' ' ILE . 28.6 m -109.58 141.04 25.96 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.368 0 CA-C-O 121.241 0.543 . . . . 0.0 110.378 179.571 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 701' ' ' ASP . . . . . 0.424 ' O ' ' HD2' ' A' ' 702' ' ' ARG . 35.0 t70 -72.63 -41.21 65.76 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.411 -0.813 . . . . 0.0 111.67 -179.66 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 702' ' ' ARG . . . . . 0.424 ' HD2' ' O ' ' A' ' 701' ' ' ASP . 5.7 mpt_? -144.0 169.2 18.27 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.491 -179.136 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 703' ' ' TYR . . . . . 0.409 ' HB2' ' HA3' ' A' ' 695' ' ' GLY . 53.6 p90 -132.71 146.64 52.03 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.12 179.277 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 704' ' ' ILE . . . . . 0.617 ' HB ' HD23 ' A' ' 691' ' ' LEU . 53.5 mt -129.92 105.52 16.78 Favored Pre-proline 0 C--N 1.326 -0.428 0 CA-C-N 116.538 -0.301 . . . . 0.0 110.534 179.769 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 705' ' ' PRO . . . . . 0.637 ' HA ' ' O ' ' A' ' 692' ' ' GLY . 70.3 Cg_endo -72.32 151.9 54.74 Favored 'Trans proline' 0 C--N 1.346 0.403 0 C-N-CA 122.904 2.403 . . . . 0.0 113.711 -179.267 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 706' ' ' LEU . . . . . 0.572 HD23 HG23 ' A' ' 708' ' ' ILE . 88.9 mt -104.66 148.43 36.04 Favored Pre-proline 0 N--CA 1.453 -0.28 0 CA-C-N 115.347 -0.842 . . . . 0.0 110.003 178.954 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 707' ' ' PRO . . . . . 0.433 ' C ' ' HA ' ' A' ' 706' ' ' LEU . 58.3 Cg_endo -70.89 139.69 59.48 Favored 'Cis proline' 0 C--N 1.346 0.412 0 C-N-CA 122.956 -1.685 . . . . 0.0 112.625 -0.465 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 708' ' ' ILE . . . . . 0.572 HG23 HD23 ' A' ' 706' ' ' LEU . 3.1 pt -63.51 132.58 29.39 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-N 115.672 -0.695 . . . . 0.0 112.222 179.237 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 709' ' ' HIS . . . . . . . . . . . . . 70.4 m80 -99.57 112.43 63.52 Favored Pre-proline 0 C--N 1.322 -0.6 0 N-CA-C 107.822 -1.177 . . . . 0.0 107.822 177.252 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 710' ' ' PRO . . . . . . . . . . . . . 84.7 Cg_exo -51.51 -36.92 61.3 Favored 'Trans proline' 0 N--CA 1.478 0.568 0 C-N-CA 123.313 2.675 . . . . 0.0 114.558 -177.418 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 711' ' ' GLU . . . . . . . . . . . . . 88.7 tt0 -63.78 -43.29 96.8 Favored 'General case' 0 CA--C 1.535 0.369 0 N-CA-C 112.118 0.414 . . . . 0.0 112.118 -178.928 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 712' ' ' SER . . . . . . . . . . . . . 57.3 m -95.32 -15.66 22.96 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 111.967 0.358 . . . . 0.0 111.967 -178.803 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 713' ' ' PHE . . . . . . . . . . . . . 86.4 t80 -60.58 -49.48 77.38 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.81 0.338 . . . . 0.0 110.414 179.704 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 714' ' ' LEU . . . . . . . . . . . . . 92.0 mt -64.77 -37.25 86.98 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.804 -0.634 . . . . 0.0 110.073 179.184 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 715' ' ' GLN . . . . . . . . . . . . . 65.4 tt0 -61.57 -43.51 98.73 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.656 179.228 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 716' ' ' GLN . . . . . . . . . . . . . 30.3 mm100 -64.17 -40.57 96.41 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-N 116.494 -0.321 . . . . 0.0 110.677 179.374 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 717' ' ' VAL . . . . . . . . . . . . . 71.3 t -63.4 -43.4 98.49 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.164 0 CA-C-O 121.057 0.456 . . . . 0.0 109.824 178.928 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 718' ' ' THR . . . . . . . . . . . . . 88.1 m -61.88 -41.21 97.59 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-N 115.605 -0.725 . . . . 0.0 111.125 179.314 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 719' ' ' MET . . . . . 0.418 ' O ' HG22 ' A' ' 722' ' ' THR . 98.1 mtp -61.51 -40.41 94.49 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.28 179.998 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 720' ' ' GLY . . . . . . . . . . . . . . . -84.21 -15.57 69.05 Favored Glycine 0 CA--C 1.521 0.435 0 C-N-CA 120.435 -0.888 . . . . 0.0 112.786 179.387 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 721' ' ' LEU . . . . . . . . . . . . . 60.5 tp -67.42 -40.3 85.54 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-O 120.795 0.331 . . . . 0.0 111.611 179.709 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 722' ' ' THR . . . . . 0.418 HG22 ' O ' ' A' ' 719' ' ' MET . 15.1 t -64.67 165.94 9.53 Favored 'General case' 0 CA--C 1.535 0.376 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.322 -179.687 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 723' ' ' SER . . . . . . . . . . . . . 49.0 m 63.1 40.47 9.0 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-O 121.332 0.587 . . . . 0.0 110.699 -178.655 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 724' ' ' LEU . . . . . . . . . . . . . 60.2 tp -103.81 126.14 50.74 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.37 -0.832 . . . . 0.0 109.727 -179.991 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 725' ' ' ALA . . . . . . . . . . . . . . . -62.16 -39.8 93.83 Favored 'General case' 0 N--CA 1.464 0.26 0 N-CA-C 112.887 0.699 . . . . 0.0 112.887 -178.888 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 726' ' ' THR . . . . . . . . . . . . . 4.8 t -91.64 134.4 34.73 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.274 0.559 . . . . 0.0 111.421 -179.329 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 727' ' ' SER . . . . . . . . . . . . . 78.5 p -102.76 4.37 37.89 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.06 179.677 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 728' ' ' ALA . . . . . . . . . . . . . . . -83.27 79.55 9.36 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.298 -179.462 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 729' ' ' GLN . . . . . . . . . . . . . 77.4 mt-30 . . . . . 0 C--O 1.25 1.126 0 CA-C-O 118.407 -0.806 . . . . 0.0 111.373 179.665 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 613' ' ' GLU . . . . . 0.537 ' HA ' ' O ' ' A' ' 637' ' ' GLY . 59.7 mt-10 . . . . . 0 N--CA 1.487 1.402 0 CA-C-O 121.068 0.461 . . . . 0.0 110.619 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 614' ' ' GLY . . . . . . . . . . . . . . . -86.26 -177.3 49.79 Favored Glycine 0 CA--C 1.519 0.295 0 CA-C-N 115.668 -0.696 . . . . 0.0 112.908 -179.887 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 615' ' ' ARG . . . . . . . . . . . . . 48.1 mtm105 -111.6 131.78 55.02 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.749 0.309 . . . . 0.0 111.078 -179.764 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 616' ' ' ILE . . . . . 0.464 ' O ' ' HA ' ' A' ' 640' ' ' VAL . 85.5 mt -125.01 133.27 69.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.117 179.169 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 617' ' ' VAL . . . . . . . . . . . . . 98.0 t -107.2 127.76 62.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 120.891 0.377 . . . . 0.0 110.241 -179.992 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 618' ' ' LEU . . . . . 0.456 HD11 HD13 ' A' ' 629' ' ' ILE . 1.1 tt -109.51 127.96 54.83 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.916 -0.583 . . . . 0.0 110.795 -178.87 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 619' ' ' VAL . . . . . . . . . . . . . 61.5 t -116.93 118.66 59.54 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.426 0 N-CA-C 109.835 -0.432 . . . . 0.0 109.835 179.713 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 620' ' ' SER . . . . . 0.744 ' HB3' ' HB3' ' A' ' 662' ' ' ALA . 82.7 p -166.59 163.81 16.92 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.514 -0.767 . . . . 0.0 110.767 -179.58 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 621' ' ' GLU . . . . . . . . . . . . . 99.3 mt-10 -102.41 -5.16 24.42 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.608 -0.724 . . . . 0.0 111.187 178.572 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 622' ' ' ASP . . . . . . . . . . . . . 50.5 t0 -102.43 108.1 19.31 Favored 'General case' 0 CA--C 1.531 0.231 0 CA-C-O 121.132 0.492 . . . . 0.0 111.354 -178.308 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 623' ' ' GLU . . . . . . . . . . . . . 42.3 tt0 -64.2 -40.69 96.6 Favored 'General case' 0 CA--C 1.534 0.333 0 CA-C-N 115.296 -0.866 . . . . 0.0 112.002 179.642 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 624' ' ' ALA . . . . . . . . . . . . . . . -60.88 -43.5 98.36 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-N 116.342 -0.39 . . . . 0.0 112.05 -178.661 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 625' ' ' THR . . . . . . . . . . . . . 88.0 m -67.55 -39.92 84.98 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 109.657 -0.497 . . . . 0.0 109.657 179.495 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 626' ' ' SER . . . . . . . . . . . . . 73.1 m -61.53 -40.26 93.99 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.191 -0.913 . . . . 0.0 112.342 -179.078 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 627' ' ' THR . . . . . . . . . . . . . 74.3 p -65.97 -39.95 90.84 Favored 'General case' 0 N--CA 1.465 0.32 0 N-CA-C 112.499 0.555 . . . . 0.0 112.499 -179.506 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 628' ' ' LEU . . . . . . . . . . . . . 62.6 tp -68.28 -46.25 70.87 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 112.03 0.381 . . . . 0.0 112.03 -179.734 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 629' ' ' ILE . . . . . 0.456 HD13 HD11 ' A' ' 618' ' ' LEU . 21.4 tt -70.82 -35.93 62.29 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.358 0 N-CA-C 112.59 0.589 . . . . 0.0 112.59 -178.982 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 630' ' ' CYS . . . . . . . . . . . . . 43.0 t -61.25 -42.37 98.51 Favored 'General case' 0 CA--C 1.521 -0.162 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.067 -179.648 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 631' ' ' SER . . . . . . . . . . . . . 68.2 m -61.57 -41.53 97.53 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.249 -179.361 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 632' ' ' ILE . . . . . . . . . . . . . 97.1 mt -62.92 -48.99 85.4 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.319 0 CA-C-O 121.014 0.435 . . . . 0.0 111.048 179.84 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 633' ' ' LEU . . . . . . . . . . . . . 91.6 mt -67.72 -39.61 84.29 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.728 -0.669 . . . . 0.0 112.315 -179.412 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 634' ' ' THR . . . . . 0.546 ' HA ' ' O ' ' A' ' 638' ' ' TYR . 83.9 m -65.32 -40.03 93.2 Favored 'General case' 0 N--CA 1.464 0.225 0 CA-C-O 120.598 0.237 . . . . 0.0 111.013 -179.53 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 635' ' ' THR . . . . . . . . . . . . . 93.0 m -58.22 -37.99 75.92 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.479 179.347 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 636' ' ' ALA . . . . . . . . . . . . . . . -68.47 -9.84 51.46 Favored 'General case' 0 CA--C 1.534 0.362 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.625 179.153 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 637' ' ' GLY . . . . . 0.537 ' O ' ' HA ' ' A' ' 613' ' ' GLU . . . 101.69 7.35 48.28 Favored Glycine 0 C--N 1.333 0.393 0 C-N-CA 121.043 -0.599 . . . . 0.0 113.233 179.606 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 638' ' ' TYR . . . . . 0.546 ' O ' ' HA ' ' A' ' 634' ' ' THR . 90.9 m-85 -99.77 141.19 32.91 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.724 0.297 . . . . 0.0 111.403 -179.66 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 639' ' ' GLN . . . . . . . . . . . . . 98.3 mm-40 -90.85 135.31 33.81 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.139 179.624 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 640' ' ' VAL . . . . . 0.464 ' HA ' ' O ' ' A' ' 616' ' ' ILE . 60.2 t -117.91 129.79 73.76 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 CA-C-O 121.169 0.509 . . . . 0.0 112.285 -179.507 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 641' ' ' ILE . . . . . . . . . . . . . 4.2 mp -112.56 120.17 62.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 N-CA-C 108.382 -0.969 . . . . 0.0 108.382 178.376 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 642' ' ' TRP . . . . . . . . . . . . . 26.1 t90 -93.55 127.05 39.03 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-O 121.203 0.525 . . . . 0.0 112.316 -178.283 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 643' ' ' LEU . . . . . 0.404 HD13 ' HA ' ' A' ' 643' ' ' LEU . 0.9 OUTLIER -118.12 129.45 55.54 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-N 115.402 -0.817 . . . . 0.0 110.129 179.08 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 644' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -108.18 41.87 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.709 -0.223 . . . . 0.0 111.403 -179.414 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 645' ' ' ASP . . . . . . . . . . . . . 17.7 t0 -156.9 -31.86 0.08 Allowed 'General case' 0 N--CA 1.469 0.513 0 N-CA-C 112.796 0.665 . . . . 0.0 112.796 -178.805 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 646' ' ' GLY . . . . . . . . . . . . . . . 74.77 28.44 62.97 Favored Glycine 0 CA--C 1.52 0.371 0 C-N-CA 120.596 -0.811 . . . . 0.0 113.399 -179.675 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 647' ' ' GLU . . . . . . . . . . . . . 8.8 mm-40 -67.88 120.3 13.95 Favored 'General case' 0 N--CA 1.456 -0.126 0 CA-C-O 121.067 0.46 . . . . 0.0 110.869 179.79 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 648' ' ' VAL . . . . . . . . . . . . . 75.7 t -60.93 -40.96 87.12 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-N 115.229 -0.896 . . . . 0.0 111.404 -179.558 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 649' ' ' GLU . . . . . . . . . . . . . 79.1 mm-40 -61.63 -42.57 99.07 Favored 'General case' 0 C--N 1.332 -0.194 0 C-N-CA 120.805 -0.358 . . . . 0.0 110.277 -179.973 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 650' ' ' ARG . . . . . . . . . . . . . 6.3 mmp_? -70.37 -40.91 73.74 Favored 'General case' 0 C--O 1.233 0.189 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.612 178.629 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 651' ' ' LEU . . . . . . . . . . . . . 90.8 mt -65.01 -41.03 95.71 Favored 'General case' 0 N--CA 1.461 0.117 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.29 179.292 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 652' ' ' LEU . . . . . . . . . . . . . 62.4 tp -65.15 -43.03 93.13 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.029 178.746 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 653' ' ' ALA . . . . . . . . . . . . . . . -62.78 -39.99 95.91 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-O 121.078 0.466 . . . . 0.0 111.604 -179.919 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 654' ' ' LEU . . . . . . . . . . . . . 76.1 mt -100.53 29.77 4.27 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.036 179.782 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 655' ' ' THR . . . . . . . . . . . . . 5.7 t -43.11 109.39 0.76 Allowed Pre-proline 0 N--CA 1.468 0.428 0 O-C-N 124.248 0.967 . . . . 0.0 113.395 -178.013 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 656' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_endo -94.08 -174.6 0.39 Allowed 'Trans proline' 0 N--CA 1.462 -0.339 0 C-N-CA 124.289 3.326 . . . . 0.0 111.951 178.84 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 657' ' ' ILE . . . . . . . . . . . . . 25.3 pt -81.34 -24.74 10.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-O 121.263 0.554 . . . . 0.0 109.731 178.04 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 658' ' ' ALA . . . . . 0.451 ' HB2' ' HB2' ' A' ' 687' ' ' LYS . . . -157.78 151.29 23.67 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.324 -0.853 . . . . 0.0 111.167 -179.944 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 659' ' ' VAL . . . . . 0.571 HG13 HD11 ' A' ' 686' ' ' LEU . 20.2 m -121.16 144.33 30.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-O 121.064 0.459 . . . . 0.0 110.409 178.82 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 660' ' ' LEU . . . . . . . . . . . . . 6.1 mp -115.04 117.75 31.47 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.728 -0.669 . . . . 0.0 109.849 179.522 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 661' ' ' LEU . . . . . . . . . . . . . 10.7 mt -103.2 108.48 19.7 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 109.111 -0.7 . . . . 0.0 109.111 -179.617 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 662' ' ' ALA . . . . . 0.744 ' HB3' ' HB3' ' A' ' 620' ' ' SER . . . -104.61 131.07 52.45 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 112.41 0.522 . . . . 0.0 112.41 -178.484 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 663' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -71.47 146.58 91.78 Favored Pre-proline 0 C--N 1.327 -0.383 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.363 178.261 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 664' ' ' PRO . . . . . . . . . . . . . 66.9 Cg_endo -73.6 141.56 72.13 Favored 'Cis proline' 0 C--N 1.348 0.551 0 C-N-CA 123.245 -1.565 . . . . 0.0 112.614 -0.805 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 665' ' ' PHE . . . . . . . . . . . . . 22.6 m-85 -72.8 139.87 47.32 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.703 -0.681 . . . . 0.0 111.193 179.783 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 666' ' ' SER . . . . . . . . . . . . . 10.8 p -95.56 -29.26 14.45 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 116.33 -0.396 . . . . 0.0 111.718 179.84 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 667' ' ' TYR . . . . . . . . . . . . . 13.6 p90 -74.09 -18.75 60.77 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.296 -0.411 . . . . 0.0 112.089 179.852 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 668' ' ' GLY . . . . . . . . . . . . . . . 100.41 -104.58 2.81 Favored Glycine 0 CA--C 1.521 0.417 0 C-N-CA 120.649 -0.786 . . . . 0.0 113.635 179.675 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 669' ' ' ASP . . . . . . . . . . . . . 28.5 t70 -82.62 111.19 18.36 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-O 120.981 0.419 . . . . 0.0 111.424 -178.411 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 670' ' ' VAL . . . . . . . . . . . . . 11.7 p -65.36 -32.62 59.01 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.394 0 N-CA-C 113.482 0.919 . . . . 0.0 113.482 -179.192 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 671' ' ' GLN . . . . . . . . . . . . . 22.1 mp0 -61.85 -41.9 98.38 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-O 120.703 0.287 . . . . 0.0 111.11 -179.124 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 672' ' ' GLU . . . . . . . . . . . . . 95.4 mt-10 -65.44 -40.44 93.28 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.994 179.248 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 673' ' ' LEU . . . . . . . . . . . . . 64.2 tp -63.42 -44.82 93.5 Favored 'General case' 0 CA--C 1.52 -0.175 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.107 179.104 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 674' ' ' VAL . . . . . . . . . . . . . 59.7 t -62.71 -44.35 99.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 115.503 -0.771 . . . . 0.0 109.729 179.783 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 675' ' ' ASP . . . . . . . . . . . . . 38.0 t70 -60.48 -41.18 93.7 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 115.925 -0.579 . . . . 0.0 110.585 178.731 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 676' ' ' GLN . . . . . 0.415 ' O ' ' HG2' ' A' ' 680' ' ' ARG . 77.0 mt-30 -70.2 -41.42 73.71 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.499 -0.318 . . . . 0.0 111.005 -179.55 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 677' ' ' LEU . . . . . . . . . . . . . 87.8 mt -66.74 -41.84 87.21 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.927 179.506 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 678' ' ' ARG . . . . . 0.445 ' NH1' ' HD3' ' A' ' 683' ' ' PRO . 7.8 mmm180 -67.52 -36.83 81.79 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-O 121.178 0.513 . . . . 0.0 111.314 179.572 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 679' ' ' GLN . . . . . . . . . . . . . 64.5 tt0 -63.51 -39.01 93.31 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.461 -0.79 . . . . 0.0 110.848 179.794 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 680' ' ' ARG . . . . . 0.415 ' HG2' ' O ' ' A' ' 676' ' ' GLN . 37.1 mmt180 -87.28 -41.04 13.96 Favored 'General case' 0 C--N 1.331 -0.203 0 N-CA-C 112.294 0.479 . . . . 0.0 112.294 -179.078 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 681' ' ' CYS . . . . . . . . . . . . . 76.9 m -124.84 137.98 54.28 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.212 0.529 . . . . 0.0 111.625 -178.948 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 682' ' ' THR . . . . . 0.468 ' HB ' ' HD2' ' A' ' 683' ' ' PRO . 66.2 p -70.24 159.46 84.49 Favored Pre-proline 0 C--N 1.323 -0.564 0 CA-C-N 115.596 -0.729 . . . . 0.0 109.69 178.762 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 683' ' ' PRO . . . . . 0.468 ' HD2' ' HB ' ' A' ' 682' ' ' THR . 23.5 Cg_endo -60.81 -27.75 85.31 Favored 'Trans proline' 0 C--N 1.349 0.598 0 C-N-CA 121.779 1.653 . . . . 0.0 112.092 -179.786 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 684' ' ' GLU . . . . . . . . . . . . . 51.6 mp0 -71.98 -38.94 69.63 Favored 'General case' 0 C--N 1.333 -0.142 0 CA-C-O 121.044 0.45 . . . . 0.0 110.288 178.924 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 685' ' ' GLN . . . . . . . . . . . . . 65.0 tt0 -71.56 -42.24 68.07 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 115.392 -0.822 . . . . 0.0 112.267 -179.728 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 686' ' ' LEU . . . . . 0.571 HD11 HG13 ' A' ' 659' ' ' VAL . 65.3 tp -135.88 120.53 18.32 Favored 'General case' 0 C--N 1.332 -0.193 0 N-CA-C 112.513 0.56 . . . . 0.0 112.513 -178.044 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 687' ' ' LYS . . . . . 0.451 ' HB2' ' HB2' ' A' ' 658' ' ' ALA . 73.6 mmtt -91.21 146.46 23.81 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 121.158 0.504 . . . . 0.0 110.031 177.553 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 688' ' ' ILE . . . . . . . . . . . . . 76.8 mt -123.81 121.1 61.49 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.771 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.811 -179.013 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 689' ' ' PHE . . . . . . . . . . . . . 98.6 m-85 -121.36 141.4 50.99 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.631 -0.713 . . . . 0.0 110.81 179.257 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 690' ' ' ILE . . . . . 0.47 ' CD1' HG11 ' A' ' 700' ' ' VAL . 97.5 mt -117.77 132.86 66.34 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.495 0 CA-C-O 121.184 0.516 . . . . 0.0 111.995 179.722 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 691' ' ' LEU . . . . . 0.409 ' HG ' ' HB ' ' A' ' 704' ' ' ILE . 3.7 mp -112.88 129.4 56.47 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-N 115.522 -0.763 . . . . 0.0 110.717 179.736 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 692' ' ' GLY . . . . . 0.645 ' O ' ' HA ' ' A' ' 705' ' ' PRO . . . 173.4 -173.57 45.77 Favored Glycine 0 N--CA 1.448 -0.555 0 C-N-CA 120.898 -0.667 . . . . 0.0 111.723 -179.907 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 693' ' ' SER . . . . . . . . . . . . . 80.8 p -64.59 -35.69 81.8 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.985 0.422 . . . . 0.0 110.73 179.568 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 694' ' ' LYS . . . . . . . . . . . . . 23.2 pttp -142.41 135.95 29.04 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.011 178.535 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 695' ' ' GLY . . . . . 0.497 ' HA3' ' CG ' ' A' ' 703' ' ' TYR . . . -75.73 131.59 12.15 Favored Glycine 0 N--CA 1.448 -0.511 0 C-N-CA 120.595 -0.812 . . . . 0.0 112.269 179.646 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 696' ' ' ASN . . . . . . . . . . . . . 29.3 m120 -63.96 -38.69 92.01 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-O 120.57 0.224 . . . . 0.0 111.39 179.947 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 697' ' ' TYR . . . . . . . . . . . . . 2.6 t80 58.84 35.75 24.38 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-N 115.651 -0.704 . . . . 0.0 111.637 -179.87 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 698' ' ' GLN . . . . . . . . . . . . . 97.3 mm-40 -107.32 82.66 1.7 Allowed 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.627 -0.26 . . . . 0.0 110.825 179.934 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 699' ' ' GLY . . . . . . . . . . . . . . . 80.12 15.24 79.19 Favored Glycine 0 CA--C 1.52 0.385 0 C-N-CA 120.338 -0.934 . . . . 0.0 113.463 179.366 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 700' ' ' VAL . . . . . 0.47 HG11 ' CD1' ' A' ' 690' ' ' ILE . 31.4 m -107.75 152.04 9.6 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-O 121.226 0.536 . . . . 0.0 110.9 -179.215 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 701' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -69.74 -42.01 74.51 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.143 -0.935 . . . . 0.0 112.599 -178.42 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 702' ' ' ARG . . . . . . . . . . . . . 37.9 ttm180 -162.7 158.15 22.68 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.776 0.322 . . . . 0.0 111.078 -178.562 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 703' ' ' TYR . . . . . 0.497 ' CG ' ' HA3' ' A' ' 695' ' ' GLY . 52.8 p90 -124.82 147.76 48.56 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.255 -0.43 . . . . 0.0 109.93 179.285 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 704' ' ' ILE . . . . . 0.409 ' HB ' ' HG ' ' A' ' 691' ' ' LEU . 58.7 mt -123.76 102.46 35.24 Favored Pre-proline 0 C--N 1.326 -0.423 0 CA-C-O 120.833 0.349 . . . . 0.0 111.223 -179.482 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 705' ' ' PRO . . . . . 0.645 ' HA ' ' O ' ' A' ' 692' ' ' GLY . 34.5 Cg_exo -60.96 143.19 99.29 Favored 'Trans proline' 0 C--N 1.348 0.514 0 C-N-CA 123.456 2.771 . . . . 0.0 113.883 179.909 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 706' ' ' LEU . . . . . 0.419 HD23 HG23 ' A' ' 708' ' ' ILE . 95.4 mt -98.66 151.97 37.67 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-N 115.403 -0.817 . . . . 0.0 109.973 178.408 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 707' ' ' PRO . . . . . . . . . . . . . 63.4 Cg_endo -72.99 139.5 61.72 Favored 'Cis proline' 0 C--N 1.345 0.379 0 C-N-CA 123.067 -1.639 . . . . 0.0 112.882 -0.19 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 708' ' ' ILE . . . . . 0.419 HG23 HD23 ' A' ' 706' ' ' LEU . 1.4 pt -66.68 134.28 30.22 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-N 115.652 -0.704 . . . . 0.0 111.913 178.715 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 709' ' ' HIS . . . . . . . . . . . . . 71.3 m80 -98.15 114.49 65.21 Favored Pre-proline 0 C--N 1.32 -0.679 0 N-CA-C 108.217 -1.031 . . . . 0.0 108.217 177.54 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 710' ' ' PRO . . . . . . . . . . . . . 85.2 Cg_exo -51.66 -37.13 63.45 Favored 'Trans proline' 0 N--CA 1.477 0.504 0 C-N-CA 123.174 2.582 . . . . 0.0 114.277 -177.957 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 711' ' ' GLU . . . . . . . . . . . . . 51.1 mp0 -64.72 -39.59 93.91 Favored 'General case' 0 CA--C 1.532 0.284 0 N-CA-C 112.458 0.54 . . . . 0.0 112.458 -178.964 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 712' ' ' SER . . . . . . . . . . . . . 80.9 p -98.6 -23.18 15.59 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 112.552 0.575 . . . . 0.0 112.552 -178.435 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 713' ' ' PHE . . . . . . . . . . . . . 82.5 t80 -59.91 -49.07 79.15 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 120.644 0.259 . . . . 0.0 111.229 -179.833 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 714' ' ' LEU . . . . . . . . . . . . . 58.8 tp -62.17 -41.03 97.92 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.189 -0.459 . . . . 0.0 109.917 179.906 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 715' ' ' GLN . . . . . . . . . . . . . 30.5 mm100 -62.95 -42.38 99.8 Favored 'General case' 0 CA--C 1.53 0.185 0 CA-C-N 115.742 -0.663 . . . . 0.0 111.124 179.02 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 716' ' ' GLN . . . . . . . . . . . . . 96.3 mt-30 -64.6 -42.4 95.59 Favored 'General case' 0 N--CA 1.462 0.169 0 CA-C-O 120.645 0.26 . . . . 0.0 111.243 179.589 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 717' ' ' VAL . . . . . . . . . . . . . 71.3 t -64.28 -44.53 97.35 Favored 'Isoleucine or valine' 0 C--O 1.233 0.213 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.456 179.288 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 718' ' ' THR . . . . . 0.475 ' O ' ' HG ' ' A' ' 721' ' ' LEU . 91.4 m -60.94 -47.0 88.42 Favored 'General case' 0 N--CA 1.457 -0.076 0 CA-C-N 115.824 -0.625 . . . . 0.0 110.907 179.904 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 719' ' ' MET . . . . . . . . . . . . . 38.6 mmt -62.55 -39.72 94.54 Favored 'General case' 0 C--O 1.234 0.264 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.404 179.356 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 720' ' ' GLY . . . . . . . . . . . . . . . -62.3 -40.22 98.73 Favored Glycine 0 N--CA 1.451 -0.316 0 CA-C-N 115.814 -0.63 . . . . 0.0 113.176 179.423 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 721' ' ' LEU . . . . . 0.475 ' HG ' ' O ' ' A' ' 718' ' ' THR . 2.6 pp -80.2 -33.43 38.18 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-N 117.087 0.444 . . . . 0.0 111.965 -179.533 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 722' ' ' THR . . . . . 0.555 ' HA ' ' O ' ' A' ' 725' ' ' ALA . 56.3 p -68.91 -18.1 64.06 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-O 120.684 0.278 . . . . 0.0 111.696 179.993 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 723' ' ' SER . . . . . . . . . . . . . 75.0 m -62.71 -38.99 92.65 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.39 178.816 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 724' ' ' LEU . . . . . 0.51 HD22 ' HA ' ' A' ' 724' ' ' LEU . 0.2 OUTLIER -87.92 -47.78 8.31 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.304 179.812 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 725' ' ' ALA . . . . . 0.555 ' O ' ' HA ' ' A' ' 722' ' ' THR . . . -150.05 156.61 41.99 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 120.845 0.355 . . . . 0.0 111.337 -179.437 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 726' ' ' THR . . . . . . . . . . . . . 75.1 p -118.64 154.27 32.95 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.467 -0.333 . . . . 0.0 110.975 -179.952 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 727' ' ' SER . . . . . . . . . . . . . 45.9 t -149.35 148.43 29.49 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.272 -179.847 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 728' ' ' ALA . . . . . . . . . . . . . . . -62.32 -39.73 93.99 Favored 'General case' 0 C--N 1.333 -0.142 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.455 179.888 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 729' ' ' GLN . . . . . . . . . . . . . 3.3 mm100 . . . . . 0 C--O 1.25 1.107 0 CA-C-O 118.373 -0.823 . . . . 0.0 111.44 179.979 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 613' ' ' GLU . . . . . . . . . . . . . 3.1 pt-20 . . . . . 0 N--CA 1.489 1.488 0 CA-C-O 121.003 0.43 . . . . 0.0 110.794 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 614' ' ' GLY . . . . . . . . . . . . . . . 100.01 148.73 23.02 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.941 -0.647 . . . . 0.0 112.577 179.981 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 615' ' ' ARG . . . . . . . . . . . . . 95.5 mtm-85 -117.72 133.32 56.06 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.566 0.222 . . . . 0.0 110.913 -179.895 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 616' ' ' ILE . . . . . 0.464 ' O ' ' HA ' ' A' ' 640' ' ' VAL . 84.9 mt -124.45 133.41 69.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 N-CA-C 109.613 -0.514 . . . . 0.0 109.613 178.627 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 617' ' ' VAL . . . . . 0.468 ' CG2' HG12 ' A' ' 659' ' ' VAL . 33.7 m -109.66 146.73 14.71 Favored 'Isoleucine or valine' 0 C--O 1.235 0.326 0 C-N-CA 120.023 -0.671 . . . . 0.0 110.32 -179.793 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 618' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -120.5 122.28 40.29 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.327 -179.765 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 619' ' ' VAL . . . . . 0.477 ' HA ' ' O ' ' A' ' 643' ' ' LEU . 59.4 t -116.46 116.19 51.47 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 N-CA-C 108.784 -0.821 . . . . 0.0 108.784 179.513 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 620' ' ' SER . . . . . 0.583 ' HB2' ' HB3' ' A' ' 662' ' ' ALA . 29.9 t -165.68 144.08 6.01 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.59 -0.732 . . . . 0.0 111.685 -179.001 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 621' ' ' GLU . . . . . . . . . . . . . 88.2 tt0 -76.69 -28.14 55.78 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.242 -0.89 . . . . 0.0 110.923 178.626 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 622' ' ' ASP . . . . . . . . . . . . . 57.2 t0 -86.13 108.07 18.14 Favored 'General case' 0 C--O 1.234 0.271 0 CA-C-O 121.075 0.464 . . . . 0.0 111.034 -178.436 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 623' ' ' GLU . . . . . . . . . . . . . 50.9 mp0 -63.98 -39.29 93.8 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.375 -0.83 . . . . 0.0 112.139 179.817 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 624' ' ' ALA . . . . . . . . . . . . . . . -60.8 -44.3 97.03 Favored 'General case' 0 N--CA 1.465 0.286 0 N-CA-C 112.447 0.536 . . . . 0.0 112.447 -178.232 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 625' ' ' THR . . . . . . . . . . . . . 87.0 m -68.34 -40.4 81.57 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.289 0.566 . . . . 0.0 109.986 179.779 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 626' ' ' SER . . . . . . . . . . . . . 68.0 m -62.83 -40.91 98.85 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.179 -0.919 . . . . 0.0 112.27 -179.074 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 627' ' ' THR . . . . . . . . . . . . . 60.4 p -67.11 -39.85 86.76 Favored 'General case' 0 N--CA 1.466 0.332 0 N-CA-C 112.77 0.656 . . . . 0.0 112.77 -179.577 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 628' ' ' LEU . . . . . . . . . . . . . 63.7 tp -64.68 -46.97 80.15 Favored 'General case' 0 N--CA 1.464 0.238 0 N-CA-C 111.858 0.318 . . . . 0.0 111.858 -179.317 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 629' ' ' ILE . . . . . 0.451 HD13 HD11 ' A' ' 691' ' ' LEU . 18.5 tt -72.52 -32.73 42.8 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.433 0 N-CA-C 112.421 0.526 . . . . 0.0 112.421 -179.12 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 630' ' ' CYS . . . . . . . . . . . . . 51.6 t -60.16 -45.0 94.56 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.275 -179.343 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 631' ' ' SER . . . . . . . . . . . . . 47.1 t -61.56 -42.31 98.65 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.009 -179.694 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 632' ' ' ILE . . . . . . . . . . . . . 97.2 mt -61.84 -48.17 89.84 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.314 0 CA-C-O 120.796 0.331 . . . . 0.0 110.679 180.0 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 633' ' ' LEU . . . . . . . . . . . . . 74.4 mt -65.82 -40.42 91.82 Favored 'General case' 0 C--O 1.234 0.281 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.863 179.635 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 634' ' ' THR . . . . . 0.537 ' HA ' ' O ' ' A' ' 638' ' ' TYR . 90.3 m -65.89 -40.78 91.88 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-O 120.718 0.294 . . . . 0.0 110.983 -179.69 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 635' ' ' THR . . . . . . . . . . . . . 91.9 m -59.44 -38.9 81.9 Favored 'General case' 0 CA--C 1.53 0.185 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.369 179.212 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 636' ' ' ALA . . . . . . . . . . . . . . . -64.33 -16.74 62.78 Favored 'General case' 0 CA--C 1.533 0.288 0 CA-C-N 115.879 -0.6 . . . . 0.0 111.385 178.989 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 637' ' ' GLY . . . . . . . . . . . . . . . 108.97 7.26 29.29 Favored Glycine 0 C--N 1.334 0.459 0 C-N-CA 120.973 -0.632 . . . . 0.0 113.227 179.693 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 638' ' ' TYR . . . . . 0.537 ' O ' ' HA ' ' A' ' 634' ' ' THR . 97.9 m-85 -100.8 141.36 33.79 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.882 0.341 . . . . 0.0 111.418 -179.961 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 639' ' ' GLN . . . . . . . . . . . . . 98.9 mm-40 -86.4 133.7 33.76 Favored 'General case' 0 CA--C 1.516 -0.339 0 N-CA-C 109.869 -0.419 . . . . 0.0 109.869 178.98 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 640' ' ' VAL . . . . . 0.464 ' HA ' ' O ' ' A' ' 616' ' ' ILE . 63.2 t -119.42 130.71 73.65 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 N-CA-C 112.411 0.522 . . . . 0.0 112.411 -179.254 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 641' ' ' ILE . . . . . . . . . . . . . 4.0 mp -113.77 120.13 62.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 N-CA-C 108.521 -0.918 . . . . 0.0 108.521 178.224 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 642' ' ' TRP . . . . . . . . . . . . . 62.8 t90 -94.42 126.45 39.7 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.224 0.535 . . . . 0.0 112.031 -178.575 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 643' ' ' LEU . . . . . 0.477 ' O ' ' HA ' ' A' ' 619' ' ' VAL . 88.3 mt -127.59 143.01 51.21 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.203 -0.908 . . . . 0.0 110.8 179.91 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 644' ' ' VAL . . . . . . . . . . . . . 3.6 p -128.89 78.82 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-O 121.796 0.808 . . . . 0.0 109.853 177.953 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 645' ' ' ASP . . . . . . . . . . . . . 37.8 t70 -176.75 -33.26 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.453 0 CA-C-N 115.452 -0.795 . . . . 0.0 111.659 -179.176 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 646' ' ' GLY . . . . . . . . . . . . . . . 72.78 28.67 66.64 Favored Glycine 0 CA--C 1.52 0.356 0 C-N-CA 120.978 -0.629 . . . . 0.0 113.26 -179.441 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 647' ' ' GLU . . . . . . . . . . . . . 4.9 tp10 -72.41 119.3 16.43 Favored 'General case' 0 N--CA 1.455 -0.191 0 CA-C-O 121.139 0.495 . . . . 0.0 110.961 -179.684 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 648' ' ' VAL . . . . . . . . . . . . . 75.5 t -61.74 -40.04 85.43 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-N 115.201 -0.909 . . . . 0.0 111.653 -179.843 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 649' ' ' GLU . . . . . . . . . . . . . 50.0 mp0 -60.9 -43.26 98.78 Favored 'General case' 0 C--N 1.332 -0.173 0 C-N-CA 120.795 -0.362 . . . . 0.0 110.424 -179.806 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 650' ' ' ARG . . . . . . . . . . . . . 84.1 mtt85 -68.89 -40.99 78.9 Favored 'General case' 0 CA--C 1.53 0.2 0 CA-C-N 116.426 -0.352 . . . . 0.0 110.541 178.453 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 651' ' ' LEU . . . . . . . . . . . . . 83.5 mt -65.52 -40.83 93.44 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 116.321 -0.399 . . . . 0.0 110.431 178.771 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 652' ' ' LEU . . . . . . . . . . . . . 61.8 tp -64.73 -42.59 95.1 Favored 'General case' 0 CA--C 1.53 0.182 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.01 178.95 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 653' ' ' ALA . . . . . . . . . . . . . . . -62.21 -39.12 91.7 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.548 179.726 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 654' ' ' LEU . . . . . . . . . . . . . 75.5 mt -99.64 30.1 3.78 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.91 -179.663 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 655' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -30.78 104.38 0.21 Allowed Pre-proline 0 N--CA 1.473 0.724 0 O-C-N 124.548 1.155 . . . . 0.0 113.876 -179.248 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 656' ' ' PRO . . . . . . . . . . . . . 20.9 Cg_endo -96.57 179.63 0.48 Allowed 'Trans proline' 0 N--CA 1.461 -0.429 0 C-N-CA 124.029 3.153 . . . . 0.0 112.454 178.878 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 657' ' ' ILE . . . . . . . . . . . . . 26.8 pt -84.17 -25.87 7.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-O 121.374 0.607 . . . . 0.0 109.914 178.09 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 658' ' ' ALA . . . . . 0.485 ' HB2' ' HB2' ' A' ' 687' ' ' LYS . . . -155.76 152.91 29.08 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.182 -0.917 . . . . 0.0 111.004 -179.655 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 659' ' ' VAL . . . . . 0.745 HG13 HD11 ' A' ' 686' ' ' LEU . 30.7 m -120.38 142.48 35.99 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-O 121.152 0.501 . . . . 0.0 110.521 179.034 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 660' ' ' LEU . . . . . . . . . . . . . 5.7 mp -114.86 116.37 28.46 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.702 -0.681 . . . . 0.0 109.777 179.316 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 661' ' ' LEU . . . . . . . . . . . . . 69.6 mt -107.59 114.88 29.17 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 109.403 -0.591 . . . . 0.0 109.403 -179.578 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 662' ' ' ALA . . . . . 0.646 ' HB2' HD12 ' A' ' 691' ' ' LEU . . . -111.33 130.26 55.73 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 113.32 0.859 . . . . 0.0 113.32 -178.352 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 663' ' ' GLU . . . . . . . . . . . . . 12.1 mm-40 -71.64 146.68 91.42 Favored Pre-proline 0 CA--C 1.534 0.342 0 CA-C-N 115.32 -0.854 . . . . 0.0 110.236 177.728 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 664' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -74.23 141.83 72.94 Favored 'Cis proline' 0 C--N 1.348 0.525 0 C-N-CA 123.382 -1.508 . . . . 0.0 112.72 -0.793 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 665' ' ' PHE . . . . . . . . . . . . . 22.1 m-30 -75.75 138.66 41.38 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.714 -0.675 . . . . 0.0 111.153 179.416 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 666' ' ' SER . . . . . . . . . . . . . 78.9 p -93.05 -23.99 18.46 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.431 -0.35 . . . . 0.0 111.64 179.88 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 667' ' ' TYR . . . . . . . . . . . . . 13.6 p90 -78.91 -17.94 54.69 Favored 'General case' 0 N--CA 1.464 0.262 0 N-CA-C 112.067 0.395 . . . . 0.0 112.067 179.593 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 668' ' ' GLY . . . . . . . . . . . . . . . 100.08 -104.82 2.88 Favored Glycine 0 CA--C 1.521 0.45 0 C-N-CA 120.477 -0.868 . . . . 0.0 114.183 178.969 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 669' ' ' ASP . . . . . . . . . . . . . 27.2 t70 -83.43 108.13 16.39 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-O 120.952 0.406 . . . . 0.0 111.838 -177.835 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 670' ' ' VAL . . . . . . . . . . . . . 9.9 p -66.44 -29.08 45.4 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.413 0 N-CA-C 113.108 0.781 . . . . 0.0 113.108 -179.744 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 671' ' ' GLN . . . . . . . . . . . . . 21.9 mp0 -61.66 -41.78 98.01 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-O 120.752 0.31 . . . . 0.0 111.185 -179.293 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 672' ' ' GLU . . . . . . . . . . . . . 95.4 mt-10 -66.91 -40.86 87.78 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.496 -0.32 . . . . 0.0 110.644 178.616 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 673' ' ' LEU . . . . . . . . . . . . . 64.2 tp -63.96 -46.14 86.0 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 115.831 -0.622 . . . . 0.0 111.105 -179.959 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 674' ' ' VAL . . . . . 0.56 HG21 ' HA3' ' A' ' 699' ' ' GLY . 8.7 p -65.71 -37.76 80.7 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.246 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.067 -179.617 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 675' ' ' ASP . . . . . 0.431 ' O ' ' HB2' ' A' ' 679' ' ' GLN . 36.9 t70 -62.15 -40.02 94.57 Favored 'General case' 0 CA--C 1.518 -0.28 0 N-CA-C 109.761 -0.459 . . . . 0.0 109.761 177.571 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 676' ' ' GLN . . . . . . . . . . . . . 96.7 mt-30 -70.44 -40.77 73.58 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.84 179.737 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 677' ' ' LEU . . . . . . . . . . . . . 86.4 mt -66.57 -40.9 89.22 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.467 179.566 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 678' ' ' ARG . . . . . 0.567 ' HA ' ' O ' ' A' ' 681' ' ' CYS . 84.9 mtp180 -80.59 -15.62 56.17 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-O 120.816 0.341 . . . . 0.0 111.639 -179.232 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 679' ' ' GLN . . . . . 0.431 ' HB2' ' O ' ' A' ' 675' ' ' ASP . 52.1 tt0 -65.2 -39.4 92.78 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.96 179.901 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 680' ' ' ARG . . . . . 0.443 ' H ' ' HG2' ' A' ' 680' ' ' ARG . 0.0 OUTLIER -107.01 -32.97 7.63 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.916 -179.651 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 681' ' ' CYS . . . . . 0.567 ' O ' ' HA ' ' A' ' 678' ' ' ARG . 72.2 m -113.78 130.25 56.47 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.862 0.363 . . . . 0.0 111.038 -179.703 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 682' ' ' THR . . . . . 0.406 ' HB ' ' HD2' ' A' ' 683' ' ' PRO . 72.8 p -75.04 158.27 84.51 Favored Pre-proline 0 C--N 1.327 -0.4 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.121 179.487 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 683' ' ' PRO . . . . . 0.406 ' HD2' ' HB ' ' A' ' 682' ' ' THR . 19.4 Cg_endo -60.58 -27.12 84.28 Favored 'Trans proline' 0 C--N 1.347 0.492 0 C-N-CA 122.038 1.825 . . . . 0.0 112.108 179.36 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 684' ' ' GLU . . . . . . . . . . . . . 51.7 mp0 -72.11 -39.58 68.79 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 120.981 0.419 . . . . 0.0 110.277 178.714 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 685' ' ' GLN . . . . . . . . . . . . . 54.0 tt0 -72.15 -42.22 66.21 Favored 'General case' 0 C--O 1.232 0.144 0 CA-C-N 115.856 -0.611 . . . . 0.0 111.41 179.523 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 686' ' ' LEU . . . . . 0.745 HD11 HG13 ' A' ' 659' ' ' VAL . 63.4 tp -127.78 116.61 20.46 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.337 -179.031 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 687' ' ' LYS . . . . . 0.485 ' HB2' ' HB2' ' A' ' 658' ' ' ALA . 68.8 mttm -85.64 146.55 26.8 Favored 'General case' 0 CA--C 1.519 -0.229 0 CA-C-O 121.129 0.49 . . . . 0.0 110.452 179.06 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 688' ' ' ILE . . . . . 0.508 HG22 HG12 ' A' ' 700' ' ' VAL . 76.9 mt -124.52 120.16 58.25 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.644 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.371 -178.632 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 689' ' ' PHE . . . . . . . . . . . . . 98.8 m-85 -119.09 144.64 46.49 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.021 -0.991 . . . . 0.0 109.981 178.831 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 690' ' ' ILE . . . . . . . . . . . . . 18.5 tt -124.79 138.32 54.55 Favored 'Isoleucine or valine' 0 C--O 1.236 0.379 0 CA-C-O 121.186 0.517 . . . . 0.0 111.526 -179.623 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 691' ' ' LEU . . . . . 0.646 HD12 ' HB2' ' A' ' 662' ' ' ALA . 63.3 mt -109.46 130.51 55.5 Favored 'General case' 0 C--O 1.233 0.229 0 CA-C-N 115.591 -0.731 . . . . 0.0 110.267 179.756 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 692' ' ' GLY . . . . . 0.672 ' O ' ' HA ' ' A' ' 705' ' ' PRO . . . 169.97 178.85 41.24 Favored Glycine 0 N--CA 1.444 -0.795 0 C-N-CA 120.808 -0.71 . . . . 0.0 111.977 179.782 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 693' ' ' SER . . . . . . . . . . . . . 79.8 p -67.69 -36.6 80.96 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.743 0.306 . . . . 0.0 111.298 179.598 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 694' ' ' LYS . . . . . . . . . . . . . 17.0 mmmt -121.31 136.65 54.94 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.191 0.519 . . . . 0.0 110.647 179.78 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 695' ' ' GLY . . . . . 0.445 ' HA3' ' CB ' ' A' ' 703' ' ' TYR . . . -101.95 17.11 55.1 Favored Glycine 0 N--CA 1.449 -0.464 0 CA-C-N 115.418 -0.81 . . . . 0.0 112.987 179.702 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 696' ' ' ASN . . . . . . . . . . . . . 64.7 t30 -80.97 69.73 7.62 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 121.193 0.521 . . . . 0.0 111.271 -179.267 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 697' ' ' TYR . . . . . . . . . . . . . 95.5 m-85 -132.15 146.9 52.34 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.689 -0.687 . . . . 0.0 110.001 179.269 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 698' ' ' GLN . . . . . . . . . . . . . 25.2 pt20 -94.2 152.32 18.81 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.719 -179.739 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 699' ' ' GLY . . . . . 0.56 ' HA3' HG21 ' A' ' 674' ' ' VAL . . . 90.66 4.59 69.91 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.651 -0.785 . . . . 0.0 113.482 179.818 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 700' ' ' VAL . . . . . 0.508 HG12 HG22 ' A' ' 688' ' ' ILE . 25.6 m -117.98 152.05 20.0 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.312 0 CA-C-N 117.369 0.585 . . . . 0.0 110.118 179.49 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 701' ' ' ASP . . . . . . . . . . . . . 64.2 m-20 -86.72 -33.2 20.09 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.789 -0.641 . . . . 0.0 111.893 -178.972 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 702' ' ' ARG . . . . . . . . . . . . . 6.2 mmp_? -150.37 163.87 37.27 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.84 0.352 . . . . 0.0 111.055 -179.29 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 703' ' ' TYR . . . . . 0.445 ' CB ' ' HA3' ' A' ' 695' ' ' GLY . 52.5 p90 -128.5 143.06 50.91 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.936 -0.574 . . . . 0.0 110.323 179.372 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 704' ' ' ILE . . . . . 0.554 ' HB ' HD23 ' A' ' 691' ' ' LEU . 47.5 mt -127.36 107.68 21.27 Favored Pre-proline 0 C--N 1.325 -0.474 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.247 179.726 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 705' ' ' PRO . . . . . 0.672 ' HA ' ' O ' ' A' ' 692' ' ' GLY . 64.7 Cg_endo -71.5 151.82 59.45 Favored 'Trans proline' 0 C--N 1.346 0.4 0 C-N-CA 122.794 2.329 . . . . 0.0 113.749 -179.157 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 706' ' ' LEU . . . . . 0.55 HD23 HG23 ' A' ' 708' ' ' ILE . 87.5 mt -105.4 147.67 35.0 Favored Pre-proline 0 N--CA 1.453 -0.32 0 CA-C-N 115.447 -0.797 . . . . 0.0 109.999 178.962 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 707' ' ' PRO . . . . . 0.434 ' C ' ' HA ' ' A' ' 706' ' ' LEU . 58.3 Cg_endo -70.76 139.5 57.92 Favored 'Cis proline' 0 C--N 1.347 0.499 0 C-N-CA 122.991 -1.67 . . . . 0.0 112.622 -0.26 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 708' ' ' ILE . . . . . 0.55 HG23 HD23 ' A' ' 706' ' ' LEU . 2.5 pt -63.48 131.64 29.09 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 115.543 -0.753 . . . . 0.0 112.233 179.196 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 709' ' ' HIS . . . . . . . . . . . . . 70.5 m80 -97.0 115.82 65.85 Favored Pre-proline 0 C--N 1.323 -0.586 0 N-CA-C 107.904 -1.147 . . . . 0.0 107.904 177.309 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 710' ' ' PRO . . . . . . . . . . . . . 20.2 Cg_endo -59.41 -30.62 93.13 Favored 'Trans proline' 0 C--N 1.345 0.362 0 C-N-CA 122.647 2.231 . . . . 0.0 114.306 -177.118 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 711' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -67.55 -40.02 84.97 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 112.02 0.378 . . . . 0.0 112.02 -179.378 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 712' ' ' SER . . . . . . . . . . . . . 50.5 m -95.1 -23.2 17.42 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 112.017 0.377 . . . . 0.0 112.017 -178.917 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 713' ' ' PHE . . . . . . . . . . . . . 66.9 t80 -59.97 -49.74 76.48 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-O 120.725 0.297 . . . . 0.0 111.198 -179.757 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 714' ' ' LEU . . . . . . . . . . . . . 90.6 mt -64.6 -38.03 89.59 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.173 179.346 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 715' ' ' GLN . . . . . . . . . . . . . 53.9 tt0 -61.78 -43.86 98.02 Favored 'General case' 0 CA--C 1.532 0.266 0 CA-C-N 115.638 -0.71 . . . . 0.0 110.759 179.093 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 716' ' ' GLN . . . . . . . . . . . . . 87.9 mt-30 -64.26 -41.87 96.75 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-N 116.506 -0.316 . . . . 0.0 111.257 179.456 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 717' ' ' VAL . . . . . . . . . . . . . 69.4 t -63.48 -45.76 96.99 Favored 'Isoleucine or valine' 0 C--O 1.231 0.113 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.196 179.34 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 718' ' ' THR . . . . . . . . . . . . . 89.0 m -62.7 -44.55 95.94 Favored 'General case' 0 CA--C 1.529 0.146 0 CA-C-N 115.857 -0.611 . . . . 0.0 110.793 179.486 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 719' ' ' MET . . . . . . . . . . . . . 10.9 tpt -60.43 -47.01 87.96 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.396 179.67 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 720' ' ' GLY . . . . . . . . . . . . . . . -63.19 -40.73 99.44 Favored Glycine 0 C--N 1.332 0.343 0 C-N-CA 120.747 -0.74 . . . . 0.0 111.906 178.604 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 721' ' ' LEU . . . . . . . . . . . . . 62.2 tp -62.37 -43.31 99.13 Favored 'General case' 0 CA--C 1.531 0.217 0 C-N-CA 122.758 0.423 . . . . 0.0 111.318 179.586 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 722' ' ' THR . . . . . . . . . . . . . 73.7 p -72.83 -11.2 60.51 Favored 'General case' 0 N--CA 1.464 0.24 0 N-CA-C 112.0 0.37 . . . . 0.0 112.0 179.975 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 723' ' ' SER . . . . . . . . . . . . . 69.7 m -88.25 -1.87 58.27 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.509 -0.314 . . . . 0.0 111.198 -179.946 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 724' ' ' LEU . . . . . . . . . . . . . 2.1 tt -62.47 -44.13 97.14 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-N 116.44 -0.345 . . . . 0.0 111.29 179.714 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 725' ' ' ALA . . . . . . . . . . . . . . . -149.04 151.3 34.25 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.757 -179.884 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 726' ' ' THR . . . . . . . . . . . . . 75.1 p -80.81 160.63 24.78 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.33 -0.395 . . . . 0.0 111.305 179.787 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 727' ' ' SER . . . . . . . . . . . . . 61.5 m -126.74 148.36 49.9 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.619 179.919 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 728' ' ' ALA . . . . . . . . . . . . . . . -70.22 142.54 52.38 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.134 179.902 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 729' ' ' GLN . . . . . . . . . . . . . 97.0 mt-30 . . . . . 0 C--O 1.247 0.969 0 CA-C-O 118.34 -0.838 . . . . 0.0 110.793 -179.848 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 613' ' ' GLU . . . . . . . . . . . . . 98.0 mt-10 . . . . . 0 N--CA 1.488 1.452 0 CA-C-O 120.887 0.375 . . . . 0.0 110.706 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 614' ' ' GLY . . . . . . . . . . . . . . . 80.31 15.09 79.24 Favored Glycine 0 N--CA 1.453 -0.171 0 C-N-CA 120.897 -0.668 . . . . 0.0 112.486 -179.61 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 615' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -110.23 148.06 32.59 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.928 0.394 . . . . 0.0 111.151 -179.509 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 616' ' ' ILE . . . . . 0.633 ' O ' ' HA ' ' A' ' 640' ' ' VAL . 82.0 mt -119.12 135.47 59.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 115.763 -0.653 . . . . 0.0 109.639 179.684 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 617' ' ' VAL . . . . . 0.476 ' CG2' HG12 ' A' ' 659' ' ' VAL . 33.4 m -109.67 147.21 14.24 Favored 'Isoleucine or valine' 0 C--O 1.234 0.283 0 C-N-CA 120.16 -0.616 . . . . 0.0 110.687 -179.714 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 618' ' ' LEU . . . . . . . . . . . . . 1.3 tt -121.47 126.52 49.46 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.413 -179.525 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 619' ' ' VAL . . . . . . . . . . . . . 67.5 t -115.02 117.0 54.28 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-O 121.088 0.471 . . . . 0.0 110.172 -179.972 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 620' ' ' SER . . . . . 0.732 ' HB2' ' HB3' ' A' ' 662' ' ' ALA . 36.7 t -172.49 146.68 1.78 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.081 -0.963 . . . . 0.0 110.459 -179.686 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 621' ' ' GLU . . . . . 0.434 ' HG3' ' OG ' ' A' ' 666' ' ' SER . 97.8 mt-10 -92.11 -2.65 56.49 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.02 178.704 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 622' ' ' ASP . . . . . . . . . . . . . 58.0 t0 -92.25 107.06 18.93 Favored 'General case' 0 CA--C 1.531 0.223 0 CA-C-O 121.06 0.457 . . . . 0.0 111.127 -178.961 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 623' ' ' GLU . . . . . . . . . . . . . 42.2 tt0 -64.39 -38.56 91.46 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-N 115.351 -0.84 . . . . 0.0 111.999 179.914 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 624' ' ' ALA . . . . . . . . . . . . . . . -60.46 -42.1 95.48 Favored 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 112.06 0.393 . . . . 0.0 112.06 -178.654 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 625' ' ' THR . . . . . . . . . . . . . 21.7 p -75.83 -37.04 59.44 Favored 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 120.604 -0.439 . . . . 0.0 111.754 179.462 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 626' ' ' SER . . . . . . . . . . . . . 89.7 p -65.69 -39.38 91.23 Favored 'General case' 0 CA--C 1.53 0.179 0 N-CA-C 111.818 0.303 . . . . 0.0 111.818 -178.71 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 627' ' ' THR . . . . . . . . . . . . . 38.6 p -69.77 -39.05 76.9 Favored 'General case' 0 N--CA 1.464 0.238 0 N-CA-C 112.224 0.453 . . . . 0.0 112.224 179.526 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 628' ' ' LEU . . . . . . . . . . . . . 61.7 tp -70.77 -44.26 67.06 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 121.057 0.456 . . . . 0.0 112.021 179.803 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 629' ' ' ILE . . . . . . . . . . . . . 14.1 tt -72.8 -30.07 31.77 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.533 0 N-CA-C 113.729 1.011 . . . . 0.0 113.729 -177.601 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 630' ' ' CYS . . . . . . . . . . . . . 19.0 p -64.89 -27.94 69.2 Favored 'General case' 0 N--CA 1.466 0.352 0 N-CA-C 112.185 0.439 . . . . 0.0 112.185 -177.996 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 631' ' ' SER . . . . . . . . . . . . . 96.8 p -66.7 -39.56 88.12 Favored 'General case' 0 C--N 1.33 -0.259 0 C-N-CA 120.938 -0.305 . . . . 0.0 111.283 179.955 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 632' ' ' ILE . . . . . . . . . . . . . 96.7 mt -64.57 -48.91 82.91 Favored 'Isoleucine or valine' 0 C--O 1.234 0.274 0 CA-C-O 120.977 0.418 . . . . 0.0 111.302 -179.587 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 633' ' ' LEU . . . . . . . . . . . . . 88.1 mt -65.1 -41.75 94.68 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-N 115.804 -0.634 . . . . 0.0 112.391 -179.038 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 634' ' ' THR . . . . . . . . . . . . . 54.9 m -68.18 -39.79 82.44 Favored 'General case' 0 CA--C 1.532 0.271 0 C-N-CA 121.209 -0.197 . . . . 0.0 111.457 -179.156 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 635' ' ' THR . . . . . . . . . . . . . 95.0 m -59.48 -38.89 82.01 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-O 120.899 0.38 . . . . 0.0 110.409 179.542 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 636' ' ' ALA . . . . . . . . . . . . . . . -63.06 -18.9 63.87 Favored 'General case' 0 CA--C 1.532 0.258 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.165 178.819 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 637' ' ' GLY . . . . . . . . . . . . . . . 107.09 2.98 36.17 Favored Glycine 0 C--N 1.332 0.342 0 C-N-CA 121.117 -0.563 . . . . 0.0 112.801 179.809 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 638' ' ' TYR . . . . . . . . . . . . . 88.9 m-85 -100.88 142.61 32.11 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.082 0.468 . . . . 0.0 111.625 -179.886 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 639' ' ' GLN . . . . . . . . . . . . . 74.2 mt-30 -90.38 139.37 30.74 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.04 -0.527 . . . . 0.0 109.923 179.308 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 640' ' ' VAL . . . . . 0.633 ' HA ' ' O ' ' A' ' 616' ' ' ILE . 7.1 p -125.06 138.83 52.98 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.585 -179.556 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 641' ' ' ILE . . . . . 0.431 ' HB ' HG12 ' A' ' 617' ' ' VAL . 48.1 mm -113.67 119.97 62.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 115.971 -0.559 . . . . 0.0 109.502 179.127 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 642' ' ' TRP . . . . . . . . . . . . . 21.6 t90 -90.68 122.13 33.18 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.047 0.451 . . . . 0.0 111.581 -179.019 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 643' ' ' LEU . . . . . . . . . . . . . 88.9 mt -121.11 138.94 53.96 Favored 'General case' 0 CA--C 1.53 0.185 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.402 179.175 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 644' ' ' VAL . . . . . . . . . . . . . 9.6 m -108.31 25.91 2.42 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 116.426 -0.352 . . . . 0.0 111.723 -179.883 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 645' ' ' ASP . . . . . . . . . . . . . 11.5 t0 -134.92 -47.6 0.73 Allowed 'General case' 0 N--CA 1.467 0.398 0 N-CA-C 112.891 0.7 . . . . 0.0 112.891 -177.928 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 646' ' ' GLY . . . . . . . . . . . . . . . 80.96 24.7 57.41 Favored Glycine 0 CA--C 1.52 0.353 0 C-N-CA 120.636 -0.792 . . . . 0.0 113.871 -179.555 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 647' ' ' GLU . . . . . . . . . . . . . 71.4 mm-40 -68.97 132.33 46.52 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-O 121.295 0.569 . . . . 0.0 111.173 179.698 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 648' ' ' VAL . . . . . . . . . . . . . 78.1 t -62.03 -40.29 86.82 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 CA-C-N 114.729 -1.123 . . . . 0.0 111.612 -179.47 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 649' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -61.39 -42.96 99.56 Favored 'General case' 0 C--N 1.331 -0.212 0 C-N-CA 120.77 -0.372 . . . . 0.0 110.56 -179.799 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 650' ' ' ARG . . . . . . . . . . . . . 80.5 mtp180 -70.02 -40.62 75.11 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-N 116.563 -0.29 . . . . 0.0 110.47 178.64 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 651' ' ' LEU . . . . . . . . . . . . . 84.9 mt -65.14 -41.14 95.05 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.449 178.745 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 652' ' ' LEU . . . . . . . . . . . . . 62.2 tp -65.52 -43.23 90.68 Favored 'General case' 0 CA--C 1.53 0.197 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.227 178.857 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 653' ' ' ALA . . . . . . . . . . . . . . . -62.31 -39.44 93.02 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-O 121.075 0.464 . . . . 0.0 111.629 179.871 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 654' ' ' LEU . . . . . . . . . . . . . 75.5 mt -101.07 30.98 3.82 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.846 -0.615 . . . . 0.0 110.325 -179.929 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 655' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -30.3 104.12 0.2 Allowed Pre-proline 0 N--CA 1.474 0.762 0 O-C-N 124.731 1.269 . . . . 0.0 114.008 -178.249 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 656' ' ' PRO . . . . . . . . . . . . . 32.7 Cg_endo -90.76 177.05 2.25 Favored 'Trans proline' 0 C--N 1.345 0.372 0 C-N-CA 124.106 3.204 . . . . 0.0 112.559 178.8 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 657' ' ' ILE . . . . . 0.497 ' O ' ' HA ' ' A' ' 686' ' ' LEU . 17.7 pt -86.91 -25.01 6.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 121.484 0.659 . . . . 0.0 109.806 177.599 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 658' ' ' ALA . . . . . . . . . . . . . . . -158.64 152.74 23.82 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.069 -0.969 . . . . 0.0 110.475 179.255 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 659' ' ' VAL . . . . . 0.492 HG13 HD21 ' A' ' 686' ' ' LEU . 34.6 m -120.21 142.27 36.7 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-O 121.43 0.633 . . . . 0.0 111.277 179.52 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 660' ' ' LEU . . . . . 0.441 HD23 ' HB2' ' A' ' 689' ' ' PHE . 21.3 mt -112.63 111.66 22.62 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.198 -0.91 . . . . 0.0 108.606 178.265 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 661' ' ' LEU . . . . . . . . . . . . . 47.3 mt -103.61 111.33 23.76 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 109.746 -0.464 . . . . 0.0 109.746 -178.797 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 662' ' ' ALA . . . . . 0.732 ' HB3' ' HB2' ' A' ' 620' ' ' SER . . . -105.67 132.68 51.51 Favored 'General case' 0 C--N 1.327 -0.413 0 N-CA-C 112.315 0.487 . . . . 0.0 112.315 -178.637 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 663' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -72.27 145.25 88.01 Favored Pre-proline 0 C--N 1.326 -0.416 0 CA-C-N 115.76 -0.655 . . . . 0.0 110.363 178.564 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 664' ' ' PRO . . . . . . . . . . . . . 69.1 Cg_endo -73.27 139.68 62.81 Favored 'Cis proline' 0 C--N 1.348 0.508 0 C-N-CA 123.122 -1.616 . . . . 0.0 112.775 -0.849 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 665' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -75.74 141.78 42.54 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.892 -0.594 . . . . 0.0 111.383 179.554 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 666' ' ' SER . . . . . 0.434 ' OG ' ' HG3' ' A' ' 621' ' ' GLU . 1.1 m -97.12 -34.94 10.96 Favored 'General case' 0 CA--C 1.53 0.191 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.389 -179.367 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 667' ' ' TYR . . . . . . . . . . . . . 22.5 p90 -63.47 -20.15 65.34 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-N 115.94 -0.573 . . . . 0.0 112.5 179.838 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 668' ' ' GLY . . . . . . . . . . . . . . . 100.82 -111.17 4.08 Favored Glycine 0 N--CA 1.449 -0.436 0 C-N-CA 120.712 -0.756 . . . . 0.0 113.74 179.482 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 669' ' ' ASP . . . . . . . . . . . . . 36.2 t70 -79.97 118.01 21.33 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-O 121.119 0.485 . . . . 0.0 112.097 -178.213 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 670' ' ' VAL . . . . . . . . . . . . . 72.2 t -61.42 -42.21 92.92 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.351 0 CA-C-N 115.355 -0.839 . . . . 0.0 112.547 -179.699 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 671' ' ' GLN . . . . . . . . . . . . . 96.8 mt-30 -61.32 -41.85 97.7 Favored 'General case' 0 N--CA 1.464 0.246 0 N-CA-C 111.985 0.365 . . . . 0.0 111.985 -178.066 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 672' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 -64.72 -40.76 95.88 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.578 0.228 . . . . 0.0 110.994 179.342 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 673' ' ' LEU . . . . . . . . . . . . . 64.5 tp -64.57 -44.6 90.2 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.189 179.103 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 674' ' ' VAL . . . . . 0.587 HG11 ' HA3' ' A' ' 699' ' ' GLY . 56.5 t -63.0 -44.18 99.51 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-N 115.718 -0.674 . . . . 0.0 109.916 179.706 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 675' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -59.42 -40.41 86.63 Favored 'General case' 0 CA--C 1.521 -0.171 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.264 179.171 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 676' ' ' GLN . . . . . 0.59 ' O ' ' HG3' ' A' ' 680' ' ' ARG . 57.0 mt-30 -70.84 -41.49 71.4 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.451 -0.341 . . . . 0.0 110.919 179.777 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 677' ' ' LEU . . . . . . . . . . . . . 85.7 mt -67.68 -41.76 83.16 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.988 179.999 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 678' ' ' ARG . . . . . 0.485 ' HA ' ' O ' ' A' ' 681' ' ' CYS . 39.9 ptt180 -73.81 -27.23 61.01 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-O 120.882 0.372 . . . . 0.0 111.439 -178.989 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 679' ' ' GLN . . . . . . . . . . . . . 52.9 tt0 -65.92 -38.61 89.12 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.613 179.326 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 680' ' ' ARG . . . . . 0.59 ' HG3' ' O ' ' A' ' 676' ' ' GLN . 49.0 mtt-85 -92.74 -41.02 10.37 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.788 -0.642 . . . . 0.0 111.914 -179.032 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 681' ' ' CYS . . . . . 0.485 ' O ' ' HA ' ' A' ' 678' ' ' ARG . 78.5 m -122.66 134.07 54.5 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 120.949 0.404 . . . . 0.0 110.718 -179.932 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 682' ' ' THR . . . . . . . . . . . . . 61.7 p -70.39 159.15 85.79 Favored Pre-proline 0 C--N 1.324 -0.52 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.43 179.669 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 683' ' ' PRO . . . . . . . . . . . . . 76.2 Cg_exo -54.83 -33.13 80.25 Favored 'Trans proline' 0 C--N 1.349 0.56 0 C-N-CA 122.629 2.219 . . . . 0.0 112.505 179.585 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 684' ' ' GLU . . . . . . . . . . . . . 51.7 mp0 -70.57 -38.78 74.14 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.653 179.724 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 685' ' ' GLN . . . . . . . . . . . . . 65.0 tt0 -71.26 -41.05 70.58 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 115.61 -0.723 . . . . 0.0 111.729 179.921 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 686' ' ' LEU . . . . . 0.497 ' HA ' ' O ' ' A' ' 657' ' ' ILE . 3.4 tt -134.42 119.42 18.55 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.454 -178.754 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 687' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -93.61 145.39 24.58 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.104 0.478 . . . . 0.0 110.289 179.061 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 688' ' ' ILE . . . . . 0.517 HG22 HG12 ' A' ' 700' ' ' VAL . 77.4 mt -120.27 122.18 67.6 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.76 0 CA-C-O 121.277 0.56 . . . . 0.0 111.421 -178.602 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 689' ' ' PHE . . . . . 0.441 ' HB2' HD23 ' A' ' 660' ' ' LEU . 92.0 m-85 -123.42 147.12 47.44 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.05 -0.977 . . . . 0.0 110.193 178.94 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 690' ' ' ILE . . . . . . . . . . . . . 18.8 tt -126.94 138.95 53.27 Favored 'Isoleucine or valine' 0 C--O 1.235 0.338 0 CA-C-O 121.349 0.595 . . . . 0.0 111.993 -179.845 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 691' ' ' LEU . . . . . 0.427 ' HG ' ' HB ' ' A' ' 704' ' ' ILE . 3.2 mp -110.88 133.48 53.34 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-N 115.347 -0.842 . . . . 0.0 111.014 -179.758 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 692' ' ' GLY . . . . . 0.552 ' O ' ' HA ' ' A' ' 705' ' ' PRO . . . 162.61 -164.24 35.61 Favored Glycine 0 N--CA 1.448 -0.531 0 C-N-CA 120.68 -0.772 . . . . 0.0 112.442 179.701 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 693' ' ' SER . . . . . . . . . . . . . 55.3 m -95.2 112.84 24.49 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 109.055 -0.72 . . . . 0.0 109.055 179.3 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 694' ' ' LYS . . . . . . . . . . . . . 88.6 tttt 63.13 80.45 0.23 Allowed 'General case' 0 N--CA 1.465 0.307 0 O-C-N 123.886 0.741 . . . . 0.0 109.479 -178.608 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 695' ' ' GLY . . . . . 0.418 ' HA3' ' HB2' ' A' ' 703' ' ' TYR . . . -75.63 55.71 2.95 Favored Glycine 0 C--N 1.332 0.313 0 CA-C-N 115.763 -0.653 . . . . 0.0 113.745 -178.726 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 696' ' ' ASN . . . . . . . . . . . . . 65.6 t30 -87.91 73.49 9.16 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 121.05 0.452 . . . . 0.0 109.998 179.385 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 697' ' ' TYR . . . . . . . . . . . . . 97.9 m-85 -127.22 145.37 50.8 Favored 'General case' 0 N--CA 1.452 -0.369 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.632 -179.606 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 698' ' ' GLN . . . . . . . . . . . . . 97.5 mt-30 -83.78 147.87 27.35 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.59 -0.732 . . . . 0.0 110.605 179.849 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 699' ' ' GLY . . . . . 0.587 ' HA3' HG11 ' A' ' 674' ' ' VAL . . . 94.35 3.58 63.08 Favored Glycine 0 CA--C 1.519 0.319 0 C-N-CA 120.503 -0.856 . . . . 0.0 113.842 179.21 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 700' ' ' VAL . . . . . 0.517 HG12 HG22 ' A' ' 688' ' ' ILE . 28.2 m -117.79 145.14 24.08 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.282 0 CA-C-N 117.604 0.702 . . . . 0.0 110.075 179.197 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 701' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -72.15 -43.93 63.88 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.558 -0.746 . . . . 0.0 111.794 -179.584 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 702' ' ' ARG . . . . . . . . . . . . . 71.9 mtp180 -146.67 164.17 33.54 Favored 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 109.845 -0.428 . . . . 0.0 109.845 -179.069 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 703' ' ' TYR . . . . . 0.418 ' HB2' ' HA3' ' A' ' 695' ' ' GLY . 52.3 p90 -122.82 146.0 47.93 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 120.877 0.37 . . . . 0.0 110.848 179.736 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 704' ' ' ILE . . . . . 0.427 ' HB ' ' HG ' ' A' ' 691' ' ' LEU . 41.1 mm -120.38 103.29 44.58 Favored Pre-proline 0 C--O 1.236 0.387 0 CA-C-N 116.092 -0.503 . . . . 0.0 110.511 179.85 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 705' ' ' PRO . . . . . 0.552 ' HA ' ' O ' ' A' ' 692' ' ' GLY . 72.8 Cg_endo -73.92 152.79 46.98 Favored 'Trans proline' 0 C--N 1.345 0.36 0 C-N-CA 122.723 2.282 . . . . 0.0 113.733 -179.547 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 706' ' ' LEU . . . . . 0.412 HD23 HG23 ' A' ' 708' ' ' ILE . 91.5 mt -105.82 150.28 38.99 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-N 115.539 -0.755 . . . . 0.0 109.812 178.792 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 707' ' ' PRO . . . . . 0.404 ' C ' ' HA ' ' A' ' 706' ' ' LEU . 59.6 Cg_endo -71.63 139.91 62.07 Favored 'Cis proline' 0 C--N 1.345 0.372 0 C-N-CA 123.058 -1.643 . . . . 0.0 112.804 -0.238 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 708' ' ' ILE . . . . . 0.412 HG23 HD23 ' A' ' 706' ' ' LEU . 1.1 pt -65.55 129.93 30.29 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-N 115.619 -0.719 . . . . 0.0 112.073 178.992 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 709' ' ' HIS . . . . . . . . . . . . . 70.0 m80 -98.88 115.08 65.95 Favored Pre-proline 0 C--N 1.322 -0.625 0 N-CA-C 108.564 -0.902 . . . . 0.0 108.564 177.482 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 710' ' ' PRO . . . . . . . . . . . . . 86.9 Cg_exo -52.27 -37.44 70.7 Favored 'Trans proline' 0 N--CA 1.477 0.537 0 C-N-CA 123.395 2.73 . . . . 0.0 114.341 -178.05 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 711' ' ' GLU . . . . . . . . . . . . . 51.0 mp0 -65.41 -40.2 93.11 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 112.248 0.462 . . . . 0.0 112.248 -178.709 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 712' ' ' SER . . . . . . . . . . . . . 50.7 m -91.38 -29.06 17.3 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 112.264 0.468 . . . . 0.0 112.264 -178.628 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 713' ' ' PHE . . . . . . . . . . . . . 91.1 t80 -58.87 -48.38 81.58 Favored 'General case' 0 N--CA 1.462 0.171 0 CA-C-O 120.498 0.19 . . . . 0.0 110.763 -179.127 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 714' ' ' LEU . . . . . . . . . . . . . 60.1 tp -62.3 -41.95 98.94 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.459 -0.337 . . . . 0.0 110.266 179.516 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 715' ' ' GLN . . . . . . . . . . . . . 30.5 mm100 -62.74 -41.94 99.43 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 116.099 -0.501 . . . . 0.0 111.177 179.252 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 716' ' ' GLN . . . . . . . . . . . . . 1.9 mp0 -66.04 -45.46 81.34 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-O 120.634 0.254 . . . . 0.0 111.159 179.318 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 717' ' ' VAL . . . . . 0.43 ' O ' ' HG ' ' A' ' 721' ' ' LEU . 65.2 t -62.68 -45.09 99.67 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.131 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.733 179.769 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 718' ' ' THR . . . . . . . . . . . . . 92.0 m -60.61 -45.3 94.56 Favored 'General case' 0 C--O 1.232 0.164 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.708 179.676 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 719' ' ' MET . . . . . . . . . . . . . 11.0 tpt -60.87 -44.45 97.02 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.218 179.271 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 720' ' ' GLY . . . . . . . . . . . . . . . -62.96 -40.8 99.74 Favored Glycine 0 C--N 1.333 0.375 0 C-N-CA 121.029 -0.605 . . . . 0.0 112.622 179.001 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 721' ' ' LEU . . . . . 0.43 ' HG ' ' O ' ' A' ' 717' ' ' VAL . 97.7 mt -64.91 -39.42 93.49 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-O 120.77 0.319 . . . . 0.0 111.587 179.857 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 722' ' ' THR . . . . . . . . . . . . . 73.6 p -72.35 -9.73 58.88 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.778 -179.875 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 723' ' ' SER . . . . . . . . . . . . . 65.1 m -88.63 -1.67 58.19 Favored 'General case' 0 CA--C 1.532 0.267 0 CA-C-N 116.442 -0.345 . . . . 0.0 111.136 179.768 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 724' ' ' LEU . . . . . . . . . . . . . 1.5 pp -129.48 169.14 15.33 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.499 -0.319 . . . . 0.0 110.56 179.857 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 725' ' ' ALA . . . . . . . . . . . . . . . -144.71 149.31 35.38 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.784 179.997 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 726' ' ' THR . . . . . . . . . . . . . 86.9 m -121.78 128.76 52.08 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.311 179.997 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 727' ' ' SER . . . . . . . . . . . . . 93.6 p -150.72 161.95 41.63 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.492 -0.322 . . . . 0.0 110.608 -179.966 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 728' ' ' ALA . . . . . . . . . . . . . . . -62.06 -39.8 93.62 Favored 'General case' 0 N--CA 1.462 0.145 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.765 179.854 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 729' ' ' GLN . . . . . . . . . . . . . 96.6 mt-30 . . . . . 0 C--O 1.25 1.1 0 CA-C-O 118.192 -0.909 . . . . 0.0 110.929 179.959 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 613' ' ' GLU . . . . . . . . . . . . . 7.4 mt-10 . . . . . 0 N--CA 1.488 1.435 0 CA-C-O 120.984 0.421 . . . . 0.0 110.76 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 614' ' ' GLY . . . . . . . . . . . . . . . -82.11 70.71 3.09 Favored Glycine 0 N--CA 1.452 -0.244 0 C-N-CA 121.022 -0.609 . . . . 0.0 112.591 -179.996 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 615' ' ' ARG . . . . . . . . . . . . . 87.2 mtm180 -115.82 141.34 48.22 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.725 0.298 . . . . 0.0 110.716 -179.838 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 616' ' ' ILE . . . . . 0.496 ' O ' ' HA ' ' A' ' 640' ' ' VAL . 85.0 mt -123.79 134.96 65.0 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 N-CA-C 109.521 -0.548 . . . . 0.0 109.521 179.153 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 617' ' ' VAL . . . . . 0.675 HG12 ' HB ' ' A' ' 641' ' ' ILE . 33.1 m -112.9 147.6 16.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 C-N-CA 120.531 -0.468 . . . . 0.0 111.129 -179.046 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 618' ' ' LEU . . . . . 0.559 ' CD1' HG21 ' A' ' 629' ' ' ILE . 4.6 tt -119.66 130.98 55.33 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.003 179.936 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 619' ' ' VAL . . . . . . . . . . . . . 71.3 t -113.98 103.48 15.45 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-N 116.008 -0.542 . . . . 0.0 109.721 179.2 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 620' ' ' SER . . . . . 0.484 ' HB2' ' HB3' ' A' ' 662' ' ' ALA . 30.3 t -172.44 151.0 2.38 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.181 -0.918 . . . . 0.0 110.273 -179.634 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 621' ' ' GLU . . . . . 0.442 ' HG3' ' OG ' ' A' ' 666' ' ' SER . 97.1 mt-10 -91.93 -2.31 56.85 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.367 179.13 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 622' ' ' ASP . . . . . . . . . . . . . 29.0 t70 -91.1 110.63 21.9 Favored 'General case' 0 C--O 1.233 0.185 0 CA-C-O 121.161 0.505 . . . . 0.0 111.335 -178.866 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 623' ' ' GLU . . . . . 0.405 ' HG2' ' CH2' ' A' ' 642' ' ' TRP . 98.0 mt-10 -64.87 -38.44 90.97 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.466 -0.788 . . . . 0.0 112.597 179.959 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 624' ' ' ALA . . . . . . . . . . . . . . . -60.99 -45.28 95.44 Favored 'General case' 0 N--CA 1.464 0.247 0 N-CA-C 113.719 1.007 . . . . 0.0 113.719 -177.324 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 625' ' ' THR . . . . . . . . . . . . . 30.8 p -72.26 -36.21 68.98 Favored 'General case' 0 CA--C 1.518 -0.258 0 C-N-CA 120.364 -0.534 . . . . 0.0 111.12 -179.713 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 626' ' ' SER . . . . . . . . . . . . . 69.0 m -65.52 -42.74 91.67 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.967 -0.561 . . . . 0.0 111.061 -179.646 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 627' ' ' THR . . . . . . . . . . . . . 90.3 m -64.29 -46.5 83.35 Favored 'General case' 0 C--O 1.236 0.377 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.791 -179.93 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 628' ' ' LEU . . . . . . . . . . . . . 60.7 tp -64.9 -44.01 90.98 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.738 -179.431 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 629' ' ' ILE . . . . . 0.559 HG21 ' CD1' ' A' ' 618' ' ' LEU . 1.3 tp -68.31 -33.62 61.52 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.382 0 CA-C-N 116.299 -0.409 . . . . 0.0 111.301 -179.088 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 630' ' ' CYS . . . . . . . . . . . . . 46.0 t -62.1 -44.04 97.51 Favored 'General case' 0 CA--C 1.521 -0.136 0 CA-C-N 115.959 -0.564 . . . . 0.0 111.409 -179.248 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 631' ' ' SER . . . . . . . . . . . . . 71.4 m -61.57 -41.98 98.19 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.526 -178.951 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 632' ' ' ILE . . . . . . . . . . . . . 96.9 mt -63.47 -49.32 83.13 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.257 0 CA-C-O 121.119 0.485 . . . . 0.0 110.995 179.958 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 633' ' ' LEU . . . . . . . . . . . . . 95.9 mt -68.75 -38.82 80.4 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.632 -0.713 . . . . 0.0 112.598 -179.264 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 634' ' ' THR . . . . . 0.479 ' HA ' ' O ' ' A' ' 638' ' ' TYR . 88.9 m -64.33 -39.96 94.94 Favored 'General case' 0 N--CA 1.462 0.161 0 CA-C-O 120.697 0.284 . . . . 0.0 110.739 -179.684 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 635' ' ' THR . . . . . . . . . . . . . 92.0 m -58.94 -38.93 80.12 Favored 'General case' 0 C--O 1.233 0.197 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.006 179.019 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 636' ' ' ALA . . . . . . . . . . . . . . . -65.45 -18.31 65.22 Favored 'General case' 0 CA--C 1.534 0.333 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.03 178.468 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 637' ' ' GLY . . . . . . . . . . . . . . . 109.14 3.66 31.34 Favored Glycine 0 C--N 1.333 0.379 0 C-N-CA 121.16 -0.543 . . . . 0.0 113.345 179.619 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 638' ' ' TYR . . . . . 0.479 ' O ' ' HA ' ' A' ' 634' ' ' THR . 94.7 m-85 -100.98 142.19 32.8 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.994 0.397 . . . . 0.0 111.929 -179.761 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 639' ' ' GLN . . . . . . . . . . . . . 78.5 mt-30 -89.88 140.32 29.73 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.661 179.636 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 640' ' ' VAL . . . . . 0.496 ' HA ' ' O ' ' A' ' 616' ' ' ILE . 58.6 t -116.11 128.98 73.24 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-O 120.958 0.409 . . . . 0.0 111.635 -179.997 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 641' ' ' ILE . . . . . 0.675 ' HB ' HG12 ' A' ' 617' ' ' VAL . 47.0 mm -110.18 119.55 59.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 N-CA-C 109.404 -0.591 . . . . 0.0 109.404 179.104 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 642' ' ' TRP . . . . . 0.405 ' CH2' ' HG2' ' A' ' 623' ' ' GLU . 25.2 t90 -89.21 125.13 34.94 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.102 0.477 . . . . 0.0 111.932 -178.69 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 643' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -117.84 129.87 55.92 Favored 'General case' 0 C--O 1.234 0.287 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.668 179.327 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 644' ' ' VAL . . . . . . . . . . . . . 6.0 m -102.13 27.85 0.86 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.895 -179.762 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 645' ' ' ASP . . . . . . . . . . . . . 37.7 t70 -155.92 -34.83 0.09 Allowed 'General case' 0 N--CA 1.47 0.528 0 N-CA-C 112.525 0.565 . . . . 0.0 112.525 -178.3 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 646' ' ' GLY . . . . . . . . . . . . . . . 75.9 28.17 61.25 Favored Glycine 0 CA--C 1.518 0.227 0 C-N-CA 120.729 -0.748 . . . . 0.0 113.366 -179.359 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 647' ' ' GLU . . . . . . . . . . . . . 86.7 tt0 -62.65 123.59 18.79 Favored 'General case' 0 N--CA 1.454 -0.233 0 CA-C-O 121.26 0.552 . . . . 0.0 110.355 179.847 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 648' ' ' VAL . . . . . . . . . . . . . 72.8 t -61.11 -40.67 86.57 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 114.952 -1.022 . . . . 0.0 112.197 -178.494 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 649' ' ' GLU . . . . . . . . . . . . . 48.9 mp0 -60.67 -43.44 97.67 Favored 'General case' 0 C--N 1.33 -0.271 0 C-N-CA 120.792 -0.363 . . . . 0.0 110.669 -179.82 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 650' ' ' ARG . . . . . . . . . . . . . 82.7 mtp180 -70.54 -41.02 73.05 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.685 178.564 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 651' ' ' LEU . . . . . 0.506 HD22 HG21 ' A' ' 617' ' ' VAL . 96.5 mt -65.48 -40.06 92.66 Favored 'General case' 0 N--CA 1.462 0.14 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.521 179.311 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 652' ' ' LEU . . . . . . . . . . . . . 62.4 tp -63.7 -43.25 97.16 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.694 178.871 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 653' ' ' ALA . . . . . . . . . . . . . . . -62.27 -39.08 91.72 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-O 121.229 0.538 . . . . 0.0 111.204 179.35 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 654' ' ' LEU . . . . . . . . . . . . . 75.9 mt -98.62 30.79 3.12 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.649 -0.705 . . . . 0.0 110.37 179.922 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 655' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -30.33 104.52 0.21 Allowed Pre-proline 0 N--CA 1.474 0.735 0 O-C-N 124.617 1.198 . . . . 0.0 113.764 -178.531 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 656' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_endo -90.44 173.75 3.13 Favored 'Trans proline' 0 C--N 1.344 0.308 0 C-N-CA 123.985 3.123 . . . . 0.0 112.922 179.388 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 657' ' ' ILE . . . . . . . . . . . . . 18.2 pt -85.05 -26.33 6.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-O 121.454 0.645 . . . . 0.0 109.66 177.369 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 658' ' ' ALA . . . . . 0.42 ' HA ' ' O ' ' A' ' 687' ' ' LYS . . . -156.6 153.24 28.3 Favored 'General case' 0 N--CA 1.449 -0.492 0 CA-C-N 115.058 -0.973 . . . . 0.0 110.627 179.915 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 659' ' ' VAL . . . . . 0.489 HG12 ' CG2' ' A' ' 617' ' ' VAL . 34.0 m -120.88 145.2 27.72 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-O 121.194 0.521 . . . . 0.0 110.961 179.242 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 660' ' ' LEU . . . . . . . . . . . . . 15.5 mt -113.42 115.69 28.47 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.45 -0.796 . . . . 0.0 109.884 178.812 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 661' ' ' LEU . . . . . . . . . . . . . 67.9 mt -104.61 107.65 18.7 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 108.818 -0.808 . . . . 0.0 108.818 179.521 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 662' ' ' ALA . . . . . 0.498 ' HB2' HD12 ' A' ' 691' ' ' LEU . . . -107.13 134.23 50.56 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 112.765 0.654 . . . . 0.0 112.765 -178.132 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 663' ' ' GLU . . . . . . . . . . . . . 9.6 mm-40 -67.86 136.61 92.29 Favored Pre-proline 0 C--N 1.325 -0.473 0 CA-C-N 115.751 -0.659 . . . . 0.0 110.768 177.63 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 664' ' ' PRO . . . . . . . . . . . . . 92.8 Cg_endo -78.07 141.79 67.37 Favored 'Cis proline' 0 C--N 1.35 0.625 0 C-N-CA 123.538 -1.442 . . . . 0.0 112.402 -1.2 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 665' ' ' PHE . . . . . 0.695 ' HZ ' HD11 ' A' ' 690' ' ' ILE . 23.4 m-85 -72.5 123.83 23.94 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.961 179.991 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 666' ' ' SER . . . . . 0.442 ' OG ' ' HG3' ' A' ' 621' ' ' GLU . 69.9 m -65.78 -41.18 92.3 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.302 179.612 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 667' ' ' TYR . . . . . . . . . . . . . 51.2 t80 -69.09 -23.61 64.03 Favored 'General case' 0 CA--C 1.533 0.314 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.692 179.935 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 668' ' ' GLY . . . . . . . . . . . . . . . 100.32 -103.69 2.68 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.504 -0.855 . . . . 0.0 112.435 -179.36 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 669' ' ' ASP . . . . . . . . . . . . . 37.5 t70 -80.7 110.21 15.98 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.91 0.386 . . . . 0.0 110.69 -179.654 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 670' ' ' VAL . . . . . 0.429 ' O ' HG23 ' A' ' 674' ' ' VAL . 12.1 m -69.46 -26.64 31.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 N-CA-C 113.726 1.009 . . . . 0.0 113.726 -179.039 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 671' ' ' GLN . . . . . . . . . . . . . 64.9 tt0 -60.41 -44.92 95.26 Favored 'General case' 0 CA--C 1.53 0.175 0 CA-C-N 118.043 0.383 . . . . 0.0 110.665 -179.293 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 672' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 -66.39 -40.13 89.48 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.648 178.854 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 673' ' ' LEU . . . . . . . . . . . . . 62.5 tp -63.1 -44.66 95.07 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.092 179.596 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 674' ' ' VAL . . . . . 0.597 HG11 ' HA3' ' A' ' 699' ' ' GLY . 53.3 t -62.78 -44.16 99.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 115.753 -0.658 . . . . 0.0 109.61 179.056 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 675' ' ' ASP . . . . . . . . . . . . . 35.9 t70 -60.03 -40.82 90.66 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.573 179.164 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 676' ' ' GLN . . . . . . . . . . . . . 96.8 mt-30 -70.76 -40.44 72.66 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.943 0.401 . . . . 0.0 110.98 -179.779 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 677' ' ' LEU . . . . . . . . . . . . . 5.1 mp -70.09 -43.75 70.47 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.053 -0.522 . . . . 0.0 111.894 179.805 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 678' ' ' ARG . . . . . 0.556 ' HA ' ' O ' ' A' ' 681' ' ' CYS . 39.8 ptt180 -69.85 -26.33 64.15 Favored 'General case' 0 N--CA 1.468 0.468 0 CA-C-O 121.114 0.483 . . . . 0.0 110.713 -179.216 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 679' ' ' GLN . . . . . . . . . . . . . 63.3 tt0 -66.51 -39.12 88.5 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.539 -0.755 . . . . 0.0 110.416 178.876 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 680' ' ' ARG . . . . . . . . . . . . . 32.7 mmt180 -90.15 -34.2 15.94 Favored 'General case' 0 N--CA 1.462 0.147 0 CA-C-N 115.945 -0.57 . . . . 0.0 111.676 -179.128 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 681' ' ' CYS . . . . . 0.615 ' SG ' ' HB2' ' A' ' 686' ' ' LEU . 27.5 t -134.18 128.76 34.66 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 109.544 -0.539 . . . . 0.0 109.544 -179.593 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 682' ' ' THR . . . . . 0.448 ' HB ' ' HD2' ' A' ' 683' ' ' PRO . 70.2 p -71.88 158.16 88.24 Favored Pre-proline 0 C--N 1.324 -0.527 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.351 -178.621 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 683' ' ' PRO . . . . . 0.448 ' HD2' ' HB ' ' A' ' 682' ' ' THR . 20.1 Cg_endo -60.42 -23.75 75.81 Favored 'Trans proline' 0 C--N 1.351 0.669 0 C-N-CA 122.519 2.146 . . . . 0.0 112.628 179.777 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 684' ' ' GLU . . . . . 0.41 ' HG2' ' OG1' ' A' ' 682' ' ' THR . 24.8 pt-20 -78.5 -18.04 55.36 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.017 0.436 . . . . 0.0 110.12 178.943 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 685' ' ' GLN . . . . . . . . . . . . . 95.0 mt-30 -99.65 -34.33 10.25 Favored 'General case' 0 CA--C 1.53 0.197 0 CA-C-N 115.88 -0.6 . . . . 0.0 111.012 179.81 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 686' ' ' LEU . . . . . 0.615 ' HB2' ' SG ' ' A' ' 681' ' ' CYS . 4.8 tt -134.09 124.59 26.41 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.94 -179.414 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 687' ' ' LYS . . . . . 0.42 ' O ' ' HA ' ' A' ' 658' ' ' ALA . 22.1 mtmm -94.46 147.01 23.68 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.2 0.524 . . . . 0.0 110.676 179.378 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 688' ' ' ILE . . . . . 0.568 HG22 HG12 ' A' ' 700' ' ' VAL . 78.0 mt -120.76 120.3 62.06 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.775 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.851 -179.325 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 689' ' ' PHE . . . . . . . . . . . . . 99.2 m-85 -119.42 145.94 45.81 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.289 -0.869 . . . . 0.0 110.091 179.327 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 690' ' ' ILE . . . . . 0.695 HD11 ' HZ ' ' A' ' 665' ' ' PHE . 19.5 tt -124.83 135.29 64.47 Favored 'Isoleucine or valine' 0 C--O 1.235 0.33 0 CA-C-O 121.267 0.556 . . . . 0.0 111.437 -179.662 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 691' ' ' LEU . . . . . 0.74 HD23 ' HB ' ' A' ' 704' ' ' ILE . 76.4 mt -107.11 126.89 52.95 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-N 115.53 -0.759 . . . . 0.0 110.219 179.93 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 692' ' ' GLY . . . . . 0.724 ' O ' ' HA ' ' A' ' 705' ' ' PRO . . . 162.72 -168.66 37.68 Favored Glycine 0 N--CA 1.447 -0.581 0 C-N-CA 120.651 -0.785 . . . . 0.0 112.125 -179.957 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 693' ' ' SER . . . . . . . . . . . . . 62.4 m -98.73 126.52 44.38 Favored 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 109.117 -0.697 . . . . 0.0 109.117 179.42 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 694' ' ' LYS . . . . . . . . . . . . . 99.3 mttt 59.67 59.35 2.56 Favored 'General case' 0 N--CA 1.465 0.291 0 O-C-N 123.772 0.67 . . . . 0.0 110.234 -179.075 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 695' ' ' GLY . . . . . . . . . . . . . . . -70.27 52.05 0.81 Allowed Glycine 0 CA--C 1.524 0.606 0 CA-C-N 115.559 -0.746 . . . . 0.0 114.219 -178.913 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 696' ' ' ASN . . . . . . . . . . . . . 66.0 t30 -89.4 78.3 7.2 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.938 0.399 . . . . 0.0 110.32 179.438 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 697' ' ' TYR . . . . . . . . . . . . . 97.6 m-85 -128.08 150.24 50.04 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.401 -179.668 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 698' ' ' GLN . . . . . . . . . . . . . 98.0 mt-30 -82.74 148.19 28.0 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.723 -0.671 . . . . 0.0 110.665 -179.626 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 699' ' ' GLY . . . . . 0.597 ' HA3' HG11 ' A' ' 674' ' ' VAL . . . 94.08 3.61 63.57 Favored Glycine 0 N--CA 1.449 -0.462 0 C-N-CA 120.579 -0.82 . . . . 0.0 113.707 179.449 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 700' ' ' VAL . . . . . 0.568 HG12 HG22 ' A' ' 688' ' ' ILE . 26.6 m -117.82 142.42 32.26 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.344 0 CA-C-N 117.594 0.697 . . . . 0.0 110.506 179.256 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 701' ' ' ASP . . . . . . . . . . . . . 36.9 t70 -72.8 -41.58 64.78 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.499 -0.773 . . . . 0.0 111.795 -179.787 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 702' ' ' ARG . . . . . . . . . . . . . 4.5 mmp_? -146.11 158.42 43.87 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.942 -178.92 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 703' ' ' TYR . . . . . . . . . . . . . 25.5 p90 -119.3 137.99 53.32 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.377 179.438 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 704' ' ' ILE . . . . . 0.74 ' HB ' HD23 ' A' ' 691' ' ' LEU . 31.2 mm -119.45 106.35 42.6 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 120.752 0.31 . . . . 0.0 110.63 -179.914 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 705' ' ' PRO . . . . . 0.724 ' HA ' ' O ' ' A' ' 692' ' ' GLY . 72.9 Cg_endo -72.93 149.08 46.63 Favored 'Trans proline' 0 C--N 1.346 0.441 0 C-N-CA 122.851 2.368 . . . . 0.0 113.791 -179.455 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 706' ' ' LEU . . . . . 0.621 HD23 HG23 ' A' ' 708' ' ' ILE . 91.0 mt -105.83 148.72 36.99 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-N 115.409 -0.814 . . . . 0.0 109.789 178.415 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 707' ' ' PRO . . . . . 0.519 ' C ' ' HA ' ' A' ' 706' ' ' LEU . 38.9 Cg_exo -64.29 137.91 30.3 Favored 'Cis proline' 0 C--N 1.35 0.615 0 C-N-CA 123.725 -1.365 . . . . 0.0 112.809 -1.137 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 708' ' ' ILE . . . . . 0.621 HG23 HD23 ' A' ' 706' ' ' LEU . 1.1 pt -66.36 139.24 21.5 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-O 121.227 0.537 . . . . 0.0 111.752 178.562 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 709' ' ' HIS . . . . . . . . . . . . . 70.5 m80 -105.65 111.53 64.72 Favored Pre-proline 0 C--N 1.319 -0.746 0 N-CA-C 108.637 -0.875 . . . . 0.0 108.637 177.676 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 710' ' ' PRO . . . . . . . . . . . . . 88.5 Cg_exo -52.95 -37.95 78.86 Favored 'Trans proline' 0 N--CA 1.478 0.582 0 C-N-CA 123.472 2.782 . . . . 0.0 114.31 -178.394 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 711' ' ' GLU . . . . . . . . . . . . . 42.5 tt0 -64.93 -42.36 94.75 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 112.277 0.473 . . . . 0.0 112.277 -178.611 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 712' ' ' SER . . . . . . . . . . . . . 46.3 m -89.64 -27.35 20.22 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 112.463 0.542 . . . . 0.0 112.463 -178.242 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 713' ' ' PHE . . . . . . . . . . . . . 88.6 t80 -59.32 -48.71 80.61 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-O 120.706 0.288 . . . . 0.0 110.988 -179.456 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 714' ' ' LEU . . . . . . . . . . . . . 59.1 tp -62.63 -41.89 99.28 Favored 'General case' 0 C--O 1.235 0.294 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.343 179.868 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 715' ' ' GLN . . . . . . . . . . . . . 59.3 mt-30 -63.69 -41.59 98.13 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.416 179.175 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 716' ' ' GLN . . . . . . . . . . . . . 82.9 mt-30 -64.29 -41.87 96.67 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-N 116.791 -0.186 . . . . 0.0 111.15 179.683 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 717' ' ' VAL . . . . . . . . . . . . . 68.2 t -63.84 -45.04 98.19 Favored 'Isoleucine or valine' 0 C--O 1.232 0.165 0 CA-C-O 121.057 0.455 . . . . 0.0 109.931 178.622 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 718' ' ' THR . . . . . . . . . . . . . 89.3 m -62.46 -44.27 96.82 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 115.517 -0.765 . . . . 0.0 110.858 179.521 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 719' ' ' MET . . . . . . . . . . . . . 63.5 tpp -59.98 -47.59 85.19 Favored 'General case' 0 N--CA 1.463 0.185 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.564 179.746 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 720' ' ' GLY . . . . . . . . . . . . . . . -62.64 -40.87 99.7 Favored Glycine 0 C--N 1.335 0.512 0 C-N-CA 120.638 -0.792 . . . . 0.0 111.752 178.738 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 721' ' ' LEU . . . . . . . . . . . . . 65.6 tp -62.7 -45.6 92.02 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.663 0.268 . . . . 0.0 111.315 179.156 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 722' ' ' THR . . . . . . . . . . . . . 73.1 p -70.95 -27.87 64.06 Favored 'General case' 0 N--CA 1.463 0.185 0 N-CA-C 112.539 0.57 . . . . 0.0 112.539 -179.834 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 723' ' ' SER . . . . . . . . . . . . . 73.0 p -71.57 -20.53 62.0 Favored 'General case' 0 CA--C 1.531 0.221 0 C-N-CA 121.194 -0.202 . . . . 0.0 111.467 179.967 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 724' ' ' LEU . . . . . . . . . . . . . 65.5 tp -63.0 -46.63 86.75 Favored 'General case' 0 CA--C 1.53 0.204 0 CA-C-N 116.471 -0.331 . . . . 0.0 111.348 179.984 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 725' ' ' ALA . . . . . . . . . . . . . . . -155.99 149.45 24.77 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.963 -179.879 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 726' ' ' THR . . . . . . . . . . . . . 72.7 p -81.01 159.96 24.69 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.398 -0.364 . . . . 0.0 111.243 179.951 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 727' ' ' SER . . . . . . . . . . . . . 98.3 p -153.08 162.54 41.19 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.566 -179.953 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 728' ' ' ALA . . . . . . . . . . . . . . . -148.24 154.06 39.55 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.652 179.987 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 729' ' ' GLN . . . . . . . . . . . . . 96.7 mt-30 . . . . . 0 C--O 1.248 1.0 0 CA-C-O 118.25 -0.881 . . . . 0.0 110.826 179.9 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 613' ' ' GLU . . . . . . . . . . . . . 3.3 mt-10 . . . . . 0 N--CA 1.488 1.469 0 CA-C-O 121.106 0.479 . . . . 0.0 110.626 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 614' ' ' GLY . . . . . . . . . . . . . . . 100.5 150.1 24.2 Favored Glycine 0 N--CA 1.451 -0.355 0 CA-C-N 115.664 -0.698 . . . . 0.0 112.163 -179.464 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 615' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -117.49 137.72 52.35 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.944 0.402 . . . . 0.0 111.271 -179.695 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 616' ' ' ILE . . . . . 0.467 ' O ' ' HA ' ' A' ' 640' ' ' VAL . 87.9 mt -122.71 133.23 69.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 115.73 -0.668 . . . . 0.0 109.669 178.943 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 617' ' ' VAL . . . . . 0.468 HG23 ' HB3' ' A' ' 656' ' ' PRO . 99.6 t -106.45 127.68 61.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-O 121.148 0.499 . . . . 0.0 110.235 -179.907 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 618' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -106.41 126.19 51.93 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.604 -178.771 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 619' ' ' VAL . . . . . 0.402 ' HA ' ' O ' ' A' ' 643' ' ' LEU . 59.6 t -115.78 118.46 58.86 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 N-CA-C 109.92 -0.4 . . . . 0.0 109.92 179.93 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 620' ' ' SER . . . . . 0.567 ' HB2' ' HB3' ' A' ' 662' ' ' ALA . 32.5 t -172.19 139.39 1.06 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.664 -0.698 . . . . 0.0 111.116 -179.472 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 621' ' ' GLU . . . . . 0.46 ' HB3' ' HB3' ' A' ' 666' ' ' SER . 25.9 pt-20 -84.05 -11.47 56.67 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.935 -0.575 . . . . 0.0 111.415 178.586 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 622' ' ' ASP . . . . . . . . . . . . . 62.5 t0 -91.4 107.48 19.24 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-O 120.854 0.359 . . . . 0.0 110.544 -179.051 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 623' ' ' GLU . . . . . . . . . . . . . 25.5 pm0 -67.2 -31.04 71.15 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.91 -0.587 . . . . 0.0 112.262 -179.884 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 624' ' ' ALA . . . . . . . . . . . . . . . -63.93 -45.35 89.62 Favored 'General case' 0 N--CA 1.464 0.23 0 N-CA-C 112.433 0.531 . . . . 0.0 112.433 -178.695 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 625' ' ' THR . . . . . . . . . . . . . 20.5 p -76.01 -36.13 59.27 Favored 'General case' 0 CA--C 1.517 -0.312 0 C-N-CA 120.95 -0.3 . . . . 0.0 111.34 179.943 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 626' ' ' SER . . . . . . . . . . . . . 68.5 m -63.44 -41.67 98.67 Favored 'General case' 0 N--CA 1.453 -0.286 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.324 -179.247 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 627' ' ' THR . . . . . . . . . . . . . 92.4 m -62.71 -47.05 85.27 Favored 'General case' 0 CA--C 1.532 0.286 0 CA-C-O 120.947 0.403 . . . . 0.0 111.506 179.846 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 628' ' ' LEU . . . . . . . . . . . . . 62.2 tp -66.77 -43.87 82.89 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.153 -0.476 . . . . 0.0 112.043 -179.736 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 629' ' ' ILE . . . . . . . . . . . . . 1.5 tp -70.21 -35.48 63.38 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.473 0 N-CA-C 113.236 0.828 . . . . 0.0 113.236 -177.965 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 630' ' ' CYS . . . . . . . . . . . . . 18.4 p -67.95 -29.48 68.54 Favored 'General case' 0 CA--C 1.521 -0.164 0 C-N-CA 121.071 -0.251 . . . . 0.0 111.202 -178.921 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 631' ' ' SER . . . . . . . . . . . . . 68.1 m -64.89 -41.81 95.3 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.887 179.558 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 632' ' ' ILE . . . . . . . . . . . . . 96.6 mt -63.54 -48.84 85.08 Favored 'Isoleucine or valine' 0 C--O 1.234 0.243 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.882 -179.972 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 633' ' ' LEU . . . . . . . . . . . . . 85.7 mt -65.36 -40.93 94.19 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-N 115.77 -0.65 . . . . 0.0 112.308 -179.492 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 634' ' ' THR . . . . . 0.523 ' HA ' ' O ' ' A' ' 638' ' ' TYR . 91.7 m -67.04 -40.5 87.2 Favored 'General case' 0 CA--C 1.531 0.222 0 CA-C-O 120.53 0.205 . . . . 0.0 111.207 -179.456 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 635' ' ' THR . . . . . . . . . . . . . 93.8 m -59.2 -38.59 80.27 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-O 120.845 0.355 . . . . 0.0 110.458 179.628 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 636' ' ' ALA . . . . . . . . . . . . . . . -63.87 -17.21 62.94 Favored 'General case' 0 CA--C 1.533 0.292 0 CA-C-N 115.922 -0.581 . . . . 0.0 111.453 178.981 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 637' ' ' GLY . . . . . . . . . . . . . . . 109.03 7.34 29.07 Favored Glycine 0 C--N 1.333 0.392 0 C-N-CA 120.888 -0.672 . . . . 0.0 113.077 179.866 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 638' ' ' TYR . . . . . 0.523 ' O ' ' HA ' ' A' ' 634' ' ' THR . 96.6 m-85 -100.26 140.56 34.33 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.828 0.347 . . . . 0.0 111.461 -179.936 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 639' ' ' GLN . . . . . . . . . . . . . 79.0 mt-30 -87.13 134.36 33.52 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 109.57 -0.53 . . . . 0.0 109.57 178.851 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 640' ' ' VAL . . . . . 0.467 ' HA ' ' O ' ' A' ' 616' ' ' ILE . 62.9 t -119.04 131.33 72.12 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 N-CA-C 112.756 0.651 . . . . 0.0 112.756 -178.62 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 641' ' ' ILE . . . . . 0.418 ' HB ' HG22 ' A' ' 617' ' ' VAL . 46.4 mm -109.87 118.58 57.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 N-CA-C 108.24 -1.022 . . . . 0.0 108.24 177.966 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 642' ' ' TRP . . . . . . . . . . . . . 22.1 t90 -90.79 125.77 35.81 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 112.558 0.577 . . . . 0.0 112.558 -177.981 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 643' ' ' LEU . . . . . 0.425 ' HA ' HD13 ' A' ' 643' ' ' LEU . 0.8 OUTLIER -122.03 133.96 54.8 Favored 'General case' 0 C--O 1.232 0.182 0 CA-C-N 115.477 -0.783 . . . . 0.0 109.713 178.73 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 644' ' ' VAL . . . . . . . . . . . . . 18.8 m -105.13 13.87 7.54 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 N-CA-C 112.915 0.709 . . . . 0.0 112.915 -179.109 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 645' ' ' ASP . . . . . . . . . . . . . 40.1 p30 -137.31 -18.17 1.31 Allowed 'General case' 0 N--CA 1.472 0.639 0 N-CA-C 114.292 1.219 . . . . 0.0 114.292 -178.191 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 646' ' ' GLY . . . . . . . . . . . . . . . 67.39 28.64 73.67 Favored Glycine 0 CA--C 1.522 0.508 0 C-N-CA 120.875 -0.679 . . . . 0.0 114.084 179.58 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 647' ' ' GLU . . . . . . . . . . . . . 48.1 mt-10 -67.67 125.16 25.35 Favored 'General case' 0 C--N 1.333 -0.123 0 CA-C-N 117.694 0.747 . . . . 0.0 111.389 -179.396 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 648' ' ' VAL . . . . . . . . . . . . . 78.5 t -61.53 -39.17 82.06 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-N 114.541 -1.209 . . . . 0.0 111.536 -179.718 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 649' ' ' GLU . . . . . . . . . . . . . 50.2 mp0 -60.26 -42.83 96.19 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 120.84 0.353 . . . . 0.0 110.204 -179.69 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 650' ' ' ARG . . . . . . . . . . . . . 11.3 mpt_? -72.07 -41.67 67.1 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.532 178.405 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 651' ' ' LEU . . . . . . . . . . . . . 87.2 mt -63.52 -41.41 98.5 Favored 'General case' 0 N--CA 1.463 0.182 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.508 179.413 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 652' ' ' LEU . . . . . . . . . . . . . 61.0 tp -65.17 -43.8 90.57 Favored 'General case' 0 CA--C 1.531 0.223 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.21 179.008 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 653' ' ' ALA . . . . . . . . . . . . . . . -62.72 -39.36 93.82 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-O 120.98 0.419 . . . . 0.0 111.828 179.825 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 654' ' ' LEU . . . . . . . . . . . . . 74.6 mt -101.36 30.32 4.28 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.986 -179.459 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 655' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -31.08 104.25 0.21 Allowed Pre-proline 0 N--CA 1.472 0.664 0 O-C-N 124.488 1.117 . . . . 0.0 113.86 -179.175 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 656' ' ' PRO . . . . . 0.468 ' HB3' HG23 ' A' ' 617' ' ' VAL . 35.5 Cg_endo -91.07 178.16 1.89 Allowed 'Trans proline' 0 C--N 1.345 0.365 0 C-N-CA 123.635 2.89 . . . . 0.0 112.711 178.782 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 657' ' ' ILE . . . . . . . . . . . . . 24.3 pt -84.82 -25.26 7.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-O 121.447 0.641 . . . . 0.0 109.65 177.77 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 658' ' ' ALA . . . . . 0.401 ' HA ' ' O ' ' A' ' 687' ' ' LYS . . . -157.72 153.16 26.17 Favored 'General case' 0 N--CA 1.449 -0.51 0 CA-C-N 115.035 -0.984 . . . . 0.0 110.718 179.894 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 659' ' ' VAL . . . . . . . . . . . . . 31.3 m -122.68 146.33 28.11 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-O 121.228 0.537 . . . . 0.0 110.889 179.054 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 660' ' ' LEU . . . . . . . . . . . . . 3.2 mp -115.86 118.39 32.86 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.453 -0.794 . . . . 0.0 109.785 179.141 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 661' ' ' LEU . . . . . . . . . . . . . 32.3 mt -108.37 112.96 25.66 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 109.549 -0.537 . . . . 0.0 109.549 -179.622 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 662' ' ' ALA . . . . . 0.567 ' HB3' ' HB2' ' A' ' 620' ' ' SER . . . -105.8 131.17 53.46 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 112.399 0.518 . . . . 0.0 112.399 -178.907 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 663' ' ' GLU . . . . . 0.519 ' HA ' ' C ' ' A' ' 664' ' ' PRO . 76.7 mm-40 -81.88 147.06 57.33 Favored Pre-proline 0 CA--C 1.535 0.373 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.549 178.811 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 664' ' ' PRO . . . . . 0.519 ' C ' ' HA ' ' A' ' 663' ' ' GLU . 35.9 Cg_exo -63.77 135.18 19.47 Favored 'Cis proline' 0 C--N 1.353 0.801 0 C-N-CA 123.95 -1.271 . . . . 0.0 112.354 -1.376 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 665' ' ' PHE . . . . . 0.686 ' CE2' ' HB3' ' A' ' 667' ' ' TYR . 4.4 t80 -81.63 119.77 24.23 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.332 -179.44 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 666' ' ' SER . . . . . 0.46 ' HB3' ' HB3' ' A' ' 621' ' ' GLU . 80.8 p -66.64 -38.35 86.71 Favored 'General case' 0 CA--C 1.53 0.186 0 N-CA-C 112.592 0.59 . . . . 0.0 112.592 -179.616 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 667' ' ' TYR . . . . . 0.686 ' HB3' ' CE2' ' A' ' 665' ' ' PHE . 67.8 t80 -66.58 -22.98 66.14 Favored 'General case' 0 CA--C 1.533 0.303 0 CA-C-O 120.927 0.394 . . . . 0.0 111.315 179.737 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 668' ' ' GLY . . . . . . . . . . . . . . . 101.67 -104.22 2.65 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.62 -0.8 . . . . 0.0 113.573 179.789 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 669' ' ' ASP . . . . . 0.406 ' OD2' ' HG3' ' A' ' 672' ' ' GLU . 23.9 t70 -81.82 110.77 17.44 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.076 0.465 . . . . 0.0 112.03 -177.96 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 670' ' ' VAL . . . . . . . . . . . . . 72.9 t -62.22 -39.59 84.59 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.419 0 CA-C-N 115.307 -0.861 . . . . 0.0 112.655 179.925 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 671' ' ' GLN . . . . . . . . . . . . . 20.8 mp0 -59.66 -41.81 91.44 Favored 'General case' 0 N--CA 1.465 0.286 0 N-CA-C 111.75 0.278 . . . . 0.0 111.75 -177.513 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 672' ' ' GLU . . . . . 0.406 ' HG3' ' OD2' ' A' ' 669' ' ' ASP . 95.5 mt-10 -64.3 -40.29 95.64 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-N 116.622 -0.263 . . . . 0.0 111.064 179.413 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 673' ' ' LEU . . . . . . . . . . . . . 62.4 tp -64.83 -42.88 94.59 Favored 'General case' 0 C--N 1.331 -0.204 0 N-CA-C 109.715 -0.476 . . . . 0.0 109.715 178.995 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 674' ' ' VAL . . . . . 0.62 HG11 ' HA3' ' A' ' 699' ' ' GLY . 53.7 t -62.24 -44.26 98.91 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.269 0 CA-C-N 115.463 -0.79 . . . . 0.0 109.736 179.439 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 675' ' ' ASP . . . . . 0.404 ' O ' ' HB2' ' A' ' 679' ' ' GLN . 34.9 t70 -59.21 -40.0 84.43 Favored 'General case' 0 CA--C 1.519 -0.222 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.229 178.876 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 676' ' ' GLN . . . . . . . . . . . . . 55.9 mt-30 -71.21 -41.58 70.07 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.941 179.719 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 677' ' ' LEU . . . . . . . . . . . . . 86.7 mt -68.18 -41.75 81.01 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.893 179.946 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 678' ' ' ARG . . . . . 0.544 ' HA ' ' O ' ' A' ' 681' ' ' CYS . 40.0 ptt180 -72.95 -25.13 60.92 Favored 'General case' 0 N--CA 1.467 0.382 0 CA-C-O 120.998 0.428 . . . . 0.0 110.844 -179.435 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 679' ' ' GLN . . . . . 0.404 ' HB2' ' O ' ' A' ' 675' ' ' ASP . 11.0 tp-100 -66.45 -38.67 87.88 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.62 -0.718 . . . . 0.0 110.121 178.809 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 680' ' ' ARG . . . . . . . . . . . . . 32.2 mmt180 -89.62 -43.54 10.69 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-N 115.882 -0.599 . . . . 0.0 111.338 -179.671 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 681' ' ' CYS . . . . . 0.544 ' O ' ' HA ' ' A' ' 678' ' ' ARG . 76.9 m -121.97 131.7 54.15 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.319 179.876 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 682' ' ' THR . . . . . 0.459 ' HB ' ' HD2' ' A' ' 683' ' ' PRO . 65.2 p -70.36 159.21 85.56 Favored Pre-proline 0 C--N 1.321 -0.634 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.597 -179.856 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 683' ' ' PRO . . . . . 0.459 ' HD2' ' HB ' ' A' ' 682' ' ' THR . 17.9 Cg_endo -59.39 -22.68 66.91 Favored 'Trans proline' 0 C--N 1.35 0.657 0 C-N-CA 122.569 2.18 . . . . 0.0 112.887 -179.724 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 684' ' ' GLU . . . . . 0.402 ' HG2' ' OG1' ' A' ' 682' ' ' THR . 24.8 pt-20 -81.31 -15.04 56.62 Favored 'General case' 0 CA--C 1.531 0.24 0 CA-C-O 120.893 0.378 . . . . 0.0 110.663 178.981 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 685' ' ' GLN . . . . . . . . . . . . . 90.9 mt-30 -99.19 -34.1 10.49 Favored 'General case' 0 C--N 1.333 -0.136 0 CA-C-N 116.057 -0.52 . . . . 0.0 111.869 -179.593 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 686' ' ' LEU . . . . . . . . . . . . . 3.1 tt -135.53 125.3 25.49 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.566 -0.288 . . . . 0.0 111.273 -178.932 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 687' ' ' LYS . . . . . 0.401 ' O ' ' HA ' ' A' ' 658' ' ' ALA . 75.6 mmtt -95.36 146.63 24.24 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 121.252 0.548 . . . . 0.0 110.377 179.087 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 688' ' ' ILE . . . . . 0.518 HG22 HG12 ' A' ' 700' ' ' VAL . 75.3 mt -122.62 121.01 62.47 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.781 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.194 -179.032 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 689' ' ' PHE . . . . . . . . . . . . . 97.7 m-85 -118.36 145.23 45.29 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.253 -0.885 . . . . 0.0 110.228 179.127 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 690' ' ' ILE . . . . . . . . . . . . . 18.8 tt -127.22 139.56 51.55 Favored 'Isoleucine or valine' 0 C--O 1.235 0.337 0 CA-C-O 121.196 0.522 . . . . 0.0 111.544 179.633 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 691' ' ' LEU . . . . . 0.49 HD23 ' HB ' ' A' ' 704' ' ' ILE . 81.9 mt -111.47 128.92 56.15 Favored 'General case' 0 C--O 1.235 0.327 0 CA-C-N 115.618 -0.719 . . . . 0.0 110.093 179.509 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 692' ' ' GLY . . . . . 0.611 ' O ' ' HA ' ' A' ' 705' ' ' PRO . . . -179.43 177.53 48.32 Favored Glycine 0 N--CA 1.446 -0.685 0 N-CA-C 111.48 -0.648 . . . . 0.0 111.48 -179.864 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 693' ' ' SER . . . . . . . . . . . . . 79.4 p -67.04 -39.72 87.0 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.786 0.293 . . . . 0.0 111.784 -179.794 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 694' ' ' LYS . . . . . . . . . . . . . 38.0 mtpt -133.48 133.87 42.8 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.201 0.524 . . . . 0.0 110.977 179.619 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 695' ' ' GLY . . . . . . . . . . . . . . . -124.1 108.83 1.19 Allowed Glycine 0 N--CA 1.446 -0.66 0 CA-C-N 115.473 -0.785 . . . . 0.0 112.076 178.983 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 696' ' ' ASN . . . . . . . . . . . . . 99.6 m-20 -109.41 -67.41 0.99 Allowed 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 120.826 0.346 . . . . 0.0 110.356 179.466 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 697' ' ' TYR . . . . . . . . . . . . . 53.9 p90 -157.09 155.86 31.81 Favored 'General case' 0 C--N 1.33 -0.247 0 N-CA-C 109.758 -0.46 . . . . 0.0 109.758 178.96 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 698' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER 174.58 25.42 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.284 0 O-C-N 124.062 0.851 . . . . 0.0 109.818 -179.978 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 699' ' ' GLY . . . . . 0.62 ' HA3' HG11 ' A' ' 674' ' ' VAL . . . 80.36 14.86 79.58 Favored Glycine 0 C--N 1.335 0.495 0 C-N-CA 120.337 -0.935 . . . . 0.0 111.865 -178.62 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 700' ' ' VAL . . . . . 0.518 HG12 HG22 ' A' ' 688' ' ' ILE . 23.7 m -101.92 147.58 8.53 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.502 0 CA-C-O 121.446 0.641 . . . . 0.0 111.43 -178.372 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 701' ' ' ASP . . . . . . . . . . . . . 36.7 t70 -72.46 -40.95 66.59 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 114.905 -1.043 . . . . 0.0 111.87 -179.697 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 702' ' ' ARG . . . . . . . . . . . . . 95.1 mtt-85 -143.5 157.91 44.07 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-O 121.06 0.457 . . . . 0.0 111.376 -178.573 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 703' ' ' TYR . . . . . . . . . . . . . 24.8 p90 -125.54 143.96 50.77 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.244 179.41 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 704' ' ' ILE . . . . . 0.49 ' HB ' HD23 ' A' ' 691' ' ' LEU . 56.5 mt -126.98 87.62 56.27 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-O 120.922 0.391 . . . . 0.0 110.484 179.915 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 705' ' ' PRO . . . . . 0.611 ' HA ' ' O ' ' A' ' 692' ' ' GLY . 31.4 Cg_exo -61.73 142.56 94.41 Favored 'Trans proline' 0 C--N 1.348 0.534 0 C-N-CA 123.492 2.795 . . . . 0.0 113.859 -179.462 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 706' ' ' LEU . . . . . . . . . . . . . 90.9 mt -79.22 151.36 75.4 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-N 115.443 -0.799 . . . . 0.0 110.276 178.384 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 707' ' ' PRO . . . . . . . . . . . . . 63.4 Cg_endo -72.65 139.83 63.12 Favored 'Cis proline' 0 C--N 1.347 0.475 0 C-N-CA 123.226 -1.573 . . . . 0.0 112.766 -0.297 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 708' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -69.81 116.51 10.96 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-N 115.773 -0.648 . . . . 0.0 111.639 179.108 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 709' ' ' HIS . . . . . . . . . . . . . 98.4 m-70 -91.96 118.16 68.08 Favored Pre-proline 0 C--N 1.324 -0.541 0 N-CA-C 108.379 -0.971 . . . . 0.0 108.379 177.679 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 710' ' ' PRO . . . . . . . . . . . . . 86.4 Cg_exo -52.34 -37.46 71.53 Favored 'Trans proline' 0 C--N 1.348 0.541 0 C-N-CA 123.166 2.578 . . . . 0.0 114.279 -178.173 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 711' ' ' GLU . . . . . . . . . . . . . 88.8 tt0 -64.1 -44.08 93.4 Favored 'General case' 0 CA--C 1.531 0.236 0 N-CA-C 111.954 0.353 . . . . 0.0 111.954 -179.077 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 712' ' ' SER . . . . . . . . . . . . . 50.7 m -86.66 -26.25 24.43 Favored 'General case' 0 C--N 1.331 -0.225 0 N-CA-C 111.99 0.367 . . . . 0.0 111.99 -178.824 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 713' ' ' PHE . . . . . . . . . . . . . 69.9 t80 -59.64 -49.94 75.81 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-O 120.658 0.266 . . . . 0.0 111.095 -179.769 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 714' ' ' LEU . . . . . . . . . . . . . 56.9 tp -65.05 -40.06 94.21 Favored 'General case' 0 C--O 1.235 0.308 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.323 179.741 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 715' ' ' GLN . . . . . . . . . . . . . 30.4 mm100 -62.02 -42.03 98.72 Favored 'General case' 0 N--CA 1.462 0.148 0 CA-C-N 115.904 -0.589 . . . . 0.0 111.568 179.525 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 716' ' ' GLN . . . . . . . . . . . . . 98.0 mm-40 -64.0 -41.92 97.33 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-O 120.691 0.281 . . . . 0.0 110.969 179.603 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 717' ' ' VAL . . . . . . . . . . . . . 74.7 t -64.0 -45.07 97.77 Favored 'Isoleucine or valine' 0 C--O 1.232 0.171 0 CA-C-O 121.007 0.432 . . . . 0.0 110.019 179.115 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 718' ' ' THR . . . . . . . . . . . . . 89.5 m -61.97 -45.44 93.65 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-N 115.685 -0.689 . . . . 0.0 111.005 179.573 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 719' ' ' MET . . . . . . . . . . . . . 38.5 mmt -62.84 -40.98 99.09 Favored 'General case' 0 N--CA 1.462 0.174 0 CA-C-N 116.502 -0.317 . . . . 0.0 110.641 179.385 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 720' ' ' GLY . . . . . . . . . . . . . . . -64.2 -42.13 98.07 Favored Glycine 0 CA--C 1.519 0.326 0 C-N-CA 120.828 -0.701 . . . . 0.0 112.509 178.758 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 721' ' ' LEU . . . . . . . . . . . . . 97.8 mt -67.7 -38.57 83.84 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-O 120.927 0.394 . . . . 0.0 111.933 179.95 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 722' ' ' THR . . . . . . . . . . . . . 60.3 p -89.39 2.17 54.81 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 112.905 0.706 . . . . 0.0 112.905 -178.659 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 723' ' ' SER . . . . . . . . . . . . . 91.1 p -65.12 -35.62 81.68 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.819 0.342 . . . . 0.0 110.953 179.502 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 724' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -70.24 -45.14 67.07 Favored 'General case' 0 CA--C 1.53 0.18 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.197 -179.973 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 725' ' ' ALA . . . . . . . . . . . . . . . -153.38 147.78 25.97 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.416 -0.356 . . . . 0.0 111.043 -179.865 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 726' ' ' THR . . . . . . . . . . . . . 15.3 t -151.04 159.33 44.6 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.341 179.974 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 727' ' ' SER . . . . . . . . . . . . . 40.7 t -148.85 144.82 27.17 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.562 0.22 . . . . 0.0 110.483 -179.809 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 728' ' ' ALA . . . . . . . . . . . . . . . -148.5 152.61 37.18 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.604 -179.895 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 729' ' ' GLN . . . . . . . . . . . . . 96.7 mt-30 . . . . . 0 C--O 1.25 1.098 0 CA-C-O 118.139 -0.934 . . . . 0.0 110.801 179.941 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 613' ' ' GLU . . . . . . . . . . . . . 39.9 mt-10 . . . . . 0 N--CA 1.487 1.387 0 CA-C-O 120.932 0.396 . . . . 0.0 110.73 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 614' ' ' GLY . . . . . . . . . . . . . . . -176.71 -178.19 46.27 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.819 -0.705 . . . . 0.0 112.509 -179.832 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 615' ' ' ARG . . . . . . . . . . . . . 78.4 mtp85 -114.99 131.81 56.8 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.779 0.323 . . . . 0.0 110.905 -179.737 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 616' ' ' ILE . . . . . 0.474 ' O ' ' HA ' ' A' ' 640' ' ' VAL . 83.8 mt -126.63 134.28 66.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.098 179.725 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 617' ' ' VAL . . . . . 0.644 HG12 HG12 ' A' ' 659' ' ' VAL . 0.5 OUTLIER -102.31 142.45 16.56 Favored 'Isoleucine or valine' 0 C--O 1.236 0.363 0 N-CA-C 109.656 -0.498 . . . . 0.0 109.656 -179.971 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 618' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -122.84 124.77 44.03 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.74 -178.91 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 619' ' ' VAL . . . . . . . . . . . . . 60.7 t -117.95 119.37 61.29 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 N-CA-C 109.321 -0.622 . . . . 0.0 109.321 179.825 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 620' ' ' SER . . . . . 0.647 ' HB2' ' HB3' ' A' ' 662' ' ' ALA . 32.4 t -166.31 140.09 4.17 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.942 -0.572 . . . . 0.0 111.505 -179.155 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 621' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -76.96 -28.23 55.1 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.446 -0.797 . . . . 0.0 111.034 178.884 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 622' ' ' ASP . . . . . . . . . . . . . 37.2 t70 -86.51 111.2 20.35 Favored 'General case' 0 CA--C 1.53 0.188 0 CA-C-O 121.102 0.477 . . . . 0.0 111.678 -178.646 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 623' ' ' GLU . . . . . . . . . . . . . 97.8 mt-10 -63.33 -39.15 93.75 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.342 -0.844 . . . . 0.0 112.647 -179.824 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 624' ' ' ALA . . . . . . . . . . . . . . . -60.53 -43.61 96.97 Favored 'General case' 0 N--CA 1.467 0.413 0 N-CA-C 112.662 0.615 . . . . 0.0 112.662 -178.068 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 625' ' ' THR . . . . . 0.437 ' O ' HG22 ' A' ' 629' ' ' ILE . 91.3 m -69.8 -40.24 76.08 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.113 0.483 . . . . 0.0 110.068 179.278 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 626' ' ' SER . . . . . . . . . . . . . 67.7 m -62.19 -41.53 98.44 Favored 'General case' 0 CA--C 1.531 0.236 0 CA-C-N 115.406 -0.815 . . . . 0.0 112.376 -178.774 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 627' ' ' THR . . . . . . . . . . . . . 48.8 p -68.14 -39.65 82.63 Favored 'General case' 0 N--CA 1.466 0.328 0 N-CA-C 112.427 0.529 . . . . 0.0 112.427 -179.587 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 628' ' ' LEU . . . . . . . . . . . . . 62.8 tp -65.09 -47.28 77.8 Favored 'General case' 0 N--CA 1.463 0.208 0 N-CA-C 111.983 0.364 . . . . 0.0 111.983 -179.384 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 629' ' ' ILE . . . . . 0.437 HG22 ' O ' ' A' ' 625' ' ' THR . 18.4 tt -71.93 -34.91 52.55 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.404 0 N-CA-C 112.402 0.519 . . . . 0.0 112.402 -179.119 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 630' ' ' CYS . . . . . . . . . . . . . 46.7 t -60.87 -43.01 98.98 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.143 -179.658 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 631' ' ' SER . . . . . . . . . . . . . 67.8 m -61.66 -41.29 97.32 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.047 -179.664 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 632' ' ' ILE . . . . . . . . . . . . . 97.2 mt -62.47 -48.17 89.52 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.249 0 CA-C-O 121.013 0.435 . . . . 0.0 110.725 179.638 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 633' ' ' LEU . . . . . . . . . . . . . 79.2 mt -66.48 -40.54 89.38 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.777 -0.647 . . . . 0.0 112.649 -179.699 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 634' ' ' THR . . . . . 0.499 ' HA ' ' O ' ' A' ' 638' ' ' TYR . 61.1 m -66.24 -40.36 90.17 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.628 0.251 . . . . 0.0 110.815 -179.276 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 635' ' ' THR . . . . . . . . . . . . . 92.4 m -59.29 -39.21 82.24 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.319 179.23 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 636' ' ' ALA . . . . . . . . . . . . . . . -65.06 -17.37 64.39 Favored 'General case' 0 CA--C 1.533 0.304 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.385 178.934 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 637' ' ' GLY . . . . . . . . . . . . . . . 108.9 7.05 29.71 Favored Glycine 0 C--N 1.333 0.411 0 C-N-CA 120.906 -0.664 . . . . 0.0 113.161 179.729 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 638' ' ' TYR . . . . . 0.499 ' O ' ' HA ' ' A' ' 634' ' ' THR . 96.3 m-85 -100.07 141.0 33.48 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.797 0.332 . . . . 0.0 111.265 -179.804 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 639' ' ' GLN . . . . . . . . . . . . . 98.3 mt-30 -88.88 133.59 34.23 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.086 179.378 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 640' ' ' VAL . . . . . 0.474 ' HA ' ' O ' ' A' ' 616' ' ' ILE . 60.6 t -119.99 131.52 72.16 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 N-CA-C 112.43 0.53 . . . . 0.0 112.43 -179.106 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 641' ' ' ILE . . . . . 0.564 ' HB ' HG23 ' A' ' 617' ' ' VAL . 1.2 mp -112.59 118.98 59.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 N-CA-C 108.45 -0.944 . . . . 0.0 108.45 178.073 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 642' ' ' TRP . . . . . . . . . . . . . 28.4 t90 -93.35 128.49 39.4 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 121.345 0.593 . . . . 0.0 112.392 -178.116 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 643' ' ' LEU . . . . . 0.589 HD11 ' HE ' ' A' ' 650' ' ' ARG . 1.0 OUTLIER -121.86 135.56 54.9 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-N 115.225 -0.898 . . . . 0.0 110.389 179.388 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 644' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -109.31 32.63 0.89 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 N-CA-C 111.778 0.288 . . . . 0.0 111.778 -179.826 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 645' ' ' ASP . . . . . . . . . . . . . 15.5 t0 -150.35 -25.87 0.24 Allowed 'General case' 0 N--CA 1.471 0.594 0 N-CA-C 113.626 0.973 . . . . 0.0 113.626 -178.421 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 646' ' ' GLY . . . . . . . . . . . . . . . 72.38 28.36 68.0 Favored Glycine 0 CA--C 1.522 0.482 0 C-N-CA 120.58 -0.819 . . . . 0.0 113.325 -179.273 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 647' ' ' GLU . . . . . . . . . . . . . 7.9 mm-40 -69.0 118.39 11.85 Favored 'General case' 0 C--O 1.232 0.144 0 CA-C-O 120.969 0.414 . . . . 0.0 110.788 179.732 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 648' ' ' VAL . . . . . . . . . . . . . 28.0 m -64.09 -30.34 49.78 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-N 115.508 -0.769 . . . . 0.0 112.163 -179.255 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 649' ' ' GLU . . . . . . . . . . . . . 98.1 mt-10 -64.14 -44.3 92.57 Favored 'General case' 0 C--N 1.333 -0.127 0 CA-C-O 121.014 0.435 . . . . 0.0 110.153 179.542 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 650' ' ' ARG . . . . . 0.589 ' HE ' HD11 ' A' ' 643' ' ' LEU . 78.7 mtp85 -72.01 -41.02 68.05 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.635 178.838 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 651' ' ' LEU . . . . . 0.556 HD22 HG11 ' A' ' 617' ' ' VAL . 95.4 mt -65.62 -40.48 92.62 Favored 'General case' 0 CA--C 1.523 -0.087 0 CA-C-N 115.952 -0.567 . . . . 0.0 111.049 179.952 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 652' ' ' LEU . . . . . . . . . . . . . 62.2 tp -64.46 -43.85 92.96 Favored 'General case' 0 CA--C 1.533 0.29 0 CA-C-N 116.396 -0.366 . . . . 0.0 111.311 179.209 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 653' ' ' ALA . . . . . . . . . . . . . . . -62.68 -39.83 95.21 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-O 121.11 0.481 . . . . 0.0 111.464 -179.868 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 654' ' ' LEU . . . . . . . . . . . . . 76.1 mt -102.03 30.84 4.22 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.67 -0.695 . . . . 0.0 109.965 179.809 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 655' ' ' THR . . . . . . . . . . . . . 5.5 t -42.12 110.99 0.87 Allowed Pre-proline 0 CA--C 1.537 0.458 0 CA-C-N 115.079 -0.964 . . . . 0.0 113.531 -178.132 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 656' ' ' PRO . . . . . 0.422 ' HG3' ' HB ' ' A' ' 617' ' ' VAL . 33.8 Cg_endo -91.01 -175.9 0.85 Allowed 'Trans proline' 0 C--N 1.346 0.435 0 C-N-CA 123.95 3.1 . . . . 0.0 112.343 178.956 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 657' ' ' ILE . . . . . . . . . . . . . 23.8 pt -82.82 -25.03 8.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 121.494 0.664 . . . . 0.0 109.991 177.912 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 658' ' ' ALA . . . . . 0.441 ' HB2' ' HB2' ' A' ' 687' ' ' LYS . . . -156.32 154.08 30.05 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 114.986 -1.006 . . . . 0.0 110.843 -179.706 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 659' ' ' VAL . . . . . 0.644 HG12 HG12 ' A' ' 617' ' ' VAL . 33.3 m -120.04 143.3 32.17 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-O 121.292 0.567 . . . . 0.0 110.982 179.378 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 660' ' ' LEU . . . . . . . . . . . . . 13.0 mt -115.16 114.91 25.9 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.418 -0.81 . . . . 0.0 109.666 178.727 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 661' ' ' LEU . . . . . . . . . . . . . 64.7 mt -106.49 112.57 25.62 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 109.125 -0.694 . . . . 0.0 109.125 -179.977 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 662' ' ' ALA . . . . . 0.647 ' HB3' ' HB2' ' A' ' 620' ' ' SER . . . -107.49 133.02 52.58 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 113.11 0.781 . . . . 0.0 113.11 -178.164 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 663' ' ' GLU . . . . . . . . . . . . . 97.8 mt-10 -80.23 146.45 62.51 Favored Pre-proline 0 C--N 1.326 -0.439 0 CA-C-N 115.276 -0.875 . . . . 0.0 110.087 178.365 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 664' ' ' PRO . . . . . . . . . . . . . 67.1 Cg_endo -72.93 139.57 62.04 Favored 'Cis proline' 0 C--N 1.349 0.553 0 C-N-CA 123.217 -1.576 . . . . 0.0 112.771 -0.893 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 665' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -87.63 144.08 26.86 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.747 -0.66 . . . . 0.0 111.409 179.306 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 666' ' ' SER . . . . . . . . . . . . . 77.9 p -98.48 -20.25 17.2 Favored 'General case' 0 CA--C 1.531 0.232 0 N-CA-C 112.035 0.383 . . . . 0.0 112.035 -179.99 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 667' ' ' TYR . . . . . . . . . . . . . 14.7 p90 -70.44 -17.18 62.99 Favored 'General case' 0 N--CA 1.466 0.373 0 N-CA-C 112.179 0.437 . . . . 0.0 112.179 179.548 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 668' ' ' GLY . . . . . . . . . . . . . . . 100.16 -109.16 3.65 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.518 -0.848 . . . . 0.0 113.734 179.119 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 669' ' ' ASP . . . . . . . . . . . . . 27.1 t70 -84.43 110.72 18.85 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.83 0.348 . . . . 0.0 111.278 -178.363 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 670' ' ' VAL . . . . . . . . . . . . . 14.5 p -64.21 -32.65 58.31 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.416 0 N-CA-C 112.983 0.734 . . . . 0.0 112.983 -179.3 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 671' ' ' GLN . . . . . . . . . . . . . 21.1 mp0 -61.93 -42.17 98.79 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-O 120.854 0.359 . . . . 0.0 110.758 -179.419 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 672' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 -65.8 -39.77 91.25 Favored 'General case' 0 N--CA 1.461 0.086 0 CA-C-N 116.048 -0.523 . . . . 0.0 111.043 179.159 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 673' ' ' LEU . . . . . . . . . . . . . 63.9 tp -62.49 -43.98 97.49 Favored 'General case' 0 C--N 1.333 -0.15 0 N-CA-C 109.639 -0.504 . . . . 0.0 109.639 179.149 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 674' ' ' VAL . . . . . 0.568 HG11 ' HA3' ' A' ' 699' ' ' GLY . 52.9 t -62.88 -44.57 99.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 115.419 -0.809 . . . . 0.0 109.606 178.825 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 675' ' ' ASP . . . . . . . . . . . . . 35.4 t70 -59.71 -40.61 88.53 Favored 'General case' 0 CA--C 1.522 -0.103 0 CA-C-N 115.745 -0.662 . . . . 0.0 110.773 179.314 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 676' ' ' GLN . . . . . . . . . . . . . 78.5 mt-30 -70.5 -41.29 72.85 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.903 0.382 . . . . 0.0 110.906 -179.866 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 677' ' ' LEU . . . . . . . . . . . . . 63.9 tp -68.16 -44.23 76.46 Favored 'General case' 0 N--CA 1.447 -0.578 0 CA-C-N 115.956 -0.566 . . . . 0.0 111.506 179.894 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 678' ' ' ARG . . . . . 0.582 ' HA ' ' O ' ' A' ' 681' ' ' CYS . 39.8 ptt180 -71.2 -24.8 62.29 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-O 120.983 0.421 . . . . 0.0 110.948 -179.208 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 679' ' ' GLN . . . . . . . . . . . . . 53.2 tt0 -65.92 -38.86 89.79 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.213 178.912 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 680' ' ' ARG . . . . . . . . . . . . . 31.7 mmt180 -89.37 -42.98 11.23 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.261 -179.781 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 681' ' ' CYS . . . . . 0.582 ' O ' ' HA ' ' A' ' 678' ' ' ARG . 77.3 m -122.87 133.26 54.43 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.275 179.787 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 682' ' ' THR . . . . . 0.424 ' HB ' ' HD2' ' A' ' 683' ' ' PRO . 61.3 p -68.33 158.53 84.37 Favored Pre-proline 0 C--N 1.323 -0.576 0 CA-C-N 116.407 -0.361 . . . . 0.0 110.391 -179.689 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 683' ' ' PRO . . . . . 0.424 ' HD2' ' HB ' ' A' ' 682' ' ' THR . 19.0 Cg_endo -58.89 -26.78 82.21 Favored 'Trans proline' 0 C--N 1.349 0.59 0 C-N-CA 122.226 1.951 . . . . 0.0 112.308 -179.952 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 684' ' ' GLU . . . . . . . . . . . . . 51.6 mp0 -71.61 -39.31 70.57 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 121.178 0.513 . . . . 0.0 109.94 178.36 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 685' ' ' GLN . . . . . . . . . . . . . 90.9 mt-30 -72.19 -40.36 67.95 Favored 'General case' 0 C--O 1.231 0.123 0 CA-C-N 115.414 -0.812 . . . . 0.0 112.032 179.471 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 686' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -126.22 114.19 17.99 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.209 -0.45 . . . . 0.0 112.006 -178.264 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 687' ' ' LYS . . . . . 0.441 ' HB2' ' HB2' ' A' ' 658' ' ' ALA . 75.7 mmtt -84.81 144.85 28.19 Favored 'General case' 0 C--N 1.331 -0.222 0 N-CA-C 109.488 -0.56 . . . . 0.0 109.488 178.125 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 688' ' ' ILE . . . . . . . . . . . . . 76.5 mt -123.35 121.74 63.54 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.757 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.501 -178.025 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 689' ' ' PHE . . . . . . . . . . . . . 98.9 m-85 -121.63 145.06 48.37 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.095 -0.957 . . . . 0.0 110.204 178.794 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 690' ' ' ILE . . . . . . . . . . . . . 19.1 tt -124.86 139.03 52.22 Favored 'Isoleucine or valine' 0 C--O 1.235 0.303 0 CA-C-O 121.055 0.455 . . . . 0.0 111.222 179.729 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 691' ' ' LEU . . . . . 0.597 HD12 ' HB2' ' A' ' 662' ' ' ALA . 48.2 mt -112.0 138.38 48.71 Favored 'General case' 0 C--O 1.235 0.301 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.806 -179.329 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 692' ' ' GLY . . . . . 0.626 ' O ' ' HA ' ' A' ' 705' ' ' PRO . . . 165.71 -176.95 41.1 Favored Glycine 0 N--CA 1.449 -0.471 0 CA-C-N 115.868 -0.605 . . . . 0.0 111.802 179.654 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 693' ' ' SER . . . . . . . . . . . . . 79.9 p -67.32 -37.43 83.31 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.196 0.522 . . . . 0.0 110.658 179.119 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 694' ' ' LYS . . . . . . . . . . . . . 64.2 tttm -133.06 127.88 35.02 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.686 -0.688 . . . . 0.0 109.198 178.756 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 695' ' ' GLY . . . . . 0.427 ' HA3' ' HB2' ' A' ' 703' ' ' TYR . . . -70.64 129.14 18.87 Favored Glycine 0 N--CA 1.447 -0.597 0 C-N-CA 120.419 -0.896 . . . . 0.0 112.866 -179.777 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 696' ' ' ASN . . . . . . . . . . . . . 67.1 t30 -91.8 91.61 8.01 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 109.637 -0.505 . . . . 0.0 109.637 179.122 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 697' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -71.03 53.84 0.17 Allowed 'General case' 0 CA--C 1.535 0.372 0 N-CA-C 113.034 0.753 . . . . 0.0 113.034 -178.652 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 698' ' ' GLN . . . . . . . . . . . . . 99.2 mm-40 -117.08 77.15 1.09 Allowed 'General case' 0 N--CA 1.453 -0.318 0 N-CA-C 109.887 -0.412 . . . . 0.0 109.887 178.795 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 699' ' ' GLY . . . . . 0.568 ' HA3' HG11 ' A' ' 674' ' ' VAL . . . 93.97 10.65 58.48 Favored Glycine 0 CA--C 1.52 0.403 0 C-N-CA 120.482 -0.866 . . . . 0.0 113.692 -179.971 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 700' ' ' VAL . . . . . . . . . . . . . 23.3 m -110.45 146.2 15.95 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.255 0 CA-C-N 117.595 0.698 . . . . 0.0 110.16 179.813 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 701' ' ' ASP . . . . . . . . . . . . . 32.0 t0 -72.85 -43.04 63.08 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.546 -0.752 . . . . 0.0 112.035 -179.047 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 702' ' ' ARG . . . . . . . . . . . . . 95.5 mtt-85 -146.91 162.32 38.94 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-O 120.813 0.339 . . . . 0.0 110.909 -178.663 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 703' ' ' TYR . . . . . 0.427 ' HB2' ' HA3' ' A' ' 695' ' ' GLY . 51.0 p90 -124.35 144.42 50.03 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.404 179.425 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 704' ' ' ILE . . . . . 0.55 ' HB ' HD23 ' A' ' 691' ' ' LEU . 39.8 mt -125.98 94.27 42.08 Favored Pre-proline 0 C--N 1.328 -0.36 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.046 -179.726 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 705' ' ' PRO . . . . . 0.626 ' HA ' ' O ' ' A' ' 692' ' ' GLY . 84.6 Cg_endo -74.92 151.24 39.71 Favored 'Trans proline' 0 C--N 1.346 0.42 0 C-N-CA 122.929 2.42 . . . . 0.0 114.069 -178.762 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 706' ' ' LEU . . . . . 0.785 HD23 HG13 ' A' ' 708' ' ' ILE . 79.4 mt -83.19 144.06 46.35 Favored Pre-proline 0 CA--C 1.532 0.269 0 CA-C-N 115.494 -0.775 . . . . 0.0 110.429 178.599 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 707' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -74.68 141.43 71.74 Favored 'Cis proline' 0 C--N 1.345 0.393 0 C-N-CA 123.052 -1.645 . . . . 0.0 112.191 -1.233 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 708' ' ' ILE . . . . . 0.785 HG13 HD23 ' A' ' 706' ' ' LEU . 74.1 mt -78.67 119.51 27.92 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-N 116.354 -0.384 . . . . 0.0 110.327 179.433 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 709' ' ' HIS . . . . . . . . . . . . . 70.1 m80 -85.77 122.11 73.08 Favored Pre-proline 0 C--N 1.327 -0.38 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.391 179.538 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 710' ' ' PRO . . . . . . . . . . . . . 27.4 Cg_endo -61.46 -30.73 87.29 Favored 'Trans proline' 0 C--N 1.349 0.596 0 C-N-CA 122.954 2.436 . . . . 0.0 113.913 -178.765 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 711' ' ' GLU . . . . . . . . . . . . . 88.7 tt0 -64.7 -43.5 93.29 Favored 'General case' 0 CA--C 1.531 0.231 0 N-CA-C 112.138 0.422 . . . . 0.0 112.138 -179.124 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 712' ' ' SER . . . . . . . . . . . . . 67.2 m -94.48 -18.44 21.48 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 111.979 0.363 . . . . 0.0 111.979 -178.763 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 713' ' ' PHE . . . . . 0.419 ' CZ ' HD11 ' A' ' 629' ' ' ILE . 75.4 t80 -60.51 -49.23 78.37 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.843 0.354 . . . . 0.0 110.692 179.768 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 714' ' ' LEU . . . . . . . . . . . . . 92.7 mt -63.81 -38.22 90.28 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.23 179.24 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 715' ' ' GLN . . . . . . . . . . . . . 97.3 mt-30 -62.05 -39.77 93.47 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.498 179.0 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 716' ' ' GLN . . . . . . . . . . . . . 86.5 mt-30 -63.4 -41.24 98.75 Favored 'General case' 0 C--O 1.233 0.22 0 N-CA-C 109.957 -0.386 . . . . 0.0 109.957 178.404 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 717' ' ' VAL . . . . . . . . . . . . . 74.7 t -65.01 -45.39 94.69 Favored 'Isoleucine or valine' 0 C--O 1.232 0.169 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.145 178.535 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 718' ' ' THR . . . . . . . . . . . . . 40.4 p -64.31 -36.4 83.99 Favored 'General case' 0 C--O 1.234 0.243 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.339 179.517 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 719' ' ' MET . . . . . . . . . . . . . 18.6 tpt -62.89 -46.89 85.69 Favored 'General case' 0 C--O 1.232 0.182 0 N-CA-C 109.872 -0.418 . . . . 0.0 109.872 178.575 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 720' ' ' GLY . . . . . . . . . . . . . . . -65.36 -40.72 96.62 Favored Glycine 0 C--N 1.331 0.301 0 C-N-CA 120.971 -0.633 . . . . 0.0 112.222 178.553 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 721' ' ' LEU . . . . . . . . . . . . . 60.5 tp -62.65 -43.98 97.43 Favored 'General case' 0 CA--C 1.53 0.193 0 N-CA-C 111.803 0.298 . . . . 0.0 111.803 -179.771 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 722' ' ' THR . . . . . . . . . . . . . 6.1 t -71.4 -16.23 62.39 Favored 'General case' 0 CA--C 1.532 0.257 0 CA-C-O 120.664 0.268 . . . . 0.0 111.427 -179.899 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 723' ' ' SER . . . . . . . . . . . . . 56.1 m -91.19 -10.15 42.74 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.739 0.304 . . . . 0.0 110.965 179.378 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 724' ' ' LEU . . . . . . . . . . . . . 2.9 tt -65.77 -42.63 90.58 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.012 -179.995 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 725' ' ' ALA . . . . . . . . . . . . . . . -150.73 149.98 30.47 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.635 179.951 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 726' ' ' THR . . . . . . . . . . . . . 66.5 p -128.25 157.61 40.43 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.385 -0.371 . . . . 0.0 110.825 179.99 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 727' ' ' SER . . . . . . . . . . . . . 59.9 m -128.01 149.02 50.55 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.544 -0.298 . . . . 0.0 110.802 -179.962 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 728' ' ' ALA . . . . . . . . . . . . . . . -147.4 153.52 39.73 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.594 179.969 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 729' ' ' GLN . . . . . . . . . . . . . 77.8 mt-30 . . . . . 0 C--O 1.25 1.097 0 CA-C-O 118.1 -0.952 . . . . 0.0 110.733 -179.998 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 613' ' ' GLU . . . . . . . . . . . . . 75.5 mm-40 . . . . . 0 N--CA 1.488 1.47 0 CA-C-O 121.052 0.453 . . . . 0.0 110.684 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 614' ' ' GLY . . . . . . . . . . . . . . . -82.24 72.67 2.76 Favored Glycine 0 N--CA 1.453 -0.23 0 C-N-CA 121.025 -0.607 . . . . 0.0 112.446 179.903 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 615' ' ' ARG . . . . . . . . . . . . . 92.1 mtm-85 -109.84 129.72 55.6 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.688 0.28 . . . . 0.0 110.726 -179.745 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 616' ' ' ILE . . . . . 0.424 ' O ' ' HA ' ' A' ' 640' ' ' VAL . 84.4 mt -124.14 132.75 70.87 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-N 116.243 -0.435 . . . . 0.0 109.904 178.74 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 617' ' ' VAL . . . . . . . . . . . . . 97.0 t -108.03 128.47 63.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 121.04 0.448 . . . . 0.0 110.46 -179.691 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 618' ' ' LEU . . . . . 0.468 HD11 HG21 ' A' ' 629' ' ' ILE . 1.5 tt -109.35 129.88 55.51 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.773 -0.648 . . . . 0.0 110.953 -179.005 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 619' ' ' VAL . . . . . . . . . . . . . 64.1 t -117.63 119.18 60.88 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 N-CA-C 109.397 -0.594 . . . . 0.0 109.397 179.328 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 620' ' ' SER . . . . . 0.607 ' HB2' ' HB3' ' A' ' 662' ' ' ALA . 30.6 t -169.41 147.59 3.67 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.827 -0.624 . . . . 0.0 111.452 -179.239 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 621' ' ' GLU . . . . . . . . . . . . . 98.0 mt-10 -87.09 -11.27 50.68 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.573 -0.74 . . . . 0.0 110.883 178.542 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 622' ' ' ASP . . . . . . . . . . . . . 44.7 t0 -99.21 107.84 20.27 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-O 120.982 0.42 . . . . 0.0 111.529 -179.01 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 623' ' ' GLU . . . . . . . . . . . . . 24.8 pt-20 -68.21 -30.23 69.26 Favored 'General case' 0 CA--C 1.534 0.353 0 CA-C-N 115.774 -0.648 . . . . 0.0 112.071 179.474 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 624' ' ' ALA . . . . . . . . . . . . . . . -62.91 -46.67 86.71 Favored 'General case' 0 N--CA 1.465 0.311 0 N-CA-C 112.67 0.619 . . . . 0.0 112.67 -178.983 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 625' ' ' THR . . . . . . . . . . . . . 94.3 m -70.31 -40.21 74.34 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-O 121.165 0.507 . . . . 0.0 110.473 179.916 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 626' ' ' SER . . . . . . . . . . . . . 70.8 m -61.82 -40.84 96.66 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.278 -0.874 . . . . 0.0 111.88 -178.985 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 627' ' ' THR . . . . . . . . . . . . . 92.9 m -61.59 -46.15 91.06 Favored 'General case' 0 CA--C 1.533 0.316 0 N-CA-C 112.01 0.374 . . . . 0.0 112.01 -179.774 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 628' ' ' LEU . . . . . . . . . . . . . 63.6 tp -62.55 -46.68 87.25 Favored 'General case' 0 CA--C 1.533 0.318 0 N-CA-C 112.682 0.623 . . . . 0.0 112.682 -178.953 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 629' ' ' ILE . . . . . 0.468 HG21 HD11 ' A' ' 618' ' ' LEU . 21.1 tt -68.98 -33.3 58.27 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.504 0 N-CA-C 113.027 0.751 . . . . 0.0 113.027 -178.58 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 630' ' ' CYS . . . . . . . . . . . . . 82.3 m -62.41 -39.93 94.87 Favored 'General case' 0 N--CA 1.466 0.348 0 N-CA-C 112.261 0.467 . . . . 0.0 112.261 -178.937 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 631' ' ' SER . . . . . . . . . . . . . 93.4 p -63.12 -39.51 94.89 Favored 'General case' 0 C--N 1.33 -0.26 0 C-N-CA 121.071 -0.252 . . . . 0.0 111.245 -179.492 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 632' ' ' ILE . . . . . . . . . . . . . 96.9 mt -65.06 -48.51 83.62 Favored 'Isoleucine or valine' 0 C--O 1.235 0.29 0 CA-C-O 121.015 0.436 . . . . 0.0 111.059 179.617 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 633' ' ' LEU . . . . . . . . . . . . . 83.1 mt -66.85 -40.11 87.81 Favored 'General case' 0 C--O 1.233 0.221 0 N-CA-C 112.726 0.639 . . . . 0.0 112.726 -179.374 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 634' ' ' THR . . . . . 0.499 ' HA ' ' O ' ' A' ' 638' ' ' TYR . 69.0 m -65.56 -40.12 92.44 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.663 0.268 . . . . 0.0 110.746 -179.604 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 635' ' ' THR . . . . . . . . . . . . . 93.7 m -59.23 -39.17 81.89 Favored 'General case' 0 N--CA 1.464 0.225 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.223 179.157 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 636' ' ' ALA . . . . . . . . . . . . . . . -64.7 -17.89 64.51 Favored 'General case' 0 CA--C 1.534 0.336 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.289 178.905 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 637' ' ' GLY . . . . . . . . . . . . . . . 108.94 6.23 30.29 Favored Glycine 0 C--N 1.333 0.372 0 C-N-CA 120.993 -0.622 . . . . 0.0 113.168 179.722 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 638' ' ' TYR . . . . . 0.499 ' O ' ' HA ' ' A' ' 634' ' ' THR . 96.5 m-85 -100.48 142.8 31.45 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.832 0.349 . . . . 0.0 111.469 -179.817 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 639' ' ' GLN . . . . . . . . . . . . . 78.5 mt-30 -91.61 134.83 34.34 Favored 'General case' 0 CA--C 1.517 -0.292 0 CA-C-N 116.227 -0.442 . . . . 0.0 109.965 179.237 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 640' ' ' VAL . . . . . 0.424 ' HA ' ' O ' ' A' ' 616' ' ' ILE . 58.3 t -117.92 130.4 72.85 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-O 121.065 0.46 . . . . 0.0 112.175 -179.333 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 641' ' ' ILE . . . . . . . . . . . . . 47.7 mm -111.99 119.43 60.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 N-CA-C 108.564 -0.902 . . . . 0.0 108.564 178.413 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 642' ' ' TRP . . . . . . . . . . . . . 61.9 t90 -97.6 127.4 43.53 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 112.509 0.559 . . . . 0.0 112.509 -178.49 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 643' ' ' LEU . . . . . . . . . . . . . 91.1 mt -120.74 137.12 54.66 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.406 -0.815 . . . . 0.0 109.999 178.6 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 644' ' ' VAL . . . . . . . . . . . . . 5.3 p -103.36 17.73 4.64 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.563 0 CA-C-O 121.228 0.537 . . . . 0.0 111.315 -179.52 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 645' ' ' ASP . . . . . . . . . . . . . 17.3 t0 -135.03 -39.84 0.76 Allowed 'General case' 0 N--CA 1.471 0.581 0 N-CA-C 112.707 0.632 . . . . 0.0 112.707 -178.087 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 646' ' ' GLY . . . . . . . . . . . . . . . 75.64 28.74 60.7 Favored Glycine 0 CA--C 1.523 0.553 0 N-CA-C 114.948 0.739 . . . . 0.0 114.948 179.441 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 647' ' ' GLU . . . . . . . . . . . . . 98.2 mt-10 -65.6 132.31 48.53 Favored 'General case' 0 N--CA 1.457 -0.081 0 CA-C-N 118.088 0.944 . . . . 0.0 110.875 179.495 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 648' ' ' VAL . . . . . . . . . . . . . 79.6 t -61.49 -39.99 84.84 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 CA-C-N 114.801 -1.09 . . . . 0.0 111.537 -179.408 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 649' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -61.03 -42.62 98.81 Favored 'General case' 0 C--N 1.331 -0.219 0 C-N-CA 120.701 -0.4 . . . . 0.0 110.307 179.906 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 650' ' ' ARG . . . . . . . . . . . . . 95.8 mtt-85 -70.24 -40.94 74.16 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-N 116.449 -0.341 . . . . 0.0 110.419 178.304 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 651' ' ' LEU . . . . . . . . . . . . . 81.8 mt -64.49 -41.4 96.47 Favored 'General case' 0 N--CA 1.463 0.176 0 CA-C-N 116.31 -0.404 . . . . 0.0 110.547 179.133 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 652' ' ' LEU . . . . . . . . . . . . . 61.8 tp -65.04 -44.31 89.5 Favored 'General case' 0 CA--C 1.531 0.238 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.11 178.853 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 653' ' ' ALA . . . . . . . . . . . . . . . -63.05 -40.21 97.02 Favored 'General case' 0 N--CA 1.466 0.354 0 CA-C-O 121.126 0.489 . . . . 0.0 111.58 -179.964 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 654' ' ' LEU . . . . . . . . . . . . . 75.1 mt -101.31 30.34 4.25 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.048 179.91 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 655' ' ' THR . . . . . . . . . . . . . 5.3 t -42.96 109.17 0.72 Allowed Pre-proline 0 CA--C 1.537 0.451 0 O-C-N 124.186 0.929 . . . . 0.0 113.444 -178.137 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 656' ' ' PRO . . . . . . . . . . . . . 26.3 Cg_endo -92.6 -176.07 0.64 Allowed 'Trans proline' 0 N--CA 1.461 -0.413 0 C-N-CA 123.963 3.109 . . . . 0.0 112.119 178.86 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 657' ' ' ILE . . . . . . . . . . . . . 24.9 pt -83.31 -24.6 8.04 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-O 121.324 0.583 . . . . 0.0 109.826 177.988 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 658' ' ' ALA . . . . . 0.445 ' HA ' ' O ' ' A' ' 687' ' ' LYS . . . -159.19 153.27 23.53 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.23 -0.895 . . . . 0.0 111.07 179.948 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 659' ' ' VAL . . . . . . . . . . . . . 27.8 m -123.27 147.67 27.48 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-O 121.281 0.562 . . . . 0.0 111.07 179.211 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 660' ' ' LEU . . . . . . . . . . . . . 17.8 mt -116.41 120.84 40.09 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.349 -0.841 . . . . 0.0 109.937 178.997 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 661' ' ' LEU . . . . . . . . . . . . . 73.1 mt -108.16 112.5 25.04 Favored 'General case' 0 C--N 1.327 -0.404 0 C-N-CA 120.644 -0.422 . . . . 0.0 109.956 179.969 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 662' ' ' ALA . . . . . 0.607 ' HB3' ' HB2' ' A' ' 620' ' ' SER . . . -107.09 113.78 27.44 Favored 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 120.985 -0.286 . . . . 0.0 111.378 -179.747 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 663' ' ' GLU . . . . . 0.573 ' HA ' ' C ' ' A' ' 664' ' ' PRO . 24.6 pt-20 -65.64 145.87 99.01 Favored Pre-proline 0 C--N 1.326 -0.451 0 CA-C-N 115.871 -0.604 . . . . 0.0 111.183 179.394 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 664' ' ' PRO . . . . . 0.573 ' C ' ' HA ' ' A' ' 663' ' ' GLU . 36.1 Cg_exo -61.47 137.95 22.17 Favored 'Cis proline' 0 C--N 1.355 0.892 0 C-N-CA 124.05 -1.229 . . . . 0.0 112.732 -1.017 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 665' ' ' PHE . . . . . 0.572 ' CZ ' HD11 ' A' ' 690' ' ' ILE . 33.7 m-85 -78.34 126.0 30.16 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.046 -0.525 . . . . 0.0 111.09 -179.15 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 666' ' ' SER . . . . . . . . . . . . . 67.8 m -63.95 -43.23 96.44 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.758 179.903 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 667' ' ' TYR . . . . . . . . . . . . . 62.1 t80 -69.63 -23.53 63.51 Favored 'General case' 0 CA--C 1.532 0.274 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.74 179.865 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 668' ' ' GLY . . . . . . . . . . . . . . . 100.38 -103.45 2.63 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.352 -0.928 . . . . 0.0 112.482 -179.166 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 669' ' ' ASP . . . . . . . . . . . . . 28.1 t70 -80.3 108.07 13.61 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-O 120.893 0.378 . . . . 0.0 110.281 -179.576 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 670' ' ' VAL . . . . . 0.428 ' O ' HG23 ' A' ' 674' ' ' VAL . 17.5 m -68.84 -27.31 35.28 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.225 0 N-CA-C 113.638 0.977 . . . . 0.0 113.638 -178.664 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 671' ' ' GLN . . . . . . . . . . . . . 24.1 mp0 -61.73 -42.26 98.72 Favored 'General case' 0 C--O 1.232 0.146 0 CA-C-N 117.995 0.361 . . . . 0.0 111.014 -179.392 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 672' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 -65.77 -39.83 91.4 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.393 178.448 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 673' ' ' LEU . . . . . . . . . . . . . 63.6 tp -63.62 -44.82 92.82 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 115.586 -0.734 . . . . 0.0 110.079 179.264 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 674' ' ' VAL . . . . . 0.567 HG11 ' HA3' ' A' ' 699' ' ' GLY . 56.0 t -63.1 -44.52 99.53 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.18 0 CA-C-N 115.606 -0.725 . . . . 0.0 109.917 179.376 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 675' ' ' ASP . . . . . 0.429 ' O ' ' HB2' ' A' ' 679' ' ' GLN . 36.4 t70 -59.53 -40.14 86.21 Favored 'General case' 0 CA--C 1.52 -0.176 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.699 179.346 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 676' ' ' GLN . . . . . . . . . . . . . 55.9 mt-30 -70.26 -40.0 74.63 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.884 0.373 . . . . 0.0 111.09 -179.753 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 677' ' ' LEU . . . . . . . . . . . . . 7.0 mp -70.0 -44.21 69.83 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.696 179.918 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 678' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -74.41 -19.74 60.31 Favored 'General case' 0 N--CA 1.469 0.478 0 N-CA-C 111.884 0.327 . . . . 0.0 111.884 -179.058 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 679' ' ' GLN . . . . . 0.429 ' HB2' ' O ' ' A' ' 675' ' ' ASP . 53.6 tt0 -64.61 -39.52 93.85 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.583 -179.659 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 680' ' ' ARG . . . . . 0.402 ' H ' ' HG2' ' A' ' 680' ' ' ARG . 0.0 OUTLIER -110.51 -20.26 12.63 Favored 'General case' 0 C--N 1.332 -0.174 0 N-CA-C 112.636 0.606 . . . . 0.0 112.636 -179.14 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 681' ' ' CYS . . . . . . . . . . . . . 76.7 m -119.52 132.42 55.76 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 120.877 0.37 . . . . 0.0 111.194 -179.985 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 682' ' ' THR . . . . . 0.456 ' HB ' ' HD2' ' A' ' 683' ' ' PRO . 57.3 p -74.9 159.95 81.82 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.168 179.421 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 683' ' ' PRO . . . . . 0.456 ' HD2' ' HB ' ' A' ' 682' ' ' THR . 17.9 Cg_endo -60.02 -28.55 87.32 Favored 'Trans proline' 0 C--N 1.35 0.652 0 C-N-CA 122.063 1.842 . . . . 0.0 112.312 179.527 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 684' ' ' GLU . . . . . 0.421 ' HG2' HD12 ' A' ' 724' ' ' LEU . 97.3 mt-10 -71.64 -39.33 70.44 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-O 121.047 0.451 . . . . 0.0 109.981 178.742 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 685' ' ' GLN . . . . . . . . . . . . . 65.4 tt0 -71.63 -42.46 67.58 Favored 'General case' 0 C--O 1.232 0.155 0 CA-C-N 115.386 -0.824 . . . . 0.0 111.756 179.745 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 686' ' ' LEU . . . . . . . . . . . . . 2.6 tt -137.74 121.93 18.04 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.114 -178.805 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 687' ' ' LYS . . . . . 0.445 ' O ' ' HA ' ' A' ' 658' ' ' ALA . 61.0 mttp -102.39 146.92 27.37 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.227 179.273 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 688' ' ' ILE . . . . . 0.583 HG22 HG12 ' A' ' 700' ' ' VAL . 76.9 mt -121.35 120.96 63.47 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.797 0 CA-C-O 121.317 0.579 . . . . 0.0 111.071 -178.416 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 689' ' ' PHE . . . . . . . . . . . . . 95.4 m-85 -121.16 146.82 46.37 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.081 -0.963 . . . . 0.0 109.653 178.8 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 690' ' ' ILE . . . . . 0.572 HD11 ' CZ ' ' A' ' 665' ' ' PHE . 19.8 tt -123.52 139.02 51.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-O 121.354 0.597 . . . . 0.0 112.096 -178.635 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 691' ' ' LEU . . . . . 0.629 HD23 ' HB ' ' A' ' 704' ' ' ILE . 73.2 mt -107.24 129.41 54.88 Favored 'General case' 0 C--O 1.235 0.33 0 CA-C-N 115.345 -0.843 . . . . 0.0 109.963 179.585 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 692' ' ' GLY . . . . . 0.655 ' O ' ' HA ' ' A' ' 705' ' ' PRO . . . 171.68 178.61 42.15 Favored Glycine 0 N--CA 1.444 -0.788 0 C-N-CA 120.341 -0.933 . . . . 0.0 113.156 179.832 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 693' ' ' SER . . . . . . . . . . . . . 80.2 p -69.49 -36.38 76.46 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 120.838 0.352 . . . . 0.0 111.216 179.628 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 694' ' ' LYS . . . . . . . . . . . . . 35.6 mmtp -119.54 137.36 53.88 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.114 0.483 . . . . 0.0 110.331 179.694 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 695' ' ' GLY . . . . . 0.488 ' HA3' ' CG ' ' A' ' 703' ' ' TYR . . . -102.35 16.46 55.21 Favored Glycine 0 N--CA 1.449 -0.483 0 CA-C-N 115.545 -0.752 . . . . 0.0 113.1 179.821 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 696' ' ' ASN . . . . . . . . . . . . . 64.4 t30 -81.33 68.39 7.63 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.092 0.472 . . . . 0.0 111.241 -179.315 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 697' ' ' TYR . . . . . . . . . . . . . 97.0 m-85 -131.03 142.03 50.27 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.889 -0.596 . . . . 0.0 109.942 179.107 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 698' ' ' GLN . . . . . . . . . . . . . 21.4 mp0 -90.98 149.43 21.86 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.923 -179.439 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 699' ' ' GLY . . . . . 0.567 ' HA3' HG11 ' A' ' 674' ' ' VAL . . . 92.88 4.12 65.41 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.704 -0.76 . . . . 0.0 113.995 179.167 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 700' ' ' VAL . . . . . 0.583 HG12 HG22 ' A' ' 688' ' ' ILE . 29.2 m -119.36 147.07 23.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 117.642 0.721 . . . . 0.0 110.662 179.42 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 701' ' ' ASP . . . . . . . . . . . . . 36.5 t70 -72.9 -43.63 62.22 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.442 -0.799 . . . . 0.0 111.996 -179.569 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 702' ' ' ARG . . . . . . . . . . . . . 69.0 mtp85 -146.73 163.63 35.34 Favored 'General case' 0 C--O 1.235 0.292 0 CA-C-O 120.795 0.331 . . . . 0.0 110.776 -179.056 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 703' ' ' TYR . . . . . 0.488 ' CG ' ' HA3' ' A' ' 695' ' ' GLY . 50.3 p90 -121.4 142.03 50.4 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.092 179.247 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 704' ' ' ILE . . . . . 0.629 ' HB ' HD23 ' A' ' 691' ' ' LEU . 58.9 mt -127.09 119.26 22.16 Favored Pre-proline 0 C--N 1.327 -0.402 0 CA-C-N 116.537 -0.301 . . . . 0.0 110.501 179.83 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 705' ' ' PRO . . . . . 0.655 ' HA ' ' O ' ' A' ' 692' ' ' GLY . 72.8 Cg_endo -72.56 156.42 53.92 Favored 'Trans proline' 0 C--N 1.345 0.357 0 C-N-CA 122.926 2.417 . . . . 0.0 113.775 -179.4 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 706' ' ' LEU . . . . . 0.687 HD23 HG23 ' A' ' 708' ' ' ILE . 87.8 mt -124.4 142.75 41.12 Favored Pre-proline 0 C--N 1.33 -0.253 0 CA-C-N 115.421 -0.809 . . . . 0.0 109.692 179.104 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 707' ' ' PRO . . . . . 0.539 ' C ' ' HA ' ' A' ' 706' ' ' LEU . 31.2 Cg_exo -62.85 137.92 25.87 Favored 'Cis proline' 0 C--N 1.349 0.584 0 C-N-CA 123.752 -1.353 . . . . 0.0 112.791 -1.303 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 708' ' ' ILE . . . . . 0.687 HG23 HD23 ' A' ' 706' ' ' LEU . 2.9 pt -63.93 147.6 12.18 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-O 121.577 0.703 . . . . 0.0 112.26 179.056 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 709' ' ' HIS . . . . . . . . . . . . . 97.6 m-70 -103.65 112.17 65.48 Favored Pre-proline 0 C--N 1.32 -0.685 0 N-CA-C 107.722 -1.214 . . . . 0.0 107.722 177.491 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 710' ' ' PRO . . . . . . . . . . . . . 21.4 Cg_endo -59.51 -30.31 92.17 Favored 'Trans proline' 0 N--CA 1.475 0.432 0 C-N-CA 122.782 2.321 . . . . 0.0 114.609 -176.956 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 711' ' ' GLU . . . . . . . . . . . . . 88.7 tt0 -65.28 -43.21 91.94 Favored 'General case' 0 CA--C 1.533 0.293 0 N-CA-C 112.141 0.423 . . . . 0.0 112.141 -179.164 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 712' ' ' SER . . . . . . . . . . . . . 67.4 m -99.05 -15.08 19.17 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 112.341 0.497 . . . . 0.0 112.341 -178.711 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 713' ' ' PHE . . . . . . . . . . . . . 90.0 t80 -59.32 -48.77 80.36 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.866 0.365 . . . . 0.0 110.469 -179.721 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 714' ' ' LEU . . . . . . . . . . . . . 90.6 mt -64.0 -37.86 88.98 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.223 178.986 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 715' ' ' GLN . . . . . . . . . . . . . 97.3 mt-30 -63.25 -43.07 99.05 Favored 'General case' 0 CA--C 1.531 0.214 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.893 179.536 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 716' ' ' GLN . . . . . . . . . . . . . 2.9 mp0 -65.95 -41.83 90.75 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 116.576 -0.284 . . . . 0.0 111.154 179.296 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 717' ' ' VAL . . . . . . . . . . . . . 66.3 t -62.36 -45.47 98.69 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.175 0 CA-C-O 120.68 0.276 . . . . 0.0 110.436 179.373 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 718' ' ' THR . . . . . . . . . . . . . 89.5 m -62.37 -45.64 92.27 Favored 'General case' 0 CA--C 1.531 0.228 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.202 179.65 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 719' ' ' MET . . . . . . . . . . . . . 1.4 mpp? -66.85 -40.56 87.93 Favored 'General case' 0 N--CA 1.464 0.262 0 C-N-CA 121.157 -0.217 . . . . 0.0 110.754 179.368 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 720' ' ' GLY . . . . . . . . . . . . . . . -63.86 -42.98 98.24 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.267 -0.968 . . . . 0.0 111.36 177.968 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 721' ' ' LEU . . . . . . . . . . . . . 63.3 tp -66.88 -48.15 69.65 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 122.501 0.32 . . . . 0.0 111.196 178.647 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 722' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER 37.29 37.95 0.11 Allowed 'General case' 0 N--CA 1.478 0.969 0 N-CA-C 114.175 1.176 . . . . 0.0 114.175 -179.894 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 723' ' ' SER . . . . . 0.558 ' HA ' ' O ' ' A' ' 726' ' ' THR . 58.2 m 57.37 27.26 13.56 Favored 'General case' 0 N--CA 1.47 0.541 0 N-CA-C 112.999 0.741 . . . . 0.0 112.999 179.428 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 724' ' ' LEU . . . . . 0.423 HD13 ' HA ' ' A' ' 724' ' ' LEU . 1.7 mm? -73.87 -39.16 64.14 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-O 120.78 0.324 . . . . 0.0 111.119 179.104 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 725' ' ' ALA . . . . . . . . . . . . . . . -103.72 -49.95 3.54 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.367 -0.378 . . . . 0.0 111.47 -179.868 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 726' ' ' THR . . . . . 0.558 ' O ' ' HA ' ' A' ' 723' ' ' SER . 72.2 p -129.13 158.48 38.86 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.997 -179.894 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 727' ' ' SER . . . . . . . . . . . . . 96.2 p -149.16 162.6 39.67 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.397 -179.974 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 728' ' ' ALA . . . . . . . . . . . . . . . -146.35 153.27 40.32 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.715 -179.94 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 729' ' ' GLN . . . . . . . . . . . . . 96.8 mt-30 . . . . . 0 C--O 1.25 1.108 0 CA-C-O 118.13 -0.938 . . . . 0.0 110.839 -179.987 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 613' ' ' GLU . . . . . . . . . . . . . 57.9 mt-10 . . . . . 0 N--CA 1.488 1.454 0 CA-C-O 121.107 0.48 . . . . 0.0 110.747 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 614' ' ' GLY . . . . . . . . . . . . . . . -86.69 69.91 3.02 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.911 -0.661 . . . . 0.0 112.545 -179.898 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 615' ' ' ARG . . . . . . . . . . . . . 33.7 mtp-105 -111.39 126.55 55.05 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.077 0.465 . . . . 0.0 111.102 -179.827 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 616' ' ' ILE . . . . . 0.453 ' O ' ' HA ' ' A' ' 640' ' ' VAL . 83.8 mt -124.89 133.85 68.4 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-N 115.568 -0.742 . . . . 0.0 110.113 179.577 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 617' ' ' VAL . . . . . 0.423 HG22 ' HB ' ' A' ' 641' ' ' ILE . 96.8 t -105.43 126.67 60.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 N-CA-C 109.5 -0.555 . . . . 0.0 109.5 179.615 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 618' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -108.54 126.74 53.26 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.856 -0.611 . . . . 0.0 111.1 -178.329 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 619' ' ' VAL . . . . . . . . . . . . . 61.0 t -112.9 117.07 54.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 N-CA-C 109.04 -0.726 . . . . 0.0 109.04 179.578 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 620' ' ' SER . . . . . 0.519 ' HB2' ' HB3' ' A' ' 662' ' ' ALA . 47.9 t -163.05 135.68 5.47 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.552 -179.14 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 621' ' ' GLU . . . . . . . . . . . . . 88.2 tt0 -77.69 -28.39 51.04 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.517 -0.765 . . . . 0.0 110.843 178.697 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 622' ' ' ASP . . . . . . . . . . . . . 56.1 t0 -85.18 110.64 19.15 Favored 'General case' 0 C--O 1.235 0.342 0 CA-C-O 121.01 0.433 . . . . 0.0 111.205 -178.593 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 623' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -63.59 -39.47 94.47 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 115.444 -0.798 . . . . 0.0 112.344 179.954 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 624' ' ' ALA . . . . . . . . . . . . . . . -61.56 -44.16 97.54 Favored 'General case' 0 N--CA 1.465 0.301 0 N-CA-C 112.088 0.403 . . . . 0.0 112.088 -178.869 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 625' ' ' THR . . . . . . . . . . . . . 86.5 m -69.3 -40.66 77.57 Favored 'General case' 0 N--CA 1.454 -0.265 0 CA-C-O 121.137 0.494 . . . . 0.0 110.126 179.852 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 626' ' ' SER . . . . . . . . . . . . . 69.3 m -61.92 -41.65 98.19 Favored 'General case' 0 N--CA 1.453 -0.278 0 CA-C-N 115.412 -0.813 . . . . 0.0 111.497 -179.307 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 627' ' ' THR . . . . . . . . . . . . . 92.0 m -61.81 -46.32 90.04 Favored 'General case' 0 CA--C 1.533 0.305 0 N-CA-C 112.241 0.46 . . . . 0.0 112.241 -179.292 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 628' ' ' LEU . . . . . . . . . . . . . 62.7 tp -63.77 -47.15 82.14 Favored 'General case' 0 CA--C 1.533 0.316 0 N-CA-C 112.693 0.627 . . . . 0.0 112.693 -178.826 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 629' ' ' ILE . . . . . . . . . . . . . 17.3 tt -70.49 -36.78 67.66 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.409 0 N-CA-C 112.914 0.709 . . . . 0.0 112.914 -178.579 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 630' ' ' CYS . . . . . . . . . . . . . 85.3 m -62.9 -39.57 94.92 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-O 120.572 0.225 . . . . 0.0 110.935 -179.877 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 631' ' ' SER . . . . . . . . . . . . . 68.4 m -62.23 -41.32 98.29 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.796 179.982 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 632' ' ' ILE . . . . . 0.536 ' O ' HG22 ' A' ' 635' ' ' THR . 96.9 mt -63.12 -47.36 92.88 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.296 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.739 179.677 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 633' ' ' LEU . . . . . . . . . . . . . 80.7 mt -67.64 -40.29 84.61 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 112.425 0.528 . . . . 0.0 112.425 179.997 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 634' ' ' THR . . . . . 0.56 ' HA ' ' O ' ' A' ' 638' ' ' TYR . 90.9 m -66.06 -42.67 89.13 Favored 'General case' 0 CA--C 1.531 0.232 0 N-CA-C 111.533 0.197 . . . . 0.0 111.533 -179.051 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 635' ' ' THR . . . . . 0.536 HG22 ' O ' ' A' ' 632' ' ' ILE . 2.1 t -62.9 -17.64 61.94 Favored 'General case' 0 CA--C 1.534 0.345 0 CA-C-O 120.699 0.285 . . . . 0.0 111.32 179.651 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 636' ' ' ALA . . . . . . . . . . . . . . . -85.75 -1.84 57.61 Favored 'General case' 0 CA--C 1.53 0.211 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.825 178.852 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 637' ' ' GLY . . . . . . . . . . . . . . . 95.33 6.03 60.18 Favored Glycine 0 C--N 1.334 0.433 0 C-N-CA 120.998 -0.62 . . . . 0.0 113.152 179.873 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 638' ' ' TYR . . . . . 0.56 ' O ' ' HA ' ' A' ' 634' ' ' THR . 90.8 m-85 -100.24 142.86 31.14 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.888 0.375 . . . . 0.0 111.408 -179.839 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 639' ' ' GLN . . . . . . . . . . . . . 97.9 mt-30 -92.94 133.36 36.19 Favored 'General case' 0 CA--C 1.517 -0.31 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.082 179.241 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 640' ' ' VAL . . . . . 0.453 ' HA ' ' O ' ' A' ' 616' ' ' ILE . 57.9 t -118.08 130.56 72.77 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-O 121.122 0.487 . . . . 0.0 112.029 -179.232 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 641' ' ' ILE . . . . . 0.423 ' HB ' HG22 ' A' ' 617' ' ' VAL . 38.3 mm -107.7 116.91 52.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 N-CA-C 108.483 -0.932 . . . . 0.0 108.483 178.599 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 642' ' ' TRP . . . . . . . . . . . . . 27.4 t90 -87.17 127.13 35.15 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 112.309 0.485 . . . . 0.0 112.309 -178.623 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 643' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -122.16 128.72 51.57 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.642 -0.708 . . . . 0.0 110.2 178.97 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 644' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -107.6 39.96 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.671 -0.24 . . . . 0.0 111.526 -179.725 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 645' ' ' ASP . . . . . . . . . . . . . 36.0 t70 -154.59 -35.9 0.1 Allowed 'General case' 0 N--CA 1.469 0.486 0 N-CA-C 112.426 0.528 . . . . 0.0 112.426 -178.879 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 646' ' ' GLY . . . . . . . . . . . . . . . 77.66 20.55 73.85 Favored Glycine 0 N--CA 1.453 -0.219 0 C-N-CA 120.67 -0.776 . . . . 0.0 112.913 -179.59 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 647' ' ' GLU . . . . . . . . . . . . . 37.2 tt0 -61.45 121.15 11.96 Favored 'General case' 0 N--CA 1.456 -0.149 0 CA-C-O 120.941 0.401 . . . . 0.0 110.305 -179.764 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 648' ' ' VAL . . . . . . . . . . . . . 13.4 p -63.14 -34.14 65.03 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-N 115.493 -0.776 . . . . 0.0 112.132 -178.954 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 649' ' ' GLU . . . . . . . . . . . . . 49.0 mp0 -63.9 -42.99 97.29 Favored 'General case' 0 C--O 1.231 0.104 0 CA-C-O 121.005 0.431 . . . . 0.0 109.921 178.914 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 650' ' ' ARG . . . . . . . . . . . . . 24.9 tpp180 -67.95 -43.36 79.25 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.0 178.321 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 651' ' ' LEU . . . . . . . . . . . . . 89.6 mt -63.43 -41.42 98.68 Favored 'General case' 0 N--CA 1.462 0.144 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.361 179.206 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 652' ' ' LEU . . . . . . . . . . . . . 61.1 tp -65.41 -43.19 91.34 Favored 'General case' 0 CA--C 1.531 0.243 0 CA-C-N 116.022 -0.535 . . . . 0.0 111.083 178.611 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 653' ' ' ALA . . . . . . . . . . . . . . . -62.8 -39.72 95.15 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-O 120.931 0.396 . . . . 0.0 111.935 179.96 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 654' ' ' LEU . . . . . . . . . . . . . 78.4 mt -101.16 29.21 4.81 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.843 -179.627 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 655' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -32.16 104.76 0.23 Allowed Pre-proline 0 N--CA 1.471 0.606 0 N-CA-C 114.483 1.29 . . . . 0.0 114.483 -178.881 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 656' ' ' PRO . . . . . . . . . . . . . 25.4 Cg_endo -92.65 -177.63 0.8 Allowed 'Trans proline' 0 C--N 1.346 0.403 0 C-N-CA 123.673 2.915 . . . . 0.0 111.636 177.509 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 657' ' ' ILE . . . . . 0.68 ' HB ' HD21 ' A' ' 724' ' ' LEU . 23.0 pt -81.54 -26.11 10.02 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-O 121.394 0.616 . . . . 0.0 109.757 177.83 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 658' ' ' ALA . . . . . 0.467 ' HA ' ' O ' ' A' ' 687' ' ' LYS . . . -158.93 154.44 25.93 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.109 -0.95 . . . . 0.0 111.152 -179.759 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 659' ' ' VAL . . . . . . . . . . . . . 28.6 m -124.04 147.63 28.43 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-O 121.048 0.451 . . . . 0.0 110.995 179.174 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 660' ' ' LEU . . . . . 0.406 HD22 HD21 ' A' ' 691' ' ' LEU . 17.5 mt -115.63 117.77 31.24 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.66 -0.7 . . . . 0.0 109.555 178.656 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 661' ' ' LEU . . . . . . . . . . . . . 17.5 mt -104.96 113.05 26.41 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 109.336 -0.616 . . . . 0.0 109.336 -179.536 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 662' ' ' ALA . . . . . 0.519 ' HB3' ' HB2' ' A' ' 620' ' ' SER . . . -102.27 128.81 48.64 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 112.591 0.589 . . . . 0.0 112.591 -179.064 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 663' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -71.48 143.5 87.78 Favored Pre-proline 0 CA--C 1.533 0.296 0 CA-C-N 115.359 -0.837 . . . . 0.0 110.749 178.315 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 664' ' ' PRO . . . . . . . . . . . . . 65.8 Cg_endo -72.95 142.53 74.99 Favored 'Cis proline' 0 C--N 1.348 0.516 0 C-N-CA 123.081 -1.633 . . . . 0.0 112.315 -0.931 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 665' ' ' PHE . . . . . . . . . . . . . 60.0 m-85 -69.91 118.13 12.37 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.524 179.98 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 666' ' ' SER . . . . . . . . . . . . . 78.7 p -65.26 -35.38 80.86 Favored 'General case' 0 CA--C 1.53 0.208 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.226 179.59 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 667' ' ' TYR . . . . . 0.439 ' CD2' ' HB2' ' A' ' 673' ' ' LEU . 75.0 t80 -65.33 -22.49 66.83 Favored 'General case' 0 CA--C 1.534 0.35 0 CA-C-N 115.982 -0.554 . . . . 0.0 111.491 178.83 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 668' ' ' GLY . . . . . . . . . . . . . . . 101.45 -103.24 2.51 Favored Glycine 0 N--CA 1.45 -0.412 0 C-N-CA 120.501 -0.857 . . . . 0.0 112.117 -178.83 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 669' ' ' ASP . . . . . . . . . . . . . 37.7 t70 -80.47 106.25 12.33 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 121.075 0.464 . . . . 0.0 110.427 -179.82 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 670' ' ' VAL . . . . . . . . . . . . . 13.5 p -63.04 -32.7 57.15 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.403 0 N-CA-C 113.122 0.786 . . . . 0.0 113.122 -179.002 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 671' ' ' GLN . . . . . . . . . . . . . 30.9 mm100 -62.79 -40.84 98.58 Favored 'General case' 0 N--CA 1.463 0.183 0 CA-C-O 120.664 0.268 . . . . 0.0 111.267 -178.844 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 672' ' ' GLU . . . . . . . . . . . . . 88.8 tt0 -63.58 -43.23 97.59 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.567 179.296 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 673' ' ' LEU . . . . . 0.439 ' HB2' ' CD2' ' A' ' 667' ' ' TYR . 62.4 tp -63.44 -44.63 93.99 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.462 179.873 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 674' ' ' VAL . . . . . 0.472 HG11 ' HA3' ' A' ' 699' ' ' GLY . 60.4 t -63.11 -44.89 99.72 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.177 0 CA-C-N 115.866 -0.606 . . . . 0.0 109.813 179.398 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 675' ' ' ASP . . . . . . . . . . . . . 35.4 t70 -60.14 -40.18 88.9 Favored 'General case' 0 CA--C 1.52 -0.195 0 CA-C-N 115.804 -0.635 . . . . 0.0 110.581 178.994 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 676' ' ' GLN . . . . . . . . . . . . . 96.8 mt-30 -70.07 -41.13 74.54 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.426 -0.352 . . . . 0.0 111.053 -179.742 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 677' ' ' LEU . . . . . . . . . . . . . 84.2 mt -68.16 -41.61 81.29 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.798 179.93 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 678' ' ' ARG . . . . . 0.426 ' HA ' ' O ' ' A' ' 681' ' ' CYS . 39.9 ptt180 -73.61 -26.59 60.87 Favored 'General case' 0 N--CA 1.469 0.494 0 CA-C-O 121.003 0.43 . . . . 0.0 110.98 -179.121 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 679' ' ' GLN . . . . . . . . . . . . . 53.3 tt0 -65.96 -39.25 90.27 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.328 179.157 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 680' ' ' ARG . . . . . . . . . . . . . 29.4 mmm180 -87.42 -42.67 12.65 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.944 -0.571 . . . . 0.0 111.685 -179.537 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 681' ' ' CYS . . . . . 0.426 ' O ' ' HA ' ' A' ' 678' ' ' ARG . 76.0 m -125.24 134.98 52.12 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 121.154 0.502 . . . . 0.0 111.429 -179.391 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 682' ' ' THR . . . . . . . . . . . . . 63.0 p -71.81 161.88 76.31 Favored Pre-proline 0 C--N 1.324 -0.514 0 CA-C-N 115.659 -0.7 . . . . 0.0 110.362 179.199 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 683' ' ' PRO . . . . . . . . . . . . . 79.3 Cg_exo -53.25 -34.29 69.12 Favored 'Trans proline' 0 C--N 1.351 0.71 0 C-N-CA 122.8 2.334 . . . . 0.0 112.943 -179.959 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 684' ' ' GLU . . . . . . . . . . . . . 51.2 mp0 -69.64 -38.91 77.34 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.99 0.424 . . . . 0.0 110.432 179.563 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 685' ' ' GLN . . . . . . . . . . . . . 91.2 mt-30 -71.7 -39.96 69.84 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.724 -0.671 . . . . 0.0 111.904 179.398 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 686' ' ' LEU . . . . . . . . . . . . . 3.3 tt -142.2 120.64 12.41 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.347 -178.7 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 687' ' ' LYS . . . . . 0.467 ' O ' ' HA ' ' A' ' 658' ' ' ALA . 68.7 mttm -94.32 146.35 24.1 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.319 0.581 . . . . 0.0 110.615 178.609 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 688' ' ' ILE . . . . . 0.4 HG22 HG12 ' A' ' 700' ' ' VAL . 80.4 mt -122.6 123.08 67.63 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.784 0 CA-C-N 115.563 -0.744 . . . . 0.0 111.16 -178.521 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 689' ' ' PHE . . . . . 0.467 ' CD2' ' HB2' ' A' ' 702' ' ' ARG . 61.3 m-85 -123.51 145.55 48.77 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.232 -0.895 . . . . 0.0 110.007 179.067 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 690' ' ' ILE . . . . . . . . . . . . . 96.6 mt -121.65 135.24 62.44 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.466 0 CA-C-O 121.313 0.578 . . . . 0.0 112.441 -179.15 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 691' ' ' LEU . . . . . 0.672 HD23 ' HB ' ' A' ' 704' ' ' ILE . 35.2 mt -106.68 128.16 53.96 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-N 115.052 -0.976 . . . . 0.0 109.491 179.629 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 692' ' ' GLY . . . . . 0.743 ' O ' ' HA ' ' A' ' 705' ' ' PRO . . . 165.48 -174.41 41.26 Favored Glycine 0 N--CA 1.447 -0.601 0 C-N-CA 120.335 -0.936 . . . . 0.0 112.204 179.899 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 693' ' ' SER . . . . . . . . . . . . . 80.1 p -67.56 -37.6 82.91 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 120.807 0.336 . . . . 0.0 111.446 179.837 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 694' ' ' LYS . . . . . . . . . . . . . 35.5 mmtp -124.69 133.99 53.01 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.217 0.532 . . . . 0.0 110.85 179.657 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 695' ' ' GLY . . . . . 0.534 ' HA3' ' CB ' ' A' ' 703' ' ' TYR . . . -111.68 19.32 23.83 Favored Glycine 0 N--CA 1.449 -0.482 0 CA-C-N 115.345 -0.843 . . . . 0.0 112.5 179.575 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 696' ' ' ASN . . . . . . . . . . . . . 65.1 t30 -81.93 73.33 8.97 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.023 0.44 . . . . 0.0 111.395 -179.081 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 697' ' ' TYR . . . . . . . . . . . . . 98.9 m-85 -130.51 145.03 51.78 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.928 -0.578 . . . . 0.0 109.707 179.116 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 698' ' ' GLN . . . . . . . . . . . . . 98.2 mt-30 -84.3 145.62 28.18 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.959 -179.91 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 699' ' ' GLY . . . . . 0.472 ' HA3' HG11 ' A' ' 674' ' ' VAL . . . 94.58 5.73 61.41 Favored Glycine 0 CA--C 1.519 0.294 0 C-N-CA 120.552 -0.832 . . . . 0.0 113.776 179.481 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 700' ' ' VAL . . . . . 0.4 HG12 HG22 ' A' ' 688' ' ' ILE . 21.4 m -119.46 152.61 21.98 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.271 0 CA-C-N 117.394 0.597 . . . . 0.0 109.947 179.268 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 701' ' ' ASP . . . . . . . . . . . . . 67.8 m-20 -88.93 -39.74 13.55 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 116.006 -0.543 . . . . 0.0 112.259 -178.926 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 702' ' ' ARG . . . . . 0.467 ' HB2' ' CD2' ' A' ' 689' ' ' PHE . 91.3 mmt-85 -144.69 161.74 38.45 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-O 120.805 0.336 . . . . 0.0 110.594 -178.611 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 703' ' ' TYR . . . . . 0.534 ' CB ' ' HA3' ' A' ' 695' ' ' GLY . 53.1 p90 -133.03 147.96 52.23 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.021 -0.536 . . . . 0.0 109.617 178.596 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 704' ' ' ILE . . . . . 0.672 ' HB ' HD23 ' A' ' 691' ' ' LEU . 58.8 mt -126.05 101.13 29.31 Favored Pre-proline 0 C--N 1.324 -0.528 0 CA-C-O 120.81 0.338 . . . . 0.0 110.846 -179.651 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 705' ' ' PRO . . . . . 0.743 ' HA ' ' O ' ' A' ' 692' ' ' GLY . 73.5 Cg_endo -73.52 152.58 48.89 Favored 'Trans proline' 0 C--N 1.347 0.454 0 C-N-CA 122.927 2.418 . . . . 0.0 113.34 -179.727 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 706' ' ' LEU . . . . . 0.57 ' HA ' ' C ' ' A' ' 707' ' ' PRO . 0.7 OUTLIER -105.21 151.86 39.67 Favored Pre-proline 0 CA--C 1.534 0.355 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.835 179.017 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 707' ' ' PRO . . . . . 0.57 ' C ' ' HA ' ' A' ' 706' ' ' LEU . 37.9 Cg_endo -65.68 136.84 29.78 Favored 'Cis proline' 0 C--N 1.35 0.63 0 C-N-CA 123.026 -1.656 . . . . 0.0 112.316 0.122 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 708' ' ' ILE . . . . . 0.454 HG12 HG22 ' A' ' 704' ' ' ILE . 69.1 mt -80.7 120.33 32.07 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-N 115.606 -0.724 . . . . 0.0 110.785 -179.398 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 709' ' ' HIS . . . . . . . . . . . . . 70.1 m80 -84.85 124.04 73.2 Favored Pre-proline 0 C--N 1.327 -0.386 0 CA-C-N 116.037 -0.528 . . . . 0.0 110.148 179.174 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 710' ' ' PRO . . . . . . . . . . . . . 24.0 Cg_endo -60.74 -31.56 92.05 Favored 'Trans proline' 0 C--N 1.348 0.545 0 C-N-CA 123.043 2.495 . . . . 0.0 114.014 -178.771 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 711' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -66.43 -40.1 89.31 Favored 'General case' 0 C--N 1.331 -0.233 0 N-CA-C 112.143 0.423 . . . . 0.0 112.143 -179.343 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 712' ' ' SER . . . . . . . . . . . . . 51.0 m -95.76 -15.96 22.24 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.513 -0.312 . . . . 0.0 111.733 -178.854 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 713' ' ' PHE . . . . . . . . . . . . . 85.1 t80 -60.38 -49.74 76.4 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 120.874 0.369 . . . . 0.0 110.732 -179.994 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 714' ' ' LEU . . . . . . . . . . . . . 91.2 mt -64.39 -37.83 88.9 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.372 179.555 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 715' ' ' GLN . . . . . . . . . . . . . 99.3 mm-40 -63.68 -42.16 98.05 Favored 'General case' 0 CA--C 1.53 0.187 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.672 179.317 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 716' ' ' GLN . . . . . . . . . . . . . 30.6 mm100 -65.8 -40.39 91.85 Favored 'General case' 0 C--O 1.234 0.259 0 CA-C-N 116.431 -0.35 . . . . 0.0 110.652 179.19 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 717' ' ' VAL . . . . . . . . . . . . . 65.7 t -62.9 -44.14 99.41 Favored 'Isoleucine or valine' 0 C--O 1.232 0.152 0 N-CA-C 109.831 -0.433 . . . . 0.0 109.831 178.934 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 718' ' ' THR . . . . . . . . . . . . . 90.7 m -61.73 -45.19 94.99 Favored 'General case' 0 CA--C 1.531 0.216 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.677 179.255 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 719' ' ' MET . . . . . . . . . . . . . 39.0 mmt -63.84 -41.09 97.9 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-N 116.727 -0.215 . . . . 0.0 110.482 178.839 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 720' ' ' GLY . . . . . . . . . . . . . . . -64.5 -42.76 97.36 Favored Glycine 0 N--CA 1.452 -0.26 0 C-N-CA 120.342 -0.932 . . . . 0.0 111.248 177.941 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 721' ' ' LEU . . . . . 0.698 HD12 ' HB3' ' A' ' 724' ' ' LEU . 64.4 tp -64.75 -48.88 72.94 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 122.935 0.494 . . . . 0.0 111.163 179.002 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 722' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 33.69 -96.76 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.783 0 N-CA-C 115.132 1.531 . . . . 0.0 115.132 -179.784 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 723' ' ' SER . . . . . . . . . . . . . 57.4 m -93.39 -2.72 54.38 Favored 'General case' 0 N--CA 1.467 0.42 0 N-CA-C 114.12 1.156 . . . . 0.0 114.12 -176.942 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 724' ' ' LEU . . . . . 0.698 ' HB3' HD12 ' A' ' 721' ' ' LEU . 64.9 tp -62.35 -45.74 91.83 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-O 120.891 0.376 . . . . 0.0 111.194 179.771 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 725' ' ' ALA . . . . . . . . . . . . . . . -152.46 153.19 33.04 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.678 -179.888 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 726' ' ' THR . . . . . . . . . . . . . 67.0 p -127.52 159.27 35.08 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.823 179.921 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 727' ' ' SER . . . . . . . . . . . . . 90.1 p -72.55 159.39 33.99 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.081 179.838 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 728' ' ' ALA . . . . . . . . . . . . . . . -147.88 153.82 39.61 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.645 -179.908 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 729' ' ' GLN . . . . . . . . . . . . . 96.7 mt-30 . . . . . 0 C--O 1.248 1.025 0 CA-C-O 118.29 -0.862 . . . . 0.0 110.781 -179.999 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 613' ' ' GLU . . . . . . . . . . . . . 93.6 mt-10 . . . . . 0 N--CA 1.488 1.427 0 CA-C-O 121.051 0.453 . . . . 0.0 110.465 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 614' ' ' GLY . . . . . . . . . . . . . . . -175.71 169.22 41.89 Favored Glycine 0 N--CA 1.449 -0.446 0 CA-C-N 115.808 -0.633 . . . . 0.0 111.991 179.768 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 615' ' ' ARG . . . . . . . . . . . . . 83.9 mtp180 -117.29 132.63 56.57 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.011 0.434 . . . . 0.0 111.066 -179.971 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 616' ' ' ILE . . . . . . . . . . . . . 87.0 mt -125.18 134.31 67.19 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 115.537 -0.756 . . . . 0.0 109.995 179.361 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 617' ' ' VAL . . . . . . . . . . . . . 95.3 t -105.91 126.26 61.35 Favored 'Isoleucine or valine' 0 C--O 1.235 0.305 0 CA-C-O 121.043 0.449 . . . . 0.0 109.832 179.878 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 618' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -109.2 126.01 52.82 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.773 -0.648 . . . . 0.0 110.624 -178.536 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 619' ' ' VAL . . . . . . . . . . . . . 62.4 t -117.95 119.59 61.97 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 N-CA-C 109.492 -0.559 . . . . 0.0 109.492 179.704 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 620' ' ' SER . . . . . 0.521 ' HB2' ' HB3' ' A' ' 662' ' ' ALA . 26.9 t -166.27 139.72 4.11 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.399 -179.351 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 621' ' ' GLU . . . . . . . . . . . . . 88.2 tt0 -77.11 -28.24 54.35 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.579 -0.737 . . . . 0.0 111.125 178.977 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 622' ' ' ASP . . . . . . . . . . . . . 56.8 t0 -83.43 110.14 17.92 Favored 'General case' 0 C--O 1.234 0.287 0 CA-C-O 120.946 0.403 . . . . 0.0 111.135 -178.473 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 623' ' ' GLU . . . . . . . . . . . . . 51.3 mp0 -63.62 -39.71 95.05 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-N 115.606 -0.725 . . . . 0.0 112.206 -179.776 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 624' ' ' ALA . . . . . . . . . . . . . . . -61.27 -43.95 98.03 Favored 'General case' 0 N--CA 1.463 0.179 0 N-CA-C 112.03 0.382 . . . . 0.0 112.03 -178.668 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 625' ' ' THR . . . . . 0.439 ' O ' HG22 ' A' ' 629' ' ' ILE . 85.4 m -70.26 -41.14 73.87 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.86 0.362 . . . . 0.0 110.291 179.542 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 626' ' ' SER . . . . . . . . . . . . . 66.7 m -62.46 -41.92 99.1 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.628 -0.714 . . . . 0.0 112.342 -178.564 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 627' ' ' THR . . . . . . . . . . . . . 40.1 p -68.56 -40.49 80.6 Favored 'General case' 0 N--CA 1.464 0.248 0 N-CA-C 112.614 0.598 . . . . 0.0 112.614 -179.729 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 628' ' ' LEU . . . . . . . . . . . . . 63.0 tp -64.41 -47.07 80.56 Favored 'General case' 0 N--CA 1.464 0.227 0 N-CA-C 111.952 0.353 . . . . 0.0 111.952 -179.509 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 629' ' ' ILE . . . . . 0.439 HG22 ' O ' ' A' ' 625' ' ' THR . 20.2 tt -70.6 -34.0 55.45 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.425 0 N-CA-C 112.36 0.504 . . . . 0.0 112.36 -179.273 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 630' ' ' CYS . . . . . . . . . . . . . 51.1 t -60.63 -44.93 95.79 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.427 -179.434 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 631' ' ' SER . . . . . . . . . . . . . 47.2 t -61.64 -42.36 98.79 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.079 -179.663 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 632' ' ' ILE . . . . . . . . . . . . . 97.2 mt -61.58 -48.1 90.31 Favored 'Isoleucine or valine' 0 C--O 1.235 0.312 0 CA-C-N 116.472 -0.331 . . . . 0.0 110.857 179.98 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 633' ' ' LEU . . . . . . . . . . . . . 80.6 mt -66.07 -39.81 90.37 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.92 179.654 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 634' ' ' THR . . . . . 0.518 ' HA ' ' O ' ' A' ' 638' ' ' TYR . 89.5 m -65.25 -40.44 94.01 Favored 'General case' 0 CA--C 1.529 0.151 0 CA-C-O 120.708 0.289 . . . . 0.0 110.671 -179.946 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 635' ' ' THR . . . . . . . . . . . . . 91.9 m -59.44 -38.4 80.63 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.226 179.149 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 636' ' ' ALA . . . . . . . . . . . . . . . -63.34 -17.62 62.77 Favored 'General case' 0 CA--C 1.534 0.327 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.465 178.963 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 637' ' ' GLY . . . . . . . . . . . . . . . 109.33 4.85 30.56 Favored Glycine 0 C--N 1.333 0.403 0 C-N-CA 121.06 -0.591 . . . . 0.0 113.332 179.695 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 638' ' ' TYR . . . . . 0.518 ' O ' ' HA ' ' A' ' 634' ' ' THR . 93.5 m-85 -100.9 142.61 32.13 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.739 0.304 . . . . 0.0 111.582 179.879 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 639' ' ' GLN . . . . . . . . . . . . . 75.1 mt-30 -86.25 135.27 33.62 Favored 'General case' 0 CA--C 1.519 -0.233 0 N-CA-C 109.829 -0.434 . . . . 0.0 109.829 179.206 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 640' ' ' VAL . . . . . . . . . . . . . 60.6 t -118.04 129.96 73.63 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 N-CA-C 112.333 0.494 . . . . 0.0 112.333 -179.159 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 641' ' ' ILE . . . . . . . . . . . . . 42.4 mm -109.83 117.3 54.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 N-CA-C 108.174 -1.047 . . . . 0.0 108.174 178.308 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 642' ' ' TRP . . . . . . . . . . . . . 26.9 t90 -92.25 128.08 37.97 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.318 0.58 . . . . 0.0 112.439 -178.321 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 643' ' ' LEU . . . . . . . . . . . . . 2.8 mp -122.04 134.46 54.79 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.304 -0.862 . . . . 0.0 110.492 179.014 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 644' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -111.61 36.26 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.592 -0.276 . . . . 0.0 111.226 179.952 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 645' ' ' ASP . . . . . . . . . . . . . 20.3 t0 -151.32 -34.66 0.14 Allowed 'General case' 0 N--CA 1.469 0.515 0 N-CA-C 112.508 0.558 . . . . 0.0 112.508 -178.502 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 646' ' ' GLY . . . . . . . . . . . . . . . 74.64 28.49 63.14 Favored Glycine 0 CA--C 1.521 0.443 0 C-N-CA 120.775 -0.726 . . . . 0.0 113.934 179.821 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 647' ' ' GLU . . . . . . . . . . . . . 58.9 mm-40 -65.16 120.56 12.93 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 117.329 0.564 . . . . 0.0 110.837 179.655 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 648' ' ' VAL . . . . . . . . . . . . . 79.3 t -61.33 -41.26 89.09 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-N 115.168 -0.924 . . . . 0.0 111.824 -179.097 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 649' ' ' GLU . . . . . . . . . . . . . 79.5 mm-40 -61.15 -42.41 98.49 Favored 'General case' 0 C--N 1.332 -0.183 0 C-N-CA 120.76 -0.376 . . . . 0.0 110.148 179.968 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 650' ' ' ARG . . . . . . . . . . . . . 89.9 mmt-85 -70.91 -40.71 72.0 Favored 'General case' 0 CA--C 1.53 0.175 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.47 178.513 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 651' ' ' LEU . . . . . . . . . . . . . 84.3 mt -64.3 -41.12 97.01 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.459 179.01 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 652' ' ' LEU . . . . . . . . . . . . . 61.6 tp -64.19 -43.3 95.52 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.838 178.765 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 653' ' ' ALA . . . . . . . . . . . . . . . -63.29 -39.87 95.79 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.396 -179.862 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 654' ' ' LEU . . . . . . . . . . . . . 75.3 mt -100.76 30.36 4.04 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.679 -0.691 . . . . 0.0 110.02 179.925 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 655' ' ' THR . . . . . . . . . . . . . 6.7 t -46.4 109.89 1.1 Allowed Pre-proline 0 CA--C 1.536 0.436 0 CA-C-O 121.982 0.896 . . . . 0.0 113.314 -177.949 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 656' ' ' PRO . . . . . . . . . . . . . 27.8 Cg_endo -92.3 -174.8 0.55 Allowed 'Trans proline' 0 C--N 1.344 0.339 0 C-N-CA 124.028 3.152 . . . . 0.0 111.765 178.636 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 657' ' ' ILE . . . . . . . . . . . . . 21.5 pt -80.45 -25.45 11.36 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-O 121.237 0.541 . . . . 0.0 109.82 178.158 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 658' ' ' ALA . . . . . 0.413 ' HA ' ' O ' ' A' ' 687' ' ' LYS . . . -157.43 151.67 24.81 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.321 -0.854 . . . . 0.0 111.245 -179.816 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 659' ' ' VAL . . . . . 0.596 HG13 HD11 ' A' ' 686' ' ' LEU . 16.3 m -121.44 145.72 27.58 Favored 'Isoleucine or valine' 0 C--O 1.235 0.33 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.737 178.833 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 660' ' ' LEU . . . . . . . . . . . . . 6.0 mp -116.72 119.83 36.69 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.227 179.577 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 661' ' ' LEU . . . . . . . . . . . . . 69.0 mt -109.18 114.25 27.79 Favored 'General case' 0 C--N 1.328 -0.355 0 C-N-CA 120.624 -0.43 . . . . 0.0 109.946 -179.932 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 662' ' ' ALA . . . . . 0.521 ' HB3' ' HB2' ' A' ' 620' ' ' SER . . . -109.71 116.93 32.61 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 111.972 0.36 . . . . 0.0 111.972 -179.335 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 663' ' ' GLU . . . . . 0.517 ' HA ' ' C ' ' A' ' 664' ' ' PRO . 24.4 pt-20 -68.67 148.7 98.06 Favored Pre-proline 0 CA--C 1.538 0.488 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.747 178.782 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 664' ' ' PRO . . . . . 0.517 ' C ' ' HA ' ' A' ' 663' ' ' GLU . 43.4 Cg_endo -66.99 139.71 47.29 Favored 'Cis proline' 0 C--N 1.35 0.632 0 C-N-CA 123.351 -1.52 . . . . 0.0 112.451 -0.286 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 665' ' ' PHE . . . . . 0.486 ' HZ ' HD11 ' A' ' 690' ' ' ILE . 56.1 m-85 -80.72 124.72 29.27 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.774 -179.234 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 666' ' ' SER . . . . . . . . . . . . . 78.6 p -64.48 -35.25 80.35 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.214 179.619 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 667' ' ' TYR . . . . . . . . . . . . . 53.4 t80 -67.58 -22.05 65.4 Favored 'General case' 0 CA--C 1.535 0.37 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.207 179.206 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 668' ' ' GLY . . . . . . . . . . . . . . . 101.91 -103.79 2.55 Favored Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.672 -0.775 . . . . 0.0 112.469 -179.187 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 669' ' ' ASP . . . . . . . . . . . . . 37.5 t70 -80.46 109.53 15.05 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.033 0.444 . . . . 0.0 110.738 -179.489 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 670' ' ' VAL . . . . . . . . . . . . . 11.1 p -63.94 -30.96 51.37 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.449 0 N-CA-C 113.208 0.818 . . . . 0.0 113.208 -179.201 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 671' ' ' GLN . . . . . . . . . . . . . 57.3 mt-30 -62.06 -42.83 99.6 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-O 120.755 0.312 . . . . 0.0 111.471 -178.815 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 672' ' ' GLU . . . . . . . . . . . . . 95.2 mt-10 -65.14 -40.35 94.3 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.906 179.265 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 673' ' ' LEU . . . . . . . . . . . . . 61.8 tp -63.49 -45.35 91.13 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.127 179.518 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 674' ' ' VAL . . . . . 0.471 HG11 ' HA3' ' A' ' 699' ' ' GLY . 62.5 t -64.16 -44.98 97.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 115.59 -0.732 . . . . 0.0 110.103 179.521 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 675' ' ' ASP . . . . . . . . . . . . . 37.2 t70 -60.06 -41.34 92.15 Favored 'General case' 0 CA--C 1.52 -0.189 0 CA-C-N 116.086 -0.507 . . . . 0.0 110.912 179.344 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 676' ' ' GLN . . . . . 0.451 ' O ' ' HG3' ' A' ' 680' ' ' ARG . 55.9 mt-30 -68.52 -41.47 79.91 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.485 -0.325 . . . . 0.0 111.119 -179.485 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 677' ' ' LEU . . . . . . . . . . . . . 87.7 mt -69.87 -42.26 73.71 Favored 'General case' 0 C--O 1.22 -0.479 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.078 179.952 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 678' ' ' ARG . . . . . . . . . . . . . 80.2 ttt180 -64.67 -38.67 91.79 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-O 121.296 0.569 . . . . 0.0 110.667 -179.701 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 679' ' ' GLN . . . . . . . . . . . . . 53.1 tt0 -63.06 -38.57 91.71 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.57 -0.741 . . . . 0.0 110.256 179.307 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 680' ' ' ARG . . . . . 0.451 ' HG3' ' O ' ' A' ' 676' ' ' GLN . 91.5 mtt-85 -85.12 -35.04 22.02 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 115.983 -0.553 . . . . 0.0 112.306 -179.326 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 681' ' ' CYS . . . . . 0.481 ' SG ' ' HB3' ' A' ' 686' ' ' LEU . 18.0 p -133.11 136.79 46.03 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 121.321 0.582 . . . . 0.0 111.202 -179.185 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 682' ' ' THR . . . . . . . . . . . . . 52.6 p -73.09 159.09 86.01 Favored Pre-proline 0 C--N 1.32 -0.684 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.367 179.34 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 683' ' ' PRO . . . . . . . . . . . . . 76.9 Cg_exo -55.3 -32.29 80.5 Favored 'Trans proline' 0 C--N 1.349 0.556 0 C-N-CA 122.708 2.272 . . . . 0.0 112.408 179.32 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 684' ' ' GLU . . . . . 0.416 ' O ' HD13 ' A' ' 724' ' ' LEU . 97.5 mt-10 -70.34 -38.15 74.78 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.95 179.739 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 685' ' ' GLN . . . . . . . . . . . . . 64.7 tt0 -70.66 -41.88 71.53 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.787 -179.48 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 686' ' ' LEU . . . . . 0.596 HD11 HG13 ' A' ' 659' ' ' VAL . 60.2 tp -135.04 120.82 19.58 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.526 -179.204 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 687' ' ' LYS . . . . . 0.413 ' O ' ' HA ' ' A' ' 658' ' ' ALA . 0.9 OUTLIER -85.11 143.59 28.75 Favored 'General case' 0 CA--C 1.52 -0.206 0 N-CA-C 109.576 -0.528 . . . . 0.0 109.576 178.534 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 688' ' ' ILE . . . . . 0.47 HG22 HG12 ' A' ' 700' ' ' VAL . 76.1 mt -123.36 121.08 61.91 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.77 0 CA-C-O 121.318 0.58 . . . . 0.0 111.327 -178.638 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 689' ' ' PHE . . . . . . . . . . . . . 98.6 m-85 -116.68 141.12 48.61 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 114.965 -1.016 . . . . 0.0 109.523 178.541 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 690' ' ' ILE . . . . . 0.486 HD11 ' HZ ' ' A' ' 665' ' ' PHE . 19.9 tt -122.32 136.27 59.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-O 121.25 0.548 . . . . 0.0 111.369 -179.625 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 691' ' ' LEU . . . . . 0.437 HD21 HD12 ' A' ' 629' ' ' ILE . 1.3 mp -105.22 127.86 53.14 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.609 -0.723 . . . . 0.0 111.053 -179.712 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 692' ' ' GLY . . . . . 0.599 ' O ' ' HA ' ' A' ' 705' ' ' PRO . . . 168.55 179.66 40.97 Favored Glycine 0 N--CA 1.443 -0.857 0 CA-C-N 115.492 -0.776 . . . . 0.0 113.122 179.64 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 693' ' ' SER . . . . . . . . . . . . . 90.0 p -73.24 -21.63 60.59 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.058 0.456 . . . . 0.0 110.955 179.423 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 694' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -126.4 126.88 44.58 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.319 -179.923 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 695' ' ' GLY . . . . . 0.55 ' HA3' ' CB ' ' A' ' 703' ' ' TYR . . . -109.35 10.48 33.37 Favored Glycine 0 N--CA 1.448 -0.533 0 C-N-CA 120.692 -0.766 . . . . 0.0 113.152 -179.958 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 696' ' ' ASN . . . . . . . . . . . . . 65.7 t30 -84.12 73.1 10.44 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.144 0.497 . . . . 0.0 111.444 -179.236 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 697' ' ' TYR . . . . . . . . . . . . . 97.5 m-85 -129.91 148.28 51.76 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.827 -0.624 . . . . 0.0 109.737 179.152 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 698' ' ' GLN . . . . . . . . . . . . . 99.7 mm-40 -85.96 146.94 26.46 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.127 -179.365 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 699' ' ' GLY . . . . . 0.471 ' HA3' HG11 ' A' ' 674' ' ' VAL . . . 92.96 3.65 65.62 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.799 -0.715 . . . . 0.0 113.864 179.356 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 700' ' ' VAL . . . . . 0.47 HG12 HG22 ' A' ' 688' ' ' ILE . 26.1 m -119.46 147.77 22.86 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 117.467 0.634 . . . . 0.0 109.985 179.25 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 701' ' ' ASP . . . . . 0.538 ' O ' ' HD2' ' A' ' 702' ' ' ARG . 28.1 t0 -81.91 -41.31 21.06 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.764 -0.653 . . . . 0.0 111.739 -179.746 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 702' ' ' ARG . . . . . 0.538 ' HD2' ' O ' ' A' ' 701' ' ' ASP . 1.2 mpt_? -141.98 169.35 17.75 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.63 -178.592 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 703' ' ' TYR . . . . . 0.55 ' CB ' ' HA3' ' A' ' 695' ' ' GLY . 53.1 p90 -129.02 147.16 50.86 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.038 179.384 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 704' ' ' ILE . . . . . 0.437 ' HB ' ' HG ' ' A' ' 691' ' ' LEU . 44.5 mm -122.19 100.66 42.16 Favored Pre-proline 0 C--N 1.326 -0.448 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.868 -179.929 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 705' ' ' PRO . . . . . 0.599 ' HA ' ' O ' ' A' ' 692' ' ' GLY . 88.3 Cg_endo -76.55 149.24 30.38 Favored 'Trans proline' 0 CA--C 1.531 0.373 0 C-N-CA 122.63 2.22 . . . . 0.0 113.375 179.899 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 706' ' ' LEU . . . . . 0.584 ' HA ' ' C ' ' A' ' 707' ' ' PRO . 7.2 mp -112.13 151.52 43.7 Favored Pre-proline 0 C--N 1.33 -0.249 0 CA-C-N 115.887 -0.597 . . . . 0.0 109.539 178.509 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 707' ' ' PRO . . . . . 0.584 ' C ' ' HA ' ' A' ' 706' ' ' LEU . 43.3 Cg_exo -60.42 135.88 14.77 Favored 'Cis proline' 0 C--N 1.352 0.722 0 C-N-CA 123.849 -1.313 . . . . 0.0 113.071 -0.11 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 708' ' ' ILE . . . . . . . . . . . . . 2.8 pt -69.97 128.29 33.1 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-N 115.64 -0.709 . . . . 0.0 112.243 179.368 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 709' ' ' HIS . . . . . . . . . . . . . 67.3 m80 -99.86 115.56 65.46 Favored Pre-proline 0 C--N 1.322 -0.625 0 N-CA-C 108.208 -1.034 . . . . 0.0 108.208 177.374 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 710' ' ' PRO . . . . . . . . . . . . . 21.5 Cg_endo -59.55 -29.94 91.17 Favored 'Trans proline' 0 C--N 1.345 0.377 0 C-N-CA 122.842 2.361 . . . . 0.0 114.349 -177.297 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 711' ' ' GLU . . . . . . . . . . . . . 24.5 pt-20 -70.3 -32.21 69.88 Favored 'General case' 0 CA--C 1.532 0.268 0 N-CA-C 112.149 0.426 . . . . 0.0 112.149 -179.443 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 712' ' ' SER . . . . . . . . . . . . . 36.8 m -99.9 -24.02 14.78 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.759 -0.201 . . . . 0.0 111.395 -179.382 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 713' ' ' PHE . . . . . . . . . . . . . 72.6 t80 -59.88 -49.17 78.74 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.262 -179.473 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 714' ' ' LEU . . . . . . . . . . . . . 8.1 mp -64.12 -39.86 94.95 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-O 120.842 0.353 . . . . 0.0 110.577 179.626 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 715' ' ' GLN . . . . . . . . . . . . . 24.1 tm0? -62.08 -44.09 97.43 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.694 -0.685 . . . . 0.0 110.928 179.449 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 716' ' ' GLN . . . . . . . . . . . . . 91.2 mm-40 -66.09 -41.89 90.05 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 116.566 -0.288 . . . . 0.0 111.496 179.426 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 717' ' ' VAL . . . . . 0.716 ' O ' ' HG ' ' A' ' 721' ' ' LEU . 68.4 t -63.99 -45.26 97.27 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.1 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.505 179.474 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 718' ' ' THR . . . . . . . . . . . . . 89.2 m -60.94 -42.7 98.69 Favored 'General case' 0 C--O 1.232 0.178 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.663 179.598 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 719' ' ' MET . . . . . . . . . . . . . 11.0 tpt -60.93 -41.55 96.43 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.342 179.299 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 720' ' ' GLY . . . . . . . . . . . . . . . -72.76 -17.51 78.29 Favored Glycine 0 CA--C 1.522 0.501 0 C-N-CA 120.938 -0.648 . . . . 0.0 113.345 179.493 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 721' ' ' LEU . . . . . 0.716 ' HG ' ' O ' ' A' ' 717' ' ' VAL . 92.9 mt -84.84 -11.08 56.43 Favored 'General case' 0 N--CA 1.467 0.423 0 CA-C-N 117.038 0.419 . . . . 0.0 111.539 179.964 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 722' ' ' THR . . . . . . . . . . . . . 68.7 p -68.63 162.34 26.17 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.052 -179.687 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 723' ' ' SER . . . . . . . . . . . . . 50.5 m 63.7 28.43 14.94 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-N 115.674 -0.694 . . . . 0.0 111.038 -178.901 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 724' ' ' LEU . . . . . 0.416 HD13 ' O ' ' A' ' 684' ' ' GLU . 39.9 tp -135.96 -70.93 0.47 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.288 179.542 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 725' ' ' ALA . . . . . . . . . . . . . . . -153.44 156.71 38.71 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.498 -179.965 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 726' ' ' THR . . . . . . . . . . . . . 72.1 p -81.01 159.09 24.93 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.729 0.3 . . . . 0.0 111.087 179.664 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 727' ' ' SER . . . . . . . . . . . . . 40.3 t -150.85 146.3 26.25 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.49 -0.323 . . . . 0.0 110.254 -179.963 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 728' ' ' ALA . . . . . . . . . . . . . . . -149.14 152.6 36.37 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.461 -0.336 . . . . 0.0 110.761 -179.908 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 729' ' ' GLN . . . . . . . . . . . . . 96.2 mt-30 . . . . . 0 C--O 1.25 1.083 0 CA-C-O 118.205 -0.902 . . . . 0.0 110.724 179.887 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 613' ' ' GLU . . . . . . . . . . . . . 58.1 mt-10 . . . . . 0 N--CA 1.487 1.391 0 CA-C-O 121.045 0.45 . . . . 0.0 110.799 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 614' ' ' GLY . . . . . . . . . . . . . . . -83.64 65.19 4.16 Favored Glycine 0 N--CA 1.453 -0.182 0 C-N-CA 120.961 -0.638 . . . . 0.0 112.605 -179.865 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 615' ' ' ARG . . . . . . . . . . . . . 88.1 mtm180 -111.98 130.16 55.95 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.91 0.386 . . . . 0.0 110.722 -179.99 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 616' ' ' ILE . . . . . . . . . . . . . 84.3 mt -123.48 133.64 68.61 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.034 179.562 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 617' ' ' VAL . . . . . . . . . . . . . 90.9 t -107.24 127.72 62.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-O 120.954 0.407 . . . . 0.0 110.039 179.999 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 618' ' ' LEU . . . . . 0.446 HD11 HG21 ' A' ' 629' ' ' ILE . 0.9 OUTLIER -109.65 130.72 55.49 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.919 -0.582 . . . . 0.0 111.117 -178.714 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 619' ' ' VAL . . . . . . . . . . . . . 67.4 t -118.88 118.24 57.06 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-N 115.986 -0.552 . . . . 0.0 109.718 179.447 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 620' ' ' SER . . . . . 0.573 ' HB3' ' HB3' ' A' ' 662' ' ' ALA . 82.7 p -168.09 165.33 13.44 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.524 -0.762 . . . . 0.0 111.118 -179.418 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 621' ' ' GLU . . . . . 0.423 ' OE2' ' HA ' ' A' ' 666' ' ' SER . 99.4 mt-10 -104.65 -9.92 17.88 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.472 -0.786 . . . . 0.0 111.278 178.205 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 622' ' ' ASP . . . . . . . . . . . . . 57.2 t0 -96.81 108.17 20.79 Favored 'General case' 0 CA--C 1.53 0.186 0 CA-C-O 121.097 0.475 . . . . 0.0 111.577 -177.923 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 623' ' ' GLU . . . . . . . . . . . . . 51.1 mp0 -65.56 -38.27 89.08 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-N 115.51 -0.768 . . . . 0.0 111.944 179.199 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 624' ' ' ALA . . . . . . . . . . . . . . . -60.33 -45.17 94.38 Favored 'General case' 0 N--CA 1.465 0.318 0 N-CA-C 112.825 0.676 . . . . 0.0 112.825 -178.029 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 625' ' ' THR . . . . . . . . . . . . . 21.9 p -72.04 -32.61 67.27 Favored 'General case' 0 CA--C 1.516 -0.344 0 C-N-CA 120.491 -0.484 . . . . 0.0 110.616 179.464 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 626' ' ' SER . . . . . . . . . . . . . 68.0 m -64.83 -41.54 95.67 Favored 'General case' 0 N--CA 1.451 -0.41 0 CA-C-N 115.473 -0.785 . . . . 0.0 111.731 -179.425 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 627' ' ' THR . . . . . . . . . . . . . 72.7 p -65.41 -40.69 93.69 Favored 'General case' 0 N--CA 1.465 0.309 0 N-CA-C 112.033 0.383 . . . . 0.0 112.033 -179.654 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 628' ' ' LEU . . . . . . . . . . . . . 61.7 tp -69.55 -43.44 72.94 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.929 0.395 . . . . 0.0 111.507 179.588 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 629' ' ' ILE . . . . . 0.446 HG21 HD11 ' A' ' 618' ' ' LEU . 1.2 tp -70.03 -37.53 72.61 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.521 0 CA-C-N 115.968 -0.56 . . . . 0.0 112.375 -178.417 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 630' ' ' CYS . . . . . . . . . . . . . 88.3 m -64.55 -39.3 93.5 Favored 'General case' 0 N--CA 1.464 0.239 0 N-CA-C 111.706 0.261 . . . . 0.0 111.706 -179.618 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 631' ' ' SER . . . . . . . . . . . . . 67.4 m -61.7 -42.9 99.56 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.447 -0.342 . . . . 0.0 111.036 -179.169 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 632' ' ' ILE . . . . . . . . . . . . . 97.0 mt -63.8 -47.85 89.04 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.253 0 CA-C-O 121.057 0.456 . . . . 0.0 110.759 179.573 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 633' ' ' LEU . . . . . . . . . . . . . 83.9 mt -66.34 -40.43 89.84 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-N 115.697 -0.683 . . . . 0.0 112.372 -179.499 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 634' ' ' THR . . . . . 0.519 ' HA ' ' O ' ' A' ' 638' ' ' TYR . 91.0 m -65.93 -39.83 90.86 Favored 'General case' 0 CA--C 1.53 0.182 0 CA-C-O 120.682 0.277 . . . . 0.0 110.999 -179.741 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 635' ' ' THR . . . . . . . . . . . . . 93.6 m -58.57 -38.19 77.36 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.518 179.356 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 636' ' ' ALA . . . . . . . . . . . . . . . -68.66 -9.69 51.68 Favored 'General case' 0 CA--C 1.535 0.387 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.466 179.228 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 637' ' ' GLY . . . . . . . . . . . . . . . 101.91 8.48 45.09 Favored Glycine 0 C--N 1.334 0.437 0 C-N-CA 121.049 -0.596 . . . . 0.0 113.494 179.321 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 638' ' ' TYR . . . . . 0.519 ' O ' ' HA ' ' A' ' 634' ' ' THR . 98.8 m-85 -100.56 142.7 31.67 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.956 0.378 . . . . 0.0 111.592 -179.796 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 639' ' ' GLN . . . . . . . . . . . . . 78.5 mt-30 -92.58 134.91 34.54 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 109.525 -0.546 . . . . 0.0 109.525 178.936 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 640' ' ' VAL . . . . . . . . . . . . . 58.5 t -118.24 130.51 73.0 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 N-CA-C 112.391 0.515 . . . . 0.0 112.391 -178.963 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 641' ' ' ILE . . . . . . . . . . . . . 47.9 mm -111.6 118.99 58.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 N-CA-C 108.249 -1.019 . . . . 0.0 108.249 178.066 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 642' ' ' TRP . . . . . . . . . . . . . 75.5 t90 -99.68 128.04 45.79 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 112.689 0.626 . . . . 0.0 112.689 -178.046 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 643' ' ' LEU . . . . . . . . . . . . . 89.0 mt -119.47 136.76 54.18 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.332 -0.849 . . . . 0.0 110.264 178.97 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 644' ' ' VAL . . . . . . . . . . . . . 7.5 p -103.91 23.31 2.17 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.572 0 CA-C-O 121.4 0.619 . . . . 0.0 111.348 -179.409 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 645' ' ' ASP . . . . . . . . . . . . . 16.8 t0 -143.17 -33.75 0.44 Allowed 'General case' 0 N--CA 1.471 0.596 0 N-CA-C 113.012 0.745 . . . . 0.0 113.012 -178.239 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 646' ' ' GLY . . . . . . . . . . . . . . . 74.6 29.26 61.83 Favored Glycine 0 CA--C 1.523 0.532 0 C-N-CA 120.846 -0.692 . . . . 0.0 114.805 179.41 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 647' ' ' GLU . . . . . . . . . . . . . 93.8 mt-10 -63.45 126.5 27.68 Favored 'General case' 0 N--CA 1.461 0.081 0 CA-C-N 117.753 0.776 . . . . 0.0 111.102 179.68 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 648' ' ' VAL . . . . . . . . . . . . . 79.5 t -61.86 -39.74 84.59 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-N 114.826 -1.079 . . . . 0.0 111.504 -179.637 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 649' ' ' GLU . . . . . . . . . . . . . 50.4 mp0 -60.64 -42.52 97.09 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.872 0.368 . . . . 0.0 110.017 179.996 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 650' ' ' ARG . . . . . . . . . . . . . 16.2 mmp_? -70.39 -40.69 73.8 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.394 178.486 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 651' ' ' LEU . . . . . . . . . . . . . 81.0 mt -64.17 -41.63 97.05 Favored 'General case' 0 N--CA 1.462 0.173 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.395 178.977 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 652' ' ' LEU . . . . . . . . . . . . . 61.4 tp -65.29 -43.12 92.17 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.911 178.855 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 653' ' ' ALA . . . . . . . . . . . . . . . -62.86 -39.57 94.81 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.917 -179.969 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 654' ' ' LEU . . . . . . . . . . . . . 75.1 mt -101.24 29.8 4.53 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.094 -179.468 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 655' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -35.03 105.05 0.27 Allowed Pre-proline 0 N--CA 1.471 0.613 0 O-C-N 124.495 1.122 . . . . 0.0 113.71 -179.371 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 656' ' ' PRO . . . . . . . . . . . . . 29.7 Cg_endo -92.95 -176.29 0.6 Allowed 'Trans proline' 0 C--N 1.344 0.339 0 C-N-CA 123.732 2.955 . . . . 0.0 112.173 178.758 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 657' ' ' ILE . . . . . . . . . . . . . 19.7 pt -83.16 -26.51 7.88 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-O 121.303 0.573 . . . . 0.0 109.928 178.042 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 658' ' ' ALA . . . . . 0.424 ' HB2' ' HB2' ' A' ' 687' ' ' LYS . . . -158.33 152.97 24.7 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.171 -0.922 . . . . 0.0 111.033 -179.738 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 659' ' ' VAL . . . . . 0.4 HG13 HD11 ' A' ' 686' ' ' LEU . 20.5 m -122.34 146.55 27.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-O 121.191 0.52 . . . . 0.0 110.964 178.966 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 660' ' ' LEU . . . . . . . . . . . . . 14.4 mt -115.06 119.45 36.5 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.42 -0.809 . . . . 0.0 110.17 179.403 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 661' ' ' LEU . . . . . . . . . . . . . 70.8 mt -106.36 111.34 23.88 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 109.018 -0.734 . . . . 0.0 109.018 179.408 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 662' ' ' ALA . . . . . 0.573 ' HB3' ' HB3' ' A' ' 620' ' ' SER . . . -107.03 130.93 54.58 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 112.943 0.72 . . . . 0.0 112.943 -178.394 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 663' ' ' GLU . . . . . . . . . . . . . 8.9 mm-40 -68.37 139.08 91.87 Favored Pre-proline 0 CA--C 1.533 0.32 0 CA-C-N 115.635 -0.711 . . . . 0.0 110.889 177.768 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 664' ' ' PRO . . . . . . . . . . . . . 81.0 Cg_endo -77.57 142.0 69.58 Favored 'Cis proline' 0 C--N 1.349 0.569 0 C-N-CA 123.403 -1.499 . . . . 0.0 112.334 -1.366 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 665' ' ' PHE . . . . . 0.594 ' HZ ' HD11 ' A' ' 690' ' ' ILE . 29.0 m-85 -74.58 127.35 32.89 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.399 -179.908 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 666' ' ' SER . . . . . 0.423 ' HA ' ' OE2' ' A' ' 621' ' ' GLU . 78.1 p -69.47 -38.19 77.62 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.568 179.266 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 667' ' ' TYR . . . . . . . . . . . . . 55.4 t80 -68.8 -23.64 64.31 Favored 'General case' 0 CA--C 1.534 0.331 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.506 179.626 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 668' ' ' GLY . . . . . . . . . . . . . . . 100.29 -104.33 2.78 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.602 -0.809 . . . . 0.0 112.331 -179.404 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 669' ' ' ASP . . . . . . . . . . . . . 37.6 t70 -82.19 109.26 16.32 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.874 0.369 . . . . 0.0 110.61 -179.868 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 670' ' ' VAL . . . . . 0.436 ' O ' HG23 ' A' ' 674' ' ' VAL . 7.5 m -70.81 -23.28 23.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 N-CA-C 113.675 0.991 . . . . 0.0 113.675 -179.048 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 671' ' ' GLN . . . . . . . . . . . . . 55.3 mt-30 -61.33 -42.86 99.38 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 118.149 0.431 . . . . 0.0 110.439 -179.366 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 672' ' ' GLU . . . . . . . . . . . . . 95.8 mt-10 -66.57 -39.85 88.67 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.347 178.386 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 673' ' ' LEU . . . . . . . . . . . . . 62.8 tp -63.51 -44.83 93.18 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.646 -0.706 . . . . 0.0 110.107 179.237 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 674' ' ' VAL . . . . . 0.707 HG11 ' HA3' ' A' ' 699' ' ' GLY . 53.1 t -63.05 -43.68 99.14 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.21 0 CA-C-N 115.587 -0.733 . . . . 0.0 109.796 179.306 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 675' ' ' ASP . . . . . . . . . . . . . 37.3 t70 -59.91 -40.94 90.53 Favored 'General case' 0 CA--C 1.52 -0.178 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.335 178.955 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 676' ' ' GLN . . . . . 0.416 ' O ' ' HG2' ' A' ' 680' ' ' ARG . 55.6 mt-30 -70.32 -41.67 72.95 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.892 179.832 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 677' ' ' LEU . . . . . . . . . . . . . 85.3 mt -66.94 -42.0 86.01 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.888 179.394 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 678' ' ' ARG . . . . . . . . . . . . . 62.5 ttp180 -66.32 -38.66 88.2 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-O 121.333 0.587 . . . . 0.0 110.659 179.792 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 679' ' ' GLN . . . . . . . . . . . . . 53.6 tt0 -62.43 -38.93 91.62 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.215 -0.902 . . . . 0.0 110.674 -179.927 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 680' ' ' ARG . . . . . 0.416 ' HG2' ' O ' ' A' ' 676' ' ' GLN . 37.9 mmt180 -84.64 -43.29 14.53 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.384 -0.371 . . . . 0.0 111.24 -179.882 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 681' ' ' CYS . . . . . . . . . . . . . 73.8 m -127.89 130.31 48.33 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 120.89 0.376 . . . . 0.0 110.242 179.644 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 682' ' ' THR . . . . . 0.44 ' OG1' ' HG2' ' A' ' 684' ' ' GLU . 63.0 p -71.84 160.01 83.85 Favored Pre-proline 0 C--N 1.322 -0.607 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.854 -179.552 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 683' ' ' PRO . . . . . . . . . . . . . 76.5 Cg_exo -55.0 -30.07 67.88 Favored 'Trans proline' 0 C--N 1.35 0.642 0 C-N-CA 122.858 2.372 . . . . 0.0 112.811 179.877 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 684' ' ' GLU . . . . . 0.44 ' HG2' ' OG1' ' A' ' 682' ' ' THR . 10.8 pt-20 -75.83 -14.25 60.29 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.809 0.338 . . . . 0.0 110.998 179.817 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 685' ' ' GLN . . . . . . . . . . . . . 90.8 mt-30 -101.15 -40.04 7.38 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.505 -179.799 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 686' ' ' LEU . . . . . 0.4 HD11 HG13 ' A' ' 659' ' ' VAL . 59.9 tp -131.83 122.64 26.08 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.631 -179.145 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 687' ' ' LYS . . . . . 0.424 ' HB2' ' HB2' ' A' ' 658' ' ' ALA . 46.9 mmtm -91.89 146.56 23.65 Favored 'General case' 0 CA--C 1.521 -0.147 0 CA-C-O 121.332 0.587 . . . . 0.0 110.917 178.736 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 688' ' ' ILE . . . . . 0.592 HG22 HG12 ' A' ' 700' ' ' VAL . 78.6 mt -123.18 122.58 65.76 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.761 0 CA-C-N 115.494 -0.776 . . . . 0.0 110.543 -179.385 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 689' ' ' PHE . . . . . . . . . . . . . 71.1 m-85 -122.51 147.23 46.61 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.34 -0.845 . . . . 0.0 110.197 179.561 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 690' ' ' ILE . . . . . 0.594 HD11 ' HZ ' ' A' ' 665' ' ' PHE . 16.7 tt -122.3 135.96 60.7 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.326 0 CA-C-O 121.377 0.608 . . . . 0.0 112.26 -178.895 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 691' ' ' LEU . . . . . 0.634 HD23 ' HB ' ' A' ' 704' ' ' ILE . 79.8 mt -110.23 129.44 55.73 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-N 115.352 -0.84 . . . . 0.0 110.281 179.479 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 692' ' ' GLY . . . . . 0.72 ' O ' ' HA ' ' A' ' 705' ' ' PRO . . . 162.66 -178.09 38.54 Favored Glycine 0 N--CA 1.446 -0.68 0 C-N-CA 120.532 -0.842 . . . . 0.0 112.239 179.618 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 693' ' ' SER . . . . . . . . . . . . . 79.8 p -66.26 -36.54 83.25 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.973 0.416 . . . . 0.0 110.986 179.345 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 694' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -126.25 123.01 37.17 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.045 179.666 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 695' ' ' GLY . . . . . 0.431 ' HA3' ' HB2' ' A' ' 703' ' ' TYR . . . -112.52 18.12 22.99 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.8 -179.793 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 696' ' ' ASN . . . . . . . . . . . . . 65.2 t30 -82.05 72.94 9.11 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.189 0.519 . . . . 0.0 111.026 -179.46 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 697' ' ' TYR . . . . . . . . . . . . . 96.8 m-85 -130.71 149.81 52.18 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.632 -0.713 . . . . 0.0 109.66 179.527 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 698' ' ' GLN . . . . . . . . . . . . . 29.4 pt20 -79.93 150.05 30.65 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.959 -179.552 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 699' ' ' GLY . . . . . 0.707 ' HA3' HG11 ' A' ' 674' ' ' VAL . . . 93.34 2.42 65.83 Favored Glycine 0 N--CA 1.45 -0.425 0 C-N-CA 120.532 -0.842 . . . . 0.0 114.037 179.215 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 700' ' ' VAL . . . . . 0.592 HG12 HG22 ' A' ' 688' ' ' ILE . 24.3 m -117.58 141.94 34.06 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.255 0 CA-C-N 117.945 0.872 . . . . 0.0 110.503 179.359 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 701' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -74.28 -44.38 52.98 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.404 -0.816 . . . . 0.0 112.262 -179.34 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 702' ' ' ARG . . . . . . . . . . . . . 91.0 mmt-85 -141.67 157.29 45.25 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.737 0.303 . . . . 0.0 110.569 -178.636 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 703' ' ' TYR . . . . . 0.431 ' HB2' ' HA3' ' A' ' 695' ' ' GLY . 26.6 p90 -119.35 136.57 54.2 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.371 179.151 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 704' ' ' ILE . . . . . 0.634 ' HB ' HD23 ' A' ' 691' ' ' LEU . 60.3 mt -122.82 98.81 42.33 Favored Pre-proline 0 C--O 1.236 0.39 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.697 179.914 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 705' ' ' PRO . . . . . 0.72 ' HA ' ' O ' ' A' ' 692' ' ' GLY . 73.4 Cg_endo -73.66 154.67 49.54 Favored 'Trans proline' 0 C--N 1.345 0.393 0 C-N-CA 122.899 2.4 . . . . 0.0 113.24 -179.739 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 706' ' ' LEU . . . . . 0.655 ' HA ' ' C ' ' A' ' 707' ' ' PRO . 2.4 pp -119.99 154.97 55.77 Favored Pre-proline 0 C--N 1.328 -0.367 0 CA-C-N 115.793 -0.639 . . . . 0.0 110.566 178.981 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 707' ' ' PRO . . . . . 0.655 ' C ' ' HA ' ' A' ' 706' ' ' LEU . 53.0 Cg_exo -58.71 133.98 9.01 Favored 'Cis proline' 0 C--N 1.353 0.773 0 C-N-CA 123.698 -1.376 . . . . 0.0 112.865 -0.195 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 708' ' ' ILE . . . . . 0.413 HD13 HD12 ' A' ' 629' ' ' ILE . 12.8 pt -70.64 149.83 10.01 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-O 121.732 0.777 . . . . 0.0 112.654 -179.988 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 709' ' ' HIS . . . . . . . . . . . . . 68.4 m80 -108.13 112.19 61.54 Favored Pre-proline 0 C--N 1.317 -0.807 0 N-CA-C 107.154 -1.424 . . . . 0.0 107.154 176.864 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 710' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_endo -58.67 -30.81 93.33 Favored 'Trans proline' 0 C--N 1.345 0.386 0 C-N-CA 122.513 2.142 . . . . 0.0 113.931 -177.029 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 711' ' ' GLU . . . . . . . . . . . . . 42.6 tt0 -64.77 -42.42 95.11 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.796 0.331 . . . . 0.0 111.792 -179.927 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 712' ' ' SER . . . . . . . . . . . . . 56.8 m -96.62 -14.21 22.33 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 112.252 0.464 . . . . 0.0 112.252 -178.786 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 713' ' ' PHE . . . . . . . . . . . . . 92.3 t80 -60.66 -49.11 78.82 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-O 121.092 0.472 . . . . 0.0 110.226 179.796 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 714' ' ' LEU . . . . . 0.467 ' O ' HG12 ' A' ' 717' ' ' VAL . 91.0 mt -65.97 -36.92 84.65 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.64 -0.709 . . . . 0.0 110.143 178.885 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 715' ' ' GLN . . . . . . . . . . . . . 65.6 tt0 -62.14 -42.36 99.17 Favored 'General case' 0 CA--C 1.532 0.26 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.678 179.358 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 716' ' ' GLN . . . . . . . . . . . . . 87.7 mt-30 -64.35 -41.03 96.96 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 116.447 -0.342 . . . . 0.0 111.903 -179.874 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 717' ' ' VAL . . . . . 0.467 HG12 ' O ' ' A' ' 714' ' ' LEU . 5.5 p -69.81 -32.98 54.0 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.263 0 C-N-CA 120.414 -0.514 . . . . 0.0 110.183 179.592 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 718' ' ' THR . . . . . . . . . . . . . 93.8 m -62.15 -43.76 98.12 Favored 'General case' 0 C--O 1.232 0.168 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.436 178.285 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 719' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -61.66 -43.93 97.93 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-N 116.337 -0.392 . . . . 0.0 109.978 179.034 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 720' ' ' GLY . . . . . . . . . . . . . . . -64.26 -39.98 97.53 Favored Glycine 0 C--N 1.33 0.235 0 N-CA-C 111.389 -0.684 . . . . 0.0 111.389 177.915 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 721' ' ' LEU . . . . . . . . . . . . . 65.7 tp -62.25 -44.38 96.68 Favored 'General case' 0 CA--C 1.528 0.119 0 CA-C-N 115.456 -0.372 . . . . 0.0 111.3 179.486 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 722' ' ' THR . . . . . . . . . . . . . 67.8 p -65.86 -30.78 71.45 Favored 'General case' 0 N--CA 1.463 0.195 0 CA-C-O 120.823 0.344 . . . . 0.0 110.745 179.765 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 723' ' ' SER . . . . . . . . . . . . . 67.0 m -68.33 -40.69 81.54 Favored 'General case' 0 C--N 1.332 -0.195 0 N-CA-C 109.349 -0.611 . . . . 0.0 109.349 177.468 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 724' ' ' LEU . . . . . . . . . . . . . 67.6 tp -65.21 -46.48 80.51 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-N 115.089 -0.959 . . . . 0.0 111.567 179.139 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 725' ' ' ALA . . . . . . . . . . . . . . . -150.49 153.85 36.59 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.106 -179.483 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 726' ' ' THR . . . . . . . . . . . . . 71.2 p -72.24 -18.02 61.85 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.213 -0.449 . . . . 0.0 112.181 -179.67 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 727' ' ' SER . . . . . . . . . . . . . 90.6 p -71.71 157.19 38.38 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.767 0.318 . . . . 0.0 111.143 -179.99 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 728' ' ' ALA . . . . . . . . . . . . . . . -153.04 159.49 42.86 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.321 -0.399 . . . . 0.0 110.755 -179.792 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 729' ' ' GLN . . . . . . . . . . . . . 78.4 mt-30 . . . . . 0 C--O 1.25 1.112 0 CA-C-O 118.209 -0.9 . . . . 0.0 110.994 179.756 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 613' ' ' GLU . . . . . . . . . . . . . 57.4 mt-10 . . . . . 0 N--CA 1.487 1.421 0 CA-C-O 120.905 0.383 . . . . 0.0 110.736 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 614' ' ' GLY . . . . . . . . . . . . . . . -174.28 176.48 46.65 Favored Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.458 -179.996 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 615' ' ' ARG . . . . . . . . . . . . . 47.2 mtm105 -116.63 136.42 52.99 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.641 0.258 . . . . 0.0 110.964 -179.838 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 616' ' ' ILE . . . . . 0.409 ' O ' ' HA ' ' A' ' 640' ' ' VAL . 84.6 mt -123.04 132.58 71.14 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-N 116.116 -0.493 . . . . 0.0 109.853 178.953 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 617' ' ' VAL . . . . . . . . . . . . . 96.0 t -106.82 126.43 62.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-O 120.919 0.39 . . . . 0.0 110.078 -179.916 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 618' ' ' LEU . . . . . 0.446 HD11 HD13 ' A' ' 629' ' ' ILE . 0.9 OUTLIER -109.12 128.3 54.89 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.6 -178.727 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 619' ' ' VAL . . . . . . . . . . . . . 65.6 t -117.8 120.01 63.32 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-O 121.002 0.43 . . . . 0.0 110.04 179.952 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 620' ' ' SER . . . . . 0.643 ' HB3' ' HB3' ' A' ' 662' ' ' ALA . 90.4 p -165.37 161.72 19.12 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.391 -0.822 . . . . 0.0 110.97 -179.645 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 621' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -99.49 -12.19 20.4 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.821 -0.627 . . . . 0.0 111.423 178.456 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 622' ' ' ASP . . . . . . . . . . . . . 57.8 t0 -100.6 108.35 20.24 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-O 120.795 0.331 . . . . 0.0 111.234 -178.512 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 623' ' ' GLU . . . . . . . . . . . . . 25.4 pm0 -65.94 -30.83 71.47 Favored 'General case' 0 CA--C 1.534 0.331 0 CA-C-N 115.754 -0.657 . . . . 0.0 112.394 179.948 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 624' ' ' ALA . . . . . . . . . . . . . . . -62.53 -43.86 97.78 Favored 'General case' 0 N--CA 1.464 0.275 0 CA-C-O 120.857 0.361 . . . . 0.0 111.825 -179.2 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 625' ' ' THR . . . . . . . . . . . . . 85.5 m -68.31 -39.96 81.84 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.109 0.481 . . . . 0.0 109.976 179.669 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 626' ' ' SER . . . . . . . . . . . . . 73.1 m -61.39 -40.39 94.19 Favored 'General case' 0 N--CA 1.455 -0.21 0 CA-C-N 115.35 -0.841 . . . . 0.0 112.35 -178.878 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 627' ' ' THR . . . . . . . . . . . . . 74.9 p -65.07 -35.77 82.22 Favored 'General case' 0 N--CA 1.466 0.337 0 N-CA-C 112.381 0.511 . . . . 0.0 112.381 -179.422 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 628' ' ' LEU . . . . . . . . . . . . . 1.8 mm? -74.02 -48.13 32.23 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 112.008 0.373 . . . . 0.0 112.008 -179.673 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 629' ' ' ILE . . . . . 0.446 HD13 HD11 ' A' ' 618' ' ' LEU . 21.2 tt -69.27 -36.73 73.9 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.399 0 N-CA-C 112.456 0.539 . . . . 0.0 112.456 -178.932 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 630' ' ' CYS . . . . . . . . . . . . . 45.1 t -61.42 -42.74 99.21 Favored 'General case' 0 CA--C 1.52 -0.206 0 CA-C-O 120.606 0.241 . . . . 0.0 110.925 -179.792 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 631' ' ' SER . . . . . . . . . . . . . 69.2 m -61.64 -41.64 97.79 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.833 -179.576 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 632' ' ' ILE . . . . . . . . . . . . . 97.2 mt -63.14 -48.69 86.54 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.323 0 CA-C-O 120.981 0.419 . . . . 0.0 111.021 179.693 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 633' ' ' LEU . . . . . . . . . . . . . 87.9 mt -67.67 -39.23 84.54 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-N 115.915 -0.584 . . . . 0.0 112.381 -179.636 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 634' ' ' THR . . . . . 0.488 ' HA ' ' O ' ' A' ' 638' ' ' TYR . 86.4 m -64.93 -39.95 94.3 Favored 'General case' 0 N--CA 1.463 0.187 0 CA-C-O 120.697 0.284 . . . . 0.0 110.686 -179.746 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 635' ' ' THR . . . . . . . . . . . . . 93.2 m -58.79 -38.75 79.25 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.191 179.273 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 636' ' ' ALA . . . . . . . . . . . . . . . -64.34 -17.91 64.14 Favored 'General case' 0 CA--C 1.534 0.329 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.308 178.794 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 637' ' ' GLY . . . . . . . . . . . . . . . 108.94 4.69 31.38 Favored Glycine 0 C--N 1.334 0.437 0 C-N-CA 121.072 -0.585 . . . . 0.0 113.321 179.631 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 638' ' ' TYR . . . . . 0.488 ' O ' ' HA ' ' A' ' 634' ' ' THR . 92.6 m-85 -100.48 141.72 32.95 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.846 0.355 . . . . 0.0 111.636 -179.822 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 639' ' ' GLN . . . . . . . . . . . . . 98.6 mm-40 -88.2 136.52 32.94 Favored 'General case' 0 CA--C 1.518 -0.266 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.224 179.64 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 640' ' ' VAL . . . . . 0.409 ' HA ' ' O ' ' A' ' 616' ' ' ILE . 60.1 t -118.12 129.99 73.65 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 CA-C-O 121.098 0.475 . . . . 0.0 112.025 -179.62 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 641' ' ' ILE . . . . . . . . . . . . . 47.5 mm -111.21 119.52 59.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 N-CA-C 108.578 -0.897 . . . . 0.0 108.578 178.503 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 642' ' ' TRP . . . . . . . . . . . . . 25.1 t90 -92.66 127.51 38.19 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.178 0.514 . . . . 0.0 112.329 -178.353 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 643' ' ' LEU . . . . . 0.411 ' HA ' HD13 ' A' ' 643' ' ' LEU . 0.7 OUTLIER -119.55 130.31 55.1 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 115.495 -0.775 . . . . 0.0 110.142 178.827 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 644' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -107.73 37.79 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.718 -0.219 . . . . 0.0 111.403 -179.477 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 645' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -150.58 -37.14 0.14 Allowed 'General case' 0 N--CA 1.469 0.497 0 N-CA-C 112.544 0.572 . . . . 0.0 112.544 -178.768 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 646' ' ' GLY . . . . . . . . . . . . . . . 74.57 28.25 63.76 Favored Glycine 0 CA--C 1.519 0.308 0 C-N-CA 120.749 -0.738 . . . . 0.0 113.86 -179.856 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 647' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -70.49 128.64 36.84 Favored 'General case' 0 N--CA 1.456 -0.164 0 CA-C-N 117.263 0.532 . . . . 0.0 110.544 179.59 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 648' ' ' VAL . . . . . . . . . . . . . 76.6 t -61.42 -40.33 85.9 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 CA-C-N 115.101 -0.954 . . . . 0.0 111.237 -179.628 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 649' ' ' GLU . . . . . . . . . . . . . 50.3 mp0 -61.29 -43.48 98.8 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.743 0.306 . . . . 0.0 110.38 -179.856 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 650' ' ' ARG . . . . . . . . . . . . . 95.8 mtt-85 -69.55 -41.61 75.7 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.655 178.707 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 651' ' ' LEU . . . . . . . . . . . . . 88.4 mt -65.34 -41.18 94.15 Favored 'General case' 0 N--CA 1.462 0.15 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.648 179.379 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 652' ' ' LEU . . . . . . . . . . . . . 62.4 tp -65.95 -42.98 89.3 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.226 178.895 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 653' ' ' ALA . . . . . . . . . . . . . . . -62.89 -40.11 96.54 Favored 'General case' 0 N--CA 1.467 0.418 0 CA-C-O 121.082 0.468 . . . . 0.0 111.591 -179.645 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 654' ' ' LEU . . . . . . . . . . . . . 75.7 mt -101.6 29.63 4.76 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.103 179.849 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 655' ' ' THR . . . . . . . . . . . . . 6.2 t -43.36 109.72 0.83 Allowed Pre-proline 0 N--CA 1.467 0.399 0 O-C-N 124.24 0.963 . . . . 0.0 113.353 -177.899 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 656' ' ' PRO . . . . . . . . . . . . . 22.5 Cg_endo -93.07 -174.37 0.44 Allowed 'Trans proline' 0 C--N 1.345 0.373 0 C-N-CA 124.217 3.278 . . . . 0.0 111.852 178.744 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 657' ' ' ILE . . . . . . . . . . . . . 18.5 pt -81.13 -24.32 10.56 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-O 121.447 0.641 . . . . 0.0 109.791 177.903 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 658' ' ' ALA . . . . . 0.436 ' HB2' ' HB2' ' A' ' 687' ' ' LYS . . . -158.62 151.18 21.92 Favored 'General case' 0 N--CA 1.452 -0.332 0 CA-C-N 115.142 -0.935 . . . . 0.0 111.198 179.77 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 659' ' ' VAL . . . . . 0.463 HG13 HD11 ' A' ' 686' ' ' LEU . 19.3 m -120.86 145.19 27.7 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-O 121.325 0.583 . . . . 0.0 110.406 178.825 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 660' ' ' LEU . . . . . 0.683 HD21 HD12 ' A' ' 691' ' ' LEU . 2.0 tt -119.08 116.79 27.12 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.457 -0.792 . . . . 0.0 109.651 179.535 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 661' ' ' LEU . . . . . . . . . . . . . 41.3 mt -104.04 111.27 23.77 Favored 'General case' 0 C--N 1.323 -0.587 0 N-CA-C 109.307 -0.627 . . . . 0.0 109.307 -179.334 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 662' ' ' ALA . . . . . 0.643 ' HB3' ' HB3' ' A' ' 620' ' ' SER . . . -104.83 130.1 53.01 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 112.402 0.519 . . . . 0.0 112.402 -178.381 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 663' ' ' GLU . . . . . . . . . . . . . 98.5 mt-10 -75.19 144.74 79.24 Favored Pre-proline 0 C--N 1.325 -0.471 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.288 178.294 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 664' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -72.26 139.43 60.18 Favored 'Cis proline' 0 C--N 1.349 0.563 0 C-N-CA 123.318 -1.534 . . . . 0.0 112.825 -0.573 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 665' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -85.87 153.11 22.46 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.495 -0.775 . . . . 0.0 111.809 179.955 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 666' ' ' SER . . . . . . . . . . . . . 5.5 p -104.88 -25.12 12.74 Favored 'General case' 0 CA--C 1.53 0.207 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.894 179.938 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 667' ' ' TYR . . . . . . . . . . . . . 18.0 p90 -68.59 -20.64 64.52 Favored 'General case' 0 N--CA 1.467 0.407 0 N-CA-C 112.102 0.408 . . . . 0.0 112.102 179.756 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 668' ' ' GLY . . . . . . . . . . . . . . . 100.13 -106.37 3.14 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.611 -0.804 . . . . 0.0 113.253 179.786 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 669' ' ' ASP . . . . . . . . . . . . . 25.5 t70 -84.67 112.15 20.21 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.728 0.299 . . . . 0.0 111.007 -178.863 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 670' ' ' VAL . . . . . 0.438 ' O ' HG23 ' A' ' 674' ' ' VAL . 14.3 p -64.37 -34.66 70.74 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.333 0 N-CA-C 113.122 0.786 . . . . 0.0 113.122 -179.031 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 671' ' ' GLN . . . . . . . . . . . . . 27.7 mp0 -62.4 -42.21 99.26 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.843 0.354 . . . . 0.0 110.904 -178.936 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 672' ' ' GLU . . . . . . . . . . . . . 95.8 mt-10 -66.4 -39.6 89.13 Favored 'General case' 0 N--CA 1.462 0.169 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.95 179.061 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 673' ' ' LEU . . . . . . . . . . . . . 62.6 tp -62.48 -43.36 99.01 Favored 'General case' 0 C--N 1.331 -0.229 0 N-CA-C 109.495 -0.557 . . . . 0.0 109.495 178.864 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 674' ' ' VAL . . . . . 0.698 HG11 ' HA3' ' A' ' 699' ' ' GLY . 55.1 t -61.75 -44.83 99.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 115.256 -0.883 . . . . 0.0 109.913 178.945 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 675' ' ' ASP . . . . . . . . . . . . . 37.2 t70 -60.57 -40.11 90.48 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.396 179.058 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 676' ' ' GLN . . . . . . . . . . . . . 56.9 mt-30 -70.26 -41.29 73.66 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.006 -179.733 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 677' ' ' LEU . . . . . . . . . . . . . 85.7 mt -66.68 -42.43 86.53 Favored 'General case' 0 C--N 1.334 -0.1 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.373 179.346 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 678' ' ' ARG . . . . . 0.599 ' HA ' ' O ' ' A' ' 681' ' ' CYS . 83.6 mtp180 -72.14 -26.37 62.07 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-O 120.989 0.423 . . . . 0.0 111.371 -179.95 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 679' ' ' GLN . . . . . . . . . . . . . 52.7 tt0 -62.69 -39.01 92.64 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.589 -0.732 . . . . 0.0 110.459 179.491 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 680' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -95.41 -42.45 8.48 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.709 -179.701 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 681' ' ' CYS . . . . . 0.599 ' O ' ' HA ' ' A' ' 678' ' ' ARG . 76.7 m -121.14 131.31 54.17 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 120.774 0.321 . . . . 0.0 110.615 179.873 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 682' ' ' THR . . . . . . . . . . . . . 68.5 p -71.49 159.46 85.45 Favored Pre-proline 0 C--N 1.324 -0.506 0 CA-C-N 116.374 -0.376 . . . . 0.0 110.674 -179.978 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 683' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_exo -54.6 -31.79 71.87 Favored 'Trans proline' 0 C--N 1.35 0.643 0 C-N-CA 122.81 2.34 . . . . 0.0 112.715 179.611 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 684' ' ' GLU . . . . . . . . . . . . . 80.1 mm-40 -70.01 -39.1 76.05 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 121.084 0.469 . . . . 0.0 110.512 179.583 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 685' ' ' GLN . . . . . . . . . . . . . 91.0 mt-30 -72.85 -40.99 65.25 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.442 -0.799 . . . . 0.0 112.103 179.707 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 686' ' ' LEU . . . . . 0.463 HD11 HG13 ' A' ' 659' ' ' VAL . 60.6 tp -134.95 119.97 18.64 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.957 -178.373 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 687' ' ' LYS . . . . . 0.436 ' HB2' ' HB2' ' A' ' 658' ' ' ALA . 45.1 mmtm -89.14 146.4 24.82 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 121.356 0.598 . . . . 0.0 110.594 178.367 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 688' ' ' ILE . . . . . . . . . . . . . 75.5 mt -123.7 121.61 62.82 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.739 0 CA-C-N 115.635 -0.711 . . . . 0.0 110.663 -179.222 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 689' ' ' PHE . . . . . . . . . . . . . 91.1 m-85 -119.93 144.5 47.41 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.463 -0.789 . . . . 0.0 110.335 179.391 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 690' ' ' ILE . . . . . . . . . . . . . 19.6 tt -123.93 137.35 57.28 Favored 'Isoleucine or valine' 0 C--O 1.235 0.331 0 CA-C-O 121.361 0.601 . . . . 0.0 111.599 179.906 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 691' ' ' LEU . . . . . 0.683 HD12 HD21 ' A' ' 660' ' ' LEU . 0.5 OUTLIER -110.84 129.3 55.9 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-N 115.434 -0.803 . . . . 0.0 111.057 -179.825 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 692' ' ' GLY . . . . . 0.638 ' O ' ' HA ' ' A' ' 705' ' ' PRO . . . 177.68 -178.61 48.41 Favored Glycine 0 N--CA 1.446 -0.634 0 CA-C-N 115.613 -0.721 . . . . 0.0 111.678 179.764 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 693' ' ' SER . . . . . . . . . . . . . 80.1 p -66.47 -37.22 84.62 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.947 0.403 . . . . 0.0 110.935 179.379 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 694' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -138.87 128.1 24.12 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.88 -0.6 . . . . 0.0 109.879 179.207 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 695' ' ' GLY . . . . . 0.426 ' HA3' ' HB2' ' A' ' 703' ' ' TYR . . . -82.64 122.36 5.72 Favored Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.44 -0.886 . . . . 0.0 112.135 179.771 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 696' ' ' ASN . . . . . . . . . . . . . 99.5 m-20 -63.32 -38.15 90.05 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-O 120.782 0.325 . . . . 0.0 111.14 179.7 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 697' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER 64.94 38.23 6.51 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 115.47 -0.786 . . . . 0.0 112.156 179.641 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 698' ' ' GLN . . . . . . . . . . . . . 97.6 mt-30 -115.01 94.66 4.84 Favored 'General case' 0 N--CA 1.451 -0.403 0 N-CA-C 109.709 -0.478 . . . . 0.0 109.709 178.972 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 699' ' ' GLY . . . . . 0.698 ' HA3' HG11 ' A' ' 674' ' ' VAL . . . 90.8 8.09 65.66 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.684 -0.77 . . . . 0.0 113.295 -179.783 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 700' ' ' VAL . . . . . . . . . . . . . 33.1 m -118.38 148.94 20.91 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.333 0 O-C-N 122.246 -0.561 . . . . 0.0 110.038 179.792 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 701' ' ' ASP . . . . . . . . . . . . . 37.6 t70 -71.7 -43.96 65.05 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.593 -0.73 . . . . 0.0 112.307 -178.81 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 702' ' ' ARG . . . . . . . . . . . . . 94.4 mtt-85 -144.92 162.55 36.6 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.572 -0.285 . . . . 0.0 110.612 -178.606 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 703' ' ' TYR . . . . . 0.426 ' HB2' ' HA3' ' A' ' 695' ' ' GLY . 45.8 p90 -123.59 147.36 47.39 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 109.826 -0.435 . . . . 0.0 109.826 179.072 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 704' ' ' ILE . . . . . 0.422 ' O ' HD23 ' A' ' 691' ' ' LEU . 46.2 mt -121.98 99.28 44.13 Favored Pre-proline 0 C--N 1.327 -0.39 0 CA-C-N 116.594 -0.276 . . . . 0.0 110.927 -179.664 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 705' ' ' PRO . . . . . 0.638 ' HA ' ' O ' ' A' ' 692' ' ' GLY . 85.2 Cg_endo -79.99 141.74 15.1 Favored 'Trans proline' 0 CA--C 1.531 0.359 0 C-N-CA 122.633 2.222 . . . . 0.0 113.574 -179.941 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 706' ' ' LEU . . . . . . . . . . . . . 92.3 mt -81.76 151.27 67.59 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.412 178.03 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 707' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -75.46 142.78 75.28 Favored 'Cis proline' 0 C--N 1.346 0.416 0 C-N-CA 123.112 -1.62 . . . . 0.0 112.851 -0.776 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 708' ' ' ILE . . . . . 0.417 HG23 HD21 ' A' ' 691' ' ' LEU . 0.5 OUTLIER -69.86 106.87 1.57 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.817 178.671 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 709' ' ' HIS . . . . . . . . . . . . . 71.5 m80 -82.47 121.45 78.25 Favored Pre-proline 0 C--N 1.33 -0.277 0 N-CA-C 108.78 -0.822 . . . . 0.0 108.78 177.796 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 710' ' ' PRO . . . . . . . . . . . . . 22.6 Cg_endo -60.34 -30.4 90.94 Favored 'Trans proline' 0 C--N 1.346 0.419 0 C-N-CA 122.689 2.259 . . . . 0.0 114.081 -177.875 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 711' ' ' GLU . . . . . . . . . . . . . 51.4 mp0 -66.23 -40.48 90.3 Favored 'General case' 0 C--N 1.331 -0.23 0 N-CA-C 112.119 0.415 . . . . 0.0 112.119 -179.327 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 712' ' ' SER . . . . . . . . . . . . . 63.0 m -99.0 -17.74 18.14 Favored 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 112.194 0.442 . . . . 0.0 112.194 -178.64 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 713' ' ' PHE . . . . . . . . . . . . . 85.0 t80 -60.2 -48.65 80.84 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-O 120.744 0.307 . . . . 0.0 110.552 179.909 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 714' ' ' LEU . . . . . 0.444 ' O ' HG12 ' A' ' 717' ' ' VAL . 85.9 mt -62.9 -39.27 93.99 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.188 179.492 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 715' ' ' GLN . . . . . . . . . . . . . 97.0 mt-30 -63.57 -40.16 96.25 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.684 179.229 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 716' ' ' GLN . . . . . . . . . . . . . 96.7 mt-30 -63.72 -41.14 98.12 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-N 116.69 -0.232 . . . . 0.0 111.109 179.594 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 717' ' ' VAL . . . . . 0.504 ' O ' ' HG ' ' A' ' 721' ' ' LEU . 4.8 p -73.68 -36.07 45.83 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.34 0 C-N-CA 120.574 -0.45 . . . . 0.0 110.847 179.506 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 718' ' ' THR . . . . . . . . . . . . . 35.2 p -64.57 -36.49 84.39 Favored 'General case' 0 C--N 1.341 0.238 0 N-CA-C 111.593 0.22 . . . . 0.0 111.593 179.242 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 719' ' ' MET . . . . . . . . . . . . . 98.3 mtp -63.8 -42.31 97.73 Favored 'General case' 0 C--O 1.235 0.303 0 CA-C-O 121.199 0.523 . . . . 0.0 109.753 178.579 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 720' ' ' GLY . . . . . . . . . . . . . . . -66.9 -39.6 93.4 Favored Glycine 0 N--CA 1.451 -0.32 0 CA-C-N 115.589 -0.732 . . . . 0.0 112.402 178.305 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 721' ' ' LEU . . . . . 0.504 ' HG ' ' O ' ' A' ' 717' ' ' VAL . 97.5 mt -63.42 -39.39 94.36 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-O 120.827 0.346 . . . . 0.0 111.455 -179.726 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 722' ' ' THR . . . . . . . . . . . . . 73.4 p -71.23 -11.33 60.87 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.921 0.391 . . . . 0.0 111.401 179.582 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 723' ' ' SER . . . . . . . . . . . . . 59.5 m -91.27 -1.99 57.53 Favored 'General case' 0 CA--C 1.532 0.255 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.01 179.588 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 724' ' ' LEU . . . . . . . . . . . . . 74.8 mt -73.03 141.09 47.66 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-N 116.51 -0.313 . . . . 0.0 111.159 179.672 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 725' ' ' ALA . . . . . . . . . . . . . . . -62.67 -39.77 94.98 Favored 'General case' 0 N--CA 1.461 0.111 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.123 179.192 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 726' ' ' THR . . . . . . . . . . . . . 87.8 m -121.55 128.92 52.51 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.21 179.571 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 727' ' ' SER . . . . . . . . . . . . . 63.6 m -123.31 149.37 44.93 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.67 0.271 . . . . 0.0 110.715 -179.728 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 728' ' ' ALA . . . . . . . . . . . . . . . -130.17 145.8 51.75 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.794 179.95 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 729' ' ' GLN . . . . . . . . . . . . . 10.2 tm0? . . . . . 0 C--O 1.248 1.01 0 CA-C-O 118.137 -0.935 . . . . 0.0 110.524 179.986 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 613' ' ' GLU . . . . . . . . . . . . . 77.8 mm-40 . . . . . 0 N--CA 1.485 1.294 0 CA-C-O 120.539 0.209 . . . . 0.0 110.817 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 614' ' ' GLY . . . . . . . . . . . . . . . 178.92 178.56 48.27 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.837 -0.697 . . . . 0.0 112.058 179.958 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 615' ' ' ARG . . . . . . . . . . . . . 27.5 ptt85 -117.54 148.23 42.07 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.219 0.533 . . . . 0.0 111.503 -179.946 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 616' ' ' ILE . . . . . . . . . . . . . 84.1 mt -124.01 135.87 62.17 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-N 115.268 -0.878 . . . . 0.0 110.644 -179.077 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 617' ' ' VAL . . . . . . . . . . . . . 79.9 t -105.28 127.14 60.21 Favored 'Isoleucine or valine' 0 C--O 1.234 0.285 0 N-CA-C 109.692 -0.484 . . . . 0.0 109.692 179.507 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 618' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -110.65 125.21 53.2 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.719 -0.673 . . . . 0.0 111.004 -178.421 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 619' ' ' VAL . . . . . 0.459 ' HA ' ' O ' ' A' ' 643' ' ' LEU . 59.3 t -118.39 117.99 56.5 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 N-CA-C 109.074 -0.713 . . . . 0.0 109.074 179.135 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 620' ' ' SER . . . . . 0.57 ' HB2' ' HB3' ' A' ' 662' ' ' ALA . 31.5 t -163.69 140.9 7.18 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.929 -179.039 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 621' ' ' GLU . . . . . . . . . . . . . 88.1 tt0 -77.47 -28.22 52.23 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.315 -0.857 . . . . 0.0 111.33 178.628 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 622' ' ' ASP . . . . . . . . . . . . . 62.9 t0 -85.71 108.82 18.22 Favored 'General case' 0 C--O 1.232 0.137 0 CA-C-O 121.167 0.508 . . . . 0.0 111.349 -178.279 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 623' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -64.7 -37.71 88.52 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.272 -0.876 . . . . 0.0 112.03 179.606 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 624' ' ' ALA . . . . . . . . . . . . . . . -60.82 -45.34 94.81 Favored 'General case' 0 N--CA 1.466 0.351 0 N-CA-C 112.739 0.644 . . . . 0.0 112.739 -178.2 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 625' ' ' THR . . . . . . . . . . . . . 18.5 p -73.4 -35.88 65.92 Favored 'General case' 0 CA--C 1.517 -0.324 0 C-N-CA 120.702 -0.399 . . . . 0.0 110.883 179.546 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 626' ' ' SER . . . . . 0.429 ' O ' HG22 ' A' ' 629' ' ' ILE . 68.1 m -63.77 -42.73 97.73 Favored 'General case' 0 N--CA 1.451 -0.42 0 CA-C-N 115.73 -0.668 . . . . 0.0 111.151 -179.676 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 627' ' ' THR . . . . . . . . . . . . . 91.3 m -62.31 -47.23 85.21 Favored 'General case' 0 CA--C 1.532 0.263 0 CA-C-O 120.848 0.356 . . . . 0.0 111.602 -179.93 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 628' ' ' LEU . . . . . . . . . . . . . 62.1 tp -65.04 -44.67 88.33 Favored 'General case' 0 CA--C 1.531 0.225 0 CA-C-N 116.128 -0.487 . . . . 0.0 112.1 -179.528 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 629' ' ' ILE . . . . . 0.429 HG22 ' O ' ' A' ' 626' ' ' SER . 1.4 tp -67.13 -32.48 57.93 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.548 0 N-CA-C 112.606 0.595 . . . . 0.0 112.606 -178.291 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 630' ' ' CYS . . . . . . . . . . . . . 76.8 m -63.95 -38.74 92.21 Favored 'General case' 0 N--CA 1.466 0.335 0 N-CA-C 112.54 0.57 . . . . 0.0 112.54 -179.361 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 631' ' ' SER . . . . . . . . . . . . . 95.4 p -62.25 -39.14 91.88 Favored 'General case' 0 C--N 1.33 -0.256 0 C-N-CA 121.149 -0.22 . . . . 0.0 111.565 -178.667 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 632' ' ' ILE . . . . . 0.543 ' O ' HG22 ' A' ' 635' ' ' THR . 96.5 mt -65.09 -48.01 85.53 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.279 0 CA-C-O 121.068 0.461 . . . . 0.0 110.961 179.635 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 633' ' ' LEU . . . . . . . . . . . . . 89.2 mt -67.67 -40.44 84.45 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.879 -0.601 . . . . 0.0 112.107 -179.631 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 634' ' ' THR . . . . . 0.521 ' HA ' ' O ' ' A' ' 638' ' ' TYR . 91.6 m -67.21 -41.65 85.41 Favored 'General case' 0 CA--C 1.53 0.195 0 CA-C-O 120.532 0.206 . . . . 0.0 111.338 -179.108 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 635' ' ' THR . . . . . 0.543 HG22 ' O ' ' A' ' 632' ' ' ILE . 0.9 OUTLIER -61.21 -18.96 60.91 Favored 'General case' 0 CA--C 1.535 0.389 0 CA-C-O 120.871 0.367 . . . . 0.0 111.248 179.789 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 636' ' ' ALA . . . . . . . . . . . . . . . -82.9 -3.33 56.84 Favored 'General case' 0 CA--C 1.53 0.211 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.837 178.841 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 637' ' ' GLY . . . . . . . . . . . . . . . 95.34 5.02 60.72 Favored Glycine 0 C--N 1.331 0.299 0 C-N-CA 121.118 -0.563 . . . . 0.0 113.05 179.778 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 638' ' ' TYR . . . . . 0.521 ' O ' ' HA ' ' A' ' 634' ' ' THR . 91.8 m-85 -100.7 139.3 36.58 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.85 0.357 . . . . 0.0 111.283 -179.971 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 639' ' ' GLN . . . . . . . . . . . . . 24.4 mp0 -85.97 138.0 32.31 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 109.929 -0.397 . . . . 0.0 109.929 179.197 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 640' ' ' VAL . . . . . . . . . . . . . 58.3 t -117.28 129.87 73.09 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-O 121.054 0.454 . . . . 0.0 111.926 -179.482 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 641' ' ' ILE . . . . . . . . . . . . . 31.1 mm -107.65 115.2 48.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 N-CA-C 108.349 -0.982 . . . . 0.0 108.349 178.611 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 642' ' ' TRP . . . . . . . . . . . . . 74.8 t90 -93.95 124.66 38.1 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.251 0.548 . . . . 0.0 112.418 -178.495 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 643' ' ' LEU . . . . . 0.459 ' O ' ' HA ' ' A' ' 619' ' ' VAL . 93.1 mt -127.87 145.48 50.93 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.151 -0.931 . . . . 0.0 110.703 179.412 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 644' ' ' VAL . . . . . . . . . . . . . 3.4 p -130.9 81.86 0.66 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.44 0 CA-C-O 121.609 0.719 . . . . 0.0 110.314 178.009 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 645' ' ' ASP . . . . . . . . . . . . . 19.1 t0 -179.41 -31.68 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.609 0 CA-C-N 115.559 -0.746 . . . . 0.0 111.651 -179.654 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 646' ' ' GLY . . . . . 0.43 ' HA3' ' HB3' ' A' ' 667' ' ' TYR . . . 73.06 28.72 65.97 Favored Glycine 0 CA--C 1.519 0.314 0 C-N-CA 121.077 -0.582 . . . . 0.0 113.428 -179.472 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 647' ' ' GLU . . . . . . . . . . . . . 7.3 mm-40 -69.31 115.55 8.72 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-O 121.084 0.469 . . . . 0.0 111.239 179.882 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 648' ' ' VAL . . . . . . . . . . . . . 79.0 t -61.33 -40.38 85.95 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-N 115.273 -0.876 . . . . 0.0 111.283 -179.71 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 649' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -61.16 -42.28 98.27 Favored 'General case' 0 C--N 1.332 -0.158 0 C-N-CA 120.769 -0.372 . . . . 0.0 110.213 -179.894 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 650' ' ' ARG . . . . . . . . . . . . . 90.4 mmt-85 -70.75 -41.2 72.08 Favored 'General case' 0 C--O 1.232 0.159 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.43 178.576 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 651' ' ' LEU . . . . . . . . . . . . . 84.1 mt -64.81 -41.59 95.67 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.745 179.403 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 652' ' ' LEU . . . . . . . . . . . . . 62.6 tp -65.27 -43.76 90.21 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.213 179.017 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 653' ' ' ALA . . . . . . . . . . . . . . . -63.2 -39.91 95.99 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-O 121.081 0.467 . . . . 0.0 111.412 -179.791 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 654' ' ' LEU . . . . . . . . . . . . . 75.7 mt -100.65 30.67 3.84 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.547 -0.751 . . . . 0.0 110.094 179.914 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 655' ' ' THR . . . . . . . . . . . . . 5.8 t -44.79 109.92 0.97 Allowed Pre-proline 0 CA--C 1.539 0.557 0 N-CA-C 113.418 0.896 . . . . 0.0 113.418 -178.283 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 656' ' ' PRO . . . . . . . . . . . . . 27.4 Cg_endo -92.59 -174.68 0.51 Allowed 'Trans proline' 0 C--N 1.347 0.487 0 C-N-CA 124.369 3.379 . . . . 0.0 111.897 178.963 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 657' ' ' ILE . . . . . . . . . . . . . 23.1 pt -81.16 -25.1 10.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 121.423 0.63 . . . . 0.0 109.715 177.573 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 658' ' ' ALA . . . . . . . . . . . . . . . -157.7 152.66 25.51 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.157 -0.929 . . . . 0.0 110.993 -179.716 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 659' ' ' VAL . . . . . . . . . . . . . 24.9 m -120.93 145.33 27.58 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-O 121.116 0.484 . . . . 0.0 110.92 179.146 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 660' ' ' LEU . . . . . . . . . . . . . 2.9 mp -115.18 119.31 35.95 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.6 -0.727 . . . . 0.0 110.006 179.288 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 661' ' ' LEU . . . . . . . . . . . . . 69.2 mt -109.47 112.86 25.22 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 109.371 -0.603 . . . . 0.0 109.371 179.942 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 662' ' ' ALA . . . . . 0.67 ' HB2' HD12 ' A' ' 691' ' ' LEU . . . -110.41 131.93 54.62 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 113.431 0.9 . . . . 0.0 113.431 -178.23 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 663' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -73.12 147.0 87.8 Favored Pre-proline 0 C--N 1.326 -0.428 0 CA-C-N 115.484 -0.78 . . . . 0.0 110.208 178.11 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 664' ' ' PRO . . . . . . . . . . . . . 70.1 Cg_endo -73.89 142.86 76.02 Favored 'Cis proline' 0 C--N 1.348 0.523 0 C-N-CA 123.237 -1.568 . . . . 0.0 112.677 -0.879 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 665' ' ' PHE . . . . . 0.402 ' HZ ' HD11 ' A' ' 690' ' ' ILE . 22.1 m-85 -77.6 136.96 38.32 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.72 -0.673 . . . . 0.0 111.002 179.351 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 666' ' ' SER . . . . . . . . . . . . . 78.2 p -91.29 -23.09 20.25 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.468 -0.333 . . . . 0.0 111.551 179.619 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 667' ' ' TYR . . . . . 0.43 ' HB3' ' HA3' ' A' ' 646' ' ' GLY . 12.7 p90 -80.91 -16.13 54.42 Favored 'General case' 0 CA--C 1.531 0.218 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.956 179.651 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 668' ' ' GLY . . . . . . . . . . . . . . . 100.18 -106.83 3.22 Favored Glycine 0 CA--C 1.521 0.414 0 C-N-CA 120.601 -0.809 . . . . 0.0 113.878 179.247 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 669' ' ' ASP . . . . . . . . . . . . . 35.2 t70 -82.88 111.21 18.57 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-O 120.941 0.401 . . . . 0.0 111.977 -178.049 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 670' ' ' VAL . . . . . . . . . . . . . 9.0 p -65.9 -30.03 48.73 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.449 0 N-CA-C 113.302 0.853 . . . . 0.0 113.302 -179.742 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 671' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -61.79 -41.71 98.08 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-N 117.888 0.313 . . . . 0.0 111.108 -179.078 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 672' ' ' GLU . . . . . . . . . . . . . 95.4 mt-10 -65.27 -40.2 93.62 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.839 179.112 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 673' ' ' LEU . . . . . . . . . . . . . 65.2 tp -64.19 -44.82 90.8 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.131 179.234 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 674' ' ' VAL . . . . . 0.678 HG11 ' HA3' ' A' ' 699' ' ' GLY . 59.1 t -62.99 -43.92 99.35 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.188 0 CA-C-N 115.777 -0.647 . . . . 0.0 109.859 179.642 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 675' ' ' ASP . . . . . . . . . . . . . 37.3 t70 -59.5 -41.02 88.93 Favored 'General case' 0 CA--C 1.518 -0.285 0 CA-C-N 115.87 -0.604 . . . . 0.0 110.476 178.93 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 676' ' ' GLN . . . . . . . . . . . . . 56.9 mt-30 -71.11 -41.17 70.93 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.015 179.958 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 677' ' ' LEU . . . . . . . . . . . . . 86.2 mt -67.2 -41.83 85.16 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 116.141 -0.482 . . . . 0.0 111.88 179.973 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 678' ' ' ARG . . . . . 0.539 ' HA ' ' O ' ' A' ' 681' ' ' CYS . 14.0 ptm180 -74.23 -24.66 59.35 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-O 121.106 0.479 . . . . 0.0 110.686 -179.296 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 679' ' ' GLN . . . . . . . . . . . . . 64.6 tt0 -65.71 -39.0 90.76 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.624 -0.716 . . . . 0.0 110.152 178.792 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 680' ' ' ARG . . . . . . . . . . . . . 33.1 mmt180 -89.37 -44.15 10.4 Favored 'General case' 0 C--N 1.333 -0.136 0 CA-C-N 115.8 -0.636 . . . . 0.0 111.377 -179.554 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 681' ' ' CYS . . . . . 0.539 ' O ' ' HA ' ' A' ' 678' ' ' ARG . 77.5 m -122.73 131.43 53.78 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.576 179.996 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 682' ' ' THR . . . . . 0.471 ' HB ' ' HD2' ' A' ' 683' ' ' PRO . 63.6 p -71.29 159.54 85.24 Favored Pre-proline 0 C--N 1.322 -0.619 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.575 -179.664 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 683' ' ' PRO . . . . . 0.471 ' HD2' ' HB ' ' A' ' 682' ' ' THR . 17.8 Cg_endo -59.41 -23.95 72.58 Favored 'Trans proline' 0 C--N 1.352 0.732 0 C-N-CA 122.483 2.122 . . . . 0.0 112.823 -179.829 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 684' ' ' GLU . . . . . 0.411 ' HG2' ' OG1' ' A' ' 682' ' ' THR . 24.8 pt-20 -79.4 -15.8 57.26 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.977 0.418 . . . . 0.0 110.397 179.074 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 685' ' ' GLN . . . . . . . . . . . . . 90.8 mt-30 -98.8 -36.34 9.84 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.013 -0.539 . . . . 0.0 111.355 179.954 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 686' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -128.03 115.27 18.23 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.696 -178.946 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 687' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -84.97 142.49 29.6 Favored 'General case' 0 CA--C 1.52 -0.187 0 N-CA-C 109.553 -0.536 . . . . 0.0 109.553 178.057 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 688' ' ' ILE . . . . . 0.403 HG22 HG12 ' A' ' 700' ' ' VAL . 78.7 mt -122.03 119.74 59.41 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.768 0 CA-C-O 121.336 0.589 . . . . 0.0 111.396 -178.96 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 689' ' ' PHE . . . . . . . . . . . . . 98.5 m-85 -117.09 141.89 47.69 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 114.906 -1.043 . . . . 0.0 109.59 178.779 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 690' ' ' ILE . . . . . 0.402 HD11 ' HZ ' ' A' ' 665' ' ' PHE . 18.2 tt -123.1 135.91 61.57 Favored 'Isoleucine or valine' 0 C--O 1.237 0.398 0 CA-C-O 121.171 0.51 . . . . 0.0 111.415 -179.647 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 691' ' ' LEU . . . . . 0.67 HD12 ' HB2' ' A' ' 662' ' ' ALA . 39.6 mt -109.35 125.91 52.85 Favored 'General case' 0 C--O 1.234 0.266 0 CA-C-N 115.741 -0.663 . . . . 0.0 109.679 179.831 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 692' ' ' GLY . . . . . 0.604 ' O ' ' HA ' ' A' ' 705' ' ' PRO . . . 175.32 -179.48 46.52 Favored Glycine 0 N--CA 1.446 -0.668 0 C-N-CA 120.676 -0.774 . . . . 0.0 112.199 -179.91 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 693' ' ' SER . . . . . . . . . . . . . 80.3 p -67.09 -36.37 81.82 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 120.715 0.293 . . . . 0.0 111.632 179.776 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 694' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -123.73 137.51 54.69 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.242 0.544 . . . . 0.0 110.97 179.948 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 695' ' ' GLY . . . . . 0.415 ' HA3' ' CB ' ' A' ' 703' ' ' TYR . . . -102.9 14.72 55.94 Favored Glycine 0 N--CA 1.449 -0.436 0 CA-C-N 115.327 -0.851 . . . . 0.0 112.882 179.543 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 696' ' ' ASN . . . . . . . . . . . . . 64.7 t30 -81.23 69.74 7.91 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 121.148 0.499 . . . . 0.0 111.284 -179.217 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 697' ' ' TYR . . . . . . . . . . . . . 97.0 m-85 -131.93 146.38 52.07 Favored 'General case' 0 N--CA 1.453 -0.316 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.027 179.174 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 698' ' ' GLN . . . . . . . . . . . . . 78.4 mt-30 -93.16 147.91 22.48 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.525 -179.831 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 699' ' ' GLY . . . . . 0.678 ' HA3' HG11 ' A' ' 674' ' ' VAL . . . 94.83 4.11 61.92 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.559 -0.829 . . . . 0.0 113.576 179.687 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 700' ' ' VAL . . . . . 0.403 HG12 HG22 ' A' ' 688' ' ' ILE . 29.5 m -119.16 148.92 21.79 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.272 0 CA-C-N 117.412 0.606 . . . . 0.0 110.142 179.149 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 701' ' ' ASP . . . . . 0.41 ' O ' ' HD2' ' A' ' 702' ' ' ARG . 34.4 t0 -80.75 -42.29 22.06 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.752 -0.658 . . . . 0.0 111.92 -179.177 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 702' ' ' ARG . . . . . 0.41 ' HD2' ' O ' ' A' ' 701' ' ' ASP . 2.0 mpt_? -141.02 164.37 30.47 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.763 0.316 . . . . 0.0 110.657 -178.486 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 703' ' ' TYR . . . . . 0.415 ' CB ' ' HA3' ' A' ' 695' ' ' GLY . 52.5 p90 -131.36 144.58 51.34 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.496 179.3 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 704' ' ' ILE . . . . . 0.454 HG22 HG22 ' A' ' 708' ' ' ILE . 31.2 mm -123.41 101.46 37.49 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-N 116.056 -0.52 . . . . 0.0 109.69 179.397 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 705' ' ' PRO . . . . . 0.604 ' HA ' ' O ' ' A' ' 692' ' ' GLY . 69.0 Cg_endo -72.41 145.67 43.29 Favored 'Trans proline' 0 C--N 1.345 0.355 0 C-N-CA 122.304 2.003 . . . . 0.0 113.788 -179.093 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 706' ' ' LEU . . . . . 0.702 HD23 HG23 ' A' ' 708' ' ' ILE . 81.5 mt -98.0 148.02 33.9 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-N 115.361 -0.836 . . . . 0.0 109.899 178.317 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 707' ' ' PRO . . . . . 0.51 ' C ' ' HA ' ' A' ' 706' ' ' LEU . 38.5 Cg_exo -64.34 138.22 31.72 Favored 'Cis proline' 0 C--N 1.348 0.551 0 C-N-CA 123.922 -1.283 . . . . 0.0 112.71 -1.219 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 708' ' ' ILE . . . . . 0.702 HG23 HD23 ' A' ' 706' ' ' LEU . 1.7 pt -68.04 137.42 24.6 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-O 121.383 0.611 . . . . 0.0 111.985 178.812 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 709' ' ' HIS . . . . . . . . . . . . . 69.8 m80 -107.15 111.2 63.54 Favored Pre-proline 0 C--N 1.321 -0.647 0 N-CA-C 108.377 -0.972 . . . . 0.0 108.377 177.297 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 710' ' ' PRO . . . . . . . . . . . . . 84.3 Cg_exo -53.03 -37.84 79.46 Favored 'Trans proline' 0 N--CA 1.479 0.636 0 C-N-CA 123.31 2.673 . . . . 0.0 114.381 -178.104 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 711' ' ' GLU . . . . . . . . . . . . . 88.7 tt0 -63.65 -42.88 98.06 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 112.208 0.447 . . . . 0.0 112.208 -178.903 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 712' ' ' SER . . . . . . . . . . . . . 51.1 m -90.64 -25.43 20.12 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 112.287 0.477 . . . . 0.0 112.287 -178.458 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 713' ' ' PHE . . . . . . . . . . . . . 68.1 t80 -59.25 -49.61 77.18 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-O 120.729 0.3 . . . . 0.0 111.228 -179.492 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 714' ' ' LEU . . . . . . . . . . . . . 58.3 tp -64.44 -41.28 96.66 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.259 179.731 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 715' ' ' GLN . . . . . . . . . . . . . 98.6 mm-40 -63.11 -42.55 99.58 Favored 'General case' 0 CA--C 1.531 0.245 0 CA-C-N 115.922 -0.581 . . . . 0.0 111.66 179.699 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 716' ' ' GLN . . . . . . . . . . . . . 79.6 mt-30 -64.13 -41.72 97.12 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-O 120.493 0.187 . . . . 0.0 111.349 179.947 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 717' ' ' VAL . . . . . . . . . . . . . 69.3 t -64.11 -44.16 97.59 Favored 'Isoleucine or valine' 0 C--O 1.234 0.248 0 CA-C-O 121.007 0.432 . . . . 0.0 109.945 178.758 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 718' ' ' THR . . . . . . . . . . . . . 90.3 m -61.88 -44.73 96.22 Favored 'General case' 0 CA--C 1.529 0.166 0 CA-C-N 115.673 -0.694 . . . . 0.0 111.041 179.708 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 719' ' ' MET . . . . . . . . . . . . . 38.7 mmt -61.31 -43.37 98.99 Favored 'General case' 0 N--CA 1.464 0.225 0 CA-C-O 120.545 0.212 . . . . 0.0 110.768 179.833 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 720' ' ' GLY . . . . . . . . . . . . . . . -64.03 -40.82 98.55 Favored Glycine 0 C--N 1.333 0.368 0 C-N-CA 120.747 -0.739 . . . . 0.0 111.624 178.235 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 721' ' ' LEU . . . . . . . . . . . . . 60.5 tp -64.64 -43.94 92.07 Favored 'General case' 0 CA--C 1.534 0.329 0 CA-C-N 115.349 -0.426 . . . . 0.0 111.353 179.327 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 722' ' ' THR . . . . . . . . . . . . . 70.4 p -70.74 -19.37 62.74 Favored 'General case' 0 N--CA 1.463 0.223 0 N-CA-C 112.127 0.418 . . . . 0.0 112.127 -179.958 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 723' ' ' SER . . . . . . . . . . . . . 73.3 m -63.65 -39.77 95.18 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-O 120.684 0.278 . . . . 0.0 110.582 179.111 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 724' ' ' LEU . . . . . . . . . . . . . 64.0 tp -63.56 -46.95 83.57 Favored 'General case' 0 C--O 1.232 0.153 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.232 179.526 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 725' ' ' ALA . . . . . . . . . . . . . . . -155.15 146.39 22.82 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.735 179.998 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 726' ' ' THR . . . . . . . . . . . . . 9.8 t -150.63 152.16 33.6 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.4 -0.364 . . . . 0.0 110.855 -179.806 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 727' ' ' SER . . . . . . . . . . . . . 90.2 p -87.99 -11.98 45.82 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.305 179.85 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 728' ' ' ALA . . . . . . . . . . . . . . . -149.15 150.57 32.89 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.445 -0.343 . . . . 0.0 110.89 -179.97 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 729' ' ' GLN . . . . . . . . . . . . . 9.1 tm0? . . . . . 0 C--O 1.249 1.052 0 CA-C-O 118.355 -0.831 . . . . 0.0 110.468 -179.874 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 613' ' ' GLU . . . . . 0.434 ' HA ' ' OXT' ' A' ' 729' ' ' GLN . 3.0 pt-20 . . . . . 0 N--CA 1.488 1.436 0 CA-C-O 121.084 0.469 . . . . 0.0 110.914 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 614' ' ' GLY . . . . . . . . . . . . . . . 108.42 131.52 6.46 Favored Glycine 0 N--CA 1.453 -0.229 0 CA-C-N 115.706 -0.679 . . . . 0.0 112.348 -179.94 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 615' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -117.23 125.23 50.81 Favored 'General case' 0 C--O 1.234 0.271 0 CA-C-O 120.802 0.334 . . . . 0.0 111.448 -179.394 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 616' ' ' ILE . . . . . 0.466 ' O ' ' HA ' ' A' ' 640' ' ' VAL . 85.9 mt -126.11 133.83 67.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 115.832 -0.622 . . . . 0.0 109.789 178.994 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 617' ' ' VAL . . . . . . . . . . . . . 91.5 t -106.78 127.94 61.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 121.055 0.455 . . . . 0.0 110.309 179.999 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 618' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -109.61 127.01 54.22 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.749 -0.66 . . . . 0.0 110.617 -178.93 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 619' ' ' VAL . . . . . . . . . . . . . 68.4 t -117.75 119.5 61.81 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-O 120.897 0.379 . . . . 0.0 110.186 179.979 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 620' ' ' SER . . . . . 0.646 ' HB2' ' HB3' ' A' ' 662' ' ' ALA . 32.1 t -171.36 137.9 1.14 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.638 -0.71 . . . . 0.0 110.923 -179.715 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 621' ' ' GLU . . . . . . . . . . . . . 26.3 pt-20 -82.99 -12.8 56.97 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.002 -0.545 . . . . 0.0 111.689 178.998 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 622' ' ' ASP . . . . . . . . . . . . . 35.8 t70 -91.22 110.06 21.33 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-O 120.884 0.373 . . . . 0.0 110.676 -179.333 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 623' ' ' GLU . . . . . . . . . . . . . 51.2 mp0 -63.16 -39.78 95.65 Favored 'General case' 0 CA--C 1.531 0.243 0 N-CA-C 112.763 0.653 . . . . 0.0 112.763 -178.854 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 624' ' ' ALA . . . . . . . . . . . . . . . -61.32 -45.73 93.22 Favored 'General case' 0 N--CA 1.464 0.246 0 N-CA-C 112.739 0.644 . . . . 0.0 112.739 -177.994 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 625' ' ' THR . . . . . 0.416 ' O ' HG22 ' A' ' 629' ' ' ILE . 89.7 m -70.84 -41.26 71.7 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.928 0.394 . . . . 0.0 110.623 179.629 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 626' ' ' SER . . . . . . . . . . . . . 66.7 m -62.47 -42.78 99.72 Favored 'General case' 0 CA--C 1.53 0.203 0 CA-C-N 115.713 -0.676 . . . . 0.0 112.468 -178.29 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 627' ' ' THR . . . . . . . . . . . . . 35.7 p -66.96 -39.65 87.31 Favored 'General case' 0 N--CA 1.466 0.345 0 N-CA-C 112.545 0.572 . . . . 0.0 112.545 -179.463 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 628' ' ' LEU . . . . . . . . . . . . . 62.9 tp -64.94 -47.07 78.99 Favored 'General case' 0 CA--C 1.533 0.322 0 N-CA-C 112.215 0.45 . . . . 0.0 112.215 -179.614 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 629' ' ' ILE . . . . . 0.431 HD13 HD11 ' A' ' 691' ' ' LEU . 16.0 tt -71.83 -36.55 58.83 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.395 0 N-CA-C 112.991 0.738 . . . . 0.0 112.991 -178.814 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 630' ' ' CYS . . . . . . . . . . . . . 85.8 m -62.63 -39.59 94.32 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-O 120.6 0.238 . . . . 0.0 111.242 -179.692 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 631' ' ' SER . . . . . . . . . . . . . 67.0 m -62.12 -41.23 98.02 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.684 179.7 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 632' ' ' ILE . . . . . . . . . . . . . 97.1 mt -63.02 -47.79 91.05 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.269 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.685 179.548 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 633' ' ' LEU . . . . . . . . . . . . . 79.8 mt -66.29 -40.34 89.97 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-N 115.902 -0.59 . . . . 0.0 112.335 -179.701 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 634' ' ' THR . . . . . 0.495 ' HA ' ' O ' ' A' ' 638' ' ' TYR . 77.1 m -65.94 -40.5 91.42 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 120.749 0.309 . . . . 0.0 110.629 -179.667 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 635' ' ' THR . . . . . . . . . . . . . 92.8 m -59.12 -38.82 80.5 Favored 'General case' 0 CA--C 1.529 0.161 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.248 178.983 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 636' ' ' ALA . . . . . . . . . . . . . . . -64.3 -17.48 63.69 Favored 'General case' 0 CA--C 1.533 0.294 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.363 178.759 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 637' ' ' GLY . . . . . . . . . . . . . . . 108.98 6.6 29.92 Favored Glycine 0 C--N 1.335 0.488 0 C-N-CA 121.063 -0.589 . . . . 0.0 113.331 179.61 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 638' ' ' TYR . . . . . 0.495 ' O ' ' HA ' ' A' ' 634' ' ' THR . 91.8 m-85 -100.35 141.72 32.81 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.913 0.356 . . . . 0.0 111.516 -179.862 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 639' ' ' GLN . . . . . . . . . . . . . 97.5 mt-30 -87.56 133.86 33.72 Favored 'General case' 0 CA--C 1.517 -0.307 0 N-CA-C 109.84 -0.43 . . . . 0.0 109.84 178.959 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 640' ' ' VAL . . . . . 0.466 ' HA ' ' O ' ' A' ' 616' ' ' ILE . 58.4 t -119.71 131.52 71.99 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 N-CA-C 112.69 0.626 . . . . 0.0 112.69 -179.022 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 641' ' ' ILE . . . . . . . . . . . . . 4.1 mp -109.57 116.35 51.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 N-CA-C 107.815 -1.18 . . . . 0.0 107.815 177.891 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 642' ' ' TRP . . . . . . . . . . . . . 20.9 t90 -96.64 125.77 41.34 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 112.549 0.574 . . . . 0.0 112.549 -177.695 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 643' ' ' LEU . . . . . . . . . . . . . 89.3 mt -122.61 143.48 49.73 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-N 115.417 -0.811 . . . . 0.0 110.594 179.304 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 644' ' ' VAL . . . . . . . . . . . . . 6.3 m -110.14 23.36 4.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 N-CA-C 112.565 0.58 . . . . 0.0 112.565 -179.799 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 645' ' ' ASP . . . . . . . . . . . . . 20.4 t0 -137.15 -34.71 0.71 Allowed 'General case' 0 N--CA 1.469 0.503 0 N-CA-C 113.221 0.823 . . . . 0.0 113.221 -178.24 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 646' ' ' GLY . . . . . . . . . . . . . . . 80.37 22.69 62.17 Favored Glycine 0 CA--C 1.522 0.476 0 C-N-CA 120.624 -0.798 . . . . 0.0 113.953 -179.683 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 647' ' ' GLU . . . . . . . . . . . . . 57.6 mm-40 -62.58 120.11 10.52 Favored 'General case' 0 C--O 1.231 0.124 0 CA-C-O 121.298 0.571 . . . . 0.0 111.104 179.98 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 648' ' ' VAL . . . . . . . . . . . . . 10.9 p -64.0 -31.02 51.62 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-N 114.941 -1.027 . . . . 0.0 111.974 -179.416 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 649' ' ' GLU . . . . . . . . . . . . . 78.8 mm-40 -63.54 -43.75 96.2 Favored 'General case' 0 C--O 1.232 0.144 0 N-CA-C 109.997 -0.371 . . . . 0.0 109.997 179.775 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 650' ' ' ARG . . . . . . . . . . . . . 74.6 mtm180 -71.63 -39.43 70.43 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.332 178.389 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 651' ' ' LEU . . . . . . . . . . . . . 85.8 mt -63.49 -41.7 98.56 Favored 'General case' 0 N--CA 1.462 0.172 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.187 179.027 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 652' ' ' LEU . . . . . . . . . . . . . 61.2 tp -64.61 -43.81 92.6 Favored 'General case' 0 CA--C 1.53 0.185 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.913 178.576 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 653' ' ' ALA . . . . . . . . . . . . . . . -62.97 -39.39 94.55 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.705 179.732 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 654' ' ' LEU . . . . . . . . . . . . . 75.2 mt -100.05 29.63 4.16 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.084 -179.413 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 655' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -31.59 104.33 0.22 Allowed Pre-proline 0 N--CA 1.473 0.718 0 O-C-N 124.527 1.142 . . . . 0.0 113.637 -179.516 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 656' ' ' PRO . . . . . . . . . . . . . 28.6 Cg_endo -93.56 177.91 1.19 Allowed 'Trans proline' 0 N--CA 1.461 -0.408 0 C-N-CA 123.634 2.889 . . . . 0.0 112.739 179.211 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 657' ' ' ILE . . . . . . . . . . . . . 89.6 mt -72.98 -38.49 56.12 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 N-CA-C 108.5 -0.926 . . . . 0.0 108.5 177.831 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 658' ' ' ALA . . . . . 0.443 ' HB2' ' HB2' ' A' ' 687' ' ' LYS . . . -151.66 155.06 37.6 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 114.216 -1.356 . . . . 0.0 111.609 -178.844 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 659' ' ' VAL . . . . . . . . . . . . . 17.5 m -122.06 146.38 27.29 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.897 178.924 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 660' ' ' LEU . . . . . . . . . . . . . 5.9 mt -117.85 116.99 28.08 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.525 -0.761 . . . . 0.0 110.277 179.263 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 661' ' ' LEU . . . . . . . . . . . . . 76.3 mt -106.22 113.6 27.23 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 179.44 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 662' ' ' ALA . . . . . 0.646 ' HB3' ' HB2' ' A' ' 620' ' ' SER . . . -106.3 130.85 54.07 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 112.536 0.569 . . . . 0.0 112.536 -178.679 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 663' ' ' GLU . . . . . 0.463 ' HA ' ' C ' ' A' ' 664' ' ' PRO . 96.9 mt-10 -73.22 145.93 86.31 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-N 115.4 -0.818 . . . . 0.0 110.881 178.816 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 664' ' ' PRO . . . . . 0.463 ' C ' ' HA ' ' A' ' 663' ' ' GLU . 23.9 Cg_exo -67.38 136.8 34.27 Favored 'Cis proline' 0 C--N 1.349 0.57 0 C-N-CA 123.769 -1.346 . . . . 0.0 112.348 -1.697 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 665' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -72.79 116.15 12.93 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.921 179.66 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 666' ' ' SER . . . . . . . . . . . . . 80.2 p -64.83 -38.37 90.76 Favored 'General case' 0 CA--C 1.531 0.224 0 CA-C-N 116.131 -0.486 . . . . 0.0 112.257 -179.448 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 667' ' ' TYR . . . . . . . . . . . . . 69.1 t80 -65.67 -24.03 66.92 Favored 'General case' 0 CA--C 1.534 0.346 0 CA-C-O 120.766 0.317 . . . . 0.0 111.671 179.629 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 668' ' ' GLY . . . . . . . . . . . . . . . 100.27 -103.57 2.66 Favored Glycine 0 N--CA 1.45 -0.411 0 C-N-CA 120.395 -0.907 . . . . 0.0 112.283 -179.175 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 669' ' ' ASP . . . . . 0.428 ' OD2' ' HG3' ' A' ' 672' ' ' GLU . 27.6 t70 -82.52 103.99 12.47 Favored 'General case' 0 C--N 1.327 -0.402 0 O-C-N 122.671 -0.311 . . . . 0.0 110.246 -179.467 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 670' ' ' VAL . . . . . . . . . . . . . 16.9 m -66.46 -24.45 33.24 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.326 0 N-CA-C 113.116 0.784 . . . . 0.0 113.116 -179.126 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 671' ' ' GLN . . . . . 0.473 ' HA ' HG22 ' A' ' 674' ' ' VAL . 23.7 mp0 -62.35 -39.71 93.99 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.882 0.372 . . . . 0.0 110.723 179.837 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 672' ' ' GLU . . . . . 0.428 ' HG3' ' OD2' ' A' ' 669' ' ' ASP . 95.6 mt-10 -64.89 -38.79 92.14 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.323 178.342 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 673' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -68.23 -46.67 69.89 Favored 'General case' 0 CA--C 1.519 -0.231 0 CA-C-N 115.925 -0.58 . . . . 0.0 111.322 179.981 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 674' ' ' VAL . . . . . 0.473 HG22 ' HA ' ' A' ' 671' ' ' GLN . 34.3 m -65.37 -36.92 78.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 N-CA-C 109.977 -0.379 . . . . 0.0 109.977 -179.631 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 675' ' ' ASP . . . . . 0.433 ' O ' ' HB2' ' A' ' 679' ' ' GLN . 36.9 t70 -62.58 -40.86 98.22 Favored 'General case' 0 C--O 1.225 -0.232 0 N-CA-C 109.827 -0.435 . . . . 0.0 109.827 177.388 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 676' ' ' GLN . . . . . . . . . . . . . 55.3 mt-30 -70.64 -40.77 72.88 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.74 179.551 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 677' ' ' LEU . . . . . . . . . . . . . 85.2 mt -64.85 -41.17 95.92 Favored 'General case' 0 C--N 1.333 -0.113 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.28 179.559 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 678' ' ' ARG . . . . . 0.635 ' HA ' ' O ' ' A' ' 681' ' ' CYS . 84.9 mtp180 -81.9 -15.18 54.78 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-N 116.465 -0.334 . . . . 0.0 111.655 -179.312 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 679' ' ' GLN . . . . . 0.433 ' HB2' ' O ' ' A' ' 675' ' ' ASP . 53.1 tt0 -65.74 -39.9 91.57 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.154 179.835 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 680' ' ' ARG . . . . . 0.414 ' H ' ' HG2' ' A' ' 680' ' ' ARG . 0.0 OUTLIER -107.49 -29.12 9.4 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.405 -0.361 . . . . 0.0 111.909 -179.744 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 681' ' ' CYS . . . . . 0.635 ' O ' ' HA ' ' A' ' 678' ' ' ARG . 76.0 m -118.95 131.02 56.01 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.71 0.29 . . . . 0.0 110.563 179.684 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 682' ' ' THR . . . . . 0.411 ' HB ' ' HD2' ' A' ' 683' ' ' PRO . 63.4 p -72.69 158.08 87.87 Favored Pre-proline 0 C--N 1.325 -0.483 0 N-CA-C 110.09 -0.337 . . . . 0.0 110.09 179.859 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 683' ' ' PRO . . . . . 0.411 ' HD2' ' HB ' ' A' ' 682' ' ' THR . 18.0 Cg_endo -60.02 -26.46 82.48 Favored 'Trans proline' 0 C--N 1.348 0.543 0 C-N-CA 122.169 1.913 . . . . 0.0 112.032 179.516 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 684' ' ' GLU . . . . . . . . . . . . . 51.6 mp0 -71.3 -38.74 71.75 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 121.063 0.459 . . . . 0.0 110.352 178.571 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 685' ' ' GLN . . . . . . . . . . . . . 90.1 mt-30 -72.42 -40.73 66.89 Favored 'General case' 0 N--CA 1.462 0.127 0 CA-C-N 115.611 -0.722 . . . . 0.0 111.942 179.516 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 686' ' ' LEU . . . . . . . . . . . . . 51.5 tp -131.31 119.25 21.48 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.501 -178.81 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 687' ' ' LYS . . . . . 0.443 ' HB2' ' HB2' ' A' ' 658' ' ' ALA . 75.2 mmtt -88.4 145.4 25.81 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.381 0.61 . . . . 0.0 110.647 179.191 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 688' ' ' ILE . . . . . 0.529 HG22 HG12 ' A' ' 700' ' ' VAL . 78.1 mt -123.78 120.91 61.05 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.679 0 CA-C-N 115.572 -0.74 . . . . 0.0 110.855 -179.072 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 689' ' ' PHE . . . . . 0.471 ' CD2' ' HB2' ' A' ' 702' ' ' ARG . 97.9 m-85 -118.76 144.78 46.06 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.09 -0.959 . . . . 0.0 110.096 179.418 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 690' ' ' ILE . . . . . . . . . . . . . 18.7 tt -127.01 139.96 50.42 Favored 'Isoleucine or valine' 0 C--O 1.236 0.363 0 CA-C-O 121.113 0.482 . . . . 0.0 111.196 179.518 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 691' ' ' LEU . . . . . 0.563 HD12 ' HB2' ' A' ' 662' ' ' ALA . 58.5 mt -110.37 133.23 53.46 Favored 'General case' 0 C--O 1.234 0.272 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.142 179.94 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 692' ' ' GLY . . . . . 0.592 ' O ' ' HA ' ' A' ' 705' ' ' PRO . . . 168.31 -176.56 42.71 Favored Glycine 0 N--CA 1.446 -0.666 0 CA-C-N 115.814 -0.63 . . . . 0.0 111.836 179.933 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 693' ' ' SER . . . . . . . . . . . . . 80.1 p -67.97 -36.62 80.35 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.811 0.339 . . . . 0.0 111.19 179.497 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 694' ' ' LYS . . . . . . . . . . . . . 64.7 mttp -124.39 136.77 54.33 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.045 0.45 . . . . 0.0 110.604 179.44 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 695' ' ' GLY . . . . . 0.522 ' HA3' ' CB ' ' A' ' 703' ' ' TYR . . . -103.56 14.01 53.98 Favored Glycine 0 N--CA 1.449 -0.438 0 CA-C-N 115.512 -0.767 . . . . 0.0 112.956 179.587 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 696' ' ' ASN . . . . . . . . . . . . . 64.9 t30 -82.03 72.29 9.08 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.958 0.408 . . . . 0.0 111.531 -179.091 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 697' ' ' TYR . . . . . . . . . . . . . 97.4 m-85 -131.37 144.92 51.58 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.175 178.959 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 698' ' ' GLN . . . . . . . . . . . . . 22.2 mp0 -82.4 147.21 28.91 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.747 179.81 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 699' ' ' GLY . . . . . 0.472 ' HA3' HG21 ' A' ' 674' ' ' VAL . . . 94.21 2.55 64.0 Favored Glycine 0 C--O 1.228 -0.224 0 C-N-CA 120.722 -0.752 . . . . 0.0 114.02 179.267 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 700' ' ' VAL . . . . . 0.529 HG12 HG22 ' A' ' 688' ' ' ILE . 24.9 m -119.61 150.51 22.1 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.298 0 CA-C-N 117.706 0.753 . . . . 0.0 110.165 179.283 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 701' ' ' ASP . . . . . . . . . . . . . 28.8 t0 -88.01 -39.79 14.39 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.958 -179.387 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 702' ' ' ARG . . . . . 0.471 ' HB2' ' CD2' ' A' ' 689' ' ' PHE . 90.7 mmt-85 -140.95 161.48 37.73 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.705 -178.394 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 703' ' ' TYR . . . . . 0.522 ' CB ' ' HA3' ' A' ' 695' ' ' GLY . 52.6 p90 -130.45 146.58 52.03 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.562 179.378 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 704' ' ' ILE . . . . . 0.514 ' HB ' ' CD2' ' A' ' 691' ' ' LEU . 52.9 mt -129.1 97.19 26.78 Favored Pre-proline 0 C--O 1.234 0.258 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.317 -179.982 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 705' ' ' PRO . . . . . 0.592 ' HA ' ' O ' ' A' ' 692' ' ' GLY . 74.5 Cg_endo -74.59 154.31 44.5 Favored 'Trans proline' 0 C--N 1.347 0.456 0 C-N-CA 122.92 2.413 . . . . 0.0 113.626 -179.126 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 706' ' ' LEU . . . . . 0.467 ' HA ' ' C ' ' A' ' 707' ' ' PRO . 7.2 mp -97.1 148.6 34.63 Favored Pre-proline 0 CA--C 1.531 0.25 0 CA-C-N 115.738 -0.664 . . . . 0.0 110.041 178.892 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 707' ' ' PRO . . . . . 0.467 ' C ' ' HA ' ' A' ' 706' ' ' LEU . 55.3 Cg_endo -69.48 138.41 48.19 Favored 'Cis proline' 0 C--N 1.347 0.495 0 C-N-CA 123.001 -1.666 . . . . 0.0 112.435 -0.293 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 708' ' ' ILE . . . . . 0.469 HG12 HG22 ' A' ' 704' ' ' ILE . 71.9 mt -81.16 118.94 29.81 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-N 115.859 -0.609 . . . . 0.0 110.55 -179.94 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 709' ' ' HIS . . . . . . . . . . . . . 68.6 m80 -89.45 122.55 68.29 Favored Pre-proline 0 C--N 1.327 -0.41 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.31 179.35 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 710' ' ' PRO . . . . . . . . . . . . . 88.2 Cg_exo -52.72 -38.65 77.38 Favored 'Trans proline' 0 N--CA 1.481 0.742 0 C-N-CA 123.474 2.782 . . . . 0.0 114.7 -178.622 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 711' ' ' GLU . . . . . . . . . . . . . 88.8 tt0 -64.03 -45.55 88.38 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-O 120.946 0.403 . . . . 0.0 111.59 -178.839 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 712' ' ' SER . . . . . . . . . . . . . 50.5 m -80.59 -26.67 37.73 Favored 'General case' 0 CA--C 1.516 -0.355 0 CA-C-N 116.09 -0.505 . . . . 0.0 111.181 -179.711 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 713' ' ' PHE . . . . . 0.477 ' O ' HG23 ' A' ' 717' ' ' VAL . 86.7 t80 -60.2 -50.0 75.4 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.668 -0.242 . . . . 0.0 111.069 -179.533 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 714' ' ' LEU . . . . . 0.464 HD13 ' HA ' ' A' ' 714' ' ' LEU . 1.5 mm? -66.31 -42.88 87.65 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-O 120.853 0.358 . . . . 0.0 110.746 179.876 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 715' ' ' GLN . . . . . . . . . . . . . 72.1 tp60 -63.19 -42.26 99.3 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.924 179.525 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 716' ' ' GLN . . . . . . . . . . . . . 70.0 tp60 -65.84 -41.51 91.64 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.852 179.694 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 717' ' ' VAL . . . . . 0.477 HG23 ' O ' ' A' ' 713' ' ' PHE . 55.7 t -63.41 -42.72 97.29 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.107 0 N-CA-C 109.875 -0.417 . . . . 0.0 109.875 178.524 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 718' ' ' THR . . . . . . . . . . . . . 91.9 m -61.09 -43.85 98.25 Favored 'General case' 0 C--O 1.235 0.298 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.364 179.13 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 719' ' ' MET . . . . . 0.552 ' O ' HG22 ' A' ' 722' ' ' THR . 18.3 tpt -61.17 -45.88 92.79 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.001 178.987 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 720' ' ' GLY . . . . . . . . . . . . . . . -65.27 -37.81 94.38 Favored Glycine 0 CA--C 1.52 0.364 0 CA-C-N 116.012 -0.54 . . . . 0.0 112.294 178.286 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 721' ' ' LEU . . . . . 0.422 ' O ' HD22 ' A' ' 724' ' ' LEU . 63.9 tp -60.99 -43.42 98.86 Favored 'General case' 0 N--CA 1.463 0.223 0 C-N-CA 123.255 0.622 . . . . 0.0 112.568 -179.359 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 722' ' ' THR . . . . . 0.552 HG22 ' O ' ' A' ' 719' ' ' MET . 5.4 t -64.99 161.68 18.16 Favored 'General case' 0 CA--C 1.534 0.345 0 CA-C-O 120.756 0.312 . . . . 0.0 111.595 -179.326 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 723' ' ' SER . . . . . . . . . . . . . 50.1 m 62.49 46.79 5.44 Favored 'General case' 0 N--CA 1.467 0.423 0 CA-C-N 115.946 -0.57 . . . . 0.0 111.227 -179.215 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 724' ' ' LEU . . . . . 0.723 HD11 ' HB3' ' A' ' 727' ' ' SER . 1.3 pt? -119.87 -179.57 3.95 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.362 179.828 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 725' ' ' ALA . . . . . . . . . . . . . . . -78.41 -71.75 0.41 Allowed 'General case' 0 N--CA 1.462 0.154 0 N-CA-C 111.814 0.301 . . . . 0.0 111.814 -179.229 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 726' ' ' THR . . . . . . . . . . . . . 77.8 p -130.75 149.98 52.14 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.585 0.231 . . . . 0.0 111.206 180.0 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 727' ' ' SER . . . . . 0.723 ' HB3' HD11 ' A' ' 724' ' ' LEU . 95.6 p -157.12 161.06 39.38 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.42 -0.355 . . . . 0.0 110.513 179.799 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 728' ' ' ALA . . . . . . . . . . . . . . . -149.61 147.14 27.77 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.374 -0.376 . . . . 0.0 110.527 179.519 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 729' ' ' GLN . . . . . 0.434 ' OXT' ' HA ' ' A' ' 613' ' ' GLU . 6.4 tm0? . . . . . 0 C--O 1.25 1.08 0 CA-C-O 118.063 -0.97 . . . . 0.0 110.377 179.885 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 613' ' ' GLU . . . . . . . . . . . . . 75.6 mm-40 . . . . . 0 N--CA 1.487 1.379 0 CA-C-O 120.895 0.379 . . . . 0.0 110.698 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 614' ' ' GLY . . . . . . . . . . . . . . . -178.85 173.34 45.61 Favored Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.662 -0.78 . . . . 0.0 112.534 179.863 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 615' ' ' ARG . . . . . . . . . . . . . 35.7 mtp-105 -117.32 126.55 52.9 Favored 'General case' 0 C--O 1.234 0.271 0 CA-C-O 120.72 0.295 . . . . 0.0 111.088 -179.873 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 616' ' ' ILE . . . . . 0.447 ' O ' ' HA ' ' A' ' 640' ' ' VAL . 84.7 mt -126.35 133.96 67.53 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.29 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.398 179.483 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 617' ' ' VAL . . . . . . . . . . . . . 77.2 t -104.53 127.67 58.73 Favored 'Isoleucine or valine' 0 C--O 1.234 0.289 0 CA-C-O 120.995 0.426 . . . . 0.0 109.887 179.658 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 618' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -111.92 127.44 55.85 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.809 -0.632 . . . . 0.0 111.02 -178.456 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 619' ' ' VAL . . . . . . . . . . . . . 80.4 t -115.73 117.75 56.58 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 N-CA-C 109.262 -0.644 . . . . 0.0 109.262 179.405 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 620' ' ' SER . . . . . 0.49 ' HB2' ' HB3' ' A' ' 662' ' ' ALA . 47.2 t -162.23 139.8 8.48 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.944 -0.571 . . . . 0.0 111.554 -178.838 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 621' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -82.15 -26.89 33.05 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.747 -0.661 . . . . 0.0 111.182 178.705 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 622' ' ' ASP . . . . . . . . . . . . . 36.9 t70 -86.08 112.74 21.55 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.921 0.391 . . . . 0.0 111.64 -178.32 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 623' ' ' GLU . . . . . . . . . . . . . 50.9 mp0 -62.9 -40.02 96.3 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.438 -0.801 . . . . 0.0 112.447 -179.593 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 624' ' ' ALA . . . . . . . . . . . . . . . -60.8 -45.53 94.04 Favored 'General case' 0 N--CA 1.466 0.337 0 N-CA-C 112.592 0.59 . . . . 0.0 112.592 -178.283 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 625' ' ' THR . . . . . 0.446 ' O ' HG22 ' A' ' 629' ' ' ILE . 90.6 m -68.8 -39.86 79.87 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.965 0.412 . . . . 0.0 110.021 179.538 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 626' ' ' SER . . . . . . . . . . . . . 69.1 m -61.44 -41.13 96.73 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.494 -0.775 . . . . 0.0 111.866 -178.937 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 627' ' ' THR . . . . . . . . . . . . . 65.9 p -67.37 -35.23 78.92 Favored 'General case' 0 N--CA 1.466 0.336 0 N-CA-C 112.382 0.512 . . . . 0.0 112.382 -179.812 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 628' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -71.72 -49.42 39.55 Favored 'General case' 0 N--CA 1.463 0.22 0 N-CA-C 111.925 0.343 . . . . 0.0 111.925 -179.47 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 629' ' ' ILE . . . . . 0.446 HG22 ' O ' ' A' ' 625' ' ' THR . 18.7 tt -68.34 -37.52 78.05 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.384 0 N-CA-C 112.19 0.441 . . . . 0.0 112.19 -179.124 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 630' ' ' CYS . . . . . . . . . . . . . 48.2 t -61.61 -43.66 98.44 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.857 179.776 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 631' ' ' SER . . . . . . . . . . . . . 70.2 m -61.91 -41.51 98.0 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.962 -179.611 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 632' ' ' ILE . . . . . . . . . . . . . 97.4 mt -62.45 -48.54 87.8 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.283 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.863 179.819 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 633' ' ' LEU . . . . . . . . . . . . . 84.3 mt -67.2 -40.0 86.4 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-N 115.867 -0.606 . . . . 0.0 112.395 -179.708 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 634' ' ' THR . . . . . 0.53 ' HA ' ' O ' ' A' ' 638' ' ' TYR . 77.7 m -65.74 -40.08 91.76 Favored 'General case' 0 CA--C 1.529 0.168 0 CA-C-O 120.701 0.286 . . . . 0.0 110.852 -179.458 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 635' ' ' THR . . . . . . . . . . . . . 93.2 m -59.09 -38.95 80.71 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.261 179.28 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 636' ' ' ALA . . . . . . . . . . . . . . . -64.67 -16.84 63.44 Favored 'General case' 0 CA--C 1.533 0.305 0 CA-C-N 115.931 -0.577 . . . . 0.0 111.329 178.905 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 637' ' ' GLY . . . . . . . . . . . . . . . 108.67 7.34 29.82 Favored Glycine 0 C--N 1.333 0.413 0 C-N-CA 120.929 -0.653 . . . . 0.0 113.182 179.681 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 638' ' ' TYR . . . . . 0.53 ' O ' ' HA ' ' A' ' 634' ' ' THR . 96.5 m-85 -100.23 141.46 33.05 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.803 0.302 . . . . 0.0 111.415 -179.847 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 639' ' ' GLN . . . . . . . . . . . . . 78.5 mt-30 -87.91 133.26 33.96 Favored 'General case' 0 CA--C 1.517 -0.325 0 N-CA-C 109.796 -0.446 . . . . 0.0 109.796 179.199 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 640' ' ' VAL . . . . . 0.447 ' HA ' ' O ' ' A' ' 616' ' ' ILE . 60.1 t -118.11 130.47 72.93 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 N-CA-C 112.547 0.573 . . . . 0.0 112.547 -179.161 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 641' ' ' ILE . . . . . . . . . . . . . 4.0 mp -109.36 115.37 49.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 N-CA-C 108.013 -1.106 . . . . 0.0 108.013 178.09 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 642' ' ' TRP . . . . . . . . . . . . . 22.0 t90 -94.47 126.03 39.49 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 121.237 0.541 . . . . 0.0 112.26 -177.986 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 643' ' ' LEU . . . . . . . . . . . . . 89.6 mt -121.15 142.89 49.45 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-N 115.407 -0.815 . . . . 0.0 110.779 179.531 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 644' ' ' VAL . . . . . . . . . . . . . 5.7 m -102.93 27.26 1.01 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.81 179.711 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 645' ' ' ASP . . . . . 0.426 ' O ' ' HB2' ' A' ' 666' ' ' SER . 33.6 t70 -142.48 -73.86 0.3 Allowed 'General case' 0 N--CA 1.465 0.296 0 CA-C-O 120.736 0.303 . . . . 0.0 111.76 -179.458 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 646' ' ' GLY . . . . . . . . . . . . . . . 104.93 27.14 6.06 Favored Glycine 0 CA--C 1.518 0.278 0 C-N-CA 120.819 -0.705 . . . . 0.0 113.612 -179.894 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 647' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -71.07 143.35 50.72 Favored 'General case' 0 N--CA 1.453 -0.302 0 CA-C-O 121.529 0.681 . . . . 0.0 110.93 179.436 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 648' ' ' VAL . . . . . . . . . . . . . 78.5 t -61.22 -40.13 84.9 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 CA-C-N 114.553 -1.203 . . . . 0.0 112.666 -178.231 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 649' ' ' GLU . . . . . . . . . . . . . 98.3 mt-10 -60.31 -45.03 94.83 Favored 'General case' 0 C--O 1.232 0.157 0 C-N-CA 120.58 -0.448 . . . . 0.0 111.339 -178.531 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 650' ' ' ARG . . . . . . . . . . . . . 54.8 mmm-85 -71.02 -40.6 71.68 Favored 'General case' 0 C--N 1.33 -0.25 0 C-N-CA 121.02 -0.272 . . . . 0.0 110.987 178.682 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 651' ' ' LEU . . . . . . . . . . . . . 86.4 mt -64.52 -41.65 96.26 Favored 'General case' 0 N--CA 1.461 0.105 0 CA-C-N 116.438 -0.346 . . . . 0.0 110.615 179.393 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 652' ' ' LEU . . . . . . . . . . . . . 60.8 tp -65.81 -43.37 88.84 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.226 178.751 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 653' ' ' ALA . . . . . . . . . . . . . . . -63.02 -39.72 95.6 Favored 'General case' 0 N--CA 1.466 0.332 0 N-CA-C 112.075 0.398 . . . . 0.0 112.075 -179.802 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 654' ' ' LEU . . . . . . . . . . . . . 75.3 mt -101.74 29.15 5.1 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.091 -179.354 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 655' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -33.92 104.96 0.25 Allowed Pre-proline 0 N--CA 1.472 0.651 0 O-C-N 124.571 1.169 . . . . 0.0 114.095 -179.094 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 656' ' ' PRO . . . . . . . . . . . . . 22.8 Cg_endo -93.72 -179.35 0.81 Allowed 'Trans proline' 0 C--N 1.345 0.385 0 C-N-CA 123.814 3.009 . . . . 0.0 112.473 178.271 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 657' ' ' ILE . . . . . 0.462 ' O ' ' HA ' ' A' ' 686' ' ' LEU . 94.9 mt -72.04 -38.17 62.79 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 N-CA-C 108.557 -0.905 . . . . 0.0 108.557 177.765 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 658' ' ' ALA . . . . . . . . . . . . . . . -152.61 155.73 37.92 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 114.282 -1.326 . . . . 0.0 111.552 -178.598 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 659' ' ' VAL . . . . . 0.457 HG13 HD11 ' A' ' 686' ' ' LEU . 18.3 m -122.05 145.45 28.73 Favored 'Isoleucine or valine' 0 C--O 1.235 0.316 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.942 178.971 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 660' ' ' LEU . . . . . . . . . . . . . 5.4 mt -116.44 115.02 25.06 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.507 -0.77 . . . . 0.0 109.215 178.435 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 661' ' ' LEU . . . . . . . . . . . . . 62.0 mt -104.24 115.6 30.7 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 109.813 -0.44 . . . . 0.0 109.813 -179.088 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 662' ' ' ALA . . . . . 0.49 ' HB3' ' HB2' ' A' ' 620' ' ' SER . . . -108.42 132.23 53.98 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 112.763 0.653 . . . . 0.0 112.763 -178.973 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 663' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -76.65 146.14 76.23 Favored Pre-proline 0 C--N 1.326 -0.421 0 CA-C-N 115.376 -0.829 . . . . 0.0 109.978 178.081 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 664' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -72.43 139.97 63.59 Favored 'Cis proline' 0 C--N 1.348 0.551 0 C-N-CA 123.446 -1.481 . . . . 0.0 112.897 -0.751 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 665' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -83.87 144.52 29.18 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.366 -0.833 . . . . 0.0 112.27 -179.816 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 666' ' ' SER . . . . . 0.426 ' HB2' ' O ' ' A' ' 645' ' ' ASP . 47.9 m -98.04 -33.74 11.06 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.251 179.301 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 667' ' ' TYR . . . . . . . . . . . . . 18.9 p90 -61.67 -16.11 45.84 Favored 'General case' 0 CA--C 1.536 0.409 0 N-CA-C 112.7 0.63 . . . . 0.0 112.7 179.863 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 668' ' ' GLY . . . . . . . . . . . . . . . 101.47 -120.38 6.84 Favored Glycine 0 N--CA 1.449 -0.489 0 C-N-CA 120.614 -0.803 . . . . 0.0 113.523 179.228 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 669' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -76.26 118.52 19.06 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.995 0.426 . . . . 0.0 111.849 -178.07 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 670' ' ' VAL . . . . . 0.426 ' O ' HG23 ' A' ' 674' ' ' VAL . 77.8 t -61.78 -43.15 96.85 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.289 0 CA-C-N 115.446 -0.797 . . . . 0.0 112.345 -179.469 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 671' ' ' GLN . . . . . . . . . . . . . 20.8 mp0 -60.76 -42.53 97.65 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.562 0.22 . . . . 0.0 111.447 -178.029 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 672' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -65.11 -40.32 94.35 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.515 -0.311 . . . . 0.0 110.957 179.408 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 673' ' ' LEU . . . . . . . . . . . . . 63.1 tp -63.4 -43.52 97.3 Favored 'General case' 0 C--N 1.331 -0.23 0 N-CA-C 109.561 -0.533 . . . . 0.0 109.561 178.754 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 674' ' ' VAL . . . . . 0.734 HG11 ' HA3' ' A' ' 699' ' ' GLY . 55.0 t -61.83 -44.86 99.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 115.18 -0.918 . . . . 0.0 110.107 179.438 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 675' ' ' ASP . . . . . . . . . . . . . 99.5 m-20 -60.91 -39.61 89.99 Favored 'General case' 0 CA--C 1.519 -0.226 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.47 179.015 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 676' ' ' GLN . . . . . 0.42 ' O ' ' HG2' ' A' ' 680' ' ' ARG . 57.2 mt-30 -70.77 -41.85 71.19 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.396 -0.366 . . . . 0.0 110.709 179.788 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 677' ' ' LEU . . . . . . . . . . . . . 84.8 mt -65.21 -42.67 93.25 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.113 179.457 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 678' ' ' ARG . . . . . 0.485 ' HA ' ' O ' ' A' ' 681' ' ' CYS . 82.9 mtp180 -69.66 -35.71 75.4 Favored 'General case' 0 N--CA 1.468 0.444 0 CA-C-O 120.958 0.409 . . . . 0.0 111.194 179.677 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 679' ' ' GLN . . . . . . . . . . . . . 55.1 tt0 -63.93 -37.67 88.26 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.739 -0.664 . . . . 0.0 110.247 179.444 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 680' ' ' ARG . . . . . 0.42 ' HG2' ' O ' ' A' ' 676' ' ' GLN . 88.2 mmt-85 -84.47 -45.18 12.92 Favored 'General case' 0 N--CA 1.461 0.109 0 CA-C-N 116.321 -0.399 . . . . 0.0 110.97 179.749 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 681' ' ' CYS . . . . . 0.485 ' O ' ' HA ' ' A' ' 678' ' ' ARG . 76.8 m -127.99 132.19 49.19 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.408 179.944 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 682' ' ' THR . . . . . . . . . . . . . 69.3 p -67.55 157.5 85.72 Favored Pre-proline 0 C--N 1.322 -0.618 0 CA-C-N 116.49 -0.323 . . . . 0.0 110.233 179.891 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 683' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -59.41 -26.52 82.23 Favored 'Trans proline' 0 C--N 1.348 0.507 0 C-N-CA 122.167 1.912 . . . . 0.0 111.918 179.751 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 684' ' ' GLU . . . . . . . . . . . . . 51.9 mp0 -71.75 -38.59 70.39 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.278 0.561 . . . . 0.0 109.977 178.348 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 685' ' ' GLN . . . . . . . . . . . . . 64.9 tt0 -71.61 -41.55 68.76 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-N 115.35 -0.841 . . . . 0.0 111.418 -179.943 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 686' ' ' LEU . . . . . 0.462 ' HA ' ' O ' ' A' ' 657' ' ' ILE . 0.1 OUTLIER -138.92 127.4 23.06 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.727 -178.867 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 687' ' ' LYS . . . . . . . . . . . . . 21.2 mtmm -91.92 146.59 23.62 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.344 0.592 . . . . 0.0 110.661 179.242 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 688' ' ' ILE . . . . . 0.484 HG22 HG12 ' A' ' 700' ' ' VAL . 77.3 mt -122.75 123.56 68.55 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 CA-C-N 115.733 -0.667 . . . . 0.0 111.021 -179.277 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 689' ' ' PHE . . . . . . . . . . . . . 93.3 m-85 -122.75 147.29 46.67 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.409 -0.814 . . . . 0.0 110.408 179.166 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 690' ' ' ILE . . . . . . . . . . . . . 19.7 tt -126.66 140.88 47.66 Favored 'Isoleucine or valine' 0 C--O 1.235 0.326 0 CA-C-O 121.332 0.587 . . . . 0.0 111.965 -179.481 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 691' ' ' LEU . . . . . 0.541 HD23 ' HB ' ' A' ' 704' ' ' ILE . 77.6 mt -112.42 140.32 47.26 Favored 'General case' 0 C--O 1.234 0.263 0 CA-C-N 115.376 -0.829 . . . . 0.0 109.886 179.498 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 692' ' ' GLY . . . . . 0.474 ' O ' ' HA ' ' A' ' 705' ' ' PRO . . . 179.14 -167.64 37.92 Favored Glycine 0 N--CA 1.446 -0.658 0 C-N-CA 120.84 -0.695 . . . . 0.0 111.818 -179.675 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 693' ' ' SER . . . . . . . . . . . . . 79.9 p -63.24 -37.26 86.55 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.987 0.422 . . . . 0.0 111.019 179.836 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 694' ' ' LYS . . . . . . . . . . . . . 2.6 mmmt -143.35 -47.44 0.3 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.716 179.383 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 695' ' ' GLY . . . . . . . . . . . . . . . 114.78 129.26 4.66 Favored Glycine 0 N--CA 1.451 -0.302 0 N-CA-C 111.461 -0.656 . . . . 0.0 111.461 -179.442 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 696' ' ' ASN . . . . . . . . . . . . . 48.6 p-10 -81.11 -15.88 54.67 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 116.899 0.349 . . . . 0.0 111.822 -179.215 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 697' ' ' TYR . . . . . . . . . . . . . 2.6 t80 48.46 48.49 19.27 Favored 'General case' 0 N--CA 1.467 0.411 0 N-CA-C 112.774 0.657 . . . . 0.0 112.774 179.688 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 698' ' ' GLN . . . . . . . . . . . . . 98.5 mm-40 -111.41 96.96 6.42 Favored 'General case' 0 N--CA 1.454 -0.266 0 O-C-N 122.168 -0.333 . . . . 0.0 110.809 179.634 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 699' ' ' GLY . . . . . 0.734 ' HA3' HG11 ' A' ' 674' ' ' VAL . . . 81.42 14.34 78.67 Favored Glycine 0 CA--C 1.521 0.447 0 C-N-CA 120.49 -0.862 . . . . 0.0 113.837 179.339 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 700' ' ' VAL . . . . . 0.484 HG12 HG22 ' A' ' 688' ' ' ILE . 33.1 m -116.08 151.66 17.84 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 117.378 0.589 . . . . 0.0 110.502 -179.757 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 701' ' ' ASP . . . . . . . . . . . . . 37.4 t70 -70.37 -42.86 71.21 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.483 -0.781 . . . . 0.0 111.891 -179.052 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 702' ' ' ARG . . . . . . . . . . . . . 77.5 mtp85 -145.66 158.47 43.84 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.904 0.383 . . . . 0.0 111.167 -178.795 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 703' ' ' TYR . . . . . . . . . . . . . 50.4 p90 -120.48 136.2 54.83 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 108.918 -0.771 . . . . 0.0 108.918 178.539 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 704' ' ' ILE . . . . . 0.541 ' HB ' HD23 ' A' ' 691' ' ' LEU . 42.5 mt -125.36 98.91 34.35 Favored Pre-proline 0 C--N 1.328 -0.366 0 C-N-CA 120.512 -0.475 . . . . 0.0 111.851 -179.115 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 705' ' ' PRO . . . . . 0.474 ' HA ' ' O ' ' A' ' 692' ' ' GLY . 32.5 Cg_exo -61.59 142.96 96.43 Favored 'Trans proline' 0 C--N 1.345 0.382 0 C-N-CA 123.304 2.669 . . . . 0.0 113.226 179.239 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 706' ' ' LEU . . . . . 0.563 HD23 HG23 ' A' ' 708' ' ' ILE . 87.7 mt -98.35 149.91 36.21 Favored Pre-proline 0 C--N 1.328 -0.359 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.028 178.796 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 707' ' ' PRO . . . . . 0.4 ' C ' ' HA ' ' A' ' 706' ' ' LEU . 60.7 Cg_endo -72.35 139.84 62.71 Favored 'Cis proline' 0 C--N 1.345 0.388 0 C-N-CA 123.112 -1.62 . . . . 0.0 112.866 -0.138 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 708' ' ' ILE . . . . . 0.563 HG23 HD23 ' A' ' 706' ' ' LEU . 4.1 pt -63.67 145.13 13.96 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-N 115.538 -0.755 . . . . 0.0 112.071 178.843 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 709' ' ' HIS . . . . . 0.401 ' HA ' ' HD2' ' A' ' 710' ' ' PRO . 69.9 m80 -103.17 112.34 65.67 Favored Pre-proline 0 C--N 1.321 -0.668 0 N-CA-C 107.771 -1.196 . . . . 0.0 107.771 177.496 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 710' ' ' PRO . . . . . 0.401 ' HD2' ' HA ' ' A' ' 709' ' ' HIS . 20.1 Cg_endo -59.3 -30.18 92.2 Favored 'Trans proline' 0 N--CA 1.474 0.332 0 C-N-CA 122.658 2.238 . . . . 0.0 114.305 -177.31 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 711' ' ' GLU . . . . . . . . . . . . . 51.5 mp0 -66.67 -40.67 88.71 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 112.159 0.429 . . . . 0.0 112.159 -179.249 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 712' ' ' SER . . . . . . . . . . . . . 80.8 p -99.22 -17.91 17.89 Favored 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 112.401 0.519 . . . . 0.0 112.401 -178.701 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 713' ' ' PHE . . . . . . . . . . . . . 91.4 t80 -60.33 -49.08 79.0 Favored 'General case' 0 C--O 1.232 0.167 0 CA-C-O 120.789 0.328 . . . . 0.0 110.66 179.96 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 714' ' ' LEU . . . . . . . . . . . . . 87.9 mt -64.62 -38.45 91.06 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.524 179.311 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 715' ' ' GLN . . . . . . . . . . . . . 97.8 mt-30 -62.93 -42.61 99.86 Favored 'General case' 0 N--CA 1.461 0.096 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.144 179.541 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 716' ' ' GLN . . . . . . . . . . . . . 57.1 mt-30 -65.23 -41.0 94.82 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-N 116.584 -0.28 . . . . 0.0 111.027 179.956 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 717' ' ' VAL . . . . . . . . . . . . . 67.0 t -62.98 -44.78 99.86 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.171 0 N-CA-C 109.83 -0.433 . . . . 0.0 109.83 178.887 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 718' ' ' THR . . . . . . . . . . . . . 90.3 m -62.14 -45.24 94.3 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 115.586 -0.734 . . . . 0.0 110.853 179.472 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 719' ' ' MET . . . . . . . . . . . . . 38.6 mmt -62.05 -43.39 98.94 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 116.722 -0.217 . . . . 0.0 110.719 179.64 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 720' ' ' GLY . . . . . . . . . . . . . . . -63.68 -41.01 99.15 Favored Glycine 0 C--N 1.333 0.378 0 C-N-CA 120.693 -0.765 . . . . 0.0 111.482 178.232 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 721' ' ' LEU . . . . . . . . . . . . . 62.7 tp -63.4 -44.81 93.59 Favored 'General case' 0 CA--C 1.532 0.255 0 CA-C-N 115.329 -0.436 . . . . 0.0 111.137 179.118 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 722' ' ' THR . . . . . . . . . . . . . 71.5 p -69.66 -24.0 63.55 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-N 116.556 -0.293 . . . . 0.0 111.598 179.91 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 723' ' ' SER . . . . . . . . . . . . . 74.3 m -63.83 -39.61 94.64 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.82 0.343 . . . . 0.0 110.258 178.692 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 724' ' ' LEU . . . . . . . . . . . . . 65.1 tp -62.99 -47.08 84.66 Favored 'General case' 0 C--O 1.233 0.237 0 CA-C-N 115.827 -0.624 . . . . 0.0 111.338 179.539 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 725' ' ' ALA . . . . . . . . . . . . . . . -155.25 147.44 23.72 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.926 179.967 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 726' ' ' THR . . . . . . . . . . . . . 70.0 p -70.51 -28.04 64.66 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.594 -179.911 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 727' ' ' SER . . . . . . . . . . . . . 50.2 m 58.26 38.06 26.09 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-N 115.934 -0.575 . . . . 0.0 111.483 -179.938 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 728' ' ' ALA . . . . . . . . . . . . . . . -147.82 153.15 38.8 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.757 -179.989 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 729' ' ' GLN . . . . . . . . . . . . . 98.5 mm-40 . . . . . 0 C--O 1.247 0.961 0 CA-C-O 118.337 -0.84 . . . . 0.0 110.858 179.971 . . . . . . . . 0 0 . 1 stop_ save_